Citrus Sinensis ID: 003287

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830----
Protein Sequence
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Secondary Structure (PSIPRED)
cccccEEEEHHHHHHHHHccccccccccccccccccccEEEccccEEEEEEcccccccccEEEEEEcccccEEEEEEcccccccccccEEEEcccccEEEEEccccEEEEEcccccccccEEEEEEcccEEEEEccccccccccEEEEEccccccccccccEEEEEcccccEEEEEEcccccccccccEEEEEEcccccEEEEEEccEEEEEEEcccccEEEccccccccccccEEEEcccEEEEEEEEccccEEEEEEEcccccEEEEEEEcccccEEEEEEEcccccccccccccccEEccccccccccccccccccccccccccccEEcccccccccccEEEcccccccccccEEEEccccHHHHHHHHccccccccccccccccccccEEEEcccccEEEEcccccccccEEEEcccccccccEEEEEEEEEccccccHHHHHHHHHHHHcccccHHHcccccHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHHccccccEEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHccccccEEEccccccccccccccccccccccccEEEcccccccccccEEEEEcccccHHHHcccccEEccccccHHHHHHHHHcccccccccccccccHHHHHHHHHccccccEEEcccccccccHHHHHHHHHEEEEcccccccccccHHHHHHHHccccccccccccccEEEEEcccccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
cccccEEEEEEEEEEEccHHHHccccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEccccEEEEEEccccccccccEEEEEccccEEEEEEccccEEEEccccccccccEEEEEccccEEEEEccccccccccEEEEEccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEcccccccccEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEccccccccHcccccccEEccccccccccccccccccccccccccccEEcccccccccccEEEEcccccccccccEEcccccHHHHHHHHHHcccEEEEEEEEccccccEEEEEEcccHHHHHccccccccEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHccccEEcccccccccccccccccccccEcHHHHHHHHcccccccccccccccccEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEcccHccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEEccHHccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHccccHHHHcHHHcccccHHHHHHHHHHHHHHHccccccccccHEEEEEEcccccccccccccEEEEEcccccccccccccccccccccEEEEEEEccc
Coil and Loop (DISEMBL)
MGNPPFFFTFSCFVFLLGSLLslatdtitpatligdgeklvsssqifelgffspgkskykYLGIWYKQVPDTVVWVAnrnspivdsnavltignngnlvllnqtdgiiwssnlsrevknpvaqlldtgnlvlrekfssntsegsylwqsfdcpsdtlligmnmgwdlktgreryltswrtaddpspgnftfRLEIRVLPhlciyngsvklsctgpwnglafgadptntsylfrpiveqkEDEIIYRYESYSSRILMMLkinpsgdvQRLIWHEMSTGWqvfftapnnfcqlygycgansvcsvddtancecLKGFKLKLqnnqtwprecvrshssdcitrerfikfddiklpylvdvslnesmnlkECEAEclknctcrayanskvtgggsgclmwfGDLIDIRkitgynngqpiyvrvpdsepdkkLLWIFVILVLpaallpgffIFCRWRRKHKEKETTMESSQDLLKFDIYMSvatrtnepsegdgdakgtrrdsvlpcfsLASVSAATENFSMQcklgeggfgpvykgkllngQEVAVKRLssqsgqglkEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYeympnkslnfflfdpsrthllgwQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASnilldsdmnpkisdfgmarmfcgdelqgntkrvvgtygymspeyaldglfsvksDVFSFGVLLLETLTskrntgvydiesfnLLGHAWnlwkdnrayellspalqHEASYQMLNRYITVALLCVQekaadrptmSKVVSMITnehatlpypkqsafsyarrgekisflpssrvseacsvngvtlslispr
Flexible Loop (DISEMBL)
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSwrtaddpspgnFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFrpiveqkedEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLklqnnqtwprecvrshssdcitrerfikfddiklPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKekettmessqdllKFDIYMSVATrtnepsegdgdakgtrrDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITnehatlpypkqsafSYARRGEKISflpssrvseacsvngvtlslispr
Low Complexity Region (SEG)
MGNPPffftfscfvfLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Disordered region (IsUnstruct)
*****FFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRR**************LLKFDIYMSV*********************VLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK***********EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD*****KVVSMITNEHATLPY*****F*Y********************V**V********
Disordered Region (DISOPRED)
***PPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLS*****PVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEK************FDIYM*********************DSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY***********************VTLSLISPR
Disordered Region (DISEMBL)
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKH*********SQDLLKFDIYMSVATR**************RRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Disordered Region (DISPRO)
**NPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNE************RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR***************CSVNGVTLSLISP*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	834	2.2.26 [Sep-21-2011]
Q9S972	847	Receptor-like serine/thre	yes	no	0.953	0.938	0.453	0.0
O81905	850	Receptor-like serine/thre	no	no	0.955	0.937	0.453	0.0
Q39086	843	Receptor-like serine/thre	no	no	0.952	0.941	0.441	0.0
O81832	783	G-type lectin S-receptor-	no	no	0.894	0.952	0.444	0.0
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.940	0.941	0.421	1e-179
O81906	849	G-type lectin S-receptor-	no	no	0.967	0.950	0.408	1e-177
Q09092	857	Putative serine/threonine	N/A	no	0.972	0.946	0.413	1e-174
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.942	0.930	0.410	1e-173
P0DH86	853	G-type lectin S-receptor-	no	no	0.940	0.919	0.419	1e-171
O81833	815	G-type lectin S-receptor-	no	no	0.923	0.944	0.420	1e-168

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  679 bits (1752), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/832 (45%), Positives = 510/832 (61%), Gaps = 37/832 (4%)

Query: 24  ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSP 82
           AT+++T    I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVANR++P
Sbjct: 32  ATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNP 87

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFSSNT 140
           +  SN  L I +N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN VLR+  S N 
Sbjct: 88  LSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD--SKNN 144

Query: 141 SEGSYLWQSFDCPSDTLLIGMNMGWDLKTGR-ERYLTSWRTADDPSPGNFTFRLEIRVLP 199
               +LWQSFD P+DTLL  M MGWD K+G   R L SW+T DDPS G+F+ +L     P
Sbjct: 145 KPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFP 204

Query: 200 HLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMM 257
              IYN       +GPW G  F + P      Y+     E  + +++Y Y    + I  +
Sbjct: 205 EFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQ-QVVYSYRVNKTNIYSI 263

Query: 258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKL 317
           L ++ +G +QRL W E +  W+  + +P + C  Y  CG    C  + +  C C+KGF+ 
Sbjct: 264 LSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEP 323

Query: 318 KLQNNQTWPRE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECL 373
              N Q   R+    CVR     C  R+ F++   ++LP   + S+++ + LKECE  CL
Sbjct: 324 --MNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381

Query: 374 KNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE-PDKKLLWIF 432
           K C C A+AN+ +  GGSGC++W G L DIR       GQ +YVRV   +  DK++    
Sbjct: 382 KGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYA--KGGQDLYVRVAAGDLEDKRIKSKK 439

Query: 433 VI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMSVATRTNEPSEGD 488
           +I   + +   LL  F IF  W+RK K   T      DL++  D  M+   + +      
Sbjct: 440 IIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT-- 497

Query: 489 GDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS 547
             +K  + D + LP     +++ AT NFS   KLG+GGFG VYKG LL+G+E+AVKRLS 
Sbjct: 498 --SKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555

Query: 548 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 607
            S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  LFD +R+ 
Sbjct: 556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615

Query: 608 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
            L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMAR+F  
Sbjct: 616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675

Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFN 726
           +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y+     N
Sbjct: 676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735

Query: 727 LLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
           LLG  W  WK+ +  E++ P    AL  E     + R I + LLCVQE+A DRP MS V+
Sbjct: 736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795

Query: 783 SMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
            M+ +E   +P PK+  F   R   ++    S++  + C+VN VTLS+I  R
Sbjct: 796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  677 bits (1748), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/841 (45%), Positives = 513/841 (60%), Gaps = 44/841 (5%)

Query: 21  LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANR 79
           +S  T + + +  I     +VS   +FELGFF PG     YLGIWYK +   T VWVANR
Sbjct: 27  ISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANR 86

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNP-VAQLLDTGNLVLREKFS 137
           ++P+  S   L I ++ NLV+L+Q+D  +WS+NL+  +V++P VA+LLD GN VLR+  S
Sbjct: 87  DTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD--S 143

Query: 138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
            N++    LWQSFD P+DTLL  M +GWD KTG  R++ SW++ DDPS G+F+F+LE   
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203

Query: 198 LPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQKEDEIIYRYESYSSRIL 255
            P + ++N   ++  +GPWNG+ F   P      Y+       KE E+ Y +    S + 
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDVY 262

Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGF 315
             L I+ SG +QR  W E +  W  F+ AP + C  Y  CG    C  + +  C C+KGF
Sbjct: 263 SRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGF 322

Query: 316 KLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEA 370
           K +  N Q W        CVR     C   + F++   +KLP     S++  + +KECE 
Sbjct: 323 KPR--NPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQ 380

Query: 371 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE-PDKKLL 429
           +CL++C C A+AN+ + G GSGC+ W G+L DIR       GQ +YVR+  ++  DK+  
Sbjct: 381 KCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYA--KGGQDLYVRLAATDLEDKRNR 438

Query: 430 WIFVI---LVLPAALLPGFFIFCRWRRKHKEK---ETTMESSQ----DLLKFDIYMSVAT 479
              +I   + +   LL  F IF  W+RK K     ET +   Q    DLL  ++ +S  +
Sbjct: 439 SAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVIS--S 496

Query: 480 RTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE 539
           R +   E + D      D  LP      V+ AT NFS   KLG+GGFG VYKGKLL+GQE
Sbjct: 497 RRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE 550

Query: 540 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 599
           +AVKRLS  S QG  EFKNE+ LIA+LQH NLVRL+ CCV+ GEK+LIYEY+ N SL+  
Sbjct: 551 MAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSH 610

Query: 600 LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 659
           LFD SR   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNILLD  M PKISDF
Sbjct: 611 LFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670

Query: 660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV 719
           GMAR+F  DE + NT++VVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++SKRN G 
Sbjct: 671 GMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGF 730

Query: 720 YDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEAS----YQMLNRYITVALLCVQEKAAD 774
           Y+ +   NLLG  W  WK+ +  E++ P +   +S    +++L R I + LLCVQE+A D
Sbjct: 731 YNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAED 789

Query: 775 RPTMSKVVSMITNEHATLPYPKQSAFSYAR-RGEKISFLPSSRVSEACSVNGVTLSLISP 833
           RPTMS V+ M+ +E  T+P PK   +   R   +  S     R  E+ +VN +T+S++  
Sbjct: 790 RPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDA 849

Query: 834 R 834
           R
Sbjct: 850 R 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  663 bits (1711), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/839 (44%), Positives = 501/839 (59%), Gaps = 45/839 (5%)

Query: 21  LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANR 79
           +S  T + T +  I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVANR
Sbjct: 25  VSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANR 84

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFS 137
           ++P+  SN  L I  N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN +LR+   
Sbjct: 85  DNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD--- 140

Query: 138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
              S    LWQSFD P+DTLL  M +GWD KTG  R L SW+T DDPS G F+ +LE   
Sbjct: 141 ---SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSE 197

Query: 198 LPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRIL 255
            P   I +    L  +GPWNG+ F + P      Y+       KE E+ Y Y    + + 
Sbjct: 198 FPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLY 256

Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGF 315
             L +N +G +QRL W E +  W+  + +P + C  Y  CG    C  +   NC C+KGF
Sbjct: 257 SRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGF 316

Query: 316 KLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEA 370
           K    N Q W        C+R     C  R+ F +   +KLP      ++  + LK C+ 
Sbjct: 317 KP--VNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374

Query: 371 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE-PDKKLL 429
            CL++C C A+AN+ +  GGSGC++W  +++D+R       GQ +YVR+  +E  DK++ 
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYA--KGGQDLYVRLAAAELEDKRIK 432

Query: 430 WIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTME------SSQDLLKFDIYMSVATR 480
              +I   + +   LL  F IF  W+RK K   T          SQD L  D+ +S    
Sbjct: 433 NEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGY 492

Query: 481 TNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV 540
           T++  + +                L +++ AT NFS   KLG+GGFG VYKG+LL+G+E+
Sbjct: 493 TSKEKKSEYLELPLL--------ELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544

Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL 600
           AVKRLS  S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  L
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604

Query: 601 FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 660
           FD +R+  L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664

Query: 661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY 720
           MAR+F  +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y
Sbjct: 665 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 724

Query: 721 DI-ESFNLLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADR 775
           +     NLLG  W  WK+    E++ P    +L  +     + R I + LLCVQE+A DR
Sbjct: 725 NSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDR 784

Query: 776 PTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
           P MS V+ M+ +E   +P PK+  F   R   +     S++  + C+VN +TLS+I  R
Sbjct: 785 PVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/834 (44%), Positives = 492/834 (58%), Gaps = 88/834 (10%)

Query: 20  LLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVAN 78
           LL+ ATD +     + DG+ +VS    FE+GFFSPG S+ +YLGIWYK++   TVVWVAN
Sbjct: 19  LLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVAN 78

Query: 79  RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNL-----SREVKNPVAQLLDTGNLVLR 133
           R+SP+ D +  L +  NG+L L N  + IIWSS+         ++NP+ Q+LDTGNLV+R
Sbjct: 79  RDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR 138

Query: 134 EKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRL 193
               ++  +  Y+WQS D P D  L GM  G +  TG  R+LTSWR  DDPS GN+T ++
Sbjct: 139 ----NSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKM 194

Query: 194 EIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKEDEIIYRYESY 250
           +   +P   +   SV +  TGPWNGL F   P    N  Y +  +    E+E+ Y Y+  
Sbjct: 195 DPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVF--TEEEVYYTYKLE 252

Query: 251 SSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCE 310
           +  +L  +++NP+G +QR  W +    W  + +A  + C  Y  CG+   C+++++  C 
Sbjct: 253 NPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACR 312

Query: 311 CLKGFKLKLQNNQT---WPRECVRSHSSDCITRER-FIKFDDIKLPYLVDVSLNESMNLK 366
           CLKGF  K         W   CVR    DC   E  F+K   +KLP       +++M+L 
Sbjct: 313 CLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLN 372

Query: 367 ECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYN-NGQPIYVRVPDSEPD 425
           EC+  CL+NCTC AY+   +  GG GC++WFGDLIDIR+   YN NGQ +YVR+  S   
Sbjct: 373 ECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE---YNENGQDLYVRLASS--- 426

Query: 426 KKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPS 485
                                          E ET    S           V++R  E  
Sbjct: 427 -------------------------------EIETLQRESS---------RVSSRKQE-- 444

Query: 486 EGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRL 545
                      D  LP   L +VS AT  FS   KLG+GGFGPVYKG L  GQEVAVKRL
Sbjct: 445 ---------EEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRL 495

Query: 546 SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR 605
           S  S QG++EFKNE+ LIAKLQHRNLV+++G CV++ E++LIYEY PNKSL+ F+FD  R
Sbjct: 496 SRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKER 555

Query: 606 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 665
              L W  RV+II+GIA+G+LYLH+ SRLRIIHRDLKASN+LLDSDMN KISDFG+AR  
Sbjct: 556 RRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTL 615

Query: 666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-S 724
            GDE + NT RVVGTYGYMSPEY +DG FS+KSDVFSFGVL+LE ++ +RN G  + E  
Sbjct: 616 GGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHK 675

Query: 725 FNLLGHAWNLWKDNRAYELLSPALQHEAS-YQMLNRYITVALLCVQEKAADRPTMSKVVS 783
            NLLGHAW  + +++AYE++  A+    +    + R I + LLCVQ+   DRP MS VV 
Sbjct: 676 LNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVL 735

Query: 784 MITNEHATLPYPKQSAFSYARRGEKISFLPSSRVS---EACSVNGVTLSLISPR 834
           M+++E   L  P+Q  F   R     + L S  VS   E  S N  T+S+I PR
Sbjct: 736 MLSSEMLLLD-PRQPGFFNER-----NLLFSDTVSINLEIPSNNFQTMSVIDPR 783

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  630 bits (1624), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 356/845 (42%), Positives = 495/845 (58%), Gaps = 61/845 (7%)

Query: 23  LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANRNS 81
           ++ DTI     + DGE ++S+ + F  GFFS G S+ +Y+GIWY Q+   T+VWVANR+ 
Sbjct: 17  ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76

Query: 82  PIVDSNAVLTIGNNGNLVLL---NQTDGIIWSSNLSREVKNP--VAQLLDTGNLVLREKF 136
           PI D++ ++   N GNL +    N+T+ +IWS+N+S  +  P  VA L D GNLVL +  
Sbjct: 77  PINDTSGMVKFSNRGNLSVYASDNETE-LIWSTNVSDSMLEPTLVATLSDLGNLVLFDPV 135

Query: 137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
           +     G   W+SFD P+DT L  M +G+  K G +R LTSW++  DP  G+   R+E R
Sbjct: 136 T-----GRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERR 190

Query: 197 VLPHLCIYNGSVKLSCTGPWNGLAFGADPT-NTSYLFRPIVEQKEDEIIYRYESYSSRIL 255
             P L +Y G       G W G  +   P     Y+F       EDE+ + Y    + ++
Sbjct: 191 GFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVI 250

Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSV--DDTANCECLK 313
               +N +G + R  W      W  F++ P   C  Y +CG N  C      T  C CL 
Sbjct: 251 TRTMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLP 310

Query: 314 GFKLKLQNNQTWPRE-CVRSHSSDCITRER---------FIKFDDIKLPYLVDVSLNESM 363
           GF+ K       PR   +R  S  C  ++R         F+K   +K+P   D S++ ++
Sbjct: 311 GFEPKF------PRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNI 364

Query: 364 NLKECEAECLKNCTCRAYANS--KVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
            LKEC+  CLKNC+C AYA++  +   G  GCL W G ++D R  T  N+GQ  Y+RV  
Sbjct: 365 TLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDAR--TYLNSGQDFYIRVDK 422

Query: 422 SE---------PDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD 472
            E           K+ + + +I ++ A +L    +FC  R + K       S+       
Sbjct: 423 EELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSAN------ 476

Query: 473 IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG 532
            +  V    +E    + D     R+  LP F L ++ AAT NFS Q KLG GGFGPVYKG
Sbjct: 477 -FAPVPFDFDESFRFEQDKA---RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKG 532

Query: 533 KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 592
            L N  E+AVKRLS  SGQG++EFKNE+ LI+KLQHRNLVR++GCCVE  EK+L+YEY+P
Sbjct: 533 VLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLP 592

Query: 593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 652
           NKSL++F+F   +   L W  R++I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLDS+M
Sbjct: 593 NKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEM 652

Query: 653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            PKISDFGMAR+F G++++G T RVVGT+GYM+PEYA++G FS+KSDV+SFGVL+LE +T
Sbjct: 653 IPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIIT 712

Query: 713 SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA-SYQMLNRYITVALLCVQEK 771
            K+N+  ++ ES NL+GH W+LW++  A E++   +  E    + + + I + LLCVQE 
Sbjct: 713 GKKNSAFHE-ESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQEN 771

Query: 772 AADRPTMSKVVSMITNEHATLPYPKQSAFSYARR--GEKISFLPSSRVSEACSVNGVTLS 829
           A+DR  MS VV M+ +    LP PK  AF+ ARR  GE  + L   +     SVN VT S
Sbjct: 772 ASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACL---KGQTGISVNDVTFS 828

Query: 830 LISPR 834
            I  R
Sbjct: 829 DIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  624 bits (1609), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 350/857 (40%), Positives = 508/857 (59%), Gaps = 50/857 (5%)

Query: 10  FSCFVFLLGSLLSLATDTITPATLIGDG---EKLVSSSQIFELGFFSPGKSKYKYLGIWY 66
            S F++      S+A +TI     + DG   + LVS  + FELGFFSPG S +++LGIWY
Sbjct: 11  LSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWY 70

Query: 67  KQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREV---KNPVA 122
             + D  VVWVANR +PI D + VL I N+GNLVLL+  +  +WSSN+        N V 
Sbjct: 71  GNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVV 130

Query: 123 QLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTAD 182
            + DTGN VL E     T     +W+SF+ P+DT L  M +  + +TG      SWR+  
Sbjct: 131 SIHDTGNFVLSE-----TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSET 185

Query: 183 DPSPGNFTFRLEIRVLPHLCIYNGS-VKLSCTGPWNGLAFGADPTN---TSYLFRPIVEQ 238
           DPSPGN++  ++    P + ++ G+  +   +G WN   F   P     T+YL+   +  
Sbjct: 186 DPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSS 245

Query: 239 KEDE---IIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYC 295
             DE   + + Y      +L+  K+  +G  + L W+E    W  F + P++ C  Y  C
Sbjct: 246 PPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRC 305

Query: 296 GANSVCSVDDTAN-CECLKGFKLKLQNNQTWPRECVRSHSSDC-----ITRERFIKFDDI 349
           G   +C +  +   C C+ G++     N  W R C R     C     +  + F+    +
Sbjct: 306 GKFGICDMKGSNGICSCIHGYEQVSVGN--WSRGCRRRTPLKCERNISVGEDEFLTLKSV 363

Query: 350 KLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGY 409
           KLP   ++  +  ++ ++C   CL+NC+C AY+      GG GC++W  DL+D+++    
Sbjct: 364 KLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFEA- 417

Query: 410 NNGQPIYVRVPDSE--PDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQD 467
             G  +++R+ DSE   ++K     ++ VL   +L G F    WR K K+  +     ++
Sbjct: 418 -GGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKN 476

Query: 468 LLKFDIYMSVATRTNEPSEG---------DGDAKGTRRDSVLPCFSLASVSAATENFSMQ 518
                + ++  T++ E +           +G A  T   S LP FSL +++ AT +F  +
Sbjct: 477 T-DTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNT---SELPVFSLNAIAIATNDFCKE 532

Query: 519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
            +LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRL+GCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
            E  EK+L+YEYMPNKSL+FFLFD ++  L+ W+ R  IIEGIA+GLLYLH+ SRLRIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 698
           RDLK SN+LLD++MNPKISDFGMAR+F G++ + NT RVVGTYGYMSPEYA++GLFSVKS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712

Query: 699 DVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLN 758
           DV+SFGVLLLE ++ KRNT +   E  +L+G+AW L+   R+ EL+ P ++   S +   
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREAL 772

Query: 759 RYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGE-KISFLPSSRV 817
           R I VA+LCVQ+ AA+RP M+ V+ M+ ++ ATL  P+Q  F+  RR    ++F   S  
Sbjct: 773 RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQ 832

Query: 818 SEACSVNGVTLSLISPR 834
               S N +T +++  R
Sbjct: 833 QYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  614 bits (1583), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 356/861 (41%), Positives = 511/861 (59%), Gaps = 50/861 (5%)

Query: 6   FFFTFSCFVFLLGSLLSLATDTI--TPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLG 63
           F   F   + L+   LS+  +T+  T +  I   + LVS   IFE+GFF    S++ YLG
Sbjct: 15  FLLVFVVMI-LIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTN-SRW-YLG 71

Query: 64  IWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR--EVKNP 120
           +WYK+V D T VWVANR++P+ ++   L I  N NLVLL+ ++  +W +NL+R  E    
Sbjct: 72  MWYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPV 130

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           VA+LL  GN V+R+  SSN     YLWQSFD P+DTLL  M +G++LKTG  R+LTSWR+
Sbjct: 131 VAELLANGNFVMRD--SSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRS 188

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQ 238
           +DDPS GNF+++LE + LP   +   +  +  +GPWNG+ F   P +   SY+    +E 
Sbjct: 189 SDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIEN 248

Query: 239 KEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAP-NNFCQLYGYCGA 297
            E E+ Y +   ++     L +   G  QRL W+     W  F+++P +  C  Y  CG 
Sbjct: 249 NE-EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGP 307

Query: 298 NSVCSVDDTANCECLKGFK---LKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
            + C V+ +  C C++GF    ++  + + W   C+R     C + + F +   +KLP  
Sbjct: 308 YAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLPET 366

Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRK-ITGYNNGQ 413
              +++ S+ +KEC+  C+ +C C A+AN+ +  GGSGC++W   L DIR   T   +GQ
Sbjct: 367 TMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQ 426

Query: 414 PIYVRVPDSEPDKK--LLWIFVILVLPAALLPGFFIFCRWRRKHKEKETT------MESS 465
            +YVR+  ++  KK       + L +  ++L    +FC W+RK K  + +       + +
Sbjct: 427 DLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRN 486

Query: 466 QDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGG 525
           Q+L   ++ +S         E  G+ K    +  LP   + +V  ATENFS   KLG+GG
Sbjct: 487 QNLPMNEMVLS------SKREFSGEYKFEELE--LPLIEMETVVKATENFSSCNKLGQGG 538

Query: 526 FGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 585
           FG VYKG+LL+G+E+AVKRLS  S QG  EF NE+ LIA+LQH NLV+++GCC+E  EK+
Sbjct: 539 FGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKM 598

Query: 586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
           LIYEY+ N SL+ +LF  +R   L W  R  I  G+A+GLLYLHQ SR RIIHRDLK SN
Sbjct: 599 LIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSN 658

Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           ILLD +M PKISDFGMAR+F  DE + NT +VVGTYGYMSPEYA+ G+FS KSDVFSFGV
Sbjct: 659 ILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGV 718

Query: 706 LLLETLTSKRNTGVYDIESFN-LLGHAWNLWKDNRAYELLSPALQHEASY-------QML 757
           ++LE ++ K+N G Y+++  N LL + W+ WK+ RA E++ P +    S        Q +
Sbjct: 719 IVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEV 778

Query: 758 NRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSR- 816
            + I + LLCVQE A  RP MS VV M  +E   +P PK   +   R   ++   PSS  
Sbjct: 779 LKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELD--PSSSW 836

Query: 817 ---VSEACSVNGVTLSLISPR 834
               +E+ +VN  T S+I  R
Sbjct: 837 QCDENESWTVNQYTCSVIDAR 857

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  608 bits (1568), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 349/850 (41%), Positives = 499/850 (58%), Gaps = 64/850 (7%)

Query: 24  ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANRNSP 82
           + +TI  +  + DG+ + S  + F  GFFS G SK +Y+GIWY QV + T+VWVANR+ P
Sbjct: 21  SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGI--IWSSNLSREVKNP--VAQLLDTGNLVLREKFSS 138
           I D++ ++     GNL +    +G   IWS+++   ++ P  VA+L D GNLVL +  + 
Sbjct: 81  INDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVT- 139

Query: 139 NTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVL 198
               G   W+SF+ P++TLL  M  G+  ++G +R +TSWR+  DP  GN T+R+E R  
Sbjct: 140 ----GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGF 195

Query: 199 PHLCIYNGSVKLSCTGPWNGLAFGADPTNTS-YLFRPIVEQKEDEIIYRYESYSSRILMM 257
           P + +Y G      TG W G  +   P  T+ ++F        DE+   Y    + +   
Sbjct: 196 PQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTR 255

Query: 258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTAN--CECLKGF 315
           + +N +G +QR  W+     W  F++AP + C +Y +CG N  C    T    C CL G+
Sbjct: 256 MVLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGY 315

Query: 316 KLKLQNNQTWPRECVRSHSSDCITR----------ERFIKFDDIKLPYLVDVSLNESMNL 365
           + K       PR+     +SD  TR          E F K   +K+P    V+++ ++ L
Sbjct: 316 EPKT------PRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITL 369

Query: 366 KECEAECLKNCTCRAYANS--KVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE 423
           KECE  CLKNC+C AYA++  +   G  GCL W G+++D R  T  ++GQ  Y+RV  SE
Sbjct: 370 KECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTR--TYLSSGQDFYLRVDKSE 427

Query: 424 ----------PDKKLLWIFVILV-LPAALLPGFFIFCRWRRKHKEKETTMESSQDLL--K 470
                       K+L+ I + L+ +   LL  F  + R RR+  +     ++        
Sbjct: 428 LARWNGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSS 487

Query: 471 FDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVY 530
           FD+  S      E            R   LP F L++++ AT NF+ Q KLG GGFGPVY
Sbjct: 488 FDLEDSFILEELEDKS---------RSRELPLFELSTIATATNNFAFQNKLGAGGFGPVY 538

Query: 531 KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 590
           KG L NG E+AVKRLS  SGQG++EFKNE+ LI+KLQHRNLVR++GCCVE  EK+L+YEY
Sbjct: 539 KGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEY 598

Query: 591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 650
           +PNKSL++F+F   +   L W  R+ II GI +G+LYLHQ SRLRIIHRDLKASN+LLD+
Sbjct: 599 LPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDN 658

Query: 651 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLET 710
           +M PKI+DFG+AR+F G++++G+T RVVGTYGYMSPEYA+DG FS+KSDV+SFGVL+LE 
Sbjct: 659 EMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEI 718

Query: 711 LTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ-MLNRYITVALLCVQ 769
           +T KRN+  Y+ ES NL+ H W+ W++  A E++   +  E   +  + + + + LLCVQ
Sbjct: 719 ITGKRNSAFYE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQ 777

Query: 770 EKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR-----GEKISFLPSSRVSEACSVN 824
           E ++DRP MS VV M+ +    LP PK  AF+  RR     G      PS   S   ++N
Sbjct: 778 ENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSS--TIN 835

Query: 825 GVTLSLISPR 834
            VTL+ +  R
Sbjct: 836 DVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  602 bits (1551), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 358/854 (41%), Positives = 507/854 (59%), Gaps = 70/854 (8%)

Query: 21  LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANR 79
           +S+ T + T +  I   + +VS   +FELGFF      + YLGIWYK++   T VWVANR
Sbjct: 30  ISVNTLSATESLTISSNKTIVSPGGVFELGFFRILGDSW-YLGIWYKKISQRTYVWVANR 88

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP-VAQLLDTGNLVLREKFSS 138
           ++P+ +   +L I +N NLV+L+ +D  +WS+NL+  V++  VA+LLD GN VLR    +
Sbjct: 89  DTPLSNPIGILKI-SNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKIN 147

Query: 139 NTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVL 198
            + E  +LWQSFD P+DTLL  M +G D K G  R++TSW+++ DPS G+F F+LE   L
Sbjct: 148 ESDE--FLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGL 205

Query: 199 PHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVE-QKEDEIIYRYE------SYS 251
           P    +   +++  +GPW+GL F             I+E Q+ D+IIY +       +Y+
Sbjct: 206 PEFFGFTSFLEVYRSGPWDGLRFSG-----------ILEMQQWDDIIYNFTENREEVAYT 254

Query: 252 SRI-----LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDT 306
            R+        L IN  G ++  +W      W +F+  P + C LYG CG  + C +  +
Sbjct: 255 FRVTDHNSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTS 314

Query: 307 ANCECLKGFKLKLQNNQTWPR-----ECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
             C C+KGF  +  + Q W        C R     C   +RF +  ++K+P      +++
Sbjct: 315 PTCNCIKGF--QPLSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDK 371

Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
            + LKECE +C  +C C AYANS +  GGSGC++W G+  DIR      +GQ ++VR+  
Sbjct: 372 RIGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAA--DGQDLFVRLAA 429

Query: 422 SEPDKK----LLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTM------ESSQDLLKF 471
           +E  ++       I +I+ +   L+  F I+C W++K K    T       +  Q+L+  
Sbjct: 430 AEFGERRTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQKRARATAAPIGYRDRIQELIIT 489

Query: 472 D-IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVY 530
           + + MS   R     E          D  LP     +V  ATENFS    LG GGFG VY
Sbjct: 490 NGVVMSSGRRLLGEEE----------DLELPLTEFETVVMATENFSDSNILGRGGFGIVY 539

Query: 531 KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 590
           KG+LL+GQE+AVKRLS  S QG  EFKNE+ LIA+LQH NLVRL+ CC+   EKILIYEY
Sbjct: 540 KGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEY 599

Query: 591 MPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           + N SL+  LF+ ++ ++ L WQTR  II GIA+GLLYLHQ SR +IIHRDLKASN+LLD
Sbjct: 600 LENGSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLD 659

Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            +M PKISDFGMAR+F  DE + NT++VVGTYGYMSPEYA++G+FSVKSDVFSFGVL+LE
Sbjct: 660 KNMTPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLE 719

Query: 710 TLTSKRNTGVYDI-ESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLN------RYIT 762
            ++ KRN G ++  +  NLLG+ W  WK+ +  E++   +   +S   L       R I 
Sbjct: 720 IVSGKRNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQ 779

Query: 763 VALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSS--RVSEA 820
           + LLCVQE+A DRP MS VV M+ +E   +P PK+  +   R     +   SS  R SE+
Sbjct: 780 IGLLCVQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSES 839

Query: 821 CSVNGVTLSLISPR 834
            +VN +T+S+I+ R
Sbjct: 840 LTVNQITVSVINAR 853

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  593 bits (1529), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 353/839 (42%), Positives = 496/839 (59%), Gaps = 69/839 (8%)

Query: 21  LSLATDTITPATLIGDGEKLVSSSQIFELGFFS---PGKSKYKYLGIWYKQVPDTVVWVA 77
           ++L  + ITP   + DG+ L S  Q+F+LGFFS     + ++++LG+WY + P  VVWVA
Sbjct: 21  VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PFAVVWVA 79

Query: 78  NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREV-----KNPVAQLLDTGNLVL 132
           NRN+P+  ++  L + + G+L L +     +WSS+ S         NP+ ++  +GNL+ 
Sbjct: 80  NRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI- 138

Query: 133 REKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFR 192
                S+  E + LWQSFD P +T+L GM +G + KT  E  L+SW+T  DPSPG+FT  
Sbjct: 139 -----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLS 193

Query: 193 LEIRVLPHLCIY-NGSVKLSCT-GPWNGLAFGADPT--NTSYLFRPIVEQKEDEIIYRYE 248
           L+ R LP L +  NG    S   G WNGL+F   P     + LF         E+ Y + 
Sbjct: 194 LDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSW- 252

Query: 249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD--DT 306
           +   RI+  L +N +G + R I  + +  W +  TAP + C  Y  CGA +VC ++  +T
Sbjct: 253 TPRHRIVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVCGINSKNT 311

Query: 307 ANCECLKGFKLKLQNNQTWPRE---CVRSHSSDCITRERFIKFDDIKLPYLVDVSLN--- 360
            +C CL+GFK K        R    CV    ++C  ++ F+KF  +KLP   D S +   
Sbjct: 312 PSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLP---DTSWSWYD 368

Query: 361 --ESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVR 418
               M L++C+ +C  NC+C AYAN+ +  GG GCL+WFGDL+D+R+ + +  GQ +Y+R
Sbjct: 369 AKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF--GQDVYIR 426

Query: 419 VPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVA 478
           +                        GF       R+          +  ++   ++    
Sbjct: 427 M------------------------GFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFR 462

Query: 479 TRTNEPSEGDGDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNG 537
            +  +   G+   KG   + + LP F   ++S AT++FS    LG GGFGPVYKGKL +G
Sbjct: 463 KKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDG 522

Query: 538 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           QE+AVKRLS+ SGQG++EFKNE+ LIAKLQHRNLVRL+GCC++  E +LIYEYMPNKSL+
Sbjct: 523 QEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLD 582

Query: 598 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 657
           FF+FD  R+  L W+ R+ II G+A+G+LYLHQ SRLRIIHRDLKA N+LLD+DMNPKIS
Sbjct: 583 FFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKIS 642

Query: 658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT 717
           DFG+A+ F GD+ + +T RVVGTYGYM PEYA+DG FSVKSDVFSFGVL+LE +T K N 
Sbjct: 643 DFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNR 702

Query: 718 GVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEASY-QMLNRYITVALLCVQEKAADR 775
           G    +   NLLGH W +W ++R  E+       E S    + R I VALLCVQ+K  DR
Sbjct: 703 GFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDR 762

Query: 776 PTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
           PTM+ VV M  ++ ++LP+P Q  F   R    IS   S R     S N V+++++  R
Sbjct: 763 PTMASVVLMFGSD-SSLPHPTQPGFFTNRNVPDISSSLSLR-----SQNEVSITMLQGR 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	834
224115098	802	predicted protein [Populus trichocarpa]	0.950	0.988	0.502	0.0
359493711	1081	PREDICTED: G-type lectin S-receptor-like	0.925	0.714	0.489	0.0
224122858	831	predicted protein [Populus trichocarpa]	0.967	0.971	0.486	0.0
255587572	822	S-locus-specific glycoprotein S6 precurs	0.955	0.969	0.478	0.0
147799241	818	hypothetical protein VITISV_027305 [Viti	0.914	0.932	0.482	0.0
359493740	2422	PREDICTED: uncharacterized protein LOC10	0.944	0.325	0.468	0.0
359496546	866	PREDICTED: receptor-like serine/threonin	0.976	0.939	0.466	0.0
224122958	812	predicted protein [Populus trichocarpa]	0.952	0.977	0.454	0.0
255555127	834	S-locus-specific glycoprotein S6 precurs	0.970	0.970	0.456	0.0
302143131	1901	unnamed protein product [Vitis vinifera]	0.924	0.405	0.492	0.0

>gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa]

 Score =  795 bits (2053), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/843 (50%), Positives = 552/843 (65%), Gaps = 50/843 (5%)

Query: 1   MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
           M + PFF  FS         LS + D ITP   + DG+ L+S SQ FELGFFSPG SKY+
Sbjct: 1   MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60

Query: 61  YLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP 120
           Y+GIWYK+ P+TVVWVANRN+P+ D   VLTI N GNLVLL+Q   IIWSSN S  +  P
Sbjct: 61  YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           VAQLLD+GNLV+R+  SS  +E SY WQSFD PSDTLL GM +GW+LKTG+ERYL +WR+
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTE-SYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKE 240
             DPSPG+FT+RL+I  LP L I  GSVK   +GPWNG+ FG  P   + +F PI+ + E
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239

Query: 241 DEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSV 300
           DEI Y Y   ++ +   L +N SG V+RL+ +  ++GW   ++ P + C+ YG CGAN +
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299

Query: 301 CSVDDTANCECLKGFK------LKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
           C    +  CECLKGFK      L +QN     R+C    + DC + E F+K   +KLP L
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQNFYG-SRKCETRLTLDCQSGEGFLKLPGVKLPDL 358

Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGG--SGCLMWFGDLIDIRKITGYNNG 412
           ++  LNESMNLKECEAEC KNC+C A+A + ++GGG  SGCLMWFG+LIDIR+ +G   G
Sbjct: 359 LEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIG 418

Query: 413 QPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD 472
           Q I++RVP SE +                        R  ++ K  +T + +S   L   
Sbjct: 419 QDIHIRVPASELE----------------------MARSSKRKKMLKTALVASMSAL-LG 455

Query: 473 IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG 532
           I++S   R  E  E              P F L +++ AT NF+    +G GGFG VYKG
Sbjct: 456 IFVSGMDRRKEGMEA-------------PLFDLDTIATATNNFAPDSIIGAGGFGSVYKG 502

Query: 533 KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 592
           KLL GQE+AVK+LS  SGQG++EF+NE++LIAKLQHRNLV L+G C+ + E++LIYEYMP
Sbjct: 503 KLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEYMP 562

Query: 593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 652
           NKSL++F+FD  R+ LLGW+ R  II GIA+GLLYLHQ S+L+I+HRDLK SN+LLDS++
Sbjct: 563 NKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDSNL 622

Query: 653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            PKISDFG+AR+   D  +  T+RV+GTYGYM+PEYA+DG FSVKSDVFS GVLLLE ++
Sbjct: 623 IPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLEIIS 682

Query: 713 SKRNTG-VYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEK 771
            K+N G V+     +LLGHAW +W + RA EL+   L+  +    L R I V LLCVQ+ 
Sbjct: 683 GKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDTGLEDTSGKSQLLRCIQVGLLCVQKL 742

Query: 772 AADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLI 831
             DRP MS VV M+ NE A LP PKQ  F +  RG       +SR  ++ S N   ++++
Sbjct: 743 PEDRPVMSTVVFMLANEGAVLPQPKQPGF-FIERGSVSE--ATSRNEDSYSTNEANITIL 799

Query: 832 SPR 834
             R
Sbjct: 800 EAR 802

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera]

 Score =  758 bits (1957), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/824 (48%), Positives = 524/824 (63%), Gaps = 52/824 (6%)

Query: 25   TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
             D+I     I D E LVSS Q FELGFFSPG SK +YLGIWYK  P T VWVANRN+PI 
Sbjct: 296  ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355

Query: 85   DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
            DS  VLTI NNG LVLLNQ+  +IWS NLSR  +NPVAQLL+TGNLVLR+   SN +  S
Sbjct: 356  DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRD--GSNETSKS 413

Query: 145  YLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIY 204
            Y+WQSFD PSDT+L GM +GW+LKTG +R LTSW+++DDPS G+F++  +I VLP+L + 
Sbjct: 414  YIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLG 473

Query: 205  NGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSG 264
             GS K+  +GPWNGL F       + +++ +     DE+   YES +++I+  L +N SG
Sbjct: 474  VGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSG 533

Query: 265  DVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQT 324
             +QRL+  + S+ W   ++ P+  C+ YG+CGAN +C +     CECL GF  K Q  + 
Sbjct: 534  FLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQ--EE 591

Query: 325  W-----PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCR 379
            W        C R    DC   E F+K   +KLP L+D  +   ++L+EC+  CL NC+C 
Sbjct: 592  WDMFNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCT 651

Query: 380  AYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE-------PDKKLLWIF 432
            AYA +   G G GCLMW GDLIDIR++T   + + IY+R+  SE         KKL+ I 
Sbjct: 652  AYAYTNPNGSG-GCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIIL 710

Query: 433  VILVLPAALLPGF-FIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDA 491
            VI      L  G  F F  W+++      TM + Q+                        
Sbjct: 711  VISTFSGILTLGLSFWFRFWKKR------TMGTDQE------------------------ 740

Query: 492  KGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ 551
               + +  LP F L +++ AT NFS   K+G GGFG VYKG L  G  VAVKRLS  S Q
Sbjct: 741  -SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQ 799

Query: 552  GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 611
            G++EFKNE +LIAKLQH+NLVRL+GCC++  E+IL+YEYMPNKSL++F+FD +R  LL W
Sbjct: 800  GVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAW 859

Query: 612  QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
              R +I+ GIA+GLLYLHQ SR +IIHRDLK SNILLD ++NPKISDFG+AR+F  +E++
Sbjct: 860  DKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEME 919

Query: 672  GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV-YDIESFNLLGH 730
              TKR+VGTYGYMSPEY +DG FS+K DVFSFGVLLLE ++ ++N G  +     NLLGH
Sbjct: 920  TRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLGH 979

Query: 731  AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA 790
            AW LW+ NRA EL+   L+       + R I V LLCVQ   ADRP MS V+ M+ NE A
Sbjct: 980  AWLLWEQNRALELMDACLEDSCVASQVLRCIQVGLLCVQNLPADRPAMSSVIFMLGNEGA 1039

Query: 791  TLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
            TLP PK   F +  R    +   S ++ E  S N VT+S++  R
Sbjct: 1040 TLPQPKHPGF-FTERSSVDTDTMSGKI-ELHSENAVTISMLKGR 1081

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa]

 Score =  742 bits (1916), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/851 (48%), Positives = 537/851 (63%), Gaps = 44/851 (5%)

Query: 1   MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
           MG     F  S   FL  S+ S A ++I     + DG+ LVSS   FELGFFSPG S+ +
Sbjct: 8   MGGQTILFLLSIVFFL--SIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNR 65

Query: 61  YLGIWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKN 119
           Y+GIWYK++   TVVWVANRN+P+ DS+ +L   ++GNL  +N T+G IWSSN+SR   N
Sbjct: 66  YMGIWYKKISSFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAIN 125

Query: 120 PVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWR 179
           PVAQLLDTGNLV+R +  ++    ++LWQSFD P D+ L GM  G    TG  RYLTSW+
Sbjct: 126 PVAQLLDTGNLVVRAE--NDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWK 183

Query: 180 TADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGAD---PTNTSYLFRPIV 236
           +  DPS G +T +L+   LP   +  GSV    +GPWNGL F        N  Y F  + 
Sbjct: 184 SPSDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVF 243

Query: 237 EQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCG 296
            Q  +EI Y+Y+  +S +L  + ++P G +QR  W + +  W ++ TA  + C  +  CG
Sbjct: 244 NQ--EEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCG 301

Query: 297 ANSVCSVDDTANCECLKGFKLKLQNNQT---WPRECVRSHSSDCITRERFIKFDDIKLPY 353
           A+ VC+++++  C+CLK F+ K     T   W + CVR    DC   E FIK+  IK+P 
Sbjct: 302 AHGVCNINNSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPD 361

Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYN-NG 412
                 N+++NL+ECE  CLKNC+C AYAN  V  GGSGC++WFGDLIDIR+   YN NG
Sbjct: 362 TRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ---YNENG 418

Query: 413 QPIYVRVPDSEPDK-------KLLWIFVILV-LPAALLPGFFIFCRWRRKHKEKETTMES 464
           Q IY+R+  S  DK       K + I VI V L A  L    +F R+ RK+K+++ T E 
Sbjct: 419 QDIYIRIAASVIDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREG 478

Query: 465 SQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEG 524
           +           V T      E D   +    D  LP F LA+++ AT  FS+  KLG+G
Sbjct: 479 N-----------VVTN----PEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQG 523

Query: 525 GFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 584
           GFGPVYKG L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+L+GCC+E  E+
Sbjct: 524 GFGPVYKGILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEER 583

Query: 585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 644
           +LIYEYMPNKSL+ F+FD  R  LL W  R  II GIA+GLLYLHQ SRLRIIHRDLKAS
Sbjct: 584 MLIYEYMPNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKAS 643

Query: 645 NILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG 704
           NILLD +MNPKISDFGMAR F GDE   NT R+VGTYGYMSPEYA+DGLFSVKSDVFSFG
Sbjct: 644 NILLDYEMNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFG 703

Query: 705 VLLLETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITV 763
           VL+LE ++ ++N G    E   NLLGHAW L K+ R  +L+  ++        + R I V
Sbjct: 704 VLVLEIVSGRKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEV 763

Query: 764 ALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSV 823
           ALLCVQ+   DRP MS VV M++++   LP PK+  F   R     S   S+   E  SV
Sbjct: 764 ALLCVQKSPEDRPKMSIVVLMLSSD-IVLPQPKEPGFFTERDLSNDS--SSTIKHEISSV 820

Query: 824 NGVTLSLISPR 834
           N +T +L+  R
Sbjct: 821 NELTSTLLEAR 831

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  719 bits (1856), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/825 (47%), Positives = 516/825 (62%), Gaps = 28/825 (3%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSPIV 84
           +T+ P   + DGE L+S+   FELGFFS G S+ +YLGIWYK++P  TVVWV NR  P  
Sbjct: 10  ETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVGNREVPSF 69

Query: 85  DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
           D+  VL +   G ++L N T GIIWSSN SR  KNPV QLLD+GNL++++   +N    +
Sbjct: 70  DNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGNGNNPD--N 127

Query: 145 YLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIY 204
            +WQSFD P +TLL  M +GW+L  G  RYLTSW++ DDP+ GNF+  +++R  P L + 
Sbjct: 128 IVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRGFPQLFMK 187

Query: 205 NGSVKLSCTGPWNGLAFGADPT-NTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPS 263
            G      +GPWNGL F   P  N + +F       + EI Y YE  ++ ++  L ++  
Sbjct: 188 KGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRLIVSEK 247

Query: 264 GDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQ 323
           G ++R  W + +  W +FF+ P + C  Y  CGA + C+++    C CL+GF  K   + 
Sbjct: 248 GALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFVPKSPTDW 307

Query: 324 T---WPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRA 380
           +   W   CVR     C T + F K   +KLP      ++ SM+LKECE  CL+NC+C A
Sbjct: 308 SASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCLRNCSCLA 367

Query: 381 YANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE------PDKKLLWIFVI 434
           YANS + G  SGCL+WF  LID+RK T    GQ +Y+R+  SE        K++  I   
Sbjct: 368 YANSDIRG--SGCLLWFDHLIDMRKFT--EGGQDLYIRIAASELAKGKSHGKRVAIIVSC 423

Query: 435 LVLPAALLP-GFFIFCRWRRKH---KEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGD 490
           L++   +   G  ++ R R+++   +     +  S   + F I   +A  T   + GD  
Sbjct: 424 LIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKETYIENYGD-- 481

Query: 491 AKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG 550
             G + D+ L  F L ++  AT NFS   KLGEGGFGPVYKG LL+GQE+AVKRLS  SG
Sbjct: 482 -NGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSETSG 540

Query: 551 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG 610
           QG KEFKNE++LIA+LQHRNLV+L+GCC+   EK+LIYEYMPNKSL+ F+FD  R+ LL 
Sbjct: 541 QGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSMLLD 600

Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           W    +II GIA+GLLYLHQ SRLRIIHRDLKASNILLD DMNPKISDFG+AR F  D+ 
Sbjct: 601 WHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGKDQN 660

Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SFNLLG 729
             NTKRVVGTYGYMSPEYA+DGLFSVKSDVFSFGVL+LE ++ KRN G   ++ S NLLG
Sbjct: 661 AANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLNLLG 720

Query: 730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 789
           HAW LW + RA EL     Q E S   + R I V LLCVQ    DRP MS VV M+ +E 
Sbjct: 721 HAWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAVVVMLGSE- 779

Query: 790 ATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
           ++LP PKQ  F Y  R +      S+      S N ++ +LI PR
Sbjct: 780 SSLPQPKQPGF-YTER-DPFEADSSTSKERVWSRNEISSTLIEPR 822

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera]

 Score =  717 bits (1852), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/819 (48%), Positives = 519/819 (63%), Gaps = 56/819 (6%)

Query: 10  FSCFVFLLGSLLSL-----ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGI 64
           F+  VFL   ++S+     A D+IT    I DGE ++S+   FELGF   G SK +YLGI
Sbjct: 4   FTELVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGI 63

Query: 65  WYKQV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQ 123
           WYK+V P TVVWVANR  P+ DS+  L + + G+LV+LN ++G+IWSSN SR  +NP AQ
Sbjct: 64  WYKKVTPRTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQ 123

Query: 124 LLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADD 183
           LLD+GNLV+  K  +++   ++LWQSFD P DTLL GM  G +  TG +RYL+SW++ DD
Sbjct: 124 LLDSGNLVI--KSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDD 181

Query: 184 PSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT-------NTSYLFRPIV 236
           PS G+FT+ L+    P L + +GS  +  +GPWNG+ F   P        N S++F    
Sbjct: 182 PSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVF---- 237

Query: 237 EQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCG 296
              E E+ + Y+  +S +L  L +NP+G+VQRLIW   +  W V+ TA  + C  Y  CG
Sbjct: 238 --NEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCG 295

Query: 297 ANSVCSVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRERFIKFDDIKLPY 353
           A S C++  +  C C+KGF  K     +   W   CVR  S DC   + F K+  +KLP 
Sbjct: 296 AYSTCNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPD 355

Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQ 413
             +   NESMNLKEC + C +NC+C AY NS + GGGSGCL+WFGDLIDI++ T   NGQ
Sbjct: 356 TRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFT--ENGQ 413

Query: 414 PIYVRVPDSEPDK-----KLLWIFVILVLPAALLPGFFIFCRW--RRKHKEKETTMESSQ 466
             Y+R+  SE D      K  W+ V  V  A ++    +   +  +++ K K TT  +++
Sbjct: 414 DFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNE 473

Query: 467 DLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGF 526
                         TNE  E          D  LP F L ++  AT NFS   KLGEGGF
Sbjct: 474 -----------GAETNERQE----------DLELPLFXLDTILNATHNFSRNNKLGEGGF 512

Query: 527 GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 586
           GPVYKG L +G+E+AVKRLS +S QGL EFKNE++ I+KLQHRNLV+L+GCC+   EK+L
Sbjct: 513 GPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKML 572

Query: 587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 646
           IYEYMPNKSLNFF+FD  ++ +L W  R  II GIA+GLLYLHQ SRLRIIHRDLKA N+
Sbjct: 573 IYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNV 632

Query: 647 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 706
           LLD++MNP+ISDFGMAR F G+E    TKRVVGTYGYMSPEYA+DG++SVKSDVFSFGVL
Sbjct: 633 LLDNEMNPRISDFGMARSFGGNETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVL 692

Query: 707 LLETLTSKRNTGV-YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVAL 765
            LE ++ KRN G  +     NLLGHAW L+ +    EL+  ++ +  +   + R + V L
Sbjct: 693 XLEIISGKRNRGFNHPDHDLNLLGHAWTLYMEGTPLELIDASVGYTYNQSEVLRALNVGL 752

Query: 766 LCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR 804
           LCVQ    DRP MS VV M+++E A LP PK+  F   R
Sbjct: 753 LCVQRHPDDRPNMSSVVLMLSSEGA-LPQPKEPGFFTER 790

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera]

 Score =  715 bits (1846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/826 (46%), Positives = 517/826 (62%), Gaps = 38/826 (4%)

Query: 10  FSCFVFLLGSL-LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQ 68
           F+  V +   L +S+A DT+T   +I DGE + S+   FELGFFSP  S+ +Y+GIWYK+
Sbjct: 4   FATLVLVFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKK 63

Query: 69  VPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDT 127
           V   TVVWVANR  P+  S+ +L + + G LV+LN T+  IWSSN SR  +NP AQLLD+
Sbjct: 64  VATRTVVWVANRQIPLTASSGILKVTDRGTLVILNGTNTTIWSSNSSRPAQNPNAQLLDS 123

Query: 128 GNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPG 187
           GNLV++    S++   ++LWQSFD P +TLL GM  G +  TG +RYL+SW+T DDPS G
Sbjct: 124 GNLVMKNGNDSDSE--NFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIG 181

Query: 188 NFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKEDEII 244
           NFT+RL+    P L + NGS     +GPWNGL F   P    N+ Y +  I   KE    
Sbjct: 182 NFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKE--TY 239

Query: 245 YRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD 304
           Y +E  +S ++  L ++P G  QR  W + ++ W ++ +A  + C  Y  CG   +C ++
Sbjct: 240 YTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWILYSSAQTDDCDSYALCGVYGICEIN 299

Query: 305 DTANCECLKGFKLKLQNN---QTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
            +  CEC+KGF+ K Q+N     W   CVRS    C     F+K+  +KLP   +   NE
Sbjct: 300 RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNE 359

Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
           SMNLKEC + CL NC+C AY NS + GGGSGCL+WFGDLIDIR+ T   NGQ  Y+R+  
Sbjct: 360 SMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYT--ENGQDFYIRMAK 417

Query: 422 SEPDKKLLWIFVILVLPAALLPGFFIFCRW------------RRKHKEKETTMESSQDLL 469
           SE    L   ++ ++    +    +  C +            +RK     T       LL
Sbjct: 418 SELGMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSIVGIILL 477

Query: 470 KFDIYMSVATRTNEPSEGDG-----DAKGT-----RRDSVLPCFSLASVSAATENFSMQC 519
              + + V  +     +G+      + KG        D  LP F L ++  AT+NFS   
Sbjct: 478 SLVLTLYVLRKKRLRRKGNNLYSKHNCKGAEINEREEDLELPLFDLDTILNATDNFSNDN 537

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           KLGEGGFGPVYKG L +G+E+AVKRLS +S QGL EFKNE+  I+KLQHRNLV+L+GCC+
Sbjct: 538 KLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVKLLGCCI 597

Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
              EK+LIYEYMPNKSL+FF+FD  ++ +L W  R  II GIA+GLLYLHQ SRLRIIHR
Sbjct: 598 HGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSRLRIIHR 657

Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DLKA N+LLD++MNP+ISDFGMAR F G+E +  TKRVVGTYGYMSPEYA+DG++S+KSD
Sbjct: 658 DLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGVYSIKSD 717

Query: 700 VFSFGVLLLETLTSKRNTGV-YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLN 758
           VFSFGVL+LE +T KRN G  +   + NLLGHAW L+ + +  EL+  ++    +   + 
Sbjct: 718 VFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLELIDASMGDSCNQSEVL 777

Query: 759 RYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR 804
           R + V LLCVQ    DRP+MS VV M+++E A L  PK+  F   R
Sbjct: 778 RALNVGLLCVQRSPDDRPSMSSVVLMLSSESA-LHQPKEPGFFTER 822

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496546|ref|XP_002270295.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  715 bits (1846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/843 (46%), Positives = 531/843 (62%), Gaps = 29/843 (3%)

Query: 12  CFVFL-LGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP 70
           CF FL L  ++ ++ DTIT    I +G+ LVS+   FELGFFSPG SK+ Y+GIWYK +P
Sbjct: 33  CFCFLTLFPIIVISGDTITANQSITNGQTLVSAGGDFELGFFSPGDSKW-YVGIWYKNIP 91

Query: 71  -DTVVWVANRNSPIV--DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDT 127
            + VVWVANR++PI+   S +V+ IG+ GN+V++++   + WS+N S  V NPVAQLLDT
Sbjct: 92  KERVVWVANRDNPILTNSSGSVVKIGDRGNIVIMDEDLHVFWSTNESTAV-NPVAQLLDT 150

Query: 128 GNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPG 187
           GNLV+RE   ++    +YLWQSFD  +DTLL GM +GWD KTG  RYLTSW++ +DPS G
Sbjct: 151 GNLVVREDKDADPE--NYLWQSFDYLTDTLLPGMKLGWDQKTGSNRYLTSWKSKEDPSSG 208

Query: 188 NFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADP-TNTSYLFRPIVEQKEDEIIYR 246
           +++F+L+ R  P + I+N   K   +GPWNG+ F   P   +S +F    E  +D   Y 
Sbjct: 209 DYSFKLDPRGFPEIFIWNKQEKKYRSGPWNGVRFSGVPEMKSSSVFTFDFEWNQDGAYYS 268

Query: 247 YESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDT 306
           YE  +  I   L ++ +G +QR  W E    W +++ AP + C  Y  CG   +C  + +
Sbjct: 269 YELTNKSITSRLMVSSAGSLQRYTWIETRQVWNLYWFAPKDQCDDYRECGPYGICDTNSS 328

Query: 307 ANCECLKGFKLKLQNNQTW-----PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
             C+C +GF+ K  N Q W        C R    DC   + F+    +KLP      +++
Sbjct: 329 PVCKCPRGFEPK--NPQAWNLRDGSDGCSRKTEFDCNNGDGFLALKRMKLPETGSSFVDK 386

Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
           SM+LK+CE  C KNC+C  YAN ++T    GC++W  DL+D+R+      GQ +Y+RV  
Sbjct: 387 SMSLKDCEMTCRKNCSCTGYANPEITSD-KGCIIWTTDLLDMREYAEGEGGQDLYIRVAA 445

Query: 422 SE--------PDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDI 473
           SE           K++ +  I V  A LL G  I   W+RK  +       S+  L    
Sbjct: 446 SELGSENGSNKTVKIIKVTCITVGSAVLLLGLGICYLWKRKKMKIIVAHIVSKPGLSERS 505

Query: 474 YMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK 533
           +  +      PS+ D   +    +  LP F   ++  AT NFS   KLG+GGFG VYKG 
Sbjct: 506 HDYILNEAVIPSKRDYTDEVKTDELELPLFDFGTIVLATNNFSDTNKLGQGGFGCVYKGM 565

Query: 534 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 593
           LL G+E+AVKRL+  SGQG++EF NE+ LIA+LQHRNLV+L+GCCVE  EK+LIYEYM N
Sbjct: 566 LLEGEEIAVKRLAKNSGQGIEEFMNEVRLIARLQHRNLVQLLGCCVEMEEKMLIYEYMQN 625

Query: 594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 653
           +SL+  LFD  ++ LL W  R  II G+A+GLLYLHQ SR RIIHRDLKASN+LLD +MN
Sbjct: 626 RSLDSILFDEKKSSLLDWGRRFNIICGVARGLLYLHQDSRFRIIHRDLKASNVLLDGEMN 685

Query: 654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS 713
           PKISDFGMAR+F  D+ + NTKRVVGTYGYMSPEYA+DGLFSVKSDVFSFGVL+LE ++ 
Sbjct: 686 PKISDFGMARIFGRDQTEANTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLVLEIISG 745

Query: 714 KRNTGVYDI-ESFNLLGHAWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEK 771
           K+N G Y + +  NLLGHAW LW++ +  EL+  ++    A Y +L R I V LLCVQE 
Sbjct: 746 KKNRGFYHLNDEHNLLGHAWRLWREGKGLELMDSSVSESCAPYDVL-RCIQVGLLCVQEH 804

Query: 772 AADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLI 831
           A DRP MS VV M+++E ATLP PK   F   R+  +     SS+  E  +VN VT++++
Sbjct: 805 AEDRPVMSSVVLMLSSETATLPLPKNPGFCLGRKLVETD-SSSSKQEETFTVNQVTVTVM 863

Query: 832 SPR 834
             R
Sbjct: 864 DAR 866

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa]

 Score =  709 bits (1830), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/852 (45%), Positives = 517/852 (60%), Gaps = 58/852 (6%)

Query: 1   MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
           MG     F +S F  +L   +S A D +     + DGE LVS+   FELGFF+P  S  +
Sbjct: 1   MGVVDVIFVYSLFFSILK--ISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSR 58

Query: 61  YLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP 120
           YLG+WYK+ P TVVWVANR  PI +    L + + G LVLLN T+ I+WSSN S  V+NP
Sbjct: 59  YLGLWYKKSPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNP 118

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           VAQLLD+GNLV+R+   ++    ++LWQSFD P DTLL GM +G +L TG   +L+SW+ 
Sbjct: 119 VAQLLDSGNLVVRD--GNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKG 176

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVE 237
            ++P+PG FT  ++++  P L +   +  +   G WNG  F   P    +  Y F  +  
Sbjct: 177 KENPAPGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFN 236

Query: 238 QKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGA 297
           +  +E+ +++E  +S +   L + PSG VQ   W   +  W VF TA  + C+ Y  CGA
Sbjct: 237 R--NEVYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGA 294

Query: 298 NSVCSVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
           N+ C  + +  C+CL GF  K     N+Q W   C+R    DC  ++ F  +  +KLP  
Sbjct: 295 NARCDSNSSPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDT 354

Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQP 414
                ++S +L ECE  C++NC+C AYAN    G GSGCL WFGDLID R++     GQ 
Sbjct: 355 SSSWYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLA--EGGQD 412

Query: 415 IYVRVPDSEPD-------KKLLWIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTMES 464
           IY+R+  S+         KK     VI   ++L +++L    +FC  RRKH++     + 
Sbjct: 413 IYIRLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDR 472

Query: 465 SQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEG 524
            ++ ++                             LP   L ++  AT+NFS   KLGEG
Sbjct: 473 KEEEME-----------------------------LPMLDLTTIEHATDNFSSSKKLGEG 503

Query: 525 GFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 584
           GFG VYKG+L+ GQE+AVKRLS  SGQGL EFKNE++LIAKLQHRNLV+L+GCC+ + EK
Sbjct: 504 GFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEK 563

Query: 585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 644
           +LIYEYMPN+SL+ F+FDP+R   L W  R  II+GIA+GLLYLHQ SRLRIIHRD+KAS
Sbjct: 564 MLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKAS 623

Query: 645 NILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG 704
           NILLD+++NPKISDFG+ARMF GD+ + NTKRVVGTYGYMSPEYALDG FSVKSDVFSFG
Sbjct: 624 NILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFG 683

Query: 705 VLLLETLTSKRNTGVY--DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT 762
           VL+LE ++ K+N G    D    NLLGHAW LW +    EL+        +     R I 
Sbjct: 684 VLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEALRCIH 743

Query: 763 VALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACS 822
           VALLCVQ++  DRP MS VV M+ +E+  LP PKQ  F       +     SS   ++ S
Sbjct: 744 VALLCVQQRPEDRPNMSSVVLMLGSENP-LPQPKQPGFFMGSNPPEKD--TSSNKHQSHS 800

Query: 823 VNGVTLSLISPR 834
            N VT++L+  R
Sbjct: 801 ANEVTVTLLQAR 812

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  709 bits (1829), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/847 (45%), Positives = 537/847 (63%), Gaps = 38/847 (4%)

Query: 3   NPPF-FFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKY 61
           NP F FFTF  F        S ++DT+T    + +G+ L+S+ Q FELGFF+PG SK  Y
Sbjct: 11  NPIFLFFTFLSF---YAPRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTPGNSKNWY 67

Query: 62  LGIWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP 120
           +GIWYK + D T VWVANR++P+ +S+ +  I N  ++VL +Q + +IWSSN  +   NP
Sbjct: 68  VGIWYKNISDRTYVWVANRDNPLTNSSGIFKIFNQ-SIVLFDQGNNLIWSSNQIK-ATNP 125

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           V QLLDTG+LVLRE   +N     YLWQSFD P+DTLL  M +GWDL     RYL+SW++
Sbjct: 126 VMQLLDTGDLVLREANVNN----QYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWKS 181

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQ 238
            DDP  G+++F+L+    P + ++N   K+  +GPWNGL F   P      Y+    V  
Sbjct: 182 KDDPGAGDYSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFV-T 240

Query: 239 KEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGAN 298
            + E+ Y +   S+     L +  SG++QR  W      W  F+ AP + C  Y  CG  
Sbjct: 241 NQSEVFYSFHISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGPY 300

Query: 299 SVCSVDDTANCECLKGFKLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPY 353
            +C  + +  C+C++GF+ K  N Q W        CVR     C+  ++F+   +IKLP 
Sbjct: 301 GICDSNASPVCKCMRGFEPK--NLQAWNLRDGSGGCVRKTDLQCMN-DKFLHLKNIKLPE 357

Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQ 413
                ++  ++LK CE  CL+NC+C AYANS ++ GG+GC++WFG+L+D+R+ T    GQ
Sbjct: 358 SSTSFVDRIISLKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQYT-EGGGQ 416

Query: 414 PIYVRVPDSE-PDKKLLWIFVI--LVLPAALLPGFFIFCRWRRK--HKEKETTMESSQDL 468
            +YVR+  S+  D K +   +I   V    LL G      W+R+   KE++   E SQ+L
Sbjct: 417 DLYVRLAASDIGDGKNVAALIIGISVGIGTLLLGLAACFIWKRRSVRKEQKGVQERSQNL 476

Query: 469 LKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGP 528
           L  ++ +S        S+ D   +  + +  LP F   +++ AT+NFS + KLG+GGFG 
Sbjct: 477 LLNEVVIS--------SKRDYSGEKDKDELELPLFDFGTIATATDNFSDENKLGQGGFGC 528

Query: 529 VYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 588
           VYKG+L+ GQ VAVKRLS  S QG++EFKNE+ LIA+LQHRNLVRL+GCC+E  EK+LIY
Sbjct: 529 VYKGRLVEGQVVAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIY 588

Query: 589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 648
           EYM ++SL+  +F+ ++  LL WQ R  I+ GIA+GLLY+HQ SR RIIHRDLKASNILL
Sbjct: 589 EYMEHRSLDSVIFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILL 648

Query: 649 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLL 708
           D + NPKISDFGMAR+F GD+ + +TKRVVGTYGYMSPEYA+DG FSVKSDVFSFGVL+L
Sbjct: 649 DGEWNPKISDFGMARIFGGDQTEASTKRVVGTYGYMSPEYAMDGHFSVKSDVFSFGVLVL 708

Query: 709 ETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLC 767
           E ++  +N G Y   S  NLLGHAW LWK+ +  E+L  ++    S   + R I V LLC
Sbjct: 709 EIVSGNKNRGFYHSNSELNLLGHAWRLWKEEKGLEILDSSVGSSFSPSEVLRCIQVGLLC 768

Query: 768 VQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVT 827
           VQE+A DRPTMS VV M+++E+AT+P+PK   F   R   +     S +  E+ +VN VT
Sbjct: 769 VQERAEDRPTMSSVVLMLSSENATMPHPKTPGFCLGRNPFETD-SSSGKQDESYTVNQVT 827

Query: 828 LSLISPR 834
           ++++  R
Sbjct: 828 VTMLDAR 834

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143131|emb|CBI20426.3| unnamed protein product [Vitis vinifera]

 Score =  708 bits (1827), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/798 (49%), Positives = 523/798 (65%), Gaps = 27/798 (3%)

Query: 54   PGKSKYKYLGIWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSN 112
            PG S+ +YLGIWYK++   TVVWVA+R+ P+ DS+ +L +   G LVLLN+ +  IWSSN
Sbjct: 1114 PGSSENRYLGIWYKKISTGTVVWVADRDVPLNDSSGILKLDERGTLVLLNKANMTIWSSN 1173

Query: 113  LSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRE 172
             SR V++PVAQLLDTGNLV+R +  S+    ++LWQSFD P DT L GM  G +L TG +
Sbjct: 1174 SSRSVQSPVAQLLDTGNLVVRNENDSDPE--NFLWQSFDYPGDTFLPGMKYGKNLITGLD 1231

Query: 173  RYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTS 229
             YLTSW++ DDPS G+FT RL+ R  P + +  GSV    +GPWNGL F   P    N+ 
Sbjct: 1232 SYLTSWKSTDDPSTGDFTNRLDPRGFPQMFLKEGSVVTFRSGPWNGLRFSGMPNLKPNSI 1291

Query: 230  YLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFC 289
            Y F  ++ QKE  I Y YE  +S ++  + ++P+G +Q   W +   GW ++ TA  + C
Sbjct: 1292 YTFHFVLNQKE--IYYTYELINSSVVTRMVLSPNGVLQDYTWIDRRQGWLLYLTAQMDNC 1349

Query: 290  QLYGYCGANSVCSVDDTANCECLKGFKLKLQNN---QTWPRECVRSHSSDCITRERFIKF 346
              Y  CGA   C ++++  C CLKGF  K  N+     W   CVR    +C   + F+K+
Sbjct: 1350 DRYALCGAYGSCDINNSPACGCLKGFVPKHPNDWNVADWSGGCVRRTRLNCQNGDGFLKY 1409

Query: 347  DDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKI 406
              +KLP   D   N +MNLKEC+ +CLKNC C AYANS +  GGSGC++WFG+LIDIR+ 
Sbjct: 1410 PGVKLPDTQDSWFNMTMNLKECKMKCLKNCNCTAYANSDIRNGGSGCVLWFGNLIDIRE- 1468

Query: 407  TGYN-NGQPIYVRVPDSEPD-------KKLLWIFVILV-LPAALLPGFFIFCRWRRKHKE 457
              YN NGQ +YVR+  SE +       KKL+ I VI + L   +L   F+     ++ + 
Sbjct: 1469 --YNENGQDLYVRMAASELEEYESSDQKKLVKIIVIPIGLAGLILLVIFVILHVLKRKRL 1526

Query: 458  KETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSM 517
            K+       +  + + + S+ T  + P E D   +  + D  LP F   +++ AT+NFS 
Sbjct: 1527 KKKAPLGEGNSSQINTFCSLITMGHNP-ERDHTNESEKEDLELPLFDFDTIAEATDNFSR 1585

Query: 518  QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
              KLG+GGFGPVYKG L  GQE+AVKRLS  S QGL EFKNE++ IAKLQHRNLV+L+G 
Sbjct: 1586 SNKLGQGGFGPVYKGMLRGGQEIAVKRLSKNSRQGLDEFKNEVLCIAKLQHRNLVKLLGY 1645

Query: 578  CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
            C++  EK+LIYEYMPNKSLN F+FD +++ LL W  R  II+GIA+GLLYLHQ SRLRII
Sbjct: 1646 CIQYEEKMLIYEYMPNKSLNSFIFDQTQSMLLDWPKRFHIIKGIARGLLYLHQDSRLRII 1705

Query: 638  HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVK 697
            HRDLKASNILLD +MNPKISDFGMAR F  +E + NT RVVGTYGYMSPEYA+DGLFSVK
Sbjct: 1706 HRDLKASNILLDQEMNPKISDFGMARSFEENETEANTTRVVGTYGYMSPEYAVDGLFSVK 1765

Query: 698  SDVFSFGVLLLETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
            SDV+SFGVL+LE ++ KRN G  D +   NLLGHAW L++  R+ EL   ++Q   +   
Sbjct: 1766 SDVYSFGVLVLEIVSGKRNRGFCDPDHHLNLLGHAWRLYRKGRSIELTDASIQQSCNPLE 1825

Query: 757  LNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSR 816
            + + I V LLCVQ+   DRP+MS VV M+ +E A LP P++  F  ARR  + +   SS 
Sbjct: 1826 VLQSIHVGLLCVQQSPDDRPSMSSVVMMLGSEIA-LPQPREPGFFVARRMIEAAD-SSSG 1883

Query: 817  VSEACSVNGVTLSLISPR 834
            + E CSVN +T++ ++ R
Sbjct: 1884 IYEPCSVNDITVTFLAAR 1901

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	834
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.953	0.938	0.453	1.2e-182
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.955	0.937	0.453	1.8e-181
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.431	0.459	0.536	1.9e-179
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.954	0.944	0.444	2.1e-178
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.956	0.939	0.415	2.1e-164
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.919	0.941	0.431	5.7e-162
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.942	0.946	0.405	1.2e-152
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.955	0.946	0.400	4.7e-151
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.392	0.406	0.534	9.5e-150
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.925	0.910	0.418	1.6e-148

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1772 (628.8 bits), Expect = 1.2e-182, P = 1.2e-182
 Identities = 377/832 (45%), Positives = 510/832 (61%)

Query:    24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSP 82
             AT+++T    I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVANR++P
Sbjct:    32 ATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNP 87

Query:    83 IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFSSNT 140
             +  SN  L I +N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN VLR+  S N 
Sbjct:    88 LSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD--SKNN 144

Query:   141 SEGSYLWQSFDCPSDTLLIGMNMGWDLKTGR-ERYLTSWRTADDPSPGNFTFRLEIRVLP 199
                 +LWQSFD P+DTLL  M MGWD K+G   R L SW+T DDPS G+F+ +L     P
Sbjct:   145 KPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFP 204

Query:   200 HLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMM 257
                IYN       +GPW G  F + P      Y+     E  + +++Y Y    + I  +
Sbjct:   205 EFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQ-QVVYSYRVNKTNIYSI 263

Query:   258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKL 317
             L ++ +G +QRL W E +  W+  + +P + C  Y  CG    C  + +  C C+KGF+ 
Sbjct:   264 LSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEP 323

Query:   318 KLQNNQTWPRE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECL 373
                N Q   R+    CVR     C  R+ F++   ++LP   + S+++ + LKECE  CL
Sbjct:   324 --MNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381

Query:   374 KNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE-PDKKLLWIF 432
             K C C A+AN+ +  GGSGC++W G L DIR       GQ +YVRV   +  DK++    
Sbjct:   382 KGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYA--KGGQDLYVRVAAGDLEDKRIKSKK 439

Query:   433 VI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMSVATRTNEPSEGD 488
             +I   + +   LL  F IF  W+RK K   T      DL++  D  M+   + +      
Sbjct:   440 IIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT-- 497

Query:   489 GDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS 547
               +K  + D + LP     +++ AT NFS   KLG+GGFG VYKG LL+G+E+AVKRLS 
Sbjct:   498 --SKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555

Query:   548 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 607
              S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  LFD +R+ 
Sbjct:   556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615

Query:   608 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
              L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMAR+F  
Sbjct:   616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675

Query:   668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SFN 726
             +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y+     N
Sbjct:   676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735

Query:   727 LLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
             LLG  W  WK+ +  E++ P    AL  E     + R I + LLCVQE+A DRP MS V+
Sbjct:   736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795

Query:   783 SMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
              M+ +E   +P PK+  F   R   ++    S++  + C+VN VTLS+I  R
Sbjct:   796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1761 (625.0 bits), Expect = 1.8e-181, P = 1.8e-181
 Identities = 381/841 (45%), Positives = 517/841 (61%)

Query:    22 SLATDTITPAT--LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVAN 78
             S++ +T++ +    I     +VS   +FELGFF PG     YLGIWYK +   T VWVAN
Sbjct:    26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85

Query:    79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNP-VAQLLDTGNLVLREKF 136
             R++P+  S   L I ++ NLV+L+Q+D  +WS+NL+  +V++P VA+LLD GN VLR+  
Sbjct:    86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-- 142

Query:   137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
             S N++    LWQSFD P+DTLL  M +GWD KTG  R++ SW++ DDPS G+F+F+LE  
Sbjct:   143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query:   197 VLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQKEDEIIYRYESYSSRI 254
               P + ++N   ++  +GPWNG+ F   P      Y+       KE E+ Y +    S +
Sbjct:   203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query:   255 LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKG 314
                L I+ SG +QR  W E +  W  F+ AP + C  Y  CG    C  + +  C C+KG
Sbjct:   262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query:   315 FKLKLQNNQTWP-RE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECE 369
             FK +  N Q W  R+    CVR     C   + F++   +KLP     S++  + +KECE
Sbjct:   322 FKPR--NPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECE 379

Query:   370 AECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE-PDKKL 428
              +CL++C C A+AN+ + G GSGC+ W G+L DIR       GQ +YVR+  ++  DK+ 
Sbjct:   380 QKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYA--KGGQDLYVRLAATDLEDKRN 437

Query:   429 LWIFVI---LVLPAALLPGFFIFCRWRRKHKEK---ETTMESSQDLLKFDIYMS---VAT 479
                 +I   + +   LL  F IF  W+RK K     ET +   Q L   D+ M+   +++
Sbjct:   438 RSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQ-LRSRDLLMNEVVISS 496

Query:   480 RTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE 539
             R +   E + D      D  LP      V+ AT NFS   KLG+GGFG VYKGKLL+GQE
Sbjct:   497 RRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE 550

Query:   540 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 599
             +AVKRLS  S QG  EFKNE+ LIA+LQH NLVRL+ CCV+ GEK+LIYEY+ N SL+  
Sbjct:   551 MAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSH 610

Query:   600 LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 659
             LFD SR   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNILLD  M PKISDF
Sbjct:   611 LFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670

Query:   660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV 719
             GMAR+F  DE + NT++VVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++SKRN G 
Sbjct:   671 GMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGF 730

Query:   720 YDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEAS----YQMLNRYITVALLCVQEKAAD 774
             Y+ +   NLLG  W  WK+ +  E++ P +   +S    +++L R I + LLCVQE+A D
Sbjct:   731 YNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAED 789

Query:   775 RPTMSKVVSMITNEHATLPYPKQSAFSYARRG-EKISFLPSSRVSEACSVNGVTLSLISP 833
             RPTMS V+ M+ +E  T+P PK   +   R   +  S     R  E+ +VN +T+S++  
Sbjct:   790 RPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDA 849

Query:   834 R 834
             R
Sbjct:   850 R 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 927 (331.4 bits), Expect = 1.9e-179, Sum P(2) = 1.9e-179
 Identities = 198/369 (53%), Positives = 254/369 (68%)

Query:   472 DIYMSVATRTNEPSEGDGDAKGTRR----DSVLPCFSLASVSAATENFSMQCKLGEGGFG 527
             D+Y+ +A+   E  + +     +R+    D  LP   L +VS AT  FS   KLG+GGFG
Sbjct:   418 DLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477

Query:   528 PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 587
             PVYKG L  GQEVAVKRLS  S QG++EFKNE+ LIAKLQHRNLV+++G CV++ E++LI
Sbjct:   478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537

Query:   588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 647
             YEY PNKSL+ F+FD  R   L W  RV+II+GIA+G+LYLH+ SRLRIIHRDLKASN+L
Sbjct:   538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597

Query:   648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
             LDSDMN KISDFG+AR   GDE + NT RVVGTYGYMSPEY +DG FS+KSDVFSFGVL+
Sbjct:   598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657

Query:   708 LETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEAS-YQMLNRYITVAL 765
             LE ++ +RN G  + E   NLLGHAW  + +++AYE++  A+    +    + R I + L
Sbjct:   658 LEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGL 717

Query:   766 LCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNG 825
             LCVQ+   DRP MS VV M+++E   L  P+Q  F +  R    S   S  + E  S N 
Sbjct:   718 LCVQQDPKDRPNMSVVVLMLSSEMLLLD-PRQPGF-FNERNLLFSDTVSINL-EIPSNNF 774

Query:   826 VTLSLISPR 834
              T+S+I PR
Sbjct:   775 QTMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1732 (614.8 bits), Expect = 2.1e-178, P = 2.1e-178
 Identities = 372/837 (44%), Positives = 509/837 (60%)

Query:    22 SLATDTI--TPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVAN 78
             S++ +T+  T +  I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVAN
Sbjct:    24 SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83

Query:    79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKF 136
             R++P+  SN  L I  N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN +LR+  
Sbjct:    84 RDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD-- 140

Query:   137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
                 S    LWQSFD P+DTLL  M +GWD KTG  R L SW+T DDPS G F+ +LE  
Sbjct:   141 ----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196

Query:   197 VLPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRI 254
               P   I +    L  +GPWNG+ F + P      Y+       KE E+ Y Y    + +
Sbjct:   197 EFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNL 255

Query:   255 LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKG 314
                L +N +G +QRL W E +  W+  + +P + C  Y  CG    C  +   NC C+KG
Sbjct:   256 YSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315

Query:   315 FKLKLQNNQTWP-RE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECE 369
             FK    N Q W  R+    C+R     C  R+ F +   +KLP      ++  + LK C+
Sbjct:   316 FKPV--NEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCK 373

Query:   370 AECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE-PDKKL 428
               CL++C C A+AN+ +  GGSGC++W  +++D+R       GQ +YVR+  +E  DK++
Sbjct:   374 ERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYA--KGGQDLYVRLAAAELEDKRI 431

Query:   429 LWIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMS--VATRTN 482
                 +I   + +   LL  F IF  W+RK K   T    + D ++  D  ++  V +R  
Sbjct:   432 KNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRG 491

Query:   483 EPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAV 542
               S+   + K    +  LP   L +++ AT NFS   KLG+GGFG VYKG+LL+G+E+AV
Sbjct:   492 YTSK---EKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546

Query:   543 KRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD 602
             KRLS  S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  LFD
Sbjct:   547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606

Query:   603 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
              +R+  L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMA
Sbjct:   607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666

Query:   663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI 722
             R+F  +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y+ 
Sbjct:   667 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 726

Query:   723 E-SFNLLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPT 777
                 NLLG  W  WK+    E++ P    +L  +     + R I + LLCVQE+A DRP 
Sbjct:   727 NRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPV 786

Query:   778 MSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
             MS V+ M+ +E   +P PK+  F   R   +     S++  + C+VN +TLS+I  R
Sbjct:   787 MSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1600 (568.3 bits), Expect = 2.1e-164, P = 2.1e-164
 Identities = 350/842 (41%), Positives = 505/842 (59%)

Query:    22 SLATDTITPATLIGDG---EKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVA 77
             S+A +TI     + DG   + LVS  + FELGFFSPG S +++LGIWY  + D  VVWVA
Sbjct:    23 SMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVA 82

Query:    78 NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREV---KNPVAQLLDTGNLVLRE 134
             NR +PI D + VL I N+GNLVLL+  +  +WSSN+        N V  + DTGN VL E
Sbjct:    83 NRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSE 142

Query:   135 KFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLE 194
                  T     +W+SF+ P+DT L  M +  + +TG      SWR+  DPSPGN++  ++
Sbjct:   143 -----TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVD 197

Query:   195 IRVLPHLCIYNGS-VKLSCTGPWNGLAFGADPTN---TSYLFRPIVEQKEDE---IIYRY 247
                 P + ++ G+  +   +G WN   F   P     T+YL+   +    DE   + + Y
Sbjct:   198 PSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTY 257

Query:   248 ESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTA 307
                   +L+  K+  +G  + L W+E    W  F + P++ C  Y  CG   +C +  + 
Sbjct:   258 VPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSN 317

Query:   308 N-CECLKGFKLKLQNNQTWPRECVRSHSSDC-----ITRERFIKFDDIKLPYLVDVSLNE 361
               C C+ G++     N  W R C R     C     +  + F+    +KLP   ++  + 
Sbjct:   318 GICSCIHGYEQVSVGN--WSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDF-EIPEHN 374

Query:   362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
              ++ ++C   CL+NC+C AY  S V  GG GC++W  DL+D+++      G  +++R+ D
Sbjct:   375 LVDPEDCRERCLRNCSCNAY--SLV--GGIGCMIWNQDLVDLQQFEA--GGSSLHIRLAD 428

Query:   422 SE--PDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVAT 479
             SE   ++K     ++ VL   +L G F    WR K K+  +     ++     + ++  T
Sbjct:   429 SEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNT-DTSVVVADLT 487

Query:   480 RTNEPSE---GDGDA--KGTR-RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK 533
             ++ E +    G  D   +G     S LP FSL +++ AT +F  + +LG GGFGPVYKG 
Sbjct:   488 KSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGV 547

Query:   534 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 593
             L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRL+GCC E  EK+L+YEYMPN
Sbjct:   548 LEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPN 607

Query:   594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 653
             KSL+FFLFD ++  L+ W+ R  IIEGIA+GLLYLH+ SRLRIIHRDLK SN+LLD++MN
Sbjct:   608 KSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMN 667

Query:   654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS 713
             PKISDFGMAR+F G++ + NT RVVGTYGYMSPEYA++GLFSVKSDV+SFGVLLLE ++ 
Sbjct:   668 PKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSG 727

Query:   714 KRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAA 773
             KRNT +   E  +L+G+AW L+   R+ EL+ P ++   S +   R I VA+LCVQ+ AA
Sbjct:   728 KRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAA 787

Query:   774 DRPTMSKVVSMITNEHATLPYPKQSAFSYARRGE-KISFLPSSRVSEACSVNGVTLSLIS 832
             +RP M+ V+ M+ ++ ATL  P+Q  F+  RR    ++F   S      S N +T +++ 
Sbjct:   788 ERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVL 847

Query:   833 PR 834
              R
Sbjct:   848 GR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1577 (560.2 bits), Expect = 5.7e-162, P = 5.7e-162
 Identities = 361/837 (43%), Positives = 504/837 (60%)

Query:    16 LLGSLLSLATD--TITPATLIGDGEKLVSSSQIFELGFFSPGKSK---YKYLGIWYKQVP 70
             L+ S LS+A D   ITP   + DG+ L S  Q+F+LGFFS  + +   +++LG+WY + P
Sbjct:    14 LISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-P 72

Query:    71 DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSN-----LSREVKNPVAQLL 125
               VVWVANRN+P+  ++  L + + G+L L +     +WSS+      S+   NP+ ++ 
Sbjct:    73 FAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKIS 132

Query:   126 DTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS 185
              +GNL+      S+  E + LWQSFD P +T+L GM +G + KT  E  L+SW+T  DPS
Sbjct:   133 CSGNLI------SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPS 186

Query:   186 PGNFTFRLEIRVLPHLCIY-NGSVKLSCT-GPWNGLAFGADPT--NTSYLFRPIVEQKED 241
             PG+FT  L+ R LP L +  NG    S   G WNGL+F   P     + LF         
Sbjct:   187 PGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQ 246

Query:   242 EIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVC 301
             E+ Y +     RI+  L +N +G + R I  + +  W +  TAP + C  Y  CGA +VC
Sbjct:   247 EVNYSWTP-RHRIVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVC 304

Query:   302 SVD--DTANCECLKGFKLKLQNNQTWPRE---CVRSHSSDCITRERFIKFDDIKLPYL-- 354
              ++  +T +C CL+GFK K        R    CV    ++C  ++ F+KF  +KLP    
Sbjct:   305 GINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSW 364

Query:   355 --VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNG 412
                D   NE M L++C+ +C  NC+C AYAN+ +  GG GCL+WFGDL+D+R+ + +  G
Sbjct:   365 SWYDAK-NE-MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF--G 420

Query:   413 QPIYVRVPDSEPD---KKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLL 469
             Q +Y+R+  ++ +   ++++ + V  V+  A++    +F  +R+K  ++           
Sbjct:   421 QDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVL-VVVFACFRKKIMKR----------- 468

Query:   470 KFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPV 529
                 Y     R     E          D  LP F   ++S AT++FS    LG GGFGPV
Sbjct:   469 ----YRGENFRKGIEEE----------DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPV 514

Query:   530 YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 589
             YKGKL +GQE+AVKRLS+ SGQG++EFKNE+ LIAKLQHRNLVRL+GCC++  E +LIYE
Sbjct:   515 YKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYE 574

Query:   590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
             YMPNKSL+FF+FD  R+  L W+ R+ II G+A+G+LYLHQ SRLRIIHRDLKA N+LLD
Sbjct:   575 YMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLD 634

Query:   650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
             +DMNPKISDFG+A+ F GD+ + +T RVVGTYGYM PEYA+DG FSVKSDVFSFGVL+LE
Sbjct:   635 NDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLE 694

Query:   710 TLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEASY--QMLNRYITVALL 766
              +T K N G    +   NLLGH W +W ++R  E+       E S   ++L R I VALL
Sbjct:   695 IITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVL-RCIHVALL 753

Query:   767 CVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSV 823
             CVQ+K  DRPTM+ VV M  ++ ++LP+P Q  F   R    IS   S R     S+
Sbjct:   754 CVQQKPEDRPTMASVVLMFGSD-SSLPHPTQPGFFTNRNVPDISSSLSLRSQNEVSI 809

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1489 (529.2 bits), Expect = 1.2e-152, P = 1.2e-152
 Identities = 341/841 (40%), Positives = 493/841 (58%)

Query:    21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANR 79
             L LATD IT ++   D E +VS+   F  GFFSP  S  +Y GIW+  +P  TVVWVAN 
Sbjct:    18 LCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANS 77

Query:    80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVK-NPV-AQLLDTGNLVLREKFS 137
             NSPI DS+ +++I   GNLV+++    + WS+N+   V  N   A+LL+TGNLVL    +
Sbjct:    78 NSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLG--T 135

Query:   138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
             +NT +   LW+SF+ P +  L  M++  D KTGR   L SW++  DPSPG ++  L    
Sbjct:   136 TNTGD-EILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLP 194

Query:   198 LPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSY---LFRPIVEQKEDEIIYRYESYSSRI 254
              P L ++   + +  +GPWNG  F   P N  Y   LF   +       +    SY+   
Sbjct:   195 FPELVVWKDDLLMWRSGPWNGQYFIGLP-NMDYRINLFELTLSSDNRGSVSM--SYAGNT 251

Query:   255 LMM-LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD--DTANCEC 311
             L+    ++  G V +  W+     W+ +   P+  C  Y  CG  + C  +   T  C C
Sbjct:   252 LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMC 311

Query:   312 LKGFKLKLQ---NNQTWPRECVRSHSSDCITRER---------FIKFDDIKLPYLVDVSL 359
             ++GFK +     NN  W + CVR     C +R+          F++   +K+P+    S 
Sbjct:   312 IRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRS- 370

Query:   360 NESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRV 419
                 N ++C   CLKNC+C AY+  +    G GCL+W G+L+D+++ +G   G   Y+R+
Sbjct:   371 --GANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSG--TGVVFYIRL 422

Query:   420 PDSEPDKKL---LWIFVILVLPAALLPGFFIFCRWR-RKHKEKETTMESSQDLLKFDIYM 475
              DSE  K+    + I V L++ A L  G  +   W+  KH+EK        + ++     
Sbjct:   423 ADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERME----- 477

Query:   476 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL 535
               A  +N+            +   LP F    ++ AT NFS+  KLG+GGFG VYKG+L 
Sbjct:   478 --ALSSNDVG---AILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQ 532

Query:   536 NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS 595
              G ++AVKRLS  SGQG++EF NE+++I+KLQHRNLVRL+G C+E  E++L+YE+MP   
Sbjct:   533 EGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENC 592

Query:   596 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 655
             L+ +LFDP +  LL W+TR  II+GI +GL+YLH+ SRL+IIHRDLKASNILLD ++NPK
Sbjct:   593 LDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPK 652

Query:   656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 715
             ISDFG+AR+F G+E + +T RVVGTYGYM+PEYA+ GLFS KSDVFS GV+LLE ++ +R
Sbjct:   653 ISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRR 712

Query:   716 NTGVY-DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD 774
             N+  Y D ++ NL  +AW LW       L+ P +  E     + R + V LLCVQ+ A D
Sbjct:   713 NSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHAND 772

Query:   775 RPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEA-CSVNGVTLSLISP 833
             RP+++ V+ M+++E++ LP PKQ AF   RRG   S + SS  S+   S+N V+L+ I+ 
Sbjct:   773 RPSVATVIWMLSSENSNLPEPKQPAF-IPRRGT--SEVESSGQSDPRASINNVSLTKITG 829

Query:   834 R 834
             R
Sbjct:   830 R 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1474 (523.9 bits), Expect = 4.7e-151, P = 4.7e-151
 Identities = 338/844 (40%), Positives = 484/844 (57%)

Query:    17 LGSLLSLAT-DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQV-PDTVV 74
             L S +S +T ++ T    I +G+ L+S  + FELGFF+P  S  +Y+GIWYK + P TVV
Sbjct:    20 LCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVV 79

Query:    75 WVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLRE 134
             WVANR  P++D    L I ++GNLV++N  +  IWS+N+  E  N VA L  TG+LVL  
Sbjct:    80 WVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVL-- 137

Query:   135 KFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLE 194
                S++    + W+SF+ P+DT L GM +  +   G  R    W++  DPSPG ++  ++
Sbjct:   138 --CSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGID 195

Query:   195 IRVLPHLCIYNGSVKLSCTGPWNGLAFGADP-----TNTSYLFRPIVEQKEDEIIY-RYE 248
                   + I+ G  +   +GPWN   F   P     TN  Y F+       D  +Y  Y 
Sbjct:   196 PVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYV 255

Query:   249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD---D 305
             +  S   +   I P G  ++  W++    W +    P+  C+ Y  CG  SVC      D
Sbjct:   256 ASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFD 315

Query:   306 TANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCIT------RERFIKFDDIKLPYLVD 356
             +  C C+ GF+   Q   NN+ +   C R    +C         + F     IK+P    
Sbjct:   316 SGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGS 375

Query:   357 VSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIY 416
             V L+   N + C+  C ++C+C+AYA   V G   GC++W  DLID+        G  I 
Sbjct:   376 VVLHN--NSETCKDVCARDCSCKAYA--LVVG--IGCMIWTRDLIDMEHFE--RGGNSIN 427

Query:   417 VRVPDSE----PDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD 472
             +R+  S+     +   LWI V  V+ A LL G  I+  W+ K K  +  +   +D+   D
Sbjct:   428 IRLAGSKLGGGKENSTLWIIVFSVIGAFLL-GLCIWILWKFK-KSLKAFLWKKKDITVSD 485

Query:   473 IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG 532
             I  +    ++      GD   T  D  LP FS  SV++AT +F+ + KLG+GGFG VYKG
Sbjct:   486 IIENRDYSSSPIKVLVGDQVDTP-D--LPIFSFDSVASATGDFAEENKLGQGGFGTVYKG 542

Query:   533 KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 592
                 G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRL+GCC+E  EK+L+YEYMP
Sbjct:   543 NFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMP 602

Query:   593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 652
             NKSL+ FLFD S+   L W+ R ++I GIA+GLLYLH+ SRL+IIHRDLKASNILLD++M
Sbjct:   603 NKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEM 662

Query:   653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
             NPKISDFGMAR+F   +   NT RVVGTYGYM+PEYA++G+FS KSDV+SFGVL+LE ++
Sbjct:   663 NPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVS 722

Query:   713 SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKA 772
              ++N      +  +L+G+AW+LW   +  E++ P ++         R I V +LC Q+  
Sbjct:   723 GRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSV 782

Query:   773 ADRPTMSKVVSMITNEHATLPYPKQSAF-SYARRGE-KISFLPSSRVSEACSVNGVTLSL 830
               RP M  V+ M+ ++ + LP P+Q  F S+   G+ +++F       +  SVN VT + 
Sbjct:   783 IHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNF----DGHDVASVNDVTFTT 838

Query:   831 ISPR 834
             I  R
Sbjct:   839 IVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 9.5e-150, Sum P(2) = 9.5e-150
 Identities = 180/337 (53%), Positives = 238/337 (70%)

Query:   500 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE 559
             L  F + ++  AT NFS+  KLG+GGFG VYKGKL +G+E+AVKRLSS SGQG +EF NE
Sbjct:   476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535

Query:   560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKII 618
             ++LI+KLQHRNLVR++GCC+E+ EK+LIYE+M NKSL+ FLFD SR  L + W  R  II
Sbjct:   536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFD-SRKRLEIDWPKRFDII 594

Query:   619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             +GIA+GLLYLH  SRLR+IHRDLK SNILLD  MNPKISDFG+ARM+ G E Q NT+RVV
Sbjct:   595 QGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVV 654

Query:   679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV-YDIESFNLLGHAWNLWKD 737
             GT GYMSPEYA  G+FS KSD++SFGVL+LE ++ ++ +   Y +E   L+ +AW  W +
Sbjct:   655 GTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSE 714

Query:   738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQ 797
              R  +LL   L        + R I + LLCVQ + ADRP   ++++M+T   + LP PKQ
Sbjct:   715 YRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTT-SDLPSPKQ 773

Query:   798 SAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
               F++  R ++      S  ++  +VNG+T S+I  R
Sbjct:   774 PTFAFHTRDDE------SLSNDLITVNGMTQSVILGR 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1450 (515.5 bits), Expect = 1.6e-148, P = 1.6e-148
 Identities = 361/862 (41%), Positives = 495/862 (57%)

Query:    25 TDTITPATLIGDGEKLVSSSQ-IFELGFFSPGKSK--YKYLGIWYKQV-PDTVVWVANRN 80
             TDT+     +     LVSS + +FE GFF+P   +   +YLGIWY  + P TVVWVANR 
Sbjct:    25 TDTLRQGESLSGAATLVSSPEGVFEAGFFAPDPKQPSRQYLGIWYHSISPRTVVWVANRV 84

Query:    81 SPIVDSNAVLTIGNNGNLVLLNQT--DG-----IIWSSNLSREVKNP----VAQLLDTGN 129
             +P   ++  LT+   G+L +L+ T  +G     ++WSSN +     P     A L DTG+
Sbjct:    85 APATSASPSLTLTVTGDLRVLDGTAANGTADAPLLWSSNTTSRA-GPRGGYSAVLQDTGS 143

Query:   130 LVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL--KTGRERYL-TSWRTADDPSP 186
             L +R       SE   LW SF  P+DT+L GM +      +  +ER L TSW +  DPSP
Sbjct:   144 LEVR-------SEDGVLWDSFWHPTDTILSGMRITLQAPGRGPKERMLFTSWASETDPSP 196

Query:   187 GNFTFRLEIRVLPHLCIY-NGSVKLSCTGPWNGLAFGADPTNTSYL--FRPIVEQKEDEI 243
             G +   L+        I+ +G+V    +G WNG+ F   P    Y   F P +    D +
Sbjct:   197 GRYALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIGIPWRPLYRSGFTPAI----DPV 252

Query:   244 IYRYESYSSR--ILMMLKINPSG-DVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSV 300
             +  Y +Y++    L    + P+G D+  ++  + S  W++ +  P+N C+ Y  CG N+ 
Sbjct:   253 LGNYYTYTATNTSLQRFVVLPNGTDICYMV-RKSSQDWELVWYQPSNECEYYATCGPNAK 311

Query:   301 C--SVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRER---FIKFDDIKLP 352
             C  S D  A C CLKGF  KLQ   N   W + C+RS    C T +    F+   +IK P
Sbjct:   312 CTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCETNQSGDGFLPMGNIKWP 371

Query:   353 YLVDVSLNESMNLKE--CEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKI-TGY 409
                D S   S    E  C   CL NC+C AY  +  TG    CL W  +LID+ ++ TG 
Sbjct:   372 ---DFSYWVSTVGDEPGCRTVCLNNCSCGAYVYTATTG----CLAWGNELIDMHELQTG- 423

Query:   410 NNGQPIYVRVPDSE-----PDKKLLWIF---VILVLPAALLPGF--------FIFCRWRR 453
                  + +++P SE     P  K+  I    V+ VL A LL  +         +   WR 
Sbjct:   424 --AYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGRNIKDAVHGSWRS 481

Query:   454 KHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATE 513
             +H    ++ +S Q+    DI  S+  R ++  E DG      +   L  +SL  +  AT 
Sbjct:   482 RH----SSTQSQQNSAMLDISQSI--RFDDDVE-DG------KSHELKVYSLDRIRTATS 528

Query:   514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
             NFS   KLGEGGFGPVY G L  G+EVAVKRL   SGQGL+EFKNE++LIAKLQHRNLVR
Sbjct:   529 NFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVR 588

Query:   574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
             L+GCC+ + EKIL+YEYMPNKSL+ FLF+P +  LL W+ R  IIEGIA+GLLYLH+ SR
Sbjct:   589 LLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSR 648

Query:   634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
             LR++HRDLKASNILLD+DM PKISDFGMARMF GD+ Q NT RVVGT+GYMSPEYA++G+
Sbjct:   649 LRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGI 708

Query:   694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEA 752
             FSVKSDV+ FGVL+LE +T KR    +  E S N+ G+AW  W ++ A EL+ P ++   
Sbjct:   709 FSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASC 768

Query:   753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFL 812
             S + + R I +ALLCVQ+ A +RP +  V+ M++N+ ++LP P+        RG +I   
Sbjct:   769 SVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLML--RGREIESS 826

Query:   813 PSSRVSEACSVNGVTLSLISPR 834
              SS    + S+  VT++ +  R
Sbjct:   827 KSSEKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9S972	SD16_ARATH	2, ., 7, ., 1, 1, ., 1	0.4531	0.9532	0.9386	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_XI001046 hypothetical protein (802 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	834
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-55
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-45
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	1e-39
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	2e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-38
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	9e-36
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-31
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-31
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-30
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-29
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-28
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-27
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-26
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-26
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-26
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-25
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-25
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-25
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-22
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-22
pfam08276	66	pfam08276, PAN_2, PAN-like domain	7e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-20
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-18
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	1e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-13
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-08
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	9e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-05
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	7e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  191 bits (488), Expect = 1e-55
 Identities = 95/282 (33%), Positives = 131/282 (46%), Gaps = 38/282 (13%)

Query: 516 SMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHR 569
           ++  KLGEG FG VYKGKL         EVAVK L    S Q ++EF  E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+G C E+    ++ EYM    L  +L        L     +     IA+G+ YL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSP 686
                  IHRDL A N L+  ++  KISDFG++R    D    +  R  G      +M+P
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLGHAWNLWKDNRAYEL 743
           E   +G F+ KSDV+SFGVLL E  T     G      + +  +L +   L    R   L
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLEY---LKNGYR---L 222

Query: 744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
             P       Y        + L C  E   DRPT S++V ++
Sbjct: 223 PQPPNCPPELYD-------LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  191 bits (488), Expect = 1e-55
 Identities = 97/281 (34%), Positives = 137/281 (48%), Gaps = 35/281 (12%)

Query: 516 SMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHR 569
           ++  KLGEG FG VYKG L         EVAVK L    S Q ++EF  E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+G C E+   +++ EYMP   L  +L   +R   L     +     IA+G+ YL 
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSP 686
                  IHRDL A N L+  ++  KISDFG++R    D    +  +V G      +M+P
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173

Query: 687 EYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 744
           E   +G F+ KSDV+SFGVLL E  TL  +   G+ + E    L          + Y L 
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK---------KGYRLP 224

Query: 745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            P       Y+       + L C  E   DRPT S++V ++
Sbjct: 225 KPPNCPPELYK-------LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  183 bits (468), Expect = 1e-52
 Identities = 99/281 (35%), Positives = 137/281 (48%), Gaps = 34/281 (12%)

Query: 520 KLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 574
           KLGEG FG VYKGKL        EVAVK L    S +  K+F  E  ++ KL H N+VRL
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           +G C E+    L+ EYM    L  +L      F       L  +  +     IA+G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTYGYMSPE 687
                 + +HRDL A N L+  D+  KISDFG++R ++  D  +  T   +    +M+PE
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177

Query: 688 YALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
              DG+F+ KSDV+SFGVLL E  TL +    G+ + E    L       K  R   L  
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------KGYR---LPK 228

Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
           P    +  Y+++       L C Q    DRPT S++V  + 
Sbjct: 229 PEYCPDELYELM-------LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (451), Expect = 5e-51
 Identities = 75/193 (38%), Positives = 106/193 (54%), Gaps = 11/193 (5%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 578
           LGEGGFG VY  +    G++VA+K +  +    L E    E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
            ++    L+ EY    SL   L +      L     ++I+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 639 RDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSV 696
           RDLK  NILLDSD    K++DFG++++   D+    T   VGT  YM+PE  L  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSE 173

Query: 697 KSDVFSFGVLLLE 709
           KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (454), Expect = 9e-51
 Identities = 92/283 (32%), Positives = 134/283 (47%), Gaps = 37/283 (13%)

Query: 515 FSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQH 568
             +  KLGEG FG VYKG L         +VAVK L   +  +  +EF  E  ++ KL H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+VRL+G C +     ++ EYMP   L  FL        L  +  +++   IA+G+ YL
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRVVGTYGYMS 685
                   +HRDL A N L+  ++  KISDFG++R    D+    +G  K  +    +M+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLGHAWNLWKDNRAYE 742
           PE   DG F+ KSDV+SFGVLL E  T     G      + +  +L       +D   Y 
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLELL----EDG--YR 222

Query: 743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L  P    +  Y+++       L C      DRPT S++V  +
Sbjct: 223 LPRPENCPDELYELM-------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (421), Expect = 3e-46
 Identities = 76/200 (38%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           KLG G FG VYK K    G+ VAVK L   S+  +  +  + E+ ++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
              ++    L+ EY     L  +L         L      KI   I +GL YLH      
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-F 694
           IIHRDLK  NILLD +   KI+DFG+A+     +   +    VGT  YM+PE  L G  +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 695 SVKSDVFSFGVLLLETLTSK 714
             K DV+S GV+L E LT K
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (416), Expect = 1e-45
 Identities = 69/207 (33%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 572
           + +  KLGEG FG VY  +    G+ VA+K +  +  +  +E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           RL     ++ +  L+ EY     L   L                Q        I   L Y
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      I+HRDLK  NILLD D + K++DFG+AR     E        VGT  YM+PE
Sbjct: 113 LHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPE 166

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S GV+L E LT K
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  142 bits (359), Expect = 1e-39
 Identities = 55/121 (45%), Positives = 74/121 (61%), Gaps = 7/121 (5%)

Query: 33  LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTI 92
            +  G+ LVSS  +FELGFF        Y  I YK    TVVWVANR++P   S+  LT+
Sbjct: 3   PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTL 61

Query: 93  GNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC 152
            ++GNLV+ + +  ++WSSN +R   N V  LLD GNLVL +      S+G++LWQSFD 
Sbjct: 62  QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD------SDGNFLWQSFDY 115

Query: 153 P 153
           P
Sbjct: 116 P 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  140 bits (356), Expect = 2e-39
 Identities = 54/116 (46%), Positives = 70/116 (60%), Gaps = 7/116 (6%)

Query: 70  PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
             TVVWVANR +P+ DS+  L + ++GNLVL +    ++WSSN S +    VA L D GN
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60

Query: 130 LVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS 185
           LVL        + G  LWQSFD P+DTLL G   G ++  G  R LTSW++  DPS
Sbjct: 61  LVLY------DNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 3e-38
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 519 CKLGEGGFGPVYKGKLL-NGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
             LG G FG VY       G+ +AVK   LS  S + L+  + E+ +++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 576 GCCVEQGEK-ILIY-EYMPNKSL-----NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           G   ++ +  + I+ EY+   SL      F             Q        I +GL YL
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------ILEGLAYL 117

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H      I+HRD+K +NIL+DSD   K++DFG A+     E    T  V GT  +M+PE 
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR 715
                +   +D++S G  ++E  T K 
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  130 bits (330), Expect = 9e-36
 Identities = 52/119 (43%), Positives = 73/119 (61%), Gaps = 8/119 (6%)

Query: 33  LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTI 92
            +  G+ LVS + +FELGFF+    +  Y  I YK    TVVWVANR++P V  +  LT+
Sbjct: 3   TLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNP-VSDSCTLTL 60

Query: 93  GNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFD 151
            ++GNLVL +    ++WSSN +    N V  LLD GNLV+ +      S+G++LWQSFD
Sbjct: 61  QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD------SDGNFLWQSFD 113

Length = 114

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  134 bits (340), Expect = 3e-35
 Identities = 77/207 (37%), Positives = 106/207 (51%), Gaps = 14/207 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+ G      +VAVK L   +    + F  E  ++ KL+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64

Query: 573 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           +L   C  + E I I  EYM   SL  FL       L      V +   IA+G+ YL   
Sbjct: 65  QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL---QGNTKRVVGTYGYMSPEY 688
                IHRDL A NIL+  ++  KI+DFG+AR+   DE    +G    +  T    +PE 
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR 715
           A  G F++KSDV+SFG+LL E +T  R
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  134 bits (340), Expect = 4e-35
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 520 KLGEGGFGPVYKGKLLN-----GQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVR 573
           +LGEG FG V   +        G++VAVK L+ S   Q   +F+ E+ ++  L H N+V+
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 574 LMGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
             G C + G +   LI EY+P+ SL  +L        +  +  +     I +G+ YL   
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS- 127

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMSPEYA 689
              R IHRDL A NIL++S+   KISDFG+A++   D+             + Y +PE  
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 690 LDGLFSVKSDVFSFGVLLLETLT 712
               FS  SDV+SFGV L E  T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 1e-34
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 11/204 (5%)

Query: 514 NFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G G FG VYKG  L  G  VA+K++S +    + LK    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+ +G         +I EY  N SL   +    +            +  + QGL YLH+
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                +IHRD+KA+NIL   D   K++DFG+A           +  VVGT  +M+PE   
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172

Query: 691 DGLFSVKSDVFSFGVLLLETLTSK 714
               S  SD++S G  ++E LT  
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  132 bits (333), Expect = 2e-34
 Identities = 84/274 (30%), Positives = 132/274 (48%), Gaps = 38/274 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E F+++ KLG G FG V++G   N   VA+K L S      ++F+ E+  + +L+H++L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDP-----SRTHLL--GWQTRVKIIEGIAQGL 625
            L   C       +I E M   SL  FL  P         L+    Q        +A+G+
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            YL +      IHRDL A NIL+  D+  K++DFG+AR+   D    + K++   Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYEL 743
           PE A  G FS KSDV+SFG+LL E  T  +    G+ + E ++ +            Y +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---------TAGYRM 223

Query: 744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPT 777
             PA   +  Y+++       L C   +  DRP+
Sbjct: 224 PCPAKCPQEIYKIM-------LECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 2e-33
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 9/191 (4%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           K+G+GGFG VYK +    G+EVA+K +  +S +  ++  NE+ ++ K +H N+V+  G  
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
           +++ E  ++ E+    SL   L   S    L       + + + +GL YLH      IIH
Sbjct: 67  LKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 698
           RD+KA+NILL SD   K+ DFG++              +VGT  +M+PE      +  K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 699 DVFSFGVLLLE 709
           D++S G+  +E
Sbjct: 179 DIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  127 bits (322), Expect = 9e-33
 Identities = 71/214 (33%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 521 LGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVR 573
           LGEG FG V+ G+  + +       VAVK L   +    ++ F+ E  L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHLLGWQTRVKIIEGIA 622
             G C E    I+++EYM +  LN FL              S    L     ++I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-- 680
            G++YL   +    +HRDL   N L+  D+  KI DFGM+R    D    +  RV G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 681 --YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
               +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (311), Expect = 2e-31
 Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 50/282 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRN 570
            +      LG+G  G VYK +    G+  A+K++      +  K+   E+  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------IA 622
           +V+  G   ++GE  ++ EYM   SL   L           +   KI E         I 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----------KKVGKIPEPVLAYIARQIL 109

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           +GL YLH   +  IIHRD+K SN+L++S    KI+DFG+++    +         VGT  
Sbjct: 110 KGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVT 165

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE 742
           YMSPE      +S  +D++S G+ LLE        G +                     E
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECA-----LGKFPFLPPGQPSFF----------E 210

Query: 743 LL-------SPALQHEASYQMLNRYITVALLCVQEKAADRPT 777
           L+        P+L  E        +I+    C+Q+    RP+
Sbjct: 211 LMQAICDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (317), Expect = 2e-31
 Identities = 79/301 (26%), Positives = 124/301 (41%), Gaps = 20/301 (6%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-R 569
           ++ +  KLGEG FG VY  +  + + VA+K L+ +     + ++ F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L     ++G   L+ EY+   SL   L    R   L     + I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 630 QYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGD----ELQGNTKRVVGTYGYM 684
                 IIHRD+K  NILLD D    K+ DFG+A++         +       VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 685 SPEYALDGLF---SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 741
           +PE  L       S  SD++S G+ L E LT          ++ +       +       
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIIL-ELPT 232

Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFS 801
             L+  L       +      +    + +   +R + S  +S     H  L     S   
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292

Query: 802 Y 802
            
Sbjct: 293 K 293

Length = 384

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  123 bits (310), Expect = 3e-31
 Identities = 72/210 (34%), Positives = 111/210 (52%), Gaps = 25/210 (11%)

Query: 521 LGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
           LGEG FG VYKG+L   N +     VA+K L  +   +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLF-------------DPSRTHLLGWQTRVKIIEG 620
           L+G C ++    +++EY+ +  L+ FL              D +    L     + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVG 679
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R ++  D  +  +K ++ 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
              +M PE  L G F+ +SD++SFGV+L E
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWE 218

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 4e-31
 Identities = 85/275 (30%), Positives = 119/275 (43%), Gaps = 39/275 (14%)

Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           LG G FG V+ GK     +VA+K +   +     +F  E  ++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 640
           Q    ++ EYM N  L  +L    R   LG +  + +   + + + YL        IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 641 LKASNILLDSDMNPKISDFGMARMFCGDEL--QGNTKRVVGTYGYMSPEYALDGLFSVKS 698
           L A N L+  D   K+SDFG+AR    D+      TK  V    +  PE      FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182

Query: 699 DVFSFGVLLLETLT-------SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
           DV+SFGVL+ E  +          N+ V +  S                Y L  P L   
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS--------------AGYRLYRPKLAPT 228

Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
             Y ++         C  EK  DRP   K++S +T
Sbjct: 229 EVYTIMY-------SCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  122 bits (309), Expect = 6e-31
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 33/203 (16%)

Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           K+GEG  G VYK      G+EVA+K  RL  Q+ + +    NE++++   +H N+V    
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA-------QGLLYL 628
             +   E  ++ EYM   SL         T ++  Q  V++ E  IA       QGL YL
Sbjct: 83  SYLVGDELWVVMEYMDGGSL---------TDII-TQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSP 686
           H      +IHRD+K+ NILL  D + K++DFG    F     +  +KR  VVGT  +M+P
Sbjct: 133 HS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWMAP 185

Query: 687 EYALDGLFSVKSDVFSFGVLLLE 709
           E      +  K D++S G++ +E
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  119 bits (300), Expect = 3e-30
 Identities = 76/266 (28%), Positives = 132/266 (49%), Gaps = 27/266 (10%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG V+ G  L  ++VA+K +  +     ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           E+    L++E+M +  L+ +L   ++      +T + +   + +G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 697 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
           KSDV+SFGVL+ E  +  +    Y+  S     ++  +   N  + L  P L  ++ Y++
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTP--YENRS-----NSEVVETINAGFRLYKPRLASQSVYEL 233

Query: 757 LNRYITVALLCVQEKAADRPTMSKVV 782
           +         C +E+  DRP+ S ++
Sbjct: 234 MQH-------CWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  119 bits (301), Expect = 5e-30
 Identities = 84/299 (28%), Positives = 126/299 (42%), Gaps = 45/299 (15%)

Query: 509 SAATENFSMQCKLGEGGFGPVYKGKL--LNG----QEVAVKRL-SSQSGQGLKEFKNEMM 561
               ++ ++   LG G FG VY+G     +G     +VAVK L  S S Q   +F  E +
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKI 617
           +++K  H+N+VRL+G   E+  + ++ E M    L  FL +    P R   L  +  +  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNT 674
              +A+G  YL +      IHRD+ A N LL         KI+DFGMAR           
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL-------TSKRNTGVYDIESFNL 727
            R +    +M PE  LDG+F+ K+DV+SFGVLL E           + N  V +  +   
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT--- 235

Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
                          L  P       Y+++         C Q    DRP  + ++  I 
Sbjct: 236 -----------GGGRLDPPKGCPGPVYRIMTD-------CWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  118 bits (297), Expect = 1e-29
 Identities = 91/269 (33%), Positives = 129/269 (47%), Gaps = 29/269 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  KLG G FG V+ G      +VA+K L   S    + F  E  L+ +LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  P     L     + +   IA+G+ ++    
Sbjct: 65  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE--- 119

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R   IHRDL+A+NIL+   +  KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 176

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E         NL    R Y +  P  
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ------NL---ERGYRMPRPDN 227

Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPT 777
             E  Y+++         C +EK  +RPT
Sbjct: 228 CPEELYELMRL-------CWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (297), Expect = 1e-29
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           ++G+G FG VY  +   +G+   +K   LS+ S +  ++  NE+ ++ KL H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 577 CCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQ---GLLYLHQY 631
              E+G+  ++ EY     L+  +                 +I++   Q    L YLH  
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF----PEEQILDWFVQLCLALKYLH-- 120

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           SR +I+HRD+K  NI L S+   K+ DFG++++         T  VVGT  Y+SPE   +
Sbjct: 121 SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQN 177

Query: 692 GLFSVKSDVFSFGVLLLETLTSKR 715
             ++ KSD++S G +L E  T K 
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 2e-29
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 35/217 (16%)

Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQH 568
           +    ++GEG +G VYK +    G+ VA+K++  ++    KE        E+ L+ KL+H
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57

Query: 569 RNLVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------ 620
            N+VRL        +G   +++EYM +  L   L  P           VK  E       
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE----------VKFTESQIKCYM 106

Query: 621 --IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             + +GL YLH      I+HRD+K SNIL+++D   K++DFG+AR +        T RV+
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 679 GTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 714
            T  Y  PE  L    +  + D++S G +L E    K
Sbjct: 164 -TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-29
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 22/203 (10%)

Query: 521 LGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG            VA+K L  ++  +  KE  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 575 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLH 629
           +G C+    ++ LI + MP   L  ++ +        +LL W  +      IA+G+ YL 
Sbjct: 75  LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +    R++HRDL A N+L+ +  + KI+DFG+A++   DE + + +       +M+ E  
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 690 LDGLFSVKSDVFSFGVLLLETLT 712
           L  +++ KSDV+S+GV + E +T
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 6e-29
 Identities = 86/281 (30%), Positives = 120/281 (42%), Gaps = 43/281 (15%)

Query: 521 LGEGGFGPVYKGKLL--NGQE--VAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           LG G FG V KG  L  +G+E  VAVK L       G KEF  E  ++A+L H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRT---HLLGWQTRVKIIEGIAQGLLYLHQYS 632
           G C  +   +L+ E  P   L  +L          L     +V      A G+ YL    
Sbjct: 63  GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-- 113

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARM--FCGDELQGNT--KRVVGTYGYMSPEY 688
               +HRDL A N+LL +    KISDFGM+R      D  +  T  +  +  Y   +PE 
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169

Query: 689 ALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 746
              G FS KSDV+S+GV L E  +  +K    +   E   +L              L  P
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES---------GERLPRP 220

Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               +  Y ++         C + +  DRPT S++ S    
Sbjct: 221 EECPQEIYSIMLS-------CWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  116 bits (291), Expect = 8e-29
 Identities = 75/210 (35%), Positives = 108/210 (51%), Gaps = 22/210 (10%)

Query: 521 LGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLV 572
           LG G FG VY+G   +          VAVK L   +  Q  KEF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           +L+G C+    + +I E M    L  +L D         LL  +  + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 629 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTYG 682
            Q   +  IHRDL A N L+     D+D   KI DFG+AR ++  D  +   + ++    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +M+PE  LDG F+ +SDV+SFGVL+ E LT
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 1e-28
 Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G+G FG V  G    GQ+VAVK L   S    + F  E  ++  L+H NLV+L+G  ++
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 640
                ++ EYM   SL  +L    R  ++    ++     + +G+ YL +      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 641 LKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDGLFSVKS 698
           L A N+L+  D+  K+SDFG+A+    +  QG      G     + +PE   +  FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTKS 180

Query: 699 DVFSFGVLLLETLTSKRN 716
           DV+SFG+LL E  +  R 
Sbjct: 181 DVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 4e-28
 Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 32/267 (11%)

Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           +  KLG G FG V++G   N   VAVK L   +    K+F  E  ++ KL+H  L++L  
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 577 CCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
            C    E I I  E M   SL  +L   +   L      + +   +A G+ YL   +   
Sbjct: 69  VCT-LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN--- 123

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDG 692
            IHRDL A N+L+  +   K++DFG+AR+   D  +       G      + +PE AL  
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179

Query: 693 LFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            FS+KSDV+SFG+LL E +T  R    G+ + E          L + ++ Y +  P    
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---------LQQVDQGYRMPCPPGCP 230

Query: 751 EASYQMLNRYITVALLCVQEKAADRPT 777
           +  Y ++       L C +E   DRPT
Sbjct: 231 KELYDIM-------LDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  112 bits (281), Expect = 1e-27
 Identities = 85/273 (31%), Positives = 129/273 (47%), Gaps = 35/273 (12%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYL--HQYSRLR 635
           +Q    ++ EYM N  L  +L    R H   +Q    +++ + + +G+ YL   Q+    
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESKQF---- 121

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDG 692
            IHRDL A N L+D     K+SDFG++R    DE   +    VG+     +  PE  L  
Sbjct: 122 -IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYS 176

Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS KSDV++FGVL+ E  +  +         +    ++  + K ++   L  P L  E 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGK-------MPYERFNNSETVEKVSQGLRLYRPHLASEK 229

Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            Y ++         C  EKA +RPT  +++S I
Sbjct: 230 VYAIMYS-------CWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 1e-27
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 24/265 (9%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 578
           K+G+G FG VYKG L    EVAVK   S     LK  F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
           V++    ++ E +P  SL  FL        L  +  +++    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVVGTYGYMSPEYALDGLFSV 696
           RDL A N L+  +   KISDFGM+R   G    +    K++     + +PE    G ++ 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174

Query: 697 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
           +SDV+S+G+LL ET +            +  + +     +    Y + +P L  E  Y++
Sbjct: 175 ESDVWSYGILLWETFS-------LGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRL 227

Query: 757 LNRYITVALLCVQEKAADRPTMSKV 781
           +         C      +RP+ S++
Sbjct: 228 ML-------QCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (279), Expect = 5e-27
 Identities = 79/205 (38%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 517 MQCKLGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRN 570
               LGEG FG V  Y     N   G+ VAVK L  + GQ     +K E+ ++  L H N
Sbjct: 8   KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 571 LVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           +V+  GCC EQG K   LI EY+P  SL  +L  P   H L     +   + I +G+ YL
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PK--HKLNLAQLLLFAQQICEGMAYL 123

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF-CGDELQGNTKRVVGTYGYMSPE 687
           H       IHRDL A N+LLD+D   KI DFG+A+    G E     +       + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 688 YALDGLFSVKSDVFSFGVLLLETLT 712
              +  FS  SDV+SFGV L E LT
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 85/287 (29%), Positives = 138/287 (48%), Gaps = 42/287 (14%)

Query: 521 LGEGGFGPVYKGKL----LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V +G+L     +  +VAVK  +L   +   ++EF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 575 MGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRTHL----LGWQTRVKIIEGIAQG 624
           +G C E          ++I  +M +  L+ FL   SR       L  QT +K +  IA G
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDEL-QGNTKRVVGTYG 682
           + YL   S    IHRDL A N +L  DM   ++DFG+++ ++ GD   QG   ++     
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVK 180

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRA 740
           +++ E   D +++ KSDV++FGV + E  T  +    GV + E ++ L H       NR 
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG------NR- 233

Query: 741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             L  P    +  Y ++         C +    DRPT +K+  ++ N
Sbjct: 234 --LKQPEDCLDELYDLMYS-------CWRADPKDRPTFTKLREVLEN 271

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  109 bits (274), Expect = 2e-26
 Identities = 83/284 (29%), Positives = 121/284 (42%), Gaps = 38/284 (13%)

Query: 521 LGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVR 573
           LG G FG V+  K    +E      V VK L     +    EF+ E+ +  KL H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           L+G C E     +I EY     L  FL       +  +   L  + +V +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMS 685
           L   S  R +HRDL A N L+ S    K+S   +++     E     N    +    +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---WLA 186

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYEL 743
           PE   +  FS KSDV+SFGVL+ E  T       G+ D E  N L             EL
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------AGKLEL 238

Query: 744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             P       Y+++ R       C      DRP+ S++VS +  
Sbjct: 239 PVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 3e-26
 Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 26/205 (12%)

Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V +G+L L G++   VA+K L + S    + +F  E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 633
           G   +    ++I EYM N SL+ FL    R +         V ++ GIA G+ YL   S 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL----RENDGKFTVGQLVGMLRGIASGMKYL---SE 124

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPE 687
           +  +HRDL A NIL++S++  K+SDFG++R         +++    T G      + +PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPIRWTAPE 178

Query: 688 YALDGLFSVKSDVFSFGVLLLETLT 712
                 F+  SDV+SFG+++ E ++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  109 bits (274), Expect = 3e-26
 Identities = 84/288 (29%), Positives = 128/288 (44%), Gaps = 43/288 (14%)

Query: 520 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRL-SSQSGQGLKEFKNEMM 561
           KLGEG FG V+  +    Q+                 VAVK L    S    ++F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQT 613
           ++++L   N+ RL+G C       +I EYM N  LN FL             +  L + T
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 670
            + +   IA G+ YL     L  +HRDL   N L+  +   KI+DFGM+R ++  D   +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 730
           QG   R      +M+ E  L G F+ KSDV++FGV L E LT  R      +    ++ +
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245

Query: 731 AWNLWKDNRAYELLS-PALQHEASYQMLNRYITVALLCVQEKAADRPT 777
           A + ++D+     L  P    +  Y+++         C +    DRPT
Sbjct: 246 AGHFFRDDGRQIYLPRPPNCPKDIYELMLE-------CWRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 3e-26
 Identities = 71/204 (34%), Positives = 106/204 (51%), Gaps = 19/204 (9%)

Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKR-----LSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+G FG VY    ++ G+E+AVK+      S ++ + +   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 575 MGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQY 631
            GC +   E + I+ EYMP  S+     D  + +  L    TR K    I +G+ YLH  
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTR-KYTRQILEGVEYLH-- 121

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYGYMSPEYAL 690
               I+HRD+K +NIL DS  N K+ DFG ++        G   K V GT  +MSPE   
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 691 DGLFSVKSDVFSFGVLLLETLTSK 714
              +  K+DV+S G  ++E LT K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  108 bits (272), Expect = 4e-26
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 33/210 (15%)

Query: 521 LGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 576 GCCVEQGEK--ILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           G C   G +   L+ EY+P  SL  +L       D  +  L   Q        I +G+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG----- 682
           L      R +HRDL   NIL++S+   KI DFG+ ++   D+        V   G     
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK----EYYKVREPGESPIF 176

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           + +PE   +  FSV SDV+SFGV+L E  T
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 4e-26
 Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 57/300 (19%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLK-EFKNEMMLIAK 565
           E  ++  +LG+G FG VY+G             VA+K ++  +    + EF NE  ++ +
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYM-------------PNKSLNFFLFDPSRTHLLGWQ 612
               ++VRL+G        +++ E M             P    N  L  P+    +   
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQ 671
                   IA G+ YL      + +HRDL A N ++  D+  KI DFGM R ++  D  +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176

Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLG 729
              K ++    +M+PE   DG+F+ KSDV+SFGV+L E  TL  +   G+ + E    + 
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235

Query: 730 HAWNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              +L       ++  EL+                     +C Q     RPT  ++VS +
Sbjct: 236 DGGHLDLPENCPDKLLELMR--------------------MCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  107 bits (270), Expect = 5e-26
 Identities = 89/276 (32%), Positives = 116/276 (42%), Gaps = 32/276 (11%)

Query: 520 KLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
           KLG+G FG V +G+          VAVK L S      + +F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG---WQTRVKIIEGIAQGLLYLHQY 631
            G  V     +++ E  P  SL   L   +  H L        V+I    A G+ YL   
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYMSPEYA 689
              R IHRDL A NILL SD   KI DFG+ R      D         V  + + +PE  
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 749
               FS  SDV+ FGV L E  T       Y  E +  L  +  L K ++  E L    +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERLE---R 222

Query: 750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            EA  Q       V L C     ADRPT + +   +
Sbjct: 223 PEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  107 bits (268), Expect = 7e-26
 Identities = 89/280 (31%), Positives = 141/280 (50%), Gaps = 31/280 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNL 571
           E+  +  KLG+G FG V+ G      +VA+K L  + G  + E F  E  ++ KL+H  L
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V L     E+   I + E+M   SL  FL +    +L   Q  V +   IA G+ Y+   
Sbjct: 64  VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYA 689
            R+  IHRDL+A+NIL+  ++  KI+DFG+AR+   +E    T R    +   + +PE A
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAA 175

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
           L G F++KSDV+SFG+LL E +T  R    G+ + E          L +  R Y +  P 
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---------LEQVERGYRMPCPQ 226

Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
              E+ ++++        LC ++   +RPT   + S + +
Sbjct: 227 GCPESLHELMK-------LCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  107 bits (268), Expect = 1e-25
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 31/216 (14%)

Query: 521 LGEGGFGPVYKGK---LLNGQE---VAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVR 573
           +G+G FG V++ +   LL  +    VAVK L  + S     +F+ E  L+A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------------------LGWQTR 614
           L+G C       L++EYM    LN FL   S                       L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGN 673
           + I + +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R ++  D  + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
               +    +M PE      ++ +SDV+++GV+L E
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWE 224

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  106 bits (265), Expect = 2e-25
 Identities = 85/277 (30%), Positives = 132/277 (47%), Gaps = 28/277 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  +  KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL     ++    +I EYM   SL  FL       +L     +     IA+G+ Y+    
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R   IHRDL+A+N+L+   +  KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 177

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  +    G+ + +  + L          R Y +     
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---------QRGYRMPRMEN 228

Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
             +  Y ++         C +EKA +RPT   + S++
Sbjct: 229 CPDELYDIMK-------TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  106 bits (266), Expect = 2e-25
 Identities = 72/218 (33%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 517 MQCKLGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
           ++ +LGEG FG V+  +   LL  Q+   VAVK L   S    ++F+ E  L+  LQH++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----------------LLGWQTR 614
           +VR  G C E    ++++EYM +  LN FL    R+H                 L     
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFL----RSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           + I   IA G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +     
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            R +    +M PE  L   F+ +SD++SFGV+L E  T
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  106 bits (266), Expect = 2e-25
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 35/295 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL 566
           +  ++   L EG FG ++ G L++      +EV VK +   + +  +     E  L+  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 567 QHRNLVRLMGCCVEQGEK-ILIYEYMPNKSLNFFLFDPS-----RTHLLGWQTRVKIIEG 620
            H+N++ ++  C+E GE   ++Y YM   +L  FL             L  Q  V +   
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDE--LQGNTKRV 677
           IA G+ YLH   +  +IH+D+ A N ++D ++  KI+D  ++R +F  D   L  N  R 
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 737
           V    +M+ E  ++  +S  SDV+SFGVLL E L +   T   +I+ F +        KD
Sbjct: 183 V---KWMALESLVNKEYSSASDVWSFGVLLWE-LMTLGQTPYVEIDPFEM----AAYLKD 234

Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              Y L  P           +    V   C      +RP+ S++V  +T+ HA L
Sbjct: 235 --GYRLAQP-------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (265), Expect = 2e-25
 Identities = 82/267 (30%), Positives = 132/267 (49%), Gaps = 36/267 (13%)

Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLS----SQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VY+G  L +G   AVK +S     Q+GQ  +K+ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 575 MGCCVEQGEKILIY-EYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           +G    + + + I+ E +P  SL   L  +      ++   TR      I  GL YLH  
Sbjct: 68  LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
            R   +HRD+K +NIL+D++   K++DFGMA+           K   G+  +M+PE    
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 692 -GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            G + + +D++S G  +LE  T K      +  +         ++K  R+ EL  P +  
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--------VFKIGRSKEL--PPIPD 225

Query: 751 EASYQMLNRYITVALLCVQEKAADRPT 777
             S +  + +I   L C+Q   + RPT
Sbjct: 226 HLSDEAKD-FI---LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  105 bits (264), Expect = 2e-25
 Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 29/269 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 65  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 119

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E  T  R    G+ + E  + +          R Y +  P  
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPE 227

Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPT 777
             E+ + ++         C +++  +RPT
Sbjct: 228 CPESLHDLM-------CQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  105 bits (264), Expect = 3e-25
 Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 10/198 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E F +  KLGEG +G VYK      GQ VA+K +  +    L+E   E+ ++ +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V+  G   +  +  ++ EY    S++  +   ++T  L  +    I+    +GL YLH  
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHS- 117

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
              + IHRD+KA NILL+ +   K++DFG++        + NT  V+GT  +M+PE   +
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173

Query: 692 GLFSVKSDVFSFGVLLLE 709
             ++ K+D++S G+  +E
Sbjct: 174 IGYNNKADIWSLGITAIE 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  105 bits (265), Expect = 4e-25
 Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 46/295 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +  ++   LGEG FG V K + +          VAVK L    + + L +  +EM ++  
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHL--LGW 611
           + +H+N++ L+G C ++G   ++ EY  + +L  FL            D  R     L  
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDEL 670
           +  V     +A+G+ +L      + IHRDL A N+L+  D   KI+DFG+AR +   D  
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 671 QGNTK-RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 727
           +  T  R+     +M+PE   D +++ +SDV+SFGVLL E  TL      G+   E F L
Sbjct: 189 RKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246

Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
           L            Y +  P    +  Y ++         C  E  + RPT  ++V
Sbjct: 247 L---------KEGYRMEKPQNCTQELYHLMRD-------CWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (262), Expect = 4e-25
 Identities = 65/207 (31%), Positives = 113/207 (54%), Gaps = 15/207 (7%)

Query: 514 NFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 570
           +F +  K+G+G FG V+K  +  + +  A+K+  LS  + +  +E  +E  ++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL---LGWQTRVKIIEGIAQGLLY 627
           ++R     +++G+  ++ EY  N  L+  L       L     W+  ++I+ G+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH     +I+HRD+K+ N+ LD+  N KI D G+A++   +    NT  +VGT  Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
              D  ++ KSDV++ GV+L E  T K
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  105 bits (264), Expect = 6e-25
 Identities = 84/297 (28%), Positives = 141/297 (47%), Gaps = 43/297 (14%)

Query: 520 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 561
           KLGEG FG V+  +    ++                 VAVK L   + +  + +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQT 613
           ++++L+  N++RL+  C+      +I EYM N  LN FL         + +    + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 670
            + +   IA G+ YL   S L  +HRDL   N L+  +   KI+DFGM+R ++ GD   +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 730
           QG   R V    +MS E  L G F+  SDV++FGV L E LT  +      +    ++ +
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245

Query: 731 AWNLWKD-NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
               ++D  R   L  PAL  ++ Y+++       L C +  A +RP+  ++ + + 
Sbjct: 246 TGEFFRDQGRQVYLPKPALCPDSLYKLM-------LSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  104 bits (262), Expect = 6e-25
 Identities = 62/197 (31%), Positives = 91/197 (46%), Gaps = 20/197 (10%)

Query: 520 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLM 575
           +LG G  G V K      G+ +AVK +  +        K  +    ++ K     +V   
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           G     G+  +  EYM   SL+  L          +LG     KI   + +GL YLH   
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           + +IIHRD+K SNIL++S    K+ DFG++            K  VGT  YM+PE     
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGN 174

Query: 693 LFSVKSDVFSFGVLLLE 709
            +SVKSD++S G+ L+E
Sbjct: 175 DYSVKSDIWSLGLSLIE 191

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  104 bits (260), Expect = 9e-25
 Identities = 82/273 (30%), Positives = 121/273 (44%), Gaps = 33/273 (12%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V+ GK     +VA+K ++ +     ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    ++ E+M N  L  +L    R   L     + + + + +G+ YL + S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPEYALDGL 693
           DL A N L+ S    K+SDFGM R    DE          + G      +  PE      
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFSK 177

Query: 694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 753
           +S KSDV+SFGVL+ E  T     G    E  +       + +  R Y    P L     
Sbjct: 178 YSSKSDVWSFGVLMWEVFTE----GKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTV 230

Query: 754 YQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
           Y+       V   C  EK   RPT ++++  IT
Sbjct: 231 YE-------VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (260), Expect = 1e-24
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 516 SMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +M+ KLG G +G VY+G        VAVK L   +   ++EF  E  ++ +++H NLV+L
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C  +    +I E+M   +L  +L + +R   +     + +   I+  + YL + +  
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN-- 124

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL--QGNTKRVVGTYGYMSPEYALDG 692
             IHRDL A N L+  +   K++DFG++R+  GD        K  +    + +PE     
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180

Query: 693 LFSVKSDVFSFGVLLLETLT 712
            FS+KSDV++FGVLL E  T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  105 bits (262), Expect = 1e-24
 Identities = 88/308 (28%), Positives = 145/308 (47%), Gaps = 57/308 (18%)

Query: 520 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 561
           KLGEG FG V+  +++N Q+                 VAVK L   + +  + +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLL------------ 609
           ++++L+  N++RL+G CV++    +I EYM N  LN FL   S  HL             
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 610 -------GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
                   + + + +   IA G+ YL   S L  +HRDL   N L+  ++  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 663 R-MFCGD--ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV 719
           R ++ GD   +QG   R V    +M+ E  L G F+  SDV++FGV L E L   +    
Sbjct: 186 RNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 720 YDIESFNLLGHAWNLWKDN-RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTM 778
            ++    ++ +A   ++D  R   L  P    +  Y+++       L C      +RP+ 
Sbjct: 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM-------LQCWSRDCRERPSF 295

Query: 779 SKVVSMIT 786
           S + + +T
Sbjct: 296 SDIHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (259), Expect = 1e-24
 Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
             E+  +  KLG G FG V+ G      +VAVK L   +    + F  E  ++ KL+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           LV+L     E+   I + EYM   SL  FL D      L     V +   +A G+ Y+  
Sbjct: 63  LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEY 688
             R+  IHRDL+++NIL+   +  KI+DFG+AR+   +E    T R    +   + +PE 
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEA 174

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR 715
           AL G F++KSDV+SFG+LL E +T  R
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 24/202 (11%)

Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNLVRLMG 576
           LG+G FG V   +  + G+  A+K L  +     KE      E  +++++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 577 CCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
              +  EK+ L+ EY P   L   L     F   R      +        I   L YLH 
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE--------IVLALEYLH- 110

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
              L II+RDLK  NILLD+D + K++DFG+A+    +  + NT    GT  Y++PE  L
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166

Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              +    D +S GVLL E LT
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (255), Expect = 4e-24
 Identities = 72/196 (36%), Positives = 105/196 (53%), Gaps = 13/196 (6%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
            +GEG FG V +G+   GQ+VAVK +        + F  E  ++ KL H+NLVRL+G  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
             G  I++ E M   +L  FL    R  L+     ++    +A+G+ YL      +++HR
Sbjct: 70  HNGLYIVM-ELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124

Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DL A NIL+  D   K+SDFG+AR+  G     N+K  V    + +PE      FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKSD 179

Query: 700 VFSFGVLLLETLTSKR 715
           V+S+GVLL E  +  R
Sbjct: 180 VWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (255), Expect = 7e-24
 Identities = 63/229 (27%), Positives = 93/229 (40%), Gaps = 53/229 (23%)

Query: 521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL-QHRNLVR 573
           +GEG F  V   K     +E A+K L  +  Q +KE K      E  ++ +L  H  +++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 574 LMGCCVEQGEKILIYEYMPN----------KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           L     ++     + EY PN           SL+              +        I  
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE-------------KCTRFYAAEILL 113

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------ 677
            L YLH      IIHRDLK  NILLD DM+ KI+DFG A++   +    + K        
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 678 ------------VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
                       VGT  Y+SPE   +      SD+++ G ++ + LT K
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  102 bits (254), Expect = 8e-24
 Identities = 73/216 (33%), Positives = 114/216 (52%), Gaps = 29/216 (13%)

Query: 520 KLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 572
           +LGE  FG VYKG L         Q VA+K L  ++   L+E FK+E M+ ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLF-----------DPSRT--HLLGWQTRVKIIE 619
            L+G   ++    +I+ Y  +  L+ FL            D  +T    L     V I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTKR 676
            IA G+ +L   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+  
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            +    +MSPE  + G FS+ SD++S+GV+L E  +
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  100 bits (250), Expect = 2e-23
 Identities = 80/280 (28%), Positives = 140/280 (50%), Gaps = 43/280 (15%)

Query: 521 LGEGGFGPVYKG--KLLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLM 575
           +G G FG V++G  K+   +EVAV   + + G   K+   F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDP----SRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           G   +    ++I EYM N +L+ +L D     S   L+G      ++ GIA G+ YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL--- 123

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMS 685
           S +  +HRDL A NIL++S++  K+SDFG++R+     L+ + +    T G      + +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTA 178

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+SFG+++ E ++       +D+ +  ++         N  + L +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-YWDMSNHEVMKAI------NDGFRLPA 231

Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+  A RP    +V+++
Sbjct: 232 PMDCPSAVYQLM-------LQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  100 bits (251), Expect = 2e-23
 Identities = 72/220 (32%), Positives = 104/220 (47%), Gaps = 38/220 (17%)

Query: 520 KLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
           +LGEG FG V+  +  N         VAVK L   +    K+F+ E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-----------------LLGWQTRVK 616
             G C +    I+++EYM +  LN FL    R H                  LG    + 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFL----RAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           I   IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R    D    +  R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR 180

Query: 677 VVG----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           V G       +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  100 bits (250), Expect = 2e-23
 Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 49/277 (17%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAKLQHRNLVR 573
           LG G F   Y+ + +  G  +AVK+++      S+  + ++  + E+ L+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           ++G   E     L  E+M   S++  L  +   +  ++     +   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 632 SRLRIIHRDLKASNILLDSD-MNPKISDFGMA-RMFC----GDELQGNTKRVVGTYGYMS 685
              +IIHRD+K +N+L+DS     +I+DFG A R+        E QG   +++GT  +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY---- 741
           PE      +    DV+S G +++E  T+K         +     H   ++K   A     
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HLALIFKIASATTAPS 231

Query: 742 --ELLSPALQHEASYQMLNRYITVALLCVQEKAADRP 776
             E LSP L+             V L C++ +  DRP
Sbjct: 232 IPEHLSPGLR------------DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  100 bits (250), Expect = 2e-23
 Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 35/223 (15%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLN---GQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
           N  ++ +LGEG FG V+  +  N    Q+   VAVK L   S    K+F  E  L+  LQ
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--------------LLGWQT 613
           H ++V+  G CVE    I+++EYM +  LN FL    R H               L    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL----RAHGPDAVLMAEGNRPAELTQSQ 121

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 673
            + I + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTD 174

Query: 674 TKRVVG----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
             RV G       +M PE  +   F+ +SDV+S GV+L E  T
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 86/278 (30%), Positives = 138/278 (49%), Gaps = 37/278 (13%)

Query: 521 LGEGGFGPVYKGKLL--NGQEV--AVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G+G FG VY G L+  +GQ++  AVK L+  +  + +++F  E +++    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 576 GCCV-EQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+   +       L+G+  +V      A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
               + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D++SF++  +   L +  R   LL P 
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVY---LLQGRR---LLQPE 225

Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              +  Y+       V L C   K   RPT S++VS I
Sbjct: 226 YCPDPLYE-------VMLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 6e-23
 Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 28/207 (13%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRL-SSQSGQGLKEFKN---EMMLIAKLQHRNLVRL 574
           KLGEG +G VYK +    G+ VA+K++      +G+        E+ L+ +L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63

Query: 575 MGCCVEQGEKI-LIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           +        K+ L++EY     K           P+    + +Q        + +GL Y 
Sbjct: 64  LDVIH-TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAYC 114

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H +   RI+HRDLK  NIL++ D   K++DFG+AR F G  L+  T  VV T  Y +PE 
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEI 169

Query: 689 AL-DGLFSVKSDVFSFGVLLLETLTSK 714
            L    +S   D++S G +  E +T K
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGL-KEFKNEMMLIAKLQHRN 570
           E      +LGEG  G V K +L N   + A+K +++     L K+   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 571 LVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLY 627
           +V+  G  ++       +  EY    SL+        R   +G +   KI E + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH     +IIHRD+K SNILL      K+ DFG++    G+ +        GT  YM+PE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPE 173

Query: 688 YALDGLFSVKSDVFSFGVLLLE 709
                 +S+ SDV+S G+ LLE
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 98.4 bits (245), Expect = 9e-23
 Identities = 70/214 (32%), Positives = 112/214 (52%), Gaps = 32/214 (14%)

Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQG-------LKEFKNEMMLIAKLQHRN 570
           +G G FG VY G    +G+ +AVK+  L S S          L     E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLGWQTRVK-IIEGIAQG 624
           +V+ +G  ++     +  EY+P  S+     N+  F+         +T V+  +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---------ETLVRNFVRQILKG 118

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKR--VVGT 680
           L YLH  +R  IIHRD+K +NIL+D+    KISDFG+++    + L    N  R  + G+
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             +M+PE      ++ K+D++S G L++E LT K
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 99.4 bits (247), Expect = 1e-22
 Identities = 68/198 (34%), Positives = 111/198 (56%), Gaps = 12/198 (6%)

Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C+    + L+ + MP+  L  ++ +      +G Q  +     IA+G++YL +    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N         +M+ E      F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 695 SVKSDVFSFGVLLLETLT 712
           + +SDV+S+GV + E +T
Sbjct: 189 THQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 99.2 bits (248), Expect = 1e-22
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 39/217 (17%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN-----EMMLIAKLQ 567
            +    KLGEG +  VYK +    G+ VA+K++     +  K+  N     E+ L+ +L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMP--------NKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           H N++ L+     +    L++E+M         +KS+   +  P+        T      
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMT------ 111

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
              +GL YLH      I+HRDLK +N+L+ SD   K++DFG+AR F G   +  T +VV 
Sbjct: 112 --LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV- 164

Query: 680 TYGYMSPEYALDGLFSVKS-----DVFSFGVLLLETL 711
           T  Y +PE     LF  +      D++S G +  E L
Sbjct: 165 TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 15/201 (7%)

Query: 521 LGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG+G +G VY  + L+ Q  +A+K +  +  + ++    E+ L + L+HRN+V+ +G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 580 EQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
           E G   +  E +P  SL+  L   + P + +    QT +   + I +GL YLH     +I
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLKYLHD---NQI 129

Query: 637 IHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-- 693
           +HRD+K  N+L+++     KISDFG ++   G  +   T+   GT  YM+PE    G   
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRG 187

Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           +   +D++S G  ++E  T K
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 45/291 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAK 565
            N S    LG G FG V +       K     +VAVK L   +    +E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-----HLLGWQTRVKIIE 619
           L  H N+V L+G C   G  ++I EY     L  FL     +      LL +  +V    
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV---- 150

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKR 676
             A+G+ +L   +    IHRDL A N+LL      KI DFG+AR    D    ++GN + 
Sbjct: 151 --AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNL 734
            V    +M+PE   + +++ +SDV+S+G+LL E  +L S    G+     F      + L
Sbjct: 206 PVK---WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKL 256

Query: 735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            K+   Y +  P       Y ++         C       RPT  ++V +I
Sbjct: 257 IKE--GYRMAQPEHAPAEIYDIMKT-------CWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 97.7 bits (243), Expect = 3e-22
 Identities = 73/221 (33%), Positives = 110/221 (49%), Gaps = 34/221 (15%)

Query: 520 KLGEGGFGPVYKGKLLNGQE---------------VAVKRLSSQSGQGLK-EFKNEMMLI 563
           KLGEG FG V+  +     E               VAVK L +   +  + +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHL-----LGWQTR 614
           ++L++ N++RL+G CV      +I EYM N  LN FL     + + TH      +     
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQ 671
           + +   IA G+ YL   + L  +HRDL   N L+ +    KI+DFGM+R ++ GD   +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G   R V    +M+ E  L G F+  SDV++FGV L E  T
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 96.2 bits (239), Expect = 4e-22
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 13/204 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +   +   +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62

Query: 573 RLMGCCVEQ-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           +L+G  VE+ G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           +    +HRDL A N+L+  D   K+SDFG+ +       Q   K  V    + +PE   +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 173

Query: 692 GLFSVKSDVFSFGVLLLETLTSKR 715
             FS KSDV+SFG+LL E  +  R
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 89.3 bits (222), Expect = 7e-22
 Identities = 29/67 (43%), Positives = 44/67 (65%), Gaps = 1/67 (1%)

Query: 337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMW 396
           C   + F++  ++KLP      ++ S+ LKECE  CL NC+C AYA + +  GGSGCL+W
Sbjct: 1   CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59

Query: 397 FGDLIDI 403
            G+L+D+
Sbjct: 60  TGELVDM 66

Length = 66

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAKLQHRNLVRLMG 576
           K+GEG +G VYK +  L G+ VA+K++  +            E+ L+ +L H N+++L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLR 635
               +G+  L++E+M   +  + L    +  L   ++ +K  +  + QGL + H +    
Sbjct: 66  VFRHKGDLYLVFEFM--DTDLYKLIKDRQRGLP--ESLIKSYLYQLLQGLAFCHSH---G 118

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLF 694
           I+HRDLK  N+L++++   K++DFG+AR F            V T  Y +PE  L D  +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 695 SVKSDVFSFGVLLLETLT 712
           S   D++S G +  E L+
Sbjct: 177 STPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 81/282 (28%), Positives = 136/282 (48%), Gaps = 35/282 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 629
           +L    V +    +I E+M   SL  FL    ++     Q   K+I+    IA+G+ ++ 
Sbjct: 65  KL-HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPE 687
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE
Sbjct: 120 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 173

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLS 745
               G F++KSDV+SFG+LL+E +T  R    G+ + E    L   + + +     E L 
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL- 232

Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                            + + C + +  +RPT   + S++ +
Sbjct: 233 ---------------YNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 83/308 (26%), Positives = 130/308 (42%), Gaps = 65/308 (21%)

Query: 514 NFSMQCKLGEGGFGPVYKG-----KLLNG-QEVAVKRLSSQSGQG-LKEFKNEMMLIAKL 566
           N  +   LGEG FG V K      K   G   VAVK L   +    L++  +E  L+ ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----------------------FDPS 604
            H ++++L G C + G  +LI EY    SL  FL                       +P 
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 605 RTHL-------LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 657
              L         WQ        I++G+ YL   + ++++HRDL A N+L+      KIS
Sbjct: 121 ERALTMGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169

Query: 658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN- 716
           DFG++R    ++      +      +M+ E   D +++ +SDV+SFGVLL E +T   N 
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 717 -TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR 775
             G+     FNLL            Y +  P    E  Y ++       L C +++   R
Sbjct: 230 YPGIAPERLFNLL---------KTGYRMERPENCSEEMYNLM-------LTCWKQEPDKR 273

Query: 776 PTMSKVVS 783
           PT + +  
Sbjct: 274 PTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 22/275 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           +++ +   +G G    VY    L N ++VA+KR+   +    + E + E+  +++  H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+     V   E  L+  Y+   SL   +        L       +++ + +GL YLH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSPEY 688
             +   IHRD+KA NILL  D + KI+DFG++      GD  +   K  VGT  +M+PE 
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 689 ALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSP 746
                 +  K+D++SFG+  +E  T       Y  ++   L      L  D        P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT-----LQND-------PP 225

Query: 747 ALQHEASYQMLNR-YITVALLCVQEKAADRPTMSK 780
           +L+  A Y+  ++ +  +  LC+Q+  + RPT  +
Sbjct: 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 18/203 (8%)

Query: 521 LGEGGFGPV----YKGKLLN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V    Y  +  N G++VAVK L  +SG   + + K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL--HQ 630
            G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G+ YL   Q
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYA 689
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K  + +   + +PE  
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 690 LDGLFSVKSDVFSFGVLLLETLT 712
           +   F + SDV+SFGV L E LT
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 15/201 (7%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLM 575
           K+GEG +G VYK +  L G+ VA+K  RL ++  +G+      E+ L+ +L H N+VRL+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64

Query: 576 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
              V    K+ L++E++ +  L  ++ D S    L        +  + QG+ Y H +   
Sbjct: 65  DV-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--- 118

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-L 693
           R++HRDLK  N+L+D +   K++DFG+AR F G  ++  T  VV T  Y +PE  L    
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQ 176

Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           +S   D++S G +  E +  +
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL-------SSQSGQGLKEFKNEMMLI 563
             NF ++ K+G+G F  VYK   LL+G+ VA+K++       +      LKE      L+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGI 621
            +L H N+++ +   +E  E  ++ E      L+  +  F   +  L+  +T  K    +
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQL 115

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L ++H     RI+HRD+K +N+ + +    K+ D G+ R F       ++   VGT 
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTP 170

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            YMSPE   +  ++ KSD++S G LL E
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 78/284 (27%), Positives = 138/284 (48%), Gaps = 51/284 (17%)

Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V  G+L L G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLLYLHQYSR 633
           G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ YL   S 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYL---SD 124

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPE 687
           +  +HRDL A NIL++S++  K+SDFG++R+     L+ + +    T G      + +PE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN------RAY 741
                 F+  SDV+S+G+++ E ++       Y    +      W +   +        Y
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEMSNQDVIKAIEEGY 226

Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            L +P     A +Q++       L C Q+   +RP   ++VS++
Sbjct: 227 RLPAPMDCPAALHQLM-------LDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 12/200 (6%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           K+GEG +G VYKG+    GQ VA+K  RL S+          E+ L+ +LQH N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLR 635
             +++    LI+E++      +    P   ++      VK  +  I QG+L+ H     R
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD--AELVKSYLYQILQGILFCH---SRR 121

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LF 694
           ++HRDLK  N+L+D+    K++DFG+AR F G  ++  T  VV T  Y +PE  L    +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPRY 179

Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S   D++S G +  E  T K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 26/272 (9%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 570
           +F +  KLG+G +G VYK K L + Q  A+K   L S S +  ++  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLLYLH 629
           ++      ++  +  ++ EY P   L+  +    +   L+  Q   +I   + +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +    +I+HRDLK++NILL ++   KI D G++++      +   K  +GT  YM+PE  
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVW 173

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 749
               +S KSD++S G LL E  T         ++            K  R      P + 
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--------KVQRGK---YPPIP 222

Query: 750 HEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
              S  + N         +Q K   RP   K+
Sbjct: 223 PIYSQDLQN----FIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 15/203 (7%)

Query: 521 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+G FG VY       G+ L  ++V     S ++ + +   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 575 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            GC  ++ EK L    EYMP  S+   L   +   L    TR K    I +G+ YLH   
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSN- 125

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYMSPEYALD 691
              I+HRD+K +NIL DS  N K+ DFG ++      + G   R V GT  +MSPE    
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +  K+DV+S G  ++E LT K
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 93.6 bits (232), Expect = 5e-21
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 41/280 (14%)

Query: 521 LGEGGFGPVYKGKLLNGQ---EVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           LGEG FG V +G+L       +VAVK  +++  +   +++F +E + + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 576 GCCVEQGEK------ILIYEYMPNKSLNFFLFDPSR----THLLGWQTRVKIIEGIAQGL 625
           G C++  E       ++I  +M +  L+ FL   SR       L  Q  VK +  IA G+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDEL-QGNTKRVVGTYGY 683
            YL   S    IHRDL A N +L+ +MN  ++DFG++ +++ GD   QG   ++     +
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKW 180

Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAY 741
           ++ E   D +++ KSDV+SFGV + E  T  +    GV + E ++ L         NR  
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG------NR-- 232

Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
            L  P    +  Y +++        C      DRP+   +
Sbjct: 233 -LKQPPDCLDGLYSLMSS-------CWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.3 bits (232), Expect = 7e-21
 Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 15/198 (7%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 578
           LG G  G V K K +  G  +A K +   +   + K+   E+ ++ + +   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 579 VEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
           + +    +  E+M   SL+       P    +LG     KI   + +GL YL  Y+  RI
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRI 125

Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV 696
           +HRD+K SNIL++S    K+ DFG++    G+ +       VGT  YMSPE    G ++V
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181

Query: 697 KSDVFSFGVLLLETLTSK 714
           KSDV+S G+ ++E    K
Sbjct: 182 KSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.9 bits (231), Expect = 8e-21
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 37/217 (17%)

Query: 521 LGEGGFGPVYKG-KLLNGQEVAVK----------RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           +G+G +G VY    +  G+ +AVK          R  S+    +K  ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 570 NLVRLMGCCVEQGEKIL-IY-EYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 622
           N+V+ +G   E  E+ L I+ EY+P  S+   L     F+         Q          
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--------L 118

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGT 680
           +GL YLH      I+HRDLKA N+L+D+D   KISDFG+++    D++  N     + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173

Query: 681 YGYMSPEY-ALDGL-FSVKSDVFSFGVLLLETLTSKR 715
             +M+PE        +S K D++S G ++LE    +R
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 64/193 (33%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG+G FG V+KG L +   VAVK       Q LK +F +E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           ++    ++ E +P    +F  F   +   L  +  VK     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DL A N L+  +   KISDFGM+R         +  + +    + +PE    G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176

Query: 700 VFSFGVLLLETLT 712
           V+S+G+LL ET +
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 92.3 bits (229), Expect = 2e-20
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 26/205 (12%)

Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG V+KG  +   +     VA+K +  +SG Q  +E  + M+ +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 575 MGCCVEQGEKI-LIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           +G C   G  + L+ +  P  SL   +       DP R  LL W  +      IA+G+ Y
Sbjct: 75  LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQR--LLNWCVQ------IAKGMYY 124

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           L ++   R++HR+L A NILL SD   +I+DFG+A +   D+ +           +M+ E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 688 YALDGLFSVKSDVFSFGVLLLETLT 712
             L G ++ +SDV+S+GV + E ++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 93.1 bits (231), Expect = 2e-20
 Identities = 77/245 (31%), Positives = 119/245 (48%), Gaps = 30/245 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE--------VAVKRLSSQ-SGQGLKEFKNEMMLI 563
           +   +   LGEG FG V + +     +        VAVK L    + + L +  +EM L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 564 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTH--LL 609
             + +H+N++ L+G C ++G   +I EY    +L  FL           FD ++     L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
            ++  V     +A+G+ YL   SR R IHRDL A N+L+  D   KI+DFG+AR     +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 727
               T        +M+PE   D +++ +SDV+SFG+L+ E  TL      G+   E F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248

Query: 728 L--GH 730
           L  GH
Sbjct: 249 LREGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score = 87.0 bits (216), Expect = 2e-20
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 3/108 (2%)

Query: 213 TGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLI 270
           +GPWNG+ F   P     SY      E  E E+ Y Y   ++ I   L ++  G ++R  
Sbjct: 3   SGPWNGIRFSGIPEMQKLSYYVYNFTENNE-EVYYTYRMTNNSIYSRLTLSSEGSLERFT 61

Query: 271 WHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLK 318
           W   S  W +F++AP + C +YG CG    C V+ +  C C+KGF  K
Sbjct: 62  WIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPK 109

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 39/268 (14%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           ++G G FG VY  + +   + VA+K++S    QS +  ++   E+  + +L+H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYLHQYSR 633
           GC + +    L+ EY    +      D    H    Q      I  G  QGL YLH + R
Sbjct: 82  GCYLREHTAWLVMEYCLGSAS-----DILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
              IHRD+KA NILL      K++DFG A +        N+   VGT  +M+PE  L   
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMD 187

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSPALQ 749
           +G +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP L 
Sbjct: 188 EGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------DSPTLS 235

Query: 750 HEASYQMLNRYITVALLCVQEKAADRPT 777
                     ++     C+Q+   DRP+
Sbjct: 236 SNDWSDYFRNFVD---SCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 32/213 (15%)

Query: 520 KLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG--LKEFKNEMMLIAKLQHRNLVRLMG 576
           K+G G FG VY    L+  E+ AVK +  Q      +KE  +EM ++  L+H NLV+  G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 577 CCVEQGEKILIY-EYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
             V + EK+ I+ EY    +L   L                 RV  ++ + +GL YLH +
Sbjct: 67  VEVHR-EKVYIFMEYCSGGTLEELLEHGRILDEHV------IRVYTLQ-LLEGLAYLHSH 118

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF------CGDELQGNTKRVVGTYGYMS 685
               I+HRD+K +NI LD +   K+ DFG A          G+E+Q     + GT  YM+
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMA 171

Query: 686 PEYALDGLFSVK---SDVFSFGVLLLETLTSKR 715
           PE    G        +D++S G ++LE  T KR
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 25/214 (11%)

Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVR 573
           +LGE  FG +YKG L      + Q VA+K L    + Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--------------VKIIE 619
           L+G   ++    +++EY+    L+ FL   S    +G  +               + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVV 678
            IA G+ YL  +     +H+DL A NIL+   ++ KISD G++R ++  D  +   K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
               +M PE  + G FS  SD++SFGV+L E  +
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 11/205 (5%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 570
           NF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L+     + +  L++E++ ++ L  F+     + +     +  + + + QGL + H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCHS 118

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
           +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173

Query: 691 DG-LFSVKSDVFSFGVLLLETLTSK 714
               +S   D++S G +  E +T +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 27/193 (13%)

Query: 509 SAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL---SSQSG---QGLKEFKNEMM 561
            +   ++ +  KLGEG FG VYK  ++  G+ VA+K++   + + G     L+E K    
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK---- 59

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKI--------LIYEYMPNKSLNFFLFDPSRTHLLGWQT 613
           ++ KL+H N+V L+   VE+ +K         ++  YM +  L+  L +P    L   ++
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLT--ES 115

Query: 614 RVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
           ++K  +  + +G+ YLH+     I+HRD+KA+NIL+D+    KI+DFG+AR + G     
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 673 NTKRVVGTYGYMS 685
                 GT  Y +
Sbjct: 173 KGGGGGGTRKYTN 185

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 90.6 bits (225), Expect = 6e-20
 Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 29/204 (14%)

Query: 521 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   +++  KRL  + G+ +    NE  ++ K+  R +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                 + +  L+   M    L + +       F  +R      Q        I  GL +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ--------IICGLEH 110

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LHQ    RI++RDLK  N+LLD   N +ISD G+A    G       K   GT GYM+PE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPE 164

Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
                ++    D F+ G  L E +
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 90.8 bits (225), Expect = 7e-20
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 30/237 (12%)

Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++P++     L ++  V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 8e-20
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 20/206 (9%)

Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL---KEFKN---EMMLIAKLQHRNLVRL 574
           LG+G +G VY G    GQ +AVK++   +   L   KE++    E+ L+  L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C++     +  E++P  S++  L  F P    +    T+ +I++G+A    YLH   
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN----TKRVVGTYGYMSPEY 688
              ++HRD+K +N++L  +   K+ DFG AR      L G      K + GT  +M+PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSK 714
             +  +  KSD++S G  + E  T K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 90.4 bits (224), Expect = 9e-20
 Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 54/295 (18%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQSGQG-LKEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K ++       + A+KR+   + +   ++F  E+ ++ KL  H
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 615
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                +A+G+ YL Q    + IHRDL A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179

Query: 676 RVVGTYG--YMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 731
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239

Query: 732 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 240 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 520 KLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            +G+G FG V K      GK+L  +E+    ++ +  Q L    +E+ ++ +L+H N+VR
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63

Query: 574 LMGCCV-EQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRV---KIIEGIAQGLLYL 628
                +    + + I  EY     L   +    +         +    I   + Q LL L
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-----KYIEEEFIWRILTQLLLAL 118

Query: 629 H-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           +           ++HRDLK +NI LD++ N K+ DFG+A++   D      K  VGT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYY 176

Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLE 709
           MSPE      +  KSD++S G L+ E
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 56/175 (32%), Positives = 94/175 (53%), Gaps = 18/175 (10%)

Query: 520 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG------LKEFKNEMMLIAKLQHRNLV 572
           ++GEG  G V+K K    G+ VA+K+++ +  +G      L+E K     +   QH  +V
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+         +L+ EYMP+  L+  L D  R  L   Q +   +  + +G+ Y+H   
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVK-SYMRMLLKGVAYMHA-- 117

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
              I+HRDLK +N+L+ +D   KI+DFG+AR+F  +E +  + + V T  Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 25/206 (12%)

Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V +G+L L G+    VA+K L S  + +  ++F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           G   +    ++I E+M N +L+ FL      F      L+G      ++ GIA G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVG------MLRGIAAGMKYL- 122

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSP 686
             S +  +HRDL A NIL++S++  K+SDFG++R    D         +G      + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      F+  SDV+S+G+++ E ++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 15/210 (7%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKLQ 567
           N+ +   LG+G FG VY     + G+E+AVK++     S ++ + +   + E+ L+  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 568 HRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           H  +V+  GC  +  E+ L    E+MP  S+   L   S   L    TR K    I +G+
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGV 119

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYGYM 684
            YLH      I+HRD+K +NIL DS  N K+ DFG ++      L G   K V GT  +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           SPE      +  K+D++S G  ++E LT K
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 61/198 (30%), Positives = 109/198 (55%), Gaps = 17/198 (8%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  +V+L+G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
              G+  ++ E+ P  +++  + +  R  L   Q +V I   + + L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYAL-----D 691
           RDLKA N+LL  D + K++DFG++       ++   +R   +GT  +M+PE  +     D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 692 GLFSVKSDVFSFGVLLLE 709
             +  K+D++S G+ L+E
Sbjct: 190 TPYDYKADIWSLGITLIE 207

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 4e-19
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 17/206 (8%)

Query: 512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            + + +  +LG+G FG VYK +    G   A K +  +S + L++F  E+ ++++ +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V L      + +  ++ E+    +L+  + +  R  L   Q R  +   + + L +LH 
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRY-VCRQMLEALNFLHS 121

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
           +   ++IHRDLKA NILL  D + K++DFG++       LQ   KR   +GT  +M+PE 
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN-KSTLQ---KRDTFIGTPYWMAPEV 174

Query: 689 AL-----DGLFSVKSDVFSFGVLLLE 709
                  D  +  K+D++S G+ L+E
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.0 bits (220), Expect = 4e-19
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 35/266 (13%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL YLH ++   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHSHN--- 135

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DG 692
           +IHRD+KA NILL      K+ DFG A       +       VGT  +M+PE  L   +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189

Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSPALQHE 751
            +  K DV+S G+  +E   ++R   ++++ + + L H A N           SPALQ  
Sbjct: 190 QYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------ESPALQSG 237

Query: 752 ASYQMLNRYITVALLCVQEKAADRPT 777
              +    ++     C+Q+   DRPT
Sbjct: 238 HWSEYFRNFVDS---CLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.0 bits (220), Expect = 4e-19
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)

Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS---SQSGQGLKEFKNEMMLIAKLQHRN 570
           F+   ++G G FG VY  + +   EV A+K++S    QS +  ++   E+  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
            +   GC + +    L+ EY    + +  L +  +  L   +    I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 143

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
           ++   +IHRD+KA NILL      K++DFG A +             VGT  +M+PE  L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194

Query: 691 ---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
              +G +  K DV+S G+  +E   ++R   ++++ + + L H       N      SP 
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHI----AQNE-----SPT 243

Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           LQ          ++     C+Q+   DRPT  +++  +
Sbjct: 244 LQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 71/234 (30%), Positives = 121/234 (51%), Gaps = 26/234 (11%)

Query: 515 FSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 568
           F++   LG+G FG V + +L     + Q+VAVK L +   S   ++EF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 569 RNLVRLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKII 618
            N+++L+G  +    K      ++I  +M +  L+ FL   SR       L  QT V+ +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDEL-QGNTKR 676
             IA G+ YL   S    IHRDL A N +L+ +M   ++DFG+++ ++ GD   QG   +
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLL 728
           +     +++ E   D +++  SDV++FGV + E +T  +    GV + E +N L
Sbjct: 177 L--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 566
            N+ +   LG G FG VY     + G+E+AVK++     S ++ + +   + E+ L+  L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 567 QHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQ 623
           +H  +V+  GC  +  EK L    EYMP  S+     D  + +  L      +    I Q
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYG 682
           G+ YLH      I+HRD+K +NIL DS  N K+ DFG ++      + G   K V GT  
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           +MSPE      +  K+DV+S    ++E LT K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 19/217 (8%)

Query: 511 ATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLI 563
           A E  +M  +LG+G FG VY+G      K      VA+K ++ + S +   EF NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 564 AKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLF----DPSRTHLLGWQTRVKII 618
            +    ++VRL+G  V QG+  L I E M    L  +L     +     +    +  K+I
Sbjct: 64  KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 619 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           + +    +MSPE   DG+F+  SDV+SFGV+L E  T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 515 FSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLV 572
           F++   +G+G FG VYK       Q VA+K +   ++   +++ + E+  +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +  G  ++  +  +I EY    S      D  +   L       I+  +  GL YLH+  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYMSPEYA 689
               IHRD+KA+NILL  + + K++DFG++      +L     +    VGT  +M+PE  
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 690 LDGLFSVKSDVFSFGVLLLETLT 712
               +  K+D++S G+  +E   
Sbjct: 171 KQSGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 77/258 (29%), Positives = 126/258 (48%), Gaps = 34/258 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKG---KLLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKL-Q 567
           E+   +  +GEG FG V +    K       A+K L   + +   ++F  E+ ++ KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPS--RTH----LLGWQTR 614
           H N++ L+G C  +G   +  EY P  +L  FL        DP+  + H     L  Q  
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           ++    +A G+ YL   S  + IHRDL A N+L+  ++  KI+DFG++R   G+E+    
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173

Query: 675 KRVVGTYG--YMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGH 730
           K+ +G     +M+ E     +++ KSDV+SFGVLL E  +L      G+   E +  L  
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233

Query: 731 AWNLWK----DNRAYELL 744
            + + K    D+  YEL+
Sbjct: 234 GYRMEKPRNCDDEVYELM 251

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 25/212 (11%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQHR 569
           +F +   +G+G FG V   +  + +++ A+K ++ Q       ++   NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 570 NLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 623
            LV L     +  E + L+ + +    L + L     F          Q +  I E I  
Sbjct: 61  FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-------QVKFWICE-IVL 111

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
            L YLH      IIHRD+K  NILLD   +  I+DF +A     D     T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165

Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 715
           M+PE      +SV  D +S GV   E L  KR
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.0 bits (215), Expect = 2e-18
 Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 20/202 (9%)

Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQ 630
           +G C+    + LI + MP   L  ++ +        +LL W  +      IA+G+ YL +
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               R++HRDL A N+L+ +  + KI+DFG+A++   DE + + +       +M+ E  L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
             +++ +SDV+S+GV + E +T
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 68/270 (25%), Positives = 124/270 (45%), Gaps = 30/270 (11%)

Query: 521 LGEGGFGP--VYK----GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+G FG   +Y+      L+  +EV + RLS +     ++  NE+++++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               ++    ++  EY    +L +      +  L   +  +  +  I   + Y+H+    
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
            I+HRD+K  NI L      K+ DFG++++  G E     + VVGT  YMSPE      +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSM-AETVVGTPYYMSPELCQGVKY 178

Query: 695 SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY 754
           + KSD+++ G +L E LT KR       ++ N L     + + N    +         S 
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT-----FDATNPLNLVVKIVQGNYTPVV------SVYSS 227

Query: 755 QMLNRYITVALLCVQEKAADRPTMSKVVSM 784
           ++    I++    +Q+    RPT  +V+  
Sbjct: 228 EL----ISLVHSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLMGC 577
           +G G FG V+  +    Q++ + +          E    +NE  ++  L H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
            +E    +++ EY P  +L  ++       LL   T   I+    Q LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQILLALHHVHTKLIL 123

Query: 638 HRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPEYALDGLF 694
           HRDLK  NILLD   M  KI DFG+++      L   +K   VVGT  Y+SPE      +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISK-----ILSSKSKAYTVVGTPCYISPELCEGKPY 178

Query: 695 SVKSDVFSFGVLLLETLTSKR 715
           + KSD+++ G +L E  + KR
Sbjct: 179 NQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 86.2 bits (213), Expect = 3e-18
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 51/300 (17%)

Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 252

Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 253 --KEGHRMDKPANCTNELYMMMRD-------CWHAIPSHRPTFKQLVEDLDRILTLTTNE 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 4e-18
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 36/224 (16%)

Query: 515 FSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRL--SSQSGQGLKEFK-NEMMLIAKLQH 568
           + ++  +G G +G VYK K  N   G+E A+K+     +   G+ +    E+ L+ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 569 RNLVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLF--DPSRTHL-------LGWQTRVKI 617
            N+V L+   +E  +K   L+++Y  +       F     R  +       L WQ     
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQG- 672
              I  G+ YLH      ++HRDLK +NIL+  +       KI D G+AR+F    L+  
Sbjct: 117 ---ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPL 169

Query: 673 -NTKRVVGTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
            +   VV T  Y +PE  L      K+ D+++ G +  E LT +
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 5e-18
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L    + + L +  +EM ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSR--THLLGWQTRVKI 617
           ++ L+G C + G   ++ EY    +L  +L           FD  +     L ++  V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                +M+PE   D +++ +SDV+SFGVLL E  T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 514 NFSMQCKLGEGGFGPVY--KGKLLNGQEVAVK-RLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            + +  K+GEG FG +Y  K K  +   V  +  L+    +  +  K E++L+AK++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSL-------NFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           +V       E G   ++ EY     L          LF  S   +L W  +      I+ 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           GL ++H     +I+HRD+K+ NI L  + M  K+ DFG+AR    ++        VGT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPY 167

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           Y+SPE   +  ++ K+D++S G +L E  T K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 23/203 (11%)

Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGC 577
           ++G G FG V+ G+L  +   VAVK         LK +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
           C ++    ++ E +  +  +F  F  +    L  +  ++++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM--------SPEYA 689
           HRDL A N L+      KISDFGM+R    +E  G    V  + G M        +PE  
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDG----VYASTGGMKQIPVKWTAPEAL 168

Query: 690 LDGLFSVKSDVFSFGVLLLETLT 712
             G +S +SDV+SFG+LL E  +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 78.2 bits (193), Expect = 1e-17
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 326 PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSK 385
           P  C    S+D      F+K  D+KLP     ++  +++L+EC   CL NC+C AYA + 
Sbjct: 2   PLNCGGDGSTD-----GFLKLPDVKLPDN-ASAIT-AISLEECREACLSNCSCTAYAYNN 54

Query: 386 VTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVP 420
              G  GCL+W G L ++R     + G  +Y+R+ 
Sbjct: 55  ---GSGGCLLWNGLLNNLRS--LSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 521 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GKL   +++  KRL  +  +G +    E  ++AK+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFL---------FDPSRTHLLGWQTRVKIIEGIAQGL 625
                 + +  L+   M    L + +         F   R      Q        I  GL
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ--------IISGL 110

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            +LHQ    RII+RDLK  N+LLD+D N +ISD G+A      + Q  TK   GT G+M+
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMA 165

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           PE      +    D F+ GV L E + ++
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 16/200 (8%)

Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + L+ + MP   L     D  R +   +G Q  +     IA+G+ YL +  
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
            +R++HRDL A N+L+ S  + KI+DFG+AR+   DE + +         +M+ E  L  
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 693 LFSVKSDVFSFGVLLLETLT 712
            F+ +SDV+S+GV + E +T
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 33/212 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E++ +  ++G G +G VYK + +  G+ VA+K +  + G   +  + E+ ++ + +H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA-------QG 624
           V   G  + + +  ++ EY    SL   ++  +R  L   Q        IA       +G
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQ--------IAYVCRETLKG 113

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT--KR--VVGT 680
           L YLH+      IHRD+K +NILL  D + K++DFG++           T  KR   +GT
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGT 164

Query: 681 YGYMSPEYA---LDGLFSVKSDVFSFGVLLLE 709
             +M+PE A     G +  K D+++ G+  +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 29/218 (13%)

Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRN 570
           F +  ++GEG +G VYK +    G+ VA+K++   + + G  +   + E+ ++ +L HRN
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67

Query: 571 LVRLMGCCV----------EQGEKILIYEYMPNKSLNFF---LFDPSRTHLLGWQTRVKI 617
           +V L               ++G   L++EYM +  +      L   S  H+         
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSF 121

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
           ++ + +GL Y H+ + L   HRD+K SNILL++    K++DFG+AR++  +E +  T +V
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 678 VGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 714
           + T  Y  PE  L +  +    DV+S G +L E  T K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 20/207 (9%)

Query: 520 KLGEGGFGPVYKGKLLN--GQEVAVKRL---SSQSGQGLKEFKNEMML--IAKLQHRNLV 572
           ++GEG +G V+K + L   G+ VA+KR+   + + G  L   +   +L  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 573 RLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           RL   C       + +  L++E++ ++ L  +L D      +  +T   ++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   ++   D++S G +  E    K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 87.6 bits (217), Expect = 1e-17
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +  G  G  YKGK + NG +  VK ++  +     E  +    + KLQH N+V+L+G C 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753

Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
            +    LI+EY+  K+L+  L +      L W+ R KI  GIA+ L +LH      ++  
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           +L    I++D    P +    +  + C D     TK  + +  Y++PE       + KSD
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISS-AYVAPETRETKDITEKSD 860

Query: 700 VFSFGVLLLETLTSKRNTGVYDIES 724
           ++ FG++L+E LT K      D E 
Sbjct: 861 IYGFGLILIELLTGKSPA---DAEF 882

Length = 968

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 27/213 (12%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 570
           NF    KLGEG +  VYKG+    G+ VA+K   L ++ G      + E+ L+ +L+H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGIA 622
           +VRL      + + +L++EYM +K L  ++         DP+      +Q        + 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LL 110

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           +G+ + H+    R++HRDLK  N+L++     K++DFG+AR F G  +   +  VV T  
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLW 165

Query: 683 YMSPEYALDG-LFSVKSDVFSFGVLLLETLTSK 714
           Y +P+  L    +S   D++S G ++ E +T +
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 35/271 (12%)

Query: 520 KLGEGGFGPVYKGKLLNGQE-VAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           ++G G FG VY     +  E VAVK++S    Q+ +  ++   E+  + +L+H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           GC +++    L+ EY    + +  L +  +  L   +    I  G  QGL YLH ++   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHSHN--- 141

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DG 692
           +IHRD+KA NILL      K++DFG A               VGT  +M+PE  L   +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSPALQHE 751
            +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP LQ  
Sbjct: 196 QYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------DSPTLQSN 243

Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
                   ++     C+Q+   +RP  ++++
Sbjct: 244 EWTDSFRGFVD---YCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 70/290 (24%), Positives = 126/290 (43%), Gaps = 38/290 (13%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHR 569
           NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 621
           N+++     +E  E  ++ E      L+  +          P +T    W+  V++   +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV---WKYFVQLCSAL 119

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
                  H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT 
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 741
            YMSPE   +  ++ KSD++S G LL E    +              G   NL+   +  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS----------PFYGDKMNLYSLCKKI 220

Query: 742 ELLS-PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA 790
           E    P L  +   + L + +    +C+      RP ++ V  +    HA
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHR 569
           NF ++ K+G G F  VY+   LL+ + VA+K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 621
           N+++ +   +E  E  ++ E      L+  +          P RT    W+  V++   +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV---WKYFVQLCSAV 119

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
                  H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT 
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            YMSPE   +  ++ KSD++S G LL E
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 30/208 (14%)

Query: 521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC- 577
           +GEG +G VYK +    GQ VA+K +        +E K E  ++ K   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 578 -----CVEQGEKILIYEYMPNKS----LNFFLFDPSR--THLLGWQTRVKIIEGIAQGLL 626
                     +  L+ E     S    +        R     + +     I+    +GL 
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLRGLA 127

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           YLH+    ++IHRD+K  NILL  +   K+ DFG++     D   G     +GT  +M+P
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAP 182

Query: 687 E-----YALDGLFSVKSDVFSFGVLLLE 709
           E        D  +  +SDV+S G+  +E
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 75/252 (29%), Positives = 122/252 (48%), Gaps = 38/252 (15%)

Query: 521 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVR 573
           +GEG FG V K      G  ++     +K  +S+     ++F  E+ ++ KL  H N++ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPS--RTH----LLGWQTRVKIIEG 620
           L+G C  +G   L  EY P+ +L  FL        DP+    +     L  Q  +     
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R   G E+    K+ +G 
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGR 172

Query: 681 YG--YMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWK 736
               +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   + L K
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232

Query: 737 ----DNRAYELL 744
               D+  Y+L+
Sbjct: 233 PLNCDDEVYDLM 244

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 520 KLGEGGFGPVYKG--KLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR----NLV 572
           +LG G FG V KG  K+   Q +VA+K L +++    K  ++EMM  A++ H+     +V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           R++G C E    +L+ E      LN FL    +   +     V+++  ++ G+ YL   +
Sbjct: 59  RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               +HRDL A N+LL +    KISDFG+++    D+      R  G +   + +PE   
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECIN 171

Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS +SDV+S+G+ + E  +
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 19/200 (9%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQH---RNLVRLM 575
           +G G +G VY+GK +  G+ VA+K ++  +    + + + E+ L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G  ++     +I EY    S+   +    +   +  +    II  +   L Y+H+     
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV--VGTYGYMSPEYALDG- 692
           +IHRD+KA+NIL+ +  N K+ DFG+A +      Q ++KR   VGT  +M+PE   +G 
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 693 LFSVKSDVFSFGVLLLETLT 712
            +  K+D++S G+ + E  T
Sbjct: 178 YYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMG 576
           K+GEG +G VYK +  +  + +A+K++   Q  +G+      E+ L+ ++QH N+VRL  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 577 CCVEQGEKILIYEYMP---NKSLNF---FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
               +    L++EY+     K ++    F  +P       +Q    I+ GIA    Y H 
Sbjct: 69  VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120

Query: 631 YSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +   R++HRDLK  N+L+D   N  K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEIL 175

Query: 690 LDGL-FSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +  K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 81.9 bits (202), Expect = 6e-17
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 19/217 (8%)

Query: 511 ATENFSMQCKLGEGGFGPVYKG---KLLNGQ---EVAVKRLS-SQSGQGLKEFKNEMMLI 563
           + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  ++
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLF-------DPSRTHLLGWQTRVK 616
                 ++VRL+G   +    +++ E M +  L  +L        +         Q  ++
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTK 675
           +   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R ++  D  +   K
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            ++     M+PE   DG+F+  SD++SFGV+L E  +
Sbjct: 181 GLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 30/206 (14%)

Query: 524 GGFGPVYKG-KLLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           G +G V+   K   G   A+K +          + +   E  ++++ Q   +V+L     
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62

Query: 580 EQGEK--ILIYEYMPN---KSL--NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            QG+K   L+ EY+P     SL  N    D               I  I   L YLH   
Sbjct: 63  -QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYLHSNG 113

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARM-FCGDELQGN-----TKRVVGTYGYMSP 686
              IIHRDLK  NIL+DS+ + K++DFG++++     ++  N      KR+VGT  Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E  L    S   D +S G +L E L 
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.1 bits (200), Expect = 8e-17
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN---------------- 558
           + +Q +LG+G FG VY           VK   + + + LK  K                 
Sbjct: 2   YILQQRLGKGSFGTVY----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ 51

Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           E  L++KL H  +V+     +E+    +I EY   + L+  L +   T     + +V   
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV--C 109

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
           E   Q LL +H   + RI+HRDLKA NI L +++  KI DFG++R+  G      T    
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FT 166

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           GT  YMSPE      +  KSD++S G +L E
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 8e-17
 Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 19/200 (9%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQ---HRNLVRL 574
           +GEG +G VYK + L  G+ VA+K++    S +G+      E+ L+ +L+   H N+VRL
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 575 MGCC-VEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           +  C   + ++     L++E++ ++ L  +L    +  L     +  ++  + +G+ +LH
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   RI+HRDLK  NIL+ SD   KI+DFG+AR++     +     VV T  Y +PE  
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPEVL 178

Query: 690 LDGLFSVKSDVFSFGVLLLE 709
           L   ++   D++S G +  E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.3 bits (201), Expect = 9e-17
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 26/206 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
                  K+GEG  G V        G++VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK------IIEGIAQGL 625
           V +    +   E  ++ E++   +L         T ++   TR+       +   + + L
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGAL---------TDIVT-HTRMNEEQIATVCLAVLKAL 128

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGY 683
            +LH      +IHRD+K+ +ILL SD   K+SDFG    FC    +   +R  +VGT  +
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYW 181

Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLE 709
           M+PE      +  + D++S G++++E
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.0 bits (201), Expect = 1e-16
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 36/216 (16%)

Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIAK 565
           + +  +LG+G FG VY  +    G+ VA+K++        K+F +        E+  + K
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53

Query: 566 LQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQ 623
           L  H N+V+L     E  E   ++EYM     N +     R      ++ ++ II  I Q
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV----VG 679
           GL ++H   +    HRDLK  N+L+      KI+DFG+AR     E++  ++      V 
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIR--SRPPYTDYVS 160

Query: 680 TYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 714
           T  Y +PE  L    +S   D+++ G ++ E  T +
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)

Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
           +G G +G V        G++VA+K+LS   QS    K    E+ L+  + H N++ L+  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 578 CVEQGEKILIYEYMPNKSLNFF-------------LFDPSRTHLLGWQTRVKIIEGIAQG 624
                       + P  SL  F             L +  +   L       ++  I +G
Sbjct: 83  ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L Y+H      IIHRDLK SNI ++ D   KI DFG+AR    DE+ G     V T  Y 
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYR 182

Query: 685 SPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
           +PE  L+ +   ++ D++S G ++ E LT K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 19/206 (9%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ---HRNLVR 573
           ++G G +G VYK +   +G  VA+K +  Q+ + GL      E+ L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 574 LMGCC----VEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           LM  C     ++  K+ L++E++ ++ L  +L D      L  +T   ++    +GL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV T  Y +PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSK 714
            L   ++   D++S G +  E    K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 16/210 (7%)

Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK-NEMM 561
           ++ SV    + ++   K+G+G  G VY    +  GQEVA+K+++ Q  Q  KE   NE++
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++ + +H N+V  +   +   E  ++ EY+   SL   +   + T +   Q    +    
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQI-AAVCREC 124

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVG 679
            Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VG
Sbjct: 125 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVG 177

Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  +M+PE      +  K D++S G++ +E
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 569
             + +   +GEG +G V K +    G+ VA+K+   S+  + +K+    E+ ++ +L+H 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQG 624
           N+V L      +G   L++EY+    L           P       WQ        + Q 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV----VGT 680
           + Y H      IIHRD+K  NIL+      K+ DFG AR      L+          V T
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVAT 164

Query: 681 YGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 712
             Y +PE  + D  +    DV++ G ++ E L 
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 13/200 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 570
           E F+   ++G+G FG VYKG     +EV A+K +  +  +  +++ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKS-LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           + R  G  ++  +  +I EY+   S L+     P     +       I+  I +GL YLH
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 118

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
                R IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT  +M+PE  
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173

Query: 690 LDGLFSVKSDVFSFGVLLLE 709
               +  K+D++S G+  +E
Sbjct: 174 KQSAYDFKADIWSLGITAIE 193

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 80.2 bits (197), Expect = 3e-16
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 14/211 (6%)

Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+K+++ Q     +   NE+++
Sbjct: 10  SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + + ++ N+V  +   +   E  ++ EY+   SL     D      +       +     
Sbjct: 70  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 178

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
             +M+PE      +  K D++S G++ +E +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 14/193 (7%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           K+GEG  G V   +   +G++VAVK +  +  Q  +   NE++++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
           +   E  ++ E++   +L   +   S+T L   Q    + E + Q L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQI-ATVCESVLQALCYLHSQG---VIH 140

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFSV 696
           RD+K+ +ILL  D   K+SDFG    FC    +   KR  +VGT  +M+PE      +  
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 697 KSDVFSFGVLLLE 709
           + D++S G++++E
Sbjct: 197 EVDIWSLGIMVIE 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.4 bits (195), Expect = 5e-16
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 14/211 (6%)

Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + + ++ N+V  +   +   E  ++ EY+   SL     D      +       +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 126

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 25/202 (12%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           +LG+G FG VYK +    G   A K + ++S + L+++  E+ ++A   H N+V+L+   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
             +    ++ E+    +++  + +  R  L   Q RV + +   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL-- 690
           RDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 691 ---DGLFSVKSDVFSFGVLLLE 709
              D  +  K+DV+S G+ L+E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 521 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQS--GQGLKE-FKNEMMLIAKLQHRNLVRLMG 576
           LG GGFG V   K+ +     A+K +  +     G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              ++    ++ EY     L   L D  R     +  R   I  +     YLH      I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLH---NRGI 114

Query: 637 IHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
           I+RDLK  N+LLDS+   K+ DFG A+ +  G      T    GT  Y++PE  L+  + 
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTWTFCGTPEYVAPEIILNKGYD 170

Query: 696 VKSDVFSFGVLLLETLTSK 714
              D +S G+LL E LT +
Sbjct: 171 FSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 6e-16
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 14/211 (6%)

Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           ++ S+    + ++   K+G+G  G V+    +  GQEVA+K+++ Q     +   NE+++
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + +L++ N+V  +   +   E  ++ EY+   SL     D      +       +     
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECL 125

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L +LH     ++IHRD+K+ N+LL  D + K++DFG    FC       +KR  +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 178

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
             +M+PE      +  K D++S G++ +E +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 23/204 (11%)

Query: 520 KLGEGGFGPVYKG--KLLNGQE-VAVKRLSSQSGQGLKEFKNEMMLIAK----LQHRNLV 572
           +LG G FG V KG  K+   ++ VAVK L + +       K+E++  A     L +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           R++G C E    +L+ E      LN FL    +   +  +   +++  ++ G+ YL + +
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEY 688
               +HRDL A N+LL +    KISDFG+++    DE     + + K  V  Y   +PE 
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169

Query: 689 ALDGLFSVKSDVFSFGVLLLETLT 712
                FS KSDV+SFGVL+ E  +
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.4 bits (194), Expect = 9e-16
 Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 38/220 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSG---QGLKEFKNEMMLIAK 565
           + +    ++ EG +G VY+ +    G+ VA+K+L     + G     L+E  N ++   K
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60

Query: 566 LQHRNLVRL----MGCCVEQGEKILIY---EYMPN--KSLNFFLFDPSRTHLLGWQTRVK 616
           LQH N+V +    +G  +++     IY   EY+ +  KSL     +  +   L  Q+ VK
Sbjct: 61  LQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSL----METMKQPFL--QSEVK 109

Query: 617 -IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
            ++  +  G+ +LH      I+HRDLK SN+LL++    KI DFG+AR + G  L+  T+
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQ 165

Query: 676 RVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
            VV T  Y +PE  L    +S   D++S G +  E LT K
Sbjct: 166 LVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 12/197 (6%)

Query: 520 KLGEGGFGPVYKG--KLLNGQE--VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 574
            +GEG FG VY+G       ++  VAVK   + +   ++E F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G   E    I + E  P   L  +L      + L   + +     ++  L YL      
Sbjct: 73  IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
           R +HRD+ A N+L+ S    K+ DFG++R +  DE      +      +M+PE      F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 695 SVKSDVFSFGVLLLETL 711
           +  SDV+ FGV + E L
Sbjct: 186 TSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 56/166 (33%), Positives = 81/166 (48%), Gaps = 37/166 (22%)

Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN-------FFLFDPSRTHLLGW 611
           E+ ++  + H N+V+        GE  ++ E+M   SL         FL D +R      
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR------ 175

Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
               +I+ GIA    YLH   R  I+HRD+K SN+L++S  N KI+DFG++R+       
Sbjct: 176 ----QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 672 GNTKRVVGTYGYMSPEY--------ALDGLFSVKSDVFSFGVLLLE 709
            N+   VGT  YMSPE         A DG      D++S GV +LE
Sbjct: 225 CNSS--VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILE 265

Length = 353

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 22/199 (11%)

Query: 520 KLGEGGFGPVYKGKLLNGQE-VAVKRLSSQS-GQGLKEFK-NEMMLIAKLQHRNLVRLMG 576
           K+GEG +G V+K K     E VA+KR+      +G+      E+ L+ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 577 CCVEQGEKILIYEYMPNKSLNFF-----LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                 +  L++EY       +F       DP       +Q        + +GL + H +
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
               ++HRDLK  N+L++ +   K++DFG+AR F G  ++  +  VV T  Y  P+    
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 173

Query: 692 G-LFSVKSDVFSFGVLLLE 709
             L+S   D++S G +  E
Sbjct: 174 AKLYSTSIDMWSAGCIFAE 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV 579
           +G G +G VYKG+ +   ++A  ++   +G   +E K E+ ++ K   HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 580 EQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           ++       +  L+ E+    S+   L   ++ + L  +    I   I +GL +LHQ+  
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
            ++IHRD+K  N+LL  +   K+ DFG++     D   G     +GT  +M+PE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 691 --DGLFSVKSDVFSFGVLLLE 709
             D  +  KSD++S G+  +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 60/191 (31%), Positives = 91/191 (47%), Gaps = 33/191 (17%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQG-----LKEFKNEMMLIAKLQHRNLV 572
           K+G+G FG V+K +     Q VA+K+ L     +G     L+E K    ++  L+H N+V
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW--QTRVK--------IIEGIA 622
            L+  C  +        Y   K   + +F+     L G      VK        +++ + 
Sbjct: 75  NLIEICRTKATP-----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC---GDELQGNTKRVVG 679
            GL Y+H   R +I+HRD+KA+NIL+  D   K++DFG+AR F      +    T RVV 
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185

Query: 680 TYGYMSPEYAL 690
           T  Y  PE  L
Sbjct: 186 TLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 18/203 (8%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           ++GEG +G VY+ +   +G+ VA+K++   + + G  +   + E+ L+  L+H N+V L 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72

Query: 576 GCCV-EQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYS 632
              V +  + I L+ EY   + L   L +         +++VK ++  + +GL YLH+  
Sbjct: 73  EVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFS---ESQVKCLMLQLLRGLQYLHENF 128

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
              IIHRDLK SN+LL      KI+DFG+AR + G   +  T +VV T  Y +PE  L  
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLGC 183

Query: 693 LFSVKS-DVFSFGVLLLETLTSK 714
                + D+++ G +L E L  K
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 28/211 (13%)

Query: 519 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQH-RNLVRLM 575
            +LG G +G V K + +  G  +AVKR+ +  + Q  K    ++ +  +       V   
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 576 GCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT---HLLGWQTRVKIIEGIAQGLLYLH 629
           G    +G+  +  E M + SL+ F   ++D   T    +LG     KI   I + L YLH
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLH 120

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMSPEY 688
             S+L +IHRD+K SN+L++ +   K+ DFG++    G  +    K +  G   YM+PE 
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE- 173

Query: 689 ALDGL-----FSVKSDVFSFGVLLLETLTSK 714
            ++       + VKSDV+S G+ ++E  T +
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 74/286 (25%), Positives = 130/286 (45%), Gaps = 27/286 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 569
           E +     +GEG +G V K K    GQ VA+K+ L S+  + +K+    E+ ++ +L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           NLV L+     +    L++E++ +  L+     P   + L      K +  I +G+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            ++   IIHRD+K  NIL+      K+ DFG AR              V T  Y +PE  
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPELL 172

Query: 690 L-DGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESF--------NLLGHAWNLWKDNR 739
           + D  +    D+++ G L+ E LT +    G  DI+          NL+     +++ N 
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 740 AYELLS-PALQH----EASYQMLNRY-ITVALLCVQEKAADRPTMS 779
            +  +  P ++     E  +  L+   + +A  C++    DRP+ S
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 16/191 (8%)

Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 578
           LG G  G VYK   LL  + +AVK +       L K+  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
             +    +  E+M   SL+ +   P   H+LG     +I   + +GL YL     L+I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPE--HVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 698
           RD+K SN+L+++    K+ DFG++       +    K  VGT  YM+PE      + + S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 699 DVFSFGVLLLE 709
           DV+S G+  +E
Sbjct: 175 DVWSLGISFME 185

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 30/210 (14%)

Query: 521 LGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQH-RNLVRLM 575
           +G G FG V K  +L+   G  +AVKR+ S    +  K    ++ ++ +      +V+  
Sbjct: 12  IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 576 GCCVEQGEKILIYEYMPNKSLNF--FLFDPSRTHL----LGWQTRVKIIEGIAQGLLYLH 629
           G    +G+  +  E M      F  ++++  ++ +    LG     KI     + L YL 
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLK 124

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK-RVVGTYGYMSPE- 687
           +   L+IIHRD+K SNILLD + N K+ DFG+     G  +    K R  G   YM+PE 
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGI----SGQLVDSIAKTRDAGCRPYMAPER 178

Query: 688 ---YALDGLFSVKSDVFSFGVLLLETLTSK 714
               A DG + V+SDV+S G+ L E  T K
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 12/199 (6%)

Query: 519 CKLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLM 575
            K+GEG +G V+K +    GQ VA+K+ + S+    +K+    E+ ++ +L+H NLV L+
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
                + +  L++EY  +  LN           +      KII    Q + + H+++   
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLF 694
            IHRD+K  NIL+      K+ DFG AR+  G     +    V T  Y +PE  + D  +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178

Query: 695 SVKSDVFSFGVLLLETLTS 713
               DV++ G +  E LT 
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 29/234 (12%)

Query: 487 GDGDAKGTRRD---SVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK 543
            D  A  +  D    ++P    A    A+  +++   L  G  G V+      GQ   V 
Sbjct: 37  DDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVV 95

Query: 544 RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 603
               Q G  L E     ML+  + H +++R+    V      ++   +P+ S + + +  
Sbjct: 96  LKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLT 148

Query: 604 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 663
            R+  L     + I + I +GL YLH     RIIHRD+K  NI ++      I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Query: 664 ------MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
                  F G         + GT    +PE      ++ K+D++S G++L E L
Sbjct: 206 FPVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 52/203 (25%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E+F +  ++G G +G VYK + +N G+  A+K +  + G+     + E++++   +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLN--FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           V   G  + + +  +  E+    SL   + +  P     + + +R  +     QGL YLH
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
              +   +HRD+K +NILL  + + K++DFG++            K  +GT  +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178

Query: 690 L---DGLFSVKSDVFSFGVLLLE 709
                G ++   D+++ G+  +E
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 13/200 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +  +  +  +++ + E+ ++++     
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLYLH 629
           + +  G  ++  +  +I EY+   S    L +P        +T++  I+  I +GL YLH
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLD----ETQIATILREILKGLDYLH 118

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
              +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT  +M+PE  
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVI 173

Query: 690 LDGLFSVKSDVFSFGVLLLE 709
               +  K+D++S G+  +E
Sbjct: 174 KQSAYDSKADIWSLGITAIE 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 33/208 (15%)

Query: 521 LGEGGFGPVYKG--KLLNGQE--VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           LG G FG + +G  KL + +E  VA+  L +  S +  + F  E + + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 633
           G        +++ EYM N +L+ FL    R H   L     + ++ G+A G+ YL   S 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYL---SE 125

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS-------- 685
           +  +H+ L A  +L++SD+  KIS F           +    +    Y  MS        
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWA 175

Query: 686 -PEYALDGLFSVKSDVFSFGVLLLETLT 712
            PE      FS  SDV+SFG+++ E ++
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 37/283 (13%)

Query: 521 LGEGGFGPVYK-------GKLLNGQEVAVKRLS-----SQSGQGLKEFKNEMMLIAK-LQ 567
           LG G FG VYK         LL  +E+ V   +      +  + + +  +E+ +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLL 626
           H N+VR     +E     ++ + +    L               + R+  I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYM 684
           YLH+  R  I+HRDL  +NI+L  D    I+DFG+A+     + Q  +K   VVGT  Y 
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 744
            PE   +  +  K+DV++FG +L +  T       Y   S N+L  A  +      YE L
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFY---STNMLSLATKIV--EAVYEPL 233

Query: 745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
              +  E    ++         C+   A  RP + +V +MI++
Sbjct: 234 PEGMYSEDVTDVITS-------CLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 520 KLGEGGFGPVYKGKLL----NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
           K+GEG FG   K  L+    +G++  +K +  S  S +  +E + E+ +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
                 E G   ++ +Y     L +   +  R  L       +I++   Q  L L     
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLF---PEDQILDWFVQICLALKHVHD 119

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDG 692
            +I+HRD+K+ NI L  D   K+ DFG+AR+     EL    +  +GT  Y+SPE   + 
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPEICENR 176

Query: 693 LFSVKSDVFSFGVLLLETLTSK 714
            ++ KSD+++ G +L E  T K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 61/226 (26%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAKLQHRN 570
           +G G +G V        G++VA+K++S         F +         E+ L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 571 LVRLM-----GCCVEQGEKILIYEYMP--------------NKSLNFFLFDPSRTHLLGW 611
           ++ L+         +  +  ++ E M               +  + +FL+      +L  
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY-----QIL-- 113

Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
                      +GL YLH      +IHRDLK SNIL++S+ + KI DFG+AR    DE +
Sbjct: 114 -----------RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 672 GN--TKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
               T+ VV T  Y +PE  L    ++   D++S G +  E LT K
Sbjct: 160 KGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 34/162 (20%)

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 628
           +V   G     GE  +  E+M   SL+  L    R   ++LG     KI   + +GL YL
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYL 115

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARMFCGDELQGNTKRVVGT 680
            +  + +I+HRD+K SNIL++S    K+ DFG        MA  F            VGT
Sbjct: 116 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGT 161

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI 722
             YMSPE      ++V+SD++S G+ L+E        G Y I
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMA-----IGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 570
           E F+   ++G+G FG V+KG     Q+V A+K +  +  +  +++ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           + +  G  ++  +  +I EY+   S      D  R           +++ I +GL YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             +   IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT  +M+PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 691 DGLFSVKSDVFSFGVLLLE 709
              +  K+D++S G+  +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 521 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--IAQGLLYLHQYS 632
                 +    L+   M    L F ++        G++    +     I  GL  LHQ  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQE- 121

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             RI++RDLK  NILLD   + +ISD G+A      +     K  VGT GYM+PE   + 
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE 176

Query: 693 LFSVKSDVFSFGVLLLETLTSK 714
            ++   D ++ G LL E +  +
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVA---VKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           ++G G FG V  G+   G   A   VK L +S +      F  E+    +L H N+++ +
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW-QTRV--KIIEGIAQGLLYLHQYS 632
           G C+E    +L+ E+ P   L  +L   +R  +    Q  V  ++   +A GLL+LHQ  
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG---DELQGNTKRVVGTYGYMSPEYA 689
               IH DL   N  L +D++ KI D+G+A        D         V    +++PE  
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAV-PLRWLAPELV 174

Query: 690 L---DGLFSVK----SDVFSFGVLLLETLT 712
                 L        S+++S GV + E  T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 17/203 (8%)

Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFK---NEMMLIAKLQHRN 570
           F +  ++G+GG+G V+  K  +  E VA+KR+       L E +    E  ++   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW-QTRVKIIEGIAQGLLYLH 629
           LV+L+    +     L  EY+P       L   +   +L     R  + E     +  LH
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALH 118

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               L  IHRDLK  N L+D+  + K++DFG+++      +      VVG+  YM+PE  
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVL 170

Query: 690 LDGLFSVKSDVFSFGVLLLETLT 712
               +    D +S G +L E L 
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 72.7 bits (179), Expect = 7e-14
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 519 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 574
            K+GEG F  V K +    G+  A+K +  +  + L++  N  E+  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 575 MGCCVEQ--GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +    ++  G   L++E M    +N +     R   L  +     +  + + L ++H   
Sbjct: 64  IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-D 691
           R  I HRD+K  NIL+  D   K++DFG  R       +      + T  Y +PE  L D
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS---KPPYTEYISTRWYRAPECLLTD 173

Query: 692 GLFSVKSDVFSFGVLLLETLT 712
           G +  K D+++ G +  E L+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
            ++ +  ++G G +G VYK   L  G+  AVK +  + G      + E+ ++ + +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLN--FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           V   G  + + +  +  EY    SL   + +  P     + +  R  +     QGL YLH
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
              ++   HRD+K +NILL  + + K++DFG+A            K  +GT  +M+PE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178

Query: 690 L---DGLFSVKSDVFSFGVLLLE 709
               +G ++   D+++ G+  +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 37/211 (17%)

Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
           +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H N++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK-----------IIEGIAQG 624
                       + P +SL  F      THL+G      VK           +I  I +G
Sbjct: 85  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G     V T  Y 
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184

Query: 685 SPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
           +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 62/195 (31%), Positives = 90/195 (46%), Gaps = 15/195 (7%)

Query: 521 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLMG 576
           LG G FG V   +     +  A+K LS      LK+     NE  ++  ++H  LV L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              +     L+ EY+P   L F     S         R    + +   L YLH    L I
Sbjct: 69  SFQDDSNLYLVMEYVPGGEL-FSHLRKSG-RFPEPVARFYAAQ-VVLALEYLHS---LDI 122

Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV 696
           ++RDLK  N+LLDSD   KI+DFG A+      ++G T  + GT  Y++PE  L   +  
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177

Query: 697 KSDVFSFGVLLLETL 711
             D ++ G+L+ E L
Sbjct: 178 AVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.8 bits (181), Expect = 1e-13
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 21/165 (12%)

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           Q LL +H      +IHRD+K++NILL S+   K+ DFG ++M+         +   GT  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF---NLLGHAWNLWKDNR 739
           Y++PE      +S K+D+FS GVLL E LT KR     ++E      L G          
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR--------- 261

Query: 740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 784
            Y+ L P++  E       + I  ALL    K   RP+ SK+++M
Sbjct: 262 -YDPLPPSISPEM------QEIVTALLSSDPKR--RPSSSKLLNM 297

Length = 496

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 21/200 (10%)

Query: 521 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   + +  KR+  + G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--IAQGLLYLHQYS 632
                 +    L+   M    L F +++       G++    +     I  GL  LH+ +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLHREN 122

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALD 691
               ++RDLK  NILLD   + +ISD G+A ++  G+ ++G     VGT GYM+PE   +
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNN 175

Query: 692 GLFSVKSDVFSFGVLLLETL 711
             +++  D +  G L+ E +
Sbjct: 176 QRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V K +      +  ++L     +     +   E+ ++ +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 628
           +V   G     GE  +  E+M   SL+  L +  R    +LG     K+   + +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
            +  + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 689 ALDGLFSVKSDVFSFGVLLLE 709
                +SV+SD++S G+ L+E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 16/196 (8%)

Query: 520 KLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           K+GEG  G V    +   G++VAVK++  +  Q  +   NE++++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
           +   E  ++ E++   +L   +     TH  +  +    +   + + L YLH      +I
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140

Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFS 695
           HRD+K+ +ILL SD   K+SDFG    FC    +   KR  +VGT  +M+PE      + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 696 VKSDVFSFGVLLLETL 711
            + D++S G++++E +
Sbjct: 197 TEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 31/208 (14%)

Query: 521 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                 +    L+   M    L F +       FD  R      +        I  GL  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSP 686
           LH   R RI++RDLK  NILLD   + +ISD G+A  +  G+ ++G     VGT GYM+P
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSK 714
           E   +  ++   D +  G L+ E +  K
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 20/192 (10%)

Query: 537 GQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLM--GCCVEQGEKILIYEYM 591
           G EVA+K L + + +   +   F+ E  L A+L H N+V L+  G     G    ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--- 648
           P ++L   L   +    L      +++  +   L   H      I+HRDLK  NI++   
Sbjct: 62  PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115

Query: 649 DSDMNPKISDFGMARMFCG----DELQGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSF 703
               + K+ DFG+  +  G    D      T  V+GT  Y +PE       +  SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 704 GVLLLETLTSKR 715
           G++ LE LT +R
Sbjct: 176 GLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.8 bits (177), Expect = 3e-13
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 33/207 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 566
             + +  KLG+G +G V+K       + VA+K++     ++   Q  + F+ E+M + +L
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQEL 63

Query: 567 -QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
             H N+V+L+     + +K   L++EYM    L+  +    R ++L    +  I+  + +
Sbjct: 64  GDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRYIMYQLLK 118

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-----VV 678
            L Y+H  S   +IHRDLK SNILL+SD   K++DFG+AR     EL+ N +       V
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS--ELEENPENPVLTDYV 173

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGV 705
            T  Y +PE  L       S  ++ GV
Sbjct: 174 ATRWYRAPEILL------GSTRYTKGV 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVV 678
           IA GL +LH      II+RDLK  N++LD++ + KI+DFGM +  +F G      T+   
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
           GT  Y++PE      +    D ++FGVLL E L
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 87/337 (25%), Positives = 132/337 (39%), Gaps = 89/337 (26%)

Query: 521 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K  + + VAVK L  + G    E+K  M    +LI    H N
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72

Query: 571 LVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL------FDPSRTHLL-------------- 609
           +V L+G C + G  ++ I EY    +L+ +L      F P R                  
Sbjct: 73  VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132

Query: 610 -------------GWQT--RVKIIEGIAQG-------------LLYLHQYSR-------L 634
                        G+     +  +E   +G             + Y  Q +R        
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMSPEYALDG 692
           + IHRDL A NILL  +   KI DFG+AR    D   ++    R+     +M+PE   D 
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250

Query: 693 LFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
           +++ +SDV+SFGVLL E  +L +    GV   E F          +      + +P    
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--------CRRLKEGTRMRAPEYAT 302

Query: 751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
              Y ++       L C      DRPT S++V ++ +
Sbjct: 303 PEIYSIM-------LDCWHNNPEDRPTFSELVEILGD 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 24/172 (13%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 677
           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR    D    ++GN +  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 737
           V    +M+PE   D +++V+SDV+S+G+LL E  +  ++   Y             +  +
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP--YP-----------GILVN 321

Query: 738 NRAYELLSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
           ++ Y+++    Q     +     Y ++  +C   +  +RPT S++  +I  +
Sbjct: 322 SKFYKMVKRGYQMSRPDFAPPEIY-SIMKMCWNLEPTERPTFSQISQLIQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 510 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK--NEMMLIAKL 566
           AAT   +++ KLGEG +  VYKG   +NGQ VA+K +S ++ +G+  F    E  L+  L
Sbjct: 3   AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +H N+V L      +     ++EYM      + +  P   H   +  R+ + + + +GL 
Sbjct: 61  KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH--PYNVRLFMFQ-LLRGLA 117

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           Y+H      I+HRDLK  N+L+      K++DFG+AR       Q  +  VV T  Y  P
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPP 172

Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           +  L    +S   D++  G + +E L
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVV 678
           I  GL +LH+     II+RDLK  N+LLDS+ + KI+DFGM +  +  G      T    
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
           GT  Y++PE      +    D ++ GVLL E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 31/205 (15%)

Query: 521 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLM 575
           LG+G FG V   +L    E  A+K L         + +  M+    L    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 576 GCCVEQGEKILIY--EYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
             C  Q ++ L +  EY+    L F +     FD +R      +        I  GL +L
Sbjct: 63  --CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICGLQFL 112

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSP 686
           H+     II+RDLK  N+LLD D + KI+DFGM    C + + G  K     GT  Y++P
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGM----CKENMNGEGKASTFCGTPDYIAP 165

Query: 687 EYALDGLFSVKSDVFSFGVLLLETL 711
           E      ++   D +SFGVLL E L
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 65/250 (26%), Positives = 105/250 (42%), Gaps = 56/250 (22%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG------------------LKEFKNEMM 561
           LGEG +G V K    L G+ VA+K++                         L+E K    
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN---KSLNFFLFDPSRTHLLGWQTRVKII 618
           ++ +++H N++ L+   VE     L+ + M +   K ++       +  L   Q +  I+
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD------RKIRLTESQVKC-IL 125

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN----- 673
             I  GL  LH++     +HRDL  +NI ++S    KI+DFG+AR +             
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 674 --------TKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKR-NTGVYDIE 723
                   T +VV T  Y +PE  +    +    D++S G +  E LT K    G  +I+
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241

Query: 724 S----FNLLG 729
                F LLG
Sbjct: 242 QLGRIFELLG 251

Length = 335

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN----- 558
             +V   T  +     +G G FG V   +  L GQ VA+K++       +K F       
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54

Query: 559 ----EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 614
               E+ L+  L+H N++ L    +   E I     +    L+  L     +  L  Q  
Sbjct: 55  RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFI 110

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
              +  I +GL Y+H      ++HRDLK SNIL++ + + KI DFG+AR+    ++ G  
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTG-- 164

Query: 675 KRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
              V T  Y +PE  L    + V+ D++S G +  E L  K
Sbjct: 165 --YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 22/202 (10%)

Query: 521 LGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLK-----EFKNEMMLIAKLQHRNL 571
           LG+G FG V+  + +     GQ  A+K L   +   LK       K E  ++A++ H  +
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQ 630
           V+L      +G+  LI +++    L    F      ++  +  VK  +  +A  L +LH 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
              L II+RDLK  NILLD + + K++DFG+++     E +       GT  YM+PE   
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171

Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
               +  +D +SFGVL+ E LT
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 18/195 (9%)

Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           K+GEG  G V    +  +G+ VAVK++  +  Q  +   NE++++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQYSRLRII 637
           +   E  ++ E++   +L   +     TH    + ++  +   + + L  LH      +I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138

Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGD---ELQGNTKRVVGTYGYMSPEYALDGLF 694
           HRD+K+ +ILL  D   K+SDFG    FC     E+    K +VGT  +M+PE      +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVP-RRKSLVGTPYWMAPELISRLPY 193

Query: 695 SVKSDVFSFGVLLLE 709
             + D++S G++++E
Sbjct: 194 GPEVDIWSLGIMVIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 22/154 (14%)

Query: 519 CKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
            KLGEG +  VYKG+  L GQ VA+K  RL  + G      + E  L+  L+H N+V L 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
                +    L++EY+ +  L  ++             L  +Q        + +GL Y H
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 663
           Q    R++HRDLK  N+L+      K++DFG+AR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 29/217 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKL 566
             +     +GEG +G V        G +VA+K++S    Q      L+E K    ++ + 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60

Query: 567 QHRNLVRLMGC----CVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           +H N++ ++        E    + ++ E M        L+   +T  L        +  I
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV---V 678
            +GL Y+H  +   ++HRDLK SN+LL+++ + KI DFG+AR+   D    +T  +   V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170

Query: 679 GTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
            T  Y +PE  L+     K+ D++S G +L E L+++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 51/148 (34%), Positives = 76/148 (51%), Gaps = 12/148 (8%)

Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           KLGEG +  VYKGK  +NG+ VA+K  RL  + G      + E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 635
               +    L++EY+      +    P   H       VK+ +  + +GL Y+HQ     
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHPGGLH----PENVKLFLFQLLRGLSYIHQRY--- 123

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMAR 663
           I+HRDLK  N+L+      K++DFG+AR
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 29/204 (14%)

Query: 521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLM 575
           LG+G FG V+  +L    Q  A+K L         + +  M+    L    +H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 576 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            C  +  E +  + EY+    L F +     FD  R      +        I  GL +LH
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQFLH 113

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPE 687
                 I++RDLK  NILLD+D + KI+DFGM    C + + G+ K     GT  Y++PE
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGM----CKENMLGDAKTCTFCGTPDYIAPE 166

Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
             L   ++   D +SFGVLL E L
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           KLGEG +  VYKG+  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
               +    L++EY+ +K L  +L D    + +        +  + +GL Y H   R ++
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRKV 125

Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGL-F 694
           +HRDLK  N+L++     K++DFG+AR      +   T    V T  Y  P+  L    +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S + D++  G +  E  T +
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 18/217 (8%)

Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
           L+++      F +   +G G +G VYKG+ +   ++A  ++   +    +E K E+ ++ 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 565 KL-QHRNLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 617
           K   HRN+    G  +++       +  L+ E+    S+   L   ++ + L       I
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              I +GL +LH +   ++IHRD+K  N+LL  +   K+ DFG++     D   G     
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181

Query: 678 VGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLE 709
           +GT  +M+PE        D  +  +SD++S G+  +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQH 568
           ++      +G G FG V+  +  ++    A+K ++      LK+     NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
             ++RL     +Q    ++ EY+P   L  +L +  R       T +     I   L YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H      I++RDLK  NILLD + + K++DFG A+     +L+  T  + GT  Y++PE 
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169

Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
                 +   D ++ G+L+ E L
Sbjct: 170 IQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 577
           CK+G G +G VYK K  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 578 CVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY-----LHQ 630
            +   ++   L+++Y  +   +   F  +       +  V++  G+ + LLY     +H 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 631 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQ--GNTKRVVGTYGY 683
                ++HRDLK +NIL+  +  P     KI+D G AR+F    L+   +   VV T+ Y
Sbjct: 124 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWY 181

Query: 684 MSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
            +PE  L      K+ D+++ G +  E LTS+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)

Query: 521 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                 +    L+   M    L F +++       G+  +  I    A+    L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYA-AELCCGLEDLQRE 121

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
           RI++RDLK  NILLD   + +ISD G+A ++  G+ ++G     VGT GYM+PE   +  
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177

Query: 694 FSVKSDVFSFGVLLLETL 711
           ++   D +  G L+ E +
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 9/149 (6%)

Query: 520 KLGEGGFGPVYKGKL---LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           ++G G FG V  G++       +V VK L  S S Q   +F  E      LQH NL++ +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KIIEGIAQGLLYLHQYSR 633
           G C E    +L+ E+ P   L  +L    +  L+        ++   IA GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMA 662
              IH DL   N LL +D+  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 8/196 (4%)

Query: 521 LGEGGFG-PVYKGKLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           +GEG FG  +    + + Q+ A+K +   +S   +++ + E +L+AK++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
              G   ++ EY     L   +    R  L    T ++    +  G+ ++H+    R++H
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLH 123

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 698
           RD+K+ NI L  +   K+ DFG AR+         T   VGT  Y+ PE   +  ++ KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKS 181

Query: 699 DVFSFGVLLLETLTSK 714
           D++S G +L E  T K
Sbjct: 182 DIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E ++   ++G G +G V        G++VA+K+LS   QS    K    E+ L+  +QH 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGI 621
           N++ L+          +  +   +    F+L  P           H L       ++  +
Sbjct: 75  NVIGLLDVFTSA----VSGDEFQD----FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
             GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+ G     V T 
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178

Query: 682 GYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
            Y +PE  L+ +   ++ D++S G ++ E LT K
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 48/129 (37%), Positives = 66/129 (51%), Gaps = 9/129 (6%)

Query: 586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
           LI +Y+    L   L+   R H    + RV I E I   L +LHQ   L II+RD+K  N
Sbjct: 82  LILDYVNGGELFTHLY--QREHFTESEVRVYIAE-IVLALDHLHQ---LGIIYRDIKLEN 135

Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--DGLFSVKSDVFSF 703
           ILLDS+ +  ++DFG+++ F  +E +       GT  YM+PE      G      D +S 
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194

Query: 704 GVLLLETLT 712
           GVL  E LT
Sbjct: 195 GVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 521 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   +++  KRL  +SG+ +   + E++   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ---GLLYLHQY 631
                 +    L+   M    L + +++     L       ++I   AQ   G+L+LH  
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL----EMERVIHYSAQITCGILHLHS- 113

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
             + I++RD+K  N+LLD   N ++SD G+A      +      +  GT GYM+PE   +
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKE 168

Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +S   D F+ G  + E +  +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHRN-LVRLM 575
           K+GEG +G VYK +    G+ VA+K+       +G+      E+ L+  L     +VRL+
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 576 GCCVEQGE----KILIY---EYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLL 626
              VE  E    K  +Y   EY+ +  L  F+    R     L  +T    +  + +G+ 
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
           + H++    ++HRDLK  N+L+D      KI+D G+ R F    ++  T  +V T  Y +
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYRA 179

Query: 686 PEYALDGL-FSVKSDVFSFGVLLLETLT 712
           PE  L    +S   D++S G +  E   
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 628
           +V   G     GE  +  E+M   SL+  L    R    +LG     K+   + +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 119

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
            +  + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 689 ALDGLFSVKSDVFSFGVLLLE 709
                +SV+SD++S G+ L+E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 29/204 (14%)

Query: 521 LGEGGFGPVYKGKLL-NGQEVAVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           LG+G FG V   +L  +G+  AVK L      Q          + +L     H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 576 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            CC +  +++  + E++    L F +     FD +R      +        I   L++LH
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPE 687
                 II+RDLK  N+LLD + + K++DFGM    C + +     T    GT  Y++PE
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGM----CKEGIFNGKTTSTFCGTPDYIAPE 166

Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
              + L+    D ++ GVLL E L
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 32/147 (21%)

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           LM  C+++     I   +P               +LG     K+   I + L YL +  +
Sbjct: 95  LMSTCLDK-LLKRIQGPIPE-------------DILG-----KMTVAIVKALHYLKE--K 133

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALD- 691
             +IHRD+K SNILLD+  N K+ DFG++ R+    + +  T R  G   YM+PE  +D 
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPE-RIDP 188

Query: 692 ----GLFSVKSDVFSFGVLLLETLTSK 714
                 + +++DV+S G+ L+E  T +
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 32/175 (18%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 677
           +A+G+ +L   SR + IHRDL A NILL  +   KI DFG+AR    D     +G+ +  
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
           +    +M+PE   D +++ +SDV+SFGVLL E  +L +    GV   E F          
Sbjct: 240 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRL 290

Query: 736 KDN---RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           KD    RA E  +P +              + L C Q    +RPT S +V ++ +
Sbjct: 291 KDGTRMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 520 KLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
           +LG+G +G VYK      G  +  +E+ ++   S+  Q + E    + ++ K     +V 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIME----LDILHKAVSPYIVD 63

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
             G    +G   +  EYM   SL+        T  +      +I   + +GL +L +   
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--E 121

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY----- 688
             IIHRD+K +N+L++ +   K+ DFG++    G+ +    K  +G   YM+PE      
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGG 177

Query: 689 -ALDGLFSVKSDVFSFGVLLLE 709
              +  ++V+SDV+S G+ +LE
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 4e-11
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  ++H N++ L+
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 576 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                   +E   ++ +   +    LN  +    +   L  +    +I  + +GL Y+H 
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                IIHRDLK SN+ ++ D   +I DFG+AR    DE+ G     V T  Y +PE  L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188

Query: 691 DGL-FSVKSDVFSFGVLLLETLTSK 714
           + + ++   D++S G ++ E L  K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 10/192 (5%)

Query: 521 LGEGGFGPVYKGKLLNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 577
           +GEG +G V K +    +E VA+K+   S+  + +KE    E+ ++  L+  N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
              +G+  L++EY+    L      P+           K+   I Q +  +H   +  I+
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGV------PPEKVRSYIYQLIKAIHWCHKNDIV 122

Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVK 697
           HRD+K  N+L+  +   K+ DFG AR    +    N    V T  Y SPE  L   +   
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 698 SDVFSFGVLLLE 709
            D++S G +L E
Sbjct: 182 VDMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 521 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +G GGFG VY       GK+   + +  KR+  + G+ L   +  M+ +        +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 575 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           M       +K+  I + M    L++ L   S+  +            I  GL ++H  +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--NR 116

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
             +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT+GYM+PE    G+
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGV 171

Query: 694 -FSVKSDVFSFGVLLLETL 711
            +   +D FS G +L + L
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 14/211 (6%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
           +G+G +G V   +   +G++  +K+L+ +  S +  K  + E  L+++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 578 CVEQGEKILIYEYM---PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
              +GE  L+Y  M       L +      +  LL     V+    IA  L YLH+    
Sbjct: 68  W--EGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
            I+HRDLK  N+ L      K+ D G+AR+        +T  ++GT  YMSPE   +  +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPY 179

Query: 695 SVKSDVFSFGVLLLETLTSKRNTGVYDIESF 725
           + KSDV++ G  + E  T K      D+ S 
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.9 bits (158), Expect = 6e-11
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 26/170 (15%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 677
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN +  
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
           V    +M+PE   + +++ +SDV+S+G+LL E  +L S    G+     F      + + 
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF------YKMI 330

Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           K+   Y +LSP       Y ++         C       RPT  ++V +I
Sbjct: 331 KE--GYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 32/230 (13%)

Query: 537 GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------MGCCVEQG 582
            + VAVK++     Q +K    E+ +I +L H N+V++              +G   E  
Sbjct: 30  DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89

Query: 583 EKILIYEYMPN---KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
              ++ EYM       L           L  +Q        + +GL Y+H  +   ++HR
Sbjct: 90  SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHR 138

Query: 640 DLKASNILLDS-DMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGLFSVK 697
           DLK +N+ +++ D+  KI DFG+AR+       +G     + T  Y SP   L      K
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198

Query: 698 S-DVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           + D+++ G +  E LT K    G +++E   L+  +  + ++    ELL+
Sbjct: 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 32/187 (17%)

Query: 537 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 594
           G  VAVK+LS   Q+    K    E++L+  + H+N++ L+              + P K
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93

Query: 595 SLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 642
           SL  F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK
Sbjct: 94  SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150

Query: 643 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFS 702
            SNI++ SD   KI DFG+AR  C + +   T  VV  Y Y +PE  L   +    D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWS 207

Query: 703 FGVLLLE 709
            G ++ E
Sbjct: 208 VGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)

Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLV 572
           LG+GG+G V++ + + G +     A+K L      ++ +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L+      G+  LI EY+    L   L    R  +    T    +  I+  L +LHQ  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPEYAL 690
              II+RDLK  NILLD+  + K++DFG+    C + +     T    GT  YM+PE  +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGL----CKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
                   D +S G L+ + LT
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLT 195

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 12/148 (8%)

Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           KLGEG +  V+KG+  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 635
                    L++EY+ +K L  ++ D      +     VKI +  I +GL Y H   R +
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCH---RRK 124

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMAR 663
           ++HRDLK  N+L++     K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 30/209 (14%)

Query: 516 SMQCKLGE----GGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHR 569
            +   +G+         + K K      VAVK+  L S S + LK  + E++   +LQH 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLL-GWQTRV--KIIEGIAQGLL 626
           N++  +   +   E  ++   M   S    L    +TH   G        I++ +   L 
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALD 115

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 682
           Y+H       IHR +KAS+ILL  D    +S    +         G  +RVV  +     
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK---HGKRQRVVHDFPKSSV 169

Query: 683 ----YMSPEYALDGL--FSVKSDVFSFGV 705
               ++SPE     L  ++ KSD++S G+
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 577
           CK+G G +G VYK K  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 578 CVEQGEK--ILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEG----IAQGLLYLHQ 630
            +   ++   L+++Y  +   +   F   S+ +    Q    +++     I  G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 631 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQ--GNTKRVVGTYGY 683
                ++HRDLK +NIL+  +  P     KI+D G AR+F    L+   +   VV T+ Y
Sbjct: 127 N---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWY 181

Query: 684 MSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
            +PE  L      K+ D+++ G +  E LTS+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.4 bits (157), Expect = 7e-11
 Identities = 57/195 (29%), Positives = 82/195 (42%), Gaps = 48/195 (24%)

Query: 537 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 594
           GQ VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P K
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQK 88

Query: 595 SLNFF--------------------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           SL  F                      D  R   L +Q           G+ +LH     
Sbjct: 89  SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAG-- 138

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
            IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +
Sbjct: 139 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGY 194

Query: 695 SVKSDVFSFGVLLLE 709
               D++S G ++ E
Sbjct: 195 KENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAK 565
           NF +   LG G +G V+  + ++G +     A+K L      Q  +  +  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 566 LQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQ 623
           ++    +  +    +   K+ LI +Y+    L   L    R      +  V+I  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
            L +LH   +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE++       GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172

Query: 684 MSPEYAL--DGLFSVKSDVFSFGVLLLETLT 712
           M+P+     DG      D +S GVL+ E LT
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 49/230 (21%)

Query: 520 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ-SGQGL--KEFKNEMMLIAKLQHRNLVRLM 575
            +G+GG G VY     +  + VA+K++    S   L  K F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG--WQ-----------TRVK----II 618
             C   G+   +Y  MP      ++   +   LL   WQ           T V     I 
Sbjct: 69  SIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE-----LQGN 673
             I   + Y+H  S+  ++HRDLK  NILL       I D+G A     +E     +  +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 674 TK-----------RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            +           ++VGT  YM+PE  L    S  +D+++ GV+L + LT
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 2e-10
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 37/211 (17%)

Query: 521 LGEGGFGPV-YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
           +G G +G V        G +VA+K+L    QS    K    E+ L+  ++H N++ L+  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 578 CVEQGEKILIYEYMPNKSLN----FFLFDPSRTHLLG--------WQTRVK-IIEGIAQG 624
                       + P+ SL+    F+L  P     LG         + R++ ++  + +G
Sbjct: 83  ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  Y 
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWYR 182

Query: 685 SPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
           +PE  L+ + ++   D++S G ++ E LT K
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 7/96 (7%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           I +GL YLH      I+HRD+K  N+L++S+   KI DFG+AR+   DE +  T+ VV  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 681 YGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSK 714
           Y Y +PE  L G   ++   D++S G +  E L  +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 29/204 (14%)

Query: 521 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 575
           LG+G FG V   +L    EV A+K L         +    M    +L    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 576 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            CC +  +++  + EY+    L F +     FD  R+     +        +   L++LH
Sbjct: 63  -CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE--------VTLALMFLH 113

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPE 687
           ++    +I+RDLK  NILLD++ + K++DFGM    C + +     T    GT  Y++PE
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGM----CKEGILNGVTTTTFCGTPDYIAPE 166

Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
              +  +    D ++ GVL+ E +
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 60/224 (26%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAKLQHRN 570
           +G G +G V   K     ++VA+K+++         F N         E+ L+  L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 571 LVRL----MGCCVEQGEKI-LIYEYM---------PNKSLN-----FFLFDPSRTHLLGW 611
           ++ +         E    + ++YE M          +++L+     +FL+          
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116

Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
                    + +GL Y+H  +   ++HRDLK SN+LL+++ + KI DFG+AR        
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-D 163

Query: 672 GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
             T+ VV T  Y +PE  L+   ++   DV+S G +  E L  K
Sbjct: 164 FMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 29/223 (13%)

Query: 505 LASVSAATENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 563
           L S+   T+ + +   +G+G +G VYK     +G   AVK L   S    +E + E  ++
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72

Query: 564 AKL-QHRNLVRLMGCCVEQ-----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK- 616
             L  H N+V+  G   +      G+  L+ E     S+   +       LL    R+  
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127

Query: 617 -----IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
                I+ G   GL +LH     RIIHRD+K +NILL ++   K+ DFG++       L+
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 672 GNTKRVVGTYGYMSPEY-----ALDGLFSVKSDVFSFGVLLLE 709
            NT   VGT  +M+PE        D  +  + DV+S G+  +E
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 19/199 (9%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 575
           +G+G FG V   K   +G+  AVK L  ++    KE K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 576 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +  +K+  + +Y+    L FF     R      + R    E IA  L YLH    L
Sbjct: 63  -YSFQTADKLYFVLDYVNGGEL-FFHLQRER-SFPEPRARFYAAE-IASALGYLHS---L 115

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPEYALDG 692
            II+RDLK  NILLDS  +  ++DFG+    C + ++ +  T    GT  Y++PE     
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGL----CKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 693 LFSVKSDVFSFGVLLLETL 711
            +    D +  G +L E L
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 63/225 (28%)

Query: 520 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLV 572
            +G G +G V       +G++VA+K++           + L+E K    ++   +H N++
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67

Query: 573 --------------------RLMGCCVEQGEKILIYEYMP--NKSLNFFLFDPSRTHLLG 610
                                LM   +      +I+   P   + + +FL+         
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMESDLHH----IIHSDQPLTEEHIRYFLYQ-------- 115

Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG--D 668
                     + +GL Y+H  +   +IHRDLK SN+L++ D   +I DFGMAR       
Sbjct: 116 ----------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162

Query: 669 ELQGNTKRVVGTYGYMSPE--YALDGLFSVKSDVFSFGVLLLETL 711
           E +      V T  Y +PE   +L   ++   D++S G +  E L
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           IA GL +LH      II+RDLK  N++LDS+ + KI+DFGM +    D +   TK   GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y++PE      +    D ++FGVLL E L  +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 521 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +G GGFG VY       GK+   + +  KR+  + G+ L   +  M+ +        +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 575 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           M       +K+  I + M    L++ L   S+  +   +        I  GL ++H  +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
             +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT+GYM+PE    G 
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGT 171

Query: 694 -FSVKSDVFSFGVLLLETL 711
            +   +D FS G +L + L
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.5 bits (149), Expect = 5e-10
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 17/198 (8%)

Query: 521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 576
           LG+G FG V   +L   G+  AVK L         + +  M+   ++A       +  + 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 577 CCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           C  +  E +  + E++    L F + D  R  L  ++      E I  GL +LH      
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAE-IVCGLQFLHSKG--- 116

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV--GTYGYMSPEYALDGL 693
           II+RDLK  N++LD D + KI+DFGM    C + + G+ +     GT  Y++PE      
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGM----CKENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 694 FSVKSDVFSFGVLLLETL 711
           ++   D +SFGVLL E L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 57/207 (27%), Positives = 84/207 (40%), Gaps = 34/207 (16%)

Query: 521 LGEGGFGPV----YKGKLLNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRN 570
           LG G FG V    YK     G+  A+K L      +    + L   K         +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLL 626
           LV L  C   +     + EY     L   +    F   R               +  GL 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--------VVLGLQ 115

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVVGTYGYM 684
           YLH+    +I++RDLK  N+LLD++   KI+DFG+ +  M  GD     T    GT  ++
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPEFL 168

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETL 711
           +PE   +  ++   D +  GVL+ E L
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 57/173 (32%), Positives = 88/173 (50%), Gaps = 28/173 (16%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 677
           +A+G+ +L   SR + IHRDL A NILL  +   KI DFG+AR    D     +G+ +  
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNL 734
           +    +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +
Sbjct: 245 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 302 ----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 17/198 (8%)

Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 575
           +G+G FG V   K   +G   AVK L  ++    KE  + M    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 576 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQGLLYLHQYSR 633
               +  EK+  + +Y+    L FF     R  L   + R +     +A  + YLH    
Sbjct: 63  -YSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFL---EPRARFYAAEVASAIGYLHS--- 114

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
           L II+RDLK  NILLDS  +  ++DFG+ +   G E +  T    GT  Y++PE      
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 694 FSVKSDVFSFGVLLLETL 711
           +    D +  G +L E L
Sbjct: 173 YDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           KLGEG +  V+KG+  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 635
               +    L++EY+ +  L  +L +      L     VKI +  + +GL Y H   + +
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCH---KRK 123

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGL- 693
           I+HRDLK  N+L++     K++DFG+AR      +   T    V T  Y  P+  L    
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           +S   D++  G +L E  T +
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           I+ GL +LH   R  II+RDLK  N++LDS+ + KI+DFGM +    D +   T+   GT
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGT 164

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y++PE      +    D +++GVLL E L  +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 23/197 (11%)

Query: 524 GGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKLQHRNLVRLMGCC 578
           G FG VY   K   G   A+K L         +  N      +++ + +   + +L    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW---QTRVKIIEGIAQGLLYLHQYSRLR 635
             +    L+ EY+            S    LG        + I  +  G+  LHQ     
Sbjct: 67  QSKDYLYLVMEYLNGGDCA------SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--- 117

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
           IIHRD+K  N+L+D   + K++DFG++R   G E     K+ VGT  Y++PE  L     
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPETILGVGDD 171

Query: 696 VKSDVFSFGVLLLETLT 712
             SD +S G ++ E L 
Sbjct: 172 KMSDWWSLGCVIFEFLF 188

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 59.6 bits (144), Expect = 3e-09
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 16/167 (9%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A G+ +L   +    +HRDL A N+L+      KI DFG+AR    D    +       
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA 740
             +M+PE   + L++  SDV+SFG+LL E  T     G        +    +N  K  R 
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT----LGGTPYPELPMNEQFYNAIK--RG 358

Query: 741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           Y +  PA   +  Y+++ +       C +EK   RP  S++V ++ +
Sbjct: 359 YRMAKPAHASDEIYEIMQK-------CWEEKFEIRPDFSQLVHLVGD 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAK 565
           NF +   LG G +G V+  + + G +     A+K L      Q  + ++  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
           + Q   LV L      + +  LI +Y+    +   L+   R +    + R    E I   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGE-IILA 117

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L +LH   +L I++RD+K  NILLDS+ +  ++DFG+++ F  +E +  T    GT  YM
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173

Query: 685 SPEYALDGLFSVKS-DVFSFGVLLLETLT 712
           +PE         K+ D +S G+L+ E LT
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 6/97 (6%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVV 678
           I  GL Y+H  +   ++HRDLK  N+L+++D   KI DFG+AR F  +  E  G     V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 679 GTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
            T  Y +PE  L      K+ DV+S G +L E L  K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 521 LGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 578
           +G+G +G V+K     NG + AVK L        +E + E  ++  L  H N+V+  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 579 ----VEQGEKI-LIYEYMPNKSLN----FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
               V+ G+++ L+ E     S+      FL    R   +       I+     GL +LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPIIAYILHEALMGLQHLH 141

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY- 688
                + IHRD+K +NILL ++   K+ DFG++       L+ NT   VGT  +M+PE  
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVI 196

Query: 689 ----ALDGLFSVKSDVFSFGVLLLE 709
                LD  +  + DV+S G+  +E
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 72/250 (28%), Positives = 110/250 (44%), Gaps = 27/250 (10%)

Query: 521 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 575
           +G+G FG V   +    ++  AVK L  ++    KE K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQGLLYLHQYSRL 634
                  +   + +Y+    L F+     R  L   + R +     IA  L YLH    L
Sbjct: 63  FSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAEIASALGYLHS---L 115

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
            I++RDLK  NILLDS  +  ++DFG+ +     E  G T    GT  Y++PE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 695 SVKSDVFSFGVLLLETLTS-----KRNTG-VYDIESFNLLGHAWNLWKD--NRAYELLSP 746
               D +  G +L E L        RNT  +YD    N+L     L  +  N A  LL  
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLKPNITNSARHLLEG 229

Query: 747 ALQHEASYQM 756
            LQ + + ++
Sbjct: 230 LLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.2 bits (140), Expect = 1e-08
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 32/183 (17%)

Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE---YMPNKSLN 597
           A  R + Q        +NE++ + +L H N++++        E+IL  E   YM  +  +
Sbjct: 202 AGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANTYMITQKYD 246

Query: 598 F----FLFDPS---RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 650
           F    F++D +   +   L  QTR  I++ +   + Y+H     ++IHRD+K  NI L+ 
Sbjct: 247 FDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302

Query: 651 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE-YALDGLFSVKSDVFSFGVLLLE 709
           D    + DFG A  F   E +      VGT    SPE  A DG   + +D++S G++LL+
Sbjct: 303 DGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLD 360

Query: 710 TLT 712
            L+
Sbjct: 361 MLS 363

Length = 501

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAK----LQHRNLV 572
           ++G G FG V   ++     VA   VK L + +    KE +NE +        LQH N++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKE-QNEFLQQGDPYRILQHPNIL 58

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 626
           + +G CVE    +L++EY     L  +L         S+  LL      ++   IA G+ 
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMS 685
           ++H   +   +H DL   N  L SD+  K+ D+G+    +  D ++    + V    +++
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLA 169

Query: 686 PEYAL---DGLFSVK----SDVFSFGVLLLE 709
           PE       GL + +    S+V++ GV L E
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWE 200

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 60/197 (30%), Positives = 88/197 (44%), Gaps = 15/197 (7%)

Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 575
           +G+G FG V   K  L+G+  AVK L  +     KE K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRL 634
               +  EK+       N    FF     R+     + R +     IA  L YLH    +
Sbjct: 63  -YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLHS---I 115

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
            I++RDLK  NILLDS  +  ++DFG+ +   G      T    GT  Y++PE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 695 SVKSDVFSFGVLLLETL 711
               D +  G +L E L
Sbjct: 174 DNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 548 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 607
           ++  G K    E+ ++  + HR ++ L+        K  +   MP    + F +   R+ 
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSG 180

Query: 608 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
            L  +  + I   + + L YLH      IIHRD+K  NI LD   N  + DFG A   C 
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA---CK 234

Query: 668 DELQGNTKRVVGTYGYM---SPEY-ALDGLFSVKSDVFSFGVLLLETLTSKR 715
            +   +T +  G  G +   SPE  ALD  +  K+D++S G++L E      
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 42/220 (19%)

Query: 513 ENFSMQCKLGEGGFGPV-----------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 561
           E+F +   +G G FG V           Y  KLL+  E+ +KR  S        F  E  
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAF------FWEERD 95

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFD---PSRTHLLGWQTRVK 616
           ++A      +V+L      Q +K L  + EYMP   L   + +   P +     W  R  
Sbjct: 96  IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----W-ARFY 147

Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTK 675
             E +   L  +H       IHRD+K  N+LLD   + K++DFG   +M     ++ +T 
Sbjct: 148 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT- 202

Query: 676 RVVGTYGYMSPEYAL----DGLFSVKSDVFSFGVLLLETL 711
             VGT  Y+SPE       DG +  + D +S GV L E L
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 58/189 (30%), Positives = 87/189 (46%), Gaps = 28/189 (14%)

Query: 538 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           + VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL 
Sbjct: 50  RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99

Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156

Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213

Query: 706 LLLETLTSK 714
           ++ E +   
Sbjct: 214 IMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 55/231 (23%)

Query: 521 LGEGGFGPVYKGKLLNGQEV-AVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V+  +  +  +V A+K L      +  Q     + E  ++A      +V+L 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWIVKLY 67

Query: 576 GCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------IAQGLLY 627
                Q E+ L  + EYMP   L            +    R  +         IA+ +L 
Sbjct: 68  --YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVLA 113

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA--------RMFCGDELQGNTKR--- 676
           L    +L  IHRD+K  NIL+D+D + K++DFG+         R +  ++      R   
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 677 ----------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
                            VGT  Y++PE      + ++ D +S GV+L E L
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 16/204 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQ--EVAVKRLSSQSGQGLKEFK---NEMMLIAKLQ 567
           E+F+    LG G FG V      N     VA+KR         K+     +E  ++  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H   V L G   ++    L+ E++       FL    R     +   V      AQ +L 
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYA-AQIVLI 143

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
                 L I++RDLK  N+LLD D   K++DFG A++     +   T  + GT  Y++PE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198

Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
             L+      +D ++ G+ + E L
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 31/210 (14%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHR 569
           +F M   LG G FG V   K    G+  A+K L  +    +K+ ++   E  ++ +L H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ------ 623
            +V +M    ++     + E++    L    F    THL   +   +    +A+      
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGEL----F----THL---RKAGRFPNDVAKFYHAEL 127

Query: 624 --GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
                YLH      II+RDLK  N+LLD+  + K++DFG A+     ++   T  + GT 
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTP 179

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
            Y++PE           D ++ GVLL E +
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 59/189 (31%), Positives = 88/189 (46%), Gaps = 28/189 (14%)

Query: 538 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           + VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL 
Sbjct: 43  RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92

Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 93  EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149

Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 206

Query: 706 LLLETLTSK 714
           ++ E +  K
Sbjct: 207 IMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 2/92 (2%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++   D+ + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
             Y++PE  L   ++   D ++ GVLL E LT
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +    +HRDL A N+LL      KI DFG+AR    D    +       
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
             +M+PE   D L++  SDV+S+G+LL E  +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 5e-08
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           IA+ +L L    +  I++RDLK  NILLD+  +  + DFG+++    D    NT    GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159

Query: 681 YGYMSPEYALDGL-FSVKSDVFSFGVLLLE 709
             Y++PE  LD   ++   D +S GVL+ E
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.5 bits (133), Expect = 5e-08
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 22/203 (10%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   +   +G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
               +     + EY+    L F L     F   RT   G +        I   L YLH  
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE--------IVSALDYLHSG 114

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
              +I++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLED 169

Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 12/149 (8%)

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H  LV L  C   +     + EY+    L F +    +  L     R    E I+  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTYGYMS 685
           LH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    GT  Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFCGTPNYIA 164

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           PE      +    D ++ GVL+ E +  +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 49.9 bits (119), Expect = 9e-08
 Identities = 23/83 (27%), Positives = 44/83 (53%), Gaps = 8/83 (9%)

Query: 339 TRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMW- 396
           + + F++  + KLP    + ++   +L+EC ++CL  NC+CR++  +    G  GCL+W 
Sbjct: 2   SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWS 57

Query: 397 FGDLIDIRKITGYNNGQPIYVRV 419
              L D R     + G  +Y ++
Sbjct: 58  ESSLGDARL--FPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 2/159 (1%)

Query: 557 KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK 616
           ++E+  +A   H  +V+         + +LI EY     LN  +    + HL   +  V 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           ++    Q +L L +    +++HRDLK++NI L      K+ DFG ++ +           
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 715
             GT  Y++PE      +S K+D++S GV+L E LT  R
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 521 LGEGGFGPVYKGKLLN---------GQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRN 570
           LG+G F  +YKG L           GQEV+V   +     +    F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           LV+L G CV   E I++ EY+    L+ FL        L W+  V   + +A  L YL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119

Query: 631 YSRLRIIHRDLKASNILL---DSDMNP----KISDFGMAR-MFCGDELQGNTKRVVGTYG 682
               +++H ++   NIL+     +       K+SD G+   +   +E             
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169

Query: 683 YMSPEYALDGLFSVKS--DVFSFGVLLLE 709
           +++PE   +G  S+    D +SFG  LLE
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE 198

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-GNT-KRVV 678
           I   L YLH      +++RDLK  N++LD D + KI+DFG+    C + +  G T K   
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFC 156

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
           GT  Y++PE   D  +    D +  GV++ E +
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 44/146 (30%), Positives = 67/146 (45%), Gaps = 12/146 (8%)

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           LV L  C        L+ EY+    L F +    +  L     R    E I   L +LH+
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHE 114

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVVGTYGYMSPEY 688
                II+RDLK  N+LLD+D + K++D+GM +  +  GD     T    GT  Y++PE 
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEI 167

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSK 714
                +    D ++ GVL+ E +  +
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 21/158 (13%)

Query: 521 LGEGGFGPVYKGKL--------LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           LG+G F  ++KG          L+  EV +K L        + F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
              G CV   E I++ EY+   SL+ +L      +L+    ++++ + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 633 RLRIIHRDLKASNILL-----DSDMNP---KISDFGMA 662
              + H ++ A N+LL         NP   K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           I   L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y++PE   D  +    D +  GV++ E +  +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 13/98 (13%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVV 678
           I+  L +LH+     II+RDLK  N+LLD++ + K++D+GM    C + ++    T    
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM----CKEGIRPGDTTSTFC 157

Query: 679 GTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSK 714
           GT  Y++PE     D  FSV  D ++ GVL+ E +  +
Sbjct: 158 GTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 4/94 (4%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           I   L YLH  S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGT 159

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y++PE   D  +    D +  GV++ E +  +
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 49/216 (22%)

Query: 521 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGC- 577
           +G G FG VY+   ++  E VA+K++         ++KN E++++  L H N++ L    
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128

Query: 578 ---CVEQGEKIL----IYEYMP-------------NKSLNFFLFDPSRTHLLGWQTRVKI 617
              C ++ EK +    + E++P             N +L  FL       L  +Q     
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL-----VKLYSYQ----- 178

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKR 676
              + + L Y+H  S+  I HRDLK  N+L+D + +  K+ DFG A+     +    +  
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVS 229

Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 711
            + +  Y +PE  L    ++   D++S G ++ E +
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 16/100 (16%)

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM---------FCG----DELQ 671
           L YLH Y    I+HRDLK  N+L+ S  + K++DFG++++         + G    D  +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
              K+V GT  Y++PE  L   +    D ++ G++L E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 36/97 (37%), Positives = 47/97 (48%), Gaps = 10/97 (10%)

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTY 681
           + L Y+H  +   + HRDLK  NIL ++D   KI DFG+AR  F            V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 682 GYMSPEYALDGLFSVKS----DVFSFGVLLLETLTSK 714
            Y +PE  L G F  K     D++S G +  E LT K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 30/146 (20%), Positives = 56/146 (38%), Gaps = 13/146 (8%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCC 578
            L  G    VY       ++  +K   S+     +E +  ++ +   +    V +++   
Sbjct: 5   LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
              G   L+ E++  ++L+              + +  I E +A+ L  LHQ   L + H
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSE----------EEKEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 639 RDLKASNILLDSDMNPKISDFGMARM 664
            DL   NIL+D      I D+  A  
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQ 567
           E++ +   +G G FG V   +  + Q+V   +L S+  + +K      F  E  ++A   
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF-EMIKRSDSAFFWEERDIMAFAN 101

Query: 568 HRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKIIEGIA 622
              +V+L   C  Q +K L  + EYMP   L   + +   P +     W          A
Sbjct: 102 SPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT-----A 149

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           + +L L     + +IHRD+K  N+LLD   + K++DFG   M   +         VGT  
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPD 208

Query: 683 YMSPEY----ALDGLFSVKSDVFSFGVLLLETL 711
           Y+SPE       DG +  + D +S GV L E L
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVG 679
           IA+ +L +H   +L  +HRD+K  N+LLD + + +++DFG   +M     +Q +    VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVG 165

Query: 680 TYGYMSPEY--ALD---GLFSVKSDVFSFGVLLLETL 711
           T  Y+SPE   A++   G +  + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVG 679
           +A+ +L +    +L  +HRD+K  N+LLD + + +++DFG   R+     +Q N    VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165

Query: 680 TYGYMSPEY--ALD---GLFSVKSDVFSFGVLLLETL 711
           T  Y+SPE   A++   G +  + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 3e-06
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E F +   +  G FG VY G K  N +  AVK +         +  N+ M+      R+ 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57

Query: 572 VRLMGC--CV------EQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGW---QTRVKIIE 619
           + L      V      +    + L+ EY+    +   L      H+ G+   +  VK I 
Sbjct: 58  LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL------HIYGYFDEEMAVKYIS 111

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
            +A  L YLH++    IIHRDLK  N+L+ ++ + K++DFG++++
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 4e-06
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 46/231 (19%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA-----KLQHRNLVRL 574
           K+G G FG V+  K    QE    +  + S +GLKE +   ++I      +L+H+N+VR 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 575 MGCCVEQGEKIL--IYEYMPNKSLN------FFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +   + +  + L  + E+     L+      + +F     H +     V I   +   L 
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDITRQLLHALA 132

Query: 627 YLHQY----SRLRIIHRDLKASNILLDSDMN-----------------PKISDFGMARMF 665
           Y H      +  R++HRDLK  NI L + +                   KI DFG+++  
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSV--KSDVFSFGVLLLETLTSK 714
               ++      VGT  Y SPE  L    S   KSD+++ G ++ E  + K
Sbjct: 193 ---GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 30/97 (30%), Positives = 56/97 (57%), Gaps = 7/97 (7%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+ +L +H   ++  +HRD+K  N+L+D   + K++DFG A     +++  N+K  VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGT 166

Query: 681 YGYMSPEY--ALDG----LFSVKSDVFSFGVLLLETL 711
             Y++PE    ++G     + V+ D +S GV+  E +
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 34/127 (26%), Positives = 53/127 (41%), Gaps = 36/127 (28%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM------------ARMFCGD 668
           IA+ +L +    +L  IHRD+K  N+LLD+  + K+SDFG+             R+    
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 669 ----------------ELQGNTKR--------VVGTYGYMSPEYALDGLFSVKSDVFSFG 704
                                 KR         VGT  Y++PE  L   ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 705 VLLLETL 711
           V++ E L
Sbjct: 227 VIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 30/214 (14%)

Query: 513 ENFSMQCKLGEGGFG-----------PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 561
           E++ +   +G G FG            VY  KLL+  E+ +KR  S        F  E  
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEERD 95

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++A      +V+L     +     ++ EYMP   L   +   S   +     R       
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYT---- 148

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E        VGT 
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTP 207

Query: 682 GYMSPEY----ALDGLFSVKSDVFSFGVLLLETL 711
            Y+SPE       DG +  + D +S GV L E L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 43/196 (21%), Positives = 87/196 (44%), Gaps = 22/196 (11%)

Query: 529 VYKGKLLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK- 584
           +YKG   N +EV ++            +   +NE+  + ++   N++++ G  ++  +  
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 585 ---ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL 641
               LI EY     L   L    +   L ++T++ +     +GL  L++Y+     +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 642 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS---VKS 698
            + + L+  +   KI   G+ ++     L     + V    Y S +   D +FS   +K 
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203

Query: 699 DVFSFGVLLLETLTSK 714
           D++S GV+L E  T K
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 37/139 (26%), Positives = 57/139 (41%), Gaps = 45/139 (32%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--------------- 665
           IA+  L +    ++  IHRD+K  NIL+D D + K++DFG+   F               
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166

Query: 666 ------------------CGDELQGNTKR------------VVGTYGYMSPEYALDGLFS 695
                             CGD L+   +R            +VGT  Y++PE  L   ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226

Query: 696 VKSDVFSFGVLLLETLTSK 714
              D +S GV+L E L  +
Sbjct: 227 QLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 59/260 (22%), Positives = 96/260 (36%), Gaps = 79/260 (30%)

Query: 513 ENFSMQCKLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--- 568
           E+F     +G+G FG V    K   G+  A+K L           K+EM    +L H   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAHVKA 50

Query: 569 -RNL---------VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
            R++         V L     +     LI E++P   L         T L+ + T  + +
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSEDV 102

Query: 619 EG--IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-------------R 663
               +A+ +L +    +L  IHRD+K  NIL+D   + K+SDFG++             +
Sbjct: 103 TRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 664 MFCGDELQ-GNTKR-------------------------------VVGTYGYMSPEYALD 691
           +  G   +     R                                VGT  Y++PE  L 
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 692 GLFSVKSDVFSFGVLLLETL 711
             +  + D +S G ++ E L
Sbjct: 223 QGYGQECDWWSLGAIMFECL 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 44/216 (20%)

Query: 521 LGEGGFGPVYKGKL---------LNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 566
           LG G    +Y G L             E  +K +      S     L  F+   M+  ++
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMM-RQV 61

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H+++V L G CV   E I++ E++    L+ F+   S      W  + K+ + +A  L 
Sbjct: 62  SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALS 119

Query: 627 YLHQYSRLRIIHRDLKASNILL-----DSDMNP--KISDFG-----MARMFCGDELQGNT 674
           YL       ++H ++   NILL     D +  P  K+SD G     ++R  C + +    
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP--- 173

Query: 675 KRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLE 709
                   +++PE   D    S+ +D +SFG  L E
Sbjct: 174 --------WIAPECVEDSKNLSIAADKWSFGTTLWE 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 56/248 (22%), Positives = 91/248 (36%), Gaps = 65/248 (26%)

Query: 521 LGEGGFGPV-YKGKLLNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG G FG V    K+      A+K L  +       +   K E  ++A+  +  +VRL  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
              ++     + +Y+P   +   L     F                   IA+    +   
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELTCAVESV 117

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF-------------------------- 665
            ++  IHRD+K  NIL+D D + K++DFG+   F                          
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 666 -------CGDELQGNTKR------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVL 706
                  CGD L+   +R            +VGT  Y++PE  L   ++   D +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 707 LLETLTSK 714
           L E L  +
Sbjct: 238 LYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.1 bits (109), Expect = 6e-05
 Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 8/154 (5%)

Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           E  ++  + H ++++L G         LI   +P    + + +  ++ ++      + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             + + + YLH+    RIIHRD+KA NI ++   +  + DFG A  F  D          
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           GT    +PE      +    D++S G++L E  T
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 40.8 bits (96), Expect = 7e-05
 Identities = 16/48 (33%), Positives = 25/48 (52%)

Query: 787 NEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 834
           +E   +P PKQ  F   R   +     S++  E+ +VN VT+S+I  R
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)

Query: 537 GQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 594
           G  V V+   L + + + LK  +NE++L    +H N++             +I  +M   
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 595 SLNFFL--FDPS--RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 650
           S N  L  + P      L+G      I+ G  +GL YLHQ      IHR++KAS+IL+  
Sbjct: 85  SANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHILISG 136

Query: 651 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY----------MSPEYALDGL--FSVKS 698
           D    +S  G++ ++    L  N ++    Y +          +SPE     L  ++VKS
Sbjct: 137 DGLVSLS--GLSHLYS---LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191

Query: 699 DVFSFGVLLLETLTSK 714
           D++S G+   E  T +
Sbjct: 192 DIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 40/233 (17%)

Query: 508 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
           +  +T+ F +   LGEG FG V +      +E    ++     +  ++ K E+  + K++
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTR---------VKI 617
             +         ++   + I  Y  N++ +  +  P     LL W  +          +I
Sbjct: 184 QADPA-------DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI 236

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNP-------------KISDFGM 661
           I      L Y H  + L ++H DLK  NIL+   D+ ++P             +I D G 
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
               C DE    T  +V T  Y SPE  L   +   +D++S G ++ E  T K
Sbjct: 295 ----CCDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVG 679
           +A+ ++ +    +L  +HRD+K  NIL+D + + +++DFG       D  +Q +    VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 165

Query: 680 TYGYMSPEY--ALD---GLFSVKSDVFSFGVLLLETL 711
           T  Y+SPE   A++   G +  + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.5 bits (101), Expect = 4e-04
 Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 23/153 (15%)

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEGIAQGLL 626
           + N ++L          +LI +Y+ +  L    FD  +    L      KII  + + L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMF----CGDELQGNTKRVVGTY 681
            LH++    IIH D+K  N+L D   +   + D+G+ ++     C D          GT 
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----------GTL 170

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            Y SPE      + V  D ++ GVL  E LT K
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 33/124 (26%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-----------------R 663
           IA+ +L +    +L  IHRD+K  N+LLDS  + K+SDFG+                   
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 664 MFCGDELQG-NTKR---------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           +      Q  N+KR                VGT  Y++PE  +   ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 708 LETL 711
            E L
Sbjct: 227 YEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 32/132 (24%), Positives = 51/132 (38%), Gaps = 41/132 (31%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA------------------ 662
           IA+    +    ++  IHRD+K  NIL+D D + K++DFG+                   
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 663 ---RMFCGDELQGNTKR--------------------VVGTYGYMSPEYALDGLFSVKSD 699
               M   +E     +                     +VGT  Y++PE  L   ++   D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226

Query: 700 VFSFGVLLLETL 711
            +S GV+L E L
Sbjct: 227 WWSVGVILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.4 bits (97), Expect = 0.002
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 8/88 (9%)

Query: 521 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 572
           LG G FG V +      GK  N   VAVK L + +    +E   +E+ +++ L QH+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFL 600
            L+G C   G  ++I EY     L  FL
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 33/124 (26%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA------------RMFCGD 668
           IA+ +L +    +L  IHRD+K  N+LLD+  + K+SDFG+             R    +
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 669 -----ELQG-NTKR---------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
                  Q  N+KR                VGT  Y++PE  +   ++   D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 708 LETL 711
            E L
Sbjct: 227 YEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.9 bits (93), Expect = 0.004
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 21/157 (13%)

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEG 620
           L++++ H +L  + G CV   E I++ E++ +  L+  L    +  + + W  ++ + + 
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAW--KITVAQQ 125

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNIL-----LDSDMNP--KISDFGMARMFCGDELQGN 673
           +A  L YL   +   ++H ++ A NIL     L    +P  K+SD G++  F     +  
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREER 180

Query: 674 TKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLE 709
            +R+     +++PE    G   S  +D +SFG  LLE
Sbjct: 181 VERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	834
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
PRK10345	210	hypothetical protein; Provisional	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
smart00090	237	RIO RIO-like kinase.	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.52
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.3
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.28
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.23
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.2
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.07
KOG1243	690	consensus Protein kinase [General function predict	99.02
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.94
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.93
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.92
KOG3087	229	consensus Serine/threonine protein kinase [General	98.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.84
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.41
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.37
COG4248	637	Uncharacterized protein with protein kinase and he	98.36
PRK09902	216	hypothetical protein; Provisional	98.31
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.31
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.28
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.19
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.17
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.16
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.16
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.14
PF01636	239	APH: Phosphotransferase enzyme family This family	98.12
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.06
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.04
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.02
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.95
PLN02876	822	acyl-CoA dehydrogenase	97.86
PRK10593	297	hypothetical protein; Provisional	97.73
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.72
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.61
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.6
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.59
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.53
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.51
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.36
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.34
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.25
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.15
PRK05231	319	homoserine kinase; Provisional	96.99
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.79
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.77
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.75
PLN02236	344	choline kinase	96.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.58
KOG2270	520	consensus Serine/threonine protein kinase involved	96.22
PLN02756	418	S-methyl-5-thioribose kinase	96.1
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	95.86
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.84
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.76
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.6

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-52  Score=454.89  Aligned_cols=288  Identities=44%  Similarity=0.724  Sum_probs=253.6

Q ss_pred             CCCcccHHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeE
Q 003287          499 VLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC  578 (834)
Q Consensus       499 ~~~~~~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~  578 (834)
                      ....|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            35579999999999999999999999999999999999999999998765443145699999999999999999999999


Q ss_pred             eecC-eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          579 VEQG-EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       579 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      .+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999876544 88999999999999999999999988899999999999999999999999


Q ss_pred             cccccccccCCCcccccccc-cccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC-cccccccccccccc
Q 003287          658 DFGMARMFCGDELQGNTKRV-VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFNLLGHAWNLW  735 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~  735 (834)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... .....+..|++..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999764321  1111112 79999999999999999999999999999999999999887644 34445788888889


Q ss_pred             cccccccccCcccc-chhHH-HHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          736 KDNRAYELLSPALQ-HEASY-QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       736 ~~~~~~~l~~~~l~-~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      ..+++.+++|+.+. ..... ..+.++.+++..|++.+|.+||+|.||+++|+.+.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99999999999987 44443 68888999999999999999999999999997663

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=399.12  Aligned_cols=262  Identities=32%  Similarity=0.495  Sum_probs=215.5

Q ss_pred             CccccceecccCccceEeeEecCCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecC-eEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey  590 (834)
                      ++.+.+.||+|+||+||+|.+.....||||++.....  ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            4455567999999999999995544599999986532  22569999999999999999999999999988 79999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-CeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~~~~~  669 (834)
                      +++|+|.+++++. ....+++..+++++.|||+||.|||+.++  ||||||||+||||+.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999764 46789999999999999999999999874  99999999999999997 99999999998754322


Q ss_pred             cccccccccccccccCccccc--CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          670 LQGNTKRVVGTYGYMSPEYAL--DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                        .......||..|||||++.  ...|+.|+||||||++||||+||+.||........     +         ..+....
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-----~---------~~v~~~~  262 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-----A---------SAVVVGG  262 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-----H---------HHHHhcC
Confidence              2333478999999999999  56999999999999999999999999987553111     0         0111111


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPY  794 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~  794 (834)
                      .++..+......+..|+..||+.+|+.||++.+++.+|+.+......
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            22222333566788899999999999999999999999988665544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-45  Score=395.48  Aligned_cols=256  Identities=34%  Similarity=0.488  Sum_probs=214.7

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      +.+++++.||+|.||+||.|.++....||||.++.. ....+.|.+|+++|++|+|+|||+++++|..++.++||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            456678999999999999999987789999999764 3445789999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      .|+|.++|.+ .....+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+.+.++.+..
T Consensus       285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999999976 34567889999999999999999999998   9999999999999999999999999999654444433


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       .....-+..|.|||.+..+.|+.|||||||||+||||+| |+.|++.+...               ++.+.++...+-.
T Consensus       361 -~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~le~GyRlp  424 (468)
T KOG0197|consen  361 -SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLELLERGYRLP  424 (468)
T ss_pred             -cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHHHhccCcCC
Confidence             333445789999999999999999999999999999999 66666654432               2222223223333


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .+..++..+.+|+..||+.+|++|||++.+...|+.+.
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            33344567788999999999999999999999998873

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5e-45  Score=412.80  Aligned_cols=263  Identities=29%  Similarity=0.449  Sum_probs=222.3

Q ss_pred             hccCccccceecccCccceEeeEec------CCcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      ...+.+..+.||+|+||+||+|+..      +.+.||||.++..... ..++|++|+++++.++|||||+|+|+|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3456677889999999999999863      2467999999887655 78999999999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          584 KILIYEYMPNKSLNFFLFDPS-------R----THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      .+||+|||.+|+|.+||....       .    ...|+..+.+.||.|||.||+||-+++   +|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            999999999999999995321       1    233889999999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccc
Q 003287          653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  731 (834)
                      .|||+||||++.+...++........-+.+|||||.+..++|+.+||||||||+|||+++ |+.|+.....++.      
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------  714 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------  714 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH------
Confidence            999999999999988887766655566899999999999999999999999999999998 7778765443221      


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                      -+..+.+++         -..+..++.++.+|+..||+.+|.+||+++||-..|....+.
T Consensus       715 Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  715 IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            111222222         234556667889999999999999999999999999887443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=371.14  Aligned_cols=250  Identities=28%  Similarity=0.407  Sum_probs=209.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-eEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  589 (834)
                      .+.+.++.||+|..|+|||++++ +++.+|+|.+... .+...+++.+|++++++.+||+||+++|+|.... ...|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35667789999999999999986 5888999999554 4456688999999999999999999999999999 5999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      ||++|+|+.++..   .+.+++...-+|+.+|++||.|||+..  .||||||||+||||+..|+|||+|||.++.+.+. 
T Consensus       159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999943   356899999999999999999999632  3999999999999999999999999999987544 


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         .-....||..|||||.+.+..|+.++||||||++++|+.+|+.|+.........             ..++++....
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-------------~~~Ll~~Iv~  296 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-------------IFELLCAIVD  296 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-------------HHHHHHHHhc
Confidence               335578999999999999999999999999999999999999998764221111             1122211111


Q ss_pred             ---chhHH-HHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 ---HEASY-QMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ---~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         +..+. .++.++.+++..||++||.+||++.|+++.
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               12222 377789999999999999999999999864

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-43  Score=366.04  Aligned_cols=203  Identities=30%  Similarity=0.511  Sum_probs=182.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..+|.+.+.||+|+||+||+|++. ++..||||.+.+.  .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            367888999999999999999986 4899999999766  5566778899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC------CCeeecccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD------MNPKISDFGMA  662 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~------~~vkl~DFGla  662 (834)
                      |||.+|+|.+||+.   ...+++.++..++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999954   347899999999999999999999998   9999999999999765      45899999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE  723 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~  723 (834)
                      +.+....   .....+|++-|||||++...+|+.|+|+||+|+||||+++|+.||......
T Consensus       163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            9886433   234578999999999999999999999999999999999999999865543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-43  Score=382.62  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=212.5

Q ss_pred             cCccccceecccCccceEeeEe-cCCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..|...+.||+|||+.||+++. ..|+.||+|++.+.   .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999998 67999999999764   3445678899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      |+|++++|.++++   +++.+.+.++..+++||+.||.|||+++   |+|||||..|++|+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999994   5678999999999999999999999998   999999999999999999999999999987543


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .  ......+||+.|+|||++....++..+||||+|||||-||.|++||+.....+.      +..++..   +.     
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~---~Y-----  235 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLN---EY-----  235 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhc---Cc-----
Confidence            2  344568999999999999999999999999999999999999999987543221      0000000   00     


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ..+...+....+||.++|+.+|.+|||+++|+.
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              112234456778999999999999999999995

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=360.22  Aligned_cols=253  Identities=23%  Similarity=0.334  Sum_probs=204.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChh-------hHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      .+.|.+.+.||+|+||.|-+|... +|+.||||++++....       ......+|+++|++|+|||||++++++.+.+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            367888899999999999999865 6999999999865211       12235799999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC---CCeeecccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFG  660 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~vkl~DFG  660 (834)
                      .||||||+++|+|.+.+-.   ...+.+..-..++.|++.|+.|||+.+   |+||||||+|||+..+   ..+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            9999999999999999843   345677778899999999999999998   9999999999999765   779999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCC---CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD  737 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  737 (834)
                      +|+....   ...+...+||+.|.|||++.++.   +..|+|+||+||+||-+++|.+||........ +    .+....
T Consensus       325 lAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l----~eQI~~  396 (475)
T KOG0615|consen  325 LAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-L----KEQILK  396 (475)
T ss_pred             hhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-H----HHHHhc
Confidence            9998642   23456789999999999998764   33488999999999999999999975332210 0    001111


Q ss_pred             cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       738 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ++..      ..+.......++..++|.+||..||++||++.|+++-
T Consensus       397 G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  397 GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            1111      1223455677888999999999999999999998864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=352.01  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=210.0

Q ss_pred             cCccccceecccCccceEeeEe-cCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEee-eEeecCe-EEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG-CCVEQGE-KILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV  587 (834)
                      .+|+++++||+|.||+|||+.. .+|..||.|.+.-.  +....+....|+.+|++|+|||||++++ -+.++.+ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            5699999999999999999975 57999999998632  4556678899999999999999999998 4555555 8999


Q ss_pred             EEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          588 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYS-RLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      ||||..|+|..++... +..+.+++.++++++.|++.||.++|+.- +..|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999653 44567999999999999999999999832 234999999999999999999999999999998


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .....  .....+|||.||+||.+.+..|+.||||||+||++|||+.-++||....     +...- .....++..    
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~-~KI~qgd~~----  246 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLC-KKIEQGDYP----  246 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHH-HHHHcCCCC----
Confidence            65432  2345789999999999999999999999999999999999999987542     11110 111111111    


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                          +-....++..+.+||..|+..||+.||+...+++.+..
T Consensus       247 ----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  247 ----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                11225567788999999999999999996666655544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=380.34  Aligned_cols=266  Identities=26%  Similarity=0.400  Sum_probs=220.8

Q ss_pred             cCccccceecccCccceEeeEecC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ....+.++||.|.||+|++|+++-    ...||||.++.. .+....+|+.|+.+|.+++||||++|.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            456788999999999999999863    357999999876 455678899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      .|||+||+|+.||+...  ..+.+.+++.++++||.||.||.+.+   +|||||.++||||+.+...||+||||++.+.+
T Consensus       709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999996543  45889999999999999999999988   99999999999999999999999999998755


Q ss_pred             CCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          668 DELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       668 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      +... ..+..-.-+.+|.|||.+...+++.+|||||||++|||.++ |.+|+-.+.               +.++...++
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---------------NQdVIkaIe  848 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---------------NQDVIKAIE  848 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---------------hHHHHHHHH
Confidence            4411 11222233679999999999999999999999999999776 788854332               122333333


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCC
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQS  798 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~  798 (834)
                      ...+-..+++++..+.+|++.|||+|-.+||.+.|++.+|+.+......-+..
T Consensus       849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~  901 (996)
T KOG0196|consen  849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI  901 (996)
T ss_pred             hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence            44444556777888999999999999999999999999999985544333333

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=397.09  Aligned_cols=261  Identities=31%  Similarity=0.505  Sum_probs=218.9

Q ss_pred             ccCccccceecccCccceEeeEecC--C----cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN--G----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~--g----~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      ..+.++.+.||+|+||.||+|...+  +    ..||||.+++. +.+...+|++|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3566788899999999999998753  3    35999999876 456778999999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      +|++|||++|+|..||++.+    ....+...+.+.++.|||+|+.|||+++   +|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997642    2456889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      ||+.+...++........-+.+|||||.+.++.|+.|+|||||||+|||++| |..|++..+..+.  ..   .....+ 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~---~~~~gg-  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LL---DVLEGG-  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HH---HHHhCC-
Confidence            9998877776666655566789999999999999999999999999999999 6677765443221  10   011111 


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                        ++..|       ..+++.+.+|+.+||+.+|++||++..+++.+..+..
T Consensus       922 --RL~~P-------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 --RLDPP-------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             --ccCCC-------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence              33333       4445677889999999999999999999998887743

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.1e-41  Score=337.78  Aligned_cols=263  Identities=23%  Similarity=0.344  Sum_probs=208.1

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      +.|+.+.++|+|+||+|||++.++ |+.||||++....+  ...+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            468888899999999999999875 99999999976533  334567999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      ||+..-|.++-   +....++.+.+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+..  
T Consensus        82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            99998887765   34456889999999999999999999998   99999999999999999999999999999863  


Q ss_pred             cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCc-ccccc--------cccccccccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFNL--------LGHAWNLWKDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~~~~--------~~~~~~~~~~~~  739 (834)
                      ....-+..+.|++|+|||.+.+ ..|+..+||||+||++.||++|.+-|....+ +....        .-.-..++....
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            1223345678999999999987 6899999999999999999999999886543 22211        111111111111


Q ss_pred             cc---cccCcccc---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AY---ELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~---~l~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+   .+.++...   ...-......+++++..|++.||.+|++-+|++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11   11222211   1122234457889999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=348.85  Aligned_cols=242  Identities=26%  Similarity=0.364  Sum_probs=202.4

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|+++++||+|+||+||+++..+ ++.+|+|++++..   ....+..++|..+|.+++||.||+++-.|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4789999999999999999998764 8899999998763   23467789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      +||+.||.|..+|.   +...+++..+.-++..|+.||.|||+++   ||||||||+|||||++|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999994   4567889999999999999999999998   99999999999999999999999999996533


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .  ...+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+....     ...... ++        
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-----~~~I~~-~k--------  241 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-----YDKILK-GK--------  241 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-----HHHHhc-Cc--------
Confidence            3  2344558999999999999999999999999999999999999999986553211     000000 11        


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRP  776 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RP  776 (834)
                       ....+.-......+++...++.+|++|.
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             0111112335677899999999999995

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=356.69  Aligned_cols=264  Identities=29%  Similarity=0.458  Sum_probs=218.1

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .+...+.++||+|-||+|.++....+..||||+++..... ...+|.+|+++|.+|+||||++|+|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            4566788999999999999999987899999999876544 458999999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      |++|+|..|+..+.... +.....++|+.|||.||+||.+.+   +|||||.++|+|+|.++++||+|||+++.+...++
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999997653332 455667789999999999999988   99999999999999999999999999998887777


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh--CCCCCCCCCccccccccccccccccc-ccccccCcc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIESFNLLGHAWNLWKDN-RAYELLSPA  747 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~  747 (834)
                      .....+.+-+.+|||||.+.-++++.++|||+||+++||+++  ..+|++....+.  ..+......... ...-+..  
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~~l~~--  768 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQVVLSR--  768 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcceeccC--
Confidence            777777788999999999999999999999999999999865  567776544332  122111122111 1111222  


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                           +.-++..+.+++..||..+.++||+++++...|.+.
T Consensus       769 -----P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  769 -----PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -----CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                 333446677899999999999999999999988654

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=357.92  Aligned_cols=269  Identities=28%  Similarity=0.454  Sum_probs=216.5

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  582 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  582 (834)
                      ..+.....+.+.+.+.||+|.||+||+|++.  ..||||+++..  ..+..+.|++|+.++++-+|.||+-+.|+|....
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            3455556677888999999999999999985  37999999765  4557789999999999999999999999999887


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      . .||..+|++.+|+.+|+..+  ..+...+.++|+.|||+||.|||.++   |||||||..||+|.++++|||+||||+
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence            7 99999999999999996543  56788899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccC---CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      ..-..-..........|...|||||+++.   .+|++.+||||||+++|||++|..|+.....+..        +|..++
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------ifmVGr  607 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------IFMVGR  607 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------EEEecc
Confidence            75432222222334557889999999974   4699999999999999999999999883222211        222233


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      .+-..|...   ...+...+|.+|+..||..++++||.+.+|+.+|+.+...+
T Consensus       608 G~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  608 GYLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            322222211   22345567888999999999999999999999998874443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=342.77  Aligned_cols=263  Identities=26%  Similarity=0.382  Sum_probs=216.2

Q ss_pred             hccCccccceecccCccceEeeEe-cCCcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..+.|++.+.||.|..++||+|+. +.+..||||++..... ...+.+.+|+..|+.++||||++++..|..+..+++||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            347899999999999999999986 4589999999976533 34688999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      .||.+|++.++++..- ...+++..+..|++++++||.|||.++   .||||||+.||||+++|.|||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999996543 234889999999999999999999998   999999999999999999999999988765443


Q ss_pred             Cc-cccc-ccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          669 EL-QGNT-KRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       669 ~~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .. .... ....||+.|||||++..  ..|+.|+||||||++..||.+|..||..+..-...+...      .+....+.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL------qn~pp~~~  253 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL------QNDPPTLL  253 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh------cCCCCCcc
Confidence            21 1111 55789999999999654  359999999999999999999999999877544322211      12222222


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      -..+..+....+...+.+++..||+.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            223344455566668899999999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=348.61  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=205.1

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC--eEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~  588 (834)
                      ..++...+.||+|+||+||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3567888999999999999999865 8999999987664444677899999999999999999999855554  689999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~~~~  667 (834)
                      ||+++|+|.+++.+...  .+++..+..+++||++||+|||+++   |+||||||+||||+. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999965432  6999999999999999999999987   999999999999999 79999999999987653


Q ss_pred             -CCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCC-Cccccccccccccccccccccccc
Q 003287          668 -DELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       668 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                       ...........||+.|||||++..+ ....++|||||||++.||+||++||... ....     .........      
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-----~~~~ig~~~------  239 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-----ALLLIGRED------  239 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-----HHHHHhccC------
Confidence             1222334457899999999999964 3445999999999999999999998863 1110     000000111      


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                         ..+..+...+....+++..|++.+|+.|||++++++-.
T Consensus       240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence               11123334556678899999999999999999999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.8e-40  Score=360.78  Aligned_cols=261  Identities=28%  Similarity=0.400  Sum_probs=205.0

Q ss_pred             ccCccccceecccCccceEeeEe------cCCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC-
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG-  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-  582 (834)
                      .++|++.++||+|+||.||+|..      ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46899999999999999999974      235689999997543 33456789999999999 8999999999887654 


Q ss_pred             eEEEEEEecCCCCchhhhcCCCC---------------------------------------------------------
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSR---------------------------------------------------------  605 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  605 (834)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            68999999999999999864211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccc
Q 003287          606 --THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY  683 (834)
Q Consensus       606 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y  683 (834)
                        ...+.+.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134778899999999999999999987   999999999999999999999999999875433222222334567889


Q ss_pred             cCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHH
Q 003287          684 MSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  762 (834)
Q Consensus       684 ~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~  762 (834)
                      +|||++.+..++.++|||||||+||||++ |..||........ ..    .....+....         .+......+.+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~----~~~~~~~~~~---------~~~~~~~~l~~  308 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC----QRLKDGTRMR---------APENATPEIYR  308 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH----HHHhcCCCCC---------CCCCCCHHHHH
Confidence            99999999999999999999999999997 9999875432110 00    0111111000         11123356788


Q ss_pred             HHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          763 VALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       763 li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      |+..||+.+|++||++.|++++|+.+.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=360.69  Aligned_cols=266  Identities=29%  Similarity=0.376  Sum_probs=212.4

Q ss_pred             HHhccCccccceecccCccceEeeEecC--C--cE-EEEEEecc---cChhhHHHHHHHHHHHhccCCCceeeEeeeEee
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLN--G--QE-VAVKRLSS---QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  580 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~--g--~~-vAVK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  580 (834)
                      +..-++..+.++||+|+||.||+|++..  +  .. ||||..+.   .......+|++|+++|++++|||||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3344566677999999999999998753  2  23 89999875   346678899999999999999999999999999


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ...++||||+|++|+|.++|.+..  ..++..+++.++.++|.||+|||+++   +|||||.++|+|++.++.+||+|||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            999999999999999999996532  26899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      |++.-.  .+........-+.+|+|||.+....|+.++|||||||++||+++ |..|+........      ....    
T Consensus       308 Ls~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------~~kI----  375 (474)
T KOG0194|consen  308 LSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------KAKI----  375 (474)
T ss_pred             cccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------HHHH----
Confidence            988643  12222212346789999999999999999999999999999999 7778765432210      0000    


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCC
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  795 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p  795 (834)
                          .....+...+...+..+..++.+||+.+|++||+|.++.+.|+.+......+
T Consensus       376 ----~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  376 ----VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             ----HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence                0111111122234456777888999999999999999999999986655543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=350.58  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=209.8

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      ....+|...+.||+|+|++|++|+.. .++++|||++.+..   +...+....|-.+|.+| .||.|++|+-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34578999999999999999999875 48999999997652   23345567788899999 899999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      |+|+||+++|+|.++|.+   ...+++.....++.+|+.||+|||+.+   ||||||||+|||||+++++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999954   356889999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcc---------ccc--ccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc
Q 003287          665 FCGDELQ---------GNT--KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       665 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  733 (834)
                      +......         ...  ...+||..|.+||++.++..++.+|+|+||||||+|+.|.+||....+--.        
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--------  295 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--------  295 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--------
Confidence            8543221         112  457899999999999999999999999999999999999999986543100        


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ++  ++..     +.-+.+..+.+...+|+.+.|..||.+|++.+|+.+-
T Consensus       296 -Fq--kI~~-----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 -FQ--KIQA-----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -HH--HHHH-----hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence             00  0000     1112233344667889999999999999999998774

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=351.14  Aligned_cols=248  Identities=28%  Similarity=0.428  Sum_probs=206.6

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      .++-||+|+.|.||+|++ .++.||||+++...       ..+|+-|++|+|+||+.+.|+|.....++||||||+.|.|
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            457899999999999999 57899999886432       3578899999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      ..+|+   ..+.+.....+.+..+||.||.|||.+.   |||||||.-||||..+..|||+|||-++.+...   .....
T Consensus       200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            99994   4456888899999999999999999987   999999999999999999999999999987543   23345


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccc-ccccccCccccchhHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN-RAYELLSPALQHEASYQ  755 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~l~~~~~~~  755 (834)
                      ..||..|||||++.+.+.++|+|||||||||||||||.-|+...+....        +|.-+ ....+.       .+..
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--------IwGVGsNsL~Lp-------vPst  335 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--------IWGVGSNSLHLP-------VPST  335 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--------EEeccCCccccc-------Cccc
Confidence            7899999999999999999999999999999999999999875443211        12111 222222       2334


Q ss_pred             HHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCC
Q 003287          756 MLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPK  796 (834)
Q Consensus       756 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~  796 (834)
                      +++-+.-|+.+||+..|..||++++++.-|+.....+=.-+
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~t  376 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTT  376 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhccc
Confidence            45567779999999999999999999999988755543333

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=348.33  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=209.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhH-HHHHHHHHHHhccC-CCceeeEeeeEeecC-eEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQ-HRNLVRLMGCCVEQG-EKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lV  587 (834)
                      -++|.++++||.|.||.||+|+-. .+..||||++++...... -.-++|++.|++|+ |||||++.+++.|.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            368999999999999999999865 588999999987543322 23478999999998 999999999999988 99999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||||+ .+|.+++++.  .+.+++.++..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+||||||.+..
T Consensus        89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            99995 4788888653  778999999999999999999999998   99999999999999999999999999998754


Q ss_pred             CCcccccccccccccccCccccc-CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcc-cc----ccc-cccccccccc-c
Q 003287          668 DELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SF----NLL-GHAWNLWKDN-R  739 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~-~~----~~~-~~~~~~~~~~-~  739 (834)
                      ..   ..+..+.|++|+|||++. .+.|+.+.|+||+|||++|+.+-++-|.+.++- +.    ..+ .-.+..|.++ .
T Consensus       163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            33   334567899999999985 578999999999999999999999988775532 11    111 1111222221 1


Q ss_pred             cccccCccc-------cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 AYELLSPAL-------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ~~~l~~~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +...+.-.+       ..........+.++++..|++.||.+|||++|+++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111111       122333467788999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-39  Score=340.67  Aligned_cols=266  Identities=24%  Similarity=0.352  Sum_probs=208.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  586 (834)
                      .+.|+.+++||+|.||.||||+.. +|+.||+|++....  +.......+||.+|++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            467899999999999999999864 69999999987654  33455678899999999999999999999887  68999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |+|||++ +|.-++..  ..-.+++.++..++.|++.||+|+|+.+   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999976 45555532  2346889999999999999999999998   9999999999999999999999999999886


Q ss_pred             CCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCc-ccccccc-----cccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFNLLG-----HAWNLWKDNR  739 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~~~~~~-----~~~~~~~~~~  739 (834)
                      ...... .+..+-|..|+|||.+.+. .|+.+.|+||.||||.||+.|++.+....+ ++...+-     -....|...+
T Consensus       270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            655443 3345669999999999875 699999999999999999999999887653 2221110     0011122111


Q ss_pred             cc--cccCcccc-----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 AY--ELLSPALQ-----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ~~--~l~~~~l~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +.  ..+.+...     .+.-..+.....+|+..+|..||.+|.|+.++++.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            11  12222111     12233445677889999999999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.7e-39  Score=316.34  Aligned_cols=276  Identities=24%  Similarity=0.371  Sum_probs=212.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChh--hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .+|..+++||+|.||.||+|+.. .|+.||||+++.....  -.....+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999864 5999999999764221  23457899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      ||+ .+|...+++  +...+...++..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 578888865  3457889999999999999999999988   9999999999999999999999999999886543


Q ss_pred             cccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCc-cccccc--------ccccccccc--
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFNLL--------GHAWNLWKD--  737 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~~~~~--------~~~~~~~~~--  737 (834)
                      ...  ...+-|..|+|||.+.+. .|+...|+||.|||+.||+-|.+-+....+ ++....        ...|..+..  
T Consensus       156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            222  223679999999999875 699999999999999999999887765432 222111        111111111  


Q ss_pred             --cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCc
Q 003287          738 --NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSA  799 (834)
Q Consensus       738 --~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~  799 (834)
                        -+......+.+. ..-....+...+|+..++..+|.+|++++|++++  .-...+|.|..+.
T Consensus       234 dY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~  294 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPS  294 (318)
T ss_pred             cHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChh
Confidence              011111111111 1223345567899999999999999999999987  2224467666553

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=338.19  Aligned_cols=267  Identities=27%  Similarity=0.418  Sum_probs=208.3

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhc--cCCCceeeEeeeEeecC----eEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQG----EKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~l  586 (834)
                      ...++.++||+|+||.||||++ +++.||||++...   ..+.|++|-.+.+.  ++|+||++++++-....    ++.|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            4556778999999999999999 4599999999754   44667777666655  58999999999877665    8999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY------SRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      |+||.+.|+|.++|    ....++|.+..+|+..+++||+|||+.      .+++|+|||||++||||..|++..|+|||
T Consensus       286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999    456799999999999999999999963      45689999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCC-CC-----ccCCeeeHHHHHHHHhhCCCCCCCCCcccccc-------
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-FS-----VKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-------  727 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-------  727 (834)
                      ||..+............+||.+|||||++.+.. +.     .+.||||+|.|||||+++..-.......++.+       
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999988766666666789999999999997653 22     36899999999999999876543222222211       


Q ss_pred             ----cccccccccccccccccCccccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          728 ----LGHAWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       728 ----~~~~~~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                          .+..+...    +.+...|.+... .....+..+.+.+..||..||+.|.|+.=+-+.+.++...
T Consensus       442 ~hPt~e~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  442 NHPTLEEMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCCCHHHHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence                11111111    112222333221 1124466788999999999999999999999999888443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-38  Score=345.62  Aligned_cols=264  Identities=29%  Similarity=0.465  Sum_probs=203.2

Q ss_pred             cCccccceecccCccceEeeEecC-----------------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRL  574 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  574 (834)
                      .+|++.++||+|+||.||++.+.+                 +..||||.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578899999999999999997532                 3469999987643 3445679999999999999999999


Q ss_pred             eeeEeecCeEEEEEEecCCCCchhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 003287          575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPS----------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH  638 (834)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  638 (834)
                      ++++.+.+..++||||+++|+|.+++....                ....+++..+.+++.||+.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885321                1134788899999999999999999987   999


Q ss_pred             cCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhC--CCC
Q 003287          639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS--KRN  716 (834)
Q Consensus       639 ~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg--~~p  716 (834)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999876443322223334567899999999989999999999999999999974  455


Q ss_pred             CCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          717 TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      +.......  .............. .     .....+..++..+.+++.+||+.+|++||++.||.+.|++
T Consensus       242 ~~~~~~~~--~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQ--VIENAGEFFRDQGR-Q-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHH--HHHHHHHHhhhccc-c-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            55432211  11111000000000 0     0000111233567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=344.95  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=209.3

Q ss_pred             cCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ..|...++||+|+.|.||.++. ..++.||||++........+-..+|+.+|+..+|+|||++++.+..++++++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            5677778999999999999975 468899999998765556677899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+.+.    ...+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999983    345899999999999999999999998   99999999999999999999999999998755433 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       .....+||+.|||||++....|++|.||||||++++||+-|.+|+-....-.     ..+ +.     ...-.|.+.  
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-----Aly-LI-----a~ng~P~lk--  490 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALY-LI-----ATNGTPKLK--  490 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-----HHH-HH-----hhcCCCCcC--
Confidence             4556789999999999999999999999999999999999999976422110     000 01     111111111  


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .....+..+.+++.+||+.|+++||++.|+|+-
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            223345678889999999999999999999964

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-38  Score=353.30  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=204.3

Q ss_pred             ccCccccceecccCccceEeeEe------cCCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  583 (834)
                      .++|++.++||+|+||.||+|+.      ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35799999999999999999963      235689999997543 33456789999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCC----------------------------------------------------------
Q 003287          584 KILIYEYMPNKSLNFFLFDPSR----------------------------------------------------------  605 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  605 (834)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          606 --------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       606 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                                    ...+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788899999999999999999987   999999999999999999999999999876433222


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..|+........ .    ......+.  ....+    
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~----~~~~~~~~--~~~~~----  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-F----YKMIKEGY--RMLSP----  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-H----HHHHHhCc--cCCCC----
Confidence            22222345678999999999999999999999999999998 7888765332110 0    00111110  00011    


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                         ......+.+|+..||+.+|++||++.|++++|+..
T Consensus       340 ---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               11234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.9e-38  Score=337.32  Aligned_cols=245  Identities=19%  Similarity=0.303  Sum_probs=198.1

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChh---hHHHHHHHHHHHhccCCCceeeEeeeEee----cCeEEEEEEec
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILIYEYM  591 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~  591 (834)
                      ..||+|++|.||+|++ +|+.||||+++.....   ..+.|.+|+.++.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 7899999999764322   25778899999999999999999999977    34689999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++..   ...+++.....++.+++.||+|||+..  .++||||||+|||+++++.+||+|||+++.+....  
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999954   346889999999999999999999852  27899999999999999999999999998653221  


Q ss_pred             cccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          672 GNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||........  ...   ....+.     .+.  
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~--~~~---i~~~~~-----~~~--  242 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI--YDL---IINKNN-----SLK--  242 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH--HHH---HHhcCC-----CCC--
Confidence               22457899999999976  6899999999999999999999999975432211  000   000000     001  


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                        .+......+.+++.+||+.+|++||++.|+++.|+..
T Consensus       243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence              1112345688999999999999999999999999875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.8e-38  Score=353.20  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=204.5

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  583 (834)
                      .++|++.+.||+|+||.||+++..      ++..||||+++... ....+.+.+|+.+++.+ +|+||+++++++.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357999999999999999998742      24589999997543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCC-----------------------------------------------------------
Q 003287          584 KILIYEYMPNKSLNFFLFDPS-----------------------------------------------------------  604 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  604 (834)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885321                                                           


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          605 --------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       605 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                              ....+++.++.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...........
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788899999999999999999987   99999999999999999999999999986543322111222


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ  755 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~  755 (834)
                      ..++..|||||++.+..++.++|||||||++|||++ |+.||........ ..    ......  .....+       ..
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~----~~~~~~--~~~~~~-------~~  339 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY----KMVKRG--YQMSRP-------DF  339 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH----HHHHcc--cCccCC-------CC
Confidence            345678999999999999999999999999999997 9999875432211 00    000000  000011       11


Q ss_pred             HHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          756 MLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       756 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .+..+.+++..||+.+|++||++.+++++|+++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            235678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=317.41  Aligned_cols=236  Identities=26%  Similarity=0.336  Sum_probs=201.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|+.++.||.|+||.|.+++.+ +|..+|+|++++..   -...+...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            67999999999999999999986 48899999998763   234566788999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|.|..+|+   +.+.+++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+...  
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--  195 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence            9999999999994   4457899999999999999999999998   9999999999999999999999999999763  


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                         ..+-..+||+.|+|||++..+.|..++|.|||||++|||+.|.+||.......  +.    .        .++... 
T Consensus       196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--iY----~--------KI~~~~-  257 (355)
T KOG0616|consen  196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--IY----E--------KILEGK-  257 (355)
T ss_pred             ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--HH----H--------HHHhCc-
Confidence               34667899999999999999999999999999999999999999997644311  00    0        011111 


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCC
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADR  775 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~R  775 (834)
                       -..+..+...+.+|+...++.|-.+|
T Consensus       258 -v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 -VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence             12344455677889999999999988

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=337.86  Aligned_cols=249  Identities=22%  Similarity=0.342  Sum_probs=211.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..|+.++.||+|.||.||||... .++.||+|++.-. .....+....|+.++..++|+||.++++.+..+..+.++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777789999999999999975 4889999999765 344567889999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      |.+|++.+.|.   ....+.+....-+++++..||.|||+++   .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999983   3345578888889999999999999998   99999999999999999999999999988765443


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      ..  ...+||+.|||||++....|+.|+||||||++.+||++|.+|+...+....               .-++.....+
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------------lflIpk~~PP  229 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------------LFLIPKSAPP  229 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---------------EEeccCCCCC
Confidence            33  567899999999999988999999999999999999999999887654321               1222222233


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .....+...+.+++..||+.+|+.||++.++++-
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            3333566778999999999999999999998863

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-38  Score=345.84  Aligned_cols=257  Identities=26%  Similarity=0.376  Sum_probs=211.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .-|++.+.||.|+-|.|-+|++. .|+.+|||++.+..   ......+.+|+.+|+.+.||||+++++++++..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45889999999999999999875 59999999997752   233456789999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|.|.+++.   +...+++.++.+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|..-...
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999994   4457899999999999999999999998   999999999999999999999999999864322


Q ss_pred             CcccccccccccccccCcccccCCCCC-ccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                         ......+|.+.|.|||++.+.+|. .++||||+|||||.||||+.||+......  ++.    .++.+ .+      
T Consensus       166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--LLl----KV~~G-~f------  229 (786)
T KOG0588|consen  166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--LLL----KVQRG-VF------  229 (786)
T ss_pred             ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH--HHH----HHHcC-cc------
Confidence               233457899999999999999885 68999999999999999999998433221  111    11111 11      


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcccCCCCCC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEHATLPYP  795 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~l~~p  795 (834)
                         +.+...+.+..+|+..|+..||+.|.|++||++-  |.+. ..+|.+
T Consensus       230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~-~~~~~~  275 (786)
T KOG0588|consen  230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY-TSLPSS  275 (786)
T ss_pred             ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC-CCCChh
Confidence               2234445677889999999999999999999985  3443 344443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.9e-39  Score=342.12  Aligned_cols=244  Identities=26%  Similarity=0.406  Sum_probs=208.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.  .+...+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999876 4889999999765  34566789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+.+ +|..+|.   ....++++.+..++.+++.||.|||+..   |+|||+||+|||++..+.+|++|||+|+..... 
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9987 9999994   4457999999999999999999999987   999999999999999999999999999976432 


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                       ......+.||+-|||||...+++|+..+|.||+||||||+.+|++||-....                  .+++...+.
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------------------~~Lv~~I~~  214 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------------------TQLVKSILK  214 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------------------HHHHHHHhc
Confidence             2334567899999999999999999999999999999999999999864221                  122111111


Q ss_pred             c--hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 H--EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .  ..+......+..++...|++||..|.+-.+++.
T Consensus       215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1  122356677889999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-37  Score=334.39  Aligned_cols=257  Identities=29%  Similarity=0.483  Sum_probs=208.4

Q ss_pred             cCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......|.+|+.++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478899999999999999998643      2579999987543 334567999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          586 LIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      ++|||+++++|.+++.....             ...+++.++..++.|+++||+|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999854321             145888999999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccc
Q 003287          653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  731 (834)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.  .   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~--~---  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--I---  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--H---
Confidence            999999999987644333233334456889999999999999999999999999999998 9988865432211  0   


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                       ..+..+         .....+..++.++.+|+.+||+.+|.+||++.||++.|+.
T Consensus       237 -~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 -EMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             001111         1111223445778899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=342.71  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=204.7

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc----Ch-hhHHHHHHHHHHHhccC-CCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  583 (834)
                      ...+|.+.+.||+|+||.|++|... +++.||||++.+.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3578999999999999999999764 5899999977653    12 23456778999999998 9999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeecccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA  662 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DFGla  662 (834)
                      .++||||+.+|+|.+++.+   ...+.+.++..++.|++.|++|||+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   456788999999999999999999998   9999999999999999 99999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCC-CC-ccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGL-FS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      ....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.........     .. ...+. 
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-----~k-i~~~~-  239 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-----RK-IRKGE-  239 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-----HH-HhcCC-
Confidence            8763  2223445678999999999999977 86 7899999999999999999999863322110     00 00000 


Q ss_pred             ccccCccccchhHHHH-HHHHHHHHhcccccCcCCCCCHHHHH
Q 003287          741 YELLSPALQHEASYQM-LNRYITVALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~-~~~l~~li~~cl~~~P~~RPs~~evl  782 (834)
                        .       ..+... ...+..|+..|++.+|.+|+++.+++
T Consensus       240 --~-------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 --F-------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             --c-------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence              0       011111 56678899999999999999999999

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.4e-37  Score=338.27  Aligned_cols=263  Identities=24%  Similarity=0.324  Sum_probs=205.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999976 5889999998754 23445679999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++..   ...+++..+..++.|+++||+|||+.+  +|+||||||+|||++.++.+||+|||+++.+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999853   345889999999999999999999864  4999999999999999999999999999765322 


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccc-c----------
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD-N----------  738 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~----------  738 (834)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+........ ....... .          
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF-GRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-cccccccccCCccccCccc
Confidence               223356899999999999999999999999999999999999998654322110000 0000000 0          


Q ss_pred             ------------------ccccccCc----cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          739 ------------------RAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       739 ------------------~~~~l~~~----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                                        ...++.+-    .............+.+++.+||+.+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                              00000000    00000011245678899999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.2e-37  Score=382.38  Aligned_cols=261  Identities=25%  Similarity=0.423  Sum_probs=209.0

Q ss_pred             cCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ..++..+.||+|+||.||+|+. .+++.||||++......    ..+|++.+++++|||||+++++|.+.+..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4577788999999999999987 46899999998654322    234688999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++.      .++|.++.+++.|||+||+|||+....+|+||||||+||+++.++.+++. ||.+.....    
T Consensus       766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            9999999994      37899999999999999999997766679999999999999999988875 666544321    


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc-
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH-  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~-  750 (834)
                        .....++..|||||++.+..++.|+|||||||++|||++|+.|+............++............+++.+.. 
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence              11236789999999999999999999999999999999999998543332223333333333333344455555532 


Q ss_pred             -hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          751 -EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       751 -~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                       ........++.+++.+||+.+|++||+|.|++++|+.+..
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence             2334566778899999999999999999999999998744

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2e-37  Score=329.93  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=204.6

Q ss_pred             ccCccccceecccCccceEeeEec----CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..+...++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357899999999999999999763    35789999997653 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998543  246889999999999999999999987   9999999999999999999999999876542


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .... .......++..|+|||.+.+..++.++|||||||++||+++ |..||........  ..    .....  ...  
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~~----~~~~~--~~~--  227 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--IK----AVEDG--FRL--  227 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH----HHHCC--CCC--
Confidence            2211 11112345678999999999999999999999999999775 9999865432211  00    00000  000  


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                           ..+..++..+.+++..||+.+|++||+++++++.|+..
T Consensus       228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 11222445678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-37  Score=346.90  Aligned_cols=260  Identities=25%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             ccCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  583 (834)
                      .++|.+.++||+|+||.||+|+...      +..||||++.... ....+.+.+|++++.++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            5789999999999999999998531      3479999997543 334567999999999996 9999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCC-----------------------------------------------------------
Q 003287          584 KILIYEYMPNKSLNFFLFDPS-----------------------------------------------------------  604 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  604 (834)
                      .+|||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998885321                                                           


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC
Q 003287          605 ----------------------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS  650 (834)
Q Consensus       605 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~  650 (834)
                                                        ....+++.++..++.||++||+|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                              0124778889999999999999999987   999999999999999


Q ss_pred             CCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccc
Q 003287          651 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLG  729 (834)
Q Consensus       651 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~  729 (834)
                      ++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.........   
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~---  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence            99999999999987643322222233456788999999999999999999999999999997 88887653321110   


Q ss_pred             cccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       730 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                        ......+.         ...........+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       350 --~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         350 --YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             --HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence              00001110         0011122345688899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.5e-37  Score=331.67  Aligned_cols=251  Identities=24%  Similarity=0.306  Sum_probs=200.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .|+..+.||+|+||.||++... +++.||||.+....   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999874 68999999986542   2234567899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|..++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999988875432 335889999999999999999999987   9999999999999999999999999998753221


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......||..|+|||++.+..++.++|||||||++|||++|+.||........  .......        +..  ..
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~--------~~~--~~  221 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRR--------VKE--DQ  221 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHH--------hhc--cc
Confidence               12335689999999999999999999999999999999999999875432110  0000000        000  00


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                      ..........+.+|+..||+.+|++||+     ++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1112233456788999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.4e-38  Score=333.77  Aligned_cols=251  Identities=35%  Similarity=0.538  Sum_probs=195.6

Q ss_pred             cccceecccCccceEeeEec-----CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          516 SMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       516 ~~~~~lG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++.+.||.|.||.||+|.+.     .+..|+||.++.. ..+..+.|.+|++.+++++||||++++|++.+.+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35679999999999999886     2578999999654 33457899999999999999999999999998889999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|.++|... ....+++..+..|+.||++||+|||+.+   ++|+||+++||++++++.+||+|||+++......
T Consensus        82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999999654 2356899999999999999999999987   9999999999999999999999999998763333


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .............|+|||.+.+..++.++||||||+++|||++ |+.|+........  ..    ......  ..     
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~--~~----~~~~~~--~~-----  224 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI--IE----KLKQGQ--RL-----  224 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH--HH----HHHTTE--ET-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cc----cccccc--cc-----
Confidence            2223333457789999999999999999999999999999999 6788765432211  00    001111  11     


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                        ..+..+...+.+++..||+.+|++||++.++++.|
T Consensus       225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              11112345678899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=327.05  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=200.6

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccCh--------------hhHHHHHHHHHHHhccCCCceeeE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------------QGLKEFKNEMMLIAKLQHRNLVRL  574 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l  574 (834)
                      ...++|++++.||+|.||.|-+|+.. +++.||||++.+...              ...+..++|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34588999999999999999999864 689999999975321              124678899999999999999999


Q ss_pred             eeeEeec--CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          575 MGCCVEQ--GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       575 ~~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      +.+..+.  +.+|||+|||..|.+...=-   ....+.+.++.++++++..||+|||.++   ||||||||+|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            9998754  58999999999998765431   2223899999999999999999999998   99999999999999999


Q ss_pred             CeeeccccccccccCCC---cccccccccccccccCcccccCCC----CCccCCeeeHHHHHHHHhhCCCCCCCCCcccc
Q 003287          653 NPKISDFGMARMFCGDE---LQGNTKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLETLTSKRNTGVYDIESF  725 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwSlGvil~elltg~~p~~~~~~~~~  725 (834)
                      ++||+|||.+..+....   .........||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||-....-. 
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-  326 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-  326 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence            99999999998763321   122234478999999999998743    3567899999999999999999987532211 


Q ss_pred             cccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          726 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       726 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       +.            ..++...+.-....+..+++.+||..+|++||+.|.+..+|..-
T Consensus       327 -l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  327 -LF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             -HH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence             10            01111112112223456778899999999999999999988654

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-37  Score=332.62  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=211.8

Q ss_pred             cCccccceecccCccceEeeEec------CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .+|.+.+.||+|+||.||+++..      ++..+++|.+........+.+.+|+.++++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888899999999999999742      356799999877666666789999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC
Q 003287          587 IYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  653 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~  653 (834)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985432             1235889999999999999999999987   999999999999999999


Q ss_pred             eeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccc
Q 003287          654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       654 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  732 (834)
                      ++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+........  .    
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~----  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--I----  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----
Confidence            99999999986543332222333456789999999999999999999999999999999 9998765432211  0    


Q ss_pred             ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       733 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      .....+...+         .....+..+.+++.+||+.+|++||++.+|+++|+.+.+..
T Consensus       236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            0111111111         11123456789999999999999999999999999985543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=339.96  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=204.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.+..   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999986 48899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999943   346889999999999999999999987   99999999999999999999999999986532 


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||...........     ........  ..+..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~~~--~~~~~  222 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN-----LKYWKETL--QRPVY  222 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH-----HHhccccc--cCCCC
Confidence                22345789999999999999999999999999999999999999875443211000     00000000  00100


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ..........+.+++..||+.+|++||++.++++.
T Consensus       223 -~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 -DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             00012345567889999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.2e-37  Score=330.53  Aligned_cols=258  Identities=28%  Similarity=0.451  Sum_probs=208.1

Q ss_pred             ccCccccceecccCccceEeeEecC------CcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|.+.+.||+|+||.||+|+..+      ++.||||+++..... ..+.+.+|++++.+++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568889999999999999998643      478999999765443 567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC
Q 003287          585 ILIYEYMPNKSLNFFLFDPS-----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  653 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~  653 (834)
                      ++||||+++++|.+++....           ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999996431           2345788999999999999999999987   999999999999999999


Q ss_pred             eeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccc
Q 003287          654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       654 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  732 (834)
                      +||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..|+.....+..  ..   
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~--~~---  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV--IE---  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HH---
Confidence            99999999986543332222233446788999999999999999999999999999998 9999765432211  00   


Q ss_pred             ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       733 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                       ....+..         ...+......+.+++..||+.+|++||++.|+++.|+.
T Consensus       236 -~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 -CITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence             0001111         01112234567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=340.72  Aligned_cols=264  Identities=27%  Similarity=0.417  Sum_probs=224.3

Q ss_pred             HHHHHhccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      ...+....+..+.++||-|-||.||.|.++. .-.||||.++.. .-..++|+.|+.+|+.++|||+|+|+|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4555666778888999999999999999875 678999999764 34578999999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      |||.|||.+|+|.+||.+.. ...++....+.++.||+.||+||..++   +|||||.++|+|+.++..+||+||||++.
T Consensus       339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999997653 345777888999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ...+.+.. .....-+..|.|||-+....++.|+|||+|||+||||.| |..|+...+.               ..++++
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------------SqVY~L  478 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYGL  478 (1157)
T ss_pred             hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------------HHHHHH
Confidence            76655432 223345789999999999999999999999999999998 6667664332               224455


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ++...+.+.+..++..+.+|+++||+.+|.+||++.|+-+.|+.+..
T Consensus       479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            55555555666677889999999999999999999999999887643

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-37  Score=324.89  Aligned_cols=256  Identities=29%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.+.||+|+||.||+|...+++.||||.++... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46789999999999999999998778899999987543 34567899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+......
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 346899999999999999999999987   999999999999999999999999999876432211


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       .......+..|+|||++.+..++.++||||||++++||++ |+.|+........  ..    .....  ...       
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~----~~~~~--~~~-------  223 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV--LQ----QVDQG--YRM-------  223 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHHcC--CCC-------
Confidence             1111223468999999999999999999999999999999 8888864332110  00    00000  000       


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .........+.+++.+|++.+|++||++.++++.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            11112345688899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.1e-37  Score=325.58  Aligned_cols=256  Identities=30%  Similarity=0.448  Sum_probs=207.4

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            36799999999999999999998888899999986533 34578999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998543 2345788999999999999999999987   999999999999999999999999999876432211


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       ......++..|+|||++....++.++|||||||++|||++ |..|+........  ...    .....  ..  +    
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~~----~~~~~--~~--~----  224 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--MSA----LQRGY--RM--P----  224 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH--HHH----HHcCC--CC--C----
Confidence             1222345778999999998899999999999999999998 8888865332211  000    00000  00  0    


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                       ........+.+++.+|++.+|++||++++++++|+++
T Consensus       225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             0112335678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.7e-37  Score=329.87  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=204.8

Q ss_pred             hccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      .+++|++.+.||+|+||.||+|...      .+..||||++.... .....+|.+|+.+++.++|+||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      25679999986542 2345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          584 KILIYEYMPNKSLNFFLFDPSR-------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                      .++||||+++++|.+++.+...       ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       234678899999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccc
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      +|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..|+.....+..  ..    ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~--~~----~~  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV--LR----FV  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HH
Confidence            99999986544333222223345788999999999999999999999999999999 6788764432211  00    00


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .......         .+......+.+++.+||+.+|++||++.|++++|++
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            0111100         111223467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.3e-37  Score=328.20  Aligned_cols=268  Identities=31%  Similarity=0.398  Sum_probs=204.5

Q ss_pred             ccccceecccCccceEeeEe-----cCCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL  586 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  586 (834)
                      |++.+.||+|+||+||++..     .+++.||+|.+.... ....+.|.+|++++++++||||+++++++.+.  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     357889999987643 33567789999999999999999999998764  35789


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++++|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    35899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ..... .......++..|+|||.+.+..++.++||||||++++||++|..|+......-.................++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            32211 11122345667999999998899999999999999999999999976433211111111111111111111111


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .......+...+..+.+++..||+.+|++||++++++++|+.++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111122234567889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-37  Score=327.00  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=211.7

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ...+|++.++||+|+||.||+|+..+++.+|+|.+..........+.+|+.+++.++|+||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34679999999999999999999988999999999876665677899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++.+.. ...+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999996542 346889999999999999999999987   99999999999999999999999999987643221


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                      .  .....++..|+|||.+.+..++.++||||||++++||++ |+.|+........  ..             .+.....
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~--~~-------------~~~~~~~  222 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--YD-------------QITAGYR  222 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH--HH-------------HHHhCCc
Confidence            1  113345778999999998899999999999999999998 7888865432111  00             0000011


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            111223345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-37  Score=324.88  Aligned_cols=256  Identities=30%  Similarity=0.466  Sum_probs=206.2

Q ss_pred             cCccccceecccCccceEeeEecC----CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++.+.||+|+||+||+|+...    ...||||.++... .....+|.+|+.++.+++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578999999999999999998742    4579999987543 34456789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998543  236889999999999999999999987   99999999999999999999999999987752


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...........++..|+|||.+.+..++.++||||||++++||++ |..|+........  ..    .....  ...   
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~~----~~~~~--~~~---  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IK----AVEDG--YRL---  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--HH----HHHcC--CCC---
Confidence            222222222345678999999999999999999999999999998 8888754332211  00    00000  000   


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                          ......+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                01112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.9e-37  Score=328.09  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ..++|++++.||+|+||+||+++.+ .|+.+|+|++++..   ....+..+.|-.+|...++|.||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4589999999999999999999876 49999999998763   3355678899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||++||++..+|.   +...|++..+..++.+++-|+..||+.+   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   5568999999999999999999999998   9999999999999999999999999995431


Q ss_pred             C----------------------CCccc-----cc------------------ccccccccccCcccccCCCCCccCCee
Q 003287          667 G----------------------DELQG-----NT------------------KRVVGTYGYMSPEYALDGLFSVKSDVF  701 (834)
Q Consensus       667 ~----------------------~~~~~-----~~------------------~~~~gt~~y~aPE~~~~~~~~~ksDVw  701 (834)
                      .                      .+...     .+                  ...+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                      00010     00                  124799999999999999999999999


Q ss_pred             eHHHHHHHHhhCCCCCCCCCcccc--cccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCC--
Q 003287          702 SFGVLLLETLTSKRNTGVYDIESF--NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT--  777 (834)
Q Consensus       702 SlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs--  777 (834)
                      |||||+||||.|.+||......+.  .+..|.     .    .+.-|     .......+..+||..|+. ||++|.-  
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-----~----~l~fP-----~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-----E----TLKFP-----EEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-----h----hccCC-----CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            999999999999999987654332  111111     0    00001     111122567789999999 9999975  


Q ss_pred             -HHHHHH
Q 003287          778 -MSKVVS  783 (834)
Q Consensus       778 -~~evl~  783 (834)
                       ++||.+
T Consensus       438 G~~EIK~  444 (550)
T KOG0605|consen  438 GAEEIKK  444 (550)
T ss_pred             cHHHHhc
Confidence             555543

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=336.29  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=214.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe-EEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-KILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~  588 (834)
                      ++|..+++||+|+||.++..+.+ +++.+|+|.+.-.  +....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57899999999999999999875 5789999988644  34455578899999999999999999999999998 99999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      +|++||+|.+.+.+.+ ...++++.+.+++.|++.|+.|||+.+   |+|||||+.||+++.++.|||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997654 567899999999999999999999876   999999999999999999999999999998665


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .  .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+......              ++ -+..
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~--------------ki-~~~~  222 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL--------------KI-NRGL  222 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH--------------HH-hhcc
Confidence            4  23345789999999999999999999999999999999999999998755432110              00 1111


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ....+..++..+..++..|++.+|+.||++.+++..
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            223445567788899999999999999999999876

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.9e-37  Score=330.34  Aligned_cols=261  Identities=29%  Similarity=0.445  Sum_probs=209.8

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++.+++||||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467899999999999999999752      24569999998766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCee
Q 003287          586 LIYEYMPNKSLNFFLFDPS----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  655 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vk  655 (834)
                      +||||+++++|.+++....          ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999985321          2235899999999999999999999987   99999999999999999999


Q ss_pred             eccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccc
Q 003287          656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNL  734 (834)
Q Consensus       656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  734 (834)
                      |+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..|+........  ..    .
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~--~~----~  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IE----C  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----H
Confidence            999999986543322222233445778999999999999999999999999999998 8888764432111  00    0


Q ss_pred             ccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       735 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ...+....     .    .......+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       235 i~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11111111     0    11123468899999999999999999999999998843

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.4e-37  Score=323.07  Aligned_cols=252  Identities=30%  Similarity=0.422  Sum_probs=203.1

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.+.||+|+||.||+++..++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            468889999999999999999888889999988643 2335678999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|+|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999999985432  35889999999999999999999987   999999999999999999999999999865332221 


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+........  ...   . ....  ....+.    
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--~~~---i-~~~~--~~~~~~----  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--VEM---I-SRGF--RLYRPK----  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH---H-HCCC--CCCCCC----
Confidence            1122345678999999998899999999999999999999 8888865432111  100   0 0000  011111    


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                         .....+.+++.+||+.+|++||++.++++.|.
T Consensus       225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               12346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.5e-37  Score=327.75  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=204.3

Q ss_pred             cCccccceecccCccceEeeEe-----cCCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ++|++.+.||+|+||.||+|+.     ..++.||+|.+.... .+....+.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688889999999999999984     246789999997543 3445778999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          587 IYEYMPNKSLNFFLFDPS--------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      ||||+++++|.+++....              ....+++.+...++.|+++||+|||+.+   ++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999984321              1235788999999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccc
Q 003287          653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  731 (834)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..|+.......  ...  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--~~~--  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--VIE--  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHH--
Confidence            999999999987644332222333445778999999998899999999999999999998 888875432111  000  


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                        ........         ..+......+.+++.+||+.+|++||++.++++.|..
T Consensus       238 --~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 --MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              00000000         0111233567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=303.86  Aligned_cols=266  Identities=22%  Similarity=0.243  Sum_probs=213.9

Q ss_pred             HhccCccccceecccCccceEeeE-ecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-----e
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----E  583 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~  583 (834)
                      ...++|++.++||+|||+-||+++ ..+++.+|+|++.-...++.+..++|++.-++++||||++++++...+.     +
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            445789999999999999999998 4568899999998877778899999999999999999999999886544     4


Q ss_pred             EEEEEEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      .||+++|...|+|.+.+...+ ....+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence            899999999999999997643 3457999999999999999999999986 47999999999999999999999999998


Q ss_pred             ccccCCCcc-------cccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccc
Q 003287          663 RMFCGDELQ-------GNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       663 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  732 (834)
                      ....-.-..       ........|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-.....+. .  
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-L--  253 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-L--  253 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-E--
Confidence            764211100       1112345789999999885   44678999999999999999999999986433221111 1  


Q ss_pred             ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       733 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                               ....+.+.-.....+++.+.+++.+|++.||.+||+..+++..++.+
T Consensus       254 ---------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 ---------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     11111111111122667889999999999999999999999998765

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=338.99  Aligned_cols=243  Identities=23%  Similarity=0.355  Sum_probs=206.2

Q ss_pred             HHhccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCe
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  583 (834)
                      ....++|.++++||+|+||+|+++.++ +++.+|||.+++..   ....+..+.|..++... +||.++.++.++...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345589999999999999999999986 47899999998863   44567778888888877 59999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      ++.||||+.+|++..+.    ....+++..+.-++..|+.||.|||+++   |||||||.+|||||.+|.+||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999955444    4467899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      .-..  ....+...+||+.|||||++.+..|+.++|.|||||+|||||.|..||...++++.                  
T Consensus       517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------  576 (694)
T KOG0694|consen  517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------  576 (694)
T ss_pred             ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------
Confidence            7432  23456779999999999999999999999999999999999999999997665432                  


Q ss_pred             cCcccc--chhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          744 LSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       744 ~~~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                      .|..+.  ..++...+.+.+.|+..++..+|++|.-+
T Consensus       577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111111  11334455677889999999999999877

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.8e-37  Score=328.26  Aligned_cols=264  Identities=21%  Similarity=0.281  Sum_probs=202.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|++.+.||+|+||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999986 47899999987542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |++++.+..+..   ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2346889999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-ccccc--------cccc-cccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGHA--------WNLW-KDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~--------~~~~-~~~~  739 (834)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|+.||......... .....        ...+ ....
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 1223356899999999999989999999999999999999999999764321110 00000        0000 0000


Q ss_pred             cccccCccc------cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AYELLSPAL------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~~l~~~~l------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......+..      ........+..+.+++.+||+.+|++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000      01111224567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=350.09  Aligned_cols=270  Identities=25%  Similarity=0.324  Sum_probs=216.9

Q ss_pred             HHhccCccccceecccCccceEeeEecCC-cEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeee-Eee-----
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC-CVE-----  580 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~-----  580 (834)
                      .....++++.+.|.+|||+.||.|++..+ .++|+|++-..++...+..++|+.+|++|+ |+|||.+++. ...     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34557889999999999999999998775 999999998888888999999999999996 9999999993 221     


Q ss_pred             -cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          581 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       581 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                       .-+.+|.||||++|.|-+++......+ |.+.++++|+.++++|+++||... ++|||||||-+||||..+++.|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence             136799999999999999996544433 999999999999999999999986 67999999999999999999999999


Q ss_pred             cccccccCCCcccc-------cccccccccccCcccc---cCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccc
Q 003287          660 GMARMFCGDELQGN-------TKRVVGTYGYMSPEYA---LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  729 (834)
Q Consensus       660 Gla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~  729 (834)
                      |.|...........       .-...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+....-      
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------  264 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------  264 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence            99965322221100       0112468999999987   4678999999999999999999999999854211      


Q ss_pred             cccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc-CCCCCCCCC
Q 003287          730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH-ATLPYPKQS  798 (834)
Q Consensus       730 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~-~~l~~p~~~  798 (834)
                                  .+++-...-.....+..+|.+||..||+.+|++||++-||++.+-.+. ...|.+...
T Consensus       265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                        111111111222467788999999999999999999999999987773 344444433

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=322.24  Aligned_cols=270  Identities=24%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhc--cCCCceeeEeeeEeecC----eEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQG----EKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~  585 (834)
                      ..+..+.+.||+|.||+||+|++ .|+.||||++...++   +.+.+|.++...  |+|+||+.+++.-..+.    +++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            36788999999999999999999 689999999976544   445566666554  59999999998865443    789


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ||.+|.++|+|.+||    ....++....++++..+|.||+|||.     ++++.|.|||||++||||..++...|+|+|
T Consensus       286 LvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            999999999999999    34678999999999999999999994     578889999999999999999999999999


Q ss_pred             ccccccCC--CcccccccccccccccCcccccCCC----CC--ccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccc
Q 003287          661 MARMFCGD--ELQGNTKRVVGTYGYMSPEYALDGL----FS--VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       661 la~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~~--~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  732 (834)
                      ||-.....  ......+..+||.+|||||++.+..    |.  ..+||||||.|+||+.....--+...+-...+.+.+.
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            99876543  2334456678999999999986542    22  3589999999999998743221111111111111111


Q ss_pred             ccccccccc-----cccCccccc-hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          733 NLWKDNRAY-----ELLSPALQH-EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       733 ~~~~~~~~~-----~l~~~~l~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .....++..     +.+.|.+.. -.....+..+.+|+..||..+|..|-|+--+.+.|.++.
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            111111111     112222221 234566788999999999999999999999999998874

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-37  Score=334.55  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             cCccccceecccCccceEeeEec-CCc----EEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .+|++.+.||+|+||.||+|++. +++    .||||+++... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56999999999999999999864 333    48999987543 34567899999999999999999999999764 5789


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ++||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998543  345788999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+.........      ......  .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~------~~~~~~--~~~~~  232 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKG--ERLPQ  232 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHHhCC--CCCCC
Confidence            4332222222334678999999999999999999999999999998 89998654322110      000000  01111


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      +       ..+...+.+++..||+.+|++||++.+++..|..+.
T Consensus       233 ~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         233 P-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             C-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1       112345778999999999999999999999988773

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.3e-37  Score=336.66  Aligned_cols=244  Identities=23%  Similarity=0.258  Sum_probs=199.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67999999999999999999976 58899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999853   345788999999999999999999987   999999999999999999999999999865332


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  .    .....+..   .    
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~----~~i~~~~~---~----  233 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI--Y----EKILAGRL---K----  233 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH--H----HHHhcCCc---C----
Confidence                 2235689999999999999999999999999999999999999865332110  0    00001100   0    


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                         .+......+.+++..||+.||.+||+     +.++++
T Consensus       234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               01112345778999999999999997     677763

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=332.93  Aligned_cols=245  Identities=22%  Similarity=0.230  Sum_probs=200.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999976 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999853   346889999999999999999999987   999999999999999999999999999865322


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.||........  ..    ......      .  
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~~----~i~~~~------~--  215 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI--YE----KILAGK------L--  215 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCC------c--
Confidence                 2235689999999999999999999999999999999999999875432110  00    000000      0  


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~  784 (834)
                        ..+......+.+++.+||+.||.+||+     ++|+++.
T Consensus       216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              011122346788999999999999995     7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=329.34  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=212.3

Q ss_pred             hccCccccceecccCccceEeeEecC---C--cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN---G--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~---g--~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      ..+...+.++||+|-||.||+|.+.+   |  -.||||..+.. .....+.|+.|+.+|++++|||||+++|+|.+. ..
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            34556677889999999999998643   3  35899998874 455678899999999999999999999999864 67


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +||||.++.|.|..||..  +...++......++.||..||+|||+..   +|||||..+|||+.+..-+||+||||++.
T Consensus       466 WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence            899999999999999964  3456888899999999999999999987   99999999999999999999999999999


Q ss_pred             ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      +..+.+.... ...-+..|||||.+.-..++.+||||-|||.+||++. |.+||......+..        ...+...++
T Consensus       541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------~~iEnGeRl  611 (974)
T KOG4257|consen  541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------GHIENGERL  611 (974)
T ss_pred             ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------EEecCCCCC
Confidence            8777665544 4456889999999999999999999999999999887 88898754322110        011122233


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      .       .+..++..+..|+.+||..+|.+||++.++...|+.+..
T Consensus       612 P-------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  612 P-------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             C-------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            3       344455677889999999999999999999999877543

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.2e-37  Score=336.71  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec-C
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ-G  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  582 (834)
                      .++|++.+.||+|+||.||+|...      .++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999642      24789999987543 23456788899999999 899999999988654 5


Q ss_pred             eEEEEEEecCCCCchhhhcCCCC---------------------------------------------------------
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSR---------------------------------------------------------  605 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  605 (834)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            78899999999999998853211                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccccccccccc
Q 003287          606 -THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM  684 (834)
Q Consensus       606 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~  684 (834)
                       ...+++..+.+++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             126789999999999999999999987   9999999999999999999999999998764333222233345677899


Q ss_pred             CcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHH
Q 003287          685 SPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITV  763 (834)
Q Consensus       685 aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~l  763 (834)
                      |||++.+..++.++|||||||+++||++ |..|+......+. +.    ........         ...+......+.++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~----~~~~~~~~---------~~~~~~~~~~~~~l  308 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC----RRLKEGTR---------MRAPEYATPEIYSI  308 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH----HHHhccCC---------CCCCccCCHHHHHH
Confidence            9999999999999999999999999998 9888864322110 00    00011100         00111233567899


Q ss_pred             HhcccccCcCCCCCHHHHHHHhhcc
Q 003287          764 ALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       764 i~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      +.+||+.+|++||++.|+++.|+.+
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-36  Score=323.06  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=206.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .+|++.++||+|+||.||+|... .++.||+|++... ....+++.+|++++.+++|+||+++++++.++...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45888899999999999999875 4889999998754 334577899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998543 2345889999999999999999999987   999999999999999999999999999876433221


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       .......+..|+|||.+.+..++.++|||||||++|||++ |..|+...+.+..      +.....         ....
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~---------~~~~  224 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEK---------GYRM  224 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHC---------CCCC
Confidence             1112234668999999999999999999999999999998 8888765432211      000000         0111


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ..+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11122345688899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.7e-37  Score=327.42  Aligned_cols=263  Identities=27%  Similarity=0.423  Sum_probs=210.3

Q ss_pred             hccCccccceecccCccceEeeEecC-----CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEee-cCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  583 (834)
                      ..++|++.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35789999999999999999999765     6889999987543 3446778999999999999999999998876 467


Q ss_pred             EEEEEEecCCCCchhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRT-----HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                      .++++||+++++|.+++......     ..+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998654322     56899999999999999999999987   99999999999999999999999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKD  737 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  737 (834)
                      ||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+.......  +..    ....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAA----YLKD  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHH----HHHc
Confidence            999987644332222223346778999999998899999999999999999999 999986533211  111    0011


Q ss_pred             cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       738 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                      +  .....       ...++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus       235 ~--~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         235 G--YRLAQ-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             C--CCCCC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1  01001       111235678999999999999999999999999988553

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.6e-37  Score=335.17  Aligned_cols=241  Identities=22%  Similarity=0.269  Sum_probs=196.1

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.||+|+||.||+++.. +|+.||||++.+..   ......+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 58999999997542   234466888999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccc
Q 003287          595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT  674 (834)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  674 (834)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99988853   346889999999999999999999987   999999999999999999999999999753221  1223


Q ss_pred             ccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHH
Q 003287          675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY  754 (834)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~  754 (834)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ....+.      .    ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~----~~~~~~------~----~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILMEE------I----RFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HH----HHHcCC------C----CCCC
Confidence            345799999999999999999999999999999999999999865332211  00    000000      0    0112


Q ss_pred             HHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          755 QMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       755 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      .....+.+++..||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            2345678899999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=350.64  Aligned_cols=252  Identities=19%  Similarity=0.215  Sum_probs=204.7

Q ss_pred             CccccceecccCccceEeeEec-C-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-N-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999764 3 6789999876655555667889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          592 PNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       592 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++|+|.+++... .....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999888542 23446889999999999999999999987   99999999999999999999999999987654332


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..   ... .+..    .     
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~--~~---~~~-~~~~----~-----  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI--MQ---QVL-YGKY----D-----  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HHH-hCCC----C-----
Confidence            2233446799999999999999999999999999999999999999865332110  00   000 0000    0     


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+......+.+++..||+.+|++||++.++++
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            011123356888999999999999999999864

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-36  Score=327.46  Aligned_cols=260  Identities=28%  Similarity=0.456  Sum_probs=207.9

Q ss_pred             hccCccccceecccCccceEeeEecC------CcEEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      ..++|++.+.||+|+||.||++....      ...+|+|.+... ......++.+|+.++.++ +|+||+++++++.+++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            44679999999999999999998642      368999998754 334456789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          583 EKILIYEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                      ..+++|||+++|+|..++...             .....+++..+++++.|++.||+|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998532             22356889999999999999999999987   99999999999999


Q ss_pred             CCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccc
Q 003287          650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  728 (834)
Q Consensus       650 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~  728 (834)
                      .++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..|+........   
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence            999999999999987654332222233345678999999999999999999999999999998 8888765332211   


Q ss_pred             ccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          729 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       729 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                         ........         ....+......+.+|+.+|++.+|++|||+.|+++.|+.+
T Consensus       244 ---~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 ---FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ---HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence               00001110         0011122345678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=322.00  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=203.1

Q ss_pred             ccccceecccCccceEeeEecC----CcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe-----
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-----  583 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  583 (834)
                      |++.+.||+|+||.||+|+...    +..||||+++..  .....+.+.+|++.++.++|+||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998743    367999998754  23445789999999999999999999999876554     


Q ss_pred             -EEEEEEecCCCCchhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          584 -KILIYEYMPNKSLNFFLFDPS---RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       584 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                       .++++||+++++|..++....   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999985432   2346899999999999999999999987   999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  738 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  738 (834)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.......  ....    ...+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~----~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDY----LRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcC
Confidence            99987654433222233345678999999998899999999999999999999 888875433211  1100    0001


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ..         ...+......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00         011123445788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=315.22  Aligned_cols=271  Identities=26%  Similarity=0.380  Sum_probs=228.6

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEee
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMG  576 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~  576 (834)
                      ...++.....++++..++-+|.||.||.|.+.      +.+.|-||.++... .-....++.|..++..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            34566667788999999999999999999653      34678899887654 345678999999999999999999999


Q ss_pred             eEeec-CeEEEEEEecCCCCchhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC
Q 003287          577 CCVEQ-GEKILIYEYMPNKSLNFFLF-----DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS  650 (834)
Q Consensus       577 ~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~  650 (834)
                      ++.++ ...+++|.++.-|+|+.||.     +....+.+...+.+.++.|++.|++|||+++   +||.||.++|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            99765 57899999999999999997     5666778889999999999999999999988   999999999999999


Q ss_pred             CCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccc
Q 003287          651 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLG  729 (834)
Q Consensus       651 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~  729 (834)
                      ..++||+|=.+++.+.+.++.......-.+..||+||.+.+..|+.++|||||||+||||+| |+.|+...+..+..  .
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--~  509 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--H  509 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--H
Confidence            99999999999999988887776666677899999999999999999999999999999998 77887655543321  1


Q ss_pred             cccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       730 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      +.      ++.+++..|..+       ++++..++..||...|++||+++|++..|.+++.++
T Consensus       510 yl------kdGyRlaQP~NC-------PDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  510 YL------KDGYRLAQPFNC-------PDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             HH------hccceecCCCCC-------cHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            11      233455555544       457788999999999999999999999999987655

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-36  Score=327.17  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=204.0

Q ss_pred             cCccccceecccCccceEeeEecC------CcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .+|++.+.||+|+||.||+|+..+      ++.||||+++.... ...+.+.+|+.++..++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457888999999999999998632      57899999975533 23467899999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          586 LIYEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      +++||+++++|.+++...             .....+++..+..++.|++.||+|||+.+   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998421             11235788999999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccc
Q 003287          653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  731 (834)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+........  ..  
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~--  237 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--IE--  237 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH--
Confidence            999999999886543332222233456789999999998899999999999999999998 7777764332111  00  


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                        .......         ...+..+...+.+++..||+.+|++||++.++++.|+.
T Consensus       238 --~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 --MIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              0000100         01122344567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-36  Score=326.15  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=205.3

Q ss_pred             CccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      +|++.+.||+|+||.||+|+..      ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999753      23579999887553 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 003287          587 IYEYMPNKSLNFFLFDPS---------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  645 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~N  645 (834)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235789999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccc
Q 003287          646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIES  724 (834)
Q Consensus       646 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~  724 (834)
                      ||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ |..|+.....+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543322222233345778999999998899999999999999999998 888886543221


Q ss_pred             ccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .      +......         .....+......+.+++..||+.+|++||++.|+++.|+++.
T Consensus       238 ~------~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 L------FNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             H------HHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            1      0111110         011111223356888999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=336.79  Aligned_cols=248  Identities=26%  Similarity=0.356  Sum_probs=194.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .+|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56778899999999999999875 58999999986543 33456789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|....       ...+..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.... 
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            9999986432       3457788899999999999999987   9999999999999999999999999998764321 


Q ss_pred             ccccccccccccccCcccccC-----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          671 QGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                       .......||..|+|||++..     ...+.++|||||||++|||++|+.||............  ... ...       
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~~-~~~-------  291 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM--CAI-CMS-------  291 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH--HHH-hcc-------
Confidence             11233568999999998743     23456899999999999999999998733221110000  000 000       


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ............+.+|+..||+.+|++||++.|+++.
T Consensus       292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0011112334568899999999999999999999874

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=331.32  Aligned_cols=241  Identities=20%  Similarity=0.267  Sum_probs=193.5

Q ss_pred             ecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ||+|+||.||+++.. +++.||||++...   .......+.+|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999876 4789999998653   233456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      .+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999853   345889999999999999999999987   9999999999999999999999999998542221  22334


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||........  .   ..... .       +   ...+...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~--~---~~~~~-~-------~---~~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM--Y---RKILQ-E-------P---LRFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH--H---HHHHc-C-------C---CCCCCcC
Confidence            5789999999999999999999999999999999999999875332211  0   00000 0       0   0011223


Q ss_pred             HHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          757 LNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                      ...+.+++..||+.+|++||++.++.+.|
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            45678899999999999998654444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-36  Score=320.63  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=203.0

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.+.||+|+||+||+|+..++..+|||.+.... ...+.|.+|+.++.+++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688899999999999999998777789999987532 335679999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998543  236899999999999999999999987   999999999999999999999999999865433221 


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..|+........  ..    ....+...         .
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~----~~~~~~~~---------~  221 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VE----KVSQGLRL---------Y  221 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH----HHhcCCCC---------C
Confidence            1112345678999999998889999999999999999998 8888865432211  00    00000000         0


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ........+.+++..||+.+|++||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            01112356788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.8e-36  Score=325.09  Aligned_cols=264  Identities=28%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             ccCccccceecccCccceEeeEecC-----------------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceee
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVR  573 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~  573 (834)
                      ..+|++.+.||+|+||.||+++..+                 +..||+|.+.... ....+.+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3679999999999999999997643                 2468999987653 345678999999999999999999


Q ss_pred             EeeeEeecCeEEEEEEecCCCCchhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 003287          574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  645 (834)
Q Consensus       574 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~N  645 (834)
                      +++++..++..++++||+++++|.+++.+..        ....+++..+..++.|+++||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986432        1236899999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh--CCCCCCCCCcc
Q 003287          646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIE  723 (834)
Q Consensus       646 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--g~~p~~~~~~~  723 (834)
                      |+++.++.++|+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++  +..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999987644433333344556789999999998899999999999999999998  55666543321


Q ss_pred             cccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          724 SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       724 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .  ........+........      .......+.++.+++.+||+.+|++||++.|+++.|.
T Consensus       241 ~--~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q--VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H--HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1  11111111111100000      0111123356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.6e-36  Score=318.35  Aligned_cols=248  Identities=26%  Similarity=0.370  Sum_probs=197.1

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999875 68899999886543 34456799999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      .+++...  ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9998532  245789999999999999999999987   99999999999999999999999999876432211111111


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ  755 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~  755 (834)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+........               ...+........+..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~  220 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---------------REAIEQGVRLPCPEL  220 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---------------HHHHHcCCCCCCccc
Confidence            223567999999999999999999999999999998 8888764332110               000000001111122


Q ss_pred             HHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          756 MLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       756 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .+..+.+++.+|++.+|++||++.+++++|.
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3456888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-36  Score=323.62  Aligned_cols=257  Identities=28%  Similarity=0.392  Sum_probs=202.4

Q ss_pred             cCccccceecccCccceEeeEec-CCc----EEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ++|++.+.||+|+||+||+|+.. +++    .|++|.+..... ....++..|+..+++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            57888999999999999999874 344    478888764432 34467888999999999999999999875 456789


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ++||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999542  346889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ............++..|+|||++.+..++.++||||||+++|||++ |..|+........      ......+.  ....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~--~~~~  232 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGE--RLAQ  232 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCC--cCCC
Confidence            4332222334557789999999999999999999999999999998 9888865432211      00111111  1111


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      +..       ....+.+++..||+.+|++||++.|+++.|..+..
T Consensus       233 ~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         233 PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            111       22356779999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-36  Score=329.78  Aligned_cols=201  Identities=28%  Similarity=0.384  Sum_probs=175.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.++||+|+||.||+++.. +++.+|+|++... .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999876 5888999988754 33345678999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++..   ...+++..+..++.|+++||+|||+.+  +|+||||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999853   345788999999999999999999753  3999999999999999999999999999765322 


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence               1223468999999999999899999999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=350.06  Aligned_cols=258  Identities=22%  Similarity=0.303  Sum_probs=206.4

Q ss_pred             HHhccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC---
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG---  582 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---  582 (834)
                      ....++|++.+.||+|+||+||+++.. +++.||||++...  .......+.+|+..+..++|+|++++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344579999999999999999999864 6899999998654  3445667899999999999999999988775432   


Q ss_pred             -----eEEEEEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          583 -----EKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       583 -----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                           ..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999998643 23456899999999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..   ... 
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~--~~---~~~-  258 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--MH---KTL-  258 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HH---HHh-
Confidence            999999876443323333456799999999999999999999999999999999999999875432111  00   000 


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+.    ..     ..+......+.+++..||+.+|.+||++.++++.
T Consensus       259 ~~~----~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGR----YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCC----CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            000    00     1112234568889999999999999999999863

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.6e-36  Score=331.55  Aligned_cols=242  Identities=22%  Similarity=0.261  Sum_probs=196.2

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.||+|+||.||+++.. +++.||||++.+.   .......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 5899999999754   2334567889999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccc
Q 003287          595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT  674 (834)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  674 (834)
                      +|..++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            99888843   346889999999999999999999987   999999999999999999999999998754221  1122


Q ss_pred             ccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHH
Q 003287          675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY  754 (834)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~  754 (834)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .....      +..    .+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~----~~~~~------~~~----~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILME------DIK----FPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HH----HhccC------Ccc----CCC
Confidence            345789999999999999999999999999999999999999865432211  00    00000      000    111


Q ss_pred             HHHHHHHHHHhcccccCcCCCC-----CHHHHHHH
Q 003287          755 QMLNRYITVALLCVQEKAADRP-----TMSKVVSM  784 (834)
Q Consensus       755 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~  784 (834)
                      .....+.+++..||+.+|++||     ++.|+++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2345678899999999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-37  Score=315.12  Aligned_cols=248  Identities=22%  Similarity=0.362  Sum_probs=208.6

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.+++.   +++..-.+++|+++|..|+||||+.++.+|+..+..+||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            36799999999999999999986 56999999999765   456677789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||..+|.|.+|+.   ....|++.++..+++||..|+.|+|.+.   ++|||||.+|||||.++++||+||||+..+..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999994   4567999999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..   .....+|.+-|.+||++.+.+| .+..|-|||||+||-|+.|..||+..+....  +    .....+...+   |
T Consensus       206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l--v----rQIs~GaYrE---P  273 (668)
T KOG0611|consen  206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL--V----RQISRGAYRE---P  273 (668)
T ss_pred             cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH--H----HHhhcccccC---C
Confidence            32   3456789999999999999988 5789999999999999999999987553211  0    0111121111   1


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                      .-        +....-||++||-.+|++|.|..+|..-.
T Consensus       274 ~~--------PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  274 ET--------PSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             CC--------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            11        12344599999999999999999998753

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-36  Score=307.91  Aligned_cols=280  Identities=24%  Similarity=0.299  Sum_probs=211.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChh--hHHHHHHHHHHHhccCCCceeeEeeeEe--ecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCV--EQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l  586 (834)
                      .++|+.+++|++|.||.||+|+++ +++.||+|+++...+.  -...-++|+.+|.+.+|||||.+..+..  +-+..||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            467999999999999999999986 5889999999754321  1234588999999999999999988865  3457999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |||||++ +|..++....  +.+...++.-+..|+++|++|||...   |+|||||++|+|+...|.+||+|||||+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999965 6777775443  57888999999999999999999987   9999999999999999999999999999875


Q ss_pred             CCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCc-cccc----ccc----ccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFN----LLG----HAWNLWK  736 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~~~----~~~----~~~~~~~  736 (834)
                      ..  ....+..+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++.|....+ ++.+    ++.    ..|..+.
T Consensus       229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            33  3345567789999999999875 599999999999999999999998876543 2211    111    1111111


Q ss_pred             ccc------cccccCccccchhHHH-HHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCccc
Q 003287          737 DNR------AYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFS  801 (834)
Q Consensus       737 ~~~------~~~l~~~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~  801 (834)
                      .-.      ..+..-..+...+... ..+.-.+|+..++..||.+|.|++|.++-  +.....|.|..|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~  376 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMF  376 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhc
Confidence            111      0000011111111111 34566789999999999999999998874  444666777766654

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-36  Score=323.41  Aligned_cols=258  Identities=29%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             hccCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      .+++|++.+.||+|+||.||+|...+      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34679999999999999999998753      5689999886543 3345679999999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC---Ceee
Q 003287          584 KILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKI  656 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~vkl  656 (834)
                      .++||||+++++|.+++....    ....+++..++.++.||++||+|||+.+   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999985432    1235889999999999999999999987   99999999999998765   5999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccc
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      +|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||.....+..  ..    ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~  234 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--ME----FV  234 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HH
Confidence            99999987643332222222334578999999999999999999999999999997 8888875432211  00    00


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ...         .....+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       235 ~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            000         001111223456788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.5e-36  Score=323.60  Aligned_cols=263  Identities=23%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57999999999999999999875 58899999986543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            985 888887432  345788999999999999999999987   9999999999999999999999999997653221 


Q ss_pred             ccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc--------ccccccc-cccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------GHAWNLW-KDNR  739 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~--------~~~~~~~-~~~~  739 (834)
                       .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...        ...|... ....
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             11233467899999999875 5689999999999999999999999876443211 000        0000000 0001


Q ss_pred             cccccCccccc----hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AYELLSPALQH----EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~~l~~~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......+....    .........+.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11111111100    001122346789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.1e-36  Score=336.98  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=196.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .|++++.||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999875 58899999997542   3345678999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999854   345888999999999999999999987   9999999999999999999999999986432100


Q ss_pred             c---------------------------------------------ccccccccccccccCcccccCCCCCccCCeeeHH
Q 003287          670 L---------------------------------------------QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG  704 (834)
Q Consensus       670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlG  704 (834)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001234699999999999999999999999999


Q ss_pred             HHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhc--ccccCcCCCCCHHHHH
Q 003287          705 VLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALL--CVQEKAADRPTMSKVV  782 (834)
Q Consensus       705 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~--cl~~~P~~RPs~~evl  782 (834)
                      |++|||++|+.||...........     ............       .......+.+++.+  |+..+|..||++.|++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~-----i~~~~~~~~~~~-------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLK-----VINWENTLHIPP-------QVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHH-----HHccccccCCCC-------CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            999999999999975442211100     000000000000       01123445667766  5566777799999998


Q ss_pred             HH
Q 003287          783 SM  784 (834)
Q Consensus       783 ~~  784 (834)
                      +.
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            74

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-36  Score=333.63  Aligned_cols=246  Identities=22%  Similarity=0.256  Sum_probs=200.3

Q ss_pred             ccCccccceecccCccceEeeEecC--CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|++.+.||+|+||.||+|+...  +..||||++....   ....+.+.+|+.++..++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3679999999999999999998643  3689999986532   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999853   345889999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .     ......||+.|+|||++.+..++.++|||||||++|||++|..||...+....  ..    ....+..  .   
T Consensus       183 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~----~i~~~~~--~---  246 (340)
T PTZ00426        183 T-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI--YQ----KILEGII--Y---  246 (340)
T ss_pred             C-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH--HH----HHhcCCC--C---
Confidence            2     12345789999999999998999999999999999999999999875432110  00    0000100  0   


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  784 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~  784 (834)
                           .+......+.+++.+|++.+|++|+     +++++++.
T Consensus       247 -----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 -----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 0111234567899999999999995     88888764

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=336.67  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=203.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....   ......+.+|+.++..++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999976 58999999997542   234567899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++.+.   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998543   56889999999999999999999987   999999999999999999999999999865432


Q ss_pred             C---------------------------cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          669 E---------------------------LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       669 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0112234568999999999999999999999999999999999999987644


Q ss_pred             cccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCC-HHHHHHH
Q 003287          722 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-MSKVVSM  784 (834)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~  784 (834)
                      .....     ............  +.     .......+.+++..|++ +|.+||+ +.++++.
T Consensus       235 ~~~~~-----~~i~~~~~~~~~--p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETY-----NKIINWKESLRF--PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHH-----HHHhccCCcccC--CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            21110     000000000000  00     00134567789999998 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3e-36  Score=323.44  Aligned_cols=256  Identities=29%  Similarity=0.446  Sum_probs=205.1

Q ss_pred             cCccccceecccCccceEeeEec------CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .+|.+.++||+|+||.||+++..      ++..+|+|.+........+.+.+|++++++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56788899999999999999642      356899999887766677889999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCe
Q 003287          587 IYEYMPNKSLNFFLFDPSR------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  654 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~v  654 (834)
                      +|||+++++|.+++.....            ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            135789999999999999999999987   9999999999999999999


Q ss_pred             eeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccc
Q 003287          655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  733 (834)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||........  ..    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~----  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IE----  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HH----
Confidence            9999999976543322222223345788999999999999999999999999999998 8888754332111  00    


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .......  .       ..+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       236 ~~~~~~~--~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 CITQGRE--L-------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHcCcc--C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0000000  0       011123356788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.2e-36  Score=323.09  Aligned_cols=263  Identities=24%  Similarity=0.352  Sum_probs=194.6

Q ss_pred             cCccccceecccCccceEeeEec--CCcEEEEEEecccC--hhhHHHHHHHHHHHhcc---CCCceeeEeeeEee-----
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVE-----  580 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----  580 (834)
                      ++|++.+.||+|+||+||+|+..  +++.||||++....  ......+.+|+.++..+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999863  46889999986542  22334566777777665   69999999999853     


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ....++||||++ ++|.+++.... ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            356899999997 68888885432 345889999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc--cccccc----ccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLGHA----WNL  734 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~~~----~~~  734 (834)
                      +++.....   .......|++.|+|||++.+..++.++|||||||++|||++|+.||........  .+....    ...
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            99865432   223345689999999999999999999999999999999999999876432111  000000    000


Q ss_pred             cccc-cc-ccccCccc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          735 WKDN-RA-YELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       735 ~~~~-~~-~~l~~~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +... .. .....+..   ...........+.+++.+||+.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000 00 00000000   00111223456778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.5e-36  Score=318.08  Aligned_cols=259  Identities=22%  Similarity=0.381  Sum_probs=208.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+...   .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999875 6899999987542   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||+++++|.+++.... ....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885322 2345789999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.............    ..     ....+ 
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~----~~-----~~~~~-  226 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK----IE-----QCDYP-  226 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH----Hh-----cCCCC-
Confidence            221  1123467889999999998889999999999999999999999985432211111100    00     00011 


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                        ..........+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              111223446788999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-36  Score=322.04  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=207.1

Q ss_pred             ccCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.++..++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3678999999999999999998643      4689999987543 34456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          585 ILIYEYMPNKSLNFFLFDPS-------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      ++||||+++++|.+++....       ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432       1234788999999999999999999987   9999999999999999999999


Q ss_pred             cccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccc
Q 003287          658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      |||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+........  .    ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~----~~~~  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--L----KFVI  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--H----HHHh
Confidence            9999987654433223333456789999999998899999999999999999998 8888764332211  0    0111


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .+....         .+......+.+++..||+.+|++|||+.++++.|+.
T Consensus       236 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111111         111124578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.7e-36  Score=320.85  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=199.7

Q ss_pred             ccccceecccCccceEeeEecC-Cc--EEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------Ce
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GE  583 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  583 (834)
                      |.+.++||+|+||.||+|+..+ ++  .||||.++..  .....+.+.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998764 32  6999988654  344567889999999999999999999987542      24


Q ss_pred             EEEEEEecCCCCchhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          584 KILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      .+++|||+++|+|.+++...   .....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432   22345889999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||.......  ..    .....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~----~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IY----DYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHHHcCC
Confidence            9987644332222233346778999999999999999999999999999999 788876432211  11    1111111


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ...         ........+.+++.+||+.+|++||++.++++.|+.+
T Consensus       232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            110         0112334578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.3e-36  Score=322.06  Aligned_cols=272  Identities=27%  Similarity=0.402  Sum_probs=204.0

Q ss_pred             ccCccccceecccCccceEeeEec-----CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee--cCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  584 (834)
                      .++|++.+.||+|+||.||++...     +++.||||++........+.+.+|++++.+++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            357889999999999999999742     478999999987666667889999999999999999999998754  3468


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++|+||+++++|.+++.+.  ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            9999999999999998542  235889999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCccc-ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc-ccccccccc
Q 003287          665 FCGDELQG-NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN-LWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~  742 (834)
                      +....... ......++..|+|||++.+..++.++||||||++++||++|..++................ ........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            64322111 1111233456999999999899999999999999999999877654322110000000000 000000001


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .+...............+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1110000011122345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.6e-36  Score=330.87  Aligned_cols=241  Identities=22%  Similarity=0.259  Sum_probs=194.9

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.||+|+||.||+++.. +|+.||+|++....   ......+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 58999999997542   234556788999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccc
Q 003287          595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT  674 (834)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  674 (834)
                      +|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888843   346889999999999999999999987   9999999999999999999999999987532221  122


Q ss_pred             ccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHH
Q 003287          675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY  754 (834)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~  754 (834)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....  .    ......      ..    .+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~--~----~~~~~~------~~----~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF--E----LILMEE------IR----FPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH--H----HHhcCC------CC----CCC
Confidence            3356899999999999999999999999999999999999998754322110  0    000000      00    111


Q ss_pred             HHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          755 QMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       755 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      .....+.+++..||+.+|++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            2345677899999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=325.52  Aligned_cols=264  Identities=27%  Similarity=0.433  Sum_probs=201.8

Q ss_pred             cCccccceecccCccceEeeEecC---------------CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEee
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN---------------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMG  576 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~---------------g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~  576 (834)
                      ++|++.++||+|+||.||+++..+               ...||||.++.. .....+.|.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999987532               235899998764 3344567999999999999999999999


Q ss_pred             eEeecCeEEEEEEecCCCCchhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 003287          577 CCVEQGEKILIYEYMPNKSLNFFLFDPS---------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  647 (834)
Q Consensus       577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NIL  647 (834)
                      ++......++||||+++++|.+++....         ....+++..+..++.|+++||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999985421         1124688999999999999999999987   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh--CCCCCCCCCcccc
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIESF  725 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--g~~p~~~~~~~~~  725 (834)
                      ++.++.+||+|||++..+.............++..|+|||++.++.++.++|||||||+++||++  +..|+.....+..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999986543322222233445778999999999999999999999999999998  4456554322111


Q ss_pred             cccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          726 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       726 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                        .......+......      .....+...+..+.+|+.+||+.+|++||++.+|++.|..
T Consensus       242 --~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 --IENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              00000000000000      0000111123578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-37  Score=315.18  Aligned_cols=277  Identities=24%  Similarity=0.328  Sum_probs=211.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee-----cCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-----QGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~  583 (834)
                      ...|..++.||+|+||.|..+... +|+.||||++...  .....++-.+|+++|+.++|+||+.+++++..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            355666789999999999999875 5899999999733  44566788999999999999999999999865     347


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .|+|+|+| ..+|...++   ..+.++......++.||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            89999999 678888883   3345889999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCc-ccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  741 (834)
                      ...........+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|+.-|.+.+. ++..+.........++.+.
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8765433344466788999999999864 5799999999999999999999999887653 3322221111111111111


Q ss_pred             cc--------cC--cccc----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcccCCCCCC
Q 003287          742 EL--------LS--PALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEHATLPYP  795 (834)
Q Consensus       742 ~l--------~~--~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~l~~p  795 (834)
                      .+        +.  |...    ...-........+|+.+||..||.+|+|++|.++-  |+..+..-..|
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            11        00  0000    11112334567889999999999999999999864  55554444444

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.6e-36  Score=338.84  Aligned_cols=261  Identities=27%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             hccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccC-CCceeeEeeeEeecC
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQG  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  582 (834)
                      ..++|.+.++||+|+||.||+|++.      .++.||||+++... ....+.+.+|++++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3457888899999999999999853      24689999997643 233457899999999997 999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCC----------------------------------------------------------
Q 003287          583 EKILIYEYMPNKSLNFFLFDPS----------------------------------------------------------  604 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  604 (834)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999985421                                                          


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 003287          605 -------------------------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  647 (834)
Q Consensus       605 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NIL  647 (834)
                                                           ....+++..++.++.||++||+|||+.+   ++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                 1124677888999999999999999887   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccc
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  726 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~  726 (834)
                      +++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||+++||++ |..|+........ 
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence            99999999999999986533221112223356789999999999899999999999999999998 8888764332111 


Q ss_pred             ccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       727 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                          .......+.  ..       ..+......+.+++..||+.+|++||+++||++.|+.+
T Consensus       351 ----~~~~~~~~~--~~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 ----FYNAIKRGY--RM-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ----HHHHHHcCC--CC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                000000000  00       01112345688899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-36  Score=317.83  Aligned_cols=252  Identities=31%  Similarity=0.450  Sum_probs=202.0

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .+|++.+.||+|+||.||+++...+..+|+|++.... ...+.|.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4588899999999999999998777889999986532 234578899999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++...  ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            99999998543  236889999999999999999999987   999999999999999999999999999865332211 


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........  ..    .....  ...       .
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~----~~~~~--~~~-------~  221 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VE----SVSAG--YRL-------Y  221 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HH----HHHcC--CcC-------C
Confidence            1111234568999999999999999999999999999999 7888865432211  00    00000  000       1


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            11123456889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.2e-36  Score=326.86  Aligned_cols=260  Identities=28%  Similarity=0.447  Sum_probs=205.7

Q ss_pred             ccCccccceecccCccceEeeEec--------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  581 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  581 (834)
                      .++|.+.+.||+|+||.||+++..        +...+|+|.+.... .....++.+|+.++.++ +|+||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367999999999999999999752        23579999997542 34556788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  648 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl  648 (834)
                      +..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999964321             235889999999999999999999987   9999999999999


Q ss_pred             cCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccc
Q 003287          649 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  727 (834)
Q Consensus       649 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~  727 (834)
                      +.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..|+.....+..  
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~--  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence            9999999999999986543222222222334578999999999999999999999999999998 7888764332111  


Q ss_pred             cccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       728 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .    .......         ..+.+......+.+++..||+.+|++||++.++++.|+.+.
T Consensus       252 ~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         252 F----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             H----HHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            0    0000110         01111223456788999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.7e-36  Score=317.54  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=209.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+++.. +++.+|||.+...   .....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888999999999999999864 6899999988653   2234567899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||+++++|.+++... .....+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988542 23456899999999999999999999987   99999999999999999999999999886543


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ...  ......++..|+|||++.+..++.++||||||+++|||++|..|+.....+......         ...+...+.
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~  227 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEQCDYPP  227 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---------hhhcCCCCC
Confidence            221  122346889999999999999999999999999999999999998643322111110         000111111


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .   ........+.+++.+||+.+|++||||.+|++++++++
T Consensus       228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1   11234557889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.1e-36  Score=325.57  Aligned_cols=264  Identities=25%  Similarity=0.322  Sum_probs=197.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 588999999875432 234567889999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |++ ++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 567666643  2345788999999999999999999987   9999999999999999999999999997543211


Q ss_pred             cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccc-------cccccccc---
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-------AWNLWKDN---  738 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~---  738 (834)
                        .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...       ....+...   
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              12233567899999999875 458899999999999999999999997543211100000       00000000   


Q ss_pred             -----ccccccCcc-ccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          739 -----RAYELLSPA-LQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       739 -----~~~~l~~~~-l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                           .......+. +... ........+.+++..||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 000000000 0000 00012345778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=335.57  Aligned_cols=252  Identities=21%  Similarity=0.275  Sum_probs=198.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+++.. +++.||||++....   ......+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999975 58999999997532   234466889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   345899999999999999999999987   999999999999999999999999999764321


Q ss_pred             Cccc------------------------------------ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh
Q 003287          669 ELQG------------------------------------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT  712 (834)
Q Consensus       669 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt  712 (834)
                      ....                                    ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112468999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCC---HHHHHH
Q 003287          713 SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT---MSKVVS  783 (834)
Q Consensus       713 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~  783 (834)
                      |..||........  .   ..............       .......+.+++..|+. +|.+|++   +.|+++
T Consensus       235 G~~Pf~~~~~~~~--~---~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQET--Y---RKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHHH--H---HHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999875432211  0   00000000000000       00123456778888986 8999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.9e-36  Score=325.19  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=206.6

Q ss_pred             ccCccccceecccCccceEeeEec--------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  581 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  581 (834)
                      .++|++.+.||+|+||.||+++..        ++..||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467889999999999999999741        24579999987542 34567789999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  648 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl  648 (834)
                      ...++||||+++|+|.+++.....             ...+++.++..++.||++||+|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999865321             235788999999999999999999987   9999999999999


Q ss_pred             cCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccc
Q 003287          649 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  727 (834)
Q Consensus       649 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~  727 (834)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+........  
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--  248 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  248 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--
Confidence            9999999999999987644333222333446778999999999899999999999999999998 6777654332111  


Q ss_pred             cccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       728 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .    ........         ..........+.+++..||+.+|++||++.|+++.|..+
T Consensus       249 ~----~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         249 F----KLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             H----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            0    00111100         001122345678899999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-35  Score=313.80  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=210.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999986 6899999988642   2334678899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||+++++|..++.+. .....+++.++..++.++++||+|||+.+   |+|+||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988543 23456889999999999999999999987   99999999999999999999999999886543


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ...  ......++..|+|||.+.+..++.++|||||||++|||++|+.|+............    ....+.        
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~--------  224 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEKCD--------  224 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh----hhhcCC--------
Confidence            221  122345788999999999889999999999999999999999998643321111100    000000        


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      ............+.+++.+||+.+|++||++.+++++|+.++
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            001111234557889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-36  Score=323.21  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=204.8

Q ss_pred             hccCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      ..++|++.+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45789999999999999999997532      4589999986543 2334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          584 KILIYEYMPNKSLNFFLFDPS-------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                      .++||||+++|+|.+++.+..       ....+.+..+..++.|++.||+|||+.+   |+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996422       1234567888999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccc
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      +|||+++.+.............++..|+|||.+.+..++.++|||||||+++||++ |..|+.....++.  ..    ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LK----FV  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HH
Confidence            99999986544333222233345678999999999999999999999999999998 6778764332211  00    00


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ......         ..+......+.+++.+||+.+|++||++.++++.|...
T Consensus       235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 MDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            000000         01112235788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-35  Score=333.46  Aligned_cols=258  Identities=19%  Similarity=0.219  Sum_probs=196.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..+|+++++||+|+||.||++... .++.||||....      ..+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999875 588999997532      4568899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +. ++|..++..   ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 678777743   245789999999999999999999987   9999999999999999999999999997542211 


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-----ccccccc-------cc--c
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-----LLGHAWN-------LW--K  736 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-----~~~~~~~-------~~--~  736 (834)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-........     .......       .+  .
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            11223457999999999999999999999999999999999999876432210000     0000000       00  0


Q ss_pred             -ccccccc---------cCcccc--chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 -DNRAYEL---------LSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 -~~~~~~l---------~~~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .....+.         ..+...  ..........+.+|+.+||+.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000000         000000  0112234567889999999999999999999985

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.6e-36  Score=322.25  Aligned_cols=263  Identities=28%  Similarity=0.441  Sum_probs=202.4

Q ss_pred             cCccccceecccCccceEeeEec-----------------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-----------------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRL  574 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-----------------~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l  574 (834)
                      ++|++.++||+|+||.||+++..                 ++..||+|++... .....+.|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998532                 2346999999754 33455789999999999999999999


Q ss_pred             eeeEeecCeEEEEEEecCCCCchhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcE
Q 003287          575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  646 (834)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NI  646 (834)
                      ++++.+.+..++||||+++++|.+++....        ....+++.++..++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            999999999999999999999999986432        1234778899999999999999999987   99999999999


Q ss_pred             EEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh--CCCCCCCCCccc
Q 003287          647 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIES  724 (834)
Q Consensus       647 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--g~~p~~~~~~~~  724 (834)
                      |++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..|+.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543332222223345678999999988899999999999999999998  566765433221


Q ss_pred             ccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .  ............ .....     ..+..+...+.+++.+||+.+|++||++.+|++.|.
T Consensus       242 ~--~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 V--IENTGEFFRDQG-RQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H--HHHHHHHHhhcc-ccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1  000000000000 00000     011123356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6e-36  Score=324.06  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=202.8

Q ss_pred             cCccccceecccCccceEeeEecC-C--cEEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-G--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g--~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998754 3  35799988753 334557789999999999 799999999999999999999


Q ss_pred             EEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCe
Q 003287          588 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  654 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~v  654 (834)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1235889999999999999999999987   9999999999999999999


Q ss_pred             eeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccc
Q 003287          655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  733 (834)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||........  ..    
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~--~~----  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL--YE----  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----
Confidence            99999998642111   11111223567999999999999999999999999999997 9999865432211  00    


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      .         +........+..+...+.+++..||+.+|.+||++.++++.|+.+..
T Consensus       230 ~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         230 K---------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             H---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0         00001111112234567889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6e-36  Score=328.07  Aligned_cols=241  Identities=25%  Similarity=0.327  Sum_probs=193.6

Q ss_pred             ceecccCccceEeeEec----CCcEEEEEEecccC----hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          519 CKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +.||+|+||.||+++..    .++.||||++....    ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999753    47899999987532    22345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++..   ...+.+..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999998843   345788889999999999999999987   9999999999999999999999999987542221 


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .   ..... ..      .    
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~--~---~~~~~-~~------~----  217 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT--I---DKILK-GK------L----  217 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH--H---HHHHc-CC------C----
Confidence             122335689999999999998999999999999999999999999875432110  0   00000 00      0    


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      ..+......+.+++..||+.+|++||     ++.++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            01112234677899999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.3e-36  Score=324.23  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=205.4

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  583 (834)
                      .++|++.+.||+|+||.||++...      .+..||||+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            367999999999999999999742      24589999987653 33456789999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999986432 234899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      .+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.........     ......+    
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-----~~~~~~~----  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-----YKLIKEG----  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-----HHHHHcC----
Confidence            6643321111222345788999999999999999999999999999998 88887643321100     0000000    


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                           ............+.+++.+|++.+|++||++.|+++.|...
T Consensus       261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 00001111235688899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-35  Score=315.84  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=203.7

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.++||+|+||.||+|+..+...||||++.... ...+.|.+|+.++.+++|+||+++++++. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            35699999999999999999998777789999997533 23467899999999999999999999875 45689999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++... ....+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999643 2345789999999999999999999987   999999999999999999999999999866433221


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       ......++..|+|||+..+..++.++||||||+++|||++ |..|+........  ..    .....         ...
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~~----~~~~~---------~~~  222 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD----QVERG---------YRM  222 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--HH----HHhcC---------CCC
Confidence             1122346778999999998999999999999999999999 7778764332111  00    00000         000


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ......+..+.+++..|++.+|++||++.+++++|+..
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            11123445678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.2e-36  Score=329.34  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=196.3

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-----eEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI  585 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  585 (834)
                      +|++.++||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999875 5899999998743  2234457889999999999999999999886432     479


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||++ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 678888743   345889999999999999999999987   999999999999999999999999999865


Q ss_pred             cCCCc-ccccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc----cc----ccc
Q 003287          666 CGDEL-QGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GH----AWN  733 (834)
Q Consensus       666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~----~~----~~~  733 (834)
                      ..... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ ...    ..    ...
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221 112234568999999999876  6789999999999999999999999875432110 000    00    000


Q ss_pred             cccccccccc---cCccccc---hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          734 LWKDNRAYEL---LSPALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       734 ~~~~~~~~~l---~~~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+......+.   +.+....   .........+.+++..||+.+|++||+++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000000   0000000   0001123457789999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-37  Score=298.20  Aligned_cols=249  Identities=27%  Similarity=0.357  Sum_probs=208.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .+...++.+|+++-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            478999999999999999999976 47789999986642   33456789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      +||.+.|.|...|.+. +...+++.....++.|+|.||.|+|..+   ||||||||+|+|++..+.+||+|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999999643 3456888899999999999999999987   9999999999999999999999999987532 


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                         .......+||..|++||...+..++.++|+|++|++.||++.|.+||......+.      +   ++-.-.++..| 
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------Y---krI~k~~~~~p-  242 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------Y---KRIRKVDLKFP-  242 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------H---HHHHHccccCC-
Confidence               3345568999999999999999999999999999999999999999986442211      0   00011111222 


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                            ........++|..|+..+|.+|.+..|++.-
T Consensus       243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  243 ------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  3344567889999999999999999998753

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-35  Score=323.99  Aligned_cols=240  Identities=25%  Similarity=0.327  Sum_probs=189.9

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 47899999997542   23344556677777654 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988843   345889999999999999999999987   9999999999999999999999999998643222  22


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .....      .+.    .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~----~i~~~------~~~----~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FD----SILND------RPH----FP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHcC------CCC----CC
Confidence            3345789999999999999999999999999999999999999875432211  00    00000      011    11


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHH-HHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMS-KVV  782 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl  782 (834)
                      ......+.+++..||+.+|++||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12334567899999999999999876 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-35  Score=314.89  Aligned_cols=253  Identities=30%  Similarity=0.459  Sum_probs=202.8

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.++||+|+||.||++...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            57889999999999999999988888999999976433 3467999999999999999999999875 456899999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++... ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            99999998643 2345789999999999999999999987   999999999999999999999999999865432211 


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+  ....    +.         ......
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~----~~---------~~~~~~  223 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQ----VE---------RGYRMP  223 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH----HH---------cCCCCC
Confidence            1112335678999999998899999999999999999999 888886433211  0000    00         000111


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      ........+.+++.+|++.+|++|||+.++++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            122334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.1e-36  Score=315.40  Aligned_cols=247  Identities=27%  Similarity=0.380  Sum_probs=196.1

Q ss_pred             eecccCccceEeeEec---CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          520 KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +||+|+||.||+|.+.   +++.+|||+++...  ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999653   47889999986543  334678999999999999999999999875 45779999999999


Q ss_pred             CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc-cc
Q 003287          595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-GN  673 (834)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~  673 (834)
                      +|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........ ..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   245889999999999999999999987   999999999999999999999999999876433221 11


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      .....++..|+|||.+....++.++||||||+++|||++ |..||........  ..    ....+..         ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~----~i~~~~~---------~~~  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV--TQ----MIESGER---------MEC  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHCCCC---------CCC
Confidence            122234678999999988889999999999999999998 8999875432211  10    0111110         111


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      +......+.+++.+||+.+|++||++.+|++.|++.
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-35  Score=319.79  Aligned_cols=271  Identities=26%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             cCccccceecccCccceEeeEe-----cCCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  584 (834)
                      ..|++++.||+|+||.||+++.     .++..||+|.++... ....+.+.+|+.++++++|||++++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974     247889999987553 34456799999999999999999999998875  568


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++.+.  ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999998532  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      +...... .......++..|+|||++.+..++.++||||||++++||++++.|.........................+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6432211 112234567789999999988999999999999999999998765432110000000000000000000000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      +...........++..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000111123456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.8e-36  Score=334.99  Aligned_cols=202  Identities=25%  Similarity=0.350  Sum_probs=173.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .|+++++||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999875 58899999997542   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999853   245788899999999999999999987   9999999999999999999999999986432100


Q ss_pred             c---------------------------------------------ccccccccccccccCcccccCCCCCccCCeeeHH
Q 003287          670 L---------------------------------------------QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG  704 (834)
Q Consensus       670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlG  704 (834)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001234689999999999999999999999999


Q ss_pred             HHHHHHhhCCCCCCCCC
Q 003287          705 VLLLETLTSKRNTGVYD  721 (834)
Q Consensus       705 vil~elltg~~p~~~~~  721 (834)
                      |++|||++|+.||....
T Consensus       236 vil~elltG~~Pf~~~~  252 (382)
T cd05625         236 VILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.5e-36  Score=334.36  Aligned_cols=254  Identities=21%  Similarity=0.259  Sum_probs=200.7

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ..++|++.++||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999999875 58899999996532   2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999843    34788889999999999999999987   9999999999999999999999999998754


Q ss_pred             CCCcccccccccccccccCcccccCC----CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........     ............
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~~~~  267 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMDHKNSLT  267 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCCCcCC
Confidence            3221 122345789999999998653    478999999999999999999999875432110     000000000000


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCC--CCCHHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  784 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~  784 (834)
                      ..       .....+..+.+++..||+.+|.+  ||++.|+++.
T Consensus       268 ~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 FP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00       11123456778999999999987  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-35  Score=314.34  Aligned_cols=254  Identities=31%  Similarity=0.458  Sum_probs=204.5

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            36789999999999999999998889999999987543 33567899999999999999999999864 56789999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++.... ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999885432 346889999999999999999999987   999999999999999999999999999876432221


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       ......++..|+|||++....++.++||||||++++||++ |+.||........  ..    .....  ..       .
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~--~~-------~  222 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--IQ----NLERG--YR-------M  222 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--HH----HHHcC--CC-------C
Confidence             1122345678999999998999999999999999999999 9999865432111  00    00000  00       0


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .........+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            0111223568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.2e-36  Score=332.42  Aligned_cols=203  Identities=24%  Similarity=0.327  Sum_probs=175.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+++.. +++.||||++.+..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999875 48899999997542   233456888999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   346899999999999999999999987   999999999999999999999999999765321


Q ss_pred             Ccc---------------------------------cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCC
Q 003287          669 ELQ---------------------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR  715 (834)
Q Consensus       669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~  715 (834)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123479999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 003287          716 NTGVYD  721 (834)
Q Consensus       716 p~~~~~  721 (834)
                      ||....
T Consensus       235 Pf~~~~  240 (363)
T cd05628         235 PFCSET  240 (363)
T ss_pred             CCCCCC
Confidence            997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.8e-36  Score=328.49  Aligned_cols=251  Identities=23%  Similarity=0.300  Sum_probs=197.0

Q ss_pred             CccccceecccCccceEeeEec----CCcEEEEEEecccC----hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      +|++.+.||+|+||.||+++..    +++.||+|++.+..    ....+.+.+|+.++.++ +|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999999753    57899999986532    23345688899999999 599999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999853   345889999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      +..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  .....     ... .
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~-----~~~-~  225 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSR-----RIL-K  225 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHH-----HHh-c
Confidence            533221 122345789999999999875 4789999999999999999999998643321110  00000     000 0


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      .++.+    +......+.+++..||+.+|++||     +++++++
T Consensus       226 ~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111    112334577899999999999999     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.4e-36  Score=319.58  Aligned_cols=271  Identities=28%  Similarity=0.404  Sum_probs=207.3

Q ss_pred             cCccccceecccCccceEeeEec-----CCcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEee--cCeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  584 (834)
                      +.|++.+.||+|+||.||+++..     .++.||||.+...... ..+.|.+|++++++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999864     3678999999765443 56789999999999999999999999887  5578


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999543  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCc-ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ...... ........++..|+|||.+.+..++.++||||||++++||++|..|+........................+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            653221 1111223456679999999988999999999999999999999988754332211111000000000011111


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      +...........+...+.+++.+||+.+|++||++.|++++|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111111223346788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-35  Score=318.83  Aligned_cols=256  Identities=26%  Similarity=0.390  Sum_probs=202.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCc----EEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .++|++.++||+|+||+||+|+.. +++    .||||++.... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            367889999999999999999853 444    58999987543 3446778999999999999999999999875 4578


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +++||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999998542  346899999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..|+........  ..    ........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~---  230 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI--PD----LLEKGERL---  230 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HHHCCCcC---
Confidence            43322211222335678999999999999999999999999999998 8888764332111  00    00111000   


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                            .........+.+++..||+.+|++||++.++++.|+.+
T Consensus       231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                  01112344678899999999999999999999999887

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=334.72  Aligned_cols=253  Identities=21%  Similarity=0.258  Sum_probs=196.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|+++++||+|+||+||+++.. +++.||||++.+..   ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999875 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   346888999999999999999999988   999999999999999999999999999643211


Q ss_pred             Ccc------------c---------------------------------ccccccccccccCcccccCCCCCccCCeeeH
Q 003287          669 ELQ------------G---------------------------------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSF  703 (834)
Q Consensus       669 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSl  703 (834)
                      ...            .                                 ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012468999999999999999999999999


Q ss_pred             HHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCC---CCHHH
Q 003287          704 GVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR---PTMSK  780 (834)
Q Consensus       704 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~e  780 (834)
                      ||++|||++|..||........  ..   ..........+.+       .......+.+++..|++ +|.+|   +++.|
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~--~~---~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHET--YR---KIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHH--HH---HHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999999875432211  00   0000000001100       01123457789999997 66665   59988


Q ss_pred             HHHH
Q 003287          781 VVSM  784 (834)
Q Consensus       781 vl~~  784 (834)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.2e-36  Score=321.30  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=204.7

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.+.||+|+||.||+++..      ++..||+|.+.... .....++.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999863      46789999987543 34456799999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 003287          585 ILIYEYMPNKSLNFFLFDPS-------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  645 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~N  645 (834)
                      ++||||+++++|.+++....                   ....+++.+++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1234788899999999999999999987   9999999999


Q ss_pred             EEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccc
Q 003287          646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIES  724 (834)
Q Consensus       646 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~  724 (834)
                      |+++.++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986543322222222345678999999998999999999999999999998 777775432211


Q ss_pred             ccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .  ..    ....+....         .+......+.+++.+||+.+|++||++.|+++.|+.
T Consensus       241 ~--~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 V--IY----YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H--HH----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1  00    001111100         111234568889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=317.41  Aligned_cols=252  Identities=25%  Similarity=0.303  Sum_probs=200.8

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .|++.++||+|+||+||++... +++.||||++....   ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999875 58899999986532   2233567889999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|.+++... ....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888543 2345899999999999999999999987   9999999999999999999999999998653222


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......|+..|+|||++.+..++.++||||+||++|||++|+.||........  ..         .....+.. ..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~---------~~~~~~~~-~~  221 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--RE---------EVERRVKE-DQ  221 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HH---------HHHHHhhh-cc
Confidence               11234689999999999999999999999999999999999999875332110  00         00000000 01


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~  784 (834)
                      ..........+.+|+..||+.||++||     ++.++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            112223456678899999999999999     77777553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-35  Score=316.22  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=202.8

Q ss_pred             cCccccceecccCccceEeeEecC-C---cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..|++.+.||+|+||.||+|+... +   ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457889999999999999998753 3   36999998764 344567899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998543  345889999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCccccccccc---ccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccc
Q 003287          668 DELQGNTKRVV---GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       668 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ...........   .+..|+|||++.+..++.++|||||||++|||++ |..|+........  ....    ...  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--~~~i----~~~--~~~  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--INAI----EQD--YRL  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--HHHH----HcC--CcC
Confidence            22211111111   2457999999999999999999999999999886 9888764332111  0000    000  000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                             ..+.+.+..+.+++..||+.+|++||++.+++++|+.+
T Consensus       231 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 -------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   01122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-35  Score=326.49  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=193.1

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHH---hccCCCceeeEeeeEeecCeEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLI---AKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      |++.+.||+|+||.||+++.. +++.||||++++..   ....+.+.+|+.++   ..++||||+++++++.+....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999875 58999999997542   22345566666554   567899999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|...+..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888742    46899999999999999999999987   99999999999999999999999999875322


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .  ........|++.|+|||.+.+..++.++|||||||++|||++|+.||........  ..    ......      ..
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~----~i~~~~------~~  219 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FD----SIVNDE------VR  219 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCC------CC
Confidence            1  1223345789999999999999999999999999999999999999875432211  00    000000      00


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                          .+......+.+++.+||+.+|.+||     ++.++++
T Consensus       220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                1112345577899999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.3e-36  Score=335.68  Aligned_cols=253  Identities=21%  Similarity=0.273  Sum_probs=196.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .+|++++.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999875 48899999986532   223466889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999853   345788899999999999999999987   999999999999999999999999998543110


Q ss_pred             C-----------------------------------------cccccccccccccccCcccccCCCCCccCCeeeHHHHH
Q 003287          669 E-----------------------------------------LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL  707 (834)
Q Consensus       669 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil  707 (834)
                      .                                         .........||+.|||||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001134699999999999999999999999999999


Q ss_pred             HHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCC---CHHHHHHH
Q 003287          708 LETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRP---TMSKVVSM  784 (834)
Q Consensus       708 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~evl~~  784 (834)
                      |||++|+.||...........     ............       .......+.+++..|+ .+|++|+   ++.|+++-
T Consensus       235 yell~G~~Pf~~~~~~~~~~~-----i~~~~~~~~~~~-------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLK-----VINWETTLHIPS-------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHH-----HhccCccccCCC-------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999999976543211000     000000000000       0112334556777765 4999999   78888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-35  Score=331.61  Aligned_cols=255  Identities=20%  Similarity=0.251  Sum_probs=199.3

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ...++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999976 4789999998653   2233456889999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999999843    34788899999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCC----CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........     ...........
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-----~~~i~~~~~~~  266 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-----YSKIMDHKNSL  266 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCccc
Confidence            43221 122345799999999998754    378899999999999999999999975432110     00011101000


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCC--CCCHHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  784 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~  784 (834)
                      ..       .........+.+++..|++.++.+  ||++.|+++.
T Consensus       267 ~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            10       011123455677888899855543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.5e-36  Score=328.66  Aligned_cols=242  Identities=22%  Similarity=0.255  Sum_probs=194.6

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 58999999997542   234567788999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      +|..++..   ...+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99988843   3468899999999999999999997 55   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+....      .....      ...+    +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~------~i~~~------~~~~----p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------LILME------EIRF----P  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH------HHhcC------CCCC----C
Confidence            233568999999999999999999999999999999999999986543221100      00000      0001    1


Q ss_pred             HHHHHHHHHHHhcccccCcCCCC-----CHHHHHHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  784 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~  784 (834)
                      ......+.+++..||+.+|++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            12234677899999999999996     89988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-35  Score=323.02  Aligned_cols=260  Identities=28%  Similarity=0.452  Sum_probs=205.7

Q ss_pred             cCccccceecccCccceEeeEec--------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      ++|.+.++||+|+||.||+++..        ....||+|.+.... .....++.+|+.++.++ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            67889999999999999999742        24579999987543 34567789999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                      ..++||||+++|+|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999985432             1245889999999999999999999987   99999999999999


Q ss_pred             CCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccc
Q 003287          650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  728 (834)
Q Consensus       650 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~  728 (834)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+........  .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~  246 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--F  246 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence            999999999999986643322222222334568999999999999999999999999999999 7888764332211  0


Q ss_pred             ccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          729 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       729 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                          .........         ..+......+.+++.+||+.+|++||++.|+++.|..+..
T Consensus       247 ----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         247 ----KLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                000111000         1112233467789999999999999999999999988744

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-35  Score=314.49  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=202.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .+|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++++..++..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            57999999999999999999974 58899999997655455567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence            99999998843   345789999999999999999999987   9999999999999999999999999998653221  


Q ss_pred             cccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          672 GNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .......++..|+|||.+.   ...++.++|||||||+++||++|+.|+.......... .     ....   ....+..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~-----~~~~---~~~~~~~  231 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-L-----MSKS---NFQPPKL  231 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-e-----eecC---CCCCCCC
Confidence            1122346888999999884   3457889999999999999999999985432211100 0     0000   0000111


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                      .  ........+.+++..||+.+|++||+++++++.|
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0  0112345788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.3e-36  Score=330.24  Aligned_cols=252  Identities=20%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+++.. +++.||||+++...   ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999875 58899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+.  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998543  246889999999999999999999987   999999999999999999999999999876433


Q ss_pred             CcccccccccccccccCccccc------CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYAL------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........     ............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~  229 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQRFLK  229 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCCccC
Confidence            221 223346899999999986      45678999999999999999999999875432111     000111111111


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+       .......+.+|+..|++ +|.+||++.++++
T Consensus       230 ~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 FPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            100       11233557789999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-35  Score=323.49  Aligned_cols=242  Identities=21%  Similarity=0.303  Sum_probs=190.2

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+++.. +++.||+|++++.   .....+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999975 4789999999754   233455678899888877 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            999888743   346889999999999999999999987   9999999999999999999999999997532211  12


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc---cccccccccccccccccccCccccc
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF---NLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ....+.........          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence            2345789999999999999999999999999999999999999864221110   00000000000000          0


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                      ..+......+.+++..||+.+|++||+.
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1112234567789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-35  Score=325.91  Aligned_cols=241  Identities=24%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             CccccceecccCccceEeeEecC-CcEEEEEEeccc---ChhhHHHHHHHHHHHhccCC-CceeeEeeeEeecCeEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~  588 (834)
                      +|++++.||+|+||.||+|+..+ ++.||||++.+.   .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58889999999999999998764 789999999754   23345678889999999976 46888999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988843   345789999999999999999999987   999999999999999999999999998753211


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ...   .. ..      ..  
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~---i~-~~------~~--  218 (324)
T cd05587         155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQS---IM-EH------NV--  218 (324)
T ss_pred             --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHH---HH-cC------CC--
Confidence              1123345689999999999999999999999999999999999999875432211  000   00 00      00  


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                        ..+......+.+++..||+.+|.+|++.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              0111233467789999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.8e-35  Score=314.90  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=204.2

Q ss_pred             ccCccccceecccCccceEeeEecC-C---cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|+..+.||+|+||.||+|++.. +   ..+|||.+... .....+.+.+|++++.+++|+|++++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578888999999999999998753 3   37999998755 33456779999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998542  246889999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCcccc-cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          667 GDELQGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       667 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ....... ......+..|+|||++....++.++|||||||++|||++ |+.|+........  ..    .....      
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~--~~----~i~~~------  226 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--MK----AINDG------  226 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhcC------
Confidence            3221111 111223467999999998899999999999999999997 9999864332110  00    00000      


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                         ............+.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               00011112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-35  Score=322.00  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=201.6

Q ss_pred             cCccccceecccCccceEeeEec-CCc--EEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~--~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++.+.||+|+||.||+|+.. ++.  .+|+|.+... .......+.+|++++.++ +|+||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57889999999999999999875 343  4688887653 334556789999999999 899999999999999999999


Q ss_pred             EEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCe
Q 003287          588 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  654 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~v  654 (834)
                      |||+++++|.+++....             ....+++.+++.++.|+++||+|||+.+   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986432             1235889999999999999999999987   9999999999999999999


Q ss_pred             eeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccc
Q 003287          655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  733 (834)
                      ||+|||+++....   ........++..|+|||++.+..++.++|||||||+++||+| |..||......+.  ..    
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----  234 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE----  234 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HH----
Confidence            9999999864211   111111234668999999988889999999999999999998 9998864332211  00    


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .....         .....+......+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00000         000011123346788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=331.58  Aligned_cols=253  Identities=28%  Similarity=0.367  Sum_probs=210.0

Q ss_pred             cCccccceecccCccceEeeEecC--Cc--EEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN--GQ--EVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++..+.++||+|.||.|++|.+..  |+  .||||.+...... ....|++|+.+|.+|+|+|+++|+|+..+ ...+||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            455677899999999999998753  43  6899999876443 67899999999999999999999999987 788999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      +|.++.|+|.+-|++ .....+.......++.|||.||.||.+++   +|||||..+|+||-....|||+||||.+.+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999977 44566788899999999999999999987   99999999999999999999999999998865


Q ss_pred             CCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          668 DELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       668 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .+.. .......-+..|+|||.+....|+.++|||+|||++|||+| |..||....               ...+.+.+|
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---------------g~qIL~~iD  329 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---------------GIQILKNID  329 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---------------HHHHHHhcc
Confidence            4432 22233445789999999999999999999999999999999 556765432               122333344


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                      ..-+-..+..+++++++++..||..+|++||++..+++.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            3333344556778999999999999999999999998554

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=336.73  Aligned_cols=256  Identities=29%  Similarity=0.387  Sum_probs=212.3

Q ss_pred             ccccceecccCccceEeeEe-cCC----cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKL-LNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~-~~g----~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .+..++||+|+||+||||.+ ++|    -+||||++... ..+..+++++|+.+|.+++|||++||+|+|.... ..||.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34567999999999999986 343    47999998765 3456789999999999999999999999998776 89999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      +||+.|.|.++++.+  +..+..+..+.|..|||+||.|||.+.   ++||||.++||||.+...+||.|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999999653  456888999999999999999999876   999999999999999999999999999998776


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ...-......-.+.|||-|.+....|+.++|||||||++||++| |.+|......++.               .+++...
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI---------------~dlle~g  916 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI---------------PDLLEKG  916 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh---------------hHHHhcc
Confidence            65555555556789999999999999999999999999999998 8888776554332               1111111


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                      .+-..+..+..++..++.+||..|+..||+++++.+.+.+...+
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            11222334556788899999999999999999999999887544

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-35  Score=328.81  Aligned_cols=261  Identities=27%  Similarity=0.410  Sum_probs=201.3

Q ss_pred             ccCccccceecccCccceEeeEe------cCCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec-C
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ-G  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  582 (834)
                      .++|++.+.||+|+||.||+|+.      .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            36799999999999999999973      246889999997543 33456788999999999 789999999988654 4


Q ss_pred             eEEEEEEecCCCCchhhhcCCCC---------------------------------------------------------
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSR---------------------------------------------------------  605 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  605 (834)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998853210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccccc
Q 003287          606 -------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV  678 (834)
Q Consensus       606 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  678 (834)
                             ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124678888999999999999999987   9999999999999999999999999998653322212222234


Q ss_pred             ccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhHHHHH
Q 003287          679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQML  757 (834)
Q Consensus       679 gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~  757 (834)
                      ++..|+|||++.+..++.++||||||+++|||++ |..|+........ ..    .....+....  .+       ....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~----~~~~~~~~~~--~~-------~~~~  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC----RRLKEGTRMR--AP-------DYTT  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HH----HHHhccCCCC--CC-------CCCC
Confidence            5678999999999999999999999999999997 8888764322110 00    0001110000  01       1122


Q ss_pred             HHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          758 NRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       758 ~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      ..+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            45788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-35  Score=306.45  Aligned_cols=266  Identities=25%  Similarity=0.341  Sum_probs=202.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChh--hHHHHHHHHHHHhccCCCc-eeeEeeeEeecC------
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQG------  582 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------  582 (834)
                      ..|..+++||+|+||+||+|+.. +|+.||+|++....++  ......+|+.++++|+|+| |+++.+++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45777889999999999999875 5899999999765432  3455689999999999999 999999998877      


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            789999999 45788888553322 45777889999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-----cccc----cc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-----NLLG----HA  731 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-----~~~~----~~  731 (834)
                      |+.+.-.  .......++|..|+|||++.+. .|+...||||+|||+.||++++.-|....+.+.     .++.    ..
T Consensus       167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9965321  1224456789999999999987 799999999999999999999988876554211     1111    11


Q ss_pred             cccccccccccccC-----ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          732 WNLWKDNRAYELLS-----PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       732 ~~~~~~~~~~~l~~-----~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      |+....-.-....-     +...............+++.+|++.+|.+|.|+..+++.
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            21111100011000     111011111112467889999999999999999999986

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-35  Score=310.73  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=204.6

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|+||.||+++.. +++.|++|.+...  .....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999875 5899999998643  344567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2356889999999999999999999987   99999999999999999999999999987643321


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......++..|+|||++.+..++.++||||||++++||++|+.|+........  ..    ....+         ...
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~---------~~~  219 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL--IL----KIIRG---------VFP  219 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHcC---------CCC
Confidence              12334678899999999999999999999999999999999999875442110  00    00000         001


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .........+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1112344578899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-35  Score=311.98  Aligned_cols=251  Identities=27%  Similarity=0.425  Sum_probs=205.4

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.+.||+|+||.||++.. .++.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35788999999999999999987 488999999976544 5678999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            9999999985432 236899999999999999999999987   9999999999999999999999999998763221  


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                         .....+..|+|||++....++.++||||||++++||++ |..|+........  ..    ....+         ...
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~----~~~~~---------~~~  218 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP----HVEKG---------YRM  218 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHhcC---------CCC
Confidence               12334678999999998899999999999999999997 8888765432211  00    00000         000


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ..+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11122346678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-35  Score=324.03  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=205.4

Q ss_pred             cCccccceecccCccceEeeEecC--------CcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      .+|++.+.||+|+||.||+++...        +..||+|.+.... ....+++.+|+.++.++ +|+||+++++++.+..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            568999999999999999997421        2479999887543 34567899999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                      ..++++||+++|+|.+++....             ....+++.+++.++.|+++||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986421             2345788999999999999999999987   99999999999999


Q ss_pred             CCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccc
Q 003287          650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  728 (834)
Q Consensus       650 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~  728 (834)
                      .++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+.....+...  
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--  246 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--  246 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence            999999999999986643322222222344568999999999999999999999999999998 77887644322110  


Q ss_pred             ccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          729 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       729 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                          ........         ..........+.+++.+||+.+|++||++.|+++.|..+.
T Consensus       247 ----~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         247 ----KLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ----HHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                00001100         0111123356788999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=311.35  Aligned_cols=250  Identities=36%  Similarity=0.516  Sum_probs=204.5

Q ss_pred             ceecccCccceEeeEecC----CcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+++...    +..||||.+...... ..+.+.+|++.+..++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998754    789999999765433 367899999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          594 KSLNFFLFDPSR------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       594 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ++|.+++.....      ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965422      367899999999999999999999987   99999999999999999999999999987754


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...........++..|+|||.+....++.++||||||++++||++ |..|+........  ..    .....        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~----~~~~~--------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LE----YLRKG--------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHHcC--------
Confidence            432233344567889999999998899999999999999999999 5888875432111  00    00000        


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                       .....+...+..+.+++..||+.+|++||++.|+++.|+
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             001111223467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.2e-35  Score=313.44  Aligned_cols=254  Identities=25%  Similarity=0.351  Sum_probs=194.0

Q ss_pred             ceecccCccceEeeEecC---CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          519 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.||+|+||.||+|+..+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998643   4679999987653 334457899999999999999999999999999999999999999


Q ss_pred             CchhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          595 SLNFFLFDPS--RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       595 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|.+++....  .....++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  2234667788899999999999999987   9999999999999999999999999997644333222


Q ss_pred             ccccccccccccCcccccCC-------CCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          673 NTKRVVGTYGYMSPEYALDG-------LFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~-------~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||..........  .    ..........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~--~----~~~~~~~~~~  231 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT--Y----TVREQQLKLP  231 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH--H----HhhcccCCCC
Confidence            22334578889999998642       35789999999999999996 999987544322100  0    0001111222


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ++.+..    .....+.+++..|+ .+|++||+++||+..|+
T Consensus       232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222221    12335677889998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=311.87  Aligned_cols=252  Identities=28%  Similarity=0.389  Sum_probs=201.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-----hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ++|++.+.||+|++|.||++... +++.||+|.+....     ....+.+.+|+.++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999875 58999999886432     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853   345788999999999999999999987   9999999999999999999999999997653


Q ss_pred             CCCcccc-cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+........     ........       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~-------  223 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-----IFKIATQP-------  223 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-----HHHHhccC-------
Confidence            3221111 1234578899999999999999999999999999999999999864322110     00000000       


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        .....+......+.+++..||+.+|++||++.|+++.
T Consensus       224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 --TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              0011112234567889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-35  Score=324.19  Aligned_cols=241  Identities=25%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +|++.+.||+|+||.||+|+.. +++.||||++.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999876 47899999987542   22345567788888777 6899999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|..++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   345889999999999999999999987   999999999999999999999999999754221


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ......      .  
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~----~i~~~~------~--  218 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ----SIMEHN------V--  218 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCC------C--
Confidence            1  122345689999999999999999999999999999999999999875442211  00    000000      0  


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                        ..+......+.+++..|++.+|++|++.
T Consensus       219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              0111234567889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-35  Score=322.14  Aligned_cols=247  Identities=20%  Similarity=0.301  Sum_probs=194.0

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+++.. +++.||||++++..   ....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 58899999997542   23456688899999998 799999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999888843   346899999999999999999999987   999999999999999999999999998753211  112


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc---cccccccccccccccccccCccccc
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF---NLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ....+.......+.        .  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--
Confidence            2345789999999999999999999999999999999999999964322110   00000000011100        0  


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCC------HHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPT------MSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~  783 (834)
                      ..+......+.+++..||+.+|.+||+      +.++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            011123456788999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-36  Score=312.08  Aligned_cols=261  Identities=23%  Similarity=0.290  Sum_probs=194.7

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-----eEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l  586 (834)
                      -.|+..+++|+|+||.||+|++.+ ++.||||+.-....    .--+|+++|++++|||||+|+-++....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            357778999999999999999865 78999999865422    2246899999999999999998886543     3468


Q ss_pred             EEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeecccccccc
Q 003287          587 IYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARM  664 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DFGla~~  664 (834)
                      ||||||. +|.++++.. .....++...+.-+..||.+||+|||+.+   |+||||||+|+|+|.+ |.+||+|||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999986 566666431 23456777888889999999999999977   9999999999999976 9999999999998


Q ss_pred             ccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-cccccccccccccc----
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDN----  738 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~----  738 (834)
                      +...+.   ......|+.|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...+... ....-.+......+    
T Consensus       176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            865442   2446679999999999875 69999999999999999999999988754321 11000000000000    


Q ss_pred             ---ccccccCccccc-----hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          739 ---RAYELLSPALQH-----EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       739 ---~~~~l~~~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         ...+...|.+..     -.......+..+++.++++.+|.+|.++.|++..
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence               000111111111     1233345678899999999999999999998864

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-35  Score=316.15  Aligned_cols=246  Identities=25%  Similarity=0.326  Sum_probs=195.1

Q ss_pred             ecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ||+|+||+||+++.. +++.||||.+....   ....+.+..|+.++++++|+||+++.+++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999875 58899999986542   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccc
Q 003287          597 NFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK  675 (834)
Q Consensus       597 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  675 (834)
                      ..++... .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8887542 23456899999999999999999999987   99999999999999999999999999986543221  223


Q ss_pred             cccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHH
Q 003287          676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ  755 (834)
Q Consensus       676 ~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~  755 (834)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . .        ........  ...+..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~-~--------~~~~~~~~--~~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-E-L--------KQRILNDS--VTYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-H-H--------HHhhcccC--CCCccc
Confidence            3568999999999999999999999999999999999999987533211000 0 0        00000000  011223


Q ss_pred             HHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          756 MLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       756 ~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      ....+.+++..||+.+|++||     +++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            445678899999999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-35  Score=311.08  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=195.1

Q ss_pred             eecccCccceEeeEec---CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCC
Q 003287          520 KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS  595 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs  595 (834)
                      .||+|+||.||+|++.   .+..||||++.... ....+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999764   35679999987653 334567999999999999999999999875 457899999999999


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc-ccc
Q 003287          596 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-GNT  674 (834)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~  674 (834)
                      |.+++...  ...+++..+.+++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||+++.+...... ...
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99998532  346899999999999999999999987   999999999999999999999999999865332211 111


Q ss_pred             ccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      ....++..|+|||++....++.++||||||+++|||++ |..|+........  .    .....+.         ....+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~---------~~~~~  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--M----SFIEQGK---------RLDCP  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--H----HHHHCCC---------CCCCC
Confidence            12234578999999998889999999999999999996 9999865432211  0    0000110         01111


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ......+.+++..||+.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            22345677899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-35  Score=324.06  Aligned_cols=242  Identities=21%  Similarity=0.324  Sum_probs=193.6

Q ss_pred             ceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+|+... ++.||||++.+..   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999998764 7899999997542   33445678899998876 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|...+..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988843   345889999999999999999999987   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..   ... ...   ...+       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~---~i~-~~~---~~~p-------  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--FE---SIL-HDD---VLYP-------  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--HH---HHH-cCC---CCCC-------
Confidence            2345689999999999999999999999999999999999999975442211  00   000 000   0011       


Q ss_pred             HHHHHHHHHHHhcccccCcCCCC-------CHHHHHHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRP-------TMSKVVSM  784 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RP-------s~~evl~~  784 (834)
                      ......+.+++..||+.+|++||       ++.++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11234677899999999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.1e-36  Score=327.29  Aligned_cols=238  Identities=26%  Similarity=0.297  Sum_probs=192.1

Q ss_pred             ceecccCccceEeeEe----cCCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          519 CKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      +.||+|+||.||+++.    ..|+.||||++....  ......+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999975    257899999997543  2234567889999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|+|.+++.+   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999998843   345899999999999999999999987   9999999999999999999999999998653221  1


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||........  ..   .... ...          ..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~---~i~~-~~~----------~~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET--MT---MILK-AKL----------GM  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH--HH---HHHc-CCC----------CC
Confidence            22345789999999999998899999999999999999999999875432111  00   0000 000          01


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSK  780 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~e  780 (834)
                      +......+.+++..||+.+|++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1123356778999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.2e-35  Score=310.86  Aligned_cols=253  Identities=30%  Similarity=0.455  Sum_probs=202.2

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.++||+|+||.||++....+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688899999999999999998777789999886533 34567899999999999999999999875 456899999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++........ 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999999643 2345789999999999999999999987   999999999999999999999999999875432211 


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..|+........  ..    .....  ..       ..
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~----~~~~~--~~-------~~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--LE----QVERG--YR-------MP  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC--CC-------CC
Confidence            1122345678999999998999999999999999999999 8888764332110  00    00000  00       01


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112334568889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.5e-35  Score=309.24  Aligned_cols=247  Identities=28%  Similarity=0.376  Sum_probs=198.1

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCch
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN  597 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  597 (834)
                      ++||+|+||.||+|...+++.||+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988889999999876543 33457899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccc
Q 003287          598 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV  677 (834)
Q Consensus       598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  677 (834)
                      +++...  ...+.+..+..++.|++++|.|||+.+   ++||||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            988543  235789999999999999999999987   999999999999999999999999999764322211 11122


Q ss_pred             cccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       678 ~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      .++..|+|||++.+..++.++||||||+++|||++ |..||........  ..    .....  ..       .......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~----~~~~~--~~-------~~~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--RE----QVEKG--YR-------MSCPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HH----HHHcC--CC-------CCCCCCC
Confidence            34678999999998899999999999999999998 8888865432111  00    00000  00       0111123


Q ss_pred             HHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          757 LNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            456888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.7e-35  Score=314.01  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=198.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.++||+|+||.||+|+.. +++.||||++... .....+++.+|+.++.+++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999864 6889999998654 334456789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|..+.       .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996543       3678889999999999999999987   999999999999999999999999999865322  


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccc-cccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG-HAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~  749 (834)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.||............ .........     ..+.+ 
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL-  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC-
Confidence              123356899999999999999999999999999999999999998653321110000 000000000     00111 


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ........+.+++.+|++.+|++||+++|+++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              011233467889999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.2e-35  Score=313.09  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=203.7

Q ss_pred             cCccccceecccCccceEeeEec----CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .+|++.+.||+|+||.||+|+..    .+..+|+|.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57889999999999999999864    23479999987543 33456889999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998543  245789999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCccc-ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          668 DELQG-NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       668 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ..... ......++..|+|||++.+..++.++||||||++++|+++ |..|+........  ...    ....  ...  
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~~----~~~~--~~~--  228 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IKA----IEEG--YRL--  228 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HHH----HhCC--CcC--
Confidence            22111 1111223568999999999899999999999999999886 9999865432211  000    0000  000  


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                           ......+..+.+++.+|++.+|++||+|.++++.|+.+
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 01112345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-35  Score=308.62  Aligned_cols=248  Identities=29%  Similarity=0.415  Sum_probs=199.1

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCch
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN  597 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  597 (834)
                      ++||+|+||.||++...+++.||+|++...... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765433 5678999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccc
Q 003287          598 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV  677 (834)
Q Consensus       598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  677 (834)
                      +++...  ...+++..+..++.+++++|+|||+.+   ++||||||+||+++.++.+||+|||+++..............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998543  235788999999999999999999987   999999999999999999999999999865422222111222


Q ss_pred             cccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       678 ~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      ..+..|+|||.+.+..++.++||||||++++||++ |..|+.........  .    .....  ...       ..+...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~--~----~~~~~--~~~-------~~~~~~  220 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR--E----RIESG--YRM-------PAPQLC  220 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH--H----HHhcC--CCC-------CCCccC
Confidence            34667999999998899999999999999999999 77777654321110  0    00000  000       111223


Q ss_pred             HHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          757 LNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            456888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-35  Score=311.49  Aligned_cols=255  Identities=31%  Similarity=0.476  Sum_probs=206.0

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.++||+|+||.||++...+++.||||.+.... ...+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46899999999999999999998888899999987543 34577899999999999999999999999989999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..... 
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            999999999653 2346899999999999999999999987   99999999999999999999999999987643211 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      ........+..|+|||.+.+..++.++||||||++++||++ |+.|+........  ...    ...  .....      
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~----~~~--~~~~~------  224 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV--LEQ----VER--GYRMP------  224 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH----HHc--CCCCC------
Confidence            11112234578999999999899999999999999999998 8888864332110  000    000  00000      


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                       .+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       225 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 -RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             011124567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.2e-35  Score=320.32  Aligned_cols=240  Identities=24%  Similarity=0.309  Sum_probs=190.8

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999976 58899999997542   23345667788887755 899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999988843   345788999999999999999999987   999999999999999999999999998753211  112


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ....      ..+...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~--~~----~~~~------~~~~~~----  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL--FE----SIRV------DTPHYP----  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH----HHHh------CCCCCC----
Confidence            2345689999999999999999999999999999999999999875432211  00    0000      011111    


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHH-HHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMS-KVV  782 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl  782 (834)
                      ......+.+++..||+.+|++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11234577899999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-35  Score=346.82  Aligned_cols=262  Identities=23%  Similarity=0.279  Sum_probs=205.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.++||+|+||.||+|+.. .++.||||++....   ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999875 48999999997542   234567999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          589 EYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ||+++++|.+++....        ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234567788999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCc----------------ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc
Q 003287          661 MARMFCGDEL----------------QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  724 (834)
Q Consensus       661 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~  724 (834)
                      +++.......                ........||+.|||||++.+..++.++|||||||+++||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                001123469999999999999999999999999999999999999986533221


Q ss_pred             ccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCC-CHHHHHHHhhcccC
Q 003287          725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNEHA  790 (834)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~  790 (834)
                      ....         .   ...++... ......+..+.+++.+|++.+|++|| +++++++.|+....
T Consensus       239 i~~~---------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYR---------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhh---------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1000         0   00011000 00113345677899999999999995 67888888877644

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-35  Score=323.53  Aligned_cols=236  Identities=23%  Similarity=0.329  Sum_probs=190.3

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||+||+++.. +++.||||++.+.   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 4889999998753   223456677888888877 799999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988843   345889999999999999999999987   9999999999999999999999999987542211  12


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..    .......   .       .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~----~i~~~~~---~-------~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL--FE----AILNDEV---V-------YP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HH----HHhcCCC---C-------CC
Confidence            2345689999999999999999999999999999999999999975442211  00    0000100   0       01


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                      ......+.+++..||+.+|++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1123467889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.2e-35  Score=315.98  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=203.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            67999999999999999999864 58899999997765556678899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++.+    ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            99999999842    35788999999999999999999987   99999999999999999999999999876533221 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       ......+++.|+|||.+.+..++.++|||||||++|||++|+.||......... ..    ..... ...     +  .
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-~~----~~~~~-~~~-----~--~  237 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YL----IATNG-TPE-----L--Q  237 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-HH----HhcCC-CCC-----C--C
Confidence             122346888999999999988999999999999999999999998654321110 00    00000 000     0  0


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+......+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            11223456788999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.6e-35  Score=312.94  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=191.6

Q ss_pred             ceecccCccceEeeEecC---CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          519 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.||+|+||+||+|+..+   ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   4578999876543 334567899999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          595 SLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       595 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|.+++.....  ....++.....++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999965432  234567888999999999999999987   9999999999999999999999999987643332222


Q ss_pred             ccccccccccccCcccccC-------CCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          673 NTKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..|+........  ..   .... .....+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~---~~~~-~~~~~~~  231 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK---QVVR-EQDIKLP  231 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH---HHhh-ccCccCC
Confidence            2233445778999998743       456889999999999999999 6777764332110  00   0001 1111222


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .+...    ......+.+++..|+ .+|++||+++||+++|.
T Consensus       232 ~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22222    223345667888888 49999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-35  Score=311.90  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=195.5

Q ss_pred             ceecccCccceEeeEecC-Cc--EEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+|++.+ +.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 43  5799988754 334557889999999999 899999999999999999999999999


Q ss_pred             CCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          594 KSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       594 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      |+|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985432             1235789999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +++....   .........+..|+|||++....++.++||||||++++||++ |..||...+....  ..    ..... 
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~-  227 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE----KLPQG-  227 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--HH----HHhCC-
Confidence            9863211   111111233567999999988899999999999999999997 9999864332211  00    00000 


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                              ...+........+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                    00001112234678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.8e-35  Score=309.57  Aligned_cols=249  Identities=31%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             ceecccCccceEeeEecC--C--cEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  3  3699999987655 567789999999999999999999999988 889999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc-c
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-G  672 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~  672 (834)
                      ++|.+++.+... ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865432 56899999999999999999999987   999999999999999999999999999876442211 1


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||++.+..++.++|||||||+++||++ |+.|+........  ...   .....  ....       
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~---~~~~~--~~~~-------  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--LKK---IDKEG--ERLE-------  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH---HHhcC--CcCC-------
Confidence            1223456789999999999999999999999999999999 9999864332211  000   00000  0000       


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11123456888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.7e-35  Score=309.05  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=199.4

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEe-ecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV-EQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~  591 (834)
                      ++|++.+.||+|+||.||++.. .++.||+|.+....  ..+.+.+|+.++++++|+|++++++++. ++...++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            5788999999999999999987 47889999986532  3467899999999999999999999765 456789999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999985432 335889999999999999999999987   9999999999999999999999999987643221  


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                         ....++..|+|||++.+..++.++||||||+++|||++ |+.|+........  ..    ....+.         ..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~--~~----~~~~~~---------~~  218 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP----RVEKGY---------KM  218 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHhcCC---------CC
Confidence               22334678999999999899999999999999999998 8888764332111  00    000000         00


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ......+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            11112345678899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.9e-35  Score=327.53  Aligned_cols=258  Identities=19%  Similarity=0.243  Sum_probs=200.7

Q ss_pred             HHHHhccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC
Q 003287          507 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  582 (834)
Q Consensus       507 ~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  582 (834)
                      .+....++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445689999999999999999999976 4789999998643   2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999999843    34788889999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCC----CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  738 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  738 (834)
                      +.+..... .......||+.|+|||++...    .++.++|||||||++|||++|+.||...+....     ........
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~  263 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMNHK  263 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----HHHHHcCC
Confidence            87643221 122345799999999998754    378999999999999999999999975432110     00111111


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCC--CCCHHHHHHH
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  784 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~  784 (834)
                      ......+       .......+.+++..|++..+.+  ||++.|+++.
T Consensus       264 ~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1111111       1223456778999999844433  7788888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.7e-35  Score=320.73  Aligned_cols=241  Identities=26%  Similarity=0.351  Sum_probs=191.4

Q ss_pred             ceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||+||+|+..+ ++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999764 7899999997642   23345567788888764 999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999999843   345789999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ...      ...+..    +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~----~i~------~~~~~~----~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--FQ----SIR------MDNPCY----P  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--HH----HHH------hCCCCC----C
Confidence            2345689999999999999999999999999999999999999875432211  00    000      001111    1


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHH-HHHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMS-KVVS  783 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl~  783 (834)
                      ......+.+++..||+.+|++||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            12234577899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-35  Score=308.30  Aligned_cols=248  Identities=31%  Similarity=0.451  Sum_probs=196.7

Q ss_pred             ceecccCccceEeeEecC----CcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      ++||+|+||.||+|+...    +..+|+|.+..... ...+++.+|+.++++++|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997532    26899999976543 34567999999999999999999999875 5578999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc-c
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-G  672 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~  672 (834)
                      ++|.+++...   ..+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999543   36889999999999999999999987   999999999999999999999999999866432211 1


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...+....  ...    .....  ..       .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~--~~~----~~~~~--~~-------~  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--IAM----LESGE--RL-------P  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH--HHH----HHcCC--cC-------C
Confidence            1112234568999999999999999999999999999998 9999865432211  110    00010  00       1


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1112335678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-34  Score=307.80  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=204.5

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++.+++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4679999999999999999999877888999988754 3345678999999999999999999999887 7889999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998653 2345788999999999999999999987   999999999999999999999999999876432221


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       ......++..|+|||++....++.++|||||||+++||++ |+.|+...+....  ..    ........         
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~----~~~~~~~~---------  222 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IR----ALERGYRM---------  222 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHhCCCCC---------
Confidence             1222345678999999998899999999999999999999 8888865332111  00    00011000         


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .........+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0112234567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.1e-35  Score=312.33  Aligned_cols=251  Identities=31%  Similarity=0.498  Sum_probs=199.2

Q ss_pred             ceecccCccceEeeEecC-------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          519 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +.||+|+||.||+|+..+       ++.+|||.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998643       2579999886543 24567889999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-----Ceeeccccc
Q 003287          591 MPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-----NPKISDFGM  661 (834)
Q Consensus       591 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-----~vkl~DFGl  661 (834)
                      +++++|.+++.+..    ....+++.++..++.|+++||+|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    2345788999999999999999999887   99999999999999887     899999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      ++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.......  ....    ...+. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~-  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQH----VTAGG-  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHH----HhcCC-
Confidence            986644332222223345788999999999999999999999999999998 898886433211  1100    00000 


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                              ........+..+.+++.+||+.+|.+||++.++++.|.+
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    001112234567899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.8e-35  Score=319.99  Aligned_cols=237  Identities=23%  Similarity=0.269  Sum_probs=186.7

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHH-HHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEM-MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      ++||+|+||.||+|+.. +++.||+|++.+..   ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999975 58899999986532   22234455555 467889999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      ++|...+..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            999888743   345788899999999999999999987   999999999999999999999999998753221  122


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ......        .  ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~----~i~~~~--------~--~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM--YD----NILHKP--------L--QLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH--HH----HHhcCC--------C--CCC
Confidence            3345789999999999999999999999999999999999999875432211  00    000000        0  011


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMS  779 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~  779 (834)
                      ......+.+++.+||+.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            12234678899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.3e-35  Score=321.50  Aligned_cols=241  Identities=24%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||+||+++.. +++.||||++.+..   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999876 47899999997542   33456678899999888 799999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++.+   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999988843   346899999999999999999999987   9999999999999999999999999987532111  12


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ......      ..    .+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~----~i~~~~------~~----~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQ----SILEDE------VR----YP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HH----HHHcCC------CC----CC
Confidence            2335689999999999999999999999999999999999999875432211  00    000000      00    11


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCH-----HHHHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTM-----SKVVS  783 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~  783 (834)
                      ......+.+++.+||+.+|++||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1234567889999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-35  Score=305.74  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=207.8

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .+.|+++++||.|.-|+||++++.+ +..+|+|++.+..   .....+...|-+||+.++||.++.|++.++.+...+||
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3578899999999999999999875 5899999998753   33456678899999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||||++|+|..++++ +..+.+++..+.-++.+++-||+|||-.+   ||.|||||+||||.++|++-|+||.|+.....
T Consensus       156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999988754 35667999999999999999999999998   99999999999999999999999999853210


Q ss_pred             C----------------------------------C--------------------cccccccccccccccCcccccCCC
Q 003287          668 D----------------------------------E--------------------LQGNTKRVVGTYGYMSPEYALDGL  693 (834)
Q Consensus       668 ~----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~  693 (834)
                      .                                  .                    ........+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            0                                  0                    001122357999999999999999


Q ss_pred             CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcC
Q 003287          694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAA  773 (834)
Q Consensus       694 ~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~  773 (834)
                      .+.++|.|+|||+||||+.|..||.....+..              ...++...+.-......+..+.+||+..|.+||.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999987654322              1111111121111225567788999999999999


Q ss_pred             CCCC----HHHHHH
Q 003287          774 DRPT----MSKVVS  783 (834)
Q Consensus       774 ~RPs----~~evl~  783 (834)
                      +|..    +.||.+
T Consensus       378 kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhccccchHHhhc
Confidence            9998    777765

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.4e-35  Score=319.15  Aligned_cols=256  Identities=29%  Similarity=0.467  Sum_probs=200.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCc----EEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .++|+..+.||+|+||.||+|+.. +++    .||+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            357888899999999999999864 343    579998875432 3345789999999999999999999998754 567


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +++||+++|+|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            999999999999998543  235789999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .............++..|+|||++.+..++.++||||||+++|||++ |+.|+........  .    .....+.  ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~--~~~  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--P----DLLEKGE--RLP  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHCCC--CCC
Confidence            43322222223445778999999999999999999999999999997 8888865332111  0    0111111  011


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .+       ......+.+++..||..+|++||++.++++.|+.+
T Consensus       232 ~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         232 QP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11       11234577899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=300.98  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=211.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +-|.++++||+|+||.|||+.++ .|+.||||.+...  ...+++..|+.+|.+.+.|++|+++|.+.....+++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            45788999999999999999876 4999999998654  45688999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ..|+..++++  .+++.|.+.++..+++..++||+|||...   -||||||+.||||+.+|.+||+|||.|..+..  .-
T Consensus       111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TM  183 (502)
T KOG0574|consen  111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TM  183 (502)
T ss_pred             CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hH
Confidence            9999999995  35678999999999999999999999876   89999999999999999999999999987743  23


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      .....+.||+.|||||++..-.|+.++||||||++..||.-|++|+.....-.-..           -+.....|.+  .
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-----------MIPT~PPPTF--~  250 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-----------MIPTKPPPTF--K  250 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----------eccCCCCCCC--C
Confidence            34456889999999999999999999999999999999999999987543211000           0111112222  2


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+...+..+.+++.+||-+.|++|.|+.++++-
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            345667888999999999999999999988764

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-34  Score=308.68  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=200.5

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++.+++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34556666679999999999999865 57889999988766667788999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~~~~  667 (834)
                      ||+++++|.+++.........++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||++..+..
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999864322212277888899999999999999987   999999999999986 67999999999976532


Q ss_pred             CCcccccccccccccccCcccccCCC--CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ..  .......++..|+|||++....  ++.++||||||+++|||++|+.|+...........       ... ...   
T Consensus       162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-------~~~-~~~---  228 (268)
T cd06624         162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-------KVG-MFK---  228 (268)
T ss_pred             CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-------hhh-hhc---
Confidence            22  1122345789999999987643  78999999999999999999999864322111000       000 000   


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        .....+......+.+++.+||+.+|++||++.|+++
T Consensus       229 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 --IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              001112233456788999999999999999999885

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.7e-35  Score=320.36  Aligned_cols=237  Identities=25%  Similarity=0.284  Sum_probs=187.8

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHH-HHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||+||+|+.. +++.||||++.+..   .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999975 58999999997532   222344555544 56789999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999988853   346889999999999999999999987   999999999999999999999999998753221  122


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .. ....      ..+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~---~i-~~~~------~~~~----  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM--YD---NI-LNKP------LRLK----  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH--HH---HH-HcCC------CCCC----
Confidence            3345689999999999999999999999999999999999999875432211  00   00 0000      0011    


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMS  779 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~  779 (834)
                      ......+.+++..||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11245678899999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.4e-35  Score=312.24  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=192.8

Q ss_pred             ecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ||+|+||.||+++.. +|+.||+|++....   ......+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 58999999986432   12234566799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      .+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++..+....   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            8887543 2335888999999999999999999987   9999999999999999999999999998654321   1223


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.|+......... ....     .    ......... .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~-----~----~~~~~~~~~-~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELK-----R----RTLEDEVKF-EHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHH-----H----Hhhcccccc-ccccC
Confidence            46899999999999989999999999999999999999998643221100 0000     0    000000000 01123


Q ss_pred             HHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          757 LNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+.+++..||+.+|++||++.|+++.
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            4567899999999999999999877643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.3e-35  Score=311.98  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=198.4

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec------C
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ------G  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~  582 (834)
                      ++..|++.+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.++.++ +|+||+++++++.+.      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567889999999999999999875 48899999986543 3456788999999998 799999999998753      4


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            689999999999999998643 2346889999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD  737 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  737 (834)
                      ......  ........|+..|+|||++.     +..++.++|||||||++|||++|+.|+..........     .... 
T Consensus       159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~-  230 (272)
T cd06637         159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR-  230 (272)
T ss_pred             eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc-
Confidence            865322  12233456889999999986     3458889999999999999999999986433211100     0000 


Q ss_pred             cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       738 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......        .......+.+++.+||+.+|.+||++.++++
T Consensus       231 ~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000000        1122346788999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.7e-35  Score=334.50  Aligned_cols=263  Identities=18%  Similarity=0.279  Sum_probs=192.1

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec--------
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--------  581 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  581 (834)
                      ...+|++.+.||+|+||.||+|+.. .++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3468999999999999999999875 58899999886432    2345799999999999999999886432        


Q ss_pred             CeEEEEEEecCCCCchhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-Ceeeccc
Q 003287          582 GEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDF  659 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DF  659 (834)
                      ...++||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999985 56565532 233456899999999999999999999987   99999999999999665 7999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cccccc-----c
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHA-----W  732 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~-----~  732 (834)
                      |+++.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ ......     .
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9998764322   22235689999999998764 689999999999999999999999875432110 000000     0


Q ss_pred             cccc--ccccccc-----cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          733 NLWK--DNRAYEL-----LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       733 ~~~~--~~~~~~l-----~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..+.  .....+.     ....+....+...+..+.+|+..||+.+|.+|||+.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000  0000000     00011111112234578899999999999999999999843

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-34  Score=307.14  Aligned_cols=240  Identities=21%  Similarity=0.339  Sum_probs=189.2

Q ss_pred             ceecccCccceEeeEecC-------------CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          519 CKLGEGGFGPVYKGKLLN-------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      +.||+|+||.||+|+...             ...||+|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999987655555678899999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC-------eeecc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-------PKISD  658 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-------vkl~D  658 (834)
                      +||||+++++|..++...  ...+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999888532  345889999999999999999999987   999999999999987664       89999


Q ss_pred             ccccccccCCCcccccccccccccccCccccc-CCCCCccCCeeeHHHHHHHHh-hCCCCCCCCCccccccccccccccc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETL-TSKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      ||++.....      .....++..|+|||++. +..++.++|||||||++|||+ +|..|+..........      ...
T Consensus       156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~  223 (262)
T cd05077         156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER------FYE  223 (262)
T ss_pred             CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH------HHh
Confidence            999875422      12245788999999987 467899999999999999998 5777765432111000      000


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                       . .....     .    .....+.+|+..||+.+|++||++.++++.|+
T Consensus       224 -~-~~~~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 -G-QCMLV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -c-CccCC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             0 00000     1    11245788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.8e-35  Score=312.13  Aligned_cols=264  Identities=25%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999875 58999999986542  23346788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++ ++|.+++........+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 688888755444467899999999999999999999987   9999999999999999999999999997653221 


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc--c----ccccccccccc---c
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--L----GHAWNLWKDNR---A  740 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~----~~~~~~~~~~~---~  740 (834)
                       .......++..|+|||++.+. .++.++||||||++++||++|+.|+..........  .    ......|....   .
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             112233568899999988754 57899999999999999999999987543211000  0    00000000000   0


Q ss_pred             cc-ccCc---cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          741 YE-LLSP---ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       741 ~~-l~~~---~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .. ....   ............++.+++.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00 0000   0000111123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-35  Score=311.54  Aligned_cols=257  Identities=28%  Similarity=0.424  Sum_probs=203.8

Q ss_pred             cCccccceecccCccceEeeEecC-C----cEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-G----QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g----~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .+|++.+.||+|+||.||+|...+ +    ..||+|.+.... .....++.+|+.++.+++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578889999999999999998643 3    268999887654 3455788999999999999999999999987 78999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |+||+++|+|.+++...  ...+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998543  234899999999999999999999977   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ............++..|+|||.+....++.++||||||++++|+++ |+.|+.....++..  .    ......  ....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~----~~~~~~--~~~~  232 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP--D----LLEKGE--RLPQ  232 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH--H----HHhCCC--CCCC
Confidence            3322111122234568999999988899999999999999999998 99998754322210  0    000000  0011


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      +       ......+.+++.+||..+|.+||++.++++.|+.+..
T Consensus       233 ~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         233 P-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             C-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1       1122457789999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-34  Score=329.34  Aligned_cols=261  Identities=19%  Similarity=0.234  Sum_probs=195.9

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ...|.+.+.||+|+||.||+++... ++.||||....      ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999864 78999996432      3457899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +. ++|..++...  ...+++.++..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6787777432  346899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcc--cccccccccccccccc-----cccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE--SFNLLGHAWNLWKDNR-----AYEL  743 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~-----~~~l  743 (834)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++-.....  ................     ....
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            22223457999999999999999999999999999999999988654322111  0000000000000000     0000


Q ss_pred             ----------------cCccccch---hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          744 ----------------LSPALQHE---ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       744 ----------------~~~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                                      ..+.....   ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                            00000000   001122367789999999999999999999864

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.3e-35  Score=319.99  Aligned_cols=242  Identities=22%  Similarity=0.300  Sum_probs=190.8

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||+||+++.. +++.||||++.+..   ....+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999875 47899999997642   23456688999999888 699999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999888843   346899999999999999999999987   999999999999999999999999998753211  112


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-ccccccccccccccccccccCccccchh
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...............          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCC
Confidence            234578999999999999999999999999999999999999996432211 111111111111000          001


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                      +......+.+++..||+.+|++||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11223456789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-34  Score=314.12  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=201.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.++||+|+||.||+++.. ++..+|+|.+... ......++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36899999999999999999875 4788999988654 233456788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++...   ..+++..+..++.|+++||+|||+..  +++|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            9999999998533   45889999999999999999999842  3999999999999999999999999998765322  


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc-ccccccccccc-----------
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGHAWNLWKDN-----------  738 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~-----------  738 (834)
                        ......++..|+|||.+.+..++.++||||||++++||++|+.|+...+...... ...........           
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              1233568899999999988889999999999999999999999986433211100 00000000000           


Q ss_pred             ------ccccccCccc---cch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          739 ------RAYELLSPAL---QHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       739 ------~~~~l~~~~l---~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                            ...++.+...   .+. ....+...+.+++.+||+.+|++||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000000000   000 001134568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.3e-35  Score=309.31  Aligned_cols=252  Identities=24%  Similarity=0.407  Sum_probs=201.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+.+.+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57889999999999999999875 58899999987665555667889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++..   ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+...  .
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--I  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--c
Confidence            99999998843   346889999999999999999999987   999999999999999999999999998765322  1


Q ss_pred             cccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          672 GNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .......|+..|+|||++.   ...++.++|||||||++|||++|..|+........ ...    ... ..   ...+..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~----~~~-~~---~~~~~~  231 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL----MTK-SN---FQPPKL  231 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHh----hhc-cC---CCCCcc
Confidence            2223456899999999974   45688999999999999999999999754332110 000    000 00   000000


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..  .......+.+++.+|++.+|++||+++++++
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00  0112345778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-34  Score=310.30  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=200.9

Q ss_pred             CccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .|++.+.||+|+||.||+++... +..+|+|.+........+.+.+|+++++.++||||+++++++.++...++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            46788999999999999999764 78899999977666667889999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|..++.+.  ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            99999887532  346899999999999999999999987   9999999999999999999999999987643221  1


Q ss_pred             ccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          673 NTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.|+......... .    .... ........  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~----~~~~-~~~~~~~~--  230 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL-L----KIAK-SEPPTLAQ--  230 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH-H----HHhh-cCCCCCCC--
Confidence            223356889999999984     345788999999999999999999998653321110 0    0000 00001111  


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                           +......+.+++..||+.+|++||++.++++.
T Consensus       231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 11234567899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=295.83  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=201.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++.|++-+.||+|.|+.||+.... .|+.+|+|++...  .....+++.+|+.+-+.|+||||++|.....+.+..+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467889999999999999999754 6999999987533  3447788999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCeeeccccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vkl~DFGla~~~  665 (834)
                      |+|.+++|-.-+-   .+..+++..+-..++||+++|.|+|.++   |||||+||+|+||.+   ..-+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999865552   2245778888899999999999999998   999999999999953   456899999999988


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ...   ...-...||++|||||++...+|+..+|||+.|||||-|+.|..||-..+....  .    +....+. +    
T Consensus       164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl--y----e~I~~g~-y----  229 (355)
T KOG0033|consen  164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--Y----EQIKAGA-Y----  229 (355)
T ss_pred             CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH--H----HHHhccc-c----
Confidence            622   222346799999999999999999999999999999999999999876443221  0    0111110 0    


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl  782 (834)
                       ...+.......++..+|++.||..||.+|.|+.|.+
T Consensus       230 -d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  230 -DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             -CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence             011222334456778899999999999999998765

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-35  Score=310.24  Aligned_cols=249  Identities=30%  Similarity=0.472  Sum_probs=199.9

Q ss_pred             ccccceecccCccceEeeEecC-CcEEEEEEecccChhhH--HHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      |++.+.||+|+||+||+++... ++.||+|++........  ....+|+.++.+++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999865 67899999987654332  23456999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++.   ....+++..+..++.|+++||++||+.+   |+|+||||+||+++.++.++|+|||++...  ....
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence            9999999995   4556899999999999999999999987   999999999999999999999999999764  1122


Q ss_pred             cccccccccccccCccccc-CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-ccccccccccccccccccccCcccc
Q 003287          672 GNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                      .......++..|+|||++. +..++.++||||+|+++++|++|..|+....... ....            .........
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~------------~~~~~~~~~  220 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII------------EKILKRPLP  220 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH------------HHHHHTHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh------------hhccccccc
Confidence            3334466899999999998 8889999999999999999999999987541110 0000            000000000


Q ss_pred             ch--hHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 HE--ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..  ........+.+++..||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  00011267889999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-34  Score=311.76  Aligned_cols=250  Identities=26%  Similarity=0.330  Sum_probs=198.2

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      |+..+.||+|+||.||++... +++.||||.+....   ....+.+.+|+.++.+++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999875 58899999986542   22345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++... ....+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            9999999988543 2245889999999999999999999987   9999999999999999999999999987653221 


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||.........  .         ....... ....
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~---------~~~~~~~-~~~~  222 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--E---------EVERLVK-EVQE  222 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--H---------HHHhhhh-hhhh
Confidence              112346899999999999999999999999999999999999998753211000  0         0000000 0000


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                      .........+.+|+..||+.+|++||+     +.|+++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            111223456788999999999999999     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-34  Score=310.79  Aligned_cols=262  Identities=24%  Similarity=0.354  Sum_probs=193.1

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhcc---CCCceeeEeeeEeec-----C
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQ-----G  582 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~  582 (834)
                      +|++.+.||+|+||+||+|+.. +++.||+|.+.....  .....+.+|+.++.++   +||||+++++++.+.     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999876 588999999875421  2233456677776665   799999999988653     4


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++ +|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999984 787777543 2345899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc--ccccc----cccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLGH----AWNLWK  736 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~~----~~~~~~  736 (834)
                      +.+....   ......++..|+|||++.+..++.++|||||||++|||++|+.||........  .....    ....+.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8764321   22335678999999999999999999999999999999999999865432110  00000    000000


Q ss_pred             cc-cc-ccccCccc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 DN-RA-YELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ~~-~~-~~l~~~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .. .. .....+..   ...........+.+++.+|++.||++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00 00 00000000   01112234456789999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.3e-35  Score=308.28  Aligned_cols=251  Identities=31%  Similarity=0.450  Sum_probs=193.1

Q ss_pred             ceecccCccceEeeEecC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEe-ecCeEEEEEEecC
Q 003287          519 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV-EQGEKILIYEYMP  592 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~~  592 (834)
                      +.||+|+||.||+|+..+    ...||||++... .....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998632    457999998643 3345678899999999999999999999876 4556899999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc-
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-  671 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-  671 (834)
                      +++|.+++.+.  ...+.+..+..++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||+++.+...... 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998543  234677888999999999999999987   999999999999999999999999999865332211 


Q ss_pred             -cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCC-CCCCCCCcccccccccccccccccccccccCcccc
Q 003287          672 -GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       672 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                       .......++..|+|||.+.+..++.++||||||+++|||++|. .|+......  .+...   ... +.  ...     
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~---~~~-~~--~~~-----  222 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DITVY---LLQ-GR--RLL-----  222 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---Hhc-CC--CCC-----
Confidence             1112334577899999999889999999999999999999965 455432211  11110   000 00  000     


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                        .+...+..+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       223 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 --QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              01122346788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.7e-35  Score=307.05  Aligned_cols=252  Identities=28%  Similarity=0.468  Sum_probs=202.4

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .+|++.+.||+|+||.||++...+++.+|+|++.... .....|.+|++++++++|||++++++++.+....++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4688899999999999999998778899999986542 234678999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            99999998542  235789999999999999999999987   999999999999999999999999999765332211 


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |..|+........  ...    ...  ......+..   
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~--~~~~~~~~~---  225 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV--VET----INA--GFRLYKPRL---  225 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHH----HhC--CCCCCCCCC---
Confidence            1122235678999999998899999999999999999998 8888764332211  000    000  011111211   


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                          ....+.+|+.+||+.+|++||++.++++.|.
T Consensus       226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                2356888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-34  Score=304.88  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=204.4

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|++.++||+|+||.||+|+..+ ++.+|+|.+.....  .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            678999999999999999999865 78999999875433  678999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++..  ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+..... 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999843  2356899999999999999999999987   99999999999999999999999999987643221 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       ......++..|+|||++.+..++.++||||||++++||++|+.|+............      ...     ..+..  .
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------~~~-----~~~~~--~  220 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------PNK-----PPPTL--S  220 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------ccC-----CCCCC--C
Confidence             223345788999999999999999999999999999999999998754322110000      000     00000  1


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+......+.+++..||+.+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            12233456888999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=318.42  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=212.4

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEecccChh---hHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ---GLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~  585 (834)
                      ....|++.+.||+|.||.||+++.+. |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+.+++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34679999999999999999999875 999999999776432   4568899999999998 999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC----CCeeeccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFGM  661 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~----~~vkl~DFGl  661 (834)
                      +|||++.+|.|.+.+...    .+++.++..++.||+.+++|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998654    2999999999999999999999987   9999999999999643    5799999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      +.....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||..........      ....+   
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~---  253 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG---  253 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC---
Confidence            998754   345567899999999999999999999999999999999999999998655332211      00001   


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         +.....+........+.+++..++..||..|+++.++++
T Consensus       254 ---~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  254 ---DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence               112233344455677889999999999999999999998

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-34  Score=307.93  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             CccccceecccCccceEeeEecCCcEEEEEEecccC------hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      +|++.+.||+|+||+||+|...+++.+|||.+....      ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998789999999886432      22345688999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      +||+++++|.+++.+.   ..+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998532   35788999999999999999999987   99999999999999999999999999986532


Q ss_pred             CC----cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          668 DE----LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       668 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ..    .........++..|+|||++.+..++.++||||||++++||++|+.||...+.......     .   .. ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----~---~~-~~~  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-----I---GA-HRG  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-----h---hh-ccC
Confidence            11    11112334688999999999998999999999999999999999999875432111000     0   00 000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+.+    +......+.+++.+||+.+|++||++.|+++
T Consensus       226 ~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01111    1223456788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-34  Score=305.56  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.++...++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999875 5889999998643 3345577889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999888532 3345789999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       ......++..|+|||++.+..++.++||||||+++|+|++|..||...+....  .   ... ......         .
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~---~~~-~~~~~~---------~  219 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--I---LKV-CQGSYK---------P  219 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--H---HHH-hcCCCC---------C
Confidence             12235688899999999998999999999999999999999999875332111  0   000 001000         0


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+......+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            111233457789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-34  Score=309.79  Aligned_cols=256  Identities=29%  Similarity=0.396  Sum_probs=203.6

Q ss_pred             cCccccceecccCccceEeeEec------CCcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ++|++.+.||+|+||.||+|+..      +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999864      2467999998765443 4678999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRT------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999644321      26899999999999999999999987   999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  738 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  738 (834)
                      |+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..|+........  ..    ....+
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~--~~----~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--LN----RLQAG  234 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH--HH----HHHcC
Confidence            99875533221 12223456778999999988889999999999999999999 6777754322111  00    00101


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ... ..       .....+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       235 ~~~-~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLE-LP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcC-CC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            110 00       01123356888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.5e-35  Score=326.16  Aligned_cols=203  Identities=23%  Similarity=0.335  Sum_probs=175.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+++.. +++.||||++....   ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999876 58899999997532   234567888999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853   345889999999999999999999987   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------------cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCC
Q 003287          669 ELQ---------------------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR  715 (834)
Q Consensus       669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~  715 (834)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113469999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 003287          716 NTGVYD  721 (834)
Q Consensus       716 p~~~~~  721 (834)
                      ||....
T Consensus       235 Pf~~~~  240 (360)
T cd05627         235 PFCSET  240 (360)
T ss_pred             CCCCCC
Confidence            987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-34  Score=321.87  Aligned_cols=261  Identities=24%  Similarity=0.275  Sum_probs=195.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      .++|++.+.||+|+||.||+++.. .++.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999875 5899999998653  2334567889999999999999999999986543      


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||++++ |...+.     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence            579999999764 544442     23778889999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc--cc---cc-------
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--LL---GH-------  730 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~---~~-------  730 (834)
                      +......   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+.....  ..   ..       
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            7643221   223356899999999999999999999999999999999999999754321100  00   00       


Q ss_pred             -----cccccccc------ccccccCcccc---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          731 -----AWNLWKDN------RAYELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       731 -----~~~~~~~~------~~~~l~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                           ........      ...++......   ..........+.+++.+||+.||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 00000000      00000000000   00111223567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.7e-35  Score=326.83  Aligned_cols=261  Identities=23%  Similarity=0.295  Sum_probs=197.0

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-----eEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI  585 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  585 (834)
                      +|++.++||+|+||.||+++.. +++.||||++...  .....+++.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999874 6899999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +|+||+. ++|.+.+..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 567776632   346899999999999999999999987   999999999999999999999999999865


Q ss_pred             cCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc-----
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR-----  739 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  739 (834)
                      ..... .......+++.|+|||++.+. .++.++|||||||+++||++|+.||...+....  ............     
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence            33221 122334678999999999874 579999999999999999999999875442110  000000000000     


Q ss_pred             -----cc-ccc-Cccccc------hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 -----AY-ELL-SPALQH------EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 -----~~-~l~-~~~l~~------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                           .. .+. .+....      .........+.+++.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 00 000 000000      0111224567899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6e-35  Score=320.46  Aligned_cols=240  Identities=23%  Similarity=0.262  Sum_probs=188.0

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHH-HHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEM-MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||+||+++.. +++.||+|++.+..   ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999876 47889999987532   12233444444 456788999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|.+++..   ...+.+..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999998853   345778888899999999999999987   999999999999999999999999999754221  122


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..    .......          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~----~i~~~~~----------~~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YD----NILNKPL----------QLK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HH----HHHhCCc----------CCC
Confidence            3345799999999999999999999999999999999999999875432211  00    0000000          011


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHHHHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~evl  782 (834)
                      ......+.+++..|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            12334677899999999999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.3e-35  Score=319.02  Aligned_cols=241  Identities=23%  Similarity=0.340  Sum_probs=192.7

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +|+..+.||+|+||+||+++.. +++.||||++.+..   ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999875 58899999987542   234456788999998885 577888999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998843   345889999999999999999999987   999999999999999999999999998754322


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..   ... ....        
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~---~i~-~~~~--------  218 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--FQ---SIM-EHNV--------  218 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH---HHH-hCCC--------
Confidence            1  122335689999999999999999999999999999999999999875432211  00   000 0000        


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                        ..+......+.+++..|++.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              0111233467789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-34  Score=307.15  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=200.0

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccCh---------hhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.....         +..+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999875 578999998865322         123568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++|+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999943   345788999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcc----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          664 MFCGDELQ----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       664 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      .+......    .......++..|+|||.+.+..++.++||||||+++|||++|+.||........        ..   .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~---~  223 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--------IF---K  223 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--------HH---H
Confidence            76432111    111234578899999999998999999999999999999999999875332110        00   0


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......+.    .+......+.+++.+||+.+|.+||++.|+++
T Consensus       224 ~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 IGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            00011111    12234456788999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-34  Score=325.10  Aligned_cols=261  Identities=21%  Similarity=0.261  Sum_probs=199.4

Q ss_pred             ccCccccceecccCccceEeeEec---CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..+|++++.||+|+||.||++...   .++.||||.+...     ..+.+|+.++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            467999999999999999999753   3578999988653     23468999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      |++. ++|.+++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 57777772   3456899999999999999999999987   999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cccccccccc-------cccc-
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLW-------KDNR-  739 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~-------~~~~-  739 (834)
                      ..........||+.|+|||++....++.++|||||||++|||++|+.||........ ..........       .... 
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            333333456799999999999999999999999999999999999999865432210 0000000000       0000 


Q ss_pred             ---------cccccCcccc-ch--hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 ---------AYELLSPALQ-HE--ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ---------~~~l~~~~l~-~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                               ......+... +.  ........+.+++..||+.+|++||++.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     0000000000 00  001223467789999999999999999999976

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.3e-35  Score=311.27  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=201.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34777889999999999999875 47899999987543 34556789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++.    ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            99999999884    245889999999999999999999987   9999999999999999999999999998654322 


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       .......++..|+|||++.+..++.++||||||++++||++|+.|+..........      .....     ..+    
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~-----~~~----  219 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------LIPKN-----SPP----  219 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------hhhcC-----CCC----
Confidence             12223457889999999999999999999999999999999999976432211100      00000     011    


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .........+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            1112234567889999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=308.64  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=203.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999876 58899999987543 34556789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999999843    27899999999999999999999987   9999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       .......++..|+|||++.+..++.++||||||+++|||++|+.|+...+....  ..    ......     .+.+..
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~----~~~~~~-----~~~~~~  220 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LF----LIPKNN-----PPSLEG  220 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HH----HhhhcC-----CCCCcc
Confidence             222335678899999999998899999999999999999999999865432111  00    000010     111111


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .   .+...+.+++.+||+.+|++||+++++++.
T Consensus       221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0   134567889999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.7e-34  Score=310.22  Aligned_cols=251  Identities=25%  Similarity=0.420  Sum_probs=201.7

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +.|++.++||+|+||.||+|+... ++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            578999999999999999999864 8899999998777667788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|..++.+.  ...+++..+..++.|++++|+|||+.+   ++||||||+||+++.++.+||+|||++......  .
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~  164 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L  164 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence            999998887432  245889999999999999999999987   999999999999999999999999998754221  1


Q ss_pred             cccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          672 GNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .......++..|+|||++.     ...++.++|||||||++|||++|..|+......... .     ......     .+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~-----~~~~~~-----~~  233 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-L-----KIAKSE-----PP  233 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH-H-----HHhcCC-----Cc
Confidence            1223356788999999985     345788999999999999999999998653321100 0     000000     00


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..  ..+......+.+++.+||+.+|++||++.|+++
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00  011123346778999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.2e-34  Score=311.90  Aligned_cols=251  Identities=22%  Similarity=0.351  Sum_probs=204.6

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..+|++.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            368999999999999999999864 6899999999766555567789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999999843    35788999999999999999999987   99999999999999999999999999976533221


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......     ....+ ....       
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~-~~~~-------  235 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG-TPEL-------  235 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC-CCCC-------
Confidence              12234678899999999999999999999999999999999999865432111000     00000 0000       


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..+......+.+++..||+.+|++||++.++++.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0112234557789999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.5e-35  Score=320.19  Aligned_cols=238  Identities=23%  Similarity=0.268  Sum_probs=188.0

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHH-HHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||+||+++.. +|+.||||++.+..   .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 58999999986542   223345555554 56778999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            999888843   346889999999999999999999987   999999999999999999999999998753221  122


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .......      .+..   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~----~~~~~~~------~~~~---  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM--YD----NILHKPL------VLRP---  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--HH----HHHcCCc------cCCC---
Confidence            3345789999999999999999999999999999999999999875432211  00    0000000      0111   


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMSK  780 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~e  780 (834)
                       .....+.+++..|++.+|++||++.+
T Consensus       218 -~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         218 -GASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence             12345678999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-34  Score=306.83  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..|+..++||+|+||.||+|+.. .++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35778889999999999999875 58899999987543 44567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998842    35788999999999999999999987   99999999999999999999999999987643321


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......++..|+|||++.+..++.++||||||+++|||++|..|+.........               .........
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------~~~~~~~~~  219 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------------FLIPKNNPP  219 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---------------hhhhcCCCC
Confidence              222345788999999999889999999999999999999999998654321110               000111111


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .........+.+++..||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2223455678899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=315.84  Aligned_cols=263  Identities=22%  Similarity=0.335  Sum_probs=198.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.++||+|+||.||+|+.. +++.||||.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999875 57889999987543 22345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            985 777777432  345788999999999999999999987   9999999999999999999999999997643221 


Q ss_pred             ccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cccc--------ccccccccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLG--------HAWNLWKDNRA  740 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~--------~~~~~~~~~~~  740 (834)
                       .......++..|+|||++.+ ..++.++|||||||+++||++|+.||...+.... ....        ..|..+.....
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence             11223457899999999865 4689999999999999999999999976543211 0000        00000000000


Q ss_pred             -ccccCccccc----hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          741 -YELLSPALQH----EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       741 -~~l~~~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .....+....    .........+.+++..|++.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             0000000000    011123456788999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-34  Score=307.74  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=199.9

Q ss_pred             ccccceecccCccceEeeEec----CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      |++.+.||+|+||.||+|.+.    .++.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999863    3688999998654  3345677899999999999999999999886542      


Q ss_pred             eEEEEEEecCCCCchhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                      ..++++||+++|+|..++...   .....+++....+++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            347899999999998887432   12235788999999999999999999987   999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  738 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  738 (834)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |+.|+...+....  ...    ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~--~~~----~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI--YNY----LIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH--HHH----HHcC
Confidence            99987643332222223345678999999999999999999999999999999 7888764332111  000    0000


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .  ...       ........+.+++.+|++.+|++||++.++++.|+++
T Consensus       232 ~--~~~-------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 N--RLK-------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C--cCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0  000       0112335788899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-34  Score=308.36  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             cCccccceecccCccceEeeEecC----CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            568888999999999999998643    2479999987654 4556789999999999999999999998875 567899


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999543  235899999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..... .....++..|+|||.+....++.++||||||++++||++ |..||........  ..    ......  ...  
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~--~~~--  228 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IG----RIENGE--RLP--  228 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH----HHHcCC--cCC--
Confidence            32211 112334568999999988889999999999999999996 9999865432211  00    000000  000  


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                           .+...+..+.+++.+|+..+|++||++.++++.|+++.
T Consensus       229 -----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         229 -----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 11123456888999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.4e-34  Score=302.88  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=203.9

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  ......++.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999865 5889999988654  344567789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++.... ...+++.++..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986432 346889999999999999999999987   99999999999999999999999999987643331


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......++..|+|||.+.+..++.++||||||++++||++|..|+........     .... ..+..    .     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----~~~~-~~~~~----~-----  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-----VVKI-VQGNY----T-----  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHH-HcCCC----C-----
Confidence              22335689999999999988899999999999999999999999865332111     0000 00000    0     


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .........+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            0112334567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=317.64  Aligned_cols=255  Identities=20%  Similarity=0.258  Sum_probs=195.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+++.. +++.||||++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999975 4889999999753   2234466889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998532  345889999999999999999999988   999999999999999999999999999765432


Q ss_pred             CcccccccccccccccCcccccC-----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      .. .......||+.|+|||++..     ..++.++|||||||++|||++|+.||........  .   ...........+
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~---~~i~~~~~~~~~  229 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--Y---GKIMNHKEHFQF  229 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--H---HHHHcCCCcccC
Confidence            21 11223468999999999863     4578899999999999999999999865332111  0   001111111111


Q ss_pred             cCccccchhHHHHHHHHHHHHhccccc--CcCCCCCHHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQE--KAADRPTMSKVVSM  784 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~--~P~~RPs~~evl~~  784 (834)
                      ..      ........+.+++..|+..  ++..||++.++++-
T Consensus       230 ~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00      0111334566777776654  44447899888876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-34  Score=310.88  Aligned_cols=253  Identities=22%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++++.||+|+||.||+++.. .++.||+|.+... .......+.+|+.++.+++|+||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36889999999999999999986 6899999988654 334457889999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|..++........+++..+..++.|+++||.|||+..  +|+|+||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999999865433457899999999999999999999742  3999999999999999999999999999765322  


Q ss_pred             ccccccccccccccCcccccCCC------CCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                        ......++..|+|||.+.+..      ++.++|||||||++|||++|+.||........  ...         .....
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~---------~~~~~  223 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQ---------LSAIV  223 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHH---------HHHHh
Confidence              122345788999999985543      58899999999999999999999864322110  000         00000


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +. .....+..+...+.+++.+||+.+|++||++.++++
T Consensus       224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            00 011122235567788999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-34  Score=309.59  Aligned_cols=239  Identities=22%  Similarity=0.325  Sum_probs=187.6

Q ss_pred             eecccCccceEeeEecC-------------------------CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeE
Q 003287          520 KLGEGGFGPVYKGKLLN-------------------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL  574 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l  574 (834)
                      +||+|+||.||+|.+..                         ...||+|++.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13589999876555556778999999999999999999


Q ss_pred             eeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC--
Q 003287          575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM--  652 (834)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~--  652 (834)
                      ++++.+....++||||+++|+|..++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999988542  346789999999999999999999987   99999999999997654  


Q ss_pred             -----CeeeccccccccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHh-hCCCCCCCCCcccc
Q 003287          653 -----NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETL-TSKRNTGVYDIESF  725 (834)
Q Consensus       653 -----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~ell-tg~~p~~~~~~~~~  725 (834)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3799999998653221      12346788999998875 56899999999999999985 68888764332111


Q ss_pred             cccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          726 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       726 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .  .    .....       .....    .....+.+++..||+.+|++||++.++++.|+
T Consensus       231 ~--~----~~~~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 E--R----FYEKK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H--H----HHHhc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            0  0    00000       00001    11235788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-34  Score=306.42  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=191.3

Q ss_pred             ceecccCccceEeeEecCC---cEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          519 CKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.||+|+||.||+++..++   ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999976443   356777776543 345678999999999999999999999999999999999999999


Q ss_pred             CchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          595 SLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       595 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      +|.+++.+.. .....+...+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999996532 2334667778899999999999999987   99999999999999999999999999865332222222


Q ss_pred             cccccccccccCcccccC-------CCCCccCCeeeHHHHHHHHhhC-CCCCCCCCcccccccccccccccccccccccC
Q 003287          674 TKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.......  ...   ... .+....+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~---~~~-~~~~~~~~~  231 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLN---HVI-KDQQVKLFK  231 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---HHH-hhcccccCC
Confidence            234567889999998753       2457899999999999999975 55665332211  000   001 112223333


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      +.+...    ....+.+++..|| .+|++||++++|++.|.
T Consensus       232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333322    3356777889999 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-34  Score=304.17  Aligned_cols=238  Identities=24%  Similarity=0.417  Sum_probs=189.0

Q ss_pred             ceecccCccceEeeEecCCc-----------EEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          519 CKLGEGGFGPVYKGKLLNGQ-----------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999986432           5888887654333 6789999999999999999999999988 788999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-------Ceeecccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-------NPKISDFG  660 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-------~vkl~DFG  660 (834)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999986432  26889999999999999999999987   99999999999999888       79999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCC--CCCccCCeeeHHHHHHHHhhC-CCCCCCCCcccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWNLWKD  737 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  737 (834)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+.........  .    .+..
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~--~----~~~~  221 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--R----FYQD  221 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--H----HHhc
Confidence            9986532      2223466789999999876  789999999999999999995 6666543211100  0    0000


Q ss_pred             cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       738 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .  .....+.         ...+.+++.+||+.+|++||++.++++.|+
T Consensus       222 ~--~~~~~~~---------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 Q--HRLPMPD---------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C--CCCCCCC---------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0  0000000         156788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.6e-34  Score=315.69  Aligned_cols=263  Identities=19%  Similarity=0.263  Sum_probs=195.1

Q ss_pred             ccceeccc--CccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          517 MQCKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       517 ~~~~lG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++++||+|  +|++||+++.. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  78999999875 58999999997542  334456788999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++.... ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985432 234889999999999999999999987   999999999999999999999999876543221110


Q ss_pred             -----cccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccc---cccccccc-----
Q 003287          672 -----GNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL---GHAWNLWK-----  736 (834)
Q Consensus       672 -----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~-----  736 (834)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.||...........   ........     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                 01122346778999999976  4589999999999999999999999875332111000   00000000     


Q ss_pred             -------------ccccccc-----cCc----cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 -------------DNRAYEL-----LSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 -------------~~~~~~l-----~~~----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                                   .....+.     ..+    .............+.+++..||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                         0000000     000    0001122234567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-34  Score=311.85  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=204.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .+|++.+.||.|+||.||+|... +++.||||.+........+.+.+|+.+++.++|+|++++++++.+....++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            57999999999999999999864 68999999997655555678899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++.+    ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+..... 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999998842    35889999999999999999999987   99999999999999999999999999886543321 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+.......     ... .....+.       
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-----~~~-~~~~~~~-------  236 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IAT-NGTPELQ-------  236 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHh-cCCcccC-------
Confidence             12234688899999999998999999999999999999999999875432111000     000 0000000       


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+......+.+++.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            112233467789999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=302.93  Aligned_cols=253  Identities=24%  Similarity=0.395  Sum_probs=205.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|++.+.||+|+||.||+++.. +++.+|+|.+........+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            67999999999999999999875 47889999998766566788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+....  
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            999999988542  246889999999999999999999987   9999999999999999999999999997654321  


Q ss_pred             cccccccccccccCcccccCC---CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .......++..|+|||.+...   .++.++||||||++++||++|+.|+...........      ....   ....+.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~~~---~~~~~~~  226 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------ISKS---NFPPPKL  226 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhc---cCCCccc
Confidence            112234678899999999877   889999999999999999999999875432111000      0000   0001111


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        .........+.+++.+||+.+|.+||++.+++.
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              112334567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.1e-34  Score=306.87  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=201.3

Q ss_pred             CccccceecccCccceEeeEecC--CcEEEEEEeccc----------ChhhHHHHHHHHHHHhc-cCCCceeeEeeeEee
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLMGCCVE  580 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~--g~~vAVK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~  580 (834)
                      +|++.+.||+|+||.||+|+...  ++.+|||.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999865  688999987532          22334567788888875 799999999999999


Q ss_pred             cCeEEEEEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                      ++..++||||+++++|.+++... .....+++..+++++.|++.||.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887432 23456889999999999999999999632  3999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........  ..    ......
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--~~----~~~~~~  229 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--AT----KIVEAV  229 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--HH----HHhhcc
Confidence            9998754332   23345688999999999998899999999999999999999999864332110  00    000000


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                          ..+.    ........+.+++.+||+.+|++||++.|+.+++++
T Consensus       230 ----~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         230 ----YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ----CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                0010    011223567889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-34  Score=319.19  Aligned_cols=193  Identities=24%  Similarity=0.327  Sum_probs=165.2

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ....+|++++.||+|+||.||+|+.. .++.||+|+....      ....|+.++++++|+||+++++++.+....++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34568999999999999999999876 4788999985432      2356899999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+. ++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 577777743  3346899999999999999999999987   999999999999999999999999999753221


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT  717 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~  717 (834)
                         .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1223356899999999999999999999999999999999876554

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-34  Score=309.33  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=197.3

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      |+..+.||+|+||+||+++.. +++.||+|.+....   ......+.+|++++.+++|+|++++.+++.+++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677789999999999999875 58899999986542   22345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998885432 346899999999999999999999987   9999999999999999999999999997653221 


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......|+..|+|||++.+..++.++||||||+++|||++|..||.........  ....     ...... ..    
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~-----~~~~~~-~~----  222 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVD-----RRVLET-EE----  222 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-----Hhhhcc-cc----
Confidence              122346899999999999999999999999999999999999998754321100  0000     000000 00    


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                      .........+.+|+..|++.+|++||+     +.++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            011223345778999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=318.20  Aligned_cols=245  Identities=31%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecc---cChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..|+-++.||.|+||.||-++.. +.+.||||++.-   .+.+.+..+..|+..|.+++|||+|.+.|++..+...+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            45777889999999999999875 578899999863   34556788999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      |||- |+-.+++.-  ..+++.+.++..|..+.++||+|||+.+   .||||||+.||||.+.|.|||+|||.|.+..+ 
T Consensus       106 EYCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            9994 455555521  2356888899999999999999999998   99999999999999999999999999987543 


Q ss_pred             CcccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                           -...+|||.|||||++.   .+.|+-|+||||||++..||.-.++|.-.+..-+-.           ..+...-.
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-----------YHIAQNes  242 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----------YHIAQNES  242 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-----------HHHHhcCC
Confidence                 34578999999999985   578999999999999999999999986654422110           01112223


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      |.+.   ..+.+..+.+++..||++-|.+|||..+++.
T Consensus       243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            3333   3456778889999999999999999988764

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.1e-34  Score=303.67  Aligned_cols=250  Identities=28%  Similarity=0.416  Sum_probs=194.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-----hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  584 (834)
                      .+|+..+.||+|+||.||++... .++.||+|++....     .+..+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999875 48899999886432     23345688999999999999999999988763  577


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++++||+++++|.+++..   ...+++.....++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   235788999999999999999999887   99999999999999999999999999986


Q ss_pred             ccCCCc-ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      +..... ........++..|+|||++.+..++.++|||||||++|||++|+.||...+......     ..     ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-----~~-----~~~~  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-----KI-----ATQP  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-----HH-----hcCC
Confidence            532211 111223457889999999999899999999999999999999999987532211000     00     0000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+.    .+......+.+++ .||..+|++||+++|+++
T Consensus       226 ~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1111    1222334455666 688889999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-34  Score=318.10  Aligned_cols=198  Identities=26%  Similarity=0.357  Sum_probs=171.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-C-----CceeeEeeeEeecCeEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l  586 (834)
                      +|++++.||+|.||.|.|+.+. +++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            8999999999999999999865 5999999999764 344566678999999996 5     389999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC--CCeeecccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARM  664 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~--~~vkl~DFGla~~  664 (834)
                      |+|.+ ..+|.++|+..+ -..++...+..++.||+.||..||+.+   |||+||||+||||.+.  ..|||+|||.|..
T Consensus       266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99998 568999996543 345889999999999999999999987   9999999999999754  4699999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI  722 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~  722 (834)
                      ....-     .....++.|+|||++.+.+|+.+.||||||||+.||++|.+-|...++
T Consensus       341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            53322     246678999999999999999999999999999999999887776553

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-34  Score=315.74  Aligned_cols=255  Identities=20%  Similarity=0.257  Sum_probs=195.6

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.++||+|+||+||+++... ++.+|+|++.+..   ......+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            478999999999999999999764 7889999986532   223455888999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  245889999999999999999999987   999999999999999999999999999765332


Q ss_pred             CcccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+....     .............
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~  229 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKERFQF  229 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCCccccC
Confidence            21 1223356899999999986     34688999999999999999999999875432111     0000010000000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcC--CCCCHHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAA--DRPTMSKVVSM  784 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~--~RPs~~evl~~  784 (834)
                        +    .........+.+++..|+..++.  .|+++.|+++.
T Consensus       230 --p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 --P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              0    01112345567788887755443  46889988766

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-34  Score=316.27  Aligned_cols=255  Identities=19%  Similarity=0.259  Sum_probs=196.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+++.. +++.||||++.+.   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999876 4789999998653   2233456888999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+.  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  246889999999999999999999987   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccCcccccC-----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      .. .......||+.|+|||++.+     +.++.++|||||||+||||++|+.||...+....  ..   ...........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~---~i~~~~~~~~~  229 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHEERFQF  229 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--HH---HHHcCCCcccC
Confidence            21 12223568999999999875     5688999999999999999999999875432110  00   00000000000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCC--CCCHHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  784 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~  784 (834)
                        +    ......+..+.+++..|++..+.+  |++++++++.
T Consensus       230 --p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 --P----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --C----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              0    011123456778888888865543  4678877653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-34  Score=304.23  Aligned_cols=247  Identities=28%  Similarity=0.437  Sum_probs=198.5

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.+.||+|+||.||+++. .++.||+|.+....  ..+.+.+|+.++.+++|||++++++++.+. ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5688999999999999999975 67889999986532  346789999999999999999999998765 4799999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++.... ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.....    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999986432 345789999999999999999999987   999999999999999999999999998754221    


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       ......+..|+|||.+.+..++.++||||||++++||++ |+.|+........  ..    ....+         ....
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~---------~~~~  217 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KE----CVEKG---------YRME  217 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HH----HHhCC---------CCCC
Confidence             112234578999999998899999999999999999998 8888865432211  00    00000         0011


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112234567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-34  Score=310.23  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57889999999999999999875 58899999886543 34567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++..   ...+++..+..++.+++.||.|||+..  +++||||||+||+++.++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999998843   245889999999999999999999743  3999999999999999999999999998754221  


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......|+..|+|||++.+..++.++|||||||+++||++|+.||........... ......  +............
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~  232 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-DPMGIL--DLLQQIVQEPPPR  232 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-hhhHHH--HHHHHHhhccCCC
Confidence              12235689999999999888999999999999999999999999875432210000 000000  0000000000000


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                      .........+.+++.+|++.+|++||++.|++++.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            00112445688899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=306.65  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=208.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .-|.+.+.||+|.|..|-++++. .|..||||++.+.  +......+..|++.|+.++|||||+||.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45788899999999999999865 7999999999765  33455678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE-cCCCCeeeccccccccccCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl-~~~~~vkl~DFGla~~~~~~  668 (834)
                      .-.+|+|.+||-++  ...+.+....+++.||+.|+.|+|+.+   +|||||||+||.+ ..-|-|||.|||++..+.+.
T Consensus        98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999544  456889999999999999999999998   9999999999765 66789999999999776443


Q ss_pred             CcccccccccccccccCcccccCCCCC-ccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                         ......+|...|-|||++.+..|+ ++.||||||||||.|++|+.||+.....+.              +.-++|-.
T Consensus       173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDCK  235 (864)
T KOG4717|consen  173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDCK  235 (864)
T ss_pred             ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhccc
Confidence               344567899999999999999987 578999999999999999999986543221              11222221


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        -..+.....++.+||..||+.||.+|.+.++++..
T Consensus       236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence              23455667889999999999999999999998864

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.3e-34  Score=302.75  Aligned_cols=251  Identities=35%  Similarity=0.525  Sum_probs=200.9

Q ss_pred             ccccceecccCccceEeeEecC-----CcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +++.+.||+|+||.||+++..+     +..||+|++...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999998754     388999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854321 12899999999999999999999987   999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ...... ...++..|+|||.+.+..++.++||||||++++||++ |..|+........  ..    ........      
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~--~~----~~~~~~~~------  223 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV--LE----YLKKGYRL------  223 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHhcCCCC------
Confidence            222211 2336789999999988889999999999999999998 6777654322111  00    00001100      


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                         .........+.+++.+|++.+|++|||+.|+++.|
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               01111345688899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.6e-34  Score=303.04  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=196.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-----hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  584 (834)
                      ++|++.+.||+|+||.||+++.. +++.||||.+....     ....+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999875 48899999875321     23356788999999999999999999998764  467


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +++|||+++++|.+++.+.   ..+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998532   34788889999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ....... .......++..|+|||++.+..++.++||||||+++|||++|+.|+........ .             .+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~-------------~~~  221 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I-------------FKI  221 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H-------------HHH
Confidence            5332111 122334688999999999988899999999999999999999999864321110 0             000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .........+......+.+++..|+. +|++||+++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            00000111223344567778888885 8999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=308.32  Aligned_cols=253  Identities=24%  Similarity=0.385  Sum_probs=203.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+........+.|.+|++++++++|+||+++++.+.++...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            357999999999999999999875 5889999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++.+.  ...+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999998542  246899999999999999999999987   9999999999999999999999999987643221 


Q ss_pred             ccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          671 QGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                       .......++..|+|||++.     ...++.++||||||+++|||++|+.|+...+..... .     .+.....     
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-~-----~~~~~~~-----  225 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-L-----KILKSEP-----  225 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-H-----HHhcCCC-----
Confidence             1223356889999999975     345788999999999999999999998754322110 0     0000000     


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +.+.  .+......+.+++..||+.+|.+||++.++++-
T Consensus       226 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0000  111233467889999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.9e-34  Score=301.59  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999865 57899999987543 33567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965433356899999999999999999999987   99999999999999999999999999987654332


Q ss_pred             cc--ccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          671 QG--NTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       671 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..  ......++..|+|||++... .++.++|||||||+++||++|+.|+........ ..    .....      ..+.
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~----~~~~~------~~~~  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LM----LTLQN------DPPS  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HH----HHhcC------CCCC
Confidence            21  22334688999999998877 789999999999999999999999875432110 00    00000      0111


Q ss_pred             ccchh-HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEA-SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +.... .......+.+++..||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11110 1234466789999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.9e-35  Score=307.75  Aligned_cols=240  Identities=21%  Similarity=0.351  Sum_probs=189.9

Q ss_pred             ceecccCccceEeeEecC--------CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          519 CKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +.||+|+||.||+|....        ...||+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997642        235899988765555667889999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC--------eeecccccc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PKISDFGMA  662 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--------vkl~DFGla  662 (834)
                      +++|+|..++....  ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999996432  36789999999999999999999987   999999999999987765        699999998


Q ss_pred             ccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCC-CCCCCCCccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      .....      .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+.....  .    ... . .
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~--~----~~~-~-~  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--Q----FYE-D-R  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--H----HHH-c-c
Confidence            75432      123457889999999986 45899999999999999999995 444432211100  0    000 0 0


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ..         .+......+.+++..||+.+|++||+++++++.|+
T Consensus       222 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00         11112245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.7e-34  Score=305.93  Aligned_cols=261  Identities=24%  Similarity=0.334  Sum_probs=202.3

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEe---
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV---  579 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~---  579 (834)
                      +..+....++|++.+.||+|+||.||+++.. .++.+|+|++.... ....++.+|+.++.++ +|+||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3445567789999999999999999999875 47899999886532 2346688899999999 7999999999884   


Q ss_pred             --ecCeEEEEEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          580 --EQGEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       580 --~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                        .+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999987532 23356888999999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccC-----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~  731 (834)
                      +|||+++.+.....  ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+........ +..  
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~--  240 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK--  240 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh--
Confidence            99999986643221  2223468999999999853     4578899999999999999999999865432111 000  


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         ........+.++.       .....+.+++.+||+.+|++||++.|+++.
T Consensus       241 ---~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 ---IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               0000001111111       123457789999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.8e-34  Score=301.13  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=200.7

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEee-cCeEEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKILIYE  589 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E  589 (834)
                      +|++.+.||+|++|.||+++.. +++.||||++....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999875 47899999986532  3445678999999999999999999988764 446799999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++... ....+++.++..++.+++.||++||+.+   ++|+||||+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998643 2345899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                        .......+++.|+|||++.+..++.++||||||++++||++|+.|+...+....     .... ..+..         
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~~~-~~~~~---------  219 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VYRI-IEGKL---------  219 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHH-HhcCC---------
Confidence              122335678999999999999999999999999999999999999864332111     0000 00110         


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+......+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            01122344578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.3e-34  Score=306.47  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=200.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++|+|++++++++.+....++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999986 58999999986542  2234568899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |++++.|..++..   ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999998887632   335899999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cc-----ccc---cccccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LL-----GHA---WNLWKDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~-----~~~---~~~~~~~~  739 (834)
                      .  ......++..|+|||++.+ ..++.++||||||++++||++|+.||......+.. ..     ...   ...+....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223457889999999876 56889999999999999999999998754321110 00     000   00000000


Q ss_pred             cc---cccCccccc---hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AY---ELLSPALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~---~l~~~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..   ...++....   .........+.+++.+||+.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00   000000000   011123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.5e-34  Score=328.99  Aligned_cols=265  Identities=20%  Similarity=0.255  Sum_probs=192.1

Q ss_pred             HHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCC------CceeeEeeeE
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH------RNLVRLMGCC  578 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~  578 (834)
                      .++...+.+|+++++||+|+||+||+|... .++.||||+++... .....+..|+.++..++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            334455789999999999999999999875 47889999996432 223445667777776654      4689999988


Q ss_pred             eec-CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCC----
Q 003287          579 VEQ-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM----  652 (834)
Q Consensus       579 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~----  652 (834)
                      ... .+.++|||++ +++|.+++.+   ...+++..+..|+.||+.||+|||+. +   |+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            765 4788999988 6677777743   34688999999999999999999974 6   99999999999998765    


Q ss_pred             ------------CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCC
Q 003287          653 ------------NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY  720 (834)
Q Consensus       653 ------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~  720 (834)
                                  .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                        49999999886432     1233467899999999999999999999999999999999999999764


Q ss_pred             Cccc-cccccc----ccccccc----ccccccc------Cccccc-----------hhHHHHHHHHHHHHhcccccCcCC
Q 003287          721 DIES-FNLLGH----AWNLWKD----NRAYELL------SPALQH-----------EASYQMLNRYITVALLCVQEKAAD  774 (834)
Q Consensus       721 ~~~~-~~~~~~----~~~~~~~----~~~~~l~------~~~l~~-----------~~~~~~~~~l~~li~~cl~~~P~~  774 (834)
                      +... ......    ....|..    .+..++.      .+....           .........+.+|+..||+.||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            4211 000000    0000000    0000000      000000           000111345779999999999999


Q ss_pred             CCCHHHHHH
Q 003287          775 RPTMSKVVS  783 (834)
Q Consensus       775 RPs~~evl~  783 (834)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999996

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4e-34  Score=312.63  Aligned_cols=197  Identities=27%  Similarity=0.434  Sum_probs=160.6

Q ss_pred             cceecccCccceEeeEec---CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee--cCeEEEEEEecC
Q 003287          518 QCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIYEYMP  592 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~  592 (834)
                      .++||+|+||+||+|+..   +++.||||.+....  ....+.+|+.++++++||||+++++++.+  +...+++|||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999864   46789999986542  23457889999999999999999998864  456789999986


Q ss_pred             CCCchhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE----cCCCCeeecccccc
Q 003287          593 NKSLNFFLFDP------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMA  662 (834)
Q Consensus       593 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~vkl~DFGla  662 (834)
                      + +|.+++...      .....+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 676666321      12235889999999999999999999987   9999999999999    45678999999999


Q ss_pred             ccccCCCc-ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCC
Q 003287          663 RMFCGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVY  720 (834)
Q Consensus       663 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~  720 (834)
                      +.+..... ........+|+.|+|||++.+. .++.++||||+||+++||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87643321 1222346789999999999874 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.4e-34  Score=301.95  Aligned_cols=247  Identities=28%  Similarity=0.411  Sum_probs=200.1

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC-----hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      +|+..+.||+|+||+||+|... +++.|++|.+....     .+..+.+.+|+.++++++|+||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999986 68999999886533     23457789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      +||+++++|.+++.+   ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   235789999999999999999999987   99999999999999999999999999887543


Q ss_pred             CCcccccccccccccccCcccccCCC-CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|||++|+.|+........     ..........      
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~------  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----VFKIGRSKEL------  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-----HHHHHhcccC------
Confidence            22   223456889999999998776 89999999999999999999999865431110     0000000000      


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         ...+......+.+++.+||+.+|++||++.++++
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               0111223456778999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.2e-34  Score=318.69  Aligned_cols=262  Identities=24%  Similarity=0.259  Sum_probs=196.5

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------  581 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  581 (834)
                      ..++|++.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3478999999999999999999865 5889999999754  233456788999999999999999999988643      


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            357999999976 4555552     24788899999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c-ccc----------
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLG----------  729 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~-~~~----------  729 (834)
                      ++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.... . ...          
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9865322   122335689999999999999999999999999999999999999875432110 0 000          


Q ss_pred             -----cccccccc-cccccccCccc-----c---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          730 -----HAWNLWKD-NRAYELLSPAL-----Q---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       730 -----~~~~~~~~-~~~~~l~~~~l-----~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                           ........ .....+..+..     .   ..........+.+++.+||+.+|++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 00000000 00000000000     0   01111224567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-34  Score=309.87  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=199.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57999999999999999999875 57899999986543 23345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++ ++|.+++.+.  ...+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||++....... 
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            97 5888887542  345789999999999999999999987   9999999999999999999999999997643221 


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-c--------cccccccccc-cc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-L--------LGHAWNLWKD-NR  739 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~--------~~~~~~~~~~-~~  739 (834)
                       .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..... .        ....|..+.. ..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence             112234568899999998754 5788999999999999999999998765432110 0        0001111000 00


Q ss_pred             cccccCccccc----hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AYELLSPALQH----EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~~l~~~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......+....    .........+.+|+.+|++.+|.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000111111    111223456788999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-35  Score=317.90  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=204.9

Q ss_pred             eecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCchh
Q 003287          520 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF  598 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~  598 (834)
                      +||+|.||+||.|++.+ ...+|||-+.....+..+-+.+|+.+-++|+|.|||+++|.+.+++..-|.||.+|+|+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999865 56799999988777777888999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCeeeccccccccccCCCcccccccc
Q 003287          599 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDELQGNTKRV  677 (834)
Q Consensus       599 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~  677 (834)
                      +|...-..-.=.+.+.-.+.+||++||.|||+..   |||||||-.||||+ -.|.+||+|||-++.+..  ....+...
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            9964322222267888889999999999999998   99999999999996 478999999999988743  34456667


Q ss_pred             cccccccCcccccCCC--CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHH
Q 003287          678 VGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ  755 (834)
Q Consensus       678 ~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~  755 (834)
                      .||..|||||++..++  |+.++|||||||++.||.||++||-......-.       +++-+- +     ...+..+.+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------MFkVGm-y-----KvHP~iPee  803 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------MFKVGM-Y-----KVHPPIPEE  803 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------hhhhcc-e-----ecCCCCcHH
Confidence            8999999999998664  899999999999999999999998654322110       111110 0     012345667


Q ss_pred             HHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          756 MLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       756 ~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .......+|..|+..+|.+||++.++++-
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            77888999999999999999999999864

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-34  Score=305.98  Aligned_cols=259  Identities=24%  Similarity=0.385  Sum_probs=201.3

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEee-
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE-  580 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-  580 (834)
                      ++.++..+...|++.+.||+|+||.||+|+.. +++.+|+|++.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34444556678999999999999999999975 58899999986543 3446788899999999 79999999999853 


Q ss_pred             -----cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCee
Q 003287          581 -----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  655 (834)
Q Consensus       581 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vk  655 (834)
                           ....+++|||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+   |+|+||||+||+++.++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 457899999999999999885432 345788889999999999999999987   99999999999999999999


Q ss_pred             eccccccccccCCCcccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccc
Q 003287          656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH  730 (834)
Q Consensus       656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~  730 (834)
                      |+|||++.......  .......|+..|+|||.+.     ...++.++|||||||++|||++|..||..........   
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---  236 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---  236 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence            99999987653211  1223356889999999986     3468889999999999999999999986433211000   


Q ss_pred             ccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       731 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                              .......+..   ....+...+.+++..||+.+|.+||++.|+++
T Consensus       237 --------~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 --------LIPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------hHhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    0000000001   11123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.5e-34  Score=309.16  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=199.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|++.++||+|+||.||+|... .++.||+|++.....  ...+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999986 489999999865432  235678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|..+...   ...+++.++..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887643   234889999999999999999999987   9999999999999999999999999998754332


Q ss_pred             cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc--cccc-------cccccccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLG-------HAWNLWKDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~-------~~~~~~~~~~  739 (834)
                        .......++..|+|||++.+ ..++.++||||||++++||++|+.|+........  .+..       ..........
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence              12223457889999999875 4578899999999999999999988864331100  0000       0000000000


Q ss_pred             cc-cccCcccc-----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AY-ELLSPALQ-----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~-~l~~~~l~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .. ....+...     ..........+.+++..||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 00000000     0011234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-34  Score=317.01  Aligned_cols=261  Identities=24%  Similarity=0.309  Sum_probs=194.8

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec------
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------  581 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  581 (834)
                      ..++|++.+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3478999999999999999999875 57899999987542  23345678899999999999999999987643      


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ...++++|++ +++|.+++.    ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3568999988 778887773    345899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc----ccc----
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GHA----  731 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~----~~~----  731 (834)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ...    ...    
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865322     233568999999999877 5689999999999999999999999865332110 000    000    


Q ss_pred             cccccccccccccC--ccccch----hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          732 WNLWKDNRAYELLS--PALQHE----ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       732 ~~~~~~~~~~~l~~--~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ............+.  +.....    ........+.+++..|++.+|++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000000  000000    001122346789999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.2e-34  Score=303.33  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=199.2

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccCh----------hhHHHHHHHHHHHhccCCCceeeEeeeEeecC
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG----------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  582 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  582 (834)
                      +|.+.+.||+|+||.||+|... +++.||||.++....          ...+.+.+|+.++++++|+|++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999865 588999998753211          12346788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++++|.+++.+.   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   46888999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCC--CCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      +...............++..|+|||.+....  ++.++||||||++++||++|..|+........     ...... .. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~-~~-  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----MFKLGN-KR-  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----HHHhhc-cc-
Confidence            7653322222233456889999999987654  88999999999999999999999864321100     000000 00 


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         ..+.............+.+++..||+.+|++||++.++++.
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 ---SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ---cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence               00111111122345678889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.7e-34  Score=318.43  Aligned_cols=261  Identities=23%  Similarity=0.243  Sum_probs=196.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------C
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  582 (834)
                      .++|++.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            478999999999999999999875 4889999999753  233456788999999999999999999987543      3


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++ +|...+.     ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            57999999975 5666552     24778899999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cc-cc---c----ccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL-LG---H----AWN  733 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~-~~---~----~~~  733 (834)
                      +......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.... .. ..   .    ...
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8653221   22335689999999999999999999999999999999999999975442110 00 00   0    000


Q ss_pred             c--------cccc------ccccccCccc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          734 L--------WKDN------RAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       734 ~--------~~~~------~~~~l~~~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .        ....      ....+.....   ...........+.+++.+|++.||.+|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0        0000      0000000000   001111123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9e-34  Score=299.64  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|+||.||+++.. +++.||||++...  .....+++.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999875 5889999998643  234456889999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++... ....+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988542 2335789999999999999999999987   99999999999999999999999999986533221


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......++..|+|||++.+..++.++|||||||+++||++|+.|+........  .   .... .+..         .
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~---~~~~-~~~~---------~  219 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--V---LKII-RGSY---------P  219 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--H---HHHh-cCCC---------C
Confidence              12234578899999999999999999999999999999999999864332111  0   0000 0000         0


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+......+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            112233456888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-34  Score=340.76  Aligned_cols=260  Identities=23%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  585 (834)
                      ...+|+++++||+|+||+||+++... ++.||+|.+...  .......|..|+.++.+|+||||+++++++.+.  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            34689999999999999999998764 778999988643  334457789999999999999999999988654  5689


Q ss_pred             EEEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CceEecCCCCCcEEEcC----------
Q 003287          586 LIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSR----LRIIHRDLKASNILLDS----------  650 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiH~DIkp~NILl~~----------  650 (834)
                      |||||+++|+|.++|... .....+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998642 223468999999999999999999998542    34999999999999964          


Q ss_pred             -------CCCeeeccccccccccCCCcccccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          651 -------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       651 -------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                             ...+||+|||++..+....   ......||+.|+|||++.+  ..++.++||||||||||||++|..||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   2348999999998653322   1233568999999999864  458999999999999999999999986433


Q ss_pred             cccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH--Hhhcc
Q 003287          722 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS--MITNE  788 (834)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~  788 (834)
                      .... +..    .....       +.+.   .......+.+|+..||+.+|.+||++.|+++  .|..+
T Consensus       248 ~~~q-li~----~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        248 NFSQ-LIS----ELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             cHHH-HHH----HHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            2110 000    00000       0000   0112356788999999999999999999984  44433

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=316.94  Aligned_cols=240  Identities=22%  Similarity=0.284  Sum_probs=185.7

Q ss_pred             ecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc---CCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      ||+|+||+||+|+.. +++.||||++.+..   ......+..|..++.++   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 48999999986532   12233455666666655   699999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|..++.+   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999988843   345889999999999999999999987   9999999999999999999999999997542221  22


Q ss_pred             cccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          674 TKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      .....||..|+|||++.+. .++.++|||||||++|||++|+.||........  .    .....+. ..+..       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--~----~~i~~~~-~~~~~-------  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--Y----RNIAFGK-VRFPK-------  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--H----HHHHcCC-CCCCC-------
Confidence            3345789999999998765 489999999999999999999999865432211  0    0000000 00100       


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCC----HHHHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPT----MSKVVS  783 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~  783 (834)
                       ......+.+++..||+.+|.+||+    +.++++
T Consensus       219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             112345678999999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-33  Score=303.50  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=193.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHH-HhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMML-IAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|++.+.||+|+||.||+++.. +|+.||||+++... .....++..|+.+ ++.++||||+++++++.++...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999876 58999999987542 2334455666665 566799999999999999999999999


Q ss_pred             ecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          590 YMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       590 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |++ |+|.+++... .....+++..+..++.||+.||+|||+. +   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6787777542 2345689999999999999999999986 5   99999999999999999999999999986532


Q ss_pred             CCcccccccccccccccCcccccC----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALD----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ..   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+.........+.    ...      ..
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~------~~  223 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK----QVV------EE  223 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH----HHH------hc
Confidence            21   1122457889999998865    4568899999999999999999999864321100000    000      00


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+.+.   ....+..+.+++..||+.+|++||++.++++
T Consensus       224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011111   1123456888999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.7e-34  Score=302.65  Aligned_cols=254  Identities=27%  Similarity=0.372  Sum_probs=203.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999986 58999999987653 34557789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      +++++|.+++....  ..+++..+..++.|+++||+|||+ .+   ++|+||||+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999985432  568899999999999999999999 66   9999999999999999999999999987653221


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                          .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...+.............      .....+.+.
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~  225 (265)
T cd06605         156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI------VNEPPPRLP  225 (265)
T ss_pred             ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH------hcCCCCCCC
Confidence                1115678899999999999999999999999999999999999875432111111100000      000011111


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..   .....+.+++.+||..+|++||++.+++..
T Consensus       226 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 SG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11   145568899999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-33  Score=308.81  Aligned_cols=196  Identities=28%  Similarity=0.443  Sum_probs=159.9

Q ss_pred             ceecccCccceEeeEecC---CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee--cCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~  593 (834)
                      .+||+|+||+||+|+..+   +..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            589999999999998653   5789999986542  23467889999999999999999999854  4578999999875


Q ss_pred             CCchhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE----cCCCCeeeccccccc
Q 003287          594 KSLNFFLFDP------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  663 (834)
Q Consensus       594 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~vkl~DFGla~  663 (834)
                       +|.+++...      .....+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             566665321      12335889999999999999999999987   9999999999999    567799999999998


Q ss_pred             cccCCCcc-cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCC
Q 003287          664 MFCGDELQ-GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVY  720 (834)
Q Consensus       664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~  720 (834)
                      .+...... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76433211 122345689999999998764 5899999999999999999999998654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-34  Score=286.12  Aligned_cols=251  Identities=23%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--------hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  581 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  581 (834)
                      -++|.-.+.||+|..++|.+...+ .|+++|+|++....        ....+.-..|+.+|+++ -||+|+++.++++..
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356777889999999999998765 58899999985321        12234557799999999 699999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ...++|+|.|+.|.|.++|..   .-.+++++..+|++|+.+|++|||..+   |+||||||+|||+|++.++||+|||+
T Consensus        96 sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence            999999999999999999943   346899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccC------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALD------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      |..+...   ......+||++|+|||.+.-      ..|+...|+|++|||+|-|+.|.+||=.-.  +...+   . +.
T Consensus       170 a~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlML---R-~I  240 (411)
T KOG0599|consen  170 ACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLML---R-MI  240 (411)
T ss_pred             eeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHH---H-HH
Confidence            9987543   34456789999999998853      247889999999999999999999974211  00000   0 01


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .++..      ........+.+....+||.+||+.||.+|.|++|+++
T Consensus       241 meGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  241 MEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             Hhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            11110      1122334456677889999999999999999999875

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-33  Score=304.52  Aligned_cols=262  Identities=25%  Similarity=0.340  Sum_probs=203.0

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  581 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  581 (834)
                      ...++..+.++|++.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            33455566789999999999999999999875 58899999986532 2346678899999999 899999999998754


Q ss_pred             -----CeEEEEEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCee
Q 003287          582 -----GEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  655 (834)
Q Consensus       582 -----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vk  655 (834)
                           ...++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 3589999999999999988542 23456889999999999999999999987   99999999999999999999


Q ss_pred             eccccccccccCCCcccccccccccccccCcccccCC-----CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccc
Q 003287          656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH  730 (834)
Q Consensus       656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~  730 (834)
                      |+|||++..+.....  ......++..|+|||++...     .++.++|||||||++|||++|+.|+........ +.. 
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~-  244 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFK-  244 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHH-
Confidence            999999986543221  12234678899999998643     368899999999999999999999865432110 000 


Q ss_pred             ccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       731 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          +.......+.+       .......+.+++.+||+.+|++||++.|+++.
T Consensus       245 ----~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 ----IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                00010111111       11233468899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-33  Score=299.83  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=200.9

Q ss_pred             CccccceecccCccceEeeEe-cCCcEEEEEEecccC------hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      +|+..+.||+|+||.||+++. .+++.||+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 458999999986432      1235678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-Ceeeccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMF  665 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~  665 (834)
                      |+||+++++|.+++.+   ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   346789999999999999999999987   99999999999998776 5999999999876


Q ss_pred             cCCCcc--cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          666 CGDELQ--GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ......  .......++..|+|||.+.+..++.++||||+|++++||++|..|+.........  ..         ..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~---------~~~~  223 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--AL---------IFKI  223 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--HH---------HHHH
Confidence            433211  1122346788999999998888999999999999999999999998643321100  00         0000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .........+......+.+++.+|++.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0000111222344567888999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=304.09  Aligned_cols=264  Identities=22%  Similarity=0.307  Sum_probs=201.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|++.++||+|+||.||+|... +++.||||+++..  .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999876 4889999998653  23345778999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |++++.+..++..   ...+++.++..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998877766532   345889999999999999999999987   9999999999999999999999999998764433


Q ss_pred             cccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-c--------cccccccccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-L--------LGHAWNLWKDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~--------~~~~~~~~~~~~  739 (834)
                      . .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......... .        .......+....
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            2 122335678899999999888 8899999999999999999999988653321100 0        000000000000


Q ss_pred             -c--ccccCcccc----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 -A--YELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 -~--~~l~~~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .  .+..+....    ..........+.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             0  000011000    0111123567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-33  Score=298.58  Aligned_cols=251  Identities=27%  Similarity=0.388  Sum_probs=206.0

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||+|++|.||+++... ++.||||++..... ...+.+.+|+..+.+++|+|++++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368889999999999999999874 89999999876544 4567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      +++++|.+++...   ..+++..+..++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999543   568999999999999999999999 77   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-ccccccccccccccccccccCccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......   ..      ....+  
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---~~------~~~~~--  221 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---IC------DGPPP--  221 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---Hh------cCCCC--
Confidence            21  123467889999999999999999999999999999999999987543210 001100   00      00001  


Q ss_pred             cchhHHH-HHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          749 QHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ..... .+..+.+++..|++.+|++||++.|+++.
T Consensus       222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              11112 45678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-33  Score=307.32  Aligned_cols=256  Identities=20%  Similarity=0.260  Sum_probs=201.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+++.. .++.||||.+....   ....+.+.+|+.+++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36889999999999999999876 47899999987643   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999943   245889999999999999999999987   999999999999999999999999998742110


Q ss_pred             C-------------cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          669 E-------------LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       669 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      .             .........++..|+|||.+.+..++.++||||||+++|||++|..|+........  ..    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~--~~----~~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FG----QV  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HH
Confidence            0             00011124578899999999988999999999999999999999999864322110  00    00


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      ...   ....+..    .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       229 ~~~---~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 ISD---DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             Hhc---ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            000   0001110    01234567889999999999999998877777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-33  Score=300.94  Aligned_cols=247  Identities=24%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      -|++.++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778889999999999999864 58899999986543 334567899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++..    ..+++..+..++.|++.++.|||+.+   ++|+||||+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            99999998842    35889999999999999999999987   99999999999999999999999999976643221 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       ......++..|+|||.+.+..++.++|||||||+++||++|..|+........  ..    ......     .+    .
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~~-----~~----~  220 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--LF----LIPKNN-----PP----T  220 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--HH----HHhcCC-----CC----C
Confidence             12234678899999999988899999999999999999999999864332110  00    000000     01    1


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ........+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            112234557789999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-33  Score=302.59  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=201.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  588 (834)
                      ++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36888999999999999999985 58899999987543 24567789999999999999999999998654  4689999


Q ss_pred             EecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||+++++|.+++... .....++...+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887532 23456889999999999999999999987   99999999999999999999999999875432


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ..........+.+. 
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-  231 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPELKDE-  231 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchhhccC-
Confidence            21    1234578899999999999999999999999999999999999875432110000000 00000000000000 


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ..........+.+++.+||+.+|++|||+.|+++.
T Consensus       232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence              00011235678899999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.3e-33  Score=303.20  Aligned_cols=251  Identities=23%  Similarity=0.361  Sum_probs=204.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            368999999999999999999864 5789999998765555567889999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++.+    ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+.....
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999843    35788999999999999999999987   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        ......+++.|+|||.+....++.++||||||+++|||++|+.||......... .    .....+      .+... 
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~----~~~~~~------~~~~~-  236 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-Y----LIATNG------TPELQ-  236 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-e----ehhcCC------CCCCC-
Confidence              222346888999999999888999999999999999999999998754321110 0    000000      00010 


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ........+.+++..||+.+|++||++.++++.
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             112234467789999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.6e-33  Score=303.34  Aligned_cols=263  Identities=23%  Similarity=0.284  Sum_probs=198.6

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccChh-----hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      +|++.+.||+|+||.||+|... +++.||||++......     ....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999875 5899999999754322     345677899999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+ +++|.+++.+..  ..+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999985432  36899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc-cc----ccccccc-cc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-GH----AWNLWKD-NR  739 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~-~~----~~~~~~~-~~  739 (834)
                      ..  .......++..|+|||.+.+ ..++.++|||||||+++||++|..++........ ... ..    ....+.. ..
T Consensus       155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            22  11222346788999998865 4678999999999999999999777654332110 000 00    0000000 00


Q ss_pred             cccccCccc-----cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 AYELLSPAL-----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ~~~l~~~~l-----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .........     ...........+.+++..||+.+|++||++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000     001112335678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=300.38  Aligned_cols=248  Identities=24%  Similarity=0.428  Sum_probs=199.9

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccC---CCceeeEeeeEeecCeEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .|+..+.||+|+||.||+|+.. +++.||||.+... .....+++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778899999999999999974 6899999998754 3345567889999999996   999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++..    ..+++..+..++.|+++||.|||+.+   |+|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    36889999999999999999999987   999999999999999999999999999876443


Q ss_pred             CcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .  .......|+..|+|||.+.++ .++.++||||||+++|||++|..|+..........      .....     ..+.
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~~~~~-----~~~~  221 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------LIPKS-----KPPR  221 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------ccccC-----CCCC
Confidence            3  122334688999999998754 57899999999999999999999987543211100      00000     0111


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +...   .....+.+++..||+.+|++||++.|+++.
T Consensus       222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            1111   134567889999999999999999999863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=308.33  Aligned_cols=253  Identities=22%  Similarity=0.256  Sum_probs=201.5

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccCh---hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||++...+ ++.||||.+.....   ...+.+.+|++++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368899999999999999998764 89999999976432   24567899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999998532 3356899999999999999999999987   999999999999999999999999998765322


Q ss_pred             Ccc---------------------------cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          669 ELQ---------------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       669 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01112467889999999999899999999999999999999999987543


Q ss_pred             cccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCC----HHHHHH
Q 003287          722 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT----MSKVVS  783 (834)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~  783 (834)
                      .... +             .+.................+.+++.+||+.+|++||+    +.|+++
T Consensus       237 ~~~~-~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET-F-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH-H-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2211 0             0000000000011114567889999999999999999    666555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-33  Score=299.55  Aligned_cols=254  Identities=23%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee--cCeEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIY  588 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~  588 (834)
                      +|++.+.||.|+||.||++... +++.||+|++...  .....+++.+|++++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999865 5789999998643  33445678899999999999999999998764  44679999


Q ss_pred             EecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          589 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      ||+++++|.+++... .....+++..++.++.||++||+|||..+  ..+++|+||||+||+++.++.+||+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998543 22456899999999999999999999332  334999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .....  ......++..|+|||.+.+..++.++||||||+++++|++|+.|+...+....  ..    .....       
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~-------  225 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--AS----KIKEG-------  225 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH--HH----HHhcC-------
Confidence            43321  12234689999999999998899999999999999999999999875432111  00    00001       


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        .....+......+.+++.+|++.+|++||++.+|++.
T Consensus       226 --~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 --KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              1111223345678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=307.97  Aligned_cols=266  Identities=22%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             CccccceecccCccceEeeEecC---CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI  585 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  585 (834)
                      +|++.++||+|+||.||+|+...   ++.||||.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999754   7899999997633   33446778899999999999999999999988  7899


Q ss_pred             EEEEecCCCCchhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC----CCCeeeccc
Q 003287          586 LIYEYMPNKSLNFFLFDPS--RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----DMNPKISDF  659 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~----~~~vkl~DF  659 (834)
                      +||||+++ +|.+++....  ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999985 5656553321  2236889999999999999999999987   999999999999999    999999999


Q ss_pred             cccccccCCCc-ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccc-------cc
Q 003287          660 GMARMFCGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL-------GH  730 (834)
Q Consensus       660 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~-------~~  730 (834)
                      |+++.+..... ........++..|+|||++.+. .++.++||||||++++||++|+.|+...........       ..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987543221 1222345678899999988764 588999999999999999999999876543220000       00


Q ss_pred             cccccc-----------c-ccccc---c-----cC-ccccchhHH--HHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          731 AWNLWK-----------D-NRAYE---L-----LS-PALQHEASY--QMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       731 ~~~~~~-----------~-~~~~~---l-----~~-~~l~~~~~~--~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ....+.           . .+...   .     .. ..+......  .....+.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000           0 00000   0     00 000000111  23456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.3e-33  Score=297.64  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=201.3

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999875 688999999876544  3677899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++...   ..+++..+..++.++++||+|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999998542   35788999999999999999999987   99999999999999999999999999987644332


Q ss_pred             ccc--cccccccccccCcccccCCC---CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          671 QGN--TKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       671 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ...  .....++..|+|||++.+..   ++.++||||||++++||++|+.||...+........    . ...     ..
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~----~-~~~-----~~  224 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH----V-GAG-----HK  224 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH----H-hcC-----CC
Confidence            111  12346788999999998766   889999999999999999999998754311100000    0 000     01


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +.+..  .......+.+++..||+.+|++||++.|++.
T Consensus       225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111  1112445678999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-33  Score=296.83  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|+..+.||+|+||.||++... +++.+|||.+...  .....+.+.+|++++++++|||++++++.+..+...++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999875 5889999998654  234467899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-CeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~~~~~  669 (834)
                      +++++|.+++... ....+++..+..++.+++++|+|||+.+   ++|+||||+||+++.++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999543 2345889999999999999999999987   99999999999998654 57999999998764322


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......++..|+|||.+.+..++.++||||||+++++|++|+.|+...+....  ..   ... ....         
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~---~~~-~~~~---------  218 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VL---KIM-SGTF---------  218 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HH---HHH-hcCC---------
Confidence               12234678899999999988899999999999999999999999865432211  00   000 0000         


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..........+.+++..||+.+|++||++.|+++.
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00111234567889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.9e-34  Score=307.73  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=200.3

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .|.....||+|+||.||++... ++..||||.+........+.+.+|+..+++++|+||+++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            4444568999999999999875 588999999876655666789999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++..    ..+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  .
T Consensus       103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~  173 (292)
T cd06658         103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P  173 (292)
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence            9999998832    34789999999999999999999987   9999999999999999999999999997653322  1


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      ......++..|+|||.+.+..++.++||||||++++||++|+.|+........  ..    .     ......+....  
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~-----~~~~~~~~~~~--  240 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MR----R-----IRDNLPPRVKD--  240 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H-----HHhcCCCcccc--
Confidence            22335688999999999988999999999999999999999999864332110  00    0     00011111111  


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .......+.+++..|++.+|.+||++.|+++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11233457789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=300.80  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=200.8

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC------
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------  582 (834)
                      ++++|++.+.||+|+||.||+|+.. +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999985 578999999876443 446789999999999 7999999999997654      


Q ss_pred             eEEEEEEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999885422 2456889999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccC-----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      +.......  .......++..|+|||++..     ..++.++||||||++++||++|+.|+........ +..     ..
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~  231 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFK-----IP  231 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHH-----hh
Confidence            87653221  12233568899999998753     3477899999999999999999999864322110 000     00


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ...     .+.+  .........+.+++.+||+.+|++|||+.|+++
T Consensus       232 ~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000     0011  112234567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=302.61  Aligned_cols=262  Identities=24%  Similarity=0.326  Sum_probs=195.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67999999999999999999876 588999999865432 2234577899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++ +|.+++.+.  ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  157 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-  157 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence            985 888887543  236789999999999999999999987   9999999999999999999999999987542211 


Q ss_pred             ccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc--------ccccc---
Q 003287          671 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN--------LWKDN---  738 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~---  738 (834)
                       .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... ....+.        .+...   
T Consensus       158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHhcCCCChhhhhhhhhc
Confidence             11122346789999999876 45889999999999999999999998654311000 000000        00000   


Q ss_pred             -ccc----cccC-ccccchh-HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          739 -RAY----ELLS-PALQHEA-SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       739 -~~~----~l~~-~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       ...    .... ..+.... .......+.+++..|++.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             000    0000 0000000 0011256678999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.5e-34  Score=304.77  Aligned_cols=262  Identities=21%  Similarity=0.299  Sum_probs=195.0

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999975 58999999986532  22335678899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++ +|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            974 677766432  345899999999999999999999987   9999999999999999999999999998653221 


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccc----------ccccccccc--
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL----------GHAWNLWKD--  737 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~----------~~~~~~~~~--  737 (834)
                       .......++..|+|||++.+. .++.++|||||||++|||++|..|+.........+.          ...+.....  
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence             112234578899999998765 478999999999999999999988643221110000          000000000  


Q ss_pred             -cccccccCcccc-chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          738 -NRAYELLSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       738 -~~~~~l~~~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       ............ ..........+.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             000000000000 0111224567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-33  Score=301.13  Aligned_cols=264  Identities=22%  Similarity=0.313  Sum_probs=200.9

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999875 58999999987653  33456789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      + +++|.+++....  ..+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999885432  56899999999999999999999987   99999999999999999999999999987643321


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cc-cc-------cccccccc-cc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL-LG-------HAWNLWKD-NR  739 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~-~~-------~~~~~~~~-~~  739 (834)
                       .......++..|+|||.+.+. .++.++||||+|++++||++|..++........ .. ..       ..+..... ..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence             122335688999999998754 468999999999999999999777754322110 00 00       00000000 00


Q ss_pred             cccccCccc----cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 AYELLSPAL----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ~~~l~~~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+..+..    ......+....+.+++.+|++.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000    001112234678899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.1e-34  Score=307.00  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      |+...+||+|+||.||++... +++.||||.+........+.+.+|+.++..++||||+++++++..+...++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344558999999999999875 5899999998765555567788999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      ++|..++..    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..+....  ..
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~  173 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK  173 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence            999988732    45789999999999999999999987   9999999999999999999999999997653322  12


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....++..|+|||++.+..++.++|||||||+++||++|+.|+........  ..    .........     .  ...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~~~~-----~--~~~  240 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MK----RLRDSPPPK-----L--KNA  240 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHhccCCCC-----c--ccc
Confidence            2335688999999999998999999999999999999999999864332110  00    000000000     0  001


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ......+.+++..||+.+|++||++.++++.
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1223457789999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-34  Score=308.00  Aligned_cols=255  Identities=25%  Similarity=0.321  Sum_probs=204.1

Q ss_pred             HhccCccccceecccCccceEeeEecCCcEEEEEEecc--cChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  586 (834)
                      .....|+++++||+||.+.||++...+.+.+|+|++..  .+.+...-|++|+.+|.+| .|.+||+|++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            44578999999999999999999988888899997643  4667788999999999999 59999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||- ..+|..+|..... ....| .+..+..|++.|+.++|.++   |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99975 5688888865432 22234 77788999999999999998   99999999999884 5789999999999987


Q ss_pred             CCCcccccccccccccccCcccccCCC-----------CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGL-----------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      .+...-.....+||+.||+||.+....           .+.++||||||||||+|+.|+.||+.+...            
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------------  578 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------------  578 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------------
Confidence            776666666789999999999985432           567999999999999999999999853210            


Q ss_pred             cccccccccCccccchhHHH-HHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          736 KDNRAYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ..++..+.+|...-+++.. ....+.+++..||+.||.+||+..++|+-
T Consensus       579 -~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  579 -IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             0123334444331111100 01127889999999999999999999864

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.9e-33  Score=300.14  Aligned_cols=254  Identities=25%  Similarity=0.360  Sum_probs=205.7

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..++.|+..+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34577888999999999999999986 588999999976544 5677899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999996432  37899999999999999999999977   999999999999999999999999998765332


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .  .......++..|+|||++.+..++.++||||||+++|||++|+.|+..........      .........     .
T Consensus       170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~-----~  236 (286)
T cd06614         170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LITTKGIPP-----L  236 (286)
T ss_pred             h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcCCCC-----C
Confidence            1  11223457889999999998889999999999999999999999986533211100      000000000     0


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        .........+.+++..|++.+|.+||++.++++.
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              0111234568889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.9e-33  Score=293.26  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=205.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIY  588 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  588 (834)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999986 589999999876542  4567899999999999999999999999988  8999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++...   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998543   27899999999999999999999977   999999999999999999999999999877544


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      ..........++..|+|||.+....++.++||||||+++++|++|..|+...+.....    .+         .+.....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~---------~~~~~~~  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----LY---------KIGSSGE  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH----HH---------hccccCC
Confidence            3221233456889999999999888999999999999999999999998765411100    00         0000011


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ....+......+.+++.+|++.+|++||++.|+++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11122223567889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-33  Score=302.30  Aligned_cols=244  Identities=25%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999876 58999999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++...   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998543   56889999999999999999999987   999999999999999999999999999876433


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                           .....+++.|+|||.+.+...+.++||||||++++||++|+.|+...+....  ..    ....+.      .  
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~~------~--  215 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI--YE----KILEGK------V--  215 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHhcCC------c--
Confidence                 2334688999999999888899999999999999999999999865432110  00    000000      0  


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                        ..+......+.+++.+||+.+|.+||     ++.|+++
T Consensus       216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              01112245678899999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.3e-33  Score=302.48  Aligned_cols=246  Identities=29%  Similarity=0.433  Sum_probs=195.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +.|+..+.||+|+||+||+|+.. +++.||+|.+....   ....+++.+|+++++.++||||+++.+++.+....++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888999999999999999875 58999999986432   234467889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||++ |+|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 5666665322  245899999999999999999999987   999999999999999999999999998764321


Q ss_pred             CcccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                            ....++..|+|||++.   ...++.++||||||+++|||++|+.|+...+......     .. ....     .
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-----~~-~~~~-----~  231 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HI-AQND-----S  231 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-----HH-hcCC-----C
Confidence                  2345788999999884   4568899999999999999999999986543211100     00 0000     0


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +.+.   .......+.+++..||+.+|++||++.+++..
T Consensus       232 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1111   12244568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.9e-33  Score=298.78  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=199.9

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +|++.++||+|++|.||+|+.. +++.||||++..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999986 588999999876532 23466788999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++ +|.+++........+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            85 78888755444456899999999999999999999987   9999999999999999999999999997653221  


Q ss_pred             cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c-cc-------ccccccccccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LL-------GHAWNLWKDNRAY  741 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~-~~-------~~~~~~~~~~~~~  741 (834)
                      .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...+.... . ..       ...+..+......
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            112234568899999998664 578999999999999999999999875432211 0 00       0000000000000


Q ss_pred             cccCccc----cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ELLSPAL----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ~l~~~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ...-+..    ...........+.+++..|++.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000    01111233567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6e-33  Score=291.37  Aligned_cols=249  Identities=28%  Similarity=0.439  Sum_probs=204.2

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      +|++.+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999986 588999999987655567889999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985432  46899999999999999999999977   99999999999999999999999999987644321  


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                       .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...+.......      ...........       
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~-------  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------IATNGPPGLRN-------  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------HHhcCCCCcCc-------
Confidence             3345688999999999988899999999999999999999999875432110000      00000001111       


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......+.+++..||+.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1112456888999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.5e-33  Score=301.08  Aligned_cols=262  Identities=22%  Similarity=0.299  Sum_probs=196.6

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999875 58899999986542  22346788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++ ++|..++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 6788887543 2346889999999999999999999987   9999999999999999999999999987653221 


Q ss_pred             ccccccccccccccCcccccCCC-CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc--cc-------cccccccc---
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--LG-------HAWNLWKD---  737 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~~-------~~~~~~~~---  737 (834)
                       .......++..|+|||++.+.. ++.++||||||+++|||+||+.||..........  ..       ..+.....   
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             1122234678999999887654 6889999999999999999999986543211000  00       00000000   


Q ss_pred             --cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          738 --NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       738 --~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        .......... ...........+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              0000000000 00111123356778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.7e-33  Score=299.13  Aligned_cols=264  Identities=24%  Similarity=0.270  Sum_probs=195.5

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++|+||+++.+++.++...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999875 588999999865432 23346788999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||++ ++|..++...  ...+.+..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 6666666332  245778888999999999999999987   999999999999999999999999999764321


Q ss_pred             CcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc-----------
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK-----------  736 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------  736 (834)
                      .  .......++..|+|||++.+. .++.++|||||||++|||++|+.||........ .....+....           
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhh
Confidence            1  112234568899999998764 578899999999999999999999875432110 0000000000           


Q ss_pred             ----c-cccccccCccccchh--HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 ----D-NRAYELLSPALQHEA--SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ----~-~~~~~l~~~~l~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          . ........+......  .......+.+++.+|++.+|++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                0 000000000000000  0011346778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-33  Score=327.90  Aligned_cols=257  Identities=28%  Similarity=0.385  Sum_probs=195.2

Q ss_pred             HHhccCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEee------
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------  580 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------  580 (834)
                      ++...+|+.++.||+||||.|||++.+ ||+.+|||++... +........+|++++++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            566789999999999999999999875 8999999999765 34445678899999999999999999875532      


Q ss_pred             --------------------------------------------------------------------------------
Q 003287          581 --------------------------------------------------------------------------------  580 (834)
Q Consensus       581 --------------------------------------------------------------------------------  580 (834)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------c--------CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003287          581 -------------------------Q--------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY  627 (834)
Q Consensus       581 -------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  627 (834)
                                               +        ..+||-||||+...|.+++.+.....  .....++++++|+.||+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                     0        12578899999999988885432211  367889999999999999


Q ss_pred             HhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc----C------------CCcccccccccccccccCcccccC
Q 003287          628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC----G------------DELQGNTKRVVGTYGYMSPEYALD  691 (834)
Q Consensus       628 LH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~  691 (834)
                      +|+.+   ||||||||.||+|+++..|||+|||+|....    .            .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99998   9999999999999999999999999998721    0            011123455789999999999976


Q ss_pred             C---CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhccc
Q 003287          692 G---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCV  768 (834)
Q Consensus       692 ~---~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl  768 (834)
                      .   +|+.|+|+|||||||+||+.   ||+...+... .+.    .++.+.+..-      .+........-+.+|.+++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~-iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS-ILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHH-HHH----hcccCCCCCC------cccccccchHHHHHHHHHh
Confidence            4   49999999999999999985   4554322211 111    1111111111      1122233344567999999


Q ss_pred             ccCcCCCCCHHHHHHH
Q 003287          769 QEKAADRPTMSKVVSM  784 (834)
Q Consensus       769 ~~~P~~RPs~~evl~~  784 (834)
                      +.||.+|||+.|++..
T Consensus       856 ~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLNS  871 (1351)
T ss_pred             cCCCccCCCHHHHhhc
Confidence            9999999999999864

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.4e-33  Score=296.90  Aligned_cols=247  Identities=25%  Similarity=0.277  Sum_probs=201.0

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      +|++.+.||.|+||.||+++.. +++.||+|.+.+..   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999986 48999999997542   2346789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998432   46889999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+............   .....          ..
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~----------~~  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQET----------AD  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH---HHhcc----------cc
Confidence               223356788999999999888999999999999999999999998754432110000   00000          00


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCH--HHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTM--SKVV  782 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~--~evl  782 (834)
                      ...+......+.+++.+||+.+|.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11112234678889999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=330.20  Aligned_cols=263  Identities=30%  Similarity=0.437  Sum_probs=209.3

Q ss_pred             HHhccCccccceecccCccceEeeEecC--------CcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeE
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCC  578 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  578 (834)
                      +...++..+.+.||+|.||.|++|....        ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3344556677799999999999997531        3579999998653 34667899999999999 799999999999


Q ss_pred             eecCeEEEEEEecCCCCchhhhcCCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 003287          579 VEQGEKILIYEYMPNKSLNFFLFDPS-----------RT--HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  645 (834)
Q Consensus       579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~N  645 (834)
                      ...+..++|+||+++|+|..+|+..+           ..  ..+...+.+.++.|||+|++||++..   +|||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence            99999999999999999999997544           01  23889999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeeeccccccccccCCCccccc-ccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcc
Q 003287          646 ILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIE  723 (834)
Q Consensus       646 ILl~~~~~vkl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~  723 (834)
                      ||+.++..+||+|||+|+........... ....-+..|||||.+....|+.|+|||||||+||||+| |..|+......
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999976655443322 21114667999999999999999999999999999999 56676542211


Q ss_pred             cccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          724 SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       724 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                                    .++.+.+.+..+.+.+..+..++.+++..||+.+|++||++.++++.|+..
T Consensus       529 --------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 --------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                          011111222222223333456778899999999999999999999999884

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7e-33  Score=298.20  Aligned_cols=248  Identities=24%  Similarity=0.345  Sum_probs=199.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3445579999999999999864 688999999876555556778999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++..    ..+++.++..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999999854    45889999999999999999999987   99999999999999999999999999876543221  


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      ......|+..|+|||.+.+..++.++||||||++++||++|+.|+........  ..    .....     ..+...  .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~--~~----~~~~~-----~~~~~~--~  237 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--MK----RIRDN-----LPPKLK--N  237 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH--HH----HHHhc-----CCCCCc--c
Confidence            12234588999999999988999999999999999999999999764321110  00    00000     000110  0


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1113356889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.7e-33  Score=299.97  Aligned_cols=263  Identities=23%  Similarity=0.294  Sum_probs=197.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV  587 (834)
                      ++|++.+.||+|+||.||+|+.. +++.+|||.++...  ......+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57889999999999999999986 48899999986543  22234577899999999999999999999877  899999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 888887542  236899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc--------ccccccc--
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------GHAWNLW--  735 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~--------~~~~~~~--  735 (834)
                      ..  .......++..|+|||.+.+. .++.++|+||||++++||++|..|+........ ...        ...|..+  
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            32  112234578899999998764 468999999999999999999999875432110 000        0000000  


Q ss_pred             ----cccccccccCccccchhHHH-HHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          736 ----KDNRAYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       736 ----~~~~~~~l~~~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          ............+....... ....+.+++.+||+.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                00000000000111111111 3556788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.2e-33  Score=300.14  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=196.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|+..+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.++. |+||+++++++.++...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35667789999999999999875 48999999987543 344567899999999996 9999999999999999999999


Q ss_pred             ecCCCCchhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          590 YMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       590 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |++. +|.++...  ......+++..+..++.|+++||+|||+..  +++||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 44443211  112356899999999999999999999752  399999999999999999999999999976543


Q ss_pred             CCcccccccccccccccCcccccCC---CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ..   ......++..|+|||++.+.   .++.++|||||||++|||++|+.||......    .......      ....
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~------~~~~  227 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQV------VKGD  227 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhh------cCCC
Confidence            22   11233578899999999876   6899999999999999999999998754310    0000000      0001


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+.+.......+...+.+++.+||+.+|++||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112222223355678899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-33  Score=298.89  Aligned_cols=262  Identities=22%  Similarity=0.312  Sum_probs=196.2

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      |++.+.||+|++|.||+|... +|+.||||++....  ....+.+.+|++++++++|+|++++++++.++...+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999875 68999999987543  223467889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      + ++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||+++......  
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--  153 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--  153 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence            5 68888885432 246899999999999999999999987   9999999999999999999999999997643221  


Q ss_pred             cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc--cccc-------cccccccc-ccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLG-------HAWNLWKD-NRA  740 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~-------~~~~~~~~-~~~  740 (834)
                      .......++..|+|||++.+. .++.++||||||+++|||++|+.||...+....  ....       ..+..... ...
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            111223568899999988764 578999999999999999999999865432110  0000       00000000 000


Q ss_pred             ---ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          741 ---YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       741 ---~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         ...................+.+++.+|++.+|++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               0000000001112223457889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-33  Score=306.21  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=208.1

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .....|.+..+||+|.|++|.+++.. .+..||||.+.+..  ....+.+.+|+++|..|+|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34567999999999999999999875 59999999998753  3344668999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+.+|.+.+++.+..   .+.+.++..++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            999999999999996543   3455888899999999999999998   9999999999999999999999999999875


Q ss_pred             CCCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .   .......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+....                  .++-+
T Consensus       207 ~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------k~Lr~  265 (596)
T KOG0586|consen  207 Y---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------KELRP  265 (596)
T ss_pred             c---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------------------ccccc
Confidence            3   334456789999999999998876 5799999999999999999999985332                  12222


Q ss_pred             ccccc--hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +.+..  ..+.-+..++.++++.+|-.+|.+|++++++.+-
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            22221  2233345578889999999999999999998764

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-33  Score=306.32  Aligned_cols=269  Identities=22%  Similarity=0.320  Sum_probs=200.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-----eE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~  584 (834)
                      +++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 58999999986532 334567889999999999999999999876543     57


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++|+||+++ +|..++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 7776663    346899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc---ccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK---DNR  739 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~  739 (834)
                      ....... .......++..|+|||++.+ ..++.++|||||||+++||++|+.||...+....  .........   .+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~~~~~~~~~~~~  233 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLILGVLGTPSQED  233 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHHH
Confidence            5432211 12233568899999998765 5689999999999999999999999865332110  000000000   000


Q ss_pred             cccccC-------------cccc-chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcccC
Q 003287          740 AYELLS-------------PALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEHA  790 (834)
Q Consensus       740 ~~~l~~-------------~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~  790 (834)
                      ...+.+             +... ..........+.+++.+||+.+|++||++.|+++.  |+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            000000             0000 00112235668899999999999999999999986  655543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-32  Score=292.44  Aligned_cols=242  Identities=25%  Similarity=0.334  Sum_probs=194.4

Q ss_pred             ecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ||.|+||.||+++... ++.||+|++....   ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            7999999999999864 8999999986542   23456799999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      .+++.+.   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||+++......   ....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            9999542   35889999999999999999999987   9999999999999999999999999998764332   2223


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+......            ...+.......+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN------------DILKGNGKLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH------------HHhccCCCCCCCccc
Confidence            46788999999998888999999999999999999999998765421111110            000000011111122


Q ss_pred             HHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          757 LNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                      ...+.+++.+||+.+|++||+     +.|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            457889999999999999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.6e-33  Score=299.12  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=195.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCe-----
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE-----  583 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-----  583 (834)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....  ......+.+|+.+++++ +|+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999975 58999999886542  22346788899999999 46999999999987665     


Q ss_pred             EEEEEEecCCCCchhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeecccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFG  660 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFG  660 (834)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78887754322  346899999999999999999999987   999999999999998 8999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc--ccc-------c
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--LLG-------H  730 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~-------~  730 (834)
                      +++.+....  .......+++.|+|||++.+ ..++.++||||||+++|||++|..||.........  +..       .
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            998653221  11122346788999998865 45799999999999999999999998754321100  000       0


Q ss_pred             cccccccc-cccc--ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          731 AWNLWKDN-RAYE--LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       731 ~~~~~~~~-~~~~--l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+...... ...+  ...+.............+.+++..||+.+|.+||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000 0000  00000001111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.6e-32  Score=304.81  Aligned_cols=261  Identities=24%  Similarity=0.254  Sum_probs=197.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------C
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  582 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++...  .....+++.+|+.++++++|+||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            478999999999999999999875 5899999998653  233456778899999999999999999988643      3


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++ +|.+.+..     .++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            57999999964 77777632     2788899999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c-c---c---------
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-L---L---------  728 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~-~---~---------  728 (834)
                      +......   ......++..|+|||.+.+..++.++|||||||++++|++|+.||...+.... . +   .         
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8653322   12234578899999999999999999999999999999999999875432110 0 0   0         


Q ss_pred             --ccccc-ccc------ccccccccCccc----cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          729 --GHAWN-LWK------DNRAYELLSPAL----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       729 --~~~~~-~~~------~~~~~~l~~~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ..... ...      .....++.....    ...........+.+++.+||+.+|++||++.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              00000 000      000001111111    011122335567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.7e-33  Score=293.40  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|+||.||++... ++..||+|.+....  ....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999986 48899999986532  23456788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC-eeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-vkl~DFGla~~~~~~~  669 (834)
                      +++++|.+++.+.. ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999985432 235789999999999999999999987   999999999999998864 6999999998764322


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                      .  ......|+..|+|||++.+..++.++||||||++++||++|..|+........     ...... ..    ..+   
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-~~----~~~---  221 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-----VLKICQ-GY----FAP---  221 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhc-cc----CCC---
Confidence            1  12234588899999999988899999999999999999999999864332111     000000 00    000   


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ........+.+++.+|++.+|++||++.|+++.
T Consensus       222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              111223467889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-32  Score=300.87  Aligned_cols=262  Identities=23%  Similarity=0.268  Sum_probs=195.1

Q ss_pred             ceeccc--CccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|  +||+||++++. .++.||||++...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            467777  89999999875 6899999998653  233457789999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc-
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-  672 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-  672 (834)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999886532 235889999999999999999999987   9999999999999999999999998654332111100 


Q ss_pred             ----ccccccccccccCcccccCC--CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc---cc--------
Q 003287          673 ----NTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN---LW--------  735 (834)
Q Consensus       673 ----~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~--------  735 (834)
                          ......++..|+|||++.+.  .++.++|||||||+++||++|+.|+................   .+        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112346679999999764  47899999999999999999999987543211100000000   00        


Q ss_pred             --------------------cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          736 --------------------KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       736 --------------------~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                                          .........+..+.......+...+.+|+.+||+.+|++|||+.|+++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                0000001111122223344566788999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=297.69  Aligned_cols=260  Identities=15%  Similarity=0.175  Sum_probs=184.8

Q ss_pred             ccCccccceecccCccceEeeEecC----CcEEEEEEecccChhh-----------HHHHHHHHHHHhccCCCceeeEee
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQG-----------LKEFKNEMMLIAKLQHRNLVRLMG  576 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~~  576 (834)
                      .++|++.++||+|+||+||+|+..+    +..+|+|+........           ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3689999999999999999998754    3456777543222111           011233445566779999999999


Q ss_pred             eEeecC----eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          577 CCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       577 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            876554    34677777643 45555422   223567888999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCc-----ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc
Q 003287          653 NPKISDFGMARMFCGDEL-----QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL  727 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~  727 (834)
                      .++|+|||+++.+.....     ........||+.|+|||++.+..++.++|||||||+++||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999987643211     111223469999999999999999999999999999999999999997653221100


Q ss_pred             cccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       728 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      .....     +-...+......   .......+.+++..|++.+|++||++.++++.|+
T Consensus       244 ~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKC-----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHH-----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            00000     000111111110   1122456888999999999999999999999874

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=290.82  Aligned_cols=250  Identities=27%  Similarity=0.378  Sum_probs=197.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  584 (834)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+...     ..+....+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999875 5899999987532     233456789999999999999999999998764  468


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998843   234788999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ....... .......++..|+|||++.+..++.++|||||||+++||++|+.||........              ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~  221 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--------------IFKI  221 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--------------HHHH
Confidence            5322111 111234688999999999988899999999999999999999999864321110              0000


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .........+......+.+++.+|++ +|..||+..+++.
T Consensus       222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            00001111233345668889999999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=307.01  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +.|+++..||.|+||.|||+..++ +-..|-|++...+.+..+.|+-|+++|+.++||+||+|++.|..++.++|+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            457888899999999999998765 4456788888778888899999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      .||-.+.++..  -.+.|.+.++..+++|++.||.|||+..   |||||||+.|||++-+|.++|+|||.+....  ...
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR  184 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence            99999988854  3467899999999999999999999998   9999999999999999999999999986532  222


Q ss_pred             cccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          672 GNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .......||+.|||||+..     +.+|+.++||||||++|.||.-+.+|......-...+      .+...+...++. 
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll------KiaKSePPTLlq-  257 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSEPPTLLQ-  257 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH------HHhhcCCCcccC-
Confidence            3345678999999999874     5689999999999999999999999866433221100      111122222332 


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                            +......+.+++..||..+|..||++.++++
T Consensus       258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  2345567788999999999999999999886

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-32  Score=298.68  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=196.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +.|+..+.||+|+||.||+++.. +++.||+|++....   ......+.+|++++++++|+|++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34778899999999999999875 58899999986432   234467889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++ +|.+++...  ...+++.++..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99974 676666432  345889999999999999999999987   99999999999999999999999999875432 


Q ss_pred             CcccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                           .....++..|+|||++.   .+.++.++|||||||+++||++|+.|+........  .            .....
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~------------~~~~~  238 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L------------YHIAQ  238 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H------------HHHHh
Confidence                 22346788999999974   45689999999999999999999999764321110  0            00000


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ..............+.+++.+||+.+|.+||++.++++.+--.
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            0000011112345678899999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=295.81  Aligned_cols=262  Identities=25%  Similarity=0.339  Sum_probs=197.6

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIYE  589 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E  589 (834)
                      |++.+.||+|+||.||+|+.. +++.+|+|++....  ......+.+|+.++++++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999876 48899999997653  33446788999999999999999999999988  89999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 788887433  246899999999999999999999987   9999999999999999999999999998764432


Q ss_pred             cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cc-c-------ccccccccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL-L-------GHAWNLWKDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~-~-------~~~~~~~~~~~  739 (834)
                      . .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ .. .       ...+..+..-.
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            1 11223456788999998765 4588999999999999999999999875442110 00 0       00000000000


Q ss_pred             ccccc------CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AYELL------SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~~l~------~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .....      ...+.......+...+.+++..||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00000      000001111112567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.9e-32  Score=292.36  Aligned_cols=259  Identities=21%  Similarity=0.291  Sum_probs=193.1

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccC-CCceeeEeeeEeec--CeEEEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKILIYE  589 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E  589 (834)
                      |++.++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999875 58899999987642 222334567888999885 99999999999987  89999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |++ ++|.+++...  ...+++.++..++.|+++||+|||+.+   ++||||||+||+++. +.+||+|||+++.+....
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5777777432  246899999999999999999999987   999999999999999 999999999998764322


Q ss_pred             cccccccccccccccCccccc-CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c----ccccccc----cccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N----LLGHAWN----LWKDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~----~~~~~~~----~~~~~~  739 (834)
                      .   .....++..|+|||++. ++.++.++|||||||++|||++|..||...+..+. .    .......    ......
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            1   12245788999999765 45678999999999999999999999875432110 0    0000000    000000


Q ss_pred             cccccCcccc----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AYELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~~l~~~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......+...    .......+..+.+++..||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000    0112234678899999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-32  Score=298.71  Aligned_cols=265  Identities=25%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  586 (834)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|+.++.+++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999975 58999999986432  22234567899999999999999999998765  46899


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++ +|.+++...  ...+++.++..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 787777432  256899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc--------cccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------GHAWNLWK  736 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~--------~~~~~~~~  736 (834)
                      ...  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... ...        ...+..+.
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            322  11222345788999999875 4688999999999999999999999875432111 000        00000000


Q ss_pred             cc---ccccccCcccc--chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          737 DN---RAYELLSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       737 ~~---~~~~l~~~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .-   ....+......  ..........+.+++..|++.||++||++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00   00000000000  00011124567789999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-33  Score=307.95  Aligned_cols=246  Identities=26%  Similarity=0.353  Sum_probs=192.4

Q ss_pred             cccceecccCccceEeeEec-CCcEEEEEEecc----cChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe--EEEEE
Q 003287          516 SMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE--KILIY  588 (834)
Q Consensus       516 ~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~  588 (834)
                      +...+||+|+|-+||||.+. +|.+||--.++.    .++...++|..|+.+|+.|+|+||++++..+.+...  ..+|.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999875 376776433321    245567899999999999999999999999987765  78999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~~~~  667 (834)
                      |.|..|+|..|+.+.   +.++.+.+..|++||++||.|||++. ++|||||||-.||+|+. -|.|||+|.|||.....
T Consensus       123 EL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999544   45778899999999999999999986 68999999999999975 58999999999998643


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .    ....+.|||.|||||... ..|++.+||||||+.++||+|+..|+..-..     ..+.+..+..+.-...+.. 
T Consensus       199 s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SGiKP~sl~k-  267 (632)
T KOG0584|consen  199 S----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSGIKPAALSK-  267 (632)
T ss_pred             c----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcCCCHHHhhc-
Confidence            3    233478999999999776 7899999999999999999999999763211     1111111111111111110 


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                             -.-..+.++|..|+.. .++||++.|+|+-
T Consensus       268 -------V~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  268 -------VKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -------cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                   0123567899999999 9999999999964

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.1e-32  Score=293.14  Aligned_cols=244  Identities=25%  Similarity=0.339  Sum_probs=191.8

Q ss_pred             ecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ||+|+||+||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 58899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      .+++..... ..+++.++..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            999864322 46889999999999999999999987   999999999999999999999999998765331   11223


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      ..++..|+|||++.+..++.++||||||++++||++|+.||..........      ..... ...     .....+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-~~~-----~~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------ELKRR-TLE-----MAVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------HHHhc-ccc-----ccccCCccC
Confidence            457889999999988889999999999999999999999986543211000      00000 000     001111223


Q ss_pred             HHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          757 LNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      ...+.+++..||+.+|++||     ++.++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            45678899999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-32  Score=290.50  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=203.4

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.++||+|+||.||+++.. +++.+|+|.+....  .....++.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 57899999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      +++++|.+++.+. .....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998542 22356889999999999999999999987   999999999999999999999999999876443 


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......++..|+|||.+.+..++.++|+||||++++||++|+.|+...+......      .....         ..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~~---------~~  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY------KVQRG---------KY  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhcC---------CC
Confidence               1222457889999999999999999999999999999999999987544321100      00001         11


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..........+.+++..|++.+|++||++.|+++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1122244567889999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.5e-33  Score=292.97  Aligned_cols=247  Identities=24%  Similarity=0.312  Sum_probs=197.3

Q ss_pred             ecccCccceEeeEecC-CcEEEEEEecccCh---hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ||+|+||.||+++... ++.+|+|.+.....   ...+.+.+|+.++.+++|+||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999864 89999999875433   4567789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc------
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL------  670 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~------  670 (834)
                      .+++.+.   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998543   36899999999999999999999987   99999999999999999999999999876533211      


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      ........++..|+|||.+.....+.++||||||++++||++|..|+.........  .    ....+..        ..
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~----~~~~~~~--------~~  220 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF--Q----NILNGKI--------EW  220 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHhcCCc--------CC
Confidence            11223356788999999999888999999999999999999999998754322110  0    0000000        00


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            0000124567889999999999999999777776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=290.70  Aligned_cols=244  Identities=22%  Similarity=0.249  Sum_probs=190.1

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccCh---hhHHHHHHHHHH-HhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMML-IAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.||+|+||.||+|+.. +++.||||.+.+...   .....+..|..+ ....+|+|++++++++.+++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 589999999875432   222334555544 4455899999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      ++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999853   245889999999999999999999987   99999999999999999999999999876432      


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                      .....++..|+|||.+.+..++.++||||||++++||++|..|+........      .........      .......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~------~~~~~~~  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRRI------NWPEEVK  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhccc------CCCCccc
Confidence            2234578899999999988899999999999999999999999865432211      000000000      0001111


Q ss_pred             HHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          754 YQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       754 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ..+...+.+++.+||+.+|++||++.++.+.|+
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            123456889999999999999998877766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=294.33  Aligned_cols=248  Identities=25%  Similarity=0.312  Sum_probs=203.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +.|+.-++||+|+||.||-++.. .|+.+|.|++.+.   ..+.....++|-++|.+++.+.||.+--.++..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56788889999999999999865 5899999988654   2345566789999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ..|.+|+|..+|.+... ..++++.++-++.+|+-||++||...   ||.|||||+|||||+.|+++|+|.|||..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999977644 67999999999999999999999987   999999999999999999999999999987544


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      ..   ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||.......           +.+++.+.+. ..
T Consensus       341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----------k~eEvdrr~~-~~  405 (591)
T KOG0986|consen  341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----------KREEVDRRTL-ED  405 (591)
T ss_pred             Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----------hHHHHHHHHh-cc
Confidence            32   223489999999999999999999999999999999999999997543210           1111111000 00


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMS  779 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  779 (834)
                      ...++..++++..+|....|+.||++|.--.
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            1234456677888899999999999996443

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.4e-32  Score=293.11  Aligned_cols=242  Identities=24%  Similarity=0.297  Sum_probs=186.2

Q ss_pred             eecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHH---hccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          520 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLI---AKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .||+|+||.||+++.. +++.+|||.+.+..   ......+.+|..++   ...+|+|++.+++++.+.+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58899999886532   12223344554433   34479999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988853   345899999999999999999999987   9999999999999999999999999997653221   


Q ss_pred             ccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       .....|+..|+|||.+.. ..++.++|||||||+++||++|..||.............       .  .....    ..
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-------~--~~~~~----~~  217 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------M--TLTVN----VE  217 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-------H--hhcCC----cC
Confidence             123468999999999864 568999999999999999999999986533211110000       0  00001    11


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  784 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~  784 (834)
                      .+......+.+++..||+.+|++||     +++|+++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1223446788899999999999999     58888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-32  Score=317.62  Aligned_cols=268  Identities=19%  Similarity=0.285  Sum_probs=186.7

Q ss_pred             hccCccccceecccCccceEeeEecC--CcEEEEE------------------EecccChhhHHHHHHHHHHHhccCCCc
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVK------------------RLSSQSGQGLKEFKNEMMLIAKLQHRN  570 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~--g~~vAVK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n  570 (834)
                      ..++|+++++||+|+||+||++....  +..+++|                  .+. ........+.+|+.++.+++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34789999999999999999987532  2222222                  111 12234566889999999999999


Q ss_pred             eeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE
Q 003287          571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  648 (834)
Q Consensus       571 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl  648 (834)
                      |+++++++.+.+..++|+|++. ++|.+++.....  ........+..++.||+.||+|||+.+   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 456666543211  122345667889999999999999987   9999999999999


Q ss_pred             cCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCC-CCCCCccc-cc
Q 003287          649 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIES-FN  726 (834)
Q Consensus       649 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p-~~~~~~~~-~~  726 (834)
                      +.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +....... ..
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987643221 122235789999999999999999999999999999999998754 33221111 00


Q ss_pred             cccccc--ccccc------cccccccCc--------cccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          727 LLGHAW--NLWKD------NRAYELLSP--------ALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       727 ~~~~~~--~~~~~------~~~~~l~~~--------~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +.....  ....+      .+..+.++.        .+... ........+.+++.+||+.||.+||++.|+++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            000000  00000      000000000        00000 000122356778999999999999999999863

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=287.53  Aligned_cols=247  Identities=29%  Similarity=0.396  Sum_probs=202.0

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|++|.||+++.. +++.||+|.+.....  ...+.+.+|++++.+++|+|++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999875 578999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998433   56899999999999999999999987   99999999999999999999999999987644322


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      .  .....++..|+|||...+..++.++||||+|++++||++|..|+........     .+.... ..     .    .
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~-~~-----~----~  217 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRIVQ-DD-----H----P  217 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhc-cC-----C----C
Confidence            1  2334678899999999888899999999999999999999999864331110     000000 00     0    0


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+......+.+++.+||+.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            111122456778999999999999999999884

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-32  Score=302.96  Aligned_cols=265  Identities=25%  Similarity=0.318  Sum_probs=197.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec--CeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ--GEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~~  585 (834)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.++.++ +|+||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            468999999999999999999876 5889999988543  233456678899999999 999999999998654  3689


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||++ ++|..++..    ..+.+..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 588888743    26788999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCcc---cccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cccccc--------c
Q 003287          666 CGDELQ---GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHA--------W  732 (834)
Q Consensus       666 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~--------~  732 (834)
                      ......   .......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ......        +
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            433221   12233568899999998865 4678999999999999999999999865432110 000000        0


Q ss_pred             ccccccccccccCc----cc--cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          733 NLWKDNRAYELLSP----AL--QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       733 ~~~~~~~~~~l~~~----~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..+.......+++.    ..  ...........+.+++.+||+.+|++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000000000000    00  001111235678899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.8e-32  Score=287.62  Aligned_cols=251  Identities=23%  Similarity=0.367  Sum_probs=204.7

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+++++.++|+|++++++.+.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999975 58899999987643  24567789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      +++++|.+++.... ....+++.++..++.++++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986432 2367899999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                        .......+++.|+|||...+..++.++||||+|+++++|++|+.|+........  ..    .......         
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~----~~~~~~~---------  220 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL--AL----KILKGQY---------  220 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH--HH----HHhcCCC---------
Confidence              122334688899999999998999999999999999999999999865432111  00    0000000         


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+......+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            01111334567889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-32  Score=289.22  Aligned_cols=248  Identities=22%  Similarity=0.238  Sum_probs=191.5

Q ss_pred             HHHHhccCcccccee--cccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          507 SVSAATENFSMQCKL--GEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       507 ~~~~~~~~f~~~~~l--G~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      +.....++|++.+.+  |+|+||.||+++.. +++.+|+|.+........     |+.....+ +|+||+++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445677777776  99999999999875 578899999865322111     22222222 7999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-Ceeeccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGM  661 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGl  661 (834)
                      ..++||||+++++|.+++...   ..+++.++..++.|+++||+|||+.+   ++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999998533   37899999999999999999999987   99999999999999998 999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ++.....      ....++..|+|||++.+..++.++||||||++++||++|+.|+.....+.........     .   
T Consensus       157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~---  222 (267)
T PHA03390        157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK-----R---  222 (267)
T ss_pred             ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH-----h---
Confidence            8765322      2245789999999999999999999999999999999999998744332221111100     0   


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCC-HHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-MSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~  783 (834)
                        ....  ..........+.+++.+||+.+|.+||+ ++|+++
T Consensus       223 --~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        223 --QQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --hccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence              0000  0111134556888999999999999995 688874

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.2e-32  Score=296.13  Aligned_cols=266  Identities=23%  Similarity=0.350  Sum_probs=193.2

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      .++|++.++||+|+||.||+++.. +++.||||++....  ......+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999875 58999999886432  222345678999999999999999999987654      


Q ss_pred             --eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          583 --EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                        ..++||||+++ +|.+++..  ....+++.++..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999975 67777643  2235899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcc--cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccc----
Q 003287          661 MARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAW----  732 (834)
Q Consensus       661 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~----  732 (834)
                      ++..+......  .......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ .......    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99866432211  112234578899999988764 478899999999999999999998865432110 0000000    


Q ss_pred             -cccccc---cccc-ccCccccc-hh-----HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          733 -NLWKDN---RAYE-LLSPALQH-EA-----SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       733 -~~~~~~---~~~~-l~~~~l~~-~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       ..+...   ...+ ...+.... ..     .......+.+++.+||+.+|++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             000000   0000 00000000 00     0011245678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-34  Score=333.13  Aligned_cols=257  Identities=28%  Similarity=0.361  Sum_probs=206.0

Q ss_pred             HHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          508 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       508 ~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      ++.-+-++.-..+||.|.||.||-+... +|.-.|||-++...  ........+|+.++..++|||+|+++|+-.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            3444567777889999999999999864 58889999876543  33456678899999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +|.||||++|+|.+.+.   ..+..++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            99999999999999994   3344666667778899999999999998   99999999999999999999999999998


Q ss_pred             ccCCC--cccccccccccccccCcccccCCC---CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          665 FCGDE--LQGNTKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       665 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +.+..  .........||+.|||||++.+..   ..-++||||+|||+.||+||++||..++.+-.-...     +..++
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-----V~~gh 1458 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-----VAAGH 1458 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-----HhccC
Confidence            86552  233445678999999999997643   567899999999999999999999876643211110     11111


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .         +..+......=.+++.+||+.||++|-++.|+++.
T Consensus      1459 ~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 K---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1         12223355566789999999999999888877764

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=5.3e-32  Score=295.45  Aligned_cols=264  Identities=21%  Similarity=0.240  Sum_probs=195.3

Q ss_pred             cccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          516 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       516 ~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      .+.+.+|.|+++.||+++. +++.||||++...  .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3444555566666666555 6899999998754  344567899999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc---
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL---  670 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~---  670 (834)
                      ++|.+++.... ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+..+.....   
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999986432 235788999999999999999999987   99999999999999999999999999876532211   


Q ss_pred             --ccccccccccccccCcccccCC--CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccc---cccccccccc-----
Q 003287          671 --QGNTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL---GHAWNLWKDN-----  738 (834)
Q Consensus       671 --~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~-----  738 (834)
                        ........++..|+|||++...  .++.++|||||||+++||++|+.||...........   ......+...     
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence              1112234567889999998763  588999999999999999999999875432111000   0000000000     


Q ss_pred             --cccc----ccCcc----ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          739 --RAYE----LLSPA----LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       739 --~~~~----l~~~~----l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ....    ..++.    ........+...+.+++..||+.+|++||+++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              0000    00000    1112233455678899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=2.2e-32  Score=295.45  Aligned_cols=244  Identities=23%  Similarity=0.326  Sum_probs=196.7

Q ss_pred             cceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          518 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ..+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+|++++++++.+.+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            368999999999999875 6899999998665555667799999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      .+++..    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......  .....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            998732    35789999999999999999999987   9999999999999999999999999987654322  12233


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      ..++..|+|||.+.+..++.++||||||+++|||++|..|+........  ..    ...     +...+.+..  ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~~----~~~-----~~~~~~~~~--~~~~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MK----MIR-----DNLPPKLKN--LHKV  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHH-----hhCCcccCC--cccC
Confidence            5678999999999888899999999999999999999999864332110  00    000     000000000  0112


Q ss_pred             HHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          757 LNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ...+.+++.+||+.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            345678999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=9e-32  Score=289.13  Aligned_cols=261  Identities=24%  Similarity=0.367  Sum_probs=194.6

Q ss_pred             ccccceecccCccceEeeEecC-CcEEEEEEecccCh--hhHHHHHHHHHHHhcc---CCCceeeEeeeEeecCe-----
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--QGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGE-----  583 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----  583 (834)
                      |++.+.||+|+||.||+|+... ++.||||++.....  .....+.+|+.++.++   +|+|++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999864 89999999974322  2234566787777666   69999999999998776     


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .+++|||+++ +|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            9999999974 7888775432 235899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c-ccc-------ccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLG-------HAWNL  734 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~-~~~-------~~~~~  734 (834)
                      .+....   ......++..|+|||++.+..++.++||||||++++||++|..|+........ . ...       ..+..
T Consensus       156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            764322   11223578899999999999999999999999999999999988865432110 0 000       00000


Q ss_pred             cc--ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          735 WK--DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       735 ~~--~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..  .........+.............+.+++.+||+.+|.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00  00000000000011222344567789999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=4.7e-32  Score=292.96  Aligned_cols=265  Identities=22%  Similarity=0.306  Sum_probs=195.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|++.+.||+|++|+||+|+.. +++.||||++....  ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            47899999999999999999876 58899999986542  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeeccccccccccCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGD  668 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~~~~~  668 (834)
                      |++ ++|.+++... ....+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 4677766432 2234578888899999999999999987   999999999999985 567999999999765322


Q ss_pred             CcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc--c---cc-cccccccc---
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--L---GH-AWNLWKDN---  738 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~---~~-~~~~~~~~---  738 (834)
                      .  .......++..|+|||++.+. .++.++||||||+++|||++|+.|+..........  .   .. ....|...   
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            1  112234568899999998764 57899999999999999999999987543211000  0   00 00000000   


Q ss_pred             ----ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          739 ----RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       739 ----~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          .......+.............+.+++.+|++.+|++||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000000000001112234567889999999999999999999863

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=2.2e-32  Score=301.64  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=199.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec-----Ce
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  583 (834)
                      ..+|++.+.||+|+||+||+++.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357999999999999999999875 5899999998753  233455678899999999999999999988654     35


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++|+||+. ++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 678877743   346899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-cccc----cc----ccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLL----GH----AWN  733 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~----~~----~~~  733 (834)
                      ......  .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+... ....    ..    .+.
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            654321  12233457889999998865 468999999999999999999999986543110 0000    00    000


Q ss_pred             cccccccc-------cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcc
Q 003287          734 LWKDNRAY-------ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  788 (834)
Q Consensus       734 ~~~~~~~~-------~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~  788 (834)
                      ........       ...++.. ..........+.+++.+||+.+|++||++.|+++.  |+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            00000000       0000000 01112345678899999999999999999999976  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=5.2e-32  Score=290.40  Aligned_cols=261  Identities=24%  Similarity=0.334  Sum_probs=199.9

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      |++.+.||+|++|.||+++.. +++.+|+|++.....  .....+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999875 588999999875432  24567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++ +|.+++...  ...+++..+..++.|+++||+|||+.+   |+|+||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 777777442  246899999999999999999999987   9999999999999999999999999998764432  


Q ss_pred             cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc--------ccccccccc---c
Q 003287          672 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------GHAWNLWKD---N  738 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~--------~~~~~~~~~---~  738 (834)
                      .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...+..+. ...        ...+.....   .
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            112234578899999998876 789999999999999999999999865442110 000        000000000   0


Q ss_pred             ccccccCccc--cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          739 RAYELLSPAL--QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       739 ~~~~l~~~~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......+...  ...........+.+++..||+.+|.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000000  01223345678899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=3.1e-32  Score=300.18  Aligned_cols=266  Identities=20%  Similarity=0.295  Sum_probs=199.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEee----cCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  584 (834)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999875 58999999987542  2345677889999999999999999998763    3468


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+. ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 688888743   345899999999999999999999987   99999999999999999999999999976


Q ss_pred             ccCCCcc--cccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c----cccc----cc
Q 003287          665 FCGDELQ--GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N----LLGH----AW  732 (834)
Q Consensus       665 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~----~~~~----~~  732 (834)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... .    ....    ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432211  11123468899999999866 4689999999999999999999999865432110 0    0000    00


Q ss_pred             ccccccccccccCc---cc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          733 NLWKDNRAYELLSP---AL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       733 ~~~~~~~~~~l~~~---~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .........+..+.   ..   ...........+.+++..||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000111110000   00   011112345678899999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=304.94  Aligned_cols=267  Identities=26%  Similarity=0.361  Sum_probs=203.5

Q ss_pred             CccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------eEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------EKI  585 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~  585 (834)
                      .+...+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||+++++-.+..      ..+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3556678999999999999965 59999999997653 345677889999999999999999999866543      679


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE--cCCCC--eeeccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDMN--PKISDFGM  661 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl--~~~~~--vkl~DFGl  661 (834)
                      +|||||.+|+|...|.+.++...|++.+.+.++.+++.||.|||+++   |+||||||.||++  .++|+  -||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999999999999999999999999999999887   9999999999998  34454  59999999


Q ss_pred             cccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccc---
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD---  737 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  737 (834)
                      |+.+..+.   ......||..|++||.... +.|+..+|.|||||++||.+||..||........+.. ..|....+   
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~~~~tkkp~  246 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMWHIITKKPS  246 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhhhhhccCCC
Confidence            99875543   5567899999999999984 8899999999999999999999999976443321100 01111100   


Q ss_pred             ---------cccccccCccc--cchhHHHHHHHHHHHHhcccccCcCCCC--CHHHHHHHhhc
Q 003287          738 ---------NRAYELLSPAL--QHEASYQMLNRYITVALLCVQEKAADRP--TMSKVVSMITN  787 (834)
Q Consensus       738 ---------~~~~~l~~~~l--~~~~~~~~~~~l~~li~~cl~~~P~~RP--s~~evl~~L~~  787 (834)
                               ++..--....+  ..........++...+..++..+|++|-  ...+....+..
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d  309 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD  309 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence                     00000000001  1123444556677777778888888887  44444443333

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=7.2e-32  Score=292.52  Aligned_cols=266  Identities=25%  Similarity=0.361  Sum_probs=196.6

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC----
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----  582 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----  582 (834)
                      ...++|++.+.||+|+||.||+|+.. +++.||||+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999986 48899999986542  223456788999999999999999999987655    


Q ss_pred             ------eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          583 ------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       583 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                            ..++|+||+++ +|..++...  ...+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 566666332  346899999999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-cccccc----
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGH----  730 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~----  730 (834)
                      +|||++..+..... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+....... ......    
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999987643321 11122345778999998865 457899999999999999999999986433211 000000    


Q ss_pred             ----ccccccccccccccCc------cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          731 ----AWNLWKDNRAYELLSP------ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       731 ----~~~~~~~~~~~~l~~~------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          .+..+.+.......++      ... ......+..+.+++..||+.+|.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                0000000000000000      000 001112456889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=6.8e-32  Score=298.75  Aligned_cols=267  Identities=24%  Similarity=0.275  Sum_probs=198.3

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  581 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  581 (834)
                      ..++...+++|++.+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++.+++|+||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            4556677899999999999999999999864 68899999997532  23356788899999999999999999988643


Q ss_pred             ------CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCee
Q 003287          582 ------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  655 (834)
Q Consensus       582 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vk  655 (834)
                            ...+++++++ +++|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467888876 7788887732    35889999999999999999999987   99999999999999999999


Q ss_pred             eccccccccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc-c---
Q 003287          656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G---  729 (834)
Q Consensus       656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~-~---  729 (834)
                      |+|||+++....     ......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...+.... ... .   
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999876422     2233467889999999876 5688999999999999999999999864332110 000 0   


Q ss_pred             ----cccccccccc---cccccCcccc---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          730 ----HAWNLWKDNR---AYELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       730 ----~~~~~~~~~~---~~~l~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          ..........   ....+.....   .+........+.+++..|++.+|.+||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                0000000000   0000000000   00000124567899999999999999999998865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=5.6e-32  Score=294.63  Aligned_cols=248  Identities=31%  Similarity=0.423  Sum_probs=195.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +.|+..+.||+|+||.||+|+.. +++.+|||.+...   .....+++.+|+++++.++|+|++++++++.+....++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777889999999999999975 5788999998642   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+. |+|.+++...  ...+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 5777766422  245789999999999999999999987   999999999999999999999999998765322


Q ss_pred             CcccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                            ....++..|+|||.+.   ...++.++|||||||++|||++|..|+......... ..     ......     
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~-----~~~~~~-----  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YH-----IAQNES-----  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HH-----HhhcCC-----
Confidence                  2345788999999974   356888999999999999999999997643221100 00     000000     


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      +..   ........+.+++.+||+.+|++||++.++++.--
T Consensus       232 ~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            111   11233456788999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=6e-33  Score=274.42  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=197.1

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccC-hhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++.+.+..||+|..|.|++++... |..+|||.+.... .+..+++++.+.++.+.+ .|+||+.+|+|..+....+.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            455667789999999999999764 8999999997653 445677888888877774 8999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      .|. .-++.++.+  ..+.+++..+-++...+++||.||.+++  .|+|||+||+|||+|+.|++||+|||++-.+-...
T Consensus       172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            884 234444432  2345888888899999999999999877  69999999999999999999999999997764332


Q ss_pred             cccccccccccccccCcccccCC---CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                         ..+...|-+.|||||.+.-.   .|+.++||||||+.|+||.||+.|+..-+.+ ++.+..   ... +     ..|
T Consensus       247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltk---vln-~-----ePP  313 (391)
T KOG0983|consen  247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTK---VLN-E-----EPP  313 (391)
T ss_pred             ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHH---HHh-c-----CCC
Confidence               23445688999999998643   5889999999999999999999998864322 111110   011 1     113


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+...  ..++..+.+++..||+.|+.+||.+.++++-
T Consensus       314 ~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            33222  2266788899999999999999999999864

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=6.6e-32  Score=289.85  Aligned_cols=262  Identities=26%  Similarity=0.324  Sum_probs=196.0

Q ss_pred             ccccceecccCccceEeeEecC-CcEEEEEEecccCh-hhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEEec
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      |++.+.||+|+||+||+|+..+ ++.||||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5678899999999999999864 78999999865432 22334567999999998 999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             888988885432 346899999999999999999999987   9999999999999999999999999998654322  


Q ss_pred             cccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-----cccc-cccccccc-ccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-----LLGH-AWNLWKDN-RAYEL  743 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-----~~~~-~~~~~~~~-~~~~l  743 (834)
                       ......++..|+|||++.. ..++.++||||||++++||++|+.|+.........     .... ....+.+. .....
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             1123457889999998854 45789999999999999999999988654321100     0000 00000000 00000


Q ss_pred             cCccc-------cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          744 LSPAL-------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       744 ~~~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+...       ...........+.+++..||+.+|++||++.|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000       011111124678899999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=5.4e-32  Score=292.91  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=193.3

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccC-hhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.+.||+|+||.||+|+..+ ++.||||+++... .....++..|+.++.+.. |+||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678899999999999999999865 8999999997543 234456777887777774 999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++ +|..++...  ...+++..+..++.||++||+|||+..  +|+||||+|+||++++++.+||+|||++..+...
T Consensus        94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99854 666665332  236889999999999999999999742  3999999999999999999999999999765332


Q ss_pred             CcccccccccccccccCcccccCCC----CCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ..   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.|+....... ....   .... .......
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~---~~~~-~~~~~~~  240 (296)
T cd06618         169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT---KILQ-EEPPSLP  240 (296)
T ss_pred             Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH---HHhc-CCCCCCC
Confidence            21   12234778999999987554    7889999999999999999999986432211 0000   0000 0000000


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .       ...+...+.+++.+||+.+|++||++.++++.
T Consensus       241 ~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 P-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0       00234567889999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1e-31  Score=288.10  Aligned_cols=241  Identities=24%  Similarity=0.311  Sum_probs=186.3

Q ss_pred             eecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHH---HHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          520 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM---LIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .||+|+||.||+++.. +++.||||.+.+..   ......+..|..   ++...+||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 48899999986532   122223444443   4445689999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999988843   346899999999999999999999987   9999999999999999999999999997653221   


Q ss_pred             ccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       .....|+..|+|||.+.++ .++.++||||+|++++||++|+.||.............         ......+.+   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~---  218 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---------MTLTMAVEL---  218 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---------HhhccCCCC---
Confidence             2234689999999999754 68999999999999999999999987542211100000         000001111   


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                       +......+.+++.+|++.+|.+||     ++.++++
T Consensus       219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             112345688899999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.2e-31  Score=292.78  Aligned_cols=244  Identities=29%  Similarity=0.422  Sum_probs=191.7

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      |...+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999875 58899999986432   23446788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +. |+|.+++..  ....+++.++..++.||+.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....    
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 566666633  2345889999999999999999999987   9999999999999999999999999986432    


Q ss_pred             ccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          671 QGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                        ......++..|+|||++.   ...++.++|||||||++|||++|..|+.........     ..... .....     
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-----~~~~~-~~~~~-----  239 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQ-NDSPT-----  239 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHh-cCCCC-----
Confidence              122356888999999984   456889999999999999999999997653321100     00000 00000     


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .   ........+.+++.+||+.+|++||++.+++..
T Consensus       240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   011223457789999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=2.8e-32  Score=291.88  Aligned_cols=249  Identities=26%  Similarity=0.335  Sum_probs=202.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|++++.+++ |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999876 5899999998753   2334567889999999998 99999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++.+   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999853   336899999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCcc------------------cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccc
Q 003287          668 DELQ------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  729 (834)
Q Consensus       668 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~  729 (834)
                      ....                  .......++..|+|||++....++.++||||||++++|+++|+.|+........  ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~  232 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--FQ  232 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--HH
Confidence            3221                  222334678999999999988899999999999999999999999875432110  00


Q ss_pred             cccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCH----HHHHH
Q 003287          730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTM----SKVVS  783 (834)
Q Consensus       730 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~  783 (834)
                         ...      .     .....+......+.+++..||+.+|++||++    +|+++
T Consensus       233 ---~~~------~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 ---KIL------K-----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHH------h-----cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               000      0     0001111224567889999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=5.9e-32  Score=294.23  Aligned_cols=265  Identities=26%  Similarity=0.373  Sum_probs=194.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      .++|++.++||+|+||.||+|+.. +++.||||++.....  .....+.+|++++++++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999875 588999999865422  22346788999999999999999999875543      


Q ss_pred             --eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          583 --EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                        ..++|+||++. +|...+..  ....+++..+..++.|+++||+|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 56555533  2346899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCccc---------ccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc-
Q 003287          661 MARMFCGDELQG---------NTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-  728 (834)
Q Consensus       661 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~-  728 (834)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||++++||++|+.|+........ ... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998654322111         11234568889999988654 588999999999999999999999865432110 000 


Q ss_pred             -------cccccccccc------ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          729 -------GHAWNLWKDN------RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       729 -------~~~~~~~~~~------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                             ...+..+...      .......+.+ ..........+.+++.+||+.+|++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                   0000000000      0000000000 0011122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=8.5e-32  Score=290.03  Aligned_cols=256  Identities=24%  Similarity=0.295  Sum_probs=199.9

Q ss_pred             CccccceecccCccceEeeEec----CCcEEEEEEecccC----hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      +|++.+.||+|+||.||+++..    +++.||||.+.+..    ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999753    46889999987532    22346688999999999 699999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998843   345889999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCCC--CCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      +...... ......++..|+|||.+.+..  .+.++||||||++++||++|..|+........ ......      ....
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~------~~~~  226 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISR------RILK  226 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHH------HHHc
Confidence            6433211 122345789999999987765  78899999999999999999999864221100 000000      0000


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      . .+    ..+......+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus       227 ~-~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         227 S-KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             c-CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            0 01    11122335678899999999999999999998887653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.6e-32  Score=299.07  Aligned_cols=263  Identities=24%  Similarity=0.313  Sum_probs=194.6

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      ..+|.+.+.||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999865 58999999986532  223456889999999999999999999987543      


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46999999964 666554     235789999999999999999999987   999999999999999999999999998


Q ss_pred             ccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cccccc--------c
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHA--------W  732 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~--------~  732 (834)
                      +....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ......        .
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            76422     1223467889999999876 4688999999999999999999999975432110 000000        0


Q ss_pred             cccccccccccc--Ccccc-ch---hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcc
Q 003287          733 NLWKDNRAYELL--SPALQ-HE---ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  788 (834)
Q Consensus       733 ~~~~~~~~~~l~--~~~l~-~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~  788 (834)
                      ............  .+... ..   ........+.+++..||+.+|++||++.++++.  ++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            000000000000  00000 00   011233567899999999999999999999954  5555

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.3e-32  Score=298.24  Aligned_cols=265  Identities=23%  Similarity=0.291  Sum_probs=197.6

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-----
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  582 (834)
                      ..++|++.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4578999999999999999999864 5899999998643  2334467889999999999999999999987654     


Q ss_pred             -eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          583 -EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                       ..++||||+ +++|..++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             458999999 678888773    245889999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc--cccc---c----c
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLG---H----A  731 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~---~----~  731 (834)
                      +......     .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||...+....  ....   .    .
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9865321     223457889999999876 4588999999999999999999999875432100  0000   0    0


Q ss_pred             ccccccccccccc--Ccccc----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH--Hhhcc
Q 003287          732 WNLWKDNRAYELL--SPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS--MITNE  788 (834)
Q Consensus       732 ~~~~~~~~~~~l~--~~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~  788 (834)
                      ...+.........  -+...    ..........+.+++..|++.+|++||++.++++  .++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            0000000000000  00000    0111223446789999999999999999999994  34444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=1e-31  Score=289.71  Aligned_cols=251  Identities=24%  Similarity=0.278  Sum_probs=194.3

Q ss_pred             CccccceecccCccceEeeEe----cCCcEEEEEEecccCh----hhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQSG----QGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      +|++.+.||+|+||.||+++.    .+|+.||+|++.....    ...+++.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986    3688999999875322    2346788899999999 699999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++|+||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   ++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345788999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCC--CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      +..... .......|+..|+|||.+...  .++.++||||||+++|||++|..|+........ ..........      
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~------  226 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-QAEISRRILK------  226 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-HHHHHHHhhc------
Confidence            543221 122235688999999998753  478899999999999999999999864221100 0000000000      


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                       ..    ...+......+.+++.+||+.+|++||     +..++++
T Consensus       227 -~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         227 -SE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -cC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             00    011122345677899999999999997     5566654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.2e-32  Score=296.59  Aligned_cols=268  Identities=26%  Similarity=0.324  Sum_probs=203.3

Q ss_pred             CccccceecccCccceEeeEecC-CcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-----eEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI  585 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  585 (834)
                      +|++.+.||+|+||.||+|+... ++.||||++....  ....+.+.+|+.+++.++|+||+++++++.+..     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            57889999999999999999764 8999999987653  345577899999999999999999999998775     789


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||++ ++|.+++.+   ...+++..+..++.|+++||+|||+.+   |+|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 478888743   237899999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCc-ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc----cc-c---ccc
Q 003287          666 CGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GH-A---WNL  734 (834)
Q Consensus       666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~----~~-~---~~~  734 (834)
                      ..... ........++..|+|||++.+. .++.++||||||+++++|++|+.||........ ...    .. .   +..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            44321 0122334678899999999887 899999999999999999999999875442110 000    00 0   000


Q ss_pred             ccccccccccC---ccc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcc
Q 003287          735 WKDNRAYELLS---PAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  788 (834)
Q Consensus       735 ~~~~~~~~l~~---~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~  788 (834)
                      .......+.+.   ...   ...........+.+++..||+.+|++||++.++++.  |+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            00000000000   000   001112245678899999999999999999999974  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-33  Score=278.50  Aligned_cols=248  Identities=25%  Similarity=0.291  Sum_probs=203.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|..+++||+|.||.|-+++.+ .++.+|||++++..   ......-+.|-++|...+||.+..|.-.+...+.+++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            68999999999999999999875 58999999998763   334455677999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||..+|.|..+|.   +.+.+++....-+-..|+.||.|||+.+   ||.||||.+|.|||.+|++||+||||++.-  .
T Consensus       248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I  319 (516)
T KOG0690|consen  248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--I  319 (516)
T ss_pred             EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--c
Confidence            9999999988884   4567888888888899999999999988   999999999999999999999999999853  2


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .+...++..+||+.|+|||++.+..|..+.|.|.+||++|||++|+.||-..+.+.               +++++--. 
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---------------LFeLIl~e-  383 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---------------LFELILME-  383 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------------HHHHHHhh-
Confidence            34556778999999999999999999999999999999999999999987644322               22221100 


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCC--CHHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRP--TMSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RP--s~~evl~~  784 (834)
                      .-..+.....+...|+.-.|..+|.+|.  ..+++.+.
T Consensus       384 d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi  421 (516)
T KOG0690|consen  384 DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEI  421 (516)
T ss_pred             hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHH
Confidence            0012333345566788889999999995  33444443

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=7.6e-32  Score=298.03  Aligned_cols=264  Identities=22%  Similarity=0.277  Sum_probs=194.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec---------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ---------  581 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------  581 (834)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999875 5889999998766556667889999999999999999999776543         


Q ss_pred             -----CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCee
Q 003287          582 -----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK  655 (834)
Q Consensus       582 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vk  655 (834)
                           ...++||||++ ++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||+++ .++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 58887773    235889999999999999999999987   99999999999997 456789


Q ss_pred             eccccccccccCCCcc-cccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccc
Q 003287          656 ISDFGMARMFCGDELQ-GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAW  732 (834)
Q Consensus       656 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~  732 (834)
                      |+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999865332111 11122357889999998754 5688899999999999999999999965432110 0000000


Q ss_pred             ccccc---cccc----c-cc----Cccc-cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          733 NLWKD---NRAY----E-LL----SPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       733 ~~~~~---~~~~----~-l~----~~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .....   ....    . ..    .+.. ...........+.+++.+||+.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000   0000    0 00    0000 00011123456788999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.1e-31  Score=294.77  Aligned_cols=262  Identities=25%  Similarity=0.321  Sum_probs=196.8

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee-cCeEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKI  585 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~  585 (834)
                      ..+++|++.+.||+|+||.||+++.. +++.||||++.+.  .....+.+.+|+.++.+++||||+++++++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45688999999999999999999865 6899999988643  22345678899999999999999999999876 55789


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +|+||+ +++|..++.    ...+++.....++.|+++||+|||+.+   |+||||+|+||+++.++.+||+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 468888773    235788888899999999999999987   999999999999999999999999998754


Q ss_pred             cCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c----ccccc----cccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N----LLGHA----WNLW  735 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~----~~~~~----~~~~  735 (834)
                      ..     ......++..|+|||.+.+ ..++.++||||||++++||++|+.||........ .    .....    ...+
T Consensus       159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            22     1223456889999998866 5689999999999999999999999865432110 0    00000    0000


Q ss_pred             cccccccccCcc-cc-----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          736 KDNRAYELLSPA-LQ-----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       736 ~~~~~~~l~~~~-l~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+..+..... ..     ..........+.+++.+||+.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000 00     00111234678899999999999999999999866

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.9e-31  Score=294.05  Aligned_cols=263  Identities=24%  Similarity=0.305  Sum_probs=195.1

Q ss_pred             cCcc-ccceecccCccceEeeEec-CCcEEEEEEecccChhh--------------HHHHHHHHHHHhccCCCceeeEee
Q 003287          513 ENFS-MQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLMG  576 (834)
Q Consensus       513 ~~f~-~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~  576 (834)
                      ++|. +.+.||+|+||+||+|+.. .++.||||++.......              ...+.+|++++.+++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4467999999999999875 58999999986542211              125778999999999999999999


Q ss_pred             eEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                      ++..++..++||||++ ++|.+++..   ...+++.....++.|+++||+|||+.+   ++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 688888843   345889999999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCc------------ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcc
Q 003287          657 SDFGMARMFCGDEL------------QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIE  723 (834)
Q Consensus       657 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~  723 (834)
                      +|||+++.......            ........++..|+|||.+.+. .++.++|||||||+++||++|+.|+...+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999986542110            1111223467889999998764 4789999999999999999999998755432


Q ss_pred             ccccccccccc--------cccc---ccccccC---ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          724 SFNLLGHAWNL--------WKDN---RAYELLS---PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       724 ~~~~~~~~~~~--------~~~~---~~~~l~~---~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..  .......        |...   .......   +.............+.+++..||+.+|++||+++|++..
T Consensus       241 ~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 DQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            11  0000000        0000   0000000   000011112234568899999999999999999999963

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=286.31  Aligned_cols=261  Identities=26%  Similarity=0.334  Sum_probs=198.2

Q ss_pred             ccccceecccCccceEeeEecC-CcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      |+..+.||+|+||.||+|+... ++.||+|++....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5667899999999999999864 8999999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      + ++|.+++....  ..+++..+..++.|+++||+|||+.+   |+||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58999885432  46899999999999999999999987   99999999999999999999999999987643221 


Q ss_pred             cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c-cc-------cccccccccc---
Q 003287          672 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LL-------GHAWNLWKDN---  738 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~-~~-------~~~~~~~~~~---  738 (834)
                       ......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ . ..       ...|..+...   
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             12223457789999998776 889999999999999999999988865432110 0 00       0000000000   


Q ss_pred             -ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          739 -RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       739 -~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .....................+.+++..||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             000000000000111122457889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=1.6e-32  Score=275.76  Aligned_cols=205  Identities=28%  Similarity=0.389  Sum_probs=170.4

Q ss_pred             ccCccccceecccCccceEeeEecC-----CcEEEEEEecccChh--hHHHHHHHHHHHhccCCCceeeEeeeEee-cCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  583 (834)
                      ...|+....||+|.||.||||.-.+     .+.+|||+++...+.  -.....+|+.+++.++||||+.|..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3578999999999999999996432     347999999765321  23456889999999999999999999987 778


Q ss_pred             EEEEEEecCCCCchhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC----CCeeec
Q 003287          584 KILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKIS  657 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~----~~vkl~  657 (834)
                      .+|++||.++ +|..+|+-  ....+.++...+..|+.||+.|+.|||++-   |+||||||.||||..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999976 56666642  334467899999999999999999999987   9999999999999877    899999


Q ss_pred             cccccccccCCCc-ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCC
Q 003287          658 DFGMARMFCGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVY  720 (834)
Q Consensus       658 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~  720 (834)
                      |+|+++.+.+.-. ......++-|..|+|||.+.+. .|+++.|||+.|||+.||++-++.|...
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999998854322 2234557789999999999875 6999999999999999999988877653

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.5e-31  Score=283.43  Aligned_cols=249  Identities=27%  Similarity=0.355  Sum_probs=194.4

Q ss_pred             CccccceecccCccceEeeEecC-CcEEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      +|.+.+.||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998754 455666655431     122345677899999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      +||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++|+||||+||+++. +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888542 23457899999999999999999999987   999999999999975 569999999997764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ....  ......++..|+|||.+.+..++.++|+||||+++++|++|..|+........  ..         .......+
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~---------~~~~~~~~  223 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--VL---------RIVEGPTP  223 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HH---------HHHcCCCC
Confidence            3221  22234578899999999888899999999999999999999999864321110  00         00000111


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .    .+......+.+++.+||+.+|++||++.|+++
T Consensus       224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1    12234457888999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=3.9e-31  Score=291.13  Aligned_cols=264  Identities=23%  Similarity=0.280  Sum_probs=192.0

Q ss_pred             CccccceecccCccceEeeEec-C--CcEEEEEEecccC--hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec----Ce
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-N--GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ----GE  583 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-~--g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~  583 (834)
                      +|++.+.||+|+||.||+++.. .  ++.||||++....  ....+.+.+|+.++.++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999875 3  6789999986532  22356788899999999 599999999876433    45


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++++||++ ++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788889886 678888743   346889999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcc--cccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc--------ccc
Q 003287          664 MFCGDELQ--GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------GHA  731 (834)
Q Consensus       664 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~--------~~~  731 (834)
                      .+......  .......|+..|+|||++.+ ..++.++|||||||++++|++|+.||...+.... ...        ...
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            76432211  11233568999999998866 4689999999999999999999999875432110 000        000


Q ss_pred             cccccccccccc---c---CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          732 WNLWKDNRAYEL---L---SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       732 ~~~~~~~~~~~l---~---~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+........   .   ...............+.+++.+|++.+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000   0   0000000011123567889999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-33  Score=276.87  Aligned_cols=257  Identities=25%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++.+-+..||.|+||+|+|-.++ .|+.+|||+++... +...++++.|.+...+- +.||||+++|.+..++..++.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            44556678999999999999876 59999999998664 35678899999876666 79999999999999999999999


Q ss_pred             ecCCCCchhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          590 YMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       590 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      .|. .+|+.+...  ......+++.-+-+|....++||.||-...  .|||||+||+||||+..|.+||+|||++-.+..
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            994 455544321  123446788888889999999999998754  699999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      +-   ..+.-.|-..|||||.+..  ..|+.+|||||||++|+|+.||+-|+...+.-    .++.. .+..++...+..
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql~-~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQLC-QVVIGDPPILLF  292 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHHH-HHHcCCCCeecC
Confidence            21   1223468889999999964  34899999999999999999999998765431    11111 111122222221


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          .....++...+..++..|+.++..+||.+.+++++
T Consensus       293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                22234456778899999999999999999998865

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-32  Score=271.51  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             ceecccCccceEeeE-ecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          519 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      +.||+|+|+.|--++ +.+|.++|||++.+.......+..+|++++... .|+||++|+.+|+++...|||||-|.+|+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            579999999999886 567999999999988777888999999999999 599999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC---eeeccccccccccCCC----
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDE----  669 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---vkl~DFGla~~~~~~~----  669 (834)
                      ...|.+   ...+++.++.+++.+|+.||.+||.++   |.||||||+|||..+...   +||+||.|...+.-..    
T Consensus       164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            999853   456899999999999999999999998   999999999999976554   7999999886542111    


Q ss_pred             -cccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc-
Q 003287          670 -LQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE-  742 (834)
Q Consensus       670 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  742 (834)
                       ........+|+..|||||+..     ...|+.+.|.||||||||-||+|.+||...-.+..        .|.+++.-+ 
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~  309 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRV  309 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHH
Confidence             112234567899999999873     23589999999999999999999999976433221        122222211 


Q ss_pred             -------ccCcc---ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          743 -------LLSPA---LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       743 -------l~~~~---l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                             -+...   .........+....+++...+..++.+|.++.++++
T Consensus       310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                   11111   112233445667788999999999999999999887

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.4e-31  Score=294.20  Aligned_cols=261  Identities=25%  Similarity=0.308  Sum_probs=196.8

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe----
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE----  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  583 (834)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++++++|+|++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3578999999999999999999986 4789999998653  22344667889999999999999999998876654    


Q ss_pred             --EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          584 --KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       584 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                        .++|+||+ +++|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5689888843    45899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cc----cccc----
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL----LGHA----  731 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~----~~~~----  731 (834)
                      +......     .....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ..    ....    
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9865322     223457889999999865 3678999999999999999999999865432110 00    0000    


Q ss_pred             cccccccccccccC---cccc---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          732 WNLWKDNRAYELLS---PALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       732 ~~~~~~~~~~~l~~---~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+........+.   ....   ..........+.+++..||+.+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000000000000   0000   01111235678899999999999999999999763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-31  Score=296.33  Aligned_cols=259  Identities=22%  Similarity=0.375  Sum_probs=212.0

Q ss_pred             HHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEee---
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE---  580 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---  580 (834)
                      ..+...++.|++.+.||.|.+|.||+++.. +++.+|||++.... ...++...|+.+++.+ +|||++.++|++..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            334445678999999999999999999864 68999999987543 3446778899999988 79999999999874   


Q ss_pred             --cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecc
Q 003287          581 --QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       581 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                        +++++||||||.+|+..+++++.. ...+.|..+..|++.++.|+.|||...   ++|||||-.|||++.++.|||.|
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence              468999999999999999997765 677899999999999999999999987   99999999999999999999999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccCC-----CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  733 (834)
                      ||.+.++..  .........||+.|||||++...     .|+.++|+||||++..||--|.+|+..+.....        
T Consensus       167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--------  236 (953)
T KOG0587|consen  167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--------  236 (953)
T ss_pred             eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence            999988743  34455567899999999999643     478899999999999999999999775543211        


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ++.   +.+...|.+  ..+......+.++|..||.+|.++||++.++++.
T Consensus       237 LF~---IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 LFL---IPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hcc---CCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            111   112222222  2355677889999999999999999999998753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=277.37  Aligned_cols=256  Identities=27%  Similarity=0.387  Sum_probs=198.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-------hhhHHHHHHHHHHHhccCCCceeeEeeeEe-ecCe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV-EQGE  583 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~  583 (834)
                      ++|-++.+||+|+|++|||+.+. +.+.||||+-....       ....+...+|..+-+.|+||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            56788899999999999999754 57889999854321       112345678999999999999999999986 5567


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc---CCCCeeecccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFG  660 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~vkl~DFG  660 (834)
                      .+-|+|||++.+|+.||.   ..+.+++.++..|+.||+.||.||.+.. ++|||-||||.||||-   .-|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence            899999999999999994   4567899999999999999999999876 6799999999999994   45789999999


Q ss_pred             ccccccCCCcc-----cccccccccccccCcccccCC----CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc
Q 003287          661 MARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       661 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~  731 (834)
                      |+++...+.+.     ..+....||.+|++||.+.-+    .++.|+||||.|||+|..+.|++||+..-... +++.. 
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILqe-  696 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQE-  696 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHhh-
Confidence            99988665543     223456799999999998543    47889999999999999999999998643221 11111 


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHH
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl  782 (834)
                      ..+++..++.--..|        ....+...+|+.||+..-++|....++.
T Consensus       697 NTIlkAtEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 NTILKATEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hchhcceeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            111111222211122        2234566799999999999998877664

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.4e-31  Score=276.05  Aligned_cols=236  Identities=26%  Similarity=0.326  Sum_probs=191.8

Q ss_pred             ecccCccceEeeEec-CCcEEEEEEecccCh---hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      ||+|+||.||+++.. +++.+|+|.+.....   ...+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 489999999876432   2456889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  676 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  676 (834)
                      .+++...   ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            9998533   35889999999999999999999987   9999999999999999999999999998754322  12334


Q ss_pred             ccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      ..++..|+|||...+...+.++|+||||++++||++|..|+...+....  ..   .. ...   .       ...+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~---~~-~~~---~-------~~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI--YE---KI-LKD---P-------LRFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HH---HH-hcC---C-------CCCCCCC
Confidence            5678899999999988899999999999999999999999865432110  00   00 000   0       0111112


Q ss_pred             HHHHHHHHhcccccCcCCCCCHHH
Q 003287          757 LNRYITVALLCVQEKAADRPTMSK  780 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs~~e  780 (834)
                      ...+.+++.+||+.+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            456788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.4e-30  Score=310.63  Aligned_cols=145  Identities=28%  Similarity=0.414  Sum_probs=131.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|.+.++||+|+||.||+|+.. +++.||||++....   ......+..|+.++..++|+||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67999999999999999999986 58999999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      ||+++++|.+++..   ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999853   245788999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=291.26  Aligned_cols=241  Identities=22%  Similarity=0.243  Sum_probs=195.2

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++.|.+...+|.|+|+.|-.+... +++..+||++.+...    .-.+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3678888899999999999999865 588999999987622    224566555555 8999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE-cCCCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl-~~~~~vkl~DFGla~~~~~  667 (834)
                      |.+.++-|.+-+...    .....++..|+.+|+.|+.|||+++   ++||||||+|||+ +..++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999887766322    2223778889999999999999987   9999999999999 6999999999999998754


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .     ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ .+                +....
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e----------------i~~~i  526 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE----------------IHTRI  526 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH----------------HHHhh
Confidence            4     22345688999999999999999999999999999999999998754432 11                11111


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..+.+....+....+|+.+||+.+|.+||+|.++..-
T Consensus       527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            2222335566778899999999999999999998753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2e-30  Score=271.21  Aligned_cols=220  Identities=19%  Similarity=0.116  Sum_probs=175.8

Q ss_pred             cCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCchhhhcC
Q 003287          524 GGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD  602 (834)
Q Consensus       524 G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~  602 (834)
                      |.||.||+++.. +++.||+|++....     .+..|...+....||||+++++++.+....++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 58899999997643     234455556666799999999999999999999999999999998853


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccccccccc
Q 003287          603 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG  682 (834)
Q Consensus       603 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~  682 (834)
                      .   ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.++++|||++......     .....++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            2   34889999999999999999999987   999999999999999999999999988765321     122345678


Q ss_pred             ccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHH
Q 003287          683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  762 (834)
Q Consensus       683 y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~  762 (834)
                      |+|||.+....++.++||||+|++++||++|+.|+........           ..  ..+       ..+......+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------~~--~~~-------~~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------TH--TTL-------NIPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------cc--ccc-------CCcccCCHHHHH
Confidence            9999999888899999999999999999999987643211100           00  000       011123456788


Q ss_pred             HHhcccccCcCCCCCHH
Q 003287          763 VALLCVQEKAADRPTMS  779 (834)
Q Consensus       763 li~~cl~~~P~~RPs~~  779 (834)
                      ++.+|++.+|++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=261.59  Aligned_cols=254  Identities=20%  Similarity=0.219  Sum_probs=199.7

Q ss_pred             hccCcccc-ceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEee----cCe
Q 003287          511 ATENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE----QGE  583 (834)
Q Consensus       511 ~~~~f~~~-~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~  583 (834)
                      .+++|++. ++||-|-.|.|..+..+ .++.+|+|++...     ...++|+++--.. .|||||.+++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35677665 47999999999999875 5889999998643     4457788876666 69999999999864    346


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc---CCCCeeecccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFG  660 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~vkl~DFG  660 (834)
                      +.+|||.|++|.|..-+.+. ....+.+.++..|+.||+.|+.|||+.+   |.||||||+|+|..   .|..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999998888553 4456899999999999999999999998   99999999999996   45679999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      +|+....   .......+-|+.|.|||++....|+...|+||+||++|-|++|.+||-....  ..+.--.......+  
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g--  282 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG--  282 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc--
Confidence            9986432   3344556789999999999999999999999999999999999999864332  11110000000000  


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          .-.+..+.....++...++|+.+|..+|++|.|+.+++.-
T Consensus       283 ----qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  283 ----QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ----CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                1112334566778888999999999999999999998764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=274.50  Aligned_cols=242  Identities=24%  Similarity=0.317  Sum_probs=195.8

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  585 (834)
                      ...+|..+.+||+|+||.|.++..+. .+.+|||++++..   ....+--+.|-++|+.. +-|.++++..++..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            44678899999999999999998654 6779999998752   22333345677777777 5689999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+.+|+|-..+.   +-..+.+..++-+|..||-||-+||+++   ||.||||..|||||.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999988774   3345677888899999999999999998   999999999999999999999999999853


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      -  .....+...+||+.|+|||++..++|+..+|.|||||+||||+.|++||+..++++...              .+.+
T Consensus       501 i--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--------------aI~e  564 (683)
T KOG0696|consen  501 I--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------AIME  564 (683)
T ss_pred             c--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------HHHH
Confidence            1  22345567899999999999999999999999999999999999999999876553211              1111


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCC
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRP  776 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP  776 (834)
                      ..  -.++...+.+...+....+.+.|.+|.
T Consensus       565 hn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            11  123444555667788888889999884

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-31  Score=279.41  Aligned_cols=242  Identities=26%  Similarity=0.362  Sum_probs=194.1

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCC
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS  595 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs  595 (834)
                      +.||+|-||+||-|+.. +|+.||||++.+.  .......+++|+.+|.+++||.||.+-..|+..+..++|||-+.+.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            68999999999999875 6999999999764  23455789999999999999999999999999999999999996555


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC---CCeeeccccccccccCCCccc
Q 003287          596 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~vkl~DFGla~~~~~~~~~~  672 (834)
                      |.-+|. . ....|++....-++.||+.||.|||.++   |+|+||||+||||.+.   -++||+|||+|+++.....  
T Consensus       650 LEMILS-s-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  650 LEMILS-S-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             HHHHHH-h-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            544443 2 2345888888889999999999999998   9999999999999643   5799999999999865433  


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                       ...++||+.|+|||++.++.|...-|+||.|||+|--++|.-||....+-..++ +.+          ..+   .....
T Consensus       723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-QNA----------aFM---yPp~P  787 (888)
T KOG4236|consen  723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-QNA----------AFM---YPPNP  787 (888)
T ss_pred             -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-hcc----------ccc---cCCCc
Confidence             345789999999999999999999999999999999999999987433211111 100          111   12334


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl  782 (834)
                      ..+.....++||...||..-++|-+.++.+
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            455566778888888998888888877544

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-31  Score=301.78  Aligned_cols=259  Identities=21%  Similarity=0.242  Sum_probs=206.7

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEecC-CcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEee
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  580 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  580 (834)
                      ..++....++|.+++.||+|+||.|..++.+. ++.+|+|++++.   ......-|..|-.+|..-+.+-|+.+.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34556667899999999999999999999864 888999999873   23345678999999999999999999999999


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ...+|+|||||+||+|..++.+.   ..+++.-+.-++..|+-||..||+.|   +|||||||.|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            99999999999999999999543   26889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCccccc----C-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYAL----D-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      .+-.+..+. .......+|||.|++||++.    + +.|++..|.||+||++|||+.|..||-...     +++....++
T Consensus       221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~KIm  294 (1317)
T KOG0612|consen  221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGKIM  294 (1317)
T ss_pred             hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHHHh
Confidence            987664332 33345578999999999985    2 569999999999999999999999987533     222222222


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCC---HHHHHH
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT---MSKVVS  783 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~  783 (834)
                      ..++...+.+       ....+....+||...+. +|+.|-.   ++++..
T Consensus       295 ~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  295 NHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             chhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            3232222221       12245566778877666 6788877   777764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=239.91  Aligned_cols=260  Identities=23%  Similarity=0.323  Sum_probs=190.3

Q ss_pred             CccccceecccCccceEeeEecC-CcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +|...++||+|.||+||||+..+ ++.||+|+++..+  +......++|+-+++.++|.|||+++++...+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            46677899999999999998754 7889999886542  33346678999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      |. .+|..+..  .-...++.+.+..++.|+++||.++|+++   +.|||+||+|.|++.+|++|++|||+++.+.-.  
T Consensus        83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--  154 (292)
T KOG0662|consen   83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--  154 (292)
T ss_pred             hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence            95 45666552  23456888999999999999999999998   999999999999999999999999999976321  


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCC-CCCCCccccc-----cccc-cccccccccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFN-----LLGH-AWNLWKDNRAYE  742 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p-~~~~~~~~~~-----~~~~-~~~~~~~~~~~~  742 (834)
                      .......+-|..|.+|.++.+. -|+...|+||.|||+.|+..-.+| |...+..+..     ++.. ....|.  .+..
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp--s~t~  232 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP--SMTK  232 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC--cccc
Confidence            1122334568999999999886 489999999999999999875544 5554433210     0000 000110  0111


Q ss_pred             ccCccccc---------hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          743 LLSPALQH---------EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       743 l~~~~l~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +.|-...+         ...+.....=.+++...+.-+|..|.++++.++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11111111         011112223346777777779999999987764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.4e-31  Score=260.11  Aligned_cols=266  Identities=23%  Similarity=0.384  Sum_probs=197.3

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--------
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--------  581 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  581 (834)
                      ..|+-..+||+|.||+||+|+..+ |+.||+|++--..  +.-.....+|+++|..|+|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            457777899999999999999764 7889998764321  12234568899999999999999999988643        


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ...+|||++|+. +|..+|.+  ....++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999975 56666643  2346888999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcc--cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-cc--------ccc
Q 003287          662 ARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FN--------LLG  729 (834)
Q Consensus       662 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~--------~~~  729 (834)
                      ++.+...+..  ...+..+-|..|++||.+.+. .|+++.|||..|||+.||.++.+.+....+.. ..        ...
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9887544321  222334569999999999875 69999999999999999999998877654321 11        122


Q ss_pred             ccccccccccccccc--Cccccc--hhHHHHH------HHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          730 HAWNLWKDNRAYELL--SPALQH--EASYQML------NRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       730 ~~~~~~~~~~~~~l~--~~~l~~--~~~~~~~------~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..|..+.+-.+.+-+  .|.-.+  ....+..      ...++|+..++..||.+|+.+++++.-
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            234333333333322  111111  1111111      256789999999999999999998854

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.2e-29  Score=264.34  Aligned_cols=238  Identities=29%  Similarity=0.353  Sum_probs=192.4

Q ss_pred             CccceEeeEecC-CcEEEEEEecccChhh-HHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCchhhhcC
Q 003287          525 GFGPVYKGKLLN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD  602 (834)
Q Consensus       525 ~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~  602 (834)
                      +||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999864 8999999997665444 68899999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccccccccc
Q 003287          603 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG  682 (834)
Q Consensus       603 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~  682 (834)
                      ..   .+++..+..++.++++++.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            32   2889999999999999999999987   9999999999999999999999999998764432   2334567889


Q ss_pred             ccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHH
Q 003287          683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  762 (834)
Q Consensus       683 y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~  762 (834)
                      |++||.+....++.++||||||+++++|++|..|+........ ...    ........ .      ..........+.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~----~~~~~~~~-~------~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFK----KIGKPKPP-F------PPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHH----HHhccCCC-C------ccccccCCHHHHH
Confidence            9999999988899999999999999999999999865321110 000    00000000 0      0000003457888


Q ss_pred             HHhcccccCcCCCCCHHHHHH
Q 003287          763 VALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       763 li~~cl~~~P~~RPs~~evl~  783 (834)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.9e-29  Score=284.00  Aligned_cols=261  Identities=21%  Similarity=0.317  Sum_probs=180.0

Q ss_pred             hccCccccceecccCccceEeeEe-----------------cCCcEEEEEEecccChhhHHHH--------------HHH
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKL-----------------LNGQEVAVKRLSSQSGQGLKEF--------------KNE  559 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~~~~~--------------~~E  559 (834)
                      ..++|++.++||+|+||+||+|.+                 .+++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 2356899999875433323333              347


Q ss_pred             HHHHhccCCCce-----eeEeeeEee--------cCeEEEEEEecCCCCchhhhcCCCC---------------------
Q 003287          560 MMLIAKLQHRNL-----VRLMGCCVE--------QGEKILIYEYMPNKSLNFFLFDPSR---------------------  605 (834)
Q Consensus       560 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------  605 (834)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788876654     677777753        3568999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccC
Q 003287          606 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS  685 (834)
Q Consensus       606 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  685 (834)
                      ...+++..+..++.|++++|+|||+.+   |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123467788899999999999999987   99999999999999999999999999976533211 11122334789999


Q ss_pred             cccccCCC--------------------C--CccCCeeeHHHHHHHHhhCCC-CCCCCCcccccc--cc---cccccccc
Q 003287          686 PEYALDGL--------------------F--SVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNL--LG---HAWNLWKD  737 (834)
Q Consensus       686 PE~~~~~~--------------------~--~~ksDVwSlGvil~elltg~~-p~~~~~~~~~~~--~~---~~~~~~~~  737 (834)
                      ||.+....                    +  ..+.||||+||+++||+++.. |+.....-...+  ..   ..|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99885432                    1  134799999999999999875 554221100000  00   01111111


Q ss_pred             cccccccCccccchhHHHHHHHHHHHHhcccccCc---CCCCCHHHHHH
Q 003287          738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKA---ADRPTMSKVVS  783 (834)
Q Consensus       738 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~evl~  783 (834)
                      ...    +    -...........+++..++..+|   .+|+|++|+++
T Consensus       459 ~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            110    0    00111234567788889998765   68999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=285.38  Aligned_cols=246  Identities=27%  Similarity=0.369  Sum_probs=190.3

Q ss_pred             ccccceecccCccc-eEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEecC
Q 003287          515 FSMQCKLGEGGFGP-VYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       515 f~~~~~lG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      |.-.+.+|.|+-|+ ||+|.. +|+.||||++-..   ......+|+..|+.- +|||||++++.-.+.+..||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456789999887 799998 7899999998543   334567899999998 69999999999999999999999994


Q ss_pred             CCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---C--CCeeecccccccccc
Q 003287          593 NKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---D--MNPKISDFGMARMFC  666 (834)
Q Consensus       593 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~--~~vkl~DFGla~~~~  666 (834)
                       -+|.+++... ...........+.+..|+++||+|||+.+   ||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5789998653 11111112456788999999999999987   999999999999976   3  568999999999886


Q ss_pred             CCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhC-CCCCCCCCccccccccccccccccccccccc
Q 003287          667 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ..... .......||-+|+|||++....-+.++||||+||++|+.++| .+||+..-..+.+++.-.      ..+.. +
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~------~~L~~-L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN------YTLVH-L  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc------cceee-e
Confidence            55432 224557899999999999998888899999999999999997 889986544433333211      11111 1


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+.      .++  ...+||.+|+..+|..||++.+|+.
T Consensus       736 ~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 EPL------PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ccC------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            111      111  5678999999999999999999984

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.4e-29  Score=292.95  Aligned_cols=261  Identities=20%  Similarity=0.223  Sum_probs=167.6

Q ss_pred             hccCccccceecccCccceEeeEecC-----CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeee------Ee
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC------CV  579 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~  579 (834)
                      ..++|++.++||+|+||.||+|++.+     +..||||++......  +.+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999754     689999998653221  111111  1112222222222211      24


Q ss_pred             ecCeEEEEEEecCCCCchhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 003287          580 EQGEKILIYEYMPNKSLNFFLFDPSRT-----------------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  642 (834)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIk  642 (834)
                      ++...++||||+++++|.+++......                 .......+..++.||++||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566899999999999999988543210                 01123345679999999999999987   9999999


Q ss_pred             CCcEEEcC-CCCeeeccccccccccCCCcccccccccccccccCcccccCC----------------------CCCccCC
Q 003287          643 ASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG----------------------LFSVKSD  699 (834)
Q Consensus       643 p~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksD  699 (834)
                      |+|||++. ++.+||+|||+++.+.... ........+++.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 6899999999998653322 1122345789999999966432                      2345679


Q ss_pred             eeeHHHHHHHHhhCCCCCCCCCccc---ccccccccccccccccccccCccccch------hHHHHHHHHHHHHhccccc
Q 003287          700 VFSFGVLLLETLTSKRNTGVYDIES---FNLLGHAWNLWKDNRAYELLSPALQHE------ASYQMLNRYITVALLCVQE  770 (834)
Q Consensus       700 VwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~l~~~------~~~~~~~~l~~li~~cl~~  770 (834)
                      ||||||+||||+++..+.......-   ..........|.     ....+....+      ..........+|+.+||+.
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR-----KLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH-----HhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            9999999999999766543210000   000000000000     0111110000      0000112345799999999


Q ss_pred             CcCCCCCHHHHHHH
Q 003287          771 KAADRPTMSKVVSM  784 (834)
Q Consensus       771 ~P~~RPs~~evl~~  784 (834)
                      ||++|||+.|+++-
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999973

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.96  E-value=3e-30  Score=235.07  Aligned_cols=110  Identities=51%  Similarity=0.808  Sum_probs=83.3

Q ss_pred             CCeeEEeeCCCCCCcCC--CceEEEecCCceEEecCCCCeEEee-cCCccc-ccceEEEecCCceEEEeccCCCCCCCce
Q 003287           70 PDTVVWVANRNSPIVDS--NAVLTIGNNGNLVLLNQTDGIIWSS-NLSREV-KNPVAQLLDTGNLVLREKFSSNTSEGSY  145 (834)
Q Consensus        70 ~~~~vW~anr~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~wst-~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~  145 (834)
                      ++||||+|||+.|+.+.  ..+|.|+.||+|+|+|+.++++|+| ++.+.+ ....|+|+|+|||||+|.      .+.+
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~------~~~~   74 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS------SGNV   74 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET------TSEE
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee------cceE
Confidence            47999999999999654  4889999999999999999999999 555554 578899999999999985      7899


Q ss_pred             EEeecCCCCcccccCCccccccccCcceeeEeeccCCCCC
Q 003287          146 LWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS  185 (834)
Q Consensus       146 ~WqSFd~PtDtlLpg~~l~~~~~tg~~~~L~Sw~s~~dps  185 (834)
                      |||||||||||+||||+|+.+..+|.+..++||++.+|||
T Consensus        75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            9999999999999999999988888888899999999997

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=262.26  Aligned_cols=264  Identities=20%  Similarity=0.229  Sum_probs=199.5

Q ss_pred             HHhccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccC-C-C----ceeeEeeeEeec
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H-R----NLVRLMGCCVEQ  581 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~~~  581 (834)
                      ...+++|.+..++|+|.||.|-++.+.. +..||||+++. .....+..+-|++++.++. + |    -+|.+.+++...
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            3447899999999999999999997654 78999999865 3345566788999999993 2 2    378888889999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-----------
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----------  650 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-----------  650 (834)
                      ++.+||+|.+ +-++.++|.+. ....++...+..|+.|+++++++||+..   ++|-||||+|||+.+           
T Consensus       164 ghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence            9999999998 45888999543 3456888999999999999999999987   999999999999932           


Q ss_pred             ---------CCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          651 ---------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       651 ---------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                               +..|||+|||.|..-...     ...++.|..|.|||++.+-.++.++||||+||||+|+.+|..-|..-+
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                     335899999999864322     255788999999999999999999999999999999999999887654


Q ss_pred             ccc-cccccc--------------cccccccc--------------ccccccCccc-cchhHHHHHHHHHHHHhcccccC
Q 003287          722 IES-FNLLGH--------------AWNLWKDN--------------RAYELLSPAL-QHEASYQMLNRYITVALLCVQEK  771 (834)
Q Consensus       722 ~~~-~~~~~~--------------~~~~~~~~--------------~~~~l~~~~l-~~~~~~~~~~~l~~li~~cl~~~  771 (834)
                      ..+ ..+.+.              +...+..+              .+.+...|.. .......+...+.+|+..||..|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            211 111000              00000000              0111111110 01122344567999999999999


Q ss_pred             cCCCCCHHHHHH
Q 003287          772 AADRPTMSKVVS  783 (834)
Q Consensus       772 P~~RPs~~evl~  783 (834)
                      |.+|+|+.|++.
T Consensus       394 P~~RiTl~EAL~  405 (415)
T KOG0671|consen  394 PARRITLREALS  405 (415)
T ss_pred             ccccccHHHHhc
Confidence            999999999885

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=254.56  Aligned_cols=247  Identities=21%  Similarity=0.338  Sum_probs=197.5

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|.++++||+|+|..|.++++.. .+.+|+|++++.   ..+..+-.+.|-.+...- +||.+|-+..++..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            4789999999999999999999864 788999999764   344455566777777666 79999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |.||+++|+|--++   .+.+.++++.+.-+...|.-||.|||+.+   ||.||||..|||+|.+|++||.|+|+.+.--
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999986555   56677999999999999999999999998   9999999999999999999999999998632


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcc--ccccccccccccccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE--SFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~l~  744 (834)
                        .....+...+||+.|+|||++.+..|....|.|+|||+++||+.|+.||+.-..+  +.+-.++....        ++
T Consensus       403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------il  472 (593)
T KOG0695|consen  403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------IL  472 (593)
T ss_pred             --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hh
Confidence              2234556789999999999999999999999999999999999999999754321  11111111111        11


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCC
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRP  776 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP  776 (834)
                      ...+  ..+...+-+...++..-|.+||.+|.
T Consensus       473 ekqi--riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence            1111  12333344556788888999999984

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=275.38  Aligned_cols=242  Identities=24%  Similarity=0.279  Sum_probs=200.5

Q ss_pred             ccCccccceecccCccceEeeEecCCc-EEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQ-EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~-~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..+++.+..||-|+||.|-+++..... .+|+|++++.   +....+....|-.+|...+.|.||+++-.|.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            456777889999999999999876533 4899988765   344567788999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||-|-+|.|...|.+   +..+...+..-++..+.+|++|||+++   ||.|||||+|.+|+.+|-+||.|||+|+.+..
T Consensus       499 mEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            999999999999954   456778888889999999999999998   99999999999999999999999999998754


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-ccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .   ..+...+||+.|.|||++.++..+.++|.||||++++||++|.+||...+.-. .++.      ++.-+..     
T Consensus       573 g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGid~i-----  638 (732)
T KOG0614|consen  573 G---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGIDKI-----  638 (732)
T ss_pred             C---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhhhhh-----
Confidence            3   45667899999999999999999999999999999999999999998765422 1111      1111111     


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCC
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPT  777 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs  777 (834)
                          ..+........+|+.+....+|.+|.-
T Consensus       639 ----~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 ----EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence                223334455677888889999999976

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-29  Score=238.23  Aligned_cols=207  Identities=27%  Similarity=0.386  Sum_probs=171.4

Q ss_pred             HHHhccCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          508 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       508 ~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      ++...+....+..||+|++|.|-+-++. +|+..|+|++... ..+..++.++|+.+..+. .+|.+|.++|...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            4445566667789999999999998874 6999999999765 345667888999887776 799999999999999999


Q ss_pred             EEEEEecCCCCchhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      ++.||.|. .+|+.+..+ -.+...+++..+-+|+..+.+||.|||++-  .+||||+||+|||++.+|++|++|||++-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999994 566665533 245567889999999999999999999864  69999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccC----CCCCccCCeeeHHHHHHHHhhCCCCCCCC
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALD----GLFSVKSDVFSFGVLLLETLTSKRNTGVY  720 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwSlGvil~elltg~~p~~~~  720 (834)
                      .+.++-   ..+...|-..|||||.+..    ..|+.|+||||||+.+.||.+++.|++..
T Consensus       198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            764321   1122457789999999853    36899999999999999999999997753

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.3e-28  Score=266.85  Aligned_cols=208  Identities=24%  Similarity=0.324  Sum_probs=176.3

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEecccCh---hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ...-|..++.||-|+||+|.++...| ...+|+|.|.+.+.   ......++|-.||+.-+.+-||+|+-.|.+++.+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            34568888999999999999997654 56789999987643   345567889999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|++-.+|.   +...+.+..+.-++..+..|+++.|..+   +|||||||.|||||.+|++||.||||+.-+.
T Consensus       707 VMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence            999999999999884   4467888888899999999999999988   9999999999999999999999999985431


Q ss_pred             C---CCcc-------------------------------------cccccccccccccCcccccCCCCCccCCeeeHHHH
Q 003287          667 G---DELQ-------------------------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVL  706 (834)
Q Consensus       667 ~---~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvi  706 (834)
                      -   ..+.                                     ......+||+.|+|||++....|+...|.||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence            0   0000                                     00012479999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCCCccc
Q 003287          707 LLETLTSKRNTGVYDIES  724 (834)
Q Consensus       707 l~elltg~~p~~~~~~~~  724 (834)
                      ||||+.|+.||......+
T Consensus       861 l~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHhhCCCCccCCCCCc
Confidence            999999999998655433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.5e-26  Score=234.77  Aligned_cols=210  Identities=36%  Similarity=0.589  Sum_probs=183.6

Q ss_pred             ecccCccceEeeEecC-CcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCchh
Q 003287          521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF  598 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~  598 (834)
                      ||+|.+|.||+++..+ ++.++||++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999999765432 45789999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeeccccccccccCCCcccccccc
Q 003287          599 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRV  677 (834)
Q Consensus       599 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~  677 (834)
                      ++....  ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985432  35789999999999999999999987   999999999999999 89999999999987643321  12334


Q ss_pred             cccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHH
Q 003287          678 VGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  756 (834)
Q Consensus       678 ~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~  756 (834)
                      .+...|++||..... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999887 888999999999999998                                              


Q ss_pred             HHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          757 LNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       757 ~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             457789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.94  E-value=1.3e-27  Score=217.35  Aligned_cols=108  Identities=36%  Similarity=0.865  Sum_probs=101.7

Q ss_pred             EEecCCCCceecccCCCcc--ccccceeeccCceEEEEEEecCCceeeEEEEccCCCEEEEEEEecCCceEEEEeccCCC
Q 003287          211 SCTGPWNGLAFGADPTNTS--YLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNF  288 (834)
Q Consensus       211 ~~~g~w~g~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~  288 (834)
                      ||+|||||..|.++|++..  .+.+.++.+ .+|++|+|...+.++++|++|+.+|++++|.|++..++|.+.|++|.++
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~-~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~   79 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSN-NEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ   79 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEEC-CCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence            8999999999999999874  567777776 9999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCccccCCCCCcccccccccccc
Q 003287          289 CQLYGYCGANSVCSVDDTANCECLKGFKLKL  319 (834)
Q Consensus       289 Cd~y~~CG~~g~C~~~~~~~C~C~~Gf~~~~  319 (834)
                      ||+|+.||+||+|+.+..+.|+||+||+|++
T Consensus        80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            9999999999999988889999999999974

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=1e-27  Score=231.71  Aligned_cols=257  Identities=20%  Similarity=0.315  Sum_probs=194.6

Q ss_pred             hccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeec--CeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~l  586 (834)
                      ..++|++.+++|+|.+++||.|.. .+.+.++||+++.-   ..+.+++|+++|..|. ||||++++++..+.  ....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            357899999999999999999974 46889999999753   3467889999999997 99999999998765  46789


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeeccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMF  665 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DFGla~~~  665 (834)
                      |+||+.+.+...+.      ..+...++..++.++++||.|+|+.+   |.|||+||.|+++|.. ..++|+|+|||.++
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998876654      35677888999999999999999998   9999999999999964 56999999999987


Q ss_pred             cCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc---
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY---  741 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  741 (834)
                      .+...   -...+.+..|--||.+.+ ..|+..-|+|||||+|.+|+..+.||-.......+++.-+.. +.-+++.   
T Consensus       184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV-LGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV-LGTDELYAYL  259 (338)
T ss_pred             CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH-hChHHHHHHH
Confidence            54321   222345678889999876 458889999999999999999999987655443333221110 0000000   


Q ss_pred             ----cccCcccc----------------chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ----ELLSPALQ----------------HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ----~l~~~~l~----------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          -.++|...                .+...-...+..+++...|..|-.+|||+.|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                00111111                0001112356778999999999999999998763

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.6e-28  Score=240.10  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=189.2

Q ss_pred             ccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeec-----CeEEEEE
Q 003287          517 MQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEKILIY  588 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~  588 (834)
                      -.+.||-|+||.||.+++. +|+.||.|++...-  -...+++.+|+++|..++|.|++..+++..-.     +++|++.
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            3468999999999999875 69999999986432  23457889999999999999999998876543     3567888


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      |.| ..+|..++.   ....++...+.-+..||++||.|||+.+   |.||||||.|.|++++..+||+|||+++....+
T Consensus       137 ELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  137 ELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence            888 456766663   3456777888888999999999999988   999999999999999999999999999976444


Q ss_pred             CcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCc-cccccc----ccc-----cccccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFNLL----GHA-----WNLWKD  737 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~~~~~----~~~-----~~~~~~  737 (834)
                      + ...++..+-|..|.|||.+.+. .|+.+.||||.|||+.||+..+--|..... +..++.    +..     .-..+.
T Consensus       210 ~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  210 D-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             h-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            3 3334455679999999999875 699999999999999999988776654332 222211    100     000000


Q ss_pred             cccccc----cCcc---ccc-hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          738 NRAYEL----LSPA---LQH-EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       738 ~~~~~l----~~~~---l~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                      .+..-+    ..|.   +.. ........+..++..+++..+|+.|.+..+.+.-+..
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            000000    0000   000 0001112344567778899999999999988776543

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=8.4e-26  Score=207.80  Aligned_cols=115  Identities=47%  Similarity=0.787  Sum_probs=102.4

Q ss_pred             cccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCCCCeEEee
Q 003287           32 TLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSS  111 (834)
Q Consensus        32 ~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst  111 (834)
                      ++|.+|++|+|++|.|++|||.+......|.+|||.+.+.++||.||++.| ....+.|.|+.||+|+|+|.+|.++|+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S   80 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS   80 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence            578899999999999999999987654589999998776899999999998 6677899999999999999999999999


Q ss_pred             cCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCC
Q 003287          112 NLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCP  153 (834)
Q Consensus       112 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~P  153 (834)
                      ++.+......|+|+|+|||||++.      .+++||||||||
T Consensus        81 ~~~~~~~~~~~~L~ddGnlvl~~~------~~~~~W~Sf~~P  116 (116)
T cd00028          81 NTTRVNGNYVLVLLDDGNLVLYDS------DGNFLWQSFDYP  116 (116)
T ss_pred             cccCCCCceEEEEeCCCCEEEECC------CCCEEEcCCCCC
Confidence            987633456789999999999986      578999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=5.4e-27  Score=253.03  Aligned_cols=196  Identities=24%  Similarity=0.340  Sum_probs=167.0

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccCh--------hhHHHHHHHHHHHhccC---CCceeeEeeeEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQ---HRNLVRLMGCCV  579 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~  579 (834)
                      ..+|..++.+|+|+||.|+.+.++. ..+|+||.+.+..-        ...-..-.|+++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3568999999999999999999865 67899998876421        11112456999999997   999999999999


Q ss_pred             ecCeEEEEEEecCC-CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecc
Q 003287          580 EQGEKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       580 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                      +++..||+||-... -+|.+++   +....+.+.++..|++||+.|+++||+.+   |||||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            99999999998754 4788888   34456899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccCCCCC-ccCCeeeHHHHHHHHhhCCCCC
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNT  717 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwSlGvil~elltg~~p~  717 (834)
                      ||.|......    .....+||..|.|||++.+..|- ..-|||++|++||-++....|+
T Consensus       714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            9999875433    34457899999999999998874 5579999999999998877775

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.4e-25  Score=231.39  Aligned_cols=199  Identities=34%  Similarity=0.471  Sum_probs=172.9

Q ss_pred             ccccceecccCccceEeeEecC-CcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      |++.+.||+|++|.||++...+ ++.+|||.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999999875 899999999876544 67789999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +++|.+++.....  .+++..+..++.++++++.+||+.+   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence            9999999854321  1789999999999999999999986   9999999999999999999999999998764432 11


Q ss_pred             ccccccccccccCcccc-cCCCCCccCCeeeHHHHHHHHhhCCCCCCC
Q 003287          673 NTKRVVGTYGYMSPEYA-LDGLFSVKSDVFSFGVLLLETLTSKRNTGV  719 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwSlGvil~elltg~~p~~~  719 (834)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22345678899999998 667788899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-27  Score=258.29  Aligned_cols=253  Identities=23%  Similarity=0.353  Sum_probs=202.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|+++.++|+|.||.|||++.. .++..|||+++........-...|+-+++..+|+||+.++|-+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            468999999999999999999975 5889999999877666777788899999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      |.+|+|.+..+   ....+++.++....+...+||+|||+.+   -+|||||-.|||+++.|.+|++|||.+..+..  .
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence            99999998874   3457888999999999999999999988   79999999999999999999999999987632  3


Q ss_pred             ccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          671 QGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      -.+.+...||+.|||||+..   .+.|..++|||++|+...|+---+.|...........      +. -+   ...+|.
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~------Lm-Tk---S~~qpp  235 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF------LM-TK---SGFQPP  235 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH------Hh-hc---cCCCCC
Confidence            34556688999999999874   4679999999999999999877666643222111000      00 00   011111


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      -.. ......+.+.+++..|+..+|.+||+++.+++
T Consensus       236 ~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            111 12234456778999999999999999987654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.8e-26  Score=245.89  Aligned_cols=264  Identities=20%  Similarity=0.210  Sum_probs=204.2

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccC------CCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ------HRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~~  583 (834)
                      ...+|.+....|+|-|++|..|.... |+.||||+|..+ +...+.=+.|+++|++|+      --|+++|+-.|....+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            45789999999999999999998764 889999999764 334455578999999995      2489999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-Ceeecccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMA  662 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla  662 (834)
                      +|||+|-+ .-+|.++|.+....-.|....+..++.|+.-||..|-..+   |+|.||||.||||++.. .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999987 4678999987767777888999999999999999999887   99999999999998765 5799999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc----------------
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN----------------  726 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~----------------  726 (834)
                      ......+    .+...-+..|.|||++.+.+|+...|+||.||.||||.||+-.|.......+.                
T Consensus       585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            8765433    33345577899999999999999999999999999999999777654332210                


Q ss_pred             --------------cccccccccccc---ccccccCc-----------cccchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          727 --------------LLGHAWNLWKDN---RAYELLSP-----------ALQHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       727 --------------~~~~~~~~~~~~---~~~~l~~~-----------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                                    ++......+.+.   .+...+.|           .-.++........+.+|+..|+..||++|.+.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                          000000000000   00111111           01123445667789999999999999999999


Q ss_pred             HHHHH
Q 003287          779 SKVVS  783 (834)
Q Consensus       779 ~evl~  783 (834)
                      .|.|+
T Consensus       741 nqAL~  745 (752)
T KOG0670|consen  741 NQALK  745 (752)
T ss_pred             HHHhc
Confidence            98875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7.5e-25  Score=232.95  Aligned_cols=133  Identities=26%  Similarity=0.328  Sum_probs=110.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-----C---CceeeEeeeEee--
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLMGCCVE--  580 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--  580 (834)
                      ..+|.+.++||-|.|++||++.+. ..+.||+|+.+.. ....+..+.||++|++++     |   ..||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            368999999999999999999864 5789999998653 344566789999999983     3   379999999975  


Q ss_pred             --cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          581 --QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       581 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                        +.+.+||+|++.. +|..+|.. ...+.++...+.+|++||+.||.|||..+  +|||-||||+|||+.
T Consensus       156 pNG~HVCMVfEvLGd-nLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLGD-NLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhhhh-HHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              4589999999954 55555543 24456889999999999999999999987  799999999999993

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=7.7e-26  Score=229.63  Aligned_cols=259  Identities=25%  Similarity=0.257  Sum_probs=190.6

Q ss_pred             cCccccceecccCccceEeeEe-cCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------Ce
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GE  583 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  583 (834)
                      .+|.-++.+|.|.- .|..+-+ ..+++||+|++...  .....++..+|..++..++|+|+++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56777778999988 5555543 35899999988543  234567788999999999999999999998643      36


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .|+|||+|. .+|...+.     -.++-.+...|..|++.|++|||+.+   |+||||||+||++..++.+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            799999994 56666663     23556788899999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCc-cccc----------------
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFN----------------  726 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~~~----------------  726 (834)
                      .-..   .-..+..+.|+.|.|||++.+..+.+.+||||+||++.||++|.--|.+.+. ++..                
T Consensus       167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            6322   2345667889999999999998899999999999999999999987764331 1110                


Q ss_pred             cccccccccc------cccccccc-Cccccc--hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          727 LLGHAWNLWK------DNRAYELL-SPALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       727 ~~~~~~~~~~------~~~~~~l~-~~~l~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +...+.....      .-...+++ |.....  +.+........+++..||-.+|++|.+.+++++-
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0000011110      00111111 111111  1112233456789999999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=2.3e-25  Score=234.50  Aligned_cols=264  Identities=23%  Similarity=0.341  Sum_probs=196.7

Q ss_pred             HhccCccccceecccCccceEeeEecC----CcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      ...+.|..+++||+|.|++||++.+..    .+.||+|.+...+  ...+..+|+++|..+ -+.||+++.+++..++..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            344788999999999999999998643    6789999987653  346688999999999 599999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeeccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMAR  663 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~  663 (834)
                      .+|+||+++....+++.      .++..++..+++.+.+||+++|+.+   ||||||||+|+|.+. -+.-.|.|||||.
T Consensus       111 ~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence            99999999999888883      3567889999999999999999998   999999999999974 4677899999997


Q ss_pred             cccCC------------------------------------------CcccccccccccccccCcccccC-CCCCccCCe
Q 003287          664 MFCGD------------------------------------------ELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDV  700 (834)
Q Consensus       664 ~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV  700 (834)
                      .....                                          ..........||++|.|||++.. ...++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            21000                                          00001112469999999999975 457899999


Q ss_pred             eeHHHHHHHHhhCCCCCCCCCcccccccccc-----------------cccccccccc---------cccC-----c---
Q 003287          701 FSFGVLLLETLTSKRNTGVYDIESFNLLGHA-----------------WNLWKDNRAY---------ELLS-----P---  746 (834)
Q Consensus       701 wSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~---------~l~~-----~---  746 (834)
                      ||.|||++-+++++.||-....+-..+.+.+                 ...|....+.         +-++     +   
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            9999999999999999865443322111100                 0011101100         0010     0   


Q ss_pred             -cccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          747 -ALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       747 -~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ..... ........+.+++.+|+..+|.+|.++++.|+-
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence             00111 111223478899999999999999999998853

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.5e-25  Score=217.50  Aligned_cols=253  Identities=19%  Similarity=0.307  Sum_probs=189.7

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeee-EeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC-CVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~  588 (834)
                      .+.|.+.+.||+|.||.+-+++++. .+.+|+|.+.... ...++|.+|...--.| .|.||+.-+++ |...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3679999999999999999999864 7789999887542 3457899999876666 68999987765 55667888999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc--CCCCeeecccccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMFC  666 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~~vkl~DFGla~~~~  666 (834)
                      ||+|.|+|..-+.    ...+.+....+++.|++.|+.|+|+++   +||||||.+||||-  +..++||+|||+.+...
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999988873    345778888999999999999999998   99999999999993  44589999999987532


Q ss_pred             CCCcccccccccccccccCcccccCC-----CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDG-----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                           .......-+..|.|||.....     ...+.+|||.||++++.++||+.||.........+.  .|..|..+...
T Consensus       175 -----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~--~~~~w~~rk~~  247 (378)
T KOG1345|consen  175 -----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW--EWEQWLKRKNP  247 (378)
T ss_pred             -----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH--HHHHHhcccCc
Confidence                 112233456789999987543     256789999999999999999999985444333232  23344443333


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHh
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  785 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L  785 (834)
                      .+.+  .    -..+.+.+.++..+-+..++++|=...++.++.
T Consensus       248 ~~P~--~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 ALPK--K----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cCch--h----hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            2211  1    112345566788888999999995555555553

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=5.8e-24  Score=195.08  Aligned_cols=113  Identities=45%  Similarity=0.787  Sum_probs=98.7

Q ss_pred             cccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCCCCeEEee
Q 003287           32 TLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSS  111 (834)
Q Consensus        32 ~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst  111 (834)
                      +.|..|++|+|++|.|++|||.+... ..+.+|||+..+.++||+|||+.|+.+ ++.|.|+.||+|+|+|.+|.++|+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S   79 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS   79 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence            56888999999999999999998654 679999998766789999999999654 4889999999999999999999999


Q ss_pred             cCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCC
Q 003287          112 NLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (834)
Q Consensus       112 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~  152 (834)
                      ++........|+|+|+|||||++.      .++++||||||
T Consensus        80 ~t~~~~~~~~~~L~ddGnlvl~~~------~~~~~W~Sf~~  114 (114)
T smart00108       80 NTTGANGNYVLVLLDDGNLVIYDS------DGNFLWQSFDY  114 (114)
T ss_pred             cccCCCCceEEEEeCCCCEEEECC------CCCEEeCCCCC
Confidence            987333456789999999999985      56899999997

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.1e-24  Score=266.26  Aligned_cols=197  Identities=19%  Similarity=0.230  Sum_probs=138.8

Q ss_pred             ccCC-CceeeEeeeE-------eecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003287          565 KLQH-RNLVRLMGCC-------VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI  636 (834)
Q Consensus       565 ~l~H-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  636 (834)
                      .++| +||+++++.|       .+....++++||+ .++|.++|...  ...+++.++..++.||++||+|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4455 5777788877       2334677888987 56999999542  345899999999999999999999987   9


Q ss_pred             EecCCCCCcEEEcC-------------------CCCeeeccccccccccCCCc--------------ccccccccccccc
Q 003287          637 IHRDLKASNILLDS-------------------DMNPKISDFGMARMFCGDEL--------------QGNTKRVVGTYGY  683 (834)
Q Consensus       637 iH~DIkp~NILl~~-------------------~~~vkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  683 (834)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   45566777777654211000              0001123578899


Q ss_pred             cCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHH
Q 003287          684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITV  763 (834)
Q Consensus       684 ~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~l  763 (834)
                      ||||++.+..++.++|||||||+||||++|..|+......    ..    ...    .....+..     .........+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~----~~~----~~~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MS----SLR----HRVLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HH----HHH----HhhcChhh-----hhcCHHHHHH
Confidence            9999999999999999999999999999988775421100    00    000    00111110     1112345678


Q ss_pred             HhcccccCcCCCCCHHHHHHH
Q 003287          764 ALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       764 i~~cl~~~P~~RPs~~evl~~  784 (834)
                      +.+||+.+|.+||+|.|+++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            889999999999999999863

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.3e-22  Score=221.52  Aligned_cols=175  Identities=20%  Similarity=0.244  Sum_probs=134.5

Q ss_pred             hccCccccceecccCccceEeeEec--CCcEEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~--~g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      ...+|++.+.||+|+||+||+|+..  +++.||||++...     .....+.|.+|+++|.+++|+|+++.+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            3478999999999999999999875  4777899987533     12345679999999999999999853322   246


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC-CCCcEEEcCCCCeeecccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DI-kp~NILl~~~~~vkl~DFGla  662 (834)
                      .+|||||+++++|....  .     ..   ...++.+++++|+|||+.+   |+|||| ||+|||++.++.+||+|||+|
T Consensus        93 ~~LVmE~~~G~~L~~~~--~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         93 DGLVRGWTEGVPLHLAR--P-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             cEEEEEccCCCCHHHhC--c-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            79999999999996321  1     01   1467889999999999987   999999 999999999999999999999


Q ss_pred             ccccCCCccc------ccccccccccccCcccccCCC------CCccCCee
Q 003287          663 RMFCGDELQG------NTKRVVGTYGYMSPEYALDGL------FSVKSDVF  701 (834)
Q Consensus       663 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~~~ksDVw  701 (834)
                      +.+.......      ......+++.|+|||.+....      .+..+|-|
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9775432111      113466888999999986533      33446766

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=220.23  Aligned_cols=275  Identities=20%  Similarity=0.256  Sum_probs=202.0

Q ss_pred             CccccceecccCccceEeeEecCC--cEEEEEEecccChhhHHHHHHHHHHHhccCC----CceeeEeeeE-eecCeEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLNG--QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH----RNLVRLMGCC-VEQGEKIL  586 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l  586 (834)
                      +|++.++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    .++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  5889998766543333378889999999873    5888898888 47778999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-----CCeeeccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGM  661 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-----~~vkl~DFGl  661 (834)
                      ||+.+ +.+|.++..... .+.++..+.+.|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 678888764433 567999999999999999999999998   9999999999999865     4689999999


Q ss_pred             cc--cccCCCc-----ccc-cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc
Q 003287          662 AR--MFCGDEL-----QGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       662 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  733 (834)
                      ++  .+.....     ... .....||.+|.+++.+.+...+.+.|+||+++++.|++.|..||........ .     .
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~-----~  247 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-K-----S  247 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-H-----H
Confidence            99  3322221     111 2235699999999999999999999999999999999999999865432111 0     0


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccccc
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR  804 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~  804 (834)
                      ............. .    .......+.++...+-..+..++|....+...|.............++.|..
T Consensus       248 ~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~  313 (322)
T KOG1164|consen  248 KFEKDPRKLLTDR-F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEV  313 (322)
T ss_pred             HHHHHhhhhcccc-c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccc
Confidence            0000000011110 0    1111233445555555689999999999999988775555455445555544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=7.7e-23  Score=203.41  Aligned_cols=167  Identities=18%  Similarity=0.102  Sum_probs=124.5

Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      |+|.+++...  ...+++.++..++.||++||+|||+.+         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            6788888532  346899999999999999999999875         999999999999999  99998753321    


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhH
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  753 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~  753 (834)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+...    .. . ... ..+... ...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~----~~-~-~~~-~~~~~~-~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL----LN-G-MPA-DDPRDR-SNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH----HH-H-hcc-CCcccc-ccH
Confidence               258899999999999999999999999999999999999986432211100000    00 0 000 000000 111


Q ss_pred             HHHHH--HHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          754 YQMLN--RYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       754 ~~~~~--~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .....  .+.+++..||+.+|++||++.|+++.+...
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22222  689999999999999999999999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-22  Score=205.38  Aligned_cols=278  Identities=18%  Similarity=0.227  Sum_probs=212.8

Q ss_pred             ccCccccceecccCccceEeeE-ecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .-.|++.++||+|.||+++.|+ +-+++.||||.-...++  ..++..|....+.| ..++|..++-+-.++.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            4579999999999999999997 45799999998654432  24566777777777 56899999999899999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-----CCeeecccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGMARM  664 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-----~~vkl~DFGla~~  664 (834)
                      .+ +-+|.++..  --.+.++.+++..+|.|++.-++|+|+++   +|.|||||+|+||...     ..+.|+|||+|+.
T Consensus       105 LL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            98 556766552  13456899999999999999999999998   9999999999999744     3489999999998


Q ss_pred             ccCCCc-----ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          665 FCGDEL-----QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       665 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +.+...     ....+...||.+||+-..+.+...+.+.|+-|||-++++.|.|..||........   ...++.+.+. 
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn---K~kYeKIGe~-  254 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN---KEKYEKIGET-  254 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch---HHHHHHhccc-
Confidence            865432     2334557899999999999999999999999999999999999999987553221   0011111111 


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCccccccc
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR  805 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~~  805 (834)
                          -...-..+....++.++..-+.-.-..+-++-|.++-+...+......+..-.+-.|.|-.-
T Consensus       255 ----Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l  316 (449)
T KOG1165|consen  255 ----KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL  316 (449)
T ss_pred             ----cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence                11111122333445566666666777788999999999999888878888777777777443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.8e-22  Score=197.12  Aligned_cols=275  Identities=18%  Similarity=0.221  Sum_probs=211.8

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCC-CceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ..+|.++++||+|+||.+|.|.. .+|.+||||.-+....  ..++..|.++...|+| ..|..+..+..+...-.||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            47899999999999999999975 5799999998765433  3456778899999975 678888889999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC---CCeeecccccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMFC  666 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~vkl~DFGla~~~~  666 (834)
                      .+ +-+|.++..-  -.+.++..+++-++-|++.-++|+|.++   +|||||||+|+|+.-+   ..+.++|||||+.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 5577666521  2345778899999999999999999998   9999999999999744   468999999999875


Q ss_pred             CCCc-----ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          667 GDEL-----QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       667 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      +...     ........||.+|.+-..+.+...+.+.|+-|+|++|.++..|..||.......-   .+.++...+....
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKKMS  242 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhhcC
Confidence            4432     2233456799999999988888899999999999999999999999987543211   1111111122111


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccc
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY  802 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~  802 (834)
                      .     ........++.++.-.+..|-...-++-|...-+.+++.-+...+.--.+--|.|
T Consensus       243 ~-----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW  298 (341)
T KOG1163|consen  243 T-----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW  298 (341)
T ss_pred             C-----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence            1     1112233344566678888999999999999999999888877777776666666

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.9e-23  Score=205.48  Aligned_cols=249  Identities=20%  Similarity=0.356  Sum_probs=191.8

Q ss_pred             CccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +..+.-+|.+...|+.|+|+++ |..+++|++...  .......|.+|.-.|+.+.||||+.++|.|.....+.++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            3445668999999999999994 556777887644  2334467999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec--cccccccccCCC
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS--DFGMARMFCGDE  669 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~--DFGla~~~~~~~  669 (834)
                      +.|+|...|++. ..-..+..++++++.+||+|++|||+..+ -|..--|.++.+++|++.+.+|+  |--++.+     
T Consensus       270 p~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq-----  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-----  342 (448)
T ss_pred             cchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee-----
Confidence            999999999764 33456778899999999999999999873 23444689999999999988774  3222221     


Q ss_pred             cccccccccccccccCcccccCCCCC---ccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFS---VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                          .....-.+.||+||.+..++-+   .++|+|||+++||||.|...||.....-+.-.              .+.-.
T Consensus       343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------kiale  404 (448)
T KOG0195|consen  343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------KIALE  404 (448)
T ss_pred             ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------hhhhc
Confidence                1112236789999999876643   57899999999999999999998655332211              11111


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .++...++.....+.+|+.-|...||.+||.+..++-.|+..
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            223334445566788899999999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=3.9e-20  Score=200.45  Aligned_cols=260  Identities=30%  Similarity=0.378  Sum_probs=197.5

Q ss_pred             ccccceecccCccceEeeEecCCcEEEEEEecccChh---hHHHHHHHHHHHhccCCC-ceeeEeeeEeecCeEEEEEEe
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+++......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999986  88999999765332   467899999999999988 799999999777778999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-CeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~~~~~  669 (834)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++||||||+||+++..+ .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977643221136888999999999999999999988   99999999999999998 79999999998654433


Q ss_pred             ccc----ccccccccccccCcccccC---CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcc--ccccccccccccccccc
Q 003287          670 LQG----NTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE--SFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       670 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  740 (834)
                      ...    ......|+..|+|||.+.+   ..+....|+||+|++++++++|..|+......  .......    ......
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----ILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH----HHhcCC
Confidence            221    3456789999999999988   57889999999999999999999996654321  0000000    000000


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      . .................+.+++..++..+|..|.++.+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000000000001223456778888999999999999887764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.8e-21  Score=226.16  Aligned_cols=255  Identities=19%  Similarity=0.235  Sum_probs=191.4

Q ss_pred             cccceecccCccceEeeEec-CCcEEEEEEec----c-cChhh-HHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          516 SMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS----S-QSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       516 ~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~----~-~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ...+.+|.|++|.|+..... .....+.|...    . ..... ...+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34578999999988877643 23334444332    1 11111 222667888888999999999888887777766679


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++ +|..++..   ...+...++..++.|+..|++|||+.+   |.|||||++|+++..+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 99888833   236788899999999999999999998   999999999999999999999999999877554


Q ss_pred             Ccc--cccccccccccccCcccccCCCCCcc-CCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQ--GNTKRVVGTYGYMSPEYALDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ...  .......|...|+|||++.+..|.+. .||||.|+++..|++|+.||.................       +.-.
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~-------~~~~  546 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD-------QRNI  546 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc-------cccc
Confidence            433  44556789999999999999999875 7999999999999999999986554322110000000       0001


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..-........+.+...++..+|+.+|.+|.|+++|++.
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            111123455666778889999999999999999999865

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=2.4e-20  Score=189.63  Aligned_cols=171  Identities=15%  Similarity=0.160  Sum_probs=134.4

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhH---HH------HHHHHHHHhccCCCceeeEeeeEeec
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL---KE------FKNEMMLIAKLQHRNLVRLMGCCVEQ  581 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~~~~~~~  581 (834)
                      ...+|++.+.||.|+||.||+... ++..+|||.+........   ..      +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            358999999999999999999766 577899999975432222   22      68999999999999999999886643


Q ss_pred             --------CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC
Q 003287          582 --------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  653 (834)
Q Consensus       582 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~  653 (834)
                              ...+|||||+++.+|.++..       ++.    ....+++.+|..||..+   ++||||||+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35799999999999987641       222    34569999999999988   99999999999999988 


Q ss_pred             eeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHh
Q 003287          654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL  711 (834)
Q Consensus       654 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ell  711 (834)
                      ++|+|||..........   .           ..++....+..++|+|+|||.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999998875421110   0           01344556778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=8.3e-20  Score=183.51  Aligned_cols=139  Identities=17%  Similarity=0.167  Sum_probs=108.2

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChh--h-------HHH-----------------HHHHHHHHhccCCCce
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL  571 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni  571 (834)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999654211  1       112                 2349999999988776


Q ss_pred             eeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecCCCCCcEEEcC
Q 003287          572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDS  650 (834)
Q Consensus       572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~DIkp~NILl~~  650 (834)
                      .....+..  ...+|||||++++++...+.   ....++..+...++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  23489999999987765432   224678899999999999999999 5766   99999999999998 


Q ss_pred             CCCeeeccccccccc
Q 003287          651 DMNPKISDFGMARMF  665 (834)
Q Consensus       651 ~~~vkl~DFGla~~~  665 (834)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=6.1e-19  Score=177.72  Aligned_cols=140  Identities=19%  Similarity=0.215  Sum_probs=111.2

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChh--------------------------hHHHHHHHHHHHhccCCCce
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--------------------------GLKEFKNEMMLIAKLQHRNL  571 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni  571 (834)
                      ...||+|+||.||+|+..+|+.||||+++.....                          ....+..|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754211                          01234679999999999987


Q ss_pred             eeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcC
Q 003287          572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS  650 (834)
Q Consensus       572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~  650 (834)
                      .....+...  ..+|||||++++++.....   ....++..+...++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            554444332  3489999999886543321   12346788899999999999999999 77   99999999999999 


Q ss_pred             CCCeeecccccccccc
Q 003287          651 DMNPKISDFGMARMFC  666 (834)
Q Consensus       651 ~~~vkl~DFGla~~~~  666 (834)
                      ++.++|+|||++..+.
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8999999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=3.3e-20  Score=214.08  Aligned_cols=251  Identities=20%  Similarity=0.199  Sum_probs=179.4

Q ss_pred             CccccceecccCccceEeeEecCCcEEEEEEecccChh-hHHHHH---HHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-GLKEFK---NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++...+.||++.|=+|.++++++|. |+||++-+..+. ..+.|+   .|++ ...++|||++++.-.-..+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999998887 999999766532 334444   4444 556699999999888777778889999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC-C
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-D  668 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~-~  668 (834)
                      |+.+ +|.+-|   ..+..+...+...|+.|++.||..+|..+   |+|||||.+||||+.-.-+.|+||..-+...- +
T Consensus       102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9865 444444   34556777888899999999999999998   99999999999999999999999987765322 1


Q ss_pred             Cccccc----ccccccccccCcccccCC----------C-CCccCCeeeHHHHHHHHhhC-CCCCCCCCccccccccccc
Q 003287          669 ELQGNT----KRVVGTYGYMSPEYALDG----------L-FSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       669 ~~~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~ksDVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~  732 (834)
                      +.....    .....-.+|+|||.+...          . .+++.||||+||++.||++- +++|....     +..+. 
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr-  248 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYR-  248 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHh-
Confidence            111111    122334589999987542          1 57899999999999999985 55554211     11110 


Q ss_pred             ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       733 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                       .........++.        .-+...+.+++..|++.||+.|.+++++++.-.+.
T Consensus       249 -~~~~~~~e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  249 -SGNADDPEQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -ccCccCHHHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             000000000000        00112577899999999999999999999985543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=5.2e-19  Score=196.35  Aligned_cols=217  Identities=24%  Similarity=0.387  Sum_probs=164.5

Q ss_pred             HhccCCCceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 003287          563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  642 (834)
Q Consensus       563 l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIk  642 (834)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..  ....+++.-...++++|++||+|||+..  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999965  3456888999999999999999999865  23999999


Q ss_pred             CCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCC-------CCccCCeeeHHHHHHHHhhCCC
Q 003287          643 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-------FSVKSDVFSFGVLLLETLTSKR  715 (834)
Q Consensus       643 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDVwSlGvil~elltg~~  715 (834)
                      ++|+++|....+||+|||+.................-..-|.|||.+....       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999988764311111112222345799999987642       4677999999999999999999


Q ss_pred             CCCCCCcccc--cccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          716 NTGVYDIESF--NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       716 p~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ||........  .+...   . +. .....+.|.+....  +....+..++..||..+|++||+++++-..++.+..
T Consensus       157 ~~~~~~~~~~~~eii~~---~-~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILR---V-KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHH---H-Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9986432221  11111   1 11 11122223222111  344478899999999999999999999999988744

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=7.7e-18  Score=167.59  Aligned_cols=184  Identities=16%  Similarity=0.125  Sum_probs=138.1

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEEecccChh----hHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEEec
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ----GLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +...|++|+||+||.+.. .+.+++.+.+.....-    ....|.+|+++|.+|+ |+++++++++    ...+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            557899999999997766 6788888887654321    1235889999999995 5889999886    4569999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC-CCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DI-kp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++.+|...+.         . ....++.|++++|+++|+.+   |+|||| ||+|||++.++.++|+|||+|........
T Consensus        81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9998865431         0 12457889999999999998   999999 79999999999999999999986543221


Q ss_pred             c----c--c-----cccccccccccCcccccCC-CCC-ccCCeeeHHHHHHHHhhCCCCCC
Q 003287          671 Q----G--N-----TKRVVGTYGYMSPEYALDG-LFS-VKSDVFSFGVLLLETLTSKRNTG  718 (834)
Q Consensus       671 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~~-~ksDVwSlGvil~elltg~~p~~  718 (834)
                      .    .  .     ......++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+.-
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            0    0  0     0012357777888765432 233 56789999999999999988743

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=3e-19  Score=194.20  Aligned_cols=171  Identities=25%  Similarity=0.309  Sum_probs=126.6

Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++.|++|...+|.++|.+.......++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhee
Confidence            56778888888888888766666677788889999999999999   44   9999999999999999999999999987


Q ss_pred             cccCCC----cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccc
Q 003287          664 MFCGDE----LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  738 (834)
Q Consensus       664 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  738 (834)
                      ......    .....+...||..||+||.+.+..|+.|+||||||+||+|++. -..++...                 +
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------------~  467 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------------A  467 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------H
Confidence            664433    2234455789999999999999999999999999999999997 22221110                 0


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                      ...++-+-.+.+....+.+ .-..++.+++...|.+||++
T Consensus       468 t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  468 TLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             hhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchH
Confidence            0111111122212222222 22468899999999999933

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=4.8e-18  Score=177.91  Aligned_cols=234  Identities=18%  Similarity=0.226  Sum_probs=150.8

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEeccc---ChhhHHHHHHHHHHHhccCC----------CceeeEeeeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLMGCC  578 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H----------~niv~l~~~~  578 (834)
                      ..+...+.||.|+++.||.+++.+ ++++|||++...   .....+++++|...+..+.+          -.++..++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            345667899999999999999875 899999987533   23456778888776666432          2222222222


Q ss_pred             e---------ecC--------eEEEEEEecCCCCchhhhc---CC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 003287          579 V---------EQG--------EKILIYEYMPNKSLNFFLF---DP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII  637 (834)
Q Consensus       579 ~---------~~~--------~~~lV~Ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  637 (834)
                      .         ...        ..+++|+-+ .++|.+++.   .. .....+....+..+..|+++.+++||+.+   ++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            1         111        235677766 567776652   11 11223445566778899999999999998   99


Q ss_pred             ecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccC--------CCCCccCCeeeHHHHHHH
Q 003287          638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD--------GLFSVKSDVFSFGVLLLE  709 (834)
Q Consensus       638 H~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwSlGvil~e  709 (834)
                      |+||+|+|++++.+|.++|+||+.........     .....+..|.+||....        ..++.+.|.|+||+++|.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            99999999999999999999998876532111     11234578999997743        247889999999999999


Q ss_pred             HhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCC
Q 003287          710 TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR  775 (834)
Q Consensus       710 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R  775 (834)
                      |.++..|++....+.....                   ....+. +.++.+..||..+|+.+|++|
T Consensus       243 lWC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999986433221100                   111233 667788899999999999998

>PRK10345 hypothetical protein; Provisional

Probab=99.72  E-value=3.1e-17  Score=166.43  Aligned_cols=136  Identities=22%  Similarity=0.264  Sum_probs=106.1

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-----CCCceeeEeeeEeecC---e-EEEE
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-----QHRNLVRLMGCCVEQG---E-KILI  587 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~lV  587 (834)
                      -.+.||+|+||.||.  +++....+||++........+.+.+|+.++..+     +||||++++|++.++.   . ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            346899999999996  433333479998765444567899999999999     5799999999998874   3 3378


Q ss_pred             EEe--cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCceEecCCCCCcEEEcC----CCCeeecccc
Q 003287          588 YEY--MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL-LYLHQYSRLRIIHRDLKASNILLDS----DMNPKISDFG  660 (834)
Q Consensus       588 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~DIkp~NILl~~----~~~vkl~DFG  660 (834)
                      +||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  5689999999442    24444  35677888777 9999988   999999999999974    3479999954


Q ss_pred             ccc
Q 003287          661 MAR  663 (834)
Q Consensus       661 la~  663 (834)
                      -+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.1e-18  Score=193.20  Aligned_cols=225  Identities=24%  Similarity=0.293  Sum_probs=175.9

Q ss_pred             eecccCccceEeeEe----cCCcEEEEEEecccChh--hHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEEecC
Q 003287          520 KLGEGGFGPVYKGKL----LNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      .+|+|.||.|++++-    +.|+-+|+|.+.+....  .......|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998753    34778899988765321  1125567888888886 9999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|.|...+.   ....+.+.....+...++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+++..-...   
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            999877663   3344566677777788999999999998   9999999999999999999999999998763322   


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                         ..+||..|||||++.  .....+|.||||++++||+||..||.....                  ..++.  .....
T Consensus       152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~------------------~~Il~--~~~~~  206 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTM------------------KRILK--AELEM  206 (612)
T ss_pred             ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHH------------------HHHhh--hccCC
Confidence               128999999999998  567889999999999999999999885100                  01111  11223


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                      +.+......+++..+...+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            44555666677888888888888654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=2.2e-17  Score=195.45  Aligned_cols=198  Identities=22%  Similarity=0.241  Sum_probs=161.1

Q ss_pred             HHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC---CCceeeEeeeEeecCeEE
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~  585 (834)
                      ....+.|.+.+.||+|+||+||+|...+|+.||+|+-+....   -+|.--.+++.+|+   -+-|+.+..++.-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            345578999999999999999999988899999998765432   12222334455554   234555555666677889


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-------CCCCeeecc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-------SDMNPKISD  658 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-------~~~~vkl~D  658 (834)
                      ||+||.+.|+|.+++.   ..+.++|..+..++.|+++.+++||..+   |||+||||+|+||.       ....++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999995   5677999999999999999999999988   99999999999994       345689999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCC
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR  715 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~  715 (834)
                      ||-+..+.--..........+|-.+-.+|...+..++.++|.|.++.+++-||.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999976544333345566778999999999999999999999999999999999875

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.3e-16  Score=165.85  Aligned_cols=151  Identities=17%  Similarity=0.144  Sum_probs=116.2

Q ss_pred             HHHHHHhccCccccceecccCccceEeeE--ecCCcEEEEEEecccChh------------------------hHHHHHH
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQ------------------------GLKEFKN  558 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~--~~~g~~vAVK~l~~~~~~------------------------~~~~~~~  558 (834)
                      +.++.....-|++.+.||+|+||.||+|.  ..+|+.||||++......                        ....+..
T Consensus        20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (237)
T smart00090       20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK   99 (237)
T ss_pred             HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence            34445555678999999999999999998  567999999998643210                        1123578


Q ss_pred             HHHHHhccCCC--ceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003287          559 EMMLIAKLQHR--NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI  636 (834)
Q Consensus       559 E~~~l~~l~H~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  636 (834)
                      |+.++.++.+.  .+.++++.    ...++||||+++++|......   ...+...+...++.||+.++++||+.+  .|
T Consensus       100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~i  170 (237)
T smart00090      100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--EL  170 (237)
T ss_pred             HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CE
Confidence            99999999753  34444442    235899999999888765422   223455667899999999999999876  49


Q ss_pred             EecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          637 IHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       637 iH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||||+||+++ ++.++|+|||++...
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999999999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=2.2e-16  Score=162.01  Aligned_cols=134  Identities=20%  Similarity=0.299  Sum_probs=114.1

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccCh--------hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +.||+|++|.||+|.. .|..|+||+......        .....+.+|+.++..++|+++.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 678899998654321        1224578899999999999988888787788889999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +++++|.+++...      .. ++..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988432      12 78899999999999999987   99999999999999 88999999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=3.1e-16  Score=159.20  Aligned_cols=145  Identities=19%  Similarity=0.174  Sum_probs=114.0

Q ss_pred             HHHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccCh----------------------hhHHHHHHHHHHH
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG----------------------QGLKEFKNEMMLI  563 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~----------------------~~~~~~~~E~~~l  563 (834)
                      .++......|.+.+.||+|+||.||++...+|+.||||++.....                      .....+..|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            345555556888899999999999999988899999998754320                      0112367789999


Q ss_pred             hccCCCc--eeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC
Q 003287          564 AKLQHRN--LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL  641 (834)
Q Consensus       564 ~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DI  641 (834)
                      ..+.|++  +.+.++    ....++||||+++++|......         .....++.++++++.++|+.+   |+||||
T Consensus        88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence            9998874  444443    2456899999999998765420         235678899999999999987   999999


Q ss_pred             CCCcEEEcCCCCeeecccccccccc
Q 003287          642 KASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       642 kp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||+||++++++.++|+|||++..+.
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.66  E-value=4.5e-17  Score=132.89  Aligned_cols=66  Identities=45%  Similarity=1.095  Sum_probs=58.9

Q ss_pred             ccccceEEEeeccCCCcccccccccccChHHHHHHHhhcccccccccccccCCCccceeeccccccc
Q 003287          337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDI  403 (834)
Q Consensus       337 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~g~~~c~~w~~~l~~~  403 (834)
                      |+.+|+|+++++|++|++....+..++++++|++.||+||||+||+|.+.. ++++|++|+++|+|+
T Consensus         1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL   66 (66)
T ss_pred             CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence            555699999999999999777766779999999999999999999998665 678999999999985

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=5.7e-16  Score=157.35  Aligned_cols=130  Identities=22%  Similarity=0.351  Sum_probs=107.2

Q ss_pred             eecccCccceEeeEecCCcEEEEEEecccCh--------hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .||+|+||.||+|.. ++..|++|.......        ....++.+|++++..++|+++.....++.+....++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998653211        12356788999999999887666555666677789999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++++|.+++....          ..++.+++++|++||+.+   ++|+|++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988873321          078999999999999987   99999999999999 89999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=6.9e-16  Score=180.32  Aligned_cols=136  Identities=21%  Similarity=0.324  Sum_probs=112.1

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEE-eccc-C------hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR-LSSQ-S------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~-l~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      ..|...++||+|+||+||+|.+... .+++|+ +.+. .      ....+++.+|++++.+++|++++....++.+....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            4456678999999999999987544 344443 2221 1      11235688999999999999999888888887888


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999998873           45789999999999999987   9999999999999 678999999999975

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=3.9e-16  Score=180.94  Aligned_cols=227  Identities=21%  Similarity=0.247  Sum_probs=150.1

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..+|..+++|..|+||.||..+++. .+.+|+| +.++.--    .++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence            3689999999999999999999865 6788884 4332110    011   22223344433                  


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC--
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--  668 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~--  668 (834)
                         |+-...+.   ....++..        ++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++..-..  
T Consensus       136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               33333332   22223322        278999999988   999999999999999999999999999764211  


Q ss_pred             -----------CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc-ccccccccc
Q 003287          669 -----------ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGHAWNLWK  736 (834)
Q Consensus       669 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~  736 (834)
                                 ..+-..+.++||+.|+|||++....|...+|.|++|+|+||.+.|+.||.....++..- .......|.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence                       01112245689999999999999999999999999999999999999998765443210 000001111


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH-HhhcccCCCCCC
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS-MITNEHATLPYP  795 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~-~L~~~~~~l~~p  795 (834)
                      ++      |.        ....+..+++.+.|+.+|.+|--....++ +=+++...|++-
T Consensus       279 E~------de--------a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  279 EE------DE--------ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cc------Cc--------CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            11      11        12235677899999999999963333333 333444444443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=3.6e-15  Score=155.74  Aligned_cols=198  Identities=20%  Similarity=0.251  Sum_probs=136.7

Q ss_pred             CCCceeeEeeeEee---------------------------cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHH
Q 003287          567 QHRNLVRLMGCCVE---------------------------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE  619 (834)
Q Consensus       567 ~H~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  619 (834)
                      +|||||++.++|.+                           ....|+||.-.+ .+|.+++..    +..+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence            59999999988764                           235788887764 467777743    3456677888999


Q ss_pred             HHHHHHHHHhhcCCCceEecCCCCCcEEE--cCCC--CeeeccccccccccCC----CcccccccccccccccCcccccC
Q 003287          620 GIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDM--NPKISDFGMARMFCGD----ELQGNTKRVVGTYGYMSPEYALD  691 (834)
Q Consensus       620 ~ia~~L~yLH~~~~~~iiH~DIkp~NILl--~~~~--~vkl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  691 (834)
                      |+++|+.|||.++   |.|||+|++||||  |+|+  .+.|+|||.+-.-...    .+....-..-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   9999999999999  3443  4679999976432111    11111222356778999998864


Q ss_pred             CC------CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHh
Q 003287          692 GL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVAL  765 (834)
Q Consensus       692 ~~------~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~  765 (834)
                      .+      --.|+|.|+.|.+.||+++...||-.-.+...+...          ..+-.-|.+    +..+...+.+|+.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------Yqe~qLPal----p~~vpp~~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------YQESQLPAL----PSRVPPVARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------hhhhhCCCC----cccCChHHHHHHH
Confidence            32      125899999999999999999998642221111111          111111222    2233456778999


Q ss_pred             cccccCcCCCCCHHHHHHHhh
Q 003287          766 LCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       766 ~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ..|+.||++|++..-....|.
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999999876666553

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.2e-14  Score=139.59  Aligned_cols=135  Identities=22%  Similarity=0.238  Sum_probs=116.3

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCC--CceeeEeeeEeecCeEEEEEEecCCC
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      +.+.||+|.++.||+++..+ +.++||.......  ...+.+|+.++..++|  .++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899999866543  5678999999999976  58999999888888999999999988


Q ss_pred             CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      .+..+          +......++.+++++|++||.....+++|+||+|+||+++..+.++++|||++..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4567788899999999999987655699999999999999999999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=9.9e-15  Score=146.64  Aligned_cols=136  Identities=21%  Similarity=0.248  Sum_probs=98.7

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChh--hHHH----------------------HHHHHHHHhccCCC--ce
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--GLKE----------------------FKNEMMLIAKLQHR--NL  571 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~--ni  571 (834)
                      .+.||+|+||+||+|...+++.||||++......  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999888999999998653211  1111                      13566666666443  24


Q ss_pred             eeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcC
Q 003287          572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS  650 (834)
Q Consensus       572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~  650 (834)
                      .+.+++    ...++||||++++.+.........   . ..+...++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    246899999999654322111000   0 15678899999999999998 66   99999999999999 


Q ss_pred             CCCeeeccccccccc
Q 003287          651 DMNPKISDFGMARMF  665 (834)
Q Consensus       651 ~~~vkl~DFGla~~~  665 (834)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            999999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=2.3e-15  Score=175.38  Aligned_cols=256  Identities=20%  Similarity=0.266  Sum_probs=191.9

Q ss_pred             cCccccceecccCccceEeeEecC--CcEEEEEEecccC--hhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..|.+.+.||+|+|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457778889999999999887643  4567777765442  223344455777777776 99999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceEecCCCCCcEEEcCCC-Ceeeccccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-QYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMF  665 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~  665 (834)
                      .||..++++.+.+... .....+....-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ .++++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999998887421 1113455677789999999999999 766   99999999999999999 9999999999988


Q ss_pred             cC-CCcccccccccc-cccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          666 CG-DELQGNTKRVVG-TYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       666 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      .. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............+.     ..... 
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~-----~~~~~-  249 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK-----SNKGR-  249 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec-----ccccc-
Confidence            76 444444555678 9999999999884 567789999999999999999999987654432222211     11100 


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                           ..............++...++..+|+.|.+.+++..
T Consensus       250 -----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 -----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -----cccCccccCChhhhhcccccccCCchhccccccccc
Confidence                 001111122334556788888899999998887654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.52  E-value=7.7e-14  Score=145.39  Aligned_cols=135  Identities=23%  Similarity=0.264  Sum_probs=105.5

Q ss_pred             ceec-ccCccceEeeEecCCcEEEEEEecccC-------------hhhHHHHHHHHHHHhccCCCce--eeEeeeEeecC
Q 003287          519 CKLG-EGGFGPVYKGKLLNGQEVAVKRLSSQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLMGCCVEQG  582 (834)
Q Consensus       519 ~~lG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~  582 (834)
                      ..|| .|+.|+||+++. .+..++||++....             ......+.+|+.++.+|+|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 899999999988 47789999885311             1223567889999999998774  67777654432


Q ss_pred             ----eEEEEEEecCC-CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          583 ----EKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       583 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                          ..++|+|++++ .+|.+++.+    ..++..    .+.+|+++|.+||+.+   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 688888743    233433    3678999999999998   9999999999999999999999


Q ss_pred             cccccccc
Q 003287          658 DFGMARMF  665 (834)
Q Consensus       658 DFGla~~~  665 (834)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99998763

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.42  E-value=1.5e-13  Score=115.74  Aligned_cols=71  Identities=21%  Similarity=0.363  Sum_probs=60.7

Q ss_pred             ccccceEEEeeccCCCcccccccccccChHHHHHHHhh---cccccccccccccCCCccceeecccc-cccccccccCCC
Q 003287          337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK---NCTCRAYANSKVTGGGSGCLMWFGDL-IDIRKITGYNNG  412 (834)
Q Consensus       337 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~g~~~c~~w~~~l-~~~~~~~~~~~~  412 (834)
                      |.+++.|+++.+|++|++..      ++++||++.|++   ||||+||+|.+.   +.||++|+++| +|++++.  +.+
T Consensus         5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~--~~g   73 (80)
T cd00129           5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEF--SHG   73 (80)
T ss_pred             eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhcc--CCC
Confidence            44568899999999998654      689999999999   999999999753   35899999999 9998775  567


Q ss_pred             Cccccc
Q 003287          413 QPIYVR  418 (834)
Q Consensus       413 ~~~yvr  418 (834)
                      .++|+|
T Consensus        74 ~~Ly~r   79 (80)
T cd00129          74 FDLYEN   79 (80)
T ss_pred             ceeEeE
Confidence            889987

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=8.6e-13  Score=149.36  Aligned_cols=140  Identities=22%  Similarity=0.247  Sum_probs=100.9

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChhh----------------------------------------HHHHHH
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG----------------------------------------LKEFKN  558 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~----------------------------------------~~~~~~  558 (834)
                      +.||+|++|.||+|++.+|+.||||+.+......                                        +-.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999999999999999986542111                                        012455


Q ss_pred             HHHHHhccC----CCceeeEeeeEe-ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHhhcC
Q 003287          559 EMMLIAKLQ----HRNLVRLMGCCV-EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ-GLLYLHQYS  632 (834)
Q Consensus       559 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~  632 (834)
                      |+..+.++.    |.+-+.+-.++. .....+|||||+++++|.++......  ..   .+.+++..+++ .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            666666652    333333333333 34567999999999999887632111  11   23456666666 467888877


Q ss_pred             CCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       633 ~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                         ++|+|+||.||+++.+++++++|||++..+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=8.8e-13  Score=135.25  Aligned_cols=205  Identities=20%  Similarity=0.221  Sum_probs=141.6

Q ss_pred             HHHHhccCCCceeeEeeeEeecC-----eEEEEEEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003287          560 MMLIAKLQHRNLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSR  633 (834)
Q Consensus       560 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  633 (834)
                      ..-|-.+.|.|||++..|+.+..     ...++.|||+.|+|..+|++.+ ....+......+++-||..||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            34555667999999999986543     5789999999999999997643 3455777888899999999999999975 


Q ss_pred             CceEecCCCCCcEEEcCCCCeeecccccccc--ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHh
Q 003287          634 LRIIHRDLKASNILLDSDMNPKISDFGMARM--FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL  711 (834)
Q Consensus       634 ~~iiH~DIkp~NILl~~~~~vkl~DFGla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ell  711 (834)
                      ++|+|+++..+-|++..++-+||.--.-...  .-............+-++|.|||+=.....+.++|||+||...+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            6799999999999999999999853211111  00011112223345678999999887777888999999999999998


Q ss_pred             hCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          712 TSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       712 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      -+.-........ . ..     .....+....+...+           -..++..|++.+|..||+|.+++.
T Consensus       277 ilEiq~tnseS~-~-~~-----ee~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESK-V-EV-----EENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcce-e-eh-----hhhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            776432211100 0 00     000001111111111           124778899999999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.28  E-value=1.5e-11  Score=121.31  Aligned_cols=131  Identities=23%  Similarity=0.162  Sum_probs=98.6

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCcee-eEeeeEeecCeEEEEEEecCCCCc
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      .+.|+.|.++.||+++.. ++.|++|....... ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367899999999999874 78899999765432 233567899999998665544 444433  3346899999999887


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ....           .....++.+++++|+.||..+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5420           111345678999999999876  33469999999999999 67899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=5.5e-12  Score=140.67  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=182.6

Q ss_pred             cCccccceecc--cCccceEeeEe--c-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          513 ENFSMQCKLGE--GGFGPVYKGKL--L-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~--G~fG~Vy~~~~--~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      ..|...+.+|+  |.+|.||.+..  . +++.+|+|+-+..  .......=.+|+...+++ .|+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45666788999  99999999987  3 5788999984432  223334446677777777 599999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeeccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDF  659 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DF  659 (834)
                      ++-.|++. .+|..+...  ....++....+.+..+..+    ||.++|+.+   ++|-|+||.||++..+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999986 666666643  3344677788888888888    999999988   9999999999999999 88999999


Q ss_pred             cccccccCCCccc---ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc
Q 003287          660 GMARMFCGDELQG---NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       660 Gla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      |+...+.......   ...+..|...|++||.. .+.++.++|+|++|.+..|..++..........       .|...+
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~r  339 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQLR  339 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cccccc
Confidence            9999886654322   22344688899999965 456788999999999999999887654321100       111111


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...        +..++......++..++.++++.+|..|++.+.+...
T Consensus       340 ~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  340 QGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            111        1222222223445558889999999999988766543

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.23  E-value=1.1e-11  Score=106.97  Aligned_cols=79  Identities=37%  Similarity=0.871  Sum_probs=62.5

Q ss_pred             CCcccc---ceEEEeeccCCCcccccccccccChHHHHHHHhhcccccccccccccCCCccceeecccccccccccccCC
Q 003287          335 SDCITR---ERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNN  411 (834)
Q Consensus       335 ~~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~g~~~c~~w~~~l~~~~~~~~~~~  411 (834)
                      +.|...   +.|..+.++++|+.....  .+.++++|++.|++||+|+||+|.+   ++++|.+|.+.+.+.+...  ..
T Consensus         3 ~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~--~~   75 (84)
T cd01098           3 LNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLS--SG   75 (84)
T ss_pred             cccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeec--CC
Confidence            456443   689999999999775433  6789999999999999999999974   3578999999999876433  33


Q ss_pred             CCccccccC
Q 003287          412 GQPIYVRVP  420 (834)
Q Consensus       412 ~~~~yvrl~  420 (834)
                      +..+|+|++
T Consensus        76 ~~~~yiKv~   84 (84)
T cd01098          76 GGTLYLRLA   84 (84)
T ss_pred             CcEEEEEeC
Confidence            567898874

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.20  E-value=4.4e-11  Score=136.96  Aligned_cols=144  Identities=17%  Similarity=0.207  Sum_probs=96.1

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccChhh----------------------------------H----
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQG----------------------------------L----  553 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~----------------------------------~----  553 (834)
                      ..|+. +.||+|++|+||+|++.+ |+.||||++++...+.                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999987 9999999997542110                                  0    


Q ss_pred             --HHHHHHHHHHhccC----CCceeeEeeeEee-cCeEEEEEEecCCCCchhhhcCCCCC---CCCCHHHHHHHHHHHHH
Q 003287          554 --KEFKNEMMLIAKLQ----HRNLVRLMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRT---HLLGWQTRVKIIEGIAQ  623 (834)
Q Consensus       554 --~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~  623 (834)
                        -.|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++++.+.++..-....   ..+....+..++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence              12445665555552    4444554444443 45789999999999997743111111   11222222223333   


Q ss_pred             HHHHHhhcCCCceEecCCCCCcEEEcCCC----CeeeccccccccccC
Q 003287          624 GLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGMARMFCG  667 (834)
Q Consensus       624 ~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~vkl~DFGla~~~~~  667 (834)
                          ++..+   ++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                33444   99999999999999988    999999999987643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=9.3e-10  Score=113.38  Aligned_cols=142  Identities=17%  Similarity=0.259  Sum_probs=111.5

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccCh-hhHHHHHHHHHHHhccCC--CceeeEeeeEeecC---eEEEEEEecC
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQG---EKILIYEYMP  592 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~Ey~~  592 (834)
                      +.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+.+  .++.+++.+..+..   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778999999765432 235678899999999975  44677777766543   6689999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS----------------------------------------  632 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------  632 (834)
                      +.++...+..    ..++......++.+++++|++||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    34677788888889999999998521                                        


Q ss_pred             -------------CCceEecCCCCCcEEEcC--CCCeeecccccccc
Q 003287          633 -------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARM  664 (834)
Q Consensus       633 -------------~~~iiH~DIkp~NILl~~--~~~vkl~DFGla~~  664 (834)
                                   ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.07  E-value=1.5e-09  Score=108.49  Aligned_cols=135  Identities=15%  Similarity=0.104  Sum_probs=98.4

Q ss_pred             ceecccCccceEeeEecC-------CcEEEEEEecccC----------------------hhhHHHH----HHHHHHHhc
Q 003287          519 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS----------------------GQGLKEF----KNEMMLIAK  565 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~----------------------~~~~~~~----~~E~~~l~~  565 (834)
                      ..||.|--+.||.|...+       +..+|||+.+...                      ....+.+    .+|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997643       4799999864210                      0112233    379999999


Q ss_pred             cCC--CceeeEeeeEeecCeEEEEEEecCCCCchh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecCC
Q 003287          566 LQH--RNLVRLMGCCVEQGEKILIYEYMPNKSLNF-FLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQYSRLRIIHRDL  641 (834)
Q Consensus       566 l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~DI  641 (834)
                      +..  -++.+++++    ...+|||||+.++.+.. .+.    ...++..+...+..+++.+|..| |..+   |+|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            953  566666654    56789999998754422 121    12344556677889999999999 6766   999999


Q ss_pred             CCCcEEEcCCCCeeeccccccccc
Q 003287          642 KASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       642 kp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      ++.|||++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 478999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.02  E-value=2.4e-09  Score=120.67  Aligned_cols=167  Identities=17%  Similarity=0.228  Sum_probs=126.2

Q ss_pred             ecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHH
Q 003287          534 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT  613 (834)
Q Consensus       534 ~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~  613 (834)
                      ..++.+|.|+..+.......+...+-++.|+.++||||++++....+++..|||.|-+  ..|..++.+      ++...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence            3468899999887665544556778889999999999999999999999999999987  345555522      33556


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCC
Q 003287          614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL  693 (834)
Q Consensus       614 ~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  693 (834)
                      ....+.||++||.+||..+  .++|++|....|+|++.|+-||++|.++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6678899999999999766  599999999999999999999999998865322111  111112223456666543322


Q ss_pred             CCccCCeeeHHHHHHHHhhCC
Q 003287          694 FSVKSDVFSFGVLLLETLTSK  714 (834)
Q Consensus       694 ~~~ksDVwSlGvil~elltg~  714 (834)
                        -..|.|-||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              2459999999999999983

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=5.4e-09  Score=100.76  Aligned_cols=131  Identities=21%  Similarity=0.310  Sum_probs=101.8

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEe-cccC--h-----hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRL-SSQS--G-----QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l-~~~~--~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..+++|+-+.+|.+.+. |.++++|.- ++.-  +     -..++-.+|+.++.+++--.|.-..=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            36789999999999763 445677743 3321  1     1234567899999999766666556666788888999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +++..|.+.+...          ...++..+-+-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888433          2567778888889999988   99999999999998765 99999999975

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.93  E-value=1.2e-08  Score=111.57  Aligned_cols=169  Identities=22%  Similarity=0.297  Sum_probs=129.3

Q ss_pred             ccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee----cCeEEEEEEecCC-CCchhh
Q 003287          526 FGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILIYEYMPN-KSLNFF  599 (834)
Q Consensus       526 fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~  599 (834)
                      -.+.||+.. .+|..|++|+++....+....-..-++.++++.|.|+|++..++..    +..+++||+|.|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            456788875 4799999999965443333333456789999999999999998873    4478999999996 577777


Q ss_pred             hcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          600 LFDP------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       600 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      .+..            ......++..++.++.|+..||.++|+.+   +.-+-|.+++||++.+.+++|+..|+...+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            6532            12345778999999999999999999998   77799999999999999999999888776543


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCC
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN  716 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p  716 (834)
                      +..                |-+.   --.+-|.=.||.+++.|.||...
T Consensus       446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            320                0011   12345777899999999999654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.92  E-value=7.3e-10  Score=123.89  Aligned_cols=249  Identities=19%  Similarity=0.190  Sum_probs=174.7

Q ss_pred             HHhccCccccceecccCccceEeeEec--CCcEEEEEEecccChhhH--HHHHHHHHHHhcc-CCCceeeEeeeEeecCe
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQSGQGL--KEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  583 (834)
                      ...+.+|.++..||.|.|+.|++....  ++..+++|.+.+......  ..-..|+.+...+ .|.++++....+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            345578999999999999999998643  477899998765432222  2235566666666 68999999888888888


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeecccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA  662 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DFGla  662 (834)
                      .++--||++++++...+   .....+.+..++++..|++.++.++|+..   ++|+|+||+||++..+ +.-++.|||.+
T Consensus       341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence            89999999999887655   23345677788899999999999999877   9999999999999886 77899999998


Q ss_pred             ccccCCCccccccccccccccc--CcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYM--SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      ..+.-.     .......-+++  +|+......+..+.|++|||.-+.|.+++..-..... ..        .....+. 
T Consensus       415 t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-~~--------~~i~~~~-  479 (524)
T KOG0601|consen  415 TRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-QS--------LTIRSGD-  479 (524)
T ss_pred             ccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-cc--------eeeeccc-
Confidence            642111     11112233444  5555566788999999999999999999875422111 00        0001111 


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                          -+.+..     ....+..+..-++..++..||.+.++..+.+-
T Consensus       480 ----~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  480 ----TPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ----ccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                111111     11334456666888899999998887765443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.89  E-value=1.2e-08  Score=97.82  Aligned_cols=143  Identities=23%  Similarity=0.297  Sum_probs=107.6

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEE-ecccC-------hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKR-LSSQS-------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .+..|-+|+-+.|+++.. .|+...||. +.+.-       .-...+.++|++++.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            457899999999999988 577767773 33321       123456788999999997666666666677888889999


Q ss_pred             EecCC-CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC---Ceeecccccccc
Q 003287          589 EYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM  664 (834)
Q Consensus       589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~vkl~DFGla~~  664 (834)
                      ||+++ .++.+++....... ........++..|-+.+.-||..+   |+|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 47788875432222 222333688899999999999998   99999999999996554   358999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.84  E-value=1.4e-09  Score=127.31  Aligned_cols=207  Identities=21%  Similarity=0.224  Sum_probs=149.8

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ...+.+.+.+-+-+|.++.++.++-. .|...++|......   ....+....+-.++-..+||-+++..--+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34577888889999999999988653 25444555443221   112223333333444445677776665566677899


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      |+++|..+++|...|+...   ..+.......+..+.++++|||...   +.|+|++|.|+|...++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999998885432   3444455566677889999999876   899999999999999999999999844322


Q ss_pred             cCC-------------------------Ccc----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCC
Q 003287          666 CGD-------------------------ELQ----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN  716 (834)
Q Consensus       666 ~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p  716 (834)
                      ...                         ...    .......+|+.|.+||...+......+|.|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                         000    112235789999999999999999999999999999999999999


Q ss_pred             CCCCCc
Q 003287          717 TGVYDI  722 (834)
Q Consensus       717 ~~~~~~  722 (834)
                      +.....
T Consensus      1035 ~na~tp 1040 (1205)
T KOG0606|consen 1035 FNAETP 1040 (1205)
T ss_pred             CCCcch
Confidence            886543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=4.2e-08  Score=97.70  Aligned_cols=124  Identities=26%  Similarity=0.287  Sum_probs=82.7

Q ss_pred             eEeeEecCCcEEEEEEecccC--------------------------hhhHHHHHHHHHHHhccCCC--ceeeEeeeEee
Q 003287          529 VYKGKLLNGQEVAVKRLSSQS--------------------------GQGLKEFKNEMMLIAKLQHR--NLVRLMGCCVE  580 (834)
Q Consensus       529 Vy~~~~~~g~~vAVK~l~~~~--------------------------~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~  580 (834)
                      ||.|...+|..+|||+.....                          ........+|++.|.++..-  ++.+++.+.  
T Consensus         2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--   79 (188)
T PF01163_consen    2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN--   79 (188)
T ss_dssp             EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred             EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence            899999899999999864210                          01133467899999999765  566666542  


Q ss_pred             cCeEEEEEEecC--CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          581 QGEKILIYEYMP--NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY-LHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       581 ~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                        ..+|||||++  +..+..+....     ++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|+
T Consensus        80 --~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 --RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             --TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             --CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence              4579999999  55554443211     1133456677788886665 46666   9999999999999988 99999


Q ss_pred             cccccccc
Q 003287          658 DFGMARMF  665 (834)
Q Consensus       658 DFGla~~~  665 (834)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.2e-07  Score=99.98  Aligned_cols=134  Identities=18%  Similarity=0.139  Sum_probs=98.0

Q ss_pred             ccceEeeEecCCcEEEEEEecccChh-----------hHHHHHHHHHHHhccCC--CceeeEeeeEee-----cCeEEEE
Q 003287          526 FGPVYKGKLLNGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAKLQH--RNLVRLMGCCVE-----QGEKILI  587 (834)
Q Consensus       526 fG~Vy~~~~~~g~~vAVK~l~~~~~~-----------~~~~~~~E~~~l~~l~H--~niv~l~~~~~~-----~~~~~lV  587 (834)
                      ...|++..+ +|+.+.||+.......           ....+.+|...+.++..  -..++++++.+.     ....+||
T Consensus        35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            334666665 6788999977543211           11247889999988843  334445556543     2357899


Q ss_pred             EEecCCC-CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-------CCCeeeccc
Q 003287          588 YEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------DMNPKISDF  659 (834)
Q Consensus       588 ~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-------~~~vkl~DF  659 (834)
                      +|++++- +|.+++.+.. ....+...+..++.++++.+.-||..+   |+|+|++++|||++.       +..+.|+||
T Consensus       114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            9999986 8888874321 233456677899999999999999998   999999999999975       468999999


Q ss_pred             ccccc
Q 003287          660 GMARM  664 (834)
Q Consensus       660 Gla~~  664 (834)
                      +.++.
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.54  E-value=5.7e-07  Score=92.06  Aligned_cols=145  Identities=21%  Similarity=0.205  Sum_probs=101.9

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEeccc--------------------C--hhhHHHHHHHHHH
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--------------------S--GQGLKEFKNEMML  562 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--------------------~--~~~~~~~~~E~~~  562 (834)
                      +..+.....-..+..+||.|--+.||.|..++|.++|||.=+..                    +  .......++|.+.
T Consensus        83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~  162 (304)
T COG0478          83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA  162 (304)
T ss_pred             HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence            34444444445677899999999999999999999999953211                    0  1123446789999


Q ss_pred             HhccCCC--ceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecC
Q 003287          563 IAKLQHR--NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD  640 (834)
Q Consensus       563 l~~l~H~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D  640 (834)
                      |.+|.-.  .+.+.++.    +...+||||+++-.|...-        +.....-.++..|++-+..+-..+   |||+|
T Consensus       163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGD  227 (304)
T COG0478         163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGD  227 (304)
T ss_pred             HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccC
Confidence            9999654  66666653    4568999999997775432        122233344444444444444555   99999


Q ss_pred             CCCCcEEEcCCCCeeecccccccc
Q 003287          641 LKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       641 Ikp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +.+-||+++++|.+.++||--+..
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             CchheEEEecCCCEEEEeCccccc
Confidence            999999999999999999987654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=8.5e-07  Score=101.33  Aligned_cols=141  Identities=18%  Similarity=0.200  Sum_probs=94.7

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChhh------------------------------HH----------HHHH
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG------------------------------LK----------EFKN  558 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~------------------------------~~----------~~~~  558 (834)
                      +.|+.++-|.||+|++++|+.||||+.+..-.+.                              .+          .+..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5799999999999999999999999876432110                              11          1345


Q ss_pred             HHHHHhccC----CCceeeEeeeEe-ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcC
Q 003287          559 EMMLIAKLQ----HRNLVRLMGCCV-EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL-LYLHQYS  632 (834)
Q Consensus       559 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~  632 (834)
                      |+..+.+++    +..-+++-.++. -....+|+|||++|-.+.++..-..  ...+.   ..++..++++. ..+-..+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhcC
Confidence            666555552    233334444444 3567899999999999988852221  22332   23333333322 2222233


Q ss_pred             CCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       633 ~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                         +.|.|.+|.||+++.++++.+.|||+...+..
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               99999999999999999999999999977643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.41  E-value=1.2e-06  Score=89.29  Aligned_cols=107  Identities=24%  Similarity=0.242  Sum_probs=85.2

Q ss_pred             HHHHHHHHHHHhccC--CCceeeEeeeEeecC----eEEEEEEecCCC-CchhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 003287          553 LKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQG----EKILIYEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL  625 (834)
Q Consensus       553 ~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L  625 (834)
                      .....+|...+.+|.  .-.+.+.+++.....    ..+||+|++++. +|.+++.+..   .++......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence            346788888888884  344566677666533    458999999984 7998885422   155677889999999999


Q ss_pred             HHHhhcCCCceEecCCCCCcEEEcCCC---Ceeeccccccccc
Q 003287          626 LYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARMF  665 (834)
Q Consensus       626 ~yLH~~~~~~iiH~DIkp~NILl~~~~---~vkl~DFGla~~~  665 (834)
                      +-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999998   99999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=1.3e-07  Score=107.50  Aligned_cols=154  Identities=20%  Similarity=0.274  Sum_probs=102.8

Q ss_pred             HHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC-Cc------ccccccccccccccCcccc
Q 003287          617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-EL------QGNTKRVVGTYGYMSPEYA  689 (834)
Q Consensus       617 i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~-~~------~~~~~~~~gt~~y~aPE~~  689 (834)
                      =+.+++.|+.|+|...  .+||++|.|++|.++.++..||+.|+.+...... ++      ............|.|||++
T Consensus       104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3445669999999865  6999999999999999999999999988654331 11      1111122345689999999


Q ss_pred             cCCCCCccCCeeeHHHHHHHHhhCCCC-CCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhccc
Q 003287          690 LDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCV  768 (834)
Q Consensus       690 ~~~~~~~ksDVwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl  768 (834)
                      .+...+.++|+||+|+++|-+..|..+ +........            .......+..-......+.+.++.+=+.+++
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcch------------hhhhhcccccccccccccCcHHHHHHHHHHh
Confidence            998999999999999999999955444 332211000            0000001111111122344456666777789


Q ss_pred             ccCcCCCCCHHHHHHH
Q 003287          769 QEKAADRPTMSKVVSM  784 (834)
Q Consensus       769 ~~~P~~RPs~~evl~~  784 (834)
                      ..++..||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999987776543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.36  E-value=8.4e-06  Score=87.49  Aligned_cols=261  Identities=15%  Similarity=0.115  Sum_probs=155.8

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceee--------EeeeEeecCeEEEE
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVR--------LMGCCVEQGEKILI  587 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~--------l~~~~~~~~~~~lV  587 (834)
                      ..+.||+|+-+.+|-.-.  -..-+-|+..........+.   +..|... .||-+-.        |+|- ..+...-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence            456899999999985432  12234577765543322222   2223333 5664333        1111 112225677


Q ss_pred             EEecCCCC-chhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          588 YEYMPNKS-LNFFLFD---PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       588 ~Ey~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      |+.+++.. ...++..   ...-....|.-.++.++.+|.+.+.||..+   .+-+|+.++|+|+.+++.+.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            77776652 2222221   122345789999999999999999999988   8999999999999999999999854332


Q ss_pred             cccCCCcccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhC-CCCCCCCCcccc---ccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESF---NLLGHAWNL  734 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg-~~p~~~~~~~~~---~~~~~~~~~  734 (834)
                      ...+   .....-.+|...|.+||.-.     +..-+...|-|.|||++++++.| ++|+........   .+..    .
T Consensus       166 i~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~  238 (637)
T COG4248         166 INAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----D  238 (637)
T ss_pred             eccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----h
Confidence            2111   11122346888999999764     33456789999999999999987 889875432110   0000    0


Q ss_pred             ccccccccccC------ccccchhHHHHHHHHHHHHhcccccC--cCCCCCHHHHHHHhhcccCCCC
Q 003287          735 WKDNRAYELLS------PALQHEASYQMLNRYITVALLCVQEK--AADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       735 ~~~~~~~~l~~------~~l~~~~~~~~~~~l~~li~~cl~~~--P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      +..+......+      +.-......-....+..+..+|+...  +.-||+++..+..|..+...|-
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            00000000000      00000111122344556777787653  6789999999999988766553

>PRK09902 hypothetical protein; Provisional

Probab=98.31  E-value=7.4e-06  Score=82.21  Aligned_cols=138  Identities=16%  Similarity=0.185  Sum_probs=103.5

Q ss_pred             ecccCccceEeeEecCCcEEEEEEeccc------ChhhHHHHHHHHHHHhccCC--CceeeEeeeEe-ec----CeEEEE
Q 003287          521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQ------SGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCV-EQ----GEKILI  587 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~~g~~vAVK~l~~~------~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~-~~----~~~~lV  587 (834)
                      -|+||-+-|+.-.+ +|+.+-+|+-...      .+.....|.+|+..|.+|..  -.+.+.+ ++. ..    ...+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            46688888998877 4557889976522      13466889999999999953  3355555 332 21    246899


Q ss_pred             EEecCC-CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC--eeecccccccc
Q 003287          588 YEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARM  664 (834)
Q Consensus       588 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--vkl~DFGla~~  664 (834)
                      +|-+++ .+|.+++.+. .....+...+..++.+|++.++-||..+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 5888887443 2234577788899999999999999998   999999999999986667  99999987764

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.31  E-value=2.6e-06  Score=78.01  Aligned_cols=86  Identities=26%  Similarity=0.362  Sum_probs=61.0

Q ss_pred             EEEecCCceEEecCC-CCeEEeecCCcccc-cceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCcccccc
Q 003287           90 LTIGNNGNLVLLNQT-DGIIWSSNLSREVK-NPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL  167 (834)
Q Consensus        90 l~~~~~g~l~l~~~~-~~~~wst~~~~~~~-~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~  167 (834)
                      +.+..||+||+++.. +.++|++|+..... +..+.|.++|||||++.      .+.++|+|     +|           
T Consensus        24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~S-----~t-----------   81 (114)
T smart00108       24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG------DGRVVWSS-----NT-----------   81 (114)
T ss_pred             cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC------CCCEEEEe-----cc-----------
Confidence            455689999999765 58999999854432 25678999999999985      46789987     11           


Q ss_pred             ccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEe
Q 003287          168 KTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCT  213 (834)
Q Consensus       168 ~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~  213 (834)
                                     ....|.|.+.++.+|...++-. ...+.|.+
T Consensus        82 ---------------~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~S  111 (114)
T smart00108       82 ---------------TGANGNYVLVLLDDGNLVIYDS-DGNFLWQS  111 (114)
T ss_pred             ---------------cCCCCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence                           0124568889999987765432 23467754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.28  E-value=9.4e-06  Score=83.94  Aligned_cols=133  Identities=18%  Similarity=0.190  Sum_probs=86.7

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCc--eeeEeeeEeecCeEEEEEEecCCCC-
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMGCCVEQGEKILIYEYMPNKS-  595 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gs-  595 (834)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++..+.+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57999999999984   35567889876533  2345688999999986433  4677888777778889999999973 


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhhc-CCCc
Q 003287          596 LNFFLFDPSRTHLLGWQTRVKIIEGIAQG---------------------------------------LLYLHQY-SRLR  635 (834)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------L~yLH~~-~~~~  635 (834)
                      +...+..       +......++..+++.                                       ..+|... ....
T Consensus        82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            2211100       001111111111111                                       1222211 2335


Q ss_pred             eEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          636 IIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       636 iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++|+|+.|.||++++++ +.|+||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.19  E-value=2e-05  Score=79.41  Aligned_cols=138  Identities=17%  Similarity=0.181  Sum_probs=93.2

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHH---------HHHHHHHhccCCC---ceeeEeeeE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEF---------KNEMMLIAKLQHR---NLVRLMGCC  578 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~---------~~E~~~l~~l~H~---niv~l~~~~  578 (834)
                      ...+|+..+.+-......|.+-.. +|+.+++|.........++.|         .+++..+.+++..   ....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346788888887777777777766 678999998876544333333         2344444444322   222222222


Q ss_pred             e-----ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC
Q 003287          579 V-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  653 (834)
Q Consensus       579 ~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~  653 (834)
                      .     .....+|+|||++|..|.++..       ++.    .++..+++++.-||..+   +.|+|++|.|+++..++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     2235679999999998866541       222    34566778899999998   99999999999998554 


Q ss_pred             eeecccccccc
Q 003287          654 PKISDFGMARM  664 (834)
Q Consensus       654 vkl~DFGla~~  664 (834)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.17  E-value=2.4e-06  Score=72.17  Aligned_cols=60  Identities=35%  Similarity=0.868  Sum_probs=48.4

Q ss_pred             ceEEEeeccCCCcccccccccccChHHHHHHHhh-cccccccccccccCCCccceeec-ccccccc
Q 003287          341 ERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMWF-GDLIDIR  404 (834)
Q Consensus       341 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~g~~~c~~w~-~~l~~~~  404 (834)
                      ..|.+++++++++..... ....++++|++.|++ +|+|.||+|..   ++.+|.+|. +.+.+.+
T Consensus         4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~   65 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDAR   65 (78)
T ss_pred             ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccce
Confidence            569999999998554332 356799999999999 99999999975   456899999 7766664

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.16  E-value=6.7e-06  Score=75.54  Aligned_cols=88  Identities=22%  Similarity=0.261  Sum_probs=61.6

Q ss_pred             EEEec-CCceEEecCC-CCeEEeecCCcc-cccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCccccc
Q 003287           90 LTIGN-NGNLVLLNQT-DGIIWSSNLSRE-VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (834)
Q Consensus        90 l~~~~-~g~l~l~~~~-~~~~wst~~~~~-~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~  166 (834)
                      +.+.. ||+||+++.. +.++|++|+... .....+.|.++|||||++.      ++.++|+|=-               
T Consensus        24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~S~~---------------   82 (116)
T cd00028          24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG------SGTVVWSSNT---------------   82 (116)
T ss_pred             CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC------CCcEEEEecc---------------
Confidence            34555 9999999765 589999998642 3345678999999999985      5678998611               


Q ss_pred             cccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecC
Q 003287          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (834)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~  215 (834)
                                      ..+.+.+.+.++.+|...++-.+ ..+.|.+..
T Consensus        83 ----------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~  114 (116)
T cd00028          83 ----------------TRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD  114 (116)
T ss_pred             ----------------cCCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence                            00246688899989876654332 456776543

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.16  E-value=5.5e-07  Score=101.06  Aligned_cols=193  Identities=16%  Similarity=0.099  Sum_probs=139.7

Q ss_pred             HHHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCc-eeeEeeeEeecCeEEE
Q 003287          508 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKIL  586 (834)
Q Consensus       508 ~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~l  586 (834)
                      ++..+.-+...+-+++++++.++|.+....+....|.+...     ....-++++|.+++||| .++.++-+..+....+
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            33445556666788999999999998654444456655432     44566899999999999 7777777777778899


Q ss_pred             EEEecCCC-CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          587 IYEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       587 V~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +++++..+ +-.....  ...-.+..-+...+.+.-.+++++||+..   =+|+|    ||+..+ +..|..||+....+
T Consensus       312 ~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             hhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence            99999887 2211110  01112333344556667788999999864   48888    776655 78899999999877


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTG  718 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~  718 (834)
                      ....   ......+++.++|||+.....+..+.|+|++|+-..++--|-+|..
T Consensus       382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            5433   3455779999999999999999999999999997777777766643

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.14  E-value=7.9e-06  Score=93.07  Aligned_cols=141  Identities=18%  Similarity=0.222  Sum_probs=92.0

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChhh-------------------------------------HHHHHHHHH
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-------------------------------------LKEFKNEMM  561 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~~~~E~~  561 (834)
                      +.||.-+.|.||+|++++|+.||||+-+..-...                                     +-.|..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999865431110                                     112555665


Q ss_pred             HHhcc----CCCc---eeeEeeeEee-cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003287          562 LIAKL----QHRN---LVRLMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR  633 (834)
Q Consensus       562 ~l~~l----~H~n---iv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  633 (834)
                      ...+.    .|-+   -|.+-.++.+ ....+|+||||+|..+.+...-  ....++...+   +..+.++..  +..-.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i---~~~l~~~~~--~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDI---LNKLVEAYL--EQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHH---HHHHHHHHH--HHHHh
Confidence            55554    3555   2223333333 3578999999999988776421  2223444433   333333322  21111


Q ss_pred             CceEecCCCCCcEEEcC----CCCeeecccccccccc
Q 003287          634 LRIIHRDLKASNILLDS----DMNPKISDFGMARMFC  666 (834)
Q Consensus       634 ~~iiH~DIkp~NILl~~----~~~vkl~DFGla~~~~  666 (834)
                      .+++|+|-+|.||++..    ++++.+-|||+...+.
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            24999999999999984    6789999999998764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.12  E-value=3e-05  Score=80.28  Aligned_cols=144  Identities=22%  Similarity=0.230  Sum_probs=86.4

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCC--ceeeEeeeEee---cCeEEEEEEecC
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGCCVE---QGEKILIYEYMP  592 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~---~~~~~lV~Ey~~  592 (834)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|+.++..+...  .+.+++.+...   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4679999999999999876 69999997654  4556778888888888433  35566664432   335799999999


Q ss_pred             CCCchh----------------hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 003287          593 NKSLNF----------------FL---FDP-SRTHLLGWQT---------RVKI------------IEGIAQ-GLLYLHQ  630 (834)
Q Consensus       593 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~  630 (834)
                      +..+..                .+   +.. ..........         ....            ...+.+ .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            998877                11   000 0001111100         0000            111222 2333332


Q ss_pred             ----cCCCceEecCCCCCcEEEc-CCCCeeecccccccc
Q 003287          631 ----YSRLRIIHRDLKASNILLD-SDMNPKISDFGMARM  664 (834)
Q Consensus       631 ----~~~~~iiH~DIkp~NILl~-~~~~vkl~DFGla~~  664 (834)
                          .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                2345699999999999999 667678999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.06  E-value=1.7e-05  Score=79.42  Aligned_cols=105  Identities=23%  Similarity=0.224  Sum_probs=85.0

Q ss_pred             HHHHHHHhccCC-CceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 003287          557 KNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR  635 (834)
Q Consensus       557 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  635 (834)
                      ..|..++..+++ +++++++|+|-    .++|.||.+.+++...-.....-...+|..+.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999976 69999999994    3789999998766432111112234689999999999999999999876667


Q ss_pred             eEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          636 IIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       636 iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999877653

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.04  E-value=3.5e-05  Score=80.83  Aligned_cols=141  Identities=16%  Similarity=0.135  Sum_probs=86.9

Q ss_pred             eecccCc-cceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEEecCCCCch
Q 003287          520 KLGEGGF-GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLN  597 (834)
Q Consensus       520 ~lG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  597 (834)
                      .|-.|.. ..||+.... +..+.||+.....   .....+|++++..+. +--+.+++++....+..++|||++++.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555555 788999764 4788889876543   345677888888883 455667788777667789999999998876


Q ss_pred             hhhc-------------------CCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----c
Q 003287          598 FFLF-------------------DPSR-THLLGW--QTRVKIIE--------------------GIAQGLLYLHQ----Y  631 (834)
Q Consensus       598 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~----~  631 (834)
                      ....                   .... ...+..  ........                    .+.+.+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4421                   0000 001100  00000000                    01111222211    1


Q ss_pred             CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       632 ~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            234589999999999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.02  E-value=4.9e-05  Score=77.42  Aligned_cols=152  Identities=18%  Similarity=0.206  Sum_probs=100.6

Q ss_pred             ccHHHHHHhccCccccc---eecccCccceEeeEecCCcEEEEEEecccChhh------------------------HHH
Q 003287          503 FSLASVSAATENFSMQC---KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG------------------------LKE  555 (834)
Q Consensus       503 ~~~~~~~~~~~~f~~~~---~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~------------------------~~~  555 (834)
                      .++..+........+.+   .|.+|--+.||+|...++..+|||++.......                        ..-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            44555555555554444   456777788999988889999999986432110                        011


Q ss_pred             HHHHHHHHhccC--CCceeeEeeeEeecCeEEEEEEecCCCCc-hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003287          556 FKNEMMLIAKLQ--HRNLVRLMGCCVEQGEKILIYEYMPNKSL-NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS  632 (834)
Q Consensus       556 ~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  632 (834)
                      ..+|+..|.++.  +-.+.+.+.+.    .-.|||||+....+ .-.|    ....+...+...+..++++.+.-|-...
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            245777777773  44455555443    34799999976521 1111    1112233356777788888888877633


Q ss_pred             CCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       633 ~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                        ++||+||+.-|||+. ++.+.|+|+|-|...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              499999999999999 889999999988654

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.95  E-value=8.2e-05  Score=67.95  Aligned_cols=100  Identities=27%  Similarity=0.435  Sum_probs=66.5

Q ss_pred             CeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEee-CCCCCCcCCCceEEEecCCceEEecCCCCeEEeecCCcc
Q 003287           38 EKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVA-NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSRE  116 (834)
Q Consensus        38 ~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~a-nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~  116 (834)
                      +.+.+.+|.+.|-|-..|+     |-| |+ -..+++|.. +....- ...+.+.|..||||||+|..+.++|+|..  .
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~-~~~~~iWss~~t~~~~-~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~   81 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVL-YD-SNGSVIWSSNNTSGRG-NSGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y   81 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEE-EE-TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred             cccccccccccceECCCCe-----EEE-Ec-CCCCEEEEecccCCcc-ccCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence            4565655889998887775     444 32 245779999 433331 15688999999999999999999999943  2


Q ss_pred             cccceEEEec--CCceEEEeccCCCCCCCceEEeecCCCC
Q 003287          117 VKNPVAQLLD--TGNLVLREKFSSNTSEGSYLWQSFDCPS  154 (834)
Q Consensus       117 ~~~~~a~l~d--~GNlvl~~~~~~~~~~~~~~WqSFd~Pt  154 (834)
                      ....+...++  .||++ +..      ...+.|.|=+.|+
T Consensus        82 ptdt~L~~q~l~~~~~~-~~~------~~~~sw~s~~dps  114 (114)
T PF01453_consen   82 PTDTLLPGQKLGDGNVT-GKN------DSLTSWSSNTDPS  114 (114)
T ss_dssp             SS-EEEEEET--TSEEE-EES------TSSEEEESS----
T ss_pred             CccEEEeccCcccCCCc-ccc------ceEEeECCCCCCC
Confidence            2345556777  89999 643      4578898866663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.86  E-value=0.00016  Score=89.26  Aligned_cols=79  Identities=18%  Similarity=0.393  Sum_probs=58.8

Q ss_pred             cceecccCccceEeeEecCC---cEEEEEEecccC-hhhHHHHHHHHHHHhccC-CCce--eeEeeeEeec---CeEEEE
Q 003287          518 QCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLMGCCVEQ---GEKILI  587 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV  587 (834)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999887553   467888765432 123356889999999995 6654  7788888764   467899


Q ss_pred             EEecCCCCc
Q 003287          588 YEYMPNKSL  596 (834)
Q Consensus       588 ~Ey~~~gsL  596 (834)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>PRK10593 hypothetical protein; Provisional

Probab=97.73  E-value=0.00043  Score=74.76  Aligned_cols=79  Identities=14%  Similarity=0.122  Sum_probs=58.3

Q ss_pred             ccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCC---CceeeEeeeEeec---CeEEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH---RNLVRLMGCCVEQ---GEKILIY  588 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~---~~~~lV~  588 (834)
                      ....+.||.|..+.||+....++ .+.+|..+..  .....|.+|+..|+.|.-   ..+.++++++..+   +..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            33456899999999999977555 4666774331  123578899999998842   4688888887543   6689999


Q ss_pred             EecCCCCc
Q 003287          589 EYMPNKSL  596 (834)
Q Consensus       589 Ey~~~gsL  596 (834)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.72  E-value=0.0002  Score=74.74  Aligned_cols=74  Identities=12%  Similarity=0.200  Sum_probs=47.2

Q ss_pred             ceecccCcc-ceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCC---ceeeEeeeEeec---CeEEEEEEec
Q 003287          519 CKLGEGGFG-PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR---NLVRLMGCCVEQ---GEKILIYEYM  591 (834)
Q Consensus       519 ~~lG~G~fG-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~---~~~~lV~Ey~  591 (834)
                      +.|+.|+.. .||+.    +..+++|..+..  .....+.+|++++..+...   -+.++++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567777776 48875    235777875542  2345788899999888532   344444443322   2358899999


Q ss_pred             CCCCchh
Q 003287          592 PNKSLNF  598 (834)
Q Consensus       592 ~~gsL~~  598 (834)
                      ++.++.+
T Consensus        77 ~G~~l~~   83 (235)
T cd05155          77 EGETATA   83 (235)
T ss_pred             cCCCCCc
Confidence            9988753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.61  E-value=0.00084  Score=67.05  Aligned_cols=125  Identities=23%  Similarity=0.397  Sum_probs=90.3

Q ss_pred             cCccccceecccCc-cceEeeEecCCcEEEEEEeccc---C--------h----------hhHHHHHHHHHHHhccC---
Q 003287          513 ENFSMQCKLGEGGF-GPVYKGKLLNGQEVAVKRLSSQ---S--------G----------QGLKEFKNEMMLIAKLQ---  567 (834)
Q Consensus       513 ~~f~~~~~lG~G~f-G~Vy~~~~~~g~~vAVK~l~~~---~--------~----------~~~~~~~~E~~~l~~l~---  567 (834)
                      .+++.++.||.|.- |.|||++. +|+.+|+|.+..-   .        .          ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78999999999999 99999998 6789999994210   0        0          11234788999988885   


Q ss_pred             CCce--eeEeeeEeec------------------CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003287          568 HRNL--VRLMGCCVEQ------------------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY  627 (834)
Q Consensus       568 H~ni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  627 (834)
                      +.++  |+.+|+..-.                  ....||.||++...            .+    ..+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence            4456  8999987422                  12357777775543            11    22345667778888


Q ss_pred             HhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       628 LH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99887   999999999975     3478999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.60  E-value=0.00029  Score=68.01  Aligned_cols=130  Identities=20%  Similarity=0.270  Sum_probs=88.1

Q ss_pred             ccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceee-EeeeEeecCeEEEEEEecCC
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR-LMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      .++.+.|++|++|.||++.+ .|..+|+|+-...  .....+..|+++|..++-.++.+ ++.|-    .-++.|||+.+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence            34567899999999999998 4568999986543  44578899999999998766554 34332    22455999998


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC-CCcEEEcCCCCeeecccccccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK-ASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIk-p~NILl~~~~~vkl~DFGla~~  664 (834)
                      -.|.+.-...      ..+    -+..+++.---|...+   |-|+.|. |...+|-.++.+.|+||..|++
T Consensus        97 ~~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8886554211      112    2233444433344444   9999987 4444554555999999999874

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.59  E-value=0.00042  Score=72.10  Aligned_cols=142  Identities=19%  Similarity=0.237  Sum_probs=83.1

Q ss_pred             cceecccCccceEeeEecC--CcEEEEEEecccChhhHHHHHHHHHHHhccCCCc-eeeEeeeEeecCeEEEEEEecCCC
Q 003287          518 QCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      ++.|..|-...+|+....+  ++.|++|+....... .....+|+.++..+...+ ..++++...    ..++|||+++.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567888889999998764  678999987643222 123356888888885433 344444332    24899999997


Q ss_pred             Cchhh-------h----------cCCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHH
Q 003287          595 SLNFF-------L----------FDPSRT--------HLLG-WQTRVKIIE----------------------GIAQGLL  626 (834)
Q Consensus       595 sL~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~  626 (834)
                      ++...       +          +.....        .... +..+..+..                      .+.+.+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            76322       1          111000        0111 122111111                      1111111


Q ss_pred             H----Hhhc-CCCceEecCCCCCcEEEcC-CCCeeecccccccc
Q 003287          627 Y----LHQY-SRLRIIHRDLKASNILLDS-DMNPKISDFGMARM  664 (834)
Q Consensus       627 y----LH~~-~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~  664 (834)
                      .    +... .+..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1    2221 2346999999999999998 57899999998753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.53  E-value=0.00038  Score=73.58  Aligned_cols=139  Identities=14%  Similarity=0.095  Sum_probs=80.4

Q ss_pred             eecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCce-eeEeeeEeecCeEEEEEEecCCCCchh
Q 003287          520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKSLNF  598 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~  598 (834)
                      .+..|-...+|+... +++.+++|..............+|..+++.+....+ .+++....    ..+||||+++..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456688889998874 577888997654332211235778888888854333 33444332    368999999877643


Q ss_pred             h-----------------hcCCC-CCCCCCHHHH-HHHHHH---------HHHHHHHHhhc-----CCCceEecCCCCCc
Q 003287          599 F-----------------LFDPS-RTHLLGWQTR-VKIIEG---------IAQGLLYLHQY-----SRLRIIHRDLKASN  645 (834)
Q Consensus       599 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~iiH~DIkp~N  645 (834)
                      -                 ++... ....++.... ..+..+         +.+.+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2                 01110 0111121111 111111         11122222211     12458999999999


Q ss_pred             EEEcCCCCeeecccccccc
Q 003287          646 ILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       646 ILl~~~~~vkl~DFGla~~  664 (834)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.51  E-value=7.1e-05  Score=56.04  Aligned_cols=44  Identities=43%  Similarity=0.643  Sum_probs=33.8

Q ss_pred             cCCCCCCCCCcccccccCcccccccCCCcc--ccccccceeccccCCC
Q 003287          789 HATLPYPKQSAFSYARRGEKISFLPSSRVS--EACSVNGVTLSLISPR  834 (834)
Q Consensus       789 ~~~l~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  834 (834)
                      ...||.|++|+|+..+......  .+++..  +.||+|+||+|.|+||
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~--sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETD--SSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcC--CCcccccCCCCCeeeEEEEeEecC
Confidence            4689999999999988543322  222333  7899999999999999

; GO: 0004674 protein serine/threonine kinase activity

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.44  E-value=0.0011  Score=66.79  Aligned_cols=128  Identities=17%  Similarity=0.218  Sum_probs=87.2

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccC----------------hhhHHHHHHHHHHHhccC------CCceeeEe
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLM  575 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~  575 (834)
                      ...||+|+.-.||.  +++.....||+.....                .....++.+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            35799999999995  4456677888886654                122455566665555554      88999999


Q ss_pred             eeEeecCeEEEEEEecCC--C----CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          576 GCCVEQGEKILIYEYMPN--K----SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       576 ~~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                      |+...+...-+|+|.+.+  |    +|.+++.+    ..++. ...+.   +-+-..||-..+   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998754  2    35666622    23443 33333   334445666665   99999999999995


Q ss_pred             CCC----Ceeecc
Q 003287          650 SDM----NPKISD  658 (834)
Q Consensus       650 ~~~----~vkl~D  658 (834)
                      ...    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            432    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.36  E-value=0.00059  Score=82.37  Aligned_cols=200  Identities=19%  Similarity=0.194  Sum_probs=139.0

Q ss_pred             HHHHHHHHHHHhccCCCceeeEeeeEeecCeEE----EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003287          553 LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL  628 (834)
Q Consensus       553 ~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL  628 (834)
                      ......|...+.++.|+|++.++.+..+....-    +..|+++.-++...+.   .....+..+.+.+..++.+||+|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHH
Confidence            344456788888899999999999987665433    3457777777776663   334577888888999999999999


Q ss_pred             hhcCCCceEecCCCCC---cEEEcCCCCeeec--cccccccccCCCcccccccccccccccCcccccCCCCCc--cCCee
Q 003287          629 HQYSRLRIIHRDLKAS---NILLDSDMNPKIS--DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV--KSDVF  701 (834)
Q Consensus       629 H~~~~~~iiH~DIkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDVw  701 (834)
                      |+..   ..|.-+..+   +.-.+.++.+.++  ||+.++.+.....   ......+..+.+||......+..  ..|+|
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHH
Confidence            9985   555555554   5566677777777  9998887644322   12233456788888887766554  47999


Q ss_pred             eHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHH
Q 003287          702 SFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV  781 (834)
Q Consensus       702 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev  781 (834)
                      .+|..+..+..|..+......                 ...+++...    .    ..+.+....|+..++++|++..++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~-----------------~~~~l~~~~----~----~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAV-----------------PVSLLDVLS----T----SELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccc-----------------hhhhhcccc----c----hhhhhhhhhhcchhhhhccchhhh
Confidence            999999999988765332110                 011111111    0    135567788999999999999999


Q ss_pred             HHHhh
Q 003287          782 VSMIT  786 (834)
Q Consensus       782 l~~L~  786 (834)
                      +...-
T Consensus       432 l~~~f  436 (1351)
T KOG1035|consen  432 LTHPF  436 (1351)
T ss_pred             hhchh
Confidence            98743

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.34  E-value=0.0017  Score=72.31  Aligned_cols=75  Identities=15%  Similarity=0.201  Sum_probs=55.2

Q ss_pred             ceecccCccceEeeEecCC-cEEEEEEeccc------C-hhhHHHHHHHHHHHhccC---CCceeeEeeeEeecCeEEEE
Q 003287          519 CKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQ------S-GQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g-~~vAVK~l~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV  587 (834)
                      +.||.|.+..||++...+| +.|+||.-...      . ....+++..|.+.|..+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999999776 58999974321      1 224567788888888762   2457777776  44667899


Q ss_pred             EEecCCCC
Q 003287          588 YEYMPNKS  595 (834)
Q Consensus       588 ~Ey~~~gs  595 (834)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.25  E-value=0.0024  Score=69.02  Aligned_cols=143  Identities=17%  Similarity=0.138  Sum_probs=87.1

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCC--ceeeEeee------EeecCeEEEEEE
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGC------CVEQGEKILIYE  589 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~------~~~~~~~~lV~E  589 (834)
                      .+.|..|....+|+.... +..+++|+...   ...+....|+.++..+.+.  .+.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            457888888899998764 45788898764   2335566788888887433  24444432      123456789999


Q ss_pred             ecCCCCchhh----h----------cCC----CC----CCCCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 003287          590 YMPNKSLNFF----L----------FDP----SR----THLLGWQTRV----------KIIEGIAQGLLYLHQ----YSR  633 (834)
Q Consensus       590 y~~~gsL~~~----l----------~~~----~~----~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~  633 (834)
                      |+++..+...    .          +..    ..    .....|....          .....+.+++.++..    .-+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9999876431    0          100    00    0111221111          111223344555543    123


Q ss_pred             CceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          634 LRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       634 ~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999987788999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.15  E-value=0.0023  Score=69.38  Aligned_cols=141  Identities=26%  Similarity=0.311  Sum_probs=84.4

Q ss_pred             ceecccCccceEeeEecC-------CcEEEEEEecccChhhHHHHHHHHHHHhccCCCc-eeeEeeeEeecCeEEEEEEe
Q 003287          519 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|++++..+...+ ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456677777899988654       5789999976543 22345577888888884333 3345555432    368999


Q ss_pred             cCCCCchhhh-----------------cCCCCCC------CCC--HHHHHH--------------------------HHH
Q 003287          591 MPNKSLNFFL-----------------FDPSRTH------LLG--WQTRVK--------------------------IIE  619 (834)
Q Consensus       591 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  619 (834)
                      +++..+....                 ++.....      ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9988764321                 1110000      111  111100                          111


Q ss_pred             HHHHHHHHHhh------cCCCceEecCCCCCcEEEcCC----CCeeecccccccc
Q 003287          620 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM  664 (834)
Q Consensus       620 ~ia~~L~yLH~------~~~~~iiH~DIkp~NILl~~~----~~vkl~DFGla~~  664 (834)
                      .+.+.+..|..      ..+..++|+|+.+.|||++++    +.++|+||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22233334432      234579999999999999985    8899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.99  E-value=0.0082  Score=65.61  Aligned_cols=143  Identities=18%  Similarity=0.179  Sum_probs=78.4

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCC--CceeeEee------eEeecCeEEEEEE
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMG------CCVEQGEKILIYE  589 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~------~~~~~~~~~lV~E  589 (834)
                      .+.|+.|....+|+.+..+| .+++|+.....   .+....|+.++..|..  -.+.+.+.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35577788889999887555 68889876222   2333345555555531  12333332      1223456789999


Q ss_pred             ecCCCCchhh-----------h---cCCC--------CCCCCCH-HHHHH------------HHHH-HHHHHHHHhhc--
Q 003287          590 YMPNKSLNFF-----------L---FDPS--------RTHLLGW-QTRVK------------IIEG-IAQGLLYLHQY--  631 (834)
Q Consensus       590 y~~~gsL~~~-----------l---~~~~--------~~~~l~~-~~~~~------------i~~~-ia~~L~yLH~~--  631 (834)
                      |+++..+...           |   +...        ....+.| .....            .+.+ +...++.+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            9999764211           1   1100        0011111 11111            1111 11222333211  


Q ss_pred             --CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          632 --SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       632 --~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                        -+..++|+|++|.||+++.+...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              234699999999999999766568999998853

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.87  E-value=0.011  Score=63.66  Aligned_cols=136  Identities=20%  Similarity=0.277  Sum_probs=84.4

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecc--cChhhHHHHHHHHHHHhccCC--CceeeEeeeEeecC--eEEEEEEecC
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQG--EKILIYEYMP  592 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~--~~~lV~Ey~~  592 (834)
                      +.+-.|..-.+|..... ++++++. ...  ..........+|+.+|+.+.-  .-+.+.+++|.++.  ..+.||+|++
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            34433433344444443 7788888 331  222344556778888888742  34556678887776  7799999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHH-HHHHHHHHHHhh-----------------------------------------
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQ-----------------------------------------  630 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L~yLH~-----------------------------------------  630 (834)
                      +..+...+....    ..    .+++ ..+++.|+-||+                                         
T Consensus       109 Ge~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         109 GEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            864433331110    00    1111 234444444443                                         


Q ss_pred             ---------c-----CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          631 ---------Y-----SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       631 ---------~-----~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                               .     ++..++|+|+.+.|++++.++.+-|.||+++..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                     2     335799999999999999998899999999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.79  E-value=0.019  Score=62.35  Aligned_cols=144  Identities=19%  Similarity=0.198  Sum_probs=83.5

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCC--ceeeEeeeE------eecCeEEEEEE
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGCC------VEQGEKILIYE  589 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~------~~~~~~~lV~E  589 (834)
                      .+.++.|.-..+|+.+..++ .+++|+.....  ..++...|+.++..|...  .+.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677887889999876444 67788875432  123445566777666322  234444321      22456789999


Q ss_pred             ecCCCCchhh--------------hcCCCC------C---CCCCHHHHH------------HHHHHHHHHHHHHhh----
Q 003287          590 YMPNKSLNFF--------------LFDPSR------T---HLLGWQTRV------------KIIEGIAQGLLYLHQ----  630 (834)
Q Consensus       590 y~~~gsL~~~--------------l~~~~~------~---~~l~~~~~~------------~i~~~ia~~L~yLH~----  630 (834)
                      |+++..+...              ++....      .   ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998664311              011000      0   011121110            011223345555543    


Q ss_pred             cCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       631 ~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ..+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            2235699999999999999988778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.77  E-value=0.01  Score=63.39  Aligned_cols=70  Identities=13%  Similarity=0.038  Sum_probs=41.3

Q ss_pred             ecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC-C-C-ceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H-R-NLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       521 lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H-~-niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      .++|--..|+.....+|+.+++|.-+.  ........+|+++++.+. | + -+.++...    +.-.++|+++++..+
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~   91 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA   91 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence            344544556655545688999998643  223456788999999885 3 2 11222211    123567777777655

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.75  E-value=0.013  Score=62.60  Aligned_cols=76  Identities=16%  Similarity=0.208  Sum_probs=49.2

Q ss_pred             ccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC---CCceeeEeeeEeecCeEEEEEEec
Q 003287          515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .+..+.|+.|....+|+.. .+++.+.||+-.   ......|..|++-|+.|.   --.+.+++++....+..+||+||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3445678999999999988 578899999865   233466788888888873   456788888888777889999999


Q ss_pred             CCC
Q 003287          592 PNK  594 (834)
Q Consensus       592 ~~g  594 (834)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            887

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.72  E-value=0.011  Score=65.35  Aligned_cols=141  Identities=17%  Similarity=0.232  Sum_probs=82.8

Q ss_pred             ceecccCccceEeeEecC-----CcEEEEEEecccChhhHHHHHHHHHHHhccCCCcee-eEeeeEeecCeEEEEEEecC
Q 003287          519 CKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      +.|-.|-.-.+|+....+     ++.|++|+.......... ..+|..++..+...++. ++++.+..+    .|.||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            355557778889887532     368999988665433323 37788888888543333 455555332    5899998


Q ss_pred             CCCchhh-----------------hcCCC--CCC-CCCHHHHHHHHHH-----------------HHHHHHHH----hh-
Q 003287          593 NKSLNFF-----------------LFDPS--RTH-LLGWQTRVKIIEG-----------------IAQGLLYL----HQ-  630 (834)
Q Consensus       593 ~gsL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~-----------------ia~~L~yL----H~-  630 (834)
                      +.+|...                 ++...  ... ...+.+..++..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776422                 11111  001 1112322232211                 11112222    22 


Q ss_pred             cCCCceEecCCCCCcEEEcC-CCCeeecccccccc
Q 003287          631 YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARM  664 (834)
Q Consensus       631 ~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~  664 (834)
                      ..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346899999999999986 47899999998864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.58  E-value=0.0028  Score=66.79  Aligned_cols=143  Identities=17%  Similarity=0.138  Sum_probs=96.5

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEeccc--------------------Chh--hHHHHHHHHHH
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--------------------SGQ--GLKEFKNEMML  562 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--------------------~~~--~~~~~~~E~~~  562 (834)
                      +.++.....-+.+.++||-|--+-||.+...+|++.++|.-...                    +..  ..-...+|+..
T Consensus        84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf  163 (465)
T KOG2268|consen   84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF  163 (465)
T ss_pred             HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence            34444444457888999999999999999999999999942110                    000  12234668888


Q ss_pred             HhccC-C-CceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecC
Q 003287          563 IAKLQ-H-RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD  640 (834)
Q Consensus       563 l~~l~-H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D  640 (834)
                      |+.|. | --+.+.+++    ...++|||++.+-.|...-      ......++..-+   ..-+.-|..++   +||+|
T Consensus       164 mkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~l---m~~Iv~la~~G---lIHgD  227 (465)
T KOG2268|consen  164 MKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDL---MGLIVRLANHG---LIHGD  227 (465)
T ss_pred             HHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHH---HHHHHHHHHcC---ceecc
Confidence            88884 3 234444543    4568999999888876543      122333333333   33334455555   99999


Q ss_pred             CCCCcEEEcCCCCeeeccccccc
Q 003287          641 LKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       641 Ikp~NILl~~~~~vkl~DFGla~  663 (834)
                      ..--||++++++.++++||--..
T Consensus       228 FNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  228 FNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cchheeEEecCCCEEEeechHhh
Confidence            99999999999999999997553

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.22  E-value=0.034  Score=59.87  Aligned_cols=139  Identities=17%  Similarity=0.173  Sum_probs=94.9

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccC------------------------hhh--HHHHHHHHHHHhccCCCce
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS------------------------GQG--LKEFKNEMMLIAKLQHRNL  571 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~------------------------~~~--~~~~~~E~~~l~~l~H~ni  571 (834)
                      ..-|..|--+.||.+.-.+|..+|||+++...                        +..  .--...|+..|.+|+...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34578888999999999899999999875210                        000  0113458888888865553


Q ss_pred             eeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC
Q 003287          572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD  651 (834)
Q Consensus       572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~  651 (834)
                      ...--+..  ...+|||+|+....-   -....+...++...+..+-.++++-|.-|.+.+  ++||.||.--|+|+ .+
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd  300 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD  300 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence            32211111  245799999963221   111123345666778888888888888888877  69999999999988 56


Q ss_pred             CCeeecccccccc
Q 003287          652 MNPKISDFGMARM  664 (834)
Q Consensus       652 ~~vkl~DFGla~~  664 (834)
                      |.+.|+|-+-+..
T Consensus       301 G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 GKLYIIDVSQSVE  313 (520)
T ss_pred             CEEEEEEcccccc
Confidence            7899999887754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.10  E-value=0.057  Score=60.16  Aligned_cols=80  Identities=11%  Similarity=0.025  Sum_probs=53.1

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccC----h---hhHHHHHHHHHHHhccC---CCceeeEeeeEeecCeEEEE
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----G---QGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----~---~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV  587 (834)
                      .+.||.|..-.||+... +++.++||.-....    .   ....+-..|+..|..+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            46789999999999887 45679999754211    1   13344445566666553   247888888877  456889


Q ss_pred             EEecCC--CCchhhh
Q 003287          588 YEYMPN--KSLNFFL  600 (834)
Q Consensus       588 ~Ey~~~--gsL~~~l  600 (834)
                      ||++++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3444443

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=95.86  E-value=0.0066  Score=50.59  Aligned_cols=35  Identities=17%  Similarity=0.516  Sum_probs=28.9

Q ss_pred             ccChHHHHHHHhhcccccccccccccCCCccceeeccc
Q 003287          362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGD  399 (834)
Q Consensus       362 ~~s~~~C~~~Cl~nCsC~a~~~~~~~~g~~~c~~w~~~  399 (834)
                      ..+.++|++.|+.+|+|.||.|..   +...|+++.+.
T Consensus        24 ~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~   58 (73)
T cd01100          24 ASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE   58 (73)
T ss_pred             cCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence            568999999999999999999973   24579987664

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.84  E-value=0.06  Score=58.95  Aligned_cols=79  Identities=14%  Similarity=0.139  Sum_probs=51.2

Q ss_pred             eecccCccceEeeEecCC-cEEEEEEecc-------cChhhHHHHHHHHHHHhccC--CC-ceeeEeeeEeecCeEEEEE
Q 003287          520 KLGEGGFGPVYKGKLLNG-QEVAVKRLSS-------QSGQGLKEFKNEMMLIAKLQ--HR-NLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~~~g-~~vAVK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lV~  588 (834)
                      .||-|...-||++...+| +.|+||.-..       .-+...++..-|...|....  -| .+.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998654 6899996421       11334455566777776653  24 3444544  3556677999


Q ss_pred             EecCCC-Cchhhh
Q 003287          589 EYMPNK-SLNFFL  600 (834)
Q Consensus       589 Ey~~~g-sL~~~l  600 (834)
                      |+++.. .|...|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            999654 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.76  E-value=0.019  Score=58.70  Aligned_cols=123  Identities=20%  Similarity=0.252  Sum_probs=60.7

Q ss_pred             CcEEEEEEecccChhhHHHHHHHHHHHhccCCCce-eeEeeeEeecCeEEEEEEecCCCCchhh-h--------------
Q 003287          537 GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKSLNFF-L--------------  600 (834)
Q Consensus       537 g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l--------------  600 (834)
                      .+.|+||+....+ ........|..+++.+...++ .++++++.++    +|+||+++..|..- +              
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888886653 334566788888888854443 4555554332    57799977665331 1              


Q ss_pred             --cCC----CCCCCCCHHHHHHH----------------------HHHHHHHHHHHh----hc-CCCceEecCCCCCcEE
Q 003287          601 --FDP----SRTHLLGWQTRVKI----------------------IEGIAQGLLYLH----QY-SRLRIIHRDLKASNIL  647 (834)
Q Consensus       601 --~~~----~~~~~l~~~~~~~i----------------------~~~ia~~L~yLH----~~-~~~~iiH~DIkp~NIL  647 (834)
                        +..    .....--+.....+                      ...+.+-+..+.    .. .+..++|+|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              000    00000011222111                      011111222221    11 1235899999999999


Q ss_pred             E-cCCCCeeecccccccc
Q 003287          648 L-DSDMNPKISDFGMARM  664 (834)
Q Consensus       648 l-~~~~~vkl~DFGla~~  664 (834)
                      + +.++.++++||..|..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8999999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.60  E-value=0.072  Score=58.52  Aligned_cols=141  Identities=16%  Similarity=0.238  Sum_probs=80.9

Q ss_pred             ceecccCccceEeeEecC----CcEEEEEEecccChhhHHHHHHHHHHHhccCCCce-eeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      +.|..|-.-.+|+....+    +..|++|+....... .-...+|..++..+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            455557777889886543    248999988654432 2334678888888865444 34555553 22   58999987


Q ss_pred             CCchhh-------h----------cCCC-C-CC-CCCHHHHHHHHHHH----------------------HHHHHH----
Q 003287          594 KSLNFF-------L----------FDPS-R-TH-LLGWQTRVKIIEGI----------------------AQGLLY----  627 (834)
Q Consensus       594 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~L~y----  627 (834)
                      ..|..-       +          +... . .. .-.+....++..++                      .+-+..    
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            765321       1          1111 0 01 11122222222111                      111211    


Q ss_pred             Hhh-cCCCceEecCCCCCcEEEcC-CCCeeecccccccc
Q 003287          628 LHQ-YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARM  664 (834)
Q Consensus       628 LH~-~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~  664 (834)
                      +.+ ..+..++|.|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 12335899999999999975 57899999998864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	834
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-48
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-34
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-25
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-25
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-25
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-25
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-25
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-25
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-25
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-23
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-22
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-22
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-20
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-19
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-19
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-19
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-19
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-18
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-18
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-16
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-12
3soa_A	444	Full-Length Human Camkii Length = 444		1e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  194 bits (492), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 116/294 (39%), Positives = 169/294 (57%), Gaps = 6/294 (2%)
Query: 500 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKN 558
           L  FSL  +  A++NFS +  LG GGFG VYKG+L +G  VAVKRL  +  QG + +F+ 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKI 617
           E+ +I+   HRNL+RL G C+   E++L+Y YM N S+   L + P     L W  R +I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
             G A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++    +       V
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 203
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI---ESFNLLGHAWNL 734
            GT G+++PEY   G  S K+DVF +GV+LLE +T +R   +  +   +   LL     L
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
            K+ +   L+   LQ     + + + I VALLC Q    +RP MS+VV M+  +
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  190 bits (483), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 114/294 (38%), Positives = 167/294 (56%), Gaps = 6/294 (2%)
Query: 500 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKN 558
           L  FSL  +  A++NF  +  LG GGFG VYKG+L +G  VAVKRL  +  QG + +F+ 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKI 617
           E+ +I+   HRNL+RL G C+   E++L+Y YM N S+   L + P     L W  R +I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
             G A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++    +       V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 195
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI---ESFNLLGHAWNL 734
            G  G+++PEY   G  S K+DVF +GV+LLE +T +R   +  +   +   LL     L
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
            K+ +   L+   LQ     + + + I VALLC Q    +RP MS+VV M+  +
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/283 (39%), Positives = 168/283 (59%), Gaps = 11/283 (3%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
           L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+  ++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQ 623
             +H +LV L+G C E+ E ILIY+YM N +L   L+     T  + W+ R++I  G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-QGNTKRVV-GTY 681
           GL YLH  +   IIHRD+K+ NILLD +  PKI+DFG+++   G EL Q +   VV GT 
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK--GTELDQTHLXXVVKGTL 205
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI--ESFNLLGHAWNLWKDNR 739
           GY+ PEY + G  + KSDV+SFGV+L E L + R+  V  +  E  NL   A     + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
             +++ P L  +   + L ++   A+ C+   + DRP+M  V+
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/283 (39%), Positives = 168/283 (59%), Gaps = 11/283 (3%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
           L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+  ++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQ 623
             +H +LV L+G C E+ E ILIY+YM N +L   L+     T  + W+ R++I  G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-QGNTKRVV-GTY 681
           GL YLH  +   IIHRD+K+ NILLD +  PKI+DFG+++   G EL Q +   VV GT 
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK--GTELGQTHLXXVVKGTL 205
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI--ESFNLLGHAWNLWKDNR 739
           GY+ PEY + G  + KSDV+SFGV+L E L + R+  V  +  E  NL   A     + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
             +++ P L  +   + L ++   A+ C+   + DRP+M  V+
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 497 DSVLPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ-- 548
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 549 -SGQGLKE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT 606
            + + LK+ F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     T
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 607 HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
             L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN 726
                    R+VGT  YM+PE AL G  + KSD++SFGV+LLE +T       +      
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L        ++    + +   +    S  +   Y +VA  C+ EK   RP + KV  ++
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY-SVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 497 DSVLPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ-- 548
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 549 -SGQGLKE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT 606
            + + LK+ F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     T
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 607 HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
             L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN 726
                    R+VGT  YM+PE AL G  + KSD++SFGV+LLE +T       +      
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L        ++    + +   +    S  +   Y +VA  C+ EK   RP + KV  ++
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY-SVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  151 bits (382), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 497 DSVLPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ-- 548
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 61
Query: 549 -SGQGLKE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT 606
            + + LK+ F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     T
Sbjct: 62  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 607 HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
             L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN 726
                    R+VGT  YM+PE AL G  + KSD++SFGV+LLE +T       +      
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237
Query: 727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L        ++    + +   +    S  +   Y +VA  C+ EK   RP + KV  ++
Sbjct: 238 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY-SVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 148/299 (49%), Gaps = 16/299 (5%)
Query: 503 FSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ---SGQGL 553
           FS   +   T NF  +       K GEGGFG VYKG  +N   VAVK+L++    + + L
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 554 KE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQ 612
           K+ F  E+ + AK QH NLV L+G   +  +  L+Y Y PN SL   L     T  L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
            R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW 732
              R+VGT  Y +PE AL G  + KSD++SFGV+LLE +T       +      L     
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 240
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT 791
              ++    + +        S  +   Y +VA  C+ EK   RP + KV  ++    A+
Sbjct: 241 IEDEEKTIEDYIDKKXNDADSTSVEAXY-SVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 73
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 74  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 132 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 185
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 236
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 237 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 72
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 73  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 130
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 131 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 184
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 235
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 236 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 267

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 77  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 134
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 135 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 239
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 240 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 271

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 79
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 80  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLT-INKLLDMAAQIAEGMAFIEERN 137
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 138 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 191
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 242
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 243 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 274

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 78  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 135
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 189
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 240
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 241 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 80
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 81  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 138
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 139 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 192
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 243
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 244 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 78  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 135
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 189
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 240
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 241 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 81
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 82  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLT-INKLLDMAAQIAEGMAFIEERN 139
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 140 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 193
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 244
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 245 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 276

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 66
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 67  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 124
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 125 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 178
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 179 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 229
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 230 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 261

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  112 bits (280), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 92/279 (32%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 67
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 68  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLT-INKLLDMAAQIAEGMAFIEERN 125
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHR+L+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 126 ---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 179
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 230
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 231 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 262

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 92/279 (32%), Positives = 136/279 (48%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G  G V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+    E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAE---XTAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNL 571
           + +++ K+G G FG V++ +  +G +VAVK L  Q    + + EF  E+ ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V  MG   +     ++ EY+   SL   L        L  + R+ +   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           +   I+HRDLK+ N+L+D     K+ DFG++R+     L   +K   GT  +M+PE   D
Sbjct: 157 NP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX--SKXAAGTPEWMAPEVLRD 213
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTG 718
              + KSDV+SFGV+L E  T ++  G
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 43/278 (15%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL + S   +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIHR 127
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 183
Query: 697 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 228
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
                YQ++N        C +E+  DRP  S+++  + 
Sbjct: 229 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLA 259

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 114/207 (55%), Gaps = 6/207 (2%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNL 571
           + +++ K+G G FG V++ +  +G +VAVK L  Q    + + EF  E+ ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V  MG   +     ++ EY+   SL   L        L  + R+ +   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           +   I+HR+LK+ N+L+D     K+ DFG++R+     L  ++K   GT  +M+PE   D
Sbjct: 157 NP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRD 213
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTG 718
              + KSDV+SFGV+L E  T ++  G
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 71  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 181
Query: 697 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 226
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 227 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 76  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 186
Query: 697 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 231
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 232 ASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 263

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 183
Query: 697 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 228
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 229 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 260

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 43/279 (15%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG V+ G  LN  +VA+K +   S     +F  E  ++ KL H  LV+L G C+
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 203
Query: 697 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 204 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 248
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 249 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 280

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 43/279 (15%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           EQ    L+ E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 74  EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 184
Query: 697 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 229
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 230 ASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 113/217 (52%), Gaps = 31/217 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRN 570
            +++  +G GGFG VY+   + G EVAVK           Q ++  + E  L A L+H N
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLL 626
           ++ L G C+++    L+ E+     LN  L      P    L+ W  +      IA+G+ 
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI--LVNWAVQ------IARGMN 119
Query: 627 YLHQYSRLRIIHRDLKASNILL-----DSDMNPKI---SDFGMARMFCGDELQGNTK-RV 677
           YLH  + + IIHRDLK+SNIL+     + D++ KI   +DFG+AR     E    TK   
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 174
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            G Y +M+PE     +FS  SDV+S+GVLL E LT +
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 354
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 354
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 325
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+    ++ EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 326 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 380
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 437
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 66
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 67  QLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 121
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 122 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAAL 178
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VGEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 354
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I+I EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I+I EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 69
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 70  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 124
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 125 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 181
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 484 PSEGDGDAKGTRRDSVLPCFSLASVSA-ATENFSMQCKLGEGGFGPVYKGK---LLNGQE 539
           P+EG G             FS A V      +  ++ +LGEG FG V+  +   LL  Q+
Sbjct: 11  PTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQD 70
Query: 540 ---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 596
              VAVK L   S    ++F+ E  L+  LQH+++VR  G C E    ++++EYM +  L
Sbjct: 71  KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130
Query: 597 NFFL--FDPSRTHL----------LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 644
           N FL    P    L          LG    + +   +A G++YL   + L  +HRDL   
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 187
Query: 645 NILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG 704
           N L+   +  KI DFGM+R     +      R +    +M PE  L   F+ +SDV+SFG
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247
Query: 705 VLLLETLT 712
           V+L E  T
Sbjct: 248 VVLWEIFT 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
           +  ++ +LGEG FG V+  +   LL  Q+   VAVK L   S    ++F+ E  L+  LQ
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 78
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHL----------LGWQTRV 615
           H+++VR  G C E    ++++EYM +  LN FL    P    L          LG    +
Sbjct: 79  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 138
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
            +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      
Sbjct: 139 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           R +    +M PE  L   F+ +SDV+SFGV+L E  T
Sbjct: 196 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
           +  ++ +LGEG FG V+  +   LL  Q+   VAVK L   S    ++F+ E  L+  LQ
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 72
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHL----------LGWQTRV 615
           H+++VR  G C E    ++++EYM +  LN FL    P    L          LG    +
Sbjct: 73  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 132
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
            +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      
Sbjct: 133 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           R +    +M PE  L   F+ +SDV+SFGV+L E  T
Sbjct: 190 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 73
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 74  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL-VDMSAQIASGMAYVE--- 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW---TARQGAKFPIKWTAPEAAL 185
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 73
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 74  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL-VDMSAQIASGMAYVE--- 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 185
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 65
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 66  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 120
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 121 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 177
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 67
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 68  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 122
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 123 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 179
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  +  +LG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 71
Query: 573 RLMGCCVEQGEKILIYEYMPNKSL-NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           RL      +    +I EYM   SL +F   D     LL     +     IA+G+ Y+   
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-- 127
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYA 689
            R   IHRDL+A+N+L+   +  KI+DFG+AR+   +E    T R    +   + +PE  
Sbjct: 128 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 183
Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
             G F++KSDV+SFG+LL E +T  +    G  + +    L   + +           P 
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRM-----------PR 232
Query: 748 LQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           +++  +  Y ++        +C +EKA +RPT   + S++ +
Sbjct: 233 VENCPDELYDIMK-------MCWKEKAEERPTFDYLQSVLDD 267

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 108/205 (52%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L        + F  E  ++ KL+H  LV
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 244 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 298
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+ R+   +E    T R    +   + +PE AL
Sbjct: 299 RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY---TARQGAKFPIKWTAPEAAL 355
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ K++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 34/279 (12%)
Query: 518 QCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNL 571
           Q  +G G FG VYKG L      +EV V   + ++G   K+   F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP----SRTHLLGWQTRVKIIEGIAQGLLY 627
           +RL G   +    ++I EYM N +L+ FL +     S   L+G      ++ GIA G+ Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG------MLRGIAAGMKY 162
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSP 686
           L   + +  +HRDL A NIL++S++  K+SDFG++R+   D E    T        + +P
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 746
           E      F+  SDV+SFG+++ E +T       Y    +  L +   +   N  + L +P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMT-------YGERPYWELSNHEVMKAINDGFRLPTP 272
Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
                A YQ++       + C Q++ A RP  + +VS++
Sbjct: 273 MDCPSAIYQLM-------MQCWQQERARRPKFADIVSIL 304

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG+AR+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I++ EYM    L  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  +  +LG G FG V+ G      +VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLV 67
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL D      L     V +   +A G+ Y+    
Sbjct: 68  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE--- 122
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  IHRDL+++NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 123 RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNE---XTARQGAKFPIKWTAPEAAL 179
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E +T  R
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM    L  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 690
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN---GQE---VAVKRLSSQSGQGLKEFKNEMMLIAKL 566
            N  ++ +LGEG FG V+  +  N    Q+   VAVK L   S    K+F  E  L+  L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHL--------LGWQTRVK 616
           QH ++V+  G CVE    I+++EYM +  LN FL    P    +        L     + 
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           I + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  R
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 185
Query: 677 VVGT----YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           V G       +M PE  +   F+ +SDV+S GV+L E  T
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 34/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  +  KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 70
Query: 573 RLMGCCVEQGEKILIYEYMPNKSL-NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           RL     ++    +I E+M   SL +F   D     LL     +     IA+G+ Y+   
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-- 126
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYA 689
            R   IHRDL+A+N+L+   +  KI+DFG+AR+   +E    T R    +   + +PE  
Sbjct: 127 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 182
Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
             G F++KS+V+SFG+LL E +T  +    G  + +  + L   + +           P 
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM-----------PR 231
Query: 748 LQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           +++  +  Y ++        +C +EKA +RPT   + S++ +
Sbjct: 232 MENCPDELYDIMK-------MCWKEKAEERPTFDYLQSVLDD 266

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C+    + L+ + MP+  L  ++ +      +G Q  +     IA+G++YL +    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N         +M+ E      F
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 695 SVKSDVFSFGVLLLETLT 712
           + +SDV+S+GV + E +T
Sbjct: 220 THQSDVWSYGVTIWELMT 237

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C+    + L+ + MP+  L  ++ +      +G Q  +     IA+G++YL +    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N         +M+ E      F
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 695 SVKSDVFSFGVLLLETLT 712
           + +SDV+S+GV + E +T
Sbjct: 197 THQSDVWSYGVTIWELMT 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 113/216 (52%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 572
           +LGE  FG VYKG L         Q VA+K L  ++   L+E F++E ML A+LQH N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLF-----------DPSRT--HLLGWQTRVKIIE 619
            L+G   +     +I+ Y  +  L+ FL            D  RT    L     V ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTKR 676
            IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+  
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            +    +M+PE  + G FS+ SD++S+GV+L E  +
Sbjct: 193 PI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 113/216 (52%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 572
           +LGE  FG VYKG L         Q VA+K L  ++   L+E F++E ML A+LQH N+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLF-----------DPSRT--HLLGWQTRVKIIE 619
            L+G   +     +I+ Y  +  L+ FL            D  RT    L     V ++ 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTKR 676
            IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+  
Sbjct: 153 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            +    +M+PE  + G FS+ SD++S+GV+L E  +
Sbjct: 210 PI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 159
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 160 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 269
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 270 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 132
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 242
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 243 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 275

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 149
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 150 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 206
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 207 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 259
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 260 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG+ R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 130/278 (46%), Gaps = 16/278 (5%)
Query: 521 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V  Y     N   G+ VAVK L +  G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 575 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            GCC +QGEK L  + EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 691
               IHR+L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             F   SDV+SFGV L E LT   ++     +   L+G A       R  ELL    +  
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 789
              +       +   C + +A+ RPT   ++ ++   H
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 130/278 (46%), Gaps = 16/278 (5%)
Query: 521 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V  Y     N   G+ VAVK L +  G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 575 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            GCC +QGEK L  + EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 691
               IHR+L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             F   SDV+SFGV L E LT   ++     +   L+G A       R  ELL    +  
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 789
              +       +   C + +A+ RPT   ++ ++   H
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 140/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +        +   LL P 
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL------QGRRLLQPE 259
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 260 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 168
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 279
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 280 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 317

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 141
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 252
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 253 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 290

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 137/282 (48%), Gaps = 35/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 73
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 629
           +L     ++   I I E+M   SL  FL     +     Q   K+I+    IA+G+ ++ 
Sbjct: 74  KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIE 128
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPE 687
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE
Sbjct: 129 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 182
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
               G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPR 233
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           P    E  Y ++ R       C + +  +RPT   + S++ +
Sbjct: 234 PENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 268

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 144
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 255
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 256 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 147
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 258
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 259 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 208
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 319
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 320 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 357

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 259
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 260 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 140/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +        +   LL P 
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL------QGRRLLQPE 261
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 262 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 146
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 257
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 258 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 140/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 167
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +        +   LL P 
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL------QGRRLLQPE 278
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 279 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 316

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 246
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 629
           +L     ++   I I E+M   SL  FL    ++     Q   K+I+    IA+G+ ++ 
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPE 687
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 355
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
               G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPR 406
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           P    E  Y ++ R       C + +  +RPT   + S++ +
Sbjct: 407 PENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 441

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 147
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 258
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 259 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 127/274 (46%), Gaps = 16/274 (5%)
Query: 521 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 574
           LGEG FG V  Y     N   G+ VAVK L    G  L+  ++ E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 575 MGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            GCC +QGEK   L+ EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 691
               IHR L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             F   SDV+SFGV L E LT   +      +   L+GH        R  ELL    +  
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP 249
Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              +       +   C + +A+ RPT   +V ++
Sbjct: 250 RPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 261
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 262 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 127/274 (46%), Gaps = 16/274 (5%)
Query: 521 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 574
           LGEG FG V  Y     N   G+ VAVK L    G  L+  ++ E+ ++  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 575 MGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            GCC +QGEK   L+ EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 691
               IHR L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             F   SDV+SFGV L E LT   +      +   L+GH        R  ELL    +  
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP 248
Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              +       +   C + +A+ RPT   +V ++
Sbjct: 249 RPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 200
Query: 697 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 201 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 251
Query: 757 LNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                T+   C  EKA +RPT   ++S I +
Sbjct: 252 -----TIMYSCWHEKADERPTFKILLSNILD 277

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
           +  ++ +LGEG FG V+  +  N         VAVK L   +    K+F+ E  L+  LQ
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTR----------- 614
           H ++V+  G C +    I+++EYM +  LN FL    P    L+  Q R           
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           + I   IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R    D    + 
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDY 188
Query: 675 KRVVGT----YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            RV G       +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 521 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 154
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 747
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 265
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 266 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 303

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 184
Query: 697 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 185 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 235
Query: 757 LNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                T+   C  EKA +RPT   ++S I +
Sbjct: 236 -----TIMYSCWHEKADERPTFKILLSNILD 261

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDGLFSVK 697
           DL A N L++     K+SDFG++R    DE    T  V   +   +  PE  +   FS K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 698 SDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQML 757
           SD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y   
Sbjct: 202 SDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY--- 251
Query: 758 NRYITVALLCVQEKAADRPTMSKVVSMITN 787
               T+   C  EKA +RPT   ++S I +
Sbjct: 252 ----TIMYSCWHEKADERPTFKILLSNILD 277

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 180
Query: 697 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 181 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 231
Query: 757 LNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                T+   C  EKA +RPT   ++S I +
Sbjct: 232 -----TIMYSCWHEKADERPTFKILLSNILD 257

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 191
Query: 697 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 192 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 242
Query: 757 LNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                T+   C  EKA +RPT   ++S I +
Sbjct: 243 -----TIMYSCWHEKADERPTFKILLSNILD 268

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 696
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 185
Query: 697 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 756
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 186 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 236
Query: 757 LNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                T+   C  EKA +RPT   ++S I +
Sbjct: 237 -----TIMYSCWHEKADERPTFKILLSNILD 262

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPV----YKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V    Y  +  N G++VAVK L  +SG   + + K E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL--HQ 630
            G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G+ YL   Q
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPEY 688
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K  R    + Y +PE 
Sbjct: 147 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 689 ALDGLFSVKSDVFSFGVLLLETLT 712
            +   F + SDV+SFGV L E LT
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E  ++  +LG G FG V  GK     +VAVK +   S     EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYLHQ 630
           +  G C ++    ++ EY+ N  L  +L    R+H  G +    +++   + +G+ +L  
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPE 687
           +   + IHRDL A N L+D D+  K+SDFGM R    D+   +    VGT     + +PE
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPE 175
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
                 +S KSDV++FG+L+ E  +  +         ++L  ++  + K ++ + L  P 
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKM-------PYDLYTNSEVVLKVSQGHRLYRPH 228
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L  +  YQ++         C  E    RPT  +++S I
Sbjct: 229 LASDTIYQIMYS-------CWHELPEKRPTFQQLLSSI 259

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPV----YKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V    Y  +  N G++VAVK L  +SG   + + K E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL--HQ 630
            G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G+ YL   Q
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPEY 688
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K  R    + Y +PE 
Sbjct: 135 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 689 ALDGLFSVKSDVFSFGVLLLETLT 712
            +   F + SDV+SFGV L E LT
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ E M N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DL A N L++     K+SDFG++R    DE   +++       +  PE  +   FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 700 VFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNR 759
           +++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y     
Sbjct: 189 IWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY----- 236
Query: 760 YITVALLCVQEKAADRPTMSKVVSMITN 787
             T+   C  EKA +RPT   ++S I +
Sbjct: 237 --TIMYSCWHEKADERPTFKILLSNILD 262

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ E M N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 568
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N++RL G   +    +++ E M N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 132
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 685
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 242
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 243 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 238
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 239 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            G C   G +   LI EY+P  SL  +L   +    +     ++    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMSPEYALD 691
             R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +PE   +
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 692 GLFSVKSDVFSFGVLLLETLT 712
             FSV SDV+SFGV+L E  T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 233
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 234 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 17  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 77  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 126
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 127 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 235
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 236 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 277

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 238
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 239 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 128/268 (47%), Gaps = 21/268 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    ++ EYMP  +L  +L + +R  +      + +   I+  + YL    
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA-VVLLYMATQISSAMEYL---E 147
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 206
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ Y+LL    + E 
Sbjct: 207 TFSIKSDVWAFGVLLWEIATY----GMSPYPGIDL----------SQVYDLLEKGYRMEQ 252
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSK 780
                 +   +   C +   ADRP+ ++
Sbjct: 253 PEGCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 102 KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 151
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 152 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 260
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 261 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 302

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 127
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 128 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 261
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 262 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 49/283 (17%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V  G+L + GQ    VA+K L +  + +  ++F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 633
           G        +++ EYM N SL+ FL    RTH         V ++ G+  G+ YL   S 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG-----YMSPEY 688
           L  +HRDL A N+L+DS++  K+SDFG++R+   D     T     T G     + +PE 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEA 225
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN------RAYE 742
                FS  SDV+SFGV++ E L        Y    +      WN+   +        Y 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA-------YGERPY------WNMTNRDVISSVEEGYR 272
Query: 743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L +P     A +Q++       L C  +  A RP  S++VS++
Sbjct: 273 LPAPMGCPHALHQLM-------LDCWHKDRAQRPRFSQIVSVL 308

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 132
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 133 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 133
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 134 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 135
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 136 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 567 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-----------HLLGWQTR 614
            QH N+V L+G C   G  ++I EY     L  FL   SR              L  +  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQ 671
           +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLG 729
           GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F    
Sbjct: 224 GNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---- 276
Query: 730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
             + L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 277 --YKLVKD--GYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 324

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 126
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 127 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 134
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 135 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 98
Query: 567 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKII 618
            QH N+V L+G C   G  ++I EY     L  FL        D      L  +  +   
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTK 675
             +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN +
Sbjct: 159 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWN 733
             V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F      + 
Sbjct: 216 LPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------YK 266
Query: 734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
           L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 267 LVKD--GYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 312

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G FG VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 693 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P    
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL---------EKDYRMERPEGCP 236
Query: 751 EASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           E  Y+++         C Q   +DRP+ +++
Sbjct: 237 EKVYELMR-------ACWQWNPSDRPSFAEI 260

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
              +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 75  AP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 233
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 234 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 25/271 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 126
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 693 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P    
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL---------EKDYRMERPEGCP 236
Query: 751 EASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           E  Y+++         C Q   +DRP+ +++
Sbjct: 237 EKVYELMRA-------CWQWNPSDRPSFAEI 260

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 49/283 (17%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V  G+L + GQ    VA+K L +  + +  ++F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 633
           G        +++ EYM N SL+ FL    RTH         V ++ G+  G+ YL   S 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG-----YMSPEY 688
           L  +HRDL A N+L+DS++  K+SDFG++R+   D     T     T G     + +PE 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEA 225
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN------RAYE 742
                FS  SDV+SFGV++ E L        Y    +      WN+   +        Y 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA-------YGERPY------WNMTNRDVISSVEEGYR 272
Query: 743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L +P     A +Q++       L C  +  A RP  S++VS++
Sbjct: 273 LPAPMGCPHALHQLM-------LDCWHKDRAQRPRFSQIVSVL 308

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 133
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 567 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKII 618
            QH N+V L+G C   G  ++I EY     L  FL        D      L  +  +   
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTK 675
             +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN +
Sbjct: 167 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWN 733
             V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F      + 
Sbjct: 224 LPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------YK 274
Query: 734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
           L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 275 LVKD--GYQMAQPAFAPKNIYSIMQ-------ACWALEPTHRPTFQQICSFLQEQ 320

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYN 185
Query: 693 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P    
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL---------EKDYRMERPEGCP 236
Query: 751 EASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           E  Y+++         C Q   +DRP+ +++
Sbjct: 237 EKVYELMR-------ACWQWNPSDRPSFAEI 260

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 16/278 (5%)
Query: 521 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V  Y     N   G+ VAVK L + +G Q    +K E+ ++  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 575 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            GCC + G   L  + EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 691
               IHRDL A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             F   SDV+SFGV L E LT   ++     +   L+G A       R  ELL    +  
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 271
Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 789
              +       +   C + +A+ RPT   ++ ++   H
Sbjct: 272 RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 132
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 191
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 237
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 135/280 (48%), Gaps = 41/280 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 240
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 629
           +L     ++   I I E+M   SL  FL    ++     Q   K+I+    IA+G+ ++ 
Sbjct: 241 KLHAVVTKEPIYI-ITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+     ++           + +PE  
Sbjct: 296 QRN---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAI 341
Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
             G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  P 
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRPE 392
Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
              E  Y ++ R       C + +  +RPT   + S++ +
Sbjct: 393 NCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 425

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 95  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 144
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A            +++ G+  +M+PE      
Sbjct: 145 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 253
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 254 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 295

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A            +++ G+  +M+PE      
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 261
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 262 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIATY----GMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 633
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 690
             IIHRDLK++NI L  D+  KI DFG+A            +++ G+  +M+PE      
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 233
Query: 751 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 234 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 188
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 234
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 235 PEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 128
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 136/301 (45%), Gaps = 47/301 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 567 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQ 612
            QH N+V L+G C   G  ++I EY     L  FL           ++PS      L  +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--- 669
             +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    
Sbjct: 167 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 223
Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNL 727
           ++GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F  
Sbjct: 224 VKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-- 278
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               + L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  
Sbjct: 279 ----YKLVKD--GYQMAQPAFAPKNIYSIMQ-------ACWALEPTHRPTFQQICSFLQE 325
Query: 788 E 788
           +
Sbjct: 326 Q 326

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 235
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI E++P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSL--------REYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 235
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 141
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 200
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 201 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 246
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 247 PEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 335
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHR+L A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 394
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 440
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 45/299 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 567 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-----------HLLGWQTR 614
            QH N+V L+G C   G  ++I EY     L  FL   SR                 +  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQ 671
           +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLG 729
           GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F    
Sbjct: 224 GNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---- 276
Query: 730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
             + L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 277 --YKLVKD--GYQMAQPAFAPKNIYSIMQ-------ACWALEPTHRPTFQQICSFLQEQ 324

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 145/293 (49%), Gaps = 37/293 (12%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQG-------LKEFKNEM 560
           + A      + ++G+GGFG V+KG+L+  +  VA+K L     +G        +EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            +++ L H N+V+L G         ++ E++P   L   L D  + H + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMARMFCGDELQGNTK 675
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DFG+++         +  
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVS 184
Query: 676 RVVGTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN 733
            ++G + +M+PE   A +  ++ K+D +SF ++L   LT +   G +D  S+  +    N
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSYGKIKFI-N 240
Query: 734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
           + ++    E L P +  +   ++ N    V  LC       RP  S +V  ++
Sbjct: 241 MIRE----EGLRPTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 27/272 (9%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V  G+L + G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLF-DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G   +    ++I EYM N SL+ FL  +  R  ++     V ++ GI  G+ YL   S +
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL---SDM 150
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYALDGL 693
             +HRDL A NIL++S++  K+SDFGM+R+   D     T R       + +PE      
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 753
           F+  SDV+S+G+++ E ++       +D+ + +++            Y L  P     A 
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPPPMDCPIAL 263
Query: 754 YQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           +Q++       L C Q++ +DRP   ++V+M+
Sbjct: 264 HQLM-------LDCWQKERSDRPKFGQIVNML 288

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD              + +PE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 189
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 235
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 129
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHRDL A N L+  +   K++DFG++R+  GD              + +PE     
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 188
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 234
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 235 PEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           F+PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 27/272 (9%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V  G+L + G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLF-DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G   +    ++I EYM N SL+ FL  +  R  ++     V ++ GI  G+ YL   S +
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL---SDM 129
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYALDGL 693
             +HRDL A NIL++S++  K+SDFGM+R+   D     T R       + +PE      
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 753
           F+  SDV+S+G+++ E ++       +D+ + +++            Y L  P     A 
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPPPMDCPIAL 242
Query: 754 YQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           +Q++       L C Q++ +DRP   ++V+M+
Sbjct: 243 HQLM-------LDCWQKERSDRPKFGQIVNML 267

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 374
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           +   IHR+L A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 433
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 479
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKV 781
                 +   +   C Q   +DRP+ +++
Sbjct: 480 PEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 575 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 626
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 129
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 685
           YL      R IHR+L   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 130 YL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 27/272 (9%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V  G+L + G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLF-DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G   +    ++I EYM N SL+ FL  +  R  ++     V ++ GI  G+ YL   S +
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL---SDM 135
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYALDGL 693
             +HRDL A NIL++S++  K+SDFGM+R+   D     T R       + +PE      
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 753
           F+  SDV+S+G+++ E ++       +D+ + +++            Y L  P     A 
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPPPMDCPIAL 248
Query: 754 YQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           +Q++       L C Q++ +DRP   ++V+M+
Sbjct: 249 HQLM-------LDCWQKERSDRPKFGQIVNML 273

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK K   G+ VA+KR+      +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V L+     +    L++E+M  K L   L D ++T L   Q ++ + + + +G+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
           +   RI+HRDLK  N+L++SD   K++DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 691 DG-LFSVKSDVFSFGVLLLETLTSK 714
               +S   D++S G +  E +T K
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK K   G+ VA+KR+      +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V L+     +    L++E+M  K L   L D ++T L   Q ++ + + + +G+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
           +   RI+HRDLK  N+L++SD   K++DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 691 -DGLFSVKSDVFSFGVLLLETLTSK 714
               +S   D++S G +  E +T K
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQG-------LKEFKNEM 560
           + A      + ++G+GGFG V+KG+L+  +  VA+K L     +G        +EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            +++ L H N+V+L G         ++ E++P   L   L D  + H + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMARMFCGDELQGNTK 675
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DFG ++         +  
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-----HSVS 184
Query: 676 RVVGTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN 733
            ++G + +M+PE   A +  ++ K+D +SF ++L   LT +   G +D  S+  +    N
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSYGKIKFI-N 240
Query: 734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
           + ++    E L P +  +   ++ N    V  LC       RP  S +V  ++
Sbjct: 241 MIRE----EGLRPTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKELS 285

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 262

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 258

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
           L H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 140/301 (46%), Gaps = 45/301 (14%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G G FG V K K    ++VA+K++ S+S +  K F  E+  ++++ H N+V+L G C+ 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 581 QGEKILIYEYMPNKSLNFFLF--DP----SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                L+ EY    SL   L   +P    +  H + W  +       +QG+ YLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 635 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
            +IHRDLK  N+LL +     KI DFG A   C  ++Q +     G+  +M+PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA---C--DIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 753
           +S K DVFS+G++L E +T ++        +F ++   W +    R      P L     
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTR------PPL----- 226
Query: 754 YQMLNRYI-TVALLCVQEKAADRPTMSKVVSMITNEHATLP-------YPKQSAFSYARR 805
            + L + I ++   C  +  + RP+M ++V ++T+     P       YP Q +      
Sbjct: 227 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 286
Query: 806 G 806
           G
Sbjct: 287 G 287

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 141/301 (46%), Gaps = 45/301 (14%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G G FG V K K    ++VA+K++ S+S +  K F  E+  ++++ H N+V+L G C+ 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 581 QGEKILIYEYMPNKSLNFFLF--DP----SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                L+ EY    SL   L   +P    +  H + W  +       +QG+ YLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 635 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
            +IHRDLK  N+LL +     KI DFG A   C  ++Q +     G+  +M+PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA---C--DIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 753
           +S K DVFS+G++L E +T ++        +F ++   W +    R      P +++   
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTR-----PPLIKN--- 228
Query: 754 YQMLNRYI-TVALLCVQEKAADRPTMSKVVSMITNEHATLP-------YPKQSAFSYARR 805
              L + I ++   C  +  + RP+M ++V ++T+     P       YP Q +      
Sbjct: 229 ---LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
Query: 806 G 806
           G
Sbjct: 286 G 286

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +  +  ++ ++    SL   L        +  +  + I    A+G+ YLH  S   IIHR
Sbjct: 79  KP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSV 696
           DLK++NI L  D   KI DFG+A +          +++ G+  +M+PE         +S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 697 KSDVFSFGVLLLETLTSK 714
           +SDV++FG++L E +T +
Sbjct: 193 QSDVYAFGIVLYELMTGQ 210

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 261

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 35/271 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRN 570
           FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
            ++  GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 172
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
           ++   +IHRD+KA NILL      K+ DFG A +             VGT  +M+PE  L
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVIL 223
Query: 691 ---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSP 746
              +G +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------ESP 271
Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPT 777
           ALQ     +    ++     C+Q+   DRPT
Sbjct: 272 ALQSGHWSEYFRNFVDS---CLQKIPQDRPT 299

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 513 ENFSMQCKLGEGGFGPVY--KGKLLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQ 567
           E + +  KLG GG   VY  +  +LN + VA+K +     +  + LK F+ E+   ++L 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLL 626
           H+N+V ++    E     L+ EY+   +L+ ++     +H  L   T +     I  G+ 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIK 125
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H    +RI+HRD+K  NIL+DS+   KI DFG+A+      L   T  V+GT  Y SP
Sbjct: 126 HAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSP 181
Query: 687 EYALDGLFSVKSDVFSFGVLLLETL 711
           E A        +D++S G++L E L
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEML 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
           L H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 35/271 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRN 570
           FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
            ++  GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 133
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
           ++   +IHRD+KA NILL      K+ DFG A       +       VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 691 ---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSP 746
              +G +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------ESP 232
Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPT 777
           ALQ     +    ++     C+Q+   DRPT
Sbjct: 233 ALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           +  ++G G FG VYKGK      V + ++   + +  + F+NE+ ++ K +H N++  MG
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 577 CCVEQGEKIL--------IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
              +    I+        +Y+++  +   F +F             + I    AQG+ YL
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQ-----------LIDIARQTAQGMDYL 148
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H  +   IIHRD+K++NI L   +  KI DFG+A +          ++  G+  +M+PE 
Sbjct: 149 HAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 689 AL---DGLFSVKSDVFSFGVLLLETLTSK 714
                +  FS +SDV+S+G++L E +T +
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQG-------LKEFKNEM 560
           + A      + ++G+GGFG V+KG+L+  +  VA+K L     +G        +EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            +++ L H N+V+L G         ++ E++P   L   L D  + H + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMARMFCGDELQGNTK 675
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DF +++         +  
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-----HSVS 184
Query: 676 RVVGTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN 733
            ++G + +M+PE   A +  ++ K+D +SF ++L   LT +   G +D  S+  +    N
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSYGKIKFI-N 240
Query: 734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
           + ++    E L P +  +   ++ N    V  LC       RP  S +V  ++
Sbjct: 241 MIRE----EGLRPTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 194
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 734
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 239
Query: 735 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 240 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSS-QSGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 734
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 262
Query: 735 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 263 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 209
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 734
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 262
Query: 735 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 263 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +  +  ++ ++    SL   L        +  +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  KP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSV 696
           DLK++NI L  D   KI DFG+A            +++ G+  +M+PE         +S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 697 KSDVFSFGVLLLETLTSK 714
           +SDV++FG++L E +T +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 133/308 (43%), Gaps = 54/308 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 567 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------------------FDPSR 605
            QH N+V L+G C   G  ++I EY     L  FL                     D   
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 606 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 665
              L  +  +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 666 CGDE---LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 720
             D    ++GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+ 
Sbjct: 209 MNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 265
Query: 721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 780
               F      + L KD   Y++  PA   +  Y ++         C   +   RPT  +
Sbjct: 266 VNSKF------YKLVKD--GYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQ 310
Query: 781 VVSMITNE 788
           + S +  +
Sbjct: 311 ICSFLQEQ 318

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGKL-LNGQE---VAVKRLS-SQSGQGLKEFKNEMMLIAKLQHR 569
            +++  +G G FG V  G+L L G+    VA+K L    + +  ++F  E  ++ +  H 
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N++ L G   +    +++ EYM N SL+ FL        +     V ++ GI+ G+ YL 
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL- 140
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEY 688
             S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + +PE 
Sbjct: 141 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
                F+  SDV+S+G+++ E ++       Y    +  + +   +      Y L SP  
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVS-------YGERPYWEMTNQDVIKAVEEGYRLPSPMD 251
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              A YQ++       L C Q++   RP   ++V+M+
Sbjct: 252 CPAALYQLM-------LDCWQKERNSRPKFDEIVNML 281

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 132/288 (45%), Gaps = 48/288 (16%)
Query: 451 WRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSA 510
           +RRKH+E    +++ Q  L+   Y     RT+           T      P +S A  ++
Sbjct: 2   YRRKHQE----LQAMQMELQSPEYKLSKLRTS-----------TIMTDYNPNYSFAGKTS 46
Query: 511 AT--------ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKE 555
           +         +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +
Sbjct: 47  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 106
Query: 556 FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGW 611
           F  E ++I+K  H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L  
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 166
Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGD 668
              + +   IA G  YL +      IHRD+ A N LL         KI DFGMAR    D
Sbjct: 167 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----D 219
Query: 669 ELQGNTKRVVG----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
             + +  R  G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 220 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 219
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
              +  ++ ++    SL   L        +  +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  AP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSV 696
           DLK++NI L  D   KI DFG+A            +++ G+  +M+PE         +S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 697 KSDVFSFGVLLLETLTSK 714
           +SDV++FG++L E +T +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  +    R  
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 220
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 221 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 54/295 (18%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSS-QSGQGLKEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  H
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 615
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 187
Query: 676 RVVGT--YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 731
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 247
Query: 732 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 248 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 282

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  +    R  
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 243
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 54/295 (18%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSS-QSGQGLKEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 615
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 197
Query: 676 RVVGT--YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 731
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257
Query: 732 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 258 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 292

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 617
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 618 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 242
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            L K +   ++L                + +  +C Q     RP+  +++S I  E    
Sbjct: 243 LLDKPDNCPDML----------------LELMRMCWQYNPKMRPSFLEIISSIKEEME-- 284
Query: 793 PYPKQSAFSYA 803
           P  ++ +F Y+
Sbjct: 285 PGFREVSFYYS 295

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 147/323 (45%), Gaps = 43/323 (13%)
Query: 503 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 550
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 551 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 607
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P+  +
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 608 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 720
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 780
           + +    +     L K +   ++L         ++++        +C Q     RP+  +
Sbjct: 246 NEQVLRFVMEGGLLDKPDNCPDML---------FELMR-------MCWQYNPKMRPSFLE 289
Query: 781 VVSMITNEHATLPYPKQSAFSYA 803
           ++S I  E    P  ++ +F Y+
Sbjct: 290 IISSIKEEME--PGFREVSFYYS 310

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +   NT   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 789 H 789
Sbjct: 324 E 324

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 43/323 (13%)
Query: 503 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 550
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 551 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 607
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 608 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 720
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 180 RDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239
Query: 721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 780
           + +    +     L K +   ++L         ++++        +C Q     RP+  +
Sbjct: 240 NEQVLRFVMEGGLLDKPDNCPDML---------FELMR-------MCWQYNPKMRPSFLE 283
Query: 781 VVSMITNEHATLPYPKQSAFSYA 803
           ++S I  E    P  ++ +F Y+
Sbjct: 284 IISSIKEEME--PGFREVSFYYS 304

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 117/252 (46%), Gaps = 39/252 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 604
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
               L     +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 665 FCGDELQGNTKRVVG--TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 720
               E     KR  G     +M+ E   D +++ +SDV+SFGVLL E +T   N   G+ 
Sbjct: 200 VY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 721 DIESFNLL--GH 730
               FNLL  GH
Sbjct: 258 PERLFNLLKTGH 269

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 113/209 (54%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAP 173
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 182
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 179
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 141/311 (45%), Gaps = 37/311 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 617
           ++ +    ++VRL+G   +    ++I E M    L  +L    P+  +  +L   +  K+
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 618 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 188 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 247
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 248 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 289
Query: 793 PYPKQSAFSYA 803
           P  ++ +F Y+
Sbjct: 290 PGFREVSFYYS 300

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 690 L-DGLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 182
Query: 690 L-DGLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 678
           A G  YL +      IHRD+ A N LL         KI DFGMA+    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKG 203
Query: 679 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 117/252 (46%), Gaps = 39/252 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 604
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
               L     +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 665 FCGDELQGNTKRVVG--TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 720
               E     KR  G     +M+ E   D +++ +SDV+SFGVLL E +T   N   G+ 
Sbjct: 200 VY--EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 721 DIESFNLL--GH 730
               FNLL  GH
Sbjct: 258 PERLFNLLKTGH 269

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 116/252 (46%), Gaps = 39/252 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 604
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
               L     +     I+QG+ YL + S   ++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 665 FCGDELQGNTKRVVG--TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 720
               E     KR  G     +M+ E   D +++ +SDV+SFGVLL E +T   N   G+ 
Sbjct: 200 VY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 721 DIESFNLL--GH 730
               FNLL  GH
Sbjct: 258 PERLFNLLKTGH 269

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 43/323 (13%)
Query: 503 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 550
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 551 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 607
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 128
Query: 608 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 720
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 780
           + +    +     L K +   ++L         ++++        +C Q     RP+  +
Sbjct: 246 NEQVLRFVMEGGLLDKPDNCPDML---------FELMR-------MCWQYNPKMRPSFLE 289
Query: 781 VVSMITNEHATLPYPKQSAFSYA 803
           ++S I  E    P  ++ +F Y+
Sbjct: 290 IISSIKEEME--PGFREVSFYYS 310

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 144/323 (44%), Gaps = 43/323 (13%)
Query: 503 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 550
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 551 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 607
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 608 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 720
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 180 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239
Query: 721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 780
           + +    +     L K +   ++L   ++                +C Q     RP+  +
Sbjct: 240 NEQVLRFVMEGGLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLE 283
Query: 781 VVSMITNEHATLPYPKQSAFSYA 803
           ++S I  E    P  ++ +F Y+
Sbjct: 284 IISSIKEEME--PGFREVSFYYS 304

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 617
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 618 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 244
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 245 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 286
Query: 793 PYPKQSAFSYA 803
           P  ++ +F Y+
Sbjct: 287 PGFREVSFYYS 297

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 41/292 (14%)
Query: 521 LGEGGFGPVYKGKLLNGQ----EVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LGEG FG V +G L        +VAVK  +L + S + ++EF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 575 MGCCVE---QG--EKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGL 625
           +G C+E   QG  + ++I  +M    L+ +L     +    H +  QT +K +  IA G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH-IPLQTLLKFMVDIALGM 160
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDEL-QGNTKRVVGTYGY 683
            YL   S    +HRDL A N +L  DM   ++DFG++ +++ GD   QG   ++     +
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 215
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAY 741
           ++ E   D +++ KSDV++FGV + E  T       GV + E ++ L H   L +     
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCL 275
Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
           + L     +E  Y            C +    DRPT S +   +     +LP
Sbjct: 276 DEL-----YEIMYS-----------CWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 617
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 618 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 191 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 250
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 251 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 292
Query: 793 PYPKQSAFSYA 803
           P  ++ +F Y+
Sbjct: 293 PGFREVSFYYS 303

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 617
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 618 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 191 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 250
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 251 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 292
Query: 793 PYPKQSAFSYA 803
           P  ++ +F Y+
Sbjct: 293 PGFREVSFYYS 303

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 617
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 618 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 189 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 248
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 249 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 290
Query: 793 PYPKQSAFSYA 803
           P  ++ +F Y+
Sbjct: 291 PGFREVSFYYS 301

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 144/323 (44%), Gaps = 43/323 (13%)
Query: 503 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 550
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 31  FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 90
Query: 551 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 607
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 91  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 150
Query: 608 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 151 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 207
Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 720
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 208 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 267
Query: 721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 780
           + +    +     L K +   ++L   ++                +C Q     RP+  +
Sbjct: 268 NEQVLRFVMEGGLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLE 311
Query: 781 VVSMITNEHATLPYPKQSAFSYA 803
           ++S I  E    P  ++ +F Y+
Sbjct: 312 IISSIKEEME--PGFREVSFYYS 332

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 54/295 (18%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSS-QSGQGLKEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  H
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 615
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                +A+G+ YL   S+ + IHR+L A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 143 HFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVY--VK 194
Query: 676 RVVGT--YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 731
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 254
Query: 732 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 255 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 289

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 581 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREAAFSTKSD 187
Query: 700 VFSFGVLLLETLTSKR 715
           V+SFG+LL E  +  R
Sbjct: 188 VWSFGILLWEIYSFGR 203

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 37/311 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 617
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 618 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           I+    IA G+ YL+     + +HRDL A N  +  D   KI DFGM R     +     
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 244
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            L K +   ++L                + +  +C Q     RP+  +++S I  E    
Sbjct: 245 LLDKPDNCPDML----------------LELMRMCWQYNPKMRPSFLEIISSIKEEME-- 286
Query: 793 PYPKQSAFSYA 803
           P  ++ +F Y+
Sbjct: 287 PGFREVSFYYS 297

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 114/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL  GH
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSK 714
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 789 H 789
Sbjct: 324 E 324

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E + +  +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  +
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V+L+G     G+  ++ E+ P  +++  + +  R  L   Q +V +   + + L +LH  
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-VCRQMLEALNFLHSK 128
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYA 689
              RIIHRDLKA N+L+  + + +++DFG++       L+   KR   +GT  +M+PE  
Sbjct: 129 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 690 L-----DGLFSVKSDVFSFGVLLLE 709
           +     D  +  K+D++S G+ L+E
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIE 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 789 H 789
Sbjct: 324 E 324

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293
Query: 792 LP 793
            P
Sbjct: 294 FP 295

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSK 714
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 70  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 246
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 247 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 290
Query: 792 LP 793
            P
Sbjct: 291 FP 292

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E + +  +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  +
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V+L+G     G+  ++ E+ P  +++  + +  R  L   Q +V +   + + L +LH  
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-VCRQMLEALNFLHSK 136
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYA 689
              RIIHRDLKA N+L+  + + +++DFG++       L+   KR   +GT  +M+PE  
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 690 L-----DGLFSVKSDVFSFGVLLLE 709
           +     D  +  K+D++S G+ L+E
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIE 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSK 714
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+   RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+   RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 173
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSK 714
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKN 558
           LA +   TE   ++  LG G FG V+KG  +   E     V +K +  +SG Q  +   +
Sbjct: 24  LARIFKETELRKLKV-LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 82
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVK 616
            M+ I  L H ++VRL+G C     + L+ +Y+P  SL     D  R H   LG Q  + 
Sbjct: 83  HMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLN 137
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
               IA+G+ YL ++    ++HR+L A N+LL S    +++DFG+A +   D+ Q     
Sbjct: 138 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                 +M+ E    G ++ +SDV+S+GV + E +T
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 17/220 (7%)
Query: 501 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLK 554
           P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S +  K
Sbjct: 5   PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 63
Query: 555 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQ 612
           E  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H   +G Q
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXL----LDYVREHKDNIGSQ 118
Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
             +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + 
Sbjct: 119 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 173
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 176
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293
Query: 792 LP 793
            P
Sbjct: 294 FP 295

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 789 H 789
Sbjct: 324 E 324

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 122/244 (50%), Gaps = 26/244 (10%)
Query: 477 VATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLN 536
           + T  N   +G G+A         P  +L  +   TE F     LG G FG VYKG  + 
Sbjct: 14  IPTTENLYFQGSGEA---------PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIP 63
Query: 537 GQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 590
             E     VA+K L  + S +  KE  +E  ++A + + ++ RL+G C+    + LI + 
Sbjct: 64  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQL 122
Query: 591 MPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 648
           MP   L     D  R H   +G Q  +     IA+G+ YL      R++HRDL A N+L+
Sbjct: 123 MPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLV 175
Query: 649 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLL 708
            +  + KI+DFG+A++   +E + + +       +M+ E  L  +++ +SDV+S+GV + 
Sbjct: 176 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 235
Query: 709 ETLT 712
           E +T
Sbjct: 236 ELMT 239

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSK 714
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 189 IYTHQSDVWSYGVTVWELMT 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 176
Query: 690 LD-GLFSVKSDVFSFGVLLLETLTSK 714
           L    +S   D++S G +  E +T +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 581 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 368
Query: 700 VFSFGVLLLETLTSKR 715
           V+SFG+LL E  +  R
Sbjct: 369 VWSFGILLWEIYSFGR 384

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 504 SLAS-VSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKN 558
           SLA+ +    E+F +   LG+G F  VY+ + ++ G EVA+K +  ++      ++  +N
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           E+ +  +L+H +++ L     +     L+ E   N  +N +L   +R            +
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFM 118
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             I  G+LYLH +    I+HRDL  SN+LL  +MN KI+DFG+A        +  T  + 
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LC 173
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           GT  Y+SPE A      ++SDV+S G +    L  +
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 789 H 789
Sbjct: 324 E 324

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKN 558
           LA +   TE   ++  LG G FG V+KG  +   E     V +K +  +SG Q  +   +
Sbjct: 6   LARIFKETELRKLKV-LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 64
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVK 616
            M+ I  L H ++VRL+G C     + L+ +Y+P  SL     D  R H   LG Q  + 
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLN 119
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
               IA+G+ YL ++    ++HR+L A N+LL S    +++DFG+A +   D+ Q     
Sbjct: 120 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                 +M+ E    G ++ +SDV+S+GV + E +T
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 137
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 138 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 196 IYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 17/220 (7%)
Query: 501 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLK 554
           P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S +  K
Sbjct: 4   PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 555 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQ 612
           E  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H   +G Q
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXL----LDYVREHKDNIGSQ 117
Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
             +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + 
Sbjct: 118 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 549
           R    P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 550 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 608
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKD 119
Query: 609 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR- 133
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 134 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 192 IYTHQSDVWSYGVTVWELMT 211

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 140
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 141 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++     +F   D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 146
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 147 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 205 IYTHQSDVWSYGVTVWELMT 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 142
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 143 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 201 IYTHQSDVWSYGVTVWELMT 220

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 581 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 181
Query: 700 VFSFGVLLLETLTSKR 715
           V+SFG+LL E  +  R
Sbjct: 182 VWSFGILLWEIYSFGR 197

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 521 LGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVR 573
           +GEG FG V++ +   LL  +    VAVK L  ++   ++ +F+ E  L+A+  + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------LGWQTRVK---------- 616
           L+G C       L++EYM    LN FL   S   +       L  + RV           
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 617 ----IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQ 671
               I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R ++  D  +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA 731
            +    +    +M PE      ++ +SDV+++GV+L E  +       Y ++ +  + H 
Sbjct: 232 ADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS-------YGLQPYYGMAHE 283
Query: 732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
             ++       L  P       Y ++        LC  +  ADRP+   +
Sbjct: 284 EVIYYVRDGNILACPENCPLELYNLMR-------LCWSKLPADRPSFCSI 326

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 117/245 (47%), Gaps = 30/245 (12%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLI 563
           +  ++   LGEG FG V         K K      VAVK L   + +  L +  +EM ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 564 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLL 609
             + +H+N++ L+G C + G   +I EY    +L  +L           +D +R     +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
            ++  V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 727
               T        +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F L
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 728 L--GH 730
           L  GH
Sbjct: 318 LKEGH 322

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293
Query: 792 LP 793
            P
Sbjct: 294 FP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++     +F   D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 261
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 262 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 312
Query: 789 H 789
Sbjct: 313 E 313

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 264
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 265 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 315
Query: 789 H 789
Sbjct: 316 E 316

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 581 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 699
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 196
Query: 700 VFSFGVLLLETLTSKR 715
           V+SFG+LL E  +  R
Sbjct: 197 VWSFGILLWEIYSFGR 212

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ +  L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 566
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N+V+L+     + +  L++E++ +  L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 173
Query: 687 EYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 114/237 (48%), Gaps = 30/237 (12%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 730
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL  GH
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 263

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 140/279 (50%), Gaps = 41/279 (14%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V  G+L L G+    VA+K L    + +  ++F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII---EGIAQGLLYLHQYS 632
           G        +++ E+M N +L+ FL    R H  G  T ++++    GIA G+ YL   +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL----RKHD-GQFTVIQLVGMLRGIAAGMRYL---A 162
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSP 686
            +  +HRDL A NIL++S++  K+SDFG++R+     ++ + + V  T G      + +P
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 746
           E      F+  SDV+S+G+++ E ++       +D+ + +++            Y L +P
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPAP 270
Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
                  +Q++       L C Q++ A+RP   ++V ++
Sbjct: 271 MDCPAGLHQLM-------LDCWQKERAERPKFEQIVGIL 302

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQH 568
            E +++ C LG+G FG V K K  +  QE AVK ++  S +         E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+++L     +     ++ E      L   +    R          +II+ +  G+ Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYM 137
Query: 629 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV--VGTYGY 683
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK    +GT  Y
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYY 189
Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   +I+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 789 H 789
Sbjct: 324 E 324

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQH 568
            E +++ C LG+G FG V K K  +  QE AVK ++  S +         E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+++L     +     ++ E      L   +    R          +II+ +  G+ Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYM 137
Query: 629 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV--VGTYGY 683
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK    +GT  Y
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYY 189
Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 140
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 141 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 248
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 249 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 292
Query: 792 LP 793
            P
Sbjct: 293 FP 294

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 506 ASVSAATENF---SMQCKLGE----GGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN 558
           + V   TEN    SM  +L E    G FG V+K +LLN + VAVK    Q  Q  +  + 
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EY 67
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKI-----LIYEYMPNKSLNFFLFDPSRTHLLGWQT 613
           E+  +  ++H N+++ +G   ++G  +     LI  +    SL+ FL    + +++ W  
Sbjct: 68  EVYSLPGMKHENILQFIGA-EKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNE 122
Query: 614 RVKIIEGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
              I E +A+GL YLH+         +  I HRD+K+ N+LL +++   I+DFG+A  F 
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVF 701
             +  G+T   VGT  YM+PE  L+G  + + D F
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAF 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293
Query: 792 LP 793
            P
Sbjct: 294 FP 295

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 549
           R    P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 550 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 608
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKD 119
Query: 609 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 176
Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 131/273 (47%), Gaps = 27/273 (9%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V  G L L G+    VA+K L S  + +  ++F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   +    ++I E+M N SL+ FL        +     V ++ GIA G+ YL   + + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 155
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALDG 692
            +HRDL A NIL++S++  K+SDFG++R    D         +G      + +PE     
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            F+  SDV+S+G+++ E ++       +D+ + +++          + Y L  P     A
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP-YWDMTNQDVINAI------EQDYRLPPPMDCPSA 268
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            +Q++       L C Q+    RP   ++V+ +
Sbjct: 269 LHQLM-------LDCWQKDRNHRPKFGQIVNTL 294

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQHR 569
           E +++ C LG+G FG V K K  +  QE AVK ++  S +         E+ L+ KL H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYL 628
           N+++L     +     ++ E      L    FD   +          +II+ +  G+ Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 629 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV--VGTYGY 683
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK    +GT  Y
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYY 189
Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAV-KRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG+G FG   K       EV V K L     +  + F  E+ ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +      I EY+   +L   +   S      W  RV   + IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 640 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR------------VVGTYGYMSPE 687
           DL + N L+  + N  ++DFG+AR+   ++ Q    R            VVG   +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
                 +  K DVFSFG++L E +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 108/228 (47%), Gaps = 33/228 (14%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 575 MGCCVEQG--EKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 626
            G     G  E  L+ EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 125
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 682
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 126 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DXXVVREPGQSPI 178
Query: 683 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 729
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 226

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQG---LKEFKNEMML--I 563
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 564 AKLQHRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
              +H N+VRL   C       + +  L++E++ ++ L  +L D      +  +T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 575 MGCCVEQGEKIL--IYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 626
            G     G + L  + EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 128
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 682
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 129 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPI 181
Query: 683 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 741
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G   ++   +R  
Sbjct: 182 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLL 241
Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           ELL    +  A          +  LC      DRP+ S +
Sbjct: 242 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQG---LKEFKNEMML--I 563
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 564 AKLQHRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
              +H N+VRL   C       + +  L++E++ ++ L  +L D      +  +T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 132/301 (43%), Gaps = 51/301 (16%)
Query: 521 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 617
           ++ L+G C + G   +I  Y    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 735
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 788
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 789 H 789
Sbjct: 324 E 324

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 521 LGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG+G +G VY G+ L+ Q  +A+K +  +  +  +    E+ L   L+H+N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 580 EQGEKILIYEYMPNKSLNFFL---FDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           E G   +  E +P  SL+  L   + P +     +G+ T+      I +GL YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 141
Query: 635 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
           +I+HRD+K  N+L+++     KISDFG ++   G  +   T+   GT  YM+PE    G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 199
Query: 694 --FSVKSDVFSFGVLLLETLTSK 714
             +   +D++S G  ++E  T K
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQG---LKEFKNEMML--I 563
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 564 AKLQHRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
              +H N+VRL   C       + +  L++E++ ++ L  +L D      +  +T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 549
           R    P  +L  +   TE F     L  G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 550 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 608
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKD 119
Query: 609 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 74  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +     
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 191 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 250
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 251 YLDQPDNCPE----------------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 294
Query: 792 LP 793
            P
Sbjct: 295 FP 296

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 549
           R    P  +L  +   TE F     L  G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 550 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 608
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKD 119
Query: 609 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           L  G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 693 LFSVKSDVFSFGVLLLETLT 712
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 561
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 614
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +++   IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 732
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 791
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293
Query: 792 LP 793
            P
Sbjct: 294 FP 295

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 521 LGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG+G +G VY G+ L+ Q  +A+K +  +  +  +    E+ L   L+H+N+V+ +G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 580 EQGEKILIYEYMPNKSLNFFL---FDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           E G   +  E +P  SL+  L   + P +     +G+ T+      I +GL YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 127
Query: 635 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
           +I+HRD+K  N+L+++     KISDFG ++   G  +   T+   GT  YM+PE    G 
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 185
Query: 694 --FSVKSDVFSFGVLLLETLTSK 714
             +   +D++S G  ++E  T K
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 10/203 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E F +  KLGEG +G VYK      GQ VA+K++  +S   L+E   E+ ++ +    ++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHV 86
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V+  G   +  +  ++ EY    S++  +    R   L       I++   +GL YLH  
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH-- 142
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
             +R IHRD+KA NILL+++ + K++DFG+A        + N   V+GT  +M+PE   +
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWMAPEVIQE 199
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             ++  +D++S G+  +E    K
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 135/309 (43%), Gaps = 51/309 (16%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLI 563
           +  ++   LGEG FG V         K K      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLL 609
             + +H+N++ L+G C + G   +I  Y    +L  +L           +D +R     +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
            ++  V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 727
               T        +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSK 780
           L            + +  PA      Y M+         C     + RPT       + +
Sbjct: 272 L---------KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDR 315
Query: 781 VVSMITNEH 789
           ++++ TNE 
Sbjct: 316 ILTLTTNEE 324

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 575 MGCCVEQGEKIL--IYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 626
            G     G + L  + EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 141
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 682
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 142 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPI 194
Query: 683 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 741
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G   ++   +R  
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           ELL    +  A          +  LC      DRP+ S +
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 17/220 (7%)
Query: 501 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLK 554
           P  +L  +   TE F     LG G FG VYKG  +   E     VA+  L  + S +  K
Sbjct: 38  PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK 96
Query: 555 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQ 612
           E  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H   +G Q
Sbjct: 97  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQ 151
Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
             +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + 
Sbjct: 152 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 208
Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 209 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 26/244 (10%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQ--SGQGLKEFKN 558
           L  V    + F++   LG+G FG V + +L        +VAVK L +   +   ++EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRT----HL 608
           E   + +  H ++ +L+G  +    K      ++I  +M +  L+ FL   SR       
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFN 133
Query: 609 LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCG 667
           L  QT V+ +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R ++ G
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 668 DEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIES 724
           D   QG   ++     +++ E   D L++V SDV++FGV + E +T  +    G+ + E 
Sbjct: 191 DYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
Query: 725 FNLL 728
           +N L
Sbjct: 249 YNYL 252

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 108/228 (47%), Gaps = 33/228 (14%)
Query: 520 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 575 MGCCVEQGEKIL--IYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 626
            G     G + L  + EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 129
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 682
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 130 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPI 182
Query: 683 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 729
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G
Sbjct: 183 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 230

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 135/274 (49%), Gaps = 29/274 (10%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V +G+L   G++   VA+K L    + +  +EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFL-FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G        +++ E+M N +L+ FL  +  +  ++     V ++ GIA G+ YL + S  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 136
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALD 691
             +HRDL A NIL++S++  K+SDFG++R    +         +G      + +PE    
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             F+  SD +S+G+++ E ++       +D+ + +++          + Y L  P     
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERP-YWDMSNQDVINAI------EQDYRLPPPPDCPT 248
Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           + +Q++       L C Q+    RP   +VVS +
Sbjct: 249 SLHQLM-------LDCWQKDRNARPRFPQVVSAL 275

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 15/201 (7%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V +G+L   G++   VA+K L    + +  +EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFL-FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G        +++ E+M N +L+ FL  +  +  ++     V ++ GIA G+ YL + S  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 138
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALD 691
             +HRDL A NIL++S++  K+SDFG++R    +         +G      + +PE    
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 692 GLFSVKSDVFSFGVLLLETLT 712
             F+  SD +S+G+++ E ++
Sbjct: 198 RKFTSASDAWSYGIVMWEVMS 218

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 632
           +G C+    + L+ + MP   L     D  R +   LG Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCL----LDHVRENRGRLGSQDLLNWCMQIAKGMSYLED-- 137
Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
            +R++HRDL A N+L+ S  + KI+DFG+AR+   DE + +         +M+ E  L  
Sbjct: 138 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 693 LFSVKSDVFSFGVLLLETLT 712
            F+ +SDV+S+GV + E +T
Sbjct: 197 RFTHQSDVWSYGVTVWELMT 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           E+  +  ++G G FG V+ G+L  +   VAVK         LK +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +VRL+G C ++    ++ E +  +  +F  F  +    L  +T ++++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG----TYGYMSP 686
                 IHRDL A N L+      KISDFGM+R    +E  G      G       + +P
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAP 284
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E    G +S +SDV+SFG+LL ET +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 7/202 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           E+  +  ++G G FG V+ G+L  +   VAVK         LK +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +VRL+G C ++    ++ E +  +  +F  F  +    L  +T ++++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                 IHRDL A N L+      KISDFGM+R         +         + +PE   
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
            G +S +SDV+SFG+LL ET +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 27/273 (9%)
Query: 521 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G FG V  G L L G+    VA+K L S  + +  ++F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   +    ++I E+M N SL+ FL        +     V ++ GIA G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALDG 692
            +HR L A NIL++S++  K+SDFG++R    D         +G      + +PE     
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            F+  SDV+S+G+++ E ++       +D+ + +++          + Y L  P     A
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERP-YWDMTNQDVINAI------EQDYRLPPPMDCPSA 242
Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            +Q++       L C Q+    RP   ++V+ +
Sbjct: 243 LHQLM-------LDCWQKDRNHRPKFGQIVNTL 268

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 38/290 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHR 569
           NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 621
           N+++     +E  E  ++ E      L+  +          P RT    W+  V++   +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT---VWKYFVQLCSAL 149
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
                  H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT 
Sbjct: 150 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 200
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 741
            YMSPE   +  ++ KSD++S G LL E    +              G   NL+   +  
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS----------PFYGDKMNLYSLCKKI 250
Query: 742 ELLS-PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA 790
           E    P L  +   + L + +    +C+      RP ++ V  +    HA
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHA 297

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 126
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 126
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSEMVGT 179
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 126
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGT 179
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 12  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 127
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 128 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGT 180
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
             +M+PE      +  K D++S G++ +E +
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 558
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 81
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           E+ L+ +L H N+++L     ++G   L+ E      L   +    R          +II
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARII 138
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTK 675
             +  G+ Y+H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E     K
Sbjct: 139 RQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMK 192
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
             +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 193 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 223

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 135/291 (46%), Gaps = 48/291 (16%)
Query: 521 LGEGGFGPVYKGKLL----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G+G FG VY G+ +    N  + A+K LS  +  Q ++ F  E +L+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 576 GCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G  +  +G   ++  YM +  L  F+  P R   +  +  +     +A+G+ YL   +  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---AEQ 143
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY-ALDGL 693
           + +HRDL A N +LD     K++DFG+AR     E     +     +  +  ++ AL+ L
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH---RHARLPVKWTALESL 200
Query: 694 ----FSVKSDVFSFGVLLLETLTSK----RNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
               F+ KSDV+SFGVLL E LT      R+   +D+  F   G             L  
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-----------RLPQ 249
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNEH 789
           P    ++ YQ++ +       C +   A RPT       + ++VS +  +H
Sbjct: 250 PEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVEQIVSALLGDH 293

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 558
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP--SRTHLLGWQTRVK 616
           E+ L+ +L H N+++L     ++G   L+ E      L    FD   SR          +
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-AR 130
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGN 673
           II  +  G+ Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   E    
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
            K  +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 32/223 (14%)
Query: 507 SVSAATE------NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKEFK 557
           S+++AT+      N+ +Q  +G+G F  V   + +L G+EVAVK +     +   L++  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 558 NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 617
            E+ ++  L H N+V+L      +    L+ EY     +  +L    R  +   + R K 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF 120
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF-CGDELQGNTKR 676
            + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +  F  G++L      
Sbjct: 121 RQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCG- 175
Query: 677 VVGTYGYMSPEYALDGLFSVKS------DVFSFGVLLLETLTS 713
                   SP YA   LF  K       DV+S GV+L  TL S
Sbjct: 176 --------SPPYAAPELFQGKKYDGPEVDVWSLGVILY-TLVS 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ 567
           AT  +    ++G G +G VYK +   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 568 ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
              H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
              +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVV 173
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ 567
           AT  +    ++G G +G VYK +   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 568 ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
              H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
              +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVV 173
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 558
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 98
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           E+ L+ +L H N+++L     ++G   L+ E      L   +    R          +II
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARII 155
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTK 675
             +  G+ Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   E     K
Sbjct: 156 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMK 209
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
             +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 210 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 240

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +N  +   +G G +G VYKG L + + VAVK  S  + Q     KN +  +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 573 RLMG-----CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           R +          + E +L+ EY PN SL  +L      H   W +  ++   + +GL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 628 LH------QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-----QGNTK- 675
           LH       + +  I HRDL + N+L+ +D    ISDFG++    G+ L     + N   
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 676 RVVGTYGYMSPEYALDGLFSVKS--------DVFSFGVLLLE 709
             VGT  YM+PE  L+G  +++         D+++ G++  E
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWE 227

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 558
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 99
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           E+ L+ +L H N+++L     ++G   L+ E      L   +    R          +II
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARII 156
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTK 675
             +  G+ Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   E     K
Sbjct: 157 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMK 210
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
             +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 211 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 519 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
            K+GEG  G V   +  + G++VAVK +  +  Q  +   NE++++   QH N+V +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
            +   E  ++ E++   +L     D      L  +    + E + Q L YLH      +I
Sbjct: 111 YLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFS 695
           HRD+K+ +ILL  D   K+SDFG    FC    +   KR  +VGT  +M+PE     L++
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 696 VKSDVFSFGVLLLETL 711
            + D++S G++++E +
Sbjct: 220 TEVDIWSLGIMVIEMV 235

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 46/292 (15%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 571 LVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTH--LLGWQTRVKII 618
           +V L+G C + G  +++            Y+ +K   F  + P   +   L  +  +   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D          
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLW 735
               +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     + 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM- 270
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
              RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 271 ---RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 29/204 (14%)
Query: 520 KLGEGGFGPVYKGKLLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           +LG+G FG VYK +  N +     A K + ++S + L+++  E+ ++A   H N+V+L+ 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
               +    ++ E+    +++  + +  R  L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL 690
           IHRDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 691 -----DGLFSVKSDVFSFGVLLLE 709
                D  +  K+DV+S G+ L+E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 29/204 (14%)
Query: 520 KLGEGGFGPVYKGKLLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           +LG+G FG VYK +  N +     A K + ++S + L+++  E+ ++A   H N+V+L+ 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
               +    ++ E+    +++  + +  R  L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL 690
           IHRDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 691 -----DGLFSVKSDVFSFGVLLLE 709
                D  +  K+DV+S G+ L+E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAK 565
           EN      LG G FG V         K     +VAVK L  ++    +E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYM-PNKSLNFF-------------------LFDPS 604
           L  H N+V L+G C   G   LI+EY      LN+                    L +  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
             ++L ++  +     +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 665 FCGDE---LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              D    ++GN +  V    +M+PE   +G++++KSDV+S+G+LL E  +
Sbjct: 222 IMSDSNYVVRGNARLPVK---WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 558
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP--SRTHLLGWQTRVK 616
           E+ L+ +L H N+ +L     ++G   L+ E      L    FD   SR          +
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-AR 130
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGN 673
           II  +  G+ Y H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E    
Sbjct: 131 IIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
            K  +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVA+K +  +  +   L++   E+ ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    LI EY     +  +L    R      +++ + I    Q   Y HQ
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 129
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               RI+HRDLKA N+LLD+DMN KI+DFG +  F    + G      G     SP YA 
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDTFCG-----SPPYAA 178
Query: 691 DGLFSVKS------DVFSFGVLL 707
             LF  K       DV+S GV+L
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVIL 201

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQHRNLVRLMG 576
           LG G FG V  GK  L G +VAVK L+ Q  + L    + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
                 +  ++ EY+    L  ++    R   L  +   ++ + I  G+ Y H++    +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS- 695
           +HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  Y +PE     L++ 
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAAPEVISGRLYAG 194
Query: 696 VKSDVFSFGVLLLETL 711
            + D++S GV+L   L
Sbjct: 195 PEVDIWSSGVILYALL 210

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVA+K +  +  +   L++   E+ ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    LI EY     +  +L    R      +++ + I    Q   Y HQ
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 132
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               RI+HRDLKA N+LLD+DMN KI+DFG +  F    + G      G   Y +PE   
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYAAPE--- 183
Query: 691 DGLFSVKS------DVFSFGVLLLETLTS 713
             LF  K       DV+S GV+L  TL S
Sbjct: 184 --LFQGKKYDGPEVDVWSLGVILY-TLVS 209

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 29/204 (14%)
Query: 520 KLGEGGFGPVYKGKLLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           +LG+G FG VYK +  N +     A K + ++S + L+++  E+ ++A   H N+V+L+ 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
               +    ++ E+    +++  + +  R  L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL 690
           IHRDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 691 -----DGLFSVKSDVFSFGVLLLE 709
                D  +  K+DV+S G+ L+E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 555 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLL 609
           +FKNE+ +I  +++   +   G      E  +IYEYM N S+      FF+ D + T  +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
             Q    II+ +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 670 LQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL 727
           ++G+     GTY +M PE+  +       K D++S G+ L            Y++  F+L
Sbjct: 207 IKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLY--------VMFYNVVPFSL 254
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNR 759
                 L+ + R   +  P  ++   Y + N+
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNK 286

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ 567
           AT  +    ++G G +G VYK +   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 568 ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
              H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
              +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVV 173
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
           +V L+G C + G  +++            Y+ +K   F  +       L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDN 738
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F          +  
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXR--------RLK 261
Query: 739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               + +P       YQ +       L C   + + RPT S++V  + N
Sbjct: 262 EGTRMRAPDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVR 573
           F +   +G G +G VYKG+ +   ++A  ++   +G   +E K E+ ++ K   HRN+  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 574 LMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
             G  +++       +  L+ E+    S+   + + ++ + L  +    I   I +GL +
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSH 144
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LHQ+   ++IHRD+K  N+LL  +   K+ DFG++     D   G     +GT  +M+PE
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 199
Query: 688 YAL-----DGLFSVKSDVFSFGVLLLE 709
                   D  +  KSD++S G+  +E
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIE 226

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 524 GGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--- 580
           G FG V+K +L+N   VAVK    Q  Q  +  + E+     ++H NL++ +        
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 581 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-------- 631
            + E  LI  +    SL  +L    + +++ W     + E +++GL YLH+         
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
            +  I HRD K+ N+LL SD+   ++DFG+A  F   +  G+T   VGT  YM+PE  L+
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLE 198
Query: 692 GLFSVKSDVF------SFGVLLLETLT 712
           G  + + D F      + G++L E ++
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  + L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 620 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 674
            IA   Q L + HQ     IIHRD+K +NIL+ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX-QT 176
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 33/208 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW----QTRVKIIEGIAQGLL 626
           +V+L      +    L+ EY     +    FD    H  GW    + R K  + I   + 
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAH--GWMKEKEARAKFRQ-IVSAVQ 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMS 685
           Y HQ     I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              S
Sbjct: 121 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------S 168
Query: 686 PEYALDGLFSVKS------DVFSFGVLL 707
           P YA   LF  K       DV+S GV+L
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVIL 196

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 132/299 (44%), Gaps = 59/299 (19%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 93
Query: 571 LVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL------FDPSRT------------HLLGW 611
           +V L+G C + G  ++ I E+    +L+ +L      F P +T            HL+ +
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
             +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D   
Sbjct: 154 SFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLL 728
                      +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 729 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 265 KEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  + L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 620 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 674
            IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QT 176
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 501 PCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLK 554
           P  SLA   A   N+ +   LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 2   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 58
Query: 555 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 614
             + E+  +  L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R
Sbjct: 59  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 115
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN- 673
            +  + I   + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN 
Sbjct: 116 -RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNF 167
Query: 674 TKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 714
            K   G+  Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 501 PCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLK 554
           P  SLA   A   N+ +   LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 3   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 59
Query: 555 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 614
             + E+  +  L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R
Sbjct: 60  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 116
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN- 673
            +  + I   + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN 
Sbjct: 117 -RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNF 168
Query: 674 TKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 714
            K   G+  Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 169 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
           +V L+G C + G  +++            Y+ +K   F  +       L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 737
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 266
Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 267 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  + L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 620 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 674
            IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QT 176
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQ 567
           +++  F    KLG G +  VYKG     G  VA+K +   S +G       E+ L+ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR------VKIIE-G 620
           H N+VRL      + +  L++E+M N    +     SRT  +G   R      VK  +  
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYM---DSRT--VGNTPRGLELNLVKYFQWQ 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           + QGL + H+    +I+HRDLK  N+L++     K+ DFG+AR F G  +   +  VV T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 681 YGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSK 714
             Y +P+  +    +S   D++S G +L E +T K
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 563
           + SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE++++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
            + ++ N+V  +   +   E  ++ EY+   SL     D      +       +     Q
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 128
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTY 681
            L +LH     ++IHR++K+ NILL  D + K++DFG    FC       +KR  +VGT 
Sbjct: 129 ALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTP 181
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
            +M+PE      +  K D++S G++ +E +
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-- 577
           +G GGFG V+K K  ++G+   ++R+   + +  +E K     +AKL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIVHYNGCWD 75
Query: 578 -----CVEQGEKILIYEYMPNKSLN--------FFL-------------FDPSRTHLLGW 611
                     + +   +Y P  S N         F+              +  R   L  
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
              +++ E I +G+ Y+H     ++IHRDLK SNI L      KI DFG+      D   
Sbjct: 136 VLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--- 189
Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
           G   R  GT  YMSPE      +  + D+++ G++L E L
Sbjct: 190 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 123/249 (49%), Gaps = 23/249 (9%)
Query: 521 LGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG G FG V+K  +   G ++A K + ++  +  +E KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
            + + +L+ EY+    L   + D S    L     +  ++ I +G+ ++HQ   + I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 640 DLKASNIL-LDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVK 697
           DLK  NIL ++ D    KI DFG+AR +   E     K   GT  +++PE       S  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 698 SDVFSFGV---LLLETLTSKRNTGVYDIESF-NLLGHAWNLWKD------NRAYELLSPA 747
           +D++S GV   +LL  L+     G  D E+  N+L   W+L  +        A E +S  
Sbjct: 269 TDMWSVGVIAYMLLSGLSP--FLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326
Query: 748 LQHEASYQM 756
           L  E S+++
Sbjct: 327 LIKEKSWRI 335

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 689
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              SP YA
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 690 LDGLFSVKS------DVFSFGVLL 707
              LF  K       DV+S GV+L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 689
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L        G   Y +PE  
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPE-- 182
Query: 690 LDGLFSVKS------DVFSFGVLL 707
              LF  K       DV+S GV+L
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVIL 203

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 689
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              SP YA
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 690 LDGLFSVKS------DVFSFGVLL 707
              LF  K       DV+S GV+L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVIL 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLI 563
           A   N+ +   LGEG FG V        GQ+VA+K      L+    QG    + E+  +
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 58
Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
             L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R +  + I  
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 114
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYG 682
            + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN  K   G+  
Sbjct: 115 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSCGSPN 167
Query: 683 YMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 714
           Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLI 563
           A   N+ +   LGEG FG V        GQ+VA+K      L+    QG    + E+  +
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 62
Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
             L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R +  + I  
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 118
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYG 682
            + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN  K   G+  
Sbjct: 119 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSCGSPN 171
Query: 683 YMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 714
           Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVAV+ +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG----DELQGNTKRVVGTYGYMSP 686
                I+HRDLKA N+LLD+DMN KI+DFG +  F      DE  G            SP
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG------------SP 176
Query: 687 EYALDGLFSVKS------DVFSFGVLL 707
            YA   LF  K       DV+S GV+L
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  + L   ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 620 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 674
            IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QT 176
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  + L   ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVRLMGCCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA- 622
           H  +V +      +        ++ EY+   +L   +      H  G  T  + IE IA 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIAD 124
Query: 623 --QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVV 678
             Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T  V+
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAVI 180
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 153 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 264 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVAV+ +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 689
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              SP YA
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 690 LDGLFSVKS------DVFSFGVLL 707
              LF  K       DV+S GV+L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 155 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 205
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 265
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 266 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 309

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNE 559
           L S   A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRRE 61
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTR 614
           + + + L+H N++RL G   +     LI EY P  ++   L     FD  RT        
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-------- 113
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
              I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   +
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPS 163
Query: 675 KR---VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            R   + GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 164 SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAK 565
           A E+  +   LGEG FG VY+G   N +     VAVK          KE F +E +++  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L H ++V+L+G  +E+    +I E  P   L  +L      + L   T V     I + +
Sbjct: 66  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 122
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            YL     +  +HRD+   NIL+ S    K+ DFG++R +  DE             +MS
Sbjct: 123 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMS 178
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+ F V + E L+  +    + +E+ +++G    L K +R   L  
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIG---VLEKGDR---LPK 231
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           P L     Y ++ R       C     +DRP  +++V  +++
Sbjct: 232 PDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSD 266

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEF-----KNEMML 562
           S AT  +    ++G G +G VYK +   +G  VA+K +   +G G           E+ L
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 563 IAKLQ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 614
           + +L+   H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
             ++    +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMAL 176
Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             VV T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 153 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 264 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 117
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +   C       T  + GT
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTT-LSGT 170
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAK 565
           A E+  +   LGEG FG VY+G   N +     VAVK          KE F +E +++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L H ++V+L+G  +E+    +I E  P   L  +L      + L   T V     I + +
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 138
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            YL     +  +HRD+   NIL+ S    K+ DFG++R +  DE             +MS
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMS 194
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+ F V + E L+  +    + +E+ +++G    L K +R   L  
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIG---VLEKGDR---LPK 247
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           P L     Y ++ R       C     +DRP  +++V  +++
Sbjct: 248 PDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSD 282

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKN 558
           ++ S   A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + 
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRR 60
Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQT 613
           E+ + + L+H N++RL G   +     LI EY P  ++   L     FD  RT       
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------- 113
Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 673
               I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   
Sbjct: 114 -ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAP 162
Query: 674 TKR---VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           + R   + GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 163 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAK 565
           A E+  +   LGEG FG VY+G   N +     VAVK          KE F +E +++  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L H ++V+L+G  +E+    +I E  P   L  +L      + L   T V     I + +
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 126
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            YL     +  +HRD+   NIL+ S    K+ DFG++R +  DE             +MS
Sbjct: 127 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMS 182
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+ F V + E L+  +    + +E+ +++G    L K +R   L  
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIG---VLEKGDR---LPK 235
Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           P L     Y ++ R       C     +DRP  +++V  +++
Sbjct: 236 PDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSD 270

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 634
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK---EFKNEM 560
           + + S  ++ + +   LG GG   V+  + L   ++VAVK L +   +       F+ E 
Sbjct: 21  MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 80
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQ 612
              A L H  +V       + GE          ++ EY+   +L   +      H  G  
Sbjct: 81  QNAAALNHPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPM 130
Query: 613 TRVKIIEGIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--G 667
           T  + IE IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G
Sbjct: 131 TPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           + +   T  V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 188 NSVT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 634
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 506 ASVSAATENFSMQC--------KLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQ 551
           + V   TEN   Q         K+GEG FG          G+    +E+ + R+SS+  +
Sbjct: 9   SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 552 GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 611
              E + E+ ++A ++H N+V+      E G   ++ +Y     L F   +  +  L   
Sbjct: 69  ---ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQE 124
Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-EL 670
               +I++   Q  L L      +I+HRD+K+ NI L  D   ++ DFG+AR+     EL
Sbjct: 125 D---QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
               +  +GT  Y+SPE   +  ++ KSD+++ G +L E  T K
Sbjct: 182 ---ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 153 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 264 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P   +   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT--------ATYITE 121
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGT 174
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-- 577
           +G GGFG V+K K  ++G+   +KR+   + +  +E K     +AKL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK----ALAKLDHVNIVHYNGCWD 74
Query: 578 ----CVEQGEK----------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
                 E   K           +  E+    +L  ++ +  R   L     +++ E I +
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITK 133
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           G+ Y+H     ++I+RDLK SNI L      KI DFG+      D   G   R  GT  Y
Sbjct: 134 GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRSKGTLRY 187
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETL 711
           MSPE      +  + D+++ G++L E L
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P   +   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT--------ATYITE 121
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 171
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 634
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGT 169
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 634
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           E F+   ++G+G FG VYKG   + +EV A+K +   ++   +++ + E+ ++++     
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKS-LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           + R  G  ++  +  +I EY+   S L+     P     +       I+  I +GL YLH
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 133
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
                R IHRD+KA+N+LL    + K++DFG+A      +++ N    VGT  +M+PE  
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVI 188
Query: 690 LDGLFSVKSDVFSFGVLLLE 709
               +  K+D++S G+  +E
Sbjct: 189 KQSAYDFKADIWSLGITAIE 208

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 727
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 131
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 686
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 187
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS  SD + FGV L E  T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 506 ASVSAATENFSMQC------KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEF 556
           + V   TEN   Q       +LG+G F  V +  K+L GQE A K ++++  S +  ++ 
Sbjct: 9   SGVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL 68
Query: 557 KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK 616
           + E  +   L+H N+VRL     E+G   LI++ +    L     D              
Sbjct: 69  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASH 125
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGN 673
            I+ I + +L+ HQ   + ++HRDLK  N+LL S +     K++DFG+A      E++G 
Sbjct: 126 CIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-----IEVEGE 177
Query: 674 TKR---VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
            +      GT GY+SPE      +    D+++ GV+L
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 39/228 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH---- 568
           +F     LG+G FG V K +  L+ +  A+K++   + + L    +E+ML+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 569 ---------RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KI 617
                    RN V+ M    ++    +  EY  N++L    +D   +  L  Q     ++
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQRDEYWRL 121
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---------MFCGD 668
              I + L Y+H      IIHRDLK  NI +D   N KI DFG+A+              
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 669 ELQG---NTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETL 711
            L G   N    +GT  Y++ E  LDG   ++ K D++S G++  E +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 166
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 63
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 115
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 116 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 165
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 166 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 166
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 166
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 127
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 686
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAP 183
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS  SD + FGV L E  T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 125/299 (41%), Gaps = 58/299 (19%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 570
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 129
Query: 571 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 610
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 190 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 240
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--- 297
Query: 729 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                  +      + +P       YQ +       L C   + + RPT S++V  + N
Sbjct: 298 -----CRRLKEGTRMRAPDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHLGN 344

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAAL 166
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 117
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTL 167
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 169
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 117
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 167
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGT 169
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 121
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 171
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 127
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 686
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 183
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS  SD + FGV L E  T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 118
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 171
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 121
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 171
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 92  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 139
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 191
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 68
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 120
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 121 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 170
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 169
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLS----SQSGQGL-KEFKNEMMLIAKLQHRNLVRL 574
           LGEG F  VYK +  N  Q VA+K++     S++  G+ +    E+ L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA-QGLLYLHQYSR 633
           +     +    L++++M    L   + D S   L+   + +K    +  QGL YLHQ+  
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG- 692
             I+HRDLK +N+LLD +   K++DFG+A+ F G   +    +VV T  Y +PE      
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRWYRAPELLFGAR 188
Query: 693 LFSVKSDVFSFGVLLLETL 711
           ++ V  D+++ G +L E L
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 169
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 172
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 572
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 620
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 621 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 673
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 730
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 230 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 284
Query: 731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 285 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 328

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF 125
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 177
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 142
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 192
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 142
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDL 192
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 137
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 686
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAP 193
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS  SD + FGV L E  T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 137
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 686
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 193
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS  SD + FGV L E  T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG---- 177
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V     + +G ++AVK+LS   QS    K    E+ L+  ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P  SL  F      THL+G      VK           
Sbjct: 111 NVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 158
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 210
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + +++  D++S G ++ E LT +
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 81
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 133
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 134 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 183
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 184 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 127
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 686
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 183
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS  SD + FGV L E  T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 177
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 628
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 131
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 686
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 187
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS  SD + FGV L E  T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 61
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 113
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 114 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 163
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 164 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 572
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 620
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 621 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 673
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 730
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 207 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 261
Query: 731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 262 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 305

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG---- 201
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 572
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 620
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 621 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 673
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 166 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 730
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 223 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 277
Query: 731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 278 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 321

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   + +L G+EVAVK +     +   L++   E+ +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +    L+ EY     +  +L    R      + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK--EKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 689
                I+HRDLKA N+LLD+D N KI+DFG +  F  G++L        G   Y +PE  
Sbjct: 132 KF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPE-- 182
Query: 690 LDGLFSVKS------DVFSFGVLLLETLTS 713
              LF  K       DV+S GV+L  TL S
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVILY-TLVS 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 508 VSAATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 561
           + +  E++ +   +G G +G   K      GK+L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKII 618
           L+ +L+H N+VR     +++    L  + EY     L   +   ++    L  +  ++++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 619 EGIAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
             +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   DE     K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--DFAKE 175
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            VGT  YMSPE      ++ KSD++S G LL E
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 572
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 620
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 621 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 673
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 168 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 730
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 225 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 279
Query: 731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 280 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 323

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 521 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 572
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 620
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 621 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 673
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 730
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 230 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 284
Query: 731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 285 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 328

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 187
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 201
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 101 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 200
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAV-----KRLSSQSGQGLKEFKNEMMLIAK 565
           TE + +  +LG+G F  V +  K+L GQE A      K+LS++  Q L+    E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L+H N+VRL     E+G   LI++ +    L     D               I+ I + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR---VVG 679
           L+ HQ   + ++HR+LK  N+LL S +     K++DFG+A      E++G  +      G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQAWFGFAG 175
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           T GY+SPE      +    D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS-SQSGQGLKEFK-NEM 560
           S A  + + + +    KLGEG +G VYK    +  + VA+KR+      +G+      E+
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            L+ +LQHRN++ L           LI+EY  N    +   +P  +  +      ++I G
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNP--KISDFGMARMFCGDELQGNTK 675
           +     + H  SR R +HRDLK  N+LL   D+   P  KI DFG+AR F G  ++  T 
Sbjct: 145 VN----FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196
Query: 676 RVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 711
            ++ T  Y  PE  L    +S   D++S   +  E L
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG---- 188
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 186
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +F     LG+G FG V K +  L+ +  A+K++   + + L    +E+ML+A L H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFF---------LFDPSRTHLLGWQTRV--KIIEGI 621
           R     +E+   +     +  KS  F          L+D   +  L  Q     ++   I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---------MFCGDELQG 672
            + L Y+H      IIHRDLK  NI +D   N KI DFG+A+               L G
Sbjct: 126 LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 673 ---NTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETL 711
              N    +GT  Y++ E  LDG   ++ K D++S G++  E +
Sbjct: 183 SSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG---- 188
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG---- 188
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRL--SSQSGQGLK-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  +  N + + A+K L  +     G++ + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
           +H N++RL G   +     LI EY P  ++   L     FD  RT           I  +
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITEL 117
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VV 678
           A  L Y H     ++IHRD+K  N+LL S    KI+DFG +       +   + R   + 
Sbjct: 118 ANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALC 167
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 121
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 171
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE         K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 94
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L  C  +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 146
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 147 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            Y+SPE   +      SD+++ G ++ + + 
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVA 234

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQHRNLVRLMG 576
           LG G FG V  G+  L G +VAVK L+ Q  + L    + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
                 +  ++ EY+    L  ++    R   +  +   ++ + I   + Y H++    +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM---V 132
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS- 695
           +HRDLK  N+LLD+ MN KI+DFG++ M    E   ++    G+  Y +PE     L++ 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRLYAG 189
Query: 696 VKSDVFSFGVLLLETL 711
            + D++S GV+L   L
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 186
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 513 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
           E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLR 70
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N++RL G   +     LI EY P  ++   L   SR      Q     I  +A  L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSY 127
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYM 684
            H     R+IHRD+K  N+LL S+   KI+DFG +       +   + R   + GT  Y+
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYL 177
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLT 712
            PE     +   K D++S GVL  E L 
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLV 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 513 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
           E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLR 70
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N++RL G   +     LI EY P  ++   L   SR      Q     I  +A  L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSY 127
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYM 684
            H     R+IHRD+K  N+LL S+   KI+DFG +       +   + R   + GT  Y+
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYL 177
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLT 712
            PE     +   K D++S GVL  E L 
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLV 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             +   IHRD+KA+N+LL      K++DFG+A      +++ NT   VGT  +M+PE   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 177
Query: 691 DGLFSVKSDVFSFGVLLLE 709
              +  K+D++S G+  +E
Sbjct: 178 QSAYDSKADIWSLGITAIE 196

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 79  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 178
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 177
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 79  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 178
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 186
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 81  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 128
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 180
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 93  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 192
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 142
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             +   IHRD+KA+N+LL      K++DFG+A      +++ NT   VGT  +M+PE   
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 197
Query: 691 DGLFSVKSDVFSFGVLLLE 709
              +  K+D++S G+  +E
Sbjct: 198 QSAYDSKADIWSLGITAIE 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 188
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 94  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 193
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 80  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 127
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 179
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 118
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI++FG +       +   + R   +
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTL 168
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQHRNLVRLMG 576
           LG G FG V  G+  L G +VAVK L+ Q  + L    + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
                 +  ++ EY+    L  ++    R   +  +   ++ + I   + Y H++    +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM---V 132
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS- 695
           +HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  Y +PE     L++ 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAG 189
Query: 696 VKSDVFSFGVLLLETL 711
            + D++S GV+L   L
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 186
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 183
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 183
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG---- 187
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 183
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG---- 183
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 568
           T+ + +   +G+G F  V +  KL  G E A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+VRL     E+G   L+++ +    L     D               I+ I + +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 629 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR---VVGTYG 682
           HQ   + ++HRDLK  N+LL S       K++DFG+A      E+QG+ +      GT G
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLL 707
           Y+SPE      +    D+++ GV+L
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 187
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIA 564
           +++   E F+   ++G+G FG V+KG     Q+V A+K +   ++   +++ + E+ +++
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
           +     + +  G  ++  +  +I EY+   S      D  R           +++ I +G
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKG 132
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L YLH   +   IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT  +M
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWM 187
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE      +  K+D++S G+  +E
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIE 212

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 511 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 677
           +A  L Y H     R+IHRD+K  N+LL S    KI++FG +       +   + R   +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTL 169
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 101 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 200
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 105 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG---- 204
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 94  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 193
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 94  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 193
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 93  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 192
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 201
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 187
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 520 KLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           K+GEG  G V    +   G++VAVK++  +  Q  +   NE++++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQYSRLRII 637
           +   E  ++ E++   +L   +     TH    + ++  +   + + L YLH      +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 163
Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFS 695
           HRD+K+ +ILL SD   K+SDFG    FC    +   KR  +VGT  +M+PE      + 
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 696 VKSDVFSFGVLLLETL 711
            + D++S G++++E +
Sbjct: 220 TEVDIWSLGIMVIEMI 235

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 16/212 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRN 570
           +++ +Q  +G G    V        +E VA+KR++ +  Q  + E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           +V      V + E  L+ + +   S+     +       ++ +L   T   I+  + +GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARMFCGDELQGNTKR--VVGTYG 682
            YLH+  +   IHRD+KA NILL  D + +I+DFG+ A +  G ++  N  R   VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 683 YMSPEY--ALDGLFSVKSDVFSFGVLLLETLT 712
           +M+PE    + G +  K+D++SFG+  +E  T
Sbjct: 187 WMAPEVMEQVRG-YDFKADIWSFGITAIELAT 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 105 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 204
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 120
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 225
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 16/212 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRN 570
           +++ +Q  +G G    V        +E VA+KR++ +  Q  + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           +V      V + E  L+ + +   S+     +       ++ +L   T   I+  + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARMFCGDELQGNTKR--VVGTYG 682
            YLH+  +   IHRD+KA NILL  D + +I+DFG+ A +  G ++  N  R   VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 683 YMSPEY--ALDGLFSVKSDVFSFGVLLLETLT 712
           +M+PE    + G +  K+D++SFG+  +E  T
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIELAT 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 517 MQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 574
           +QC LG GGFG V++ K  ++    A+KR+   + +  +E    E+  +AKL+H  +VR 
Sbjct: 10  IQC-LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------------GIA 622
               +E+     +    P   L   +    + +L  W      IE             IA
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ----------G 672
           + + +LH      ++HRDLK SNI    D   K+ DFG+      DE +           
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
                VGT  YMSPE      +S K D+FS G++L E L
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 166 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 219
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 519 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 624
           +  C  +        Y   K+  + +FD     L G  + V          ++++ +  G
Sbjct: 83  IEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 681
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 682 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 712
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 157 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 210
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 225
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 176 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 229
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 174 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 227
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D+G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 146 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 199
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +   S  SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQ 226

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 143 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 196
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 19/237 (8%)
Query: 483 EPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL----NGQ 538
           +PS+ +G  K     S+       S  A   +F +   LG+G FG V+  + +    +G 
Sbjct: 1   QPSKDEGVLKEI---SITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGH 57
Query: 539 EVAVKRLSSQSGQGLKEFKNEMM--LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 596
             A+K L   + +     + +M   ++A + H  +V+L      +G+  LI +++    L
Sbjct: 58  LYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL 117
Query: 597 NFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 655
               F      ++  +  VK  +  +A GL +LH    L II+RDLK  NILLD + + K
Sbjct: 118 ----FTRLSKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIK 170
Query: 656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           ++DFG+++     E +  +    GT  YM+PE       S  +D +S+GVL+ E LT
Sbjct: 171 LTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 519 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 624
           +  C  +        Y   K   + +FD     L G  + V          ++++ +  G
Sbjct: 83  IEICRTKASP-----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 681
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 682 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 712
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 563
           +  E++ +   +G G +G   K      GK+L  +E+    ++    Q L    +E+ L+
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLL 59
Query: 564 AKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEG 620
            +L+H N+VR     +++    L  + EY     L   +   ++    L  +  ++++  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 621 IAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
           +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   D      K  V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFV 177
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           GT  YMSPE      ++ KSD++S G LL E
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 563
           +  E++ +   +G G +G   K      GK+L  +E+    ++    Q L    +E+ L+
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLL 59
Query: 564 AKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEG 620
            +L+H N+VR     +++    L  + EY     L   +   ++    L  +  ++++  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 621 IAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
           +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   D      K  V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFV 177
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           GT  YMSPE      ++ KSD++S G LL E
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++     QG K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +   +L++E++        L D     L     +  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 691 DG-LFSVKSDVFSFGVLLLETL 711
               +S   D++S G +  E +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++     QG K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +   +L++E++        L D     L     +  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 691 DG-LFSVKSDVFSFGVLLLETL 711
               +S   D++S G +  E +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 137
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT  +M+PE   
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIK 192
Query: 691 DGLFSVKSDVFSFGVLLLE 709
              +  K+D++S G+  +E
Sbjct: 193 QSAYDSKADIWSLGITAIE 211

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++     QG K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPAT-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 139 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 192
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 151 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 204
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 270
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 184
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 238
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 728
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 276

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT  +M+PE   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIK 177
Query: 691 DGLFSVKSDVFSFGVLLLE 709
              +  K+D++S G+  +E
Sbjct: 178 QSAYDSKADIWSLGITAIE 196

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 29/221 (13%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMM---- 561
            +    E+F +   LG+G FG V+  +     Q  A+K L         + +  M+    
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRV 615
           L    +H  L   M C  +  E +  + EY+    L + +     FD SR      +   
Sbjct: 72  LSLAWEHPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE--- 127
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                I  GL +LH      I++RDLK  NILLD D + KI+DFGM    C + + G+ K
Sbjct: 128 -----IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM----CKENMLGDAK 175
Query: 676 --RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
                GT  Y++PE  L   ++   D +SFGVLL E L  +
Sbjct: 176 TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 578
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 579 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 627
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 142 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 195
Query: 687 EYALDGL-FSVKSDVFSFGVLLLETL 711
           E       ++   DV+S G +L E L
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 506 ASVSAATENFSMQCK--------LGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKE 555
           + V   TEN   Q          +GEG +G V K +  + G+ VA+K+ L S   + +K+
Sbjct: 10  SGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 556 FK-NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 614
               E+ L+ +L+H NLV L+  C ++    L++E++ +  L+     P+    L +Q  
Sbjct: 70  IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVV 126
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-DELQGN 673
            K +  I  G+ + H ++   IIHRD+K  NIL+      K+ DFG AR      E+  +
Sbjct: 127 QKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 674 TKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 714
               V T  Y +PE  + D  +    DV++ G L+ E    +
Sbjct: 184 E---VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 519 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 624
           +  C  +        Y   K   + +FD     L G  + V          ++++ +  G
Sbjct: 83  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 681
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 682 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 712
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +   +L++E++        L D     L     +  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  +V T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 691 -DGLFSVKSDVFSFGVLLLETL 711
               +S   D++S G +  E +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 728
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 519 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 81
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 624
           +  C  +        Y   K   + +FD     L G  + V          ++++ +  G
Sbjct: 82  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 681
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 192
Query: 682 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 712
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+ R    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 728
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DF +AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 691 DGLFSVKSDVFSFGVLLLETLTSK 714
              +SV+SD++S G+ L+E    +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 520 KLGEGGFGPVYKGKLLNGQ-EVAVKRLS-SQSGQGL------------KEFKNEMMLIAK 565
           KLG G +G V   K  NG  E A+K +  SQ  +G             +E  NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L H N+++L     ++    L+ E+     L          H         I++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---FEQIINRHKFDECDAANIMKQILSGI 159
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
            YLH+++   I+HRD+K  NILL++    +N KI DFG++  F  D      +  +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAY 213
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLL 707
           Y++PE  L   ++ K DV+S GV++
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIM 237

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKG--KLLNGQ-EVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +LG G FG V +G  ++   Q +VA+K L   + +   +E   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 576 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G C  Q E + L+ E      L+ FL    +   +      +++  ++ G+ YL + +  
Sbjct: 77  GVC--QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDG 692
             +HRDL A N+LL +    KISDFG+++    D+    T R  G +   + +PE     
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFR 188
Query: 693 LFSVKSDVFSFGVLLLETLT 712
            FS +SDV+S+GV + E L+
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +F     LG+G FG V K +  L+ +  A+K++   + + L    +E+ L+A L H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVV 65
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFF---------LFDPSRTHLLGWQTRV--KIIEGI 621
           R     +E+   +     +  KS  F          L+D   +  L  Q     ++   I
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---------MFCGDELQG 672
            + L Y+H      IIHR+LK  NI +D   N KI DFG+A+               L G
Sbjct: 126 LEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 673 ---NTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETL 711
              N    +GT  Y++ E  LDG   ++ K D +S G++  E +
Sbjct: 183 SSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 9/206 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 569
            E++ +   LGEG  G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 690 LDGLFSVKS-DVFSFGVLLLETLTSK 714
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 728
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 728
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQ 226

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 64
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 65  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 116
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 117 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQ 201

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 32  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQ 630
           V +    +   E  ++ E++   +L   +     TH    + ++  +   + Q L  LH 
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 143
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 144 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 196
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
                +  + D++S G++++E +
Sbjct: 197 ISRLPYGPEVDIWSLGIMVIEMV 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 23  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQ 630
           V +    +   E  ++ E++   +L   +     TH  +  +    +   + Q L  LH 
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 134
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 187
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
                +  + D++S G++++E +
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMV 210

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 150
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 151 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 141
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 142 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 66
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 67  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 118
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 119 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQ 203

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 67
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 68  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 119
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 120 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQ 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLV 572
           + M+ +LG GGFG V +    + G++VA+K+   + S +  + +  E+ ++ KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------IAQG 624
                 V  G + L    +P  ++ +      R +L  ++    + EG        I+  
Sbjct: 76  SARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 625 LLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           L YLH+    RIIHRDLK  NI+L      +  KI D G A+     EL       VGT 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 715
            Y++PE      ++V  D +SFG L  E +T  R
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 154 DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQ 630
           V +    +   E  ++ E++   +L   +     TH    + ++  +   + Q L  LH 
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 265
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 266 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 318
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
                +  + D++S G++++E +
Sbjct: 319 ISRLPYGPEVDIWSLGIMVIEMV 341

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 34  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQ 630
           V +    +   E  ++ E++   +L   +     TH  +  +    +   + Q L  LH 
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 145
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 146 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 198
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
                +  + D++S G++++E +
Sbjct: 199 ISRLPYGPEVDIWSLGIMVIEMV 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 125
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++     DE+       VGT  YMSPE   
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DEM---ANEFVGTRSYMSPERLQ 179
Query: 691 DGLFSVKSDVFSFGVLLLETLTSK 714
              +SV+SD++S G+ L+E    +
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNR 223

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 90
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 142
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQ 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNR 223

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 65
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 66  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 117
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQ 202

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLV 572
           + M+ +LG GGFG V +    + G++VA+K+   + S +  + +  E+ ++ KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------IAQG 624
                 V  G + L    +P  ++ +      R +L  ++    + EG        I+  
Sbjct: 77  SARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 625 LLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           L YLH+    RIIHRDLK  NI+L      +  KI D G A+     EL       VGT 
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 188
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 715
            Y++PE      ++V  D +SFG L  E +T  R
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 92
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 144
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 145 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQ 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 90
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 142
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQ 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 29/221 (13%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMM---- 561
            +    E+F +   LG+G FG V+  +     Q  A+K L         + +  M+    
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRV 615
           L    +H  L   M C  +  E +  + EY+    L + +     FD SR      +   
Sbjct: 71  LSLAWEHPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE--- 126
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                I  GL +LH      I++RDLK  NILLD D + KI+DFGM    C + + G+ K
Sbjct: 127 -----IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM----CKENMLGDAK 174
Query: 676 --RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
                GT  Y++PE  L   ++   D +SFGVLL E L  +
Sbjct: 175 TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 27  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQ 630
           V +    +   E  ++ E++   +L   +     TH  +  +    +   + Q L  LH 
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 138
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 139 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 191
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
                +  + D++S G++++E +
Sbjct: 192 ISRLPYGPEVDIWSLGIMVIEMV 214

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 71
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 123
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 124 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQ 208

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 13/225 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 141
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 195
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWN 733
              +SV+SD++S G+ L+E    +    +G   +  F LL +  N
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVN 240

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 149
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 203
Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 728
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI  FG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 114/239 (47%), Gaps = 31/239 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRN 570
            +   M  ++G+G +G V+ GK   G++VAVK   +++     +E   E+     ++H N
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHEN 92
Query: 571 LVRLMGCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           ++  +   ++      +  LI +Y  N SL    +D  ++  L  ++ +K+      GL 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLC 148
Query: 627 YLHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD----ELQGNTKRV 677
           +LH        +  I HRDLK+ NIL+  +    I+D G+A  F  D    ++  NT+  
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-- 206
Query: 678 VGTYGYMSPEYALDGLFS------VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 730
           VGT  YM PE   + L        + +D++SFG++L E      + G+  +E + L  H
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEYQLPYH 263

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA++++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 86
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 138
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 77  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQ 630
           V +    +   E  ++ E++   +L   +     TH    + ++  +   + Q L  LH 
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 188
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 189 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 241
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
                +  + D++S G++++E +
Sbjct: 242 ISRLPYGPEVDIWSLGIMVIEMV 264

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 86
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 138
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMM 561
           +A+ +  T+++ +  +LG+G F  V +  K    QE A K ++++  S +  ++ + E  
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           +   L+H N+VRL     E+G   L+++ +    L     D               I  I
Sbjct: 83  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQI 139
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR-- 676
            + + ++HQ+    I+HRDLK  N+LL S       K++DFG+A      E+QG  +   
Sbjct: 140 LESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAI-----EVQGEQQAWF 191
Query: 677 -VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
              GT GY+SPE      +    D+++ GV+L
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 520 KLGEGGFGPVYKGKLLNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMG 576
           K+GEG +G V+K K     E VA+KR+      +G+      E+ L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                 +  L++E+       +F       DP       +Q        + +GL + H  
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKGLGFCHSR 120
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           +   ++HRDLK  N+L++ +   K++DFG+AR F G  ++  +  VV T  Y  P+    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 175
Query: 692 G-LFSVKSDVFSFGVLLLETLTSKR 715
             L+S   D++S G +  E   + R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKG--KLLNGQ-EVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 575
           +LG G FG V +G  ++   Q +VA+K L   + +   +E   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 576 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           G C  Q E + L+ E      L+ FL    +   +      +++  ++ G+ YL + +  
Sbjct: 403 GVC--QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDG 692
             +HR+L A N+LL +    KISDFG+++    D+    T R  G +   + +PE     
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFR 514
Query: 693 LFSVKSDVFSFGVLLLETLT 712
            FS +SDV+S+GV + E L+
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 513 ENFSMQCKLGEGGFGP-VYKGKLLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 566
           E+F     LGEG F   V   +L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 616
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-HTDDEMTG---- 181
Query: 677 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 152
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGLKEFKNEMM--L 562
            A    F +   LG+G FG V+  K ++G    Q  A+K L   + +     + +M   +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + ++ H  +V+L      +G+  LI +++    L    F      ++  +  VK    +A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LA 133
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           +  L L     L II+RDLK  NILLD + + K++DFG+++     E +  +    GT  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           YM+PE       +  +D +SFGVL+ E LT
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 24/259 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK---NEMMLIAKL 566
           + ++F +   LG G FG V+  +   NG+  A+K L  +    LK+ +   +E ++++ +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H  ++R+ G   +  +  +I +Y+    L   L    ++              +   L 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALE 120
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           YLH      II+RDLK  NILLD + + KI+DFG A+      +   T  + GT  Y++P
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAP 172
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 746
           E      ++   D +SFG+L+ E L     T  YD  +        N        EL  P
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTMKTYEKILNA-------ELRFP 223
Query: 747 ALQHEASYQMLNRYITVAL 765
              +E    +L+R IT  L
Sbjct: 224 PFFNEDVKDLLSRLITRDL 242

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 165 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  L+H N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 576 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                   +E   ++ +   +    LN  +    ++  L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                IIHRDLK SN+ ++ D   +I DFG+AR    +E+ G     V T  Y +PE  L
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 201
Query: 691 DGL-FSVKSDVFSFGVLLLETLTSK 714
           + + ++   D++S G ++ E L  K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + +  ++    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 165 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 509 SAATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSS-QSGQGLKEFKNEMM 561
           S   +++ M  +LG G F  V K      GK    + +  +RLSS + G   +E + E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++ +++H N++ L      + + +LI E +    L  FL   +    L      + ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 117
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RMFCGDELQGNTKR 676
             G+ YLH     RI H DLK  NI LLD ++ NP+I   DFG+A ++  G+E     K 
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 170
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVL 706
           + GT  +++PE        +++D++S GV+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGLKEFKNEMM--L 562
            A    F +   LG+G FG V+  K ++G    Q  A+K L   + +     + +M   +
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + ++ H  +V+L      +G+  LI +++    L    F      ++  +  VK    +A
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LA 134
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           +  L L     L II+RDLK  NILLD + + K++DFG+++     E +  +    GT  
Sbjct: 135 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 192
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           YM+PE       +  +D +SFGVL+ E LT
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGLKEFKNEMM--L 562
            A    F +   LG+G FG V+  K ++G    Q  A+K L   + +     + +M   +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + ++ H  +V+L      +G+  LI +++    L    F      ++  +  VK    +A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LA 133
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           +  L L     L II+RDLK  NILLD + + K++DFG+++     E +  +    GT  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           YM+PE       +  +D +SFGVL+ E LT
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  L+H N++ L+
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 576 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                   +E   ++ +   +    LN  +    +   L  +    ++  + +GL Y+H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                IIHRDLK SN+ ++ D   +I DFG+AR    +E+ G     V T  Y +PE  L
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 193
Query: 691 DGL-FSVKSDVFSFGVLLLETLTSK 714
           + + ++   D++S G ++ E L  K
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 575
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLF 694
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S + D++S G +L   L  K
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +   L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KCQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           KLGEG +  VYKGK  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
               +    L++EY+ +K L  +L D    +++        +  + +GL Y H   R ++
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGL-F 694
           +HRDLK  N+L++     K++DFG+AR      +   T    V T  Y  P+  L    +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S + D++  G +  E  T +
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 509 SAATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRL-SSQSGQGLKEFKNEMM 561
           S   +++ M  +LG G F  V K      GK    + +  +RL SS+ G   +E + E+ 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++ +++H N++ L      + + +LI E +    L  FL   +    L      + ++ I
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 138
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RMFCGDELQGNTKR 676
             G+ YLH     RI H DLK  NI LLD ++ NP+I   DFG+A ++  G+E     K 
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 191
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVL 706
           + GT  +++PE        +++D++S GV+
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQ-EVAVKRL--SSQSGQGLK-EFKNEMMLIAKLQH 568
           ++F +   LG+G FG VY  +       VA+K L  S    +G++ + + E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 623
            N++RL     ++    LI EY P   L   L     FD  RT          I+E +A 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRT--------ATIMEELAD 134
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
            L+Y H     ++IHRD+K  N+LL      KI+DFG +       L+  T  + GT  Y
Sbjct: 135 ALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT--MCGTLDY 187
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           + PE     + + K D++  GVL  E L 
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLV 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNE 559
           F + + +  ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             +  KLQH N+VRL     E+    L+++ +    L     D               I+
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ 135
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDELQGNTKR 676
            I + + Y H      I+HR+LK  N+LL S       K++DFG+A      E       
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--- 189
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
             GT GY+SPE      +S   D+++ GV+L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+VRL     E+    L+++ +    L     D               I+ I + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 629 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
           H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 686 PEYALDGLFSVKSDVFSFGVLL 707
           PE      +S   D+++ GV+L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 521 LGEGGFGPV-----YKGKLLNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKLQHRNL 571
           LGEG FG V     YK +    Q+VA+K +S Q    S   ++  + E+  +  L+H ++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHI 71
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           ++L        + +++ EY   +  ++ +     T   G +   +II  I     Y H  
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYGYMSPEYAL 690
            R +I+HRDLK  N+LLD ++N KI+DFG++ +       GN  K   G+  Y +PE   
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT----DGNFLKTSCGSPNYAAPEVIN 180
Query: 691 DGLFS-VKSDVFSFGVLLLETLTSK 714
             L++  + DV+S G++L   L  +
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 515 FSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHRN 570
           + +  KLG+G +G V+K      G+ VAVK++      S    + F+  M+L     H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 571 LVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           +V L+       ++   L+++YM        L    R ++L    +  ++  + + + YL
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-------------------DE 669
           H      ++HRD+K SNILL+++ + K++DFG++R F                     D+
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
            Q      V T  Y +PE  L      K  D++S G +L E L  K
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+VRL     E+    L+++ +    L     D               I+ I + + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 629 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
           H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 174
Query: 686 PEYALDGLFSVKSDVFSFGVLL 707
           PE      +S   D+++ GV+L
Sbjct: 175 PEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+VRL     E+    L+++ +    L     D               I+ I + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 629 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
           H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 686 PEYALDGLFSVKSDVFSFGVLL 707
           PE      +S   D+++ GV+L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 575
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYMSPEYALDGLF 694
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S + D++S G +L   L  K
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 694 FSVKS-DVFSFGVLLLETLTSK 714
              KS D++S G +L E L+++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 28/224 (12%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           ++C +G+G +G V++G    G+ VAVK  SS+  +     + E+     L+H N++  + 
Sbjct: 13  LEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIA 69
Query: 577 CCV----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--- 629
             +       +  LI  Y    SL    +D  +   L   + ++I+  IA GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 630 --QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ---GNTKRVVGTYGYM 684
                +  I HRDLK+ NIL+  +    I+D G+A M      Q   GN  R VGT  YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184
Query: 685 SPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGVYD 721
           +PE  LD    V       + D+++FG++L E      + G+ +
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 575
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLF 694
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S + D++S G +L   L  K
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 45/209 (21%)
Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRL-------SSQSGQGLKEFKNEMMLIAKLQHRNL 571
           KLG G +G V   K  L G E A+K +       +S SG  L    +E+ ++ +L H N+
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVLKQLDHPNI 83
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK----------IIEGI 621
           ++L             YE+  +K   + + +  R   L  +  ++          I++ +
Sbjct: 84  MKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVV 678
             G  YLH+++   I+HRDLK  N+LL+S   D   KI DFG++  F   E+ G  K  +
Sbjct: 131 LSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERL 184
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           GT  Y++PE  L   +  K DV+S GV+L
Sbjct: 185 GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 212

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 28/236 (11%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
           L   + A +   ++C +G+G +G V++G    G+ VAVK  SS+  +     + E+    
Sbjct: 30  LVQRTVARQITLLEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTV 86
Query: 565 KLQHRNLVRLMGCCV----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            L+H N++  +   +       +  LI  Y    SL    +D  +   L   + ++I+  
Sbjct: 87  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLS 142
Query: 621 IAQGLLYLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ---G 672
           IA GL +LH        +  I HRDLK+ NIL+  +    I+D G+A M      Q   G
Sbjct: 143 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 202
Query: 673 NTKRVVGTYGYMSPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGVYD 721
           N  R VGT  YM+PE  LD    V       + D+++FG++L E      + G+ +
Sbjct: 203 NNPR-VGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 256

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  L+H N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 576 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                   +E   ++ +   +    LN  +    +   L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                IIHRDLK SN+ ++ D   +I DFG+AR    +E+ G     V T  Y +PE  L
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 201
Query: 691 DGL-FSVKSDVFSFGVLLLETLTSK 714
           + + ++   D++S G ++ E L  K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 28/224 (12%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           ++C +G+G +G V++G    G+ VAVK  SS+  +     + E+     L+H N++  + 
Sbjct: 13  LEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIA 69
Query: 577 CCV----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--- 629
             +       +  LI  Y    SL    +D  +   L   + ++I+  IA GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 630 --QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ---GNTKRVVGTYGYM 684
                +  I HRDLK+ NIL+  +    I+D G+A M      Q   GN  R VGT  YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184
Query: 685 SPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGVYD 721
           +PE  LD    V       + D+++FG++L E      + G+ +
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 575
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 93  GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 146
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYMSPEYALDGLF 694
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S + D++S G +L   L  K
Sbjct: 204 SFEVDIWSLGCILYTLLVGK 223

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 45/209 (21%)
Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRL-------SSQSGQGLKEFKNEMMLIAKLQHRNL 571
           KLG G +G V   K  L G E A+K +       +S SG  L    +E+ ++ +L H N+
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVLKQLDHPNI 66
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK----------IIEGI 621
           ++L             YE+  +K   + + +  R   L  +  ++          I++ +
Sbjct: 67  MKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVV 678
             G  YLH+++   I+HRDLK  N+LL+S   D   KI DFG++  F   E+ G  K  +
Sbjct: 114 LSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERL 167
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           GT  Y++PE  L   +  K DV+S GV+L
Sbjct: 168 GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 569
           E +    K+GEG +G V+K +  + GQ VA+K+ L S+    +K+    E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR----THL---LGWQTRVKIIEGIA 622
           NLV L+     +    L++EY  +  L+    D  +     HL   + WQT         
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLVKSITWQT--------L 112
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           Q + + H+++    IHRD+K  NIL+      K+ DFG AR+  G     + +  V T  
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRW 167
Query: 683 YMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 712
           Y SPE  + D  +    DV++ G +  E L+
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSS-QSGQGLKEFKNEMMLIAK 565
           +++ M  +LG G F  V K      GK    + +  +RLSS + G   +E + E+ ++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           ++H N++ L      + + +LI E +    L  FL   +    L      + ++ I  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 128
Query: 626 LYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RMFCGDELQGNTKRVVGT 680
            YLH     RI H DLK  NI LLD ++ NP+I   DFG+A ++  G+E     K + GT
Sbjct: 129 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KNIFGT 181
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVL 706
             +++PE        +++D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 114/230 (49%), Gaps = 39/230 (16%)
Query: 504 SLASVSAATENFSMQC-------KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKE 555
           S A +S   +NF ++        +LG G +G V K + + +GQ +AVKR+ +       +
Sbjct: 35  SKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---Q 91
Query: 556 FKNEMMLIAKLQHRNL-----VRLMGCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT- 606
            +  +++   +  R +     V   G    +G+  +  E M + SL+ F   + D  +T 
Sbjct: 92  EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTI 150
Query: 607 --HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
              +LG     KI   I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++  
Sbjct: 151 PEDILG-----KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-- 201
Query: 665 FCGDELQGNTKRV-VGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLE 709
             G  +    K +  G   YM+PE     L    +SVKSD++S G+ ++E
Sbjct: 202 --GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 249

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 145
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 201
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 160
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       S
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 696 VKSDVFSFGVLLLETLTSK 714
            + DV+S G ++   L  K
Sbjct: 218 FEVDVWSIGCIMYTLLVGK 236

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 520 KLGEGGFGPVYKGKLLNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMG 576
           K+GEG +G V+K K     E VA+KR+      +G+      E+ L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                 +  L++E+       +F       DP       +Q        + +GL + H  
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKGLGFCHSR 120
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           +   ++HRDLK  N+L++ +   K+++FG+AR F G  ++  +  VV T  Y  P+    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 175
Query: 692 G-LFSVKSDVFSFGVLLLETLTSKR 715
             L+S   D++S G +  E   + R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG--------QEVAVKRLSSQSGQGLKEFKNEMMLIA 564
           E F +   LG+GG+G V++ + + G         +V  K +  ++ +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
           +++H  +V L+      G+  LI EY+    L   L    R  +    T    +  I+  
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L +LHQ     II+RDLK  NI+L+   + K++DFG+ +    D    +T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYM 188
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +PE  +    +   D +S G L+ + LT
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLT 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V K +   +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 628
           +V   G     GE  +  E+M   SL+  L +  R    +LG     K+   + +GL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
            +  + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YM+PE 
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAPER 184
Query: 689 ALDGLFSVKSDVFSFGVLLLE 709
                +SV+SD++S G+ L+E
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVE 205

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 162
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 696 VKSDVFSFGVLLLETLTSK 714
            + DV+S G ++   L  K
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 136
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 696 VKSDVFSFGVLLLETLTSK 714
            + DV+S G ++   L  K
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 183
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 187
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY---APECIN 187
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 125
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 181
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 137/330 (41%), Gaps = 46/330 (13%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMM 561
           +S     +NF     LG+G FG V   ++   G   AVK L          ++    E  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRV 615
           +++  ++   +  + CC +  +++  + E++    L F +     FD +R      +   
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--- 132
Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                I   L++LH      II+RDLK  N+LLD + + K++DFGM +    + +   T 
Sbjct: 133 -----IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTA 182
Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW 735
              GT  Y++PE   + L+    D ++ GVLL E L        ++ E+ + L  A  + 
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH---APFEAENEDDLFEA--IL 237
Query: 736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP 795
            D    E++ P   HE +  +L  ++T             PTM         EHA L +P
Sbjct: 238 ND----EVVYPTWLHEDATGILKSFMT-----------KNPTMRLGSLTQGGEHAILRHP 282
Query: 796 KQSAFSYAR---RGEKISFLPSSRVSEACS 822
                 +A+   R  +  F P  +  E  S
Sbjct: 283 FFKEIDWAQLNHRQIEPPFRPRIKSREDVS 312

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 193
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG--------QEVAVKRLSSQSGQGLKEFKNEMMLIA 564
           E F +   LG+GG+G V++ + + G         +V  K +  ++ +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
           +++H  +V L+      G+  LI EY+    L   L    R  +    T    +  I+  
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYG 682
           L +LHQ     II+RDLK  NI+L+   + K++DFG+    C + +     T    GT  
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL----CKESIHDGTVTHXFCGTIE 186
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           YM+PE  +    +   D +S G L+ + LT
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 520 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN----LVRL 574
           ++G G +G V K     +GQ +AVKR+ S   +  KE K  +M +  +   +    +V+ 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLF------DPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            G    +G+  +  E M      F+ +      D     +LG     KI     + L +L
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHL 141
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK-RVVGTYGYMSPE 687
            +   L+IIHRD+K SNILLD   N K+ DFG++    G  +    K R  G   YM+PE
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPE 195
Query: 688 Y----ALDGLFSVKSDVFSFGVLLLETLTSK 714
                A    + V+SDV+S G+ L E  T +
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 519 CK-LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMG 576
           CK +G G FG V++ KL+   EVA+K++        K FKN E+ ++  ++H N+V L  
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 577 CCVEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                G+K       L+ EY+P       ++  SR +        K+ + +   L+ L+ 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPET-----VYRASRHY-------AKLKQTMPMLLIKLYM 147
Query: 631 YSRLR---------IIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGT 680
           Y  LR         I HRD+K  N+LLD      K+ DFG A++    E   N   +   
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSR 205
Query: 681 YGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
           Y Y +PE       ++   D++S G ++ E +  +
Sbjct: 206 Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 110/279 (39%), Gaps = 84/279 (30%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKEFKNEMMLIA 564
           A E   +   LG G FG V +      ++      VAVK L  + G    E+K  M  + 
Sbjct: 25  ARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKML--KEGATASEYKALMTELK 82
Query: 565 KL----QHRNLVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTHLLG 610
            L     H N+V L+G C +QG  +++            Y+ +K   FFL   +  H+  
Sbjct: 83  ILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHM-- 140
Query: 611 WQTRVKIIEGIAQG---------------------------------------------- 624
              + K+  G+ QG                                              
Sbjct: 141 EPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMED 200
Query: 625 -LLYLHQYSR-------LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 673
            + Y  Q +R        + IHRDL A NILL  +   KI DFG+AR    +     +G+
Sbjct: 201 LISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGD 260
Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           T+  +    +M+PE   D ++S KSDV+S+GVLL E  +
Sbjct: 261 TRLPL---KWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 489
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 545
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 490
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 690
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 546
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              FS KSDV+SFGVL+ E  +
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 510 AATENFSMQCK-------LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FK 557
           A+T ++ +Q +       +GEG FG V++G  ++ +     VA+K   + +   ++E F 
Sbjct: 2   ASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 61
Query: 558 NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 617
            E + + +  H ++V+L+G   E    I I E      L  FL    R + L   + +  
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILY 118
Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              ++  L YL      R +HRD+ A N+L+ S+   K+ DFG++R +  D       + 
Sbjct: 119 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKG 174
Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
                +M+PE      F+  SDV+ FGV + E L
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 575
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 696 VKSDVFSFGVLLLETL 711
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 575
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 106 GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 696 VKSDVFSFGVLLLETL 711
             SDV+ FGV + E L
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 512 TENFSMQCKLGEGGFGPVY--KGKLLNGQE-VAVKRLSSQSGQGLKEFKNEMMLIAKLQH 568
           +E +    KLG G +G V   + K+ + +  + + R +S S     +   E+ ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 626
            N+++L     ++    L+ E      L    FD    H + +       II+ +  G+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEI-IHRMKFNEVDAAVIIKQVLSGVT 150
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+++   I+HRDLK  N+LL+S   D   KI DFG++ +F   E Q   K  +GT  Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYY 204
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLL 708
           ++PE  L   +  K DV+S GV+L 
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILF 228

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 575
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 696 VKSDVFSFGVLLLETL 711
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                 +    L+   M    L F ++   +      +      E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
           RI++RDLK  NILLD   + +ISD G+A  +  G  ++G     VGT GYM+PE   +  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 361
Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           ++   D ++ G LL E +  +
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 568
           T+ + +  +LG+G F  V +  K+  GQE A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+VRL     E+G   L+++ +    L     D               I+ I + + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDELQGNTKR---VVGTYG 682
           H      I+HRDLK  N+LL S       K++DFG+A      E+QG+ +      GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAI-----EVQGDQQAWFGFAGTPG 171
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLL 707
           Y+SPE      +    D+++ GV+L
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                 +    L+   M    L F ++   +      +      E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
           RI++RDLK  NILLD   + +ISD G+A  +  G  ++G     VGT GYM+PE   +  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 361
Query: 694 FSVKSDVFSFGVLLLETLTSK 714
           ++   D ++ G LL E +  +
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 509 SAATENFSMQCK-------LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-F 556
           S +T ++ +Q +       +GEG FG V++G  ++ +     VA+K   + +   ++E F
Sbjct: 2   SGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 61
Query: 557 KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK 616
             E + + +  H ++V+L+G   E    I I E      L  FL    R + L   + + 
Sbjct: 62  LQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLIL 118
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
               ++  L YL      R +HRD+ A N+L+ S+   K+ DFG++R +  D       +
Sbjct: 119 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 174
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
                 +M+PE      F+  SDV+ FGV + E L
Sbjct: 175 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 575
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 75  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 696 VKSDVFSFGVLLLETL 711
             SDV+ FGV + E L
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 575
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   E    I I E      L  FL    R   L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 696 VKSDVFSFGVLLLETL 711
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 575
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 83  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 696 VKSDVFSFGVLLLETL 711
             SDV+ FGV + E L
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 568
           T+ + +  +LG+G F  V +  K+  GQE A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N+VRL     E+G   L+++ +    L     D               I+ I + + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 629 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR---VVGTYG 682
           H      I+HRDLK  N+LL S       K++DFG+A      E+QG+ +      GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAI-----EVQGDQQAWFGFAGTPG 171
Query: 683 YMSPEYALDGLFSVKSDVFSFGVLL 707
           Y+SPE      +    D+++ GV+L
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
           +G G +G V       +G++VA+K+LS   QS    K    E++L+  +QH N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 578 CVEQGEKILIYEYMPNKSL----NFFLFDP----SRTHLLGWQTRVKIIEGIA----QGL 625
                       + P  SL    +F+L  P        ++G +   + I+ +     +GL
Sbjct: 110 ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGL 157
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            Y+H      ++HRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  Y +
Sbjct: 158 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRA 209
Query: 686 PEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
           PE  L  + ++   D++S G ++ E LT K
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 32/277 (11%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           +G+G FG VY G+      + +  +   +   LK FK E+M   + +H N+V  MG C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 640
                +I      ++L   + D ++  L   +TR +I + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTR-QIAQEIVKGMGYLHAKG---ILHKD 155
Query: 641 LKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY-----------MSPEYA 689
           LK+ N+  D+     I+DFG+  +    +      ++    G+           +SP+  
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 690 LDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            D L FS  SDVF+ G +  E    +        E+         +W+       + P L
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--------IWQMGTG---MKPNL 263
Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              +   M      + L C   +  +RPT +K++ M+
Sbjct: 264 ---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV- 579
           +G+G +G V++G L +G+ VAVK  SS+  Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 580 ---EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-----QY 631
                 +  LI  Y  + SL  FL    +   L     +++    A GL +LH       
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQ-GNTKRVVGTYGYMSPEY 688
            +  I HRD K+ N+L+ S++   I+D G+A M     D L  GN  R VGT  YM+PE 
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKRYMAPEV 188
Query: 689 -----ALDGLFSVK-SDVFSFGVLLLE 709
                  D   S K +D+++FG++L E
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWE 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQ 567
           S       +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+
Sbjct: 5   STIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLR 61
Query: 568 HRNLVRLMGCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           H N++  +    +      +  L+ +Y  + SL    FD    + +  +  +K+    A 
Sbjct: 62  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTAS 117
Query: 624 GLLYLHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKR 676
           GL +LH        +  I HRDLK+ NIL+  +    I+D G+A       D +      
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 677 VVGTYGYMSPEYALDGLFSVK-------SDVFSFGVLLLE 709
            VGT  YM+PE  LD   ++K       +D+++ G++  E
Sbjct: 178 RVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 216

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 575
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 64
Query: 576 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 631 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 684
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 685 SPEYALDGLFSVK-------SDVFSFGVLLLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 181 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 211

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 142
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+ + GT  Y++PE       S
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 696 VKSDVFSFGVLLLETLTSK 714
            + DV+S G ++   L  K
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           S+    ++     +LG G +G V K + + +GQ +AVKR+ +       + +  +++   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLD 57
Query: 566 LQHRNL-----VRLMGCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT---HLLGWQTR 614
           +  R +     V   G    +G+  +  E M + SL+ F   + D  +T    +LG    
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG---- 112
Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
            KI   I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++     D  +   
Sbjct: 113 -KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169
Query: 675 KRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLE 709
               G   YM+PE     L    +SVKSD++S G+ ++E
Sbjct: 170 ---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 37/269 (13%)
Query: 476 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT----------------ENFSMQC 519
           S+A    E    DG A+        P  + ASV+A                  + + +  
Sbjct: 2   SMAEPLKEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIE 61
Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAKLQHRNLV 572
            +G G +G V   +  L GQ+VA+K++       + + + L+E K    ++   +H N++
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNII 117
Query: 573 RL---MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            +   +   V  GE   +Y  +     +      S   L     R  + + + +GL Y+H
Sbjct: 118 AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMH 176
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVVGTYGYMSPE 687
                ++IHRDLK SN+L++ +   KI DFGMAR  C    E Q      V T  Y +PE
Sbjct: 177 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSKR 715
             L    ++   D++S G +  E L  ++
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
           +G G +G V       +G++VA+K+LS   QS    K    E++L+  +QH N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 578 CVEQGEKILIYEYMPNKSL----NFFLFDP----SRTHLLGWQTRVKIIEGIA----QGL 625
                       + P  SL    +F+L  P        ++G +   + I+ +     +GL
Sbjct: 92  ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            Y+H      ++HRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  Y +
Sbjct: 140 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRA 191
Query: 686 PEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
           PE  L  + ++   D++S G ++ E LT K
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 507 SVSAATENFSM-----QCK-LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFK 557
           SV  A   F++     Q K +G G  G V      + G  VAVK+LS   Q+    K   
Sbjct: 12  SVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 71
Query: 558 NEMMLIAKLQHRNLVRLMGCCVEQG------EKILIYEYMPNK--SLNFFLFDPSRTHLL 609
            E++L+  + H+N++ L+     Q       +  L+ E M      +     D  R   L
Sbjct: 72  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 131
Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
            +Q        +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR  C + 
Sbjct: 132 LYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 180
Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           +   T  VV  Y Y +PE  L   ++   D++S G ++ E
Sbjct: 181 MM--TPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGE 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+ + GT  Y++PE       S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 696 VKSDVFSFGVLLLETLTSK 714
            + DV+S G ++   L  K
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 560
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 241
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 297
Query: 620 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 298 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 350
Query: 679 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 711
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 560
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 298
Query: 620 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 299 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 351
Query: 679 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 711
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+ + GT  Y++PE       S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 696 VKSDVFSFGVLLLETLTSK 714
            + DV+S G ++   L  K
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 521 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 578
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 635
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 636 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 691
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 692 GLFSVKSDVFSFGVL 706
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 37/269 (13%)
Query: 476 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT----------------ENFSMQC 519
           S+A    E    DG A+        P  + ASV+A                  + + +  
Sbjct: 1   SMAEPLKEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIE 60
Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAKLQHRNLV 572
            +G G +G V   +  L GQ+VA+K++       + + + L+E K    ++   +H N++
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNII 116
Query: 573 RL---MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            +   +   V  GE   +Y  +     +      S   L     R  + + + +GL Y+H
Sbjct: 117 AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMH 175
Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVVGTYGYMSPE 687
                ++IHRDLK SN+L++ +   KI DFGMAR  C    E Q      V T  Y +PE
Sbjct: 176 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSKR 715
             L    ++   D++S G +  E L  ++
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 560
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 298
Query: 620 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 299 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 351
Query: 679 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 711
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 507 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 560
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 298
Query: 620 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 299 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 351
Query: 679 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 711
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 575
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 89
Query: 576 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 631 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 684
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 685 SPEYALDGLFSVK-------SDVFSFGVLLLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 206 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 236

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 88/161 (54%), Gaps = 16/161 (9%)
Query: 553 LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF--FLFDPSRTHLLG 610
           +++   E+ ++ KL H N+V+L+    +  E  L   YM  + +N    +  P+   L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSE 136
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-DE 669
            Q R    + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G D 
Sbjct: 137 DQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 670 LQGNTKRVVGTYGYMSPEYALD--GLFSVKS-DVFSFGVLL 707
           L  NT   VGT  +M+PE   +   +FS K+ DV++ GV L
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 515 FSMQCKLGEGGFGPVY-KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLV 572
           F  + KLG G FG V+   +  +G E  +K ++    Q  +++ + E+ ++  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 573 RLMGCCVEQGEKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           ++     +     ++ E     + L   +   +R   L      ++++ +   L Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 632 SRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
               ++H+DLK  NIL   D +P    KI DFG+A +F  DE   N     GT  YM+PE
Sbjct: 144 ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPE 196
Query: 688 -YALDGLFSVKSDVFSFGVLLLETLT 712
            +  D  F  K D++S GV++   LT
Sbjct: 197 VFKRDVTF--KCDIWSAGVVMYFLLT 220

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 575
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 102
Query: 576 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 631 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 684
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 685 SPEYALDGLFSVK-------SDVFSFGVLLLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 249

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 521 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 578
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 635
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 636 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 691
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 692 GLFSVKSDVFSFGVL 706
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 575
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 63
Query: 576 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 631 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 684
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 685 SPEYALDGLFSVK-------SDVFSFGVLLLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 180 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 210

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIA 564
           ENF +   LG G +G V+  + ++G +     A+K L      Q  +  +  + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 565 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
            ++    +  +    +   K+ LI +Y+    L  F     R      + ++ + E I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVL 170
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
            L +LH   +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +       GT  Y
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 226
Query: 684 MSPEYAL--DGLFSVKSDVFSFGVLLLETLT 712
           M+P+     D       D +S GVL+ E LT
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     +G G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EYMP   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 575
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 66
Query: 576 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 631 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 684
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 685 SPEYALDGLFSVK-------SDVFSFGVLLLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 183 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 521 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 578
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 635
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 636 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 691
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 692 GLFSVKSDVFSFGVL 706
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 13/264 (4%)
Query: 453 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 512
           R  KE E  + S   L   +    V + T   SE D  A+    +      S        
Sbjct: 331 RPQKEGERALPSIPKLANNE-KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR 389
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQ 567
           E   +   +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H ++V+L+G   E    I I E      L  FL    R   L   + +     ++  L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           L      R +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 562
Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
                 F+  SDV+ FGV + E L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     +G G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EYMP   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 521 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 578
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 635
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 636 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 691
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 692 GLFSVKSDVFSFGVL 706
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LKE +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     K++DFG+A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL----- 574
           LG GG G V+     +  + VA+K++     Q +K    E+ +I +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 575 ---------MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
                    +G   E     ++ EYM     N     P    LL    R+ + + + +GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----LLEEHARLFMYQ-LLRGL 133
Query: 626 LYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGY 683
            Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+AR+       +G+    + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 684 MSPEYALD-GLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAY 741
            SP   L    ++   D+++ G +  E LT K    G +++E   L+  +  +  +    
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250
Query: 742 ELLS 745
           ELLS
Sbjct: 251 ELLS 254

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPAFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G +G V     G+   G +VA+K+L    QS    K    E+ L+  ++H N++ L+
Sbjct: 33  VGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 576 GCCVEQGEKILIYEYMPNKSLN----FFLFDPSRTHLLG--------WQTRVK-IIEGIA 622
                         + P+++L+    F+L  P     LG         + R++ ++  + 
Sbjct: 91  DV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMXGX----VVTRW 190
Query: 683 YMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
           Y +PE  L+ + ++   D++S G ++ E +T K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 737
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 320
Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 321 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 357

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 737
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 322
Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 323 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 359

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 572
           F  +  LG G F  V   +    G+  AVK +  ++ +G +   +NE+ ++ K++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK---IIEGIAQGLLYLH 629
            L           L+ + +    L    FD  R    G+ T      +I  +   + YLH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGEL----FD--RIVEKGFYTEKDASTLIRQVLDAVYYLH 137
Query: 630 QYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMS 685
              R+ I+HRDLK  N+L    D +    ISDFG+++M    E +G+      GT GY++
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTACGTPGYVA 190
Query: 686 PEYALDGLFSVKSDVFSFGVL 706
           PE      +S   D +S GV+
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVI 211

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 737
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 315
Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 316 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 352

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 737
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 313
Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 314 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 350

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 577
           CK+G G +G VYK K  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 578 CVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY-----LHQ 630
            +   ++   L+++Y  +   +   F  +       +  V++  G+ + LLY     +H 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 631 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGD-ELQGNTKRVVGTYGYM 684
                ++HRDLK +NIL+  +  P     KI+D G AR+F    +   +   VV T+ Y 
Sbjct: 144 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 685 SPEYALDGLFSVKS-DVFSFGVLLLETLTSK 714
           +PE  L      K+ D+++ G +  E LTS+
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +++ +  +LG G FG V++  +   G   A K + +      +  + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V L     +  E ++IYE+M    L   + D    + +     V+ +  + +GL ++H+ 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 632 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +    +H DLK  NI+  +  +   K+ DFG+       + + + K   GT  + +PE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 328
Query: 690 LDGLFSVKSDVFSFGVL 706
                   +D++S GVL
Sbjct: 329 EGKPVGYYTDMWSVGVL 345

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 22  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 187
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 188 VNYEPLGLEADMWSIGVI 205

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 20  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 79
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 133
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 134 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTP 188
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYE 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 521 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 575
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G   E    I I E      L  FL    R   L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
            +HRD+ A N+L+ +    K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 696 VKSDVFSFGVLLLETL 711
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LKE +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     +++DFG+A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 22  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 187
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 188 VNYEPLGLEADMWSIGVI 205

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 111/264 (42%), Gaps = 13/264 (4%)
Query: 453 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 512
           R  KE E  + S   L   +    V + T   SE D  A+    +      S        
Sbjct: 331 RPQKEGERALPSIPKLANNE-KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR 389
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQ 567
           E   +   +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H ++V+L+G   E    I I E      L  FL    R   L   + +     ++  L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           L      R +HRD+ A N+L+ +    K+ DFG++R +  D       +      +M+PE
Sbjct: 507 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 562
Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
                 F+  SDV+ FGV + E L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     +G G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ L
Sbjct: 24  FAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                 + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    L
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---L 133
Query: 635 RIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIV 189
Query: 690 LDGLFSVKSDVFSFGVL 706
                 +++D++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ L
Sbjct: 24  FAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                 + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    L
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---L 133
Query: 635 RIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIV 189
Query: 690 LDGLFSVKSDVFSFGVL 706
                 +++D++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVI 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 578
           +GEG +G V      +    VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
                + +   Y+    +   L+   ++  L        +  I +GL Y+H  +   ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGLFSVK 697
           RDLK SN+L+++  + KI DFG+AR+   + +  G     V T  Y +PE  L+     K
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 698 S-DVFSFGVLLLETLTSK 714
           S D++S G +L E L+++
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 20/193 (10%)
Query: 521 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG G F  V+  K  L G+  A+K +           +NE+ ++ K++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK---IIEGIAQGLLYLHQYSRLRI 636
                 L+ + +    L    FD  R    G  T      +I+ +   + YLH+     I
Sbjct: 77  STTHYYLVMQLVSGGEL----FD--RILERGVYTEKDASLVIQQVLSAVKYLHENG---I 127
Query: 637 IHRDLKASNIL-LDSDMNPKI--SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 693
           +HRDLK  N+L L  + N KI  +DFG+++M    E  G      GT GY++PE      
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 694 FSVKSDVFSFGVL 706
           +S   D +S GV+
Sbjct: 184 YSKAVDCWSIGVI 196

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFKNEMMLIAKLQH 568
           A ++ F ++ +LG G    VY+ K    Q+  A+K L     +  K  + E+ ++ +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSH 107
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGL 625
            N+++L        E  L+ E +    L    FD  R    G+ +       ++ I + +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FD--RIVEKGYYSERDAADAVKQILEAV 161
Query: 626 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
            YLH+     I+HRDLK  N+L  +   D   KI+DFG++++    E Q   K V GT G
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPG 215
Query: 683 YMSPEYALDGLFSVKSDVFSFGVL 706
           Y +PE      +  + D++S G++
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGII 239

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +++ +  +LG G FG V++  +   G   A K + +      +  + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V L     +  E ++IYE+M    L   + D    + +     V+ +  + +GL ++H+ 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 632 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +    +H DLK  NI+  +  +   K+ DFG+       + + + K   GT  + +PE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 222
Query: 690 LDGLFSVKSDVFSFGVL 706
                   +D++S GVL
Sbjct: 223 EGKPVGYYTDMWSVGVL 239

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +G+G F  V +      GQ+ AVK     + +S  G   ++ K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLYLHQYSR 633
           +      G   +++E+M    L F +   +    +  +      +  I + L Y H  + 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 634 LRIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
             IIHRD+K  N+LL S  N    K+ DFG+A       L    +  VGT  +M+PE   
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 691 DGLFSVKSDVFSFGVLLLETLT 712
              +    DV+  GV+L   L+
Sbjct: 207 REPYGKPVDVWGCGVILFILLS 228

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 592
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 593 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           + +L+  +    D  R   L +Q  V        G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S GV++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGE 217
Query: 710 TL 711
            +
Sbjct: 218 MI 219

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 592
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 593 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           + +L+  +    D  R   L +Q  V        G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S GV++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGE 217
Query: 710 TL 711
            +
Sbjct: 218 MI 219

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEV--AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           ++++  +G G +G V K  +  G  +  A K++     + +  FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL     +  +  L+ E      L   +       +       +I++ +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 633 RLRIIHRDLKASNILL--DSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +L + HRDLK  N L   DS  +P K+ DFG+A  F   ++    +  VGT  Y+SP+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-V 179
Query: 690 LDGLFSVKSDVFSFGVLL 707
           L+GL+  + D +S GV++
Sbjct: 180 LEGLYGPECDEWSAGVMM 197

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTP 203
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ L
Sbjct: 24  FAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                 + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    L
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---L 133
Query: 635 RIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIV 189
Query: 690 LDGLFSVKSDVFSFGVL 706
                 +++D++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVI 206

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 105/266 (39%), Gaps = 73/266 (27%)
Query: 517 MQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 574
           +QC +G GGFG V++ K  ++    A+KR+   + +  +E    E+  +AKL+H  +VR 
Sbjct: 11  IQC-MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 575 MGCCVEQGEKILIYE----YMPNKSLNFFLFDPS-------------------------- 604
               +E   +    E    ++ ++S ++ L  PS                          
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 605 ---------------RTHLLGWQTR------------VKIIEGIAQGLLYLHQYSRLRII 637
                          + +L  W  R            + I   IA+ + +LH      ++
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LM 186
Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQ----------GNTKRVVGTYGYMSPE 687
           HRDLK SNI    D   K+ DFG+      DE +                VGT  YMSPE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE 246
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTS 713
                 +S K D+FS G++L E L S
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYS 272

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK--------RLS 546
           RD+ LP     S     EN+  +  LG G    V +       +E AVK          S
Sbjct: 2   RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 547 SQSGQGLKEFK-NEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS 604
           ++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L  F +   
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE 117
Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
           +  L   +TR KI+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG +  
Sbjct: 118 KVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS-- 171
Query: 665 FCGDELQGNTKRVVGTYGYMSPE 687
            C  +     + V GT  Y++PE
Sbjct: 172 -CQLDPGEKLREVCGTPSYLAPE 193

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 634 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 688
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 689 ALDGLFSVKSDVFSFGVL 706
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 515 FSMQCKLGEGGFGPVYKGKLLNGQEV--AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           ++++  +G G +G V K  +  G  +  A K++     + +  FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL     +  +  L+ E      L   +       +       +I++ +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 633 RLRIIHRDLKASNILL--DSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
           +L + HRDLK  N L   DS  +P K+ DFG+A  F   ++    +  VGT  Y+SP+  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-V 196
Query: 690 LDGLFSVKSDVFSFGVLL 707
           L+GL+  + D +S GV++
Sbjct: 197 LEGLYGPECDEWSAGVMM 214

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G           
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G           
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARFYA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY P   +       S    +G           
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFXEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G           
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 25  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 138
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 223

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK--------RLS 546
           RD+ LP     S     EN+  +  LG G    V +       +E AVK          S
Sbjct: 2   RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 547 SQSGQGLKEFK-NEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS 604
           ++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L  F +   
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE 117
Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
           +  L   +TR KI+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG +  
Sbjct: 118 KVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS-- 171
Query: 665 FCGDELQGNTKRVVGTYGYMSPE 687
            C  +     + V GT  Y++PE
Sbjct: 172 -CQLDPGEKLRSVCGTPSYLAPE 193

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 520 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQS-GQGLK-EFKNEMMLI--AKLQHRNLVRL 574
           +LG G F  V +      GQE A K L  +  GQ  + E  +E+ ++  AK   R ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VINL 94
Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                   E ILI EY     + F L  P    ++     +++I+ I +G+ YLHQ +  
Sbjct: 95  HEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN-- 151
Query: 635 RIIHRDLKASNILLDSDM---NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
            I+H DLK  NILL S     + KI DFGM+R   G   +   + ++GT  Y++PE    
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACE--LREIMGTPEYLAPEILNY 207
Query: 692 GLFSVKSDVFSFGVLLLETLT 712
              +  +D+++ G++    LT
Sbjct: 208 DPITTATDMWNIGIIAYMLLT 228

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 513 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKL 566
           ++F +   LG+G FG VY     + K +   +V  K  S    +G++ + + E+ + + L
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHL 71
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +H N++R+     ++    L+ E+ P   L   L    R      Q     +E +A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 128
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           Y H+    ++IHRD+K  N+L+      KI+DFG +       L+   + + GT  Y+ P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR--RRXMCGTLDYLPP 181
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E         K D++  GVL  E L 
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLV 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 116/264 (43%), Gaps = 33/264 (12%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGKLLNGQEV--AVKRLSSQSGQGLKEFKNEM----MLI 563
           A   +F     +G+G FG V   +    +EV  AVK L  ++    KE K+ M    +L+
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA 622
             ++H  LV L        +   + +Y+    L F+     R  L   + R +     IA
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAEIA 149
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGT 680
             L YLH    L I++RDLK  NILLDS  +  ++DFG+    C + ++ N  T    GT
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL----CKENIEHNSTTSTFCGT 202
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS-----KRNTG-VYDIESFNLLGHAWNL 734
             Y++PE      +    D +  G +L E L        RNT  +YD    N+L     L
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQL 258
Query: 735 WKD--NRAYELLSPALQHEASYQM 756
             +  N A  LL   LQ + + ++
Sbjct: 259 KPNITNSARHLLEGLLQKDRTKRL 282

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 513 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKL 566
           ++F +   LG+G FG VY     + K +   +V  K  S    +G++ + + E+ + + L
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHL 72
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +H N++R+     ++    L+ E+ P   L   L    R      Q     +E +A  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 129
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           Y H+    ++IHRD+K  N+L+      KI+DFG +       L+   + + GT  Y+ P
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR--RRXMCGTLDYLPP 182
Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E         K D++  GVL  E L 
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLV 208

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 520 KLGEGGFGPVYKGKLLNGQ--------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           ++G G F  VYKG  L+ +        E+  ++L+    Q    FK E   +  LQH N+
Sbjct: 33  EIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNI 87
Query: 572 VRLMGC--CVEQGEK--ILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGL 625
           VR         +G+K  +L+ E   + +L  +L  F   +  +L    R      I +GL
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR-----QILKGL 142
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYM 684
            +LH  +   IIHRDLK  NI +       KI D G+A +    +     K V+GT  + 
Sbjct: 143 QFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFX 197
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           +PE   +  +    DV++FG   LE  TS+
Sbjct: 198 APE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 146
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 146
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 545 LSSQSGQGLKEFK-NEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD 602
            S++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L  F + 
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYL 102
Query: 603 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
             +  L   +TR KI+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG +
Sbjct: 103 TEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158
Query: 663 RMFCGDELQGNTKRVVGTYGYMSPE 687
              C  +     + V GT  Y++PE
Sbjct: 159 ---CQLDPGEKLREVCGTPSYLAPE 180

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 25  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             ++  +    LV+L     +     ++ EY+P   +       S    +G         
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARF 138
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 223

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 146
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             ++  +    LV+L     +     ++ EY P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARF 146
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCG 201
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    L +L     +     ++ EY P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    L +L     +     ++ EY P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 53  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 166
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 221
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 510 AATENFSMQC-------KLGEGGFGPVYKGKLL-NGQEVAVKRL-SSQSGQGLKEFKNEM 560
            A ENF ++        +LG G +G V K + + +GQ  AVKR+ ++ + Q  K    ++
Sbjct: 24  GAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDL 83
Query: 561 MLIAK-LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT---HLLGWQT 613
            +  + +     V   G    +G+ + I   + + SL+ F   + D  +T    +LG   
Sbjct: 84  DISXRTVDCPFTVTFYGALFREGD-VWICXELXDTSLDKFYKQVIDKGQTIPEDILG--- 139
Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 673
             KI   I + L +LH  S+L +IHRD+K SN+L+++    K  DFG++     D  +  
Sbjct: 140 --KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDI 195
Query: 674 TKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLE 709
                G   Y +PE     L    +SVKSD++S G+  +E
Sbjct: 196 D---AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIE 232

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 15/224 (6%)
Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQ 551
            D   P  +L  V     NF M   LG+G FG V        +E+ A+K L         
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMV--LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDD 61
Query: 552 GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLG 610
            ++    E  ++A L     +  +  C +  +++  + EY+    L + +    +     
Sbjct: 62  DVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFK 118
Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
               V     I+ GL +LH+     II+RDLK  N++LDS+ + KI+DFGM +    D +
Sbjct: 119 EPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV 175
Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
              T+   GT  Y++PE      +    D +++GVLL E L  +
Sbjct: 176 --TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 592
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 593 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           + +L+  +    D  R   L +Q  V        G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TL 711
            +
Sbjct: 218 MI 219

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    L +L     +     ++ EY P   +       S    +G           
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFXEPHARFYA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 17/182 (9%)
Query: 539 EVAVKRLSSQSGQGLKEF-KNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSL 596
           EV  +RLS +  + ++E  + E  ++ ++  H +++ L+          L+++ M    L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 656
             F +   +  L   +TR  I+  + + + +LH  +   I+HRDLK  NILLD +M  ++
Sbjct: 188 --FDYLTEKVALSEKETR-SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEY---ALDGL---FSVKSDVFSFGVLLLET 710
           SDFG +   C  E     + + GT GY++PE    ++D     +  + D+++ GV+L   
Sbjct: 242 SDFGFS---CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 711 LT 712
           L 
Sbjct: 299 LA 300

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           IA GL +L       II+RDLK  N++LDS+ + KI+DFGM +    D +   TK   GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 505
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y++PE      +    D ++FGVLL E L  +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKN---EMMLIAKLQH 568
           ++F +   +G+G FG V   +  + +++ A+K ++ Q      E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
             LV L     ++ +  ++ + +    L + L      H      ++ I E +   L YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICE-LVMALDYL 131
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
                 RIIHRD+K  NILLD   +  I+DF +A M    E Q  T  + GT  YM+PE 
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAPEM 185
Query: 689 --ALDGL-FSVKSDVFSFGVLLLETLTSKR 715
             +  G  +S   D +S GV   E L  +R
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 576 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLXGIKH 141
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 18  SDRYELVKDIGAGNFG---VARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 129
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           Y H    +++ HRDLK  N LLD    P  KI+DFG ++      L    K  VGT  Y+
Sbjct: 130 YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYI 183
Query: 685 SPEYALDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIE 723
           +PE  L   +  K +DV+S GV L   L      G Y  E
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVML-----VGAYPFE 218

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 559
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
             +   +    LV+L     +     ++ EY P   +       S    +G  +      
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMF------SHLRRIGRFSEPHARF 146
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCG 201
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 23/236 (9%)
Query: 520 KLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           +LG G FG V++  +   G+    K +++         KNE+ ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 579 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
            ++ E +LI E++        LFD   +  + +     +  +    +GL ++H++S   I
Sbjct: 118 EDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 637 IHRDLKASNILLDSDM--NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
           +H D+K  NI+ ++    + KI DFG+A     DE+    K    T  + +PE       
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPV 227
Query: 695 SVKSDVFSFGVL---LLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRAYELLSP 746
              +D+++ GVL   LL  L+     G  D+E+  N+    W    D  A+  +SP
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEF--DEDAFSSVSP 279

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 26/229 (11%)
Query: 493 GTRRDSVLPCFSLASVSAATENFSMQCK-LGEGGFGPVYKG-KLLNGQEVAVKRLSS--Q 548
           G+  DS      +A  +        Q K +G G  G V      + G  VAVK+LS   Q
Sbjct: 1   GSHMDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ 60
Query: 549 SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------EKILIYEYMPNK--SLNFFL 600
           +    K    E++L+  + H+N++ L+     Q       +  L+ E M      +    
Sbjct: 61  NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME 120
Query: 601 FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 660
            D  R   L +Q           G+ +LH      IIHRDLK SNI++ SD   KI DFG
Sbjct: 121 LDHERMSYLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 169
Query: 661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           +AR    + +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 170 LARTASTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN---LVRLM 575
           ++G G  G V+K +    G  +AVK++  +SG   +  +  M L   L+  +   +V+  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 576 GCCVEQGEKILIYEYMPN--KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           G  +   +  +  E M    + L   +  P    +LG     K+   I + L YL +  +
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE--K 143
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY----- 688
             +IHRD+K SNILLD     K+ DFG++     D+ +    R  G   YM+PE      
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPD 200
Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSK 714
                + +++DV+S G+ L+E  T +
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 17/216 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSSQSGQGLKEFKNEMM 561
           AS S   ++F +   +G G +  V   +L     +     VK+      + +   + E  
Sbjct: 13  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 562 LIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
           +  +   H  LV L  C   +     + EY+    L F +    R   L  +        
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAE 129
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVV 678
           I+  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSXFC 182
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           GT  Y++PE      +    D ++ GVL+ E +  +
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           IA GL +L       II+RDLK  N++LDS+ + KI+DFGM +    D +   TK   GT
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 184
Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             Y++PE      +    D ++FGVLL E L  +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 561
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           ++  +    LV+L     +     ++ EY+    +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLE 709
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 17/216 (7%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSSQSGQGLKEFKNEMM 561
           AS S   ++F +   +G G +  V   +L     +     VK+      + +   + E  
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 562 LIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
           +  +   H  LV L  C   +     + EY+    L F +    R   L  +        
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAE 161
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVV 678
           I+  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFC 214
Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           GT  Y++PE      +    D ++ GVL+ E +  +
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 576 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 576 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLXGIKH 134
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 188
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 576 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLXGIKH 141
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 17  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 71
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 128
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           Y H    +++ HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y+
Sbjct: 129 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYI 182
Query: 685 SPEYALDGLFSVK-SDVFSFGVLL 707
           +PE  L   +  K +DV+S GV L
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTL 206

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 576 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 521 LGEGGFG--PVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGC 577
           +G G FG   + + KL   + VAVK +  + G  + E  + E++    L+H N+VR    
Sbjct: 28  IGSGNFGVARLMRDKL-TKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
            +      +I EY     L   + +  R             + +  G+ Y H    ++I 
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---MQIC 138
Query: 638 HRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
           HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y++PE  L   + 
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 696 VK-SDVFSFGVLL 707
            K +DV+S GV L
Sbjct: 196 GKIADVWSCGVTL 208

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 592
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 593 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           + +L+  +    D  R   L +Q        +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TL 711
            +
Sbjct: 218 MI 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 24  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 83
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 137
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 138 VLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 192
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYE 217

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 576 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 623
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 128 NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 229
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            +PE  L   +    D++S G ++ E +  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 578
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
            E+    L++E M   S+   +    R H    +  V +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASV-VVQDVASALDFLHNKG---IAH 134
Query: 639 RDLKASNILLD--SDMNP-KISDFGMARMFCGDELQGNTKRV--------VGTYGYMSPE 687
           RDLK  NIL +  + ++P KI DFG+     G +L G+   +         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGS---GIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 688 YA-----LDGLFSVKSDVFSFGVLL 707
                     ++  + D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 592
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 593 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           + +L+  +    D  R   L +Q        +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TL 711
            +
Sbjct: 218 MI 219

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 576 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 576 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 140
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 141 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 194
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 195 VILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 28/186 (15%)
Query: 538 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           + VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL 
Sbjct: 50  RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPEVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 706 LLLETL 711
           ++ E +
Sbjct: 214 IMGEMI 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 576 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 135
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 189
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 576 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 576 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 623
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 84  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 131
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 185
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            +PE  L   +    D++S G ++ E +  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 576 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 142
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 196
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 576 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 627
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 142
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 196
Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
             L   +    D++S G ++ E +  K
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 576 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 623
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 128 NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 229
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            +PE  L   +    D++S G ++ E +  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 499 VLPCFSLASVSAATENFSMQCK-LGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQ 551
           ++P  S+A      E+    C+ +G+G F  V +      GQ+ AVK     + +S  G 
Sbjct: 11  LVPRGSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL 70
Query: 552 GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 611
             ++ K E  +   L+H ++V L+      G   +++E+M    L F +   +    +  
Sbjct: 71  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 130
Query: 612 QTRV-KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARMFCG 667
           +      +  I + L Y H  +   IIHRD+K   +LL S  N    K+  FG+A     
Sbjct: 131 EAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 187
Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
             L    +  VGT  +M+PE      +    DV+  GV+L   L+
Sbjct: 188 SGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 230

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 592
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 593 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           + +L+  +    D  R   L +Q        +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TL 711
            +
Sbjct: 218 MI 219

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 38  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 151
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 576 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 623
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 83  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            +PE  L   +    D++S G ++ E +  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 516 SMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVR 573
           + Q +LG G FG V++ +    G + AVK++       L+ F+  E+M  A L    +V 
Sbjct: 77  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 130
Query: 574 LMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           L G  V +G  + I+ E +   SL   + +      L     +  +    +GL YLH  S
Sbjct: 131 LYGA-VREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 184
Query: 633 RLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPEY 688
           R RI+H D+KA N+LL SD  +  + DFG A     D L  +      + GT  +M+PE 
Sbjct: 185 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEV 243
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
            L      K DV+S   ++L  L
Sbjct: 244 VLGRSCDAKVDVWSSCCMMLHML 266

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSSQSGQGLKEFKNEMMLIA 564
           S   ++F +   +G G +  V   +L     +     VK+      + +   + E  +  
Sbjct: 1   SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 60
Query: 565 KL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           +   H  LV L  C   +     + EY+    L F +    R   L  +        I+ 
Sbjct: 61  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISL 117
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTY 681
            L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    GT 
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSXFCGTP 170
Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            Y++PE      +    D ++ GVL+ E +  +
Sbjct: 171 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 516 SMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVR 573
           + Q +LG G FG V++ +    G + AVK++       L+ F+  E+M  A L    +V 
Sbjct: 96  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 149
Query: 574 LMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           L G  V +G  + I+ E +   SL   + +      L     +  +    +GL YLH  S
Sbjct: 150 LYGA-VREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 203
Query: 633 RLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPEY 688
           R RI+H D+KA N+LL SD  +  + DFG A     D L  +      + GT  +M+PE 
Sbjct: 204 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 689 ALDGLFSVKSDVFSFGVLLLETL 711
            L      K DV+S   ++L  L
Sbjct: 263 VLGRSCDAKVDVWSSCCMMLHML 285

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFAEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 17/215 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           ++ + +   +G G FG     +     E+   +   +  +     K E++    L+H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNI 77
Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           VR     +      ++ EY     L   + +  R             + +  G+ Y H  
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA- 133
Query: 632 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
             +++ HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y++PE  
Sbjct: 134 --MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 690 LDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIE 723
           L   +  K +DV+S GV L   L      G Y  E
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVML-----VGAYPFE 218

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 578
           L EGGF  VY+ + + +G+E A+KRL S   +  +    E+  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 579 --------VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                     Q E +L+ E    + + F     SR  L    T +KI     + + ++H+
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-SCDTVLKIFYQTCRAVQHMHR 154
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA---------------RMFCGDELQGNTK 675
             +  IIHRDLK  N+LL +    K+ DFG A               R    +E+  NT 
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT- 212
Query: 676 RVVGTYGYMSPEYA-LDGLFSV--KSDVFSFGVLL 707
               T  Y +PE   L   F +  K D+++ G +L
Sbjct: 213 ----TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 32  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 91
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 145
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 146 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 200
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYE 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR   G       +  V T  Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLART-AGTSFMMEPE--VVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 706 LLLETLTSK 714
           ++ E +  K
Sbjct: 214 IMGEMVCHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 104
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 105 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 161
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 162 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGC 218
Query: 706 LLLETLTSK 714
           ++ E +  K
Sbjct: 219 IMGEMVCHK 227

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 93
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 94  EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 150
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 151 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGC 207
Query: 706 LLLETLTSK 714
           ++ E +  K
Sbjct: 208 IMGEMVCHK 216

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 117
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 171
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYL 226
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYE 251

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 32/186 (17%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 100
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 101 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 157
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 158 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 214
Query: 706 LLLETL 711
           ++ E +
Sbjct: 215 IMGEMI 220

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H  LV L  C   +     + EY+    L F +    R   L  +        I+  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNY 125
Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTYGYMS 685
           LH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    GT  Y++
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSXFCGTPNYIA 178
Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           PE      +    D ++ GVL+ E +  +
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 32/186 (17%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 706 LLLETL 711
           ++ E +
Sbjct: 214 IMGEMI 219

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 117
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 171
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 226
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYE 251

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 32/186 (17%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 706 LLLETL 711
           ++ E +
Sbjct: 214 IMGEMI 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 568
           + +F ++  LGEG +G V        G+ VA+K++    +    L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 569 RNLVRLMGC----CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            N++ +         E   ++ I + +    L+  +     T +L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----------LQGNT 674
           +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR+   DE           Q   
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGM 179
Query: 675 KRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLE 709
              V T  Y +PE  L    +S   DV+S G +L E
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+G    V++G+    G   A+K  ++ S        ++EF+    ++ KL H+N+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIVKL 72
Query: 575 MGCCVEQG--EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
                E     K+LI E+ P  SL   L +PS  + L     + ++  +  G+ +L +  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 633 RLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
              I+HR++K  NI+     D     K++DFG AR    DE       + GT  Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVXLYGTEEYLHPD 185

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 568
           + +F ++  LGEG +G V        G+ VA+K++    +    L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 569 RNLVRLMGC----CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            N++ +         E   ++ I + +    L+  +     T +L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----------LQGNT 674
           +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR+   DE           Q   
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGM 179
Query: 675 KRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLE 709
              V T  Y +PE  L    +S   DV+S G +L E
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 100/264 (37%), Gaps = 27/264 (10%)
Query: 460 TTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQC 519
           T +++  D LK      +  R+  PS+  G       + +    +          F    
Sbjct: 101 TAIQTVADGLKKQAAAEMDFRSGSPSDNSG------AEEMEVSLAKPKHRVTMNEFEYLK 154
Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLM 575
            LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 576 GCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                      + EY     L F L     F   R    G +        I   L YLH 
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH- 265
Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
            S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLE 322
Query: 691 DGLFSVKSDVFSFGVLLLETLTSK 714
           D  +    D +  GV++ E +  +
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 521 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRL 574
           LG+G    V++G+    G   A+K  ++ S        ++EF+    ++ KL H+N+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIVKL 72
Query: 575 MGCCVEQG--EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
                E     K+LI E+ P  SL   L +PS  + L     + ++  +  G+ +L +  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 633 RLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
              I+HR++K  NI+     D     K++DFG AR    DE       + GT  Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQ 230

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 686
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 687 EYALDGLFSVKSDVFSFGVL 706
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 540 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 597
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 598 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 645
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 705
           I++ SD   KI DFG+AR   G       +  V T  Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLART-AGTSFMMEPE--VVTRYYRAPEVILGMGYKENVDLWSVGC 213
Query: 706 LLLETLTSK 714
           ++ E +  K
Sbjct: 214 IMGEMVCHK 222

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 686
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 687 EYALDGLFSVKSDVFSFGVL 706
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 568
           + +F ++  LGEG +G V        G+ VA+K++    +    L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 569 RNLVRLMGC----CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            N++ +         E   ++ I + +    L+  +     T +L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----------LQGNT 674
           +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR+   DE           Q   
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGM 179
Query: 675 KRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLE 709
              V T  Y +PE  L    +S   DV+S G +L E
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+++D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  +   ++   D ++ GVL+ E
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYE 230

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 520 KLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           KLGEGGF  V     L +G   A+KR+     Q  +E + E  +     H N++RL+  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 579 V-EQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           + E+G K   +  +P         +  R     + L     + ++ GI +GL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG- 154
Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV--------GTYGYMS 685
               HRDLK +NILL  +  P + D G     C   ++G+ + +          T  Y +
Sbjct: 155 --YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 686 PEYALDGLFSVKS--------DVFSFGVLLLETLTSKRNTGVYDI 722
           PE     LFSV+S        DV+S G +L   +  +   G YD+
Sbjct: 212 PE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE---GPYDM 248

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 536 NGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 590
            GQ+ AVK     + +S  G   ++ K E  +   L+H ++V L+      G   +++E+
Sbjct: 48  TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107
Query: 591 MPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           M    L F +   +    +  +      +  I + L Y H  +   IIHRD+K   +LL 
Sbjct: 108 MDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLA 164
Query: 650 SDMNP---KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 706
           S  N    K+  FG+A       L    +  VGT  +M+PE      +    DV+  GV+
Sbjct: 165 SKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 707 LLETLT 712
           L   L+
Sbjct: 223 LFILLS 228

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 129
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           Y H    +++ HRDLK  N LLD    P  KI  FG ++      L    K  VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYI 183
Query: 685 SPEYALDGLFSVK-SDVFSFGVLL 707
           +PE  L   +  K +DV+S GV L
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTL 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 686
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 687 EYALDGLFSVKSDVFSFGVL 706
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 686
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 687 EYALDGLFSVKSDVFSFGVL 706
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVK----RLSSQSGQGL--KEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K +  + G E A K    R S  S +G+  +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 686
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 687 EYALDGLFSVKSDVFSFGVL 706
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 268
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 269 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLED 326
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 327 NDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 578
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
            E+    L++E M   S+   +    R H    +  V +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASV-VVQDVASALDFLHNKG---IAH 134
Query: 639 RDLKASNILLD--SDMNP-KISDFGMARMFCGDELQGNTKRV--------VGTYGYMSPE 687
           RDLK  NIL +  + ++P KI DF +     G +L G+   +         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGS---GIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 688 YA-----LDGLFSVKSDVFSFGVLL 707
                     ++  + D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 686
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 687 EYALDGLFSVKSDVFSFGVL 706
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 566
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 129
Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           Y H    +++ HRDLK  N LLD    P  KI  FG ++      L    K  VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYI 183
Query: 685 SPEYALDGLFSVK-SDVFSFGVLL 707
           +PE  L   +  K +DV+S GV L
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTL 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +P   L   ++   D ++ GVL+ E
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYE 230

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 126
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 127 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLED 184
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 125
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 126 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLED 183
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 184 NDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 127
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 128 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLED 185
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 186 NDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 540 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 599
           VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL  F
Sbjct: 54  VAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 103
Query: 600 --------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 647
                   L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SNI+
Sbjct: 104 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 160
Query: 648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           + SD   KI DFG+AR      +      VV  Y Y +PE  L   +    D++S G ++
Sbjct: 161 VKSDCTLKILDFGLARTAGTSFMM--VPFVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 217
Query: 708 LETL 711
            E +
Sbjct: 218 GEMI 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 39/238 (16%)
Query: 493 GTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSG 550
           GT  D      +   +S     +S+  ++G GG   V++      Q  A+K   L     
Sbjct: 36  GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 551 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLL 609
           Q L  ++NE+  + KLQ            +  +KI+ +Y+Y       + + +     L 
Sbjct: 96  QTLDSYRNEIAYLNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLN 143
Query: 610 GWQTRVKIIE---------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 660
            W  + K I+          + + +  +HQ+    I+H DLK +N L+   M  K+ DFG
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFG 199
Query: 661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS-----------DVFSFGVLL 707
           +A     D         VGT  YM PE   D   S ++           DV+S G +L
Sbjct: 200 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 564
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT   +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEAL 205
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLE 709
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E + +   LG G FG V++    + ++  + +     G      K E+ ++   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            L        E ++I+E++    L+ F    +    L  +  V  +  + + L +LH ++
Sbjct: 65  HLHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 633 RLRIIHRDLKASNILLDSDMNP--KISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 689
              I H D++  NI+  +  +   KI +FG AR    GD    N + +     Y +PE  
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVH 175
Query: 690 LDGLFSVKSDVFSFGVLL 707
              + S  +D++S G L+
Sbjct: 176 QHDVVSTATDMWSLGTLV 193

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 493 GTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSG 550
           GT  D      +   +S     +S+  ++G GG   V++      Q  A+K   L     
Sbjct: 36  GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 551 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLL 609
           Q L  ++NE+  + KLQ            +  +KI+ +Y+Y       + + +     L 
Sbjct: 96  QTLDSYRNEIAYLNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLN 143
Query: 610 GWQTRVKIIE---------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 660
            W  + K I+          + + +  +HQ+    I+H DLK +N L+   M  K+ DFG
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFG 199
Query: 661 MARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           +A     D         VGT  YM PE   D
Sbjct: 200 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/311 (24%), Positives = 128/311 (41%), Gaps = 66/311 (21%)
Query: 503 FSLASVSAATEN-------FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK 554
            SL + +AA E        F ++   G+G FG V  GK  + G  VA+K++        +
Sbjct: 6   MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65
Query: 555 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI-------LIYEYMPNK----SLNFFLFDP 603
           E +  M  +A L H N+V+L       GE+        ++ EY+P+       N++    
Sbjct: 66  ELQI-MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV 124
Query: 604 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMA 662
           +   +L      ++I  I  G L+L     + + HRD+K  N+L+ ++D   K+ DFG A
Sbjct: 125 APPPILIKVFLFQLIRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTS-------- 713
           +     E   N   +   Y Y +PE    +  ++   D++S G +  E +          
Sbjct: 180 KKLSPSE--PNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236
Query: 714 ---------------------KRNTGVYDIESFNLLGHAW-NLWKDN------RAYELLS 745
                                K N    D++ +N  G  W N++ D+       AY+LLS
Sbjct: 237 SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296
Query: 746 PALQHEASYQM 756
             LQ+    +M
Sbjct: 297 ALLQYLPEERM 307

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQHRNLVR 573
           LGEG +G V   ++L+ + +  + +             G    K E+ L+ +L+H+N+++
Sbjct: 13  LGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 574 LMGCCV--EQGEKILIYEY-----------MPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
           L+      E+ +  ++ EY           +P K      F   + H    Q        
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVCQAHGYFCQ-------- 117
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +  GL YLH      I+H+D+K  N+LL +    KIS  G+A            +   G+
Sbjct: 118 LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 681 YGYMSPEYA--LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN 738
             +  PE A  LD     K D++S GV L         TG+Y  E  N+     N+ K +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI-----TTGLYPFEGDNIYKLFENIGKGS 229
Query: 739 RA 740
            A
Sbjct: 230 YA 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 22/218 (10%)
Query: 506 ASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMM 561
           A       +F     LG+G FG V   +    G+  A+K L  +      E  +   E  
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVK 616
           ++   +H  L  L            + EY     L F L     F   R    G +    
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE---- 116
Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
               I   L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K 
Sbjct: 117 ----IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 167
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
             GT  Y++PE   D  +    D +  GV++ E +  +
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 28/199 (14%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMML 562
             S+S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 563 IAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE-- 619
           + KLQ            +  +KI+ +Y+Y       + + +     L  W  + K I+  
Sbjct: 80  LNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 127
Query: 620 -------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
                   + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D    
Sbjct: 128 ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXV 183
Query: 673 NTKRVVGTYGYMSPEYALD 691
                VGT  YM PE   D
Sbjct: 184 VKDSQVGTVNYMPPEAIKD 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 28/199 (14%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMML 562
             S+S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 563 IAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE-- 619
           + KLQ            +  +KI+ +Y+Y       + + +     L  W  + K I+  
Sbjct: 80  LNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 127
Query: 620 -------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
                   + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D    
Sbjct: 128 ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSV 183
Query: 673 NTKRVVGTYGYMSPEYALD 691
                VGT  YM PE   D
Sbjct: 184 VKDSQVGTVNYMPPEAIKD 202

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLV 572
            + Q +LG G FG V++ K    G + AVK++       L+ F+  E++  A L    +V
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 127
Query: 573 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
            L G  V +G  + I+ E +   SL   +    +   L     +  +    +GL YLH  
Sbjct: 128 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 183
Query: 632 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPE 687
              RI+H D+KA N+LL SD +   + DFG A     D L  +      + GT  +M+PE
Sbjct: 184 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
             +      K D++S   ++L  L
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHML 264

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE----FKNEMMLIAKLQ 567
            E++ +   +G G FG V   +    Q+V   +L S+     +     F  E  ++A   
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 568 HRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFL--FD-PSRTHLLGWQTRVKIIEGIA 622
              +V+L   C  Q +K L  + EYMP   L   +  +D P +     W          A
Sbjct: 134 SPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFY-----TA 181
Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           + +L L     + +IHRD+K  N+LLD   + K++DFG   M   +    +    VGT  
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTPD 240
Query: 683 YMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 712
           Y+SPE       DG +  + D +S GV L E L 
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 274

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 508 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 565
           +S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 66
Query: 566 LQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE----- 619
           LQ            +  +KI+ +Y+Y       + + +     L  W  + K I+     
Sbjct: 67  LQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK 114
Query: 620 ----GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D       
Sbjct: 115 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 170
Query: 676 RVVGTYGYMSPEYALDGLFSVKS-----------DVFSFGVLL 707
             VGT  YM PE   D   S ++           DV+S G +L
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 17/166 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHR 569
           +N+ ++  +G G +G VY     N  + VA+K+++      +  K    E+ ++ +L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 570 NLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQ 623
            ++RL    + +      E  ++ E   +     F     +T +   +  VK I+  +  
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF-----KTPIFLTEQHVKTILYNLLL 142
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
           G  ++H+     IIHRDLK +N LL+ D + KI DFG+AR    D+
Sbjct: 143 GEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 578
           LGEG +  V     L NG+E AVK +  Q+G        E+  + + Q ++N++ L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
            +     L++E +   S+   L    +      +   +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 639 RDLKASNILLDS--DMNP-KISDFGMARMF-----CGDELQGNTKRVVGTYGYMSPEYA- 689
           RDLK  NIL +S   ++P KI DF +         C            G+  YM+PE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 690 ----LDGLFSVKSDVFSFGVLLLETLT 712
                   +  + D++S GV+L   L+
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLS 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLV 572
            + Q ++G G FG V++ K    G + AVK++       L+ F+  E++  A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113
Query: 573 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
            L G  V +G  + I+ E +   SL   +    +   L     +  +    +GL YLH  
Sbjct: 114 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 632 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPE 687
              RI+H D+KA N+LL SD +   + DFG A     D L  +      + GT  +M+PE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
             +      K D++S   ++L  L
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHML 250

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 22/210 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHR 569
           +F     LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQG 624
            L  L            + EY     L F L     F   R    G +        I   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSA 117
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYL 172
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           +PE   D  +    D +  GV++ E +  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 22/210 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHR 569
           +F     LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQG 624
            L  L            + EY     L F L     F   R    G +        I   
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSA 122
Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y+
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYL 177
Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           +PE   D  +    D +  GV++ E +  +
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLV 572
            + Q ++G G FG V++ K    G + AVK++       L+ F+  E++  A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 573 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
            L G  V +G  + I+ E +   SL   +    +   L     +  +    +GL YLH  
Sbjct: 130 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 185
Query: 632 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPE 687
              RI+H D+KA N+LL SD +   + DFG A     D L  +      + GT  +M+PE
Sbjct: 186 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 688 YALDGLFSVKSDVFSFGVLLLETL 711
             +      K D++S   ++L  L
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHML 266

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 28/196 (14%)
Query: 508 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 565
           +S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 62
Query: 566 LQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE----- 619
           LQ            +  +KI+ +Y+Y       + + +     L  W  + K I+     
Sbjct: 63  LQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK 110
Query: 620 ----GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D       
Sbjct: 111 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 166
Query: 676 RVVGTYGYMSPEYALD 691
             VGT  YM PE   D
Sbjct: 167 SQVGTVNYMPPEAIKD 182

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLED 179
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED 179
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLED 179
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 508 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 565
           +S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 566 LQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE----- 619
           LQ            +  +KI+ +Y+Y       + + +     L  W  + K I+     
Sbjct: 64  LQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK 111
Query: 620 ----GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D       
Sbjct: 112 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 167
Query: 676 RVVGTYGYMSPEYALDGLFSVKS------------DVFSFGVLL 707
             VGT  YM PE A+  + S +             DV+S G +L
Sbjct: 168 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 576
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED 179
Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 28/211 (13%)
Query: 493 GTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSG 550
           GT  D      +   +S     +S+  ++G GG   V++      Q  A+K   L     
Sbjct: 36  GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 551 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLL 609
           Q L  ++NE+  + KLQ            +  +KI+ +Y+Y       + + +     L 
Sbjct: 96  QTLDSYRNEIAYLNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLN 143
Query: 610 GWQTRVKIIE---------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 660
            W  + K I+          + + +  +HQ+    I+H DLK +N L+   M  K+ DFG
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFG 199
Query: 661 MARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
           +A     D         VG   YM PE   D
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 30/229 (13%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-----------L 553
           +A + A    +++Q  +  G +G V  G    G  VA+KR+ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 554 KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGW 611
           K    E+ L+    H N++ L    V   E  +   Y+  + +        RT L  +  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--------RTDLAQVIH 125
Query: 612 QTRVKIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
             R+ I     Q  +Y     LH      ++HRDL   NILL  + +  I DF +AR   
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--- 182
Query: 667 GDELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            D    N    V    Y +PE  +    F+   D++S G ++ E    K
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 31/274 (11%)
Query: 519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
            KL E   G ++KG+   G ++ VK L  +  S +  ++F  E   +    H N++ ++G
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 577 CC--VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
            C         LI  +MP  SL   L +     ++     VK    +A+G+ +LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY---ALD 691
            I    L + ++++D DM  +IS   MA +    +  G     +    +++PE      +
Sbjct: 134 -IPRHALNSRSVMIDEDMTARIS---MADVKFSFQSPGR----MYAPAWVAPEALQKKPE 185
Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
                 +D++SF VLL E +T  R     D+ +  +            A E L P +   
Sbjct: 186 DTNRRSADMWSFAVLLWELVT--REVPFADLSNMEIGMKV--------ALEGLRPTIPPG 235
Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            S  +      +  +C+ E  A RP    +V ++
Sbjct: 236 ISPHVSK----LMKICMNEDPAKRPKFDMIVPIL 265

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 30/229 (13%)
Query: 505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-----------L 553
           +A + A    +++Q  +  G +G V  G    G  VA+KR+ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 554 KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGW 611
           K    E+ L+    H N++ L    V   E  +   Y+  + +        RT L  +  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--------RTDLAQVIH 125
Query: 612 QTRVKIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
             R+ I     Q  +Y     LH      ++HRDL   NILL  + +  I DF +AR   
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--- 182
Query: 667 GDELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            D    N    V    Y +PE  +    F+   D++S G ++ E    K
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 40/221 (18%)
Query: 512 TENFSMQCKLGEGGFGPV-----------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 560
            E++ +   +G G FG V           Y  KLL+  E+ +KR  S        F  E 
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEER 120
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            ++A      +V+L     +     ++ EYMP   L            +   +   + E 
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEK 168
Query: 621 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                 A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E      
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCD 227
Query: 676 RVVGTYGYMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 712
             VGT  Y+SPE       DG +  + D +S GV L E L 
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           ++F    +LG G +G V+K +   +G+  AVKR  S      +  K+    +A++     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP----FRGPKDRARKLAEVGSHEK 112
Query: 572 VRLMGCCV--EQG--EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQT---RVKIIEGIAQ 623
           V    CCV  EQ   E  ++Y       L   L  PS + H   W       ++   +  
Sbjct: 113 VGQHPCCVRLEQAWEEGGILY-------LQTELCGPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG----MARMFCGDELQGNTKRVVG 679
            LL L       ++H D+K +NI L      K+ DFG    +     G+  +G+ +    
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR---- 221
Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLET 710
              YM+PE  L G +   +DVFS G+ +LE 
Sbjct: 222 ---YMAPEL-LQGSYGTAADVFSLGLTILEV 248

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 40/221 (18%)
Query: 512 TENFSMQCKLGEGGFGPV-----------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 560
            E++ +   +G G FG V           Y  KLL+  E+ +KR  S        F  E 
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEER 125
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            ++A      +V+L     +     ++ EYMP   L            +   +   + E 
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEK 173
Query: 621 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                 A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E      
Sbjct: 174 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCD 232
Query: 676 RVVGTYGYMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 712
             VGT  Y+SPE       DG +  + D +S GV L E L 
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 40/221 (18%)
Query: 512 TENFSMQCKLGEGGFG-----------PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 560
            E++ +   +G G FG            VY  KLL+  E+ +KR  S        F  E 
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEER 125
Query: 561 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 620
            ++A      +V+L     +     ++ EYMP   L            +   +   + E 
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEK 173
Query: 621 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                 A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E      
Sbjct: 174 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCD 232
Query: 676 RVVGTYGYMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 712
             VGT  Y+SPE       DG +  + D +S GV L E L 
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 34/183 (18%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 580
           LG G  G +    + + ++VAVKR+  +        +   +L    +H N++R    C E
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYF--CTE 87
Query: 581 QGEKI----------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +  +            + EY+  K       +P           + +++    GL +LH 
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------ITLLQQTTSGLAHLHS 136
Query: 631 YSRLRIIHRDLKASNILL-----DSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYM 684
              L I+HRDLK  NIL+        +   ISDFG+  ++  G         V GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 685 SPE 687
           +PE
Sbjct: 194 APE 196

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--------SGQGLKEFKNEMML 562
           ++ +S    LG G FG V+        +EV VK +  +            L +   E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           +++++H N+++++     QG   L+ E      L+ F F      L        +   I 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRL-----DEPLASYIF 136
Query: 623 QGLLYLHQYSRLR-IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           + L+    Y RL+ IIHRD+K  NI++  D   K+ DFG A      +L        GT 
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTI 193
Query: 682 GYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRN 716
            Y +PE  +   +   + +++S GV L  TL  + N
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLY-TLVFEEN 228

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKG--------KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 563
            E+      LG+G F  ++KG          L+  EV +K L        + F     ++
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           +KL H++LV   G CV   E IL+ E++   SL+ +L        + W  ++++ + +A 
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAA 124
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDM-----NP---KISDFGMA 662
            + +L + +   +IH ++ A NILL  +      NP   K+SD G++
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGL--KEFKNEMMLIAKLQHR 569
           +N+ ++  +G G +G VY     N ++ VA+K+++      +  K    E+ ++ +L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 570 NLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQ 623
            ++RL    +        E  ++ E   +     F     +T +   +  +K I+  +  
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF-----KTPIFLTEEHIKTILYNLLL 140
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 663
           G  ++H+     IIHRDLK +N LL+ D + K+ DFG+AR
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   KL N  +V A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           + +  L     +     L+ +Y     L   L       L     R  +    A+ ++ +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAI 188
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPE 687
               +L  +HRD+K  NIL+D + + +++DFG       D  +Q +    VGT  Y+SPE
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPE 246
Query: 688 Y--ALD---GLFSVKSDVFSFGVLLLETL 711
              A++   G +  + D +S GV + E L
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 569
           + + ++  +G G +G V +    L  + VA+K++    +     K    E+ ++ +L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 570 NLVRLMGCC----VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           ++V+++       VE+ +++ +   + +         P     L  +T   ++  +  G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT---LLYNLLVGV 169
Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 663
            Y+H      I+HRDLK +N L++ D + K+ DFG+AR
Sbjct: 170 KYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP---KISDFGMARMFCGDELQGNTKR 676
           I + + YLH      ++HRDLK SNIL +D   NP   +I DFG A+    +   G    
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLXT 179
Query: 677 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              T  +++PE      +    D++S GVLL   LT
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLT 215

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 15/178 (8%)
Query: 539 EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 598
           E AVK +        +E +   +L+   QH N++ L     +     ++ E M    L  
Sbjct: 49  EFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-- 103
Query: 599 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP--- 654
            L    R      +    ++  I + + YLH      ++HRDLK SNIL +D   NP   
Sbjct: 104 -LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESI 159
Query: 655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +I DFG A+    +   G       T  +++PE      +    D++S GVLL   LT
Sbjct: 160 RICDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   K+ N + + A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           + +  L     ++    L+ +Y     L   L       L     R  I E +    L +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDKLPEDMARFYIGEMV----LAI 188
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
               +L  +HRD+K  N+LLD + + +++DFG   +   D+    +   VGT  Y+SPE 
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 689 --ALD---GLFSVKSDVFSFGVLLLETL 711
             A++   G +  + D +S GV + E L
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   K+ N + + A+K L+        E   F+ E  ++     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           + +  L     ++    L+ +Y     L   L       L     R  I E +    L +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDKLPEDMARFYIGEMV----LAI 204
Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
               +L  +HRD+K  N+LLD + + +++DFG   +   D+    +   VGT  Y+SPE 
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 689 --ALD---GLFSVKSDVFSFGVLLLETL 711
             A++   G +  + D +S GV + E L
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKG--------KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 563
            E+      LG+G F  ++KG          L+  EV +K L        + F     ++
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           +KL H++LV   G C    E IL+ E++   SL+ +L        + W  ++++ + +A 
Sbjct: 67  SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAW 124
Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDM-----NP---KISDFGMA 662
            + +L + +   +IH ++ A NILL  +      NP   K+SD G++
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 5/77 (6%)
Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTYGYMSPEYALDGLFS 695
           HRD+K  NIL+ +D    + DFG+A     ++L   GNT   VGT  Y +PE   +   +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT---VGTLYYXAPERFSESHAT 213
Query: 696 VKSDVFSFGVLLLETLT 712
            ++D+++   +L E LT
Sbjct: 214 YRADIYALTCVLYECLT 230

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEF------ 556
           F   S+    + + ++  +G+G +G V     +  Q  A++ +   +   +++       
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 557 --KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE-----YMPNKSLNFFLFDPS----- 604
             K E+ L+ KL H N+ RL     ++    L+ E     ++ +K LN F+ D +     
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGKCAM 132
Query: 605 ---RTHL---------------------LGWQTRVKIIEGIAQGLL-YLHQYSRLRIIHR 639
              +T +                     L +  R K+I  I + +   LH      I HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 640 DLKASNILLDSD--MNPKISDFGMARMFC---GDELQGNTKRVVGTYGYMSPEY--ALDG 692
           D+K  N L  ++     K+ DFG+++ F      E  G T +  GT  +++PE     + 
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNTTNE 251
Query: 693 LFSVKSDVFSFGVLL-LETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
            +  K D +S GVLL L  + +    GV D ++ + + +   L  +N  Y +LSP L  +
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK-KLCFENPNYNVLSP-LARD 309
Query: 752 ASYQMLNRYI 761
               +LNR +
Sbjct: 310 LLSNLLNRNV 319

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 38/223 (17%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 95
Query: 580 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 96  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 632 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 676
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 677 VVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRN 716
             GT G+ +PE   +      +   D+FS G +    L+  ++
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 38/223 (17%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 95
Query: 580 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 96  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 632 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 676
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 677 VVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRN 716
             GT G+ +PE   +      +   D+FS G +    L+  ++
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 35/191 (18%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 77
Query: 580 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 78  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 632 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 676
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 677 VVGTYGYMSPE 687
             GT G+ +PE
Sbjct: 192 PSGTSGWRAPE 202

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 35/191 (18%)
Query: 521 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 77
Query: 580 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 78  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 632 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 676
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 677 VVGTYGYMSPE 687
             GT G+ +PE
Sbjct: 192 PSGTSGWRAPE 202

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 539 EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 598
           E AVK +        +E +   +L+   QH N++ L     +     L+ E M    L  
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL-- 108
Query: 599 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP--- 654
            L    R      +    ++  I + + YLH      ++HRDLK SNIL +D   NP   
Sbjct: 109 -LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
           +I DFG A+    +   G       T  +++PE      +    D++S G+LL   L
Sbjct: 165 RICDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN------EMMLIAKLQ----HR 569
           LG+GGFG V+ G +L +  +VA+K +      G     +      E+ L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            ++RL+     Q   +L+ E  P  + + F +   +  L    +R    + +A      H
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA---IQH 154
Query: 630 QYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
            +SR  ++HRD+K  NIL+D      K+ DFG   +   DE   +     GT  Y  PE+
Sbjct: 155 CHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFD---GTRVYSPPEW 209
Query: 689 -ALDGLFSVKSDVFSFGVLLLETL 711
            +     ++ + V+S G+LL + +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMV 233

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 539 EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 598
           E AVK +        +E +   +L+   QH N++ L     +     L+ E M    L  
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL-- 108
Query: 599 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP--- 654
            L    R      +    ++  I + + YLH      ++HRDLK SNIL +D   NP   
Sbjct: 109 -LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
           +I DFG A+    +   G       T  +++PE      +    D++S G+LL   L
Sbjct: 165 RICDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 181
Query: 684 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 712
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 213

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 182
Query: 684 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 712
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 182
Query: 684 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 712
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 188
Query: 684 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 712
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 189 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 182
Query: 684 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 712
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 307
Query: 684 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 712
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 321
Query: 684 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 712
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 353

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 14/198 (7%)
Query: 521 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LGEG F    K     + Q  AVK +S +     ++    + L     H N+V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 639
           +Q    L+ E +    L  F     + H    +    I+  +   + ++H    + ++HR
Sbjct: 77  DQLHTFLVMELLNGGEL--FERIKKKKHFSETEASY-IMRKLVSAVSHMHD---VGVVHR 130
Query: 640 DLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV 696
           DLK  N+L    + ++  KI DFG AR+   D      K    T  Y +PE      +  
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDE 188
Query: 697 KSDVFSFGVLLLETLTSK 714
             D++S GV+L   L+ +
Sbjct: 189 SCDLWSLGVILYTMLSGQ 206

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	834
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-135
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-134
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-120
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-89
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-77
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-48
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-48
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-48
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-47
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-46
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-46
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-46
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-45
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-45
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-45
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-45
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-45
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-44
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-44
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-44
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-43
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-43
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-43
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-43
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-43
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-43
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-43
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-43
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-42
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-42
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-42
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-42
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-42
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-41
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-41
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-11
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	1e-11
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	2e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-10
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	9e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	3e-09
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	4e-09
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	5e-09
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	2e-08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	2e-07
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	9e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	2e-05
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	1e-04
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	1e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  404 bits (1040), Expect = e-135
 Identities = 109/307 (35%), Positives = 157/307 (51%), Gaps = 18/307 (5%)

Query: 496 RDSVLPCFSLASVSAATENFSMQC------KLGEGGFGPVYKGKLLNGQEVAVKRLSS-- 547
            D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++  
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMV 66

Query: 548 --QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR 605
              + +  ++F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 606 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 665
           T  L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF 725
                   T R+VGT  YM+PE  L G  + KSD++SFGV+LLE +T       +  E  
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQ 241

Query: 726 NLLGHAWNLWKDNRAYE-LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 784
            LL     +  + +  E  +   +  +A    +    +VA  C+ EK   RP + KV  +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

Query: 785 ITNEHAT 791
           +    A+
Sbjct: 301 LQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  401 bits (1033), Expect = e-134
 Identities = 115/291 (39%), Positives = 169/291 (58%), Gaps = 6/291 (2%)

Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 561
           FSL  +  A++NFS +  LG GGFG VYKG+L +G  VAVKRL  +  QG + +F+ E+ 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEG 620
           +I+   HRNL+RL G C+   E++L+Y YM N S+   L +   +   L W  R +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
            A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++    +    T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT---GVYDIESFNLLGHAWNLWKD 737
            G+++PEY   G  S K+DVF +GV+LLE +T +R      + + +   LL     L K+
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
            +   L+   LQ     + + + I VALLC Q    +RP MS+VV M+  +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  364 bits (936), Expect = e-120
 Identities = 103/285 (36%), Positives = 162/285 (56%), Gaps = 5/285 (1%)

Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
             L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGI 621
           ++  +H +LV L+G C E+ E ILIY+YM N +L   L+      + + W+ R++I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           A+GL YLH  +   IIHRD+K+ NILLD +  PKI+DFG+++     +    +  V GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT-GVYDIESFNLLGHAWNLWKDNRA 740
           GY+ PEY + G  + KSDV+SFGV+L E L ++         E  NL   A     + + 
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265

Query: 741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            +++ P L  +   + L ++   A+ C+   + DRP+M  V+  +
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  283 bits (726), Expect = 6e-89
 Identities = 69/308 (22%), Positives = 128/308 (41%), Gaps = 29/308 (9%)

Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
               ++   +    +      G FG V+K +L   + VAVK    Q  Q   + + E+  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 563 IAKLQHRNLVRLMGCCVE----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           +  ++H N+++ +G          +  LI  +    SL+ FL    + +++ W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 619 EGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 671
           E +A+GL YLH+         +  I HRD+K+ N+LL +++   I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 672 GNTKRVVGTYGYMSPEYALDGL-----FSVKSDVFSFGVLLLETLTSKRNTGV----YDI 722
           G+T   VGT  YM+PE     +       ++ D+++ G++L E  +           Y +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 723 ESFNLLGHAWNL--WKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMS 779
                +G   +L   ++   ++   P L  +   +  +         C    A  R +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 780 KVVSMITN 787
            V   IT 
Sbjct: 308 CVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  253 bits (649), Expect = 1e-77
 Identities = 68/332 (20%), Positives = 123/332 (37%), Gaps = 42/332 (12%)

Query: 503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
            + +  S   +N  +   +G G +G VYKG L + + VAVK  S  + Q     K  +  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60

Query: 563 IAKLQHRNLVRLMGCCVE-----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 617
           +  ++H N+ R +          + E +L+ EY PN SL  +L      H   W +  ++
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116

Query: 618 IEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG---- 667
              + +GL YLH       + +  I HRDL + N+L+ +D    ISDFG++    G    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 668 --DELQGNTKRVVGTYGYMSPEYALDGLFSV--------KSDVFSFGVLLLETLTSKRNT 717
              E        VGT  YM+PE  L+G  ++        + D+++ G++  E      + 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 718 GVYDIESFNLLGHAWNLWKDNRAYELLSPALQH----------EASYQMLNRYITVALLC 767
              +      +     +       ++     +           + +   +         C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 768 VQEKAADRPTMSKVVSMITNEHATLPYPKQSA 799
             + A  R T       +          K  +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  214 bits (546), Expect = 4e-63
 Identities = 72/295 (24%), Positives = 138/295 (46%), Gaps = 29/295 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 570
            + +++ K+G G FG V++ +  +G +VAVK L  Q    + + EF  E+ ++ +L+H N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V  MG   +     ++ EY+   SL   L        L  + R+ +   +A+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                I+HR+LK+ N+L+D     K+ DFG++R+     L   +K   GT  +M+PE   
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPALQ 749
           D   + KSDV+SFGV+L E  T ++    + ++    ++            ++     + 
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ---PWGNLNPAQVVAAV--------GFKCKRLEIP 261

Query: 750 ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN-EHATLPYPKQSAF 800
              +     ++         C   +   RP+ + ++ ++     + +P P +S  
Sbjct: 262 RNLNPQVAAIIEG-------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  209 bits (534), Expect = 1e-61
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 24/276 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +   ++  +G G FG V K K    ++VA+K++ S+S    K F  E+  ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L G C+      L+ EY    SL   L              +      +QG+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 633 RLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
              +IHRDLK  N+LL +     KI DFG A      ++Q +     G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             +S K DVFS+G++L E +T ++    +D          W +    R           +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR---PPLIKNLPK 231

Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               ++ R       C  +  + RP+M ++V ++T+
Sbjct: 232 PIESLMTR-------CWSKDPSQRPSMEEIVKIMTH 260

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  206 bits (525), Expect = 3e-60
 Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 41/311 (13%)

Query: 520 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
            LG+G FG   K      G+ + +K L     +  + F  E+ ++  L+H N+++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
            +      I EY+   +L   +          W  RV   + IA G+ YLH    + IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIH 131

Query: 639 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR------------VVGTYGYMSP 686
           RDL + N L+  + N  ++DFG+AR+   ++ Q    R            VVG   +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 746
           E      +  K DVFSFG++L E +         D     +              +   P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMDFGL----NVRGFLDRYCP 245

Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS----MITNEHATLPYPKQ----- 797
                + + +        + C       RP+  K+      +  +    LP   Q     
Sbjct: 246 PNCPPSFFPI-------TVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298

Query: 798 -SAFSYARRGE 807
              +   RRGE
Sbjct: 299 RGFWETYRRGE 309

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  201 bits (514), Expect = 4e-59
 Identities = 71/207 (34%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRL----SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
            +G GGFG VY+     G EVAVK           Q ++  + E  L A L+H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
           G C+++    L+ E+     LN  L        +     V     IA+G+ YLH  + + 
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 636 IIHRDLKASNILLDSDMNP--------KISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           IIHRDLK+SNIL+   +          KI+DFG+AR +             G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSK 714
                +FS  SDV+S+GVLL E LT +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (512), Expect = 9e-59
 Identities = 64/290 (22%), Positives = 129/290 (44%), Gaps = 37/290 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG-------LKEFKNEMMLIA 564
                + ++G+GGFG V+KG+L+ +   VA+K L     +G        +EF+ E+ +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            L H N+V+L G         ++ E++P   L   L D +    + W  +++++  IA G
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARMFCGDELQGNTKRVVG 679
           + Y+       I+HRDL++ NI L S      +  K++DFG+++     +   +   ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 680 TYGYMSPE--YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 737
            + +M+PE   A +  ++ K+D +SF ++L   LT +     +  + ++     +     
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF--DEYSYGKIKFINMIR 243

Query: 738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                   P         ++         C       RP  S +V  ++ 
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIEL-------CWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (507), Expect = 3e-58
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 570
           +  +   KL E   G ++KG+   G ++ VK L  +  S +  ++F  E   +    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 571 LVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           ++ ++G C          I  +MP  SL   L +     ++     VK    +A+G+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H    L I    L + ++++D DM  +IS   +   F        +   +    +++PE 
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178

Query: 689 ALDG----LFSVKSDVFSFGVLLLETLTSK 714
           AL           +D++SF VLL E +T +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (508), Expect = 4e-58
 Identities = 72/280 (25%), Positives = 134/280 (47%), Gaps = 27/280 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 570
              ++  ++G G FG VYKGK  +G +VAVK L+    + Q L+ FKNE+ ++ K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           ++  MG        I + ++    SL   L           +  + I    A+G+ YLH 
Sbjct: 82  ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE--- 687
                IIHRDLK++NI L  D   KI DFG+A            +++ G+  +M+PE   
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAYELLS- 745
                 +S +SDV++FG++L E +T +   + + + +          + + + + +L   
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSPDLSKV 250

Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            +   +   +++         C+++K  +RP+  ++++ I
Sbjct: 251 RSNCPKRMKRLMAE-------CLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  191 bits (487), Expect = 8e-55
 Identities = 66/285 (23%), Positives = 115/285 (40%), Gaps = 42/285 (14%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
            +G+G FG VY G+  +G EVA++ +  +  +   LK FK E+M   + +H N+V  MG 
Sbjct: 40  LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 637
           C+      +I      ++L   + D      L      +I + I +G+ YLH      I+
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA---KGIL 152

Query: 638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYMSPE------- 687
           H+DLK+ N+  D +    I+DFG+  +    +      +     G   +++PE       
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 688 --YALDGLFSVKSDVFSFGVLLLETLTSK---RNTGVYDIESFNLLGHAWNLWKDNRAYE 742
                   FS  SDVF+ G +  E    +   +      I         W +    +   
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--------IWQMGTGMKP-- 261

Query: 743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            LS     +    +L         C   +  +RPT +K++ M+  
Sbjct: 262 NLSQIGMGKEISDILLF-------CWAFEQEERPTFTKLMDMLEK 299

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (474), Expect = 3e-53
 Identities = 66/301 (21%), Positives = 119/301 (39%), Gaps = 33/301 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHR 569
             + ++   +G+G +G V++G    G+ VAVK  SS+     K +  E  +     L+H 
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62

Query: 570 NLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           N++  +   +          LI  Y    SL  +L    +   L   + ++I+  IA GL
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118

Query: 626 LYLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVV 678
            +LH        +  I HRDLK+ NIL+  +    I+D G+A M     ++L       V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 679 GTYGYMSPE------YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-----ESFNL 727
           GT  YM+PE               + D+++FG++L E      + G+ +           
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 728 LGHAWNLWKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
              ++   +     +   P +     S   L     +   C  +  + R T  ++   +T
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

Query: 787 N 787
            
Sbjct: 299 K 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 6e-53
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 35/301 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHRN 570
           +   M  ++G+G +G V+ GK   G++VAVK   +        +  E  +     ++H N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92

Query: 571 LVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           ++  +   ++         LI +Y  N SL  +L    ++  L  ++ +K+      GL 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148

Query: 627 YLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVG 679
           +LH        +  I HRDLK+ NIL+  +    I+D G+A  F    +E+       VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 680 TYGYMSPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLG 729
           T  YM PE  LD   +         +D++SFG++L E      + G+   Y +   +L+ 
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 730 H--AWNLWKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
              ++   ++    + L P+     +S + L +   +   C     A R T  +V   + 
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

Query: 787 N 787
            
Sbjct: 328 K 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (457), Expect = 2e-50
 Identities = 68/297 (22%), Positives = 126/297 (42%), Gaps = 35/297 (11%)

Query: 517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHRNLVRL 574
           +Q  +G+G FG V++GK   G+EVAVK  SS+     + +  E  +     L+H N++  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101

Query: 575 MGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +    +         L+ +Y  + SL  +L      + +  +  +K+    A GL +LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 631 -----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGY 683
                  +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 684 MSPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLGHAWN 733
           M+PE  LD   ++       ++D+++ G++  E        G+   Y +  ++L+    +
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 734 L--WKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           +   +     + L P +     S + L     +   C     A R T  ++   ++ 
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  174 bits (442), Expect = 1e-48
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 40/297 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
            +     +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 568 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           H N+V+  G C   G +   LI EY+P  SL  +L        +     ++    I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVV 678
            YL      R IHRDL   NIL++++   KI DFG+ ++   D+    ++   +      
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-- 213

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNLWKD 737
               + +PE   +  FSV SDV+SFGV+L E  T    +     E   ++G+        
Sbjct: 214 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

Query: 738 NRAYELLS-------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               ELL        P    +  Y ++         C       RP+   +   +  
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 319

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  172 bits (438), Expect = 2e-48
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 40/297 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
            +     +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 568 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           H N+V+  G C   G +   LI EY+P  SL  +L        +     ++    I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVV 678
            YL      R IHRDL   NIL++++   KI DFG+ ++   D+    ++   +      
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-- 182

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNLWKD 737
               + +PE   +  FSV SDV+SFGV+L E  T    +     E   ++G+        
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 738 NRAYELLS-------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               ELL        P    +  Y ++         C       RP+   +   +  
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 288

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  173 bits (440), Expect = 2e-48
 Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 36/294 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKL 566
                   LGEG FG V            G+ VAVK L + +G Q    +K E+ ++  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 567 QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            H ++++  GCC + G     L+ EY+P  SL  +L      H +G    +   + I +G
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGT 680
           + YLH       IHRDL A N+LLD+D   KI DFG+A+          ++ +    V  
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 201

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA 740
             + +PE   +  F   SDV+SFGV L E LT   ++     +   L+G A       R 
Sbjct: 202 -FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260

Query: 741 YELLS-------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            ELL        P       Y ++         C + +A+ RPT   ++ ++  
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLM-------KNCWETEASFRPTFENLIPILKT 307

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  174 bits (443), Expect = 4e-48
 Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 41/287 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRN 570
           E+  +  ++G G FG V+ G+L  +   VAVK    +       +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +VRL+G C ++    ++ E +       FL   +    L  +T ++++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMSPEY 688
                 IHRDL A N L+      KISDFGM+R          G  ++V     + +PE 
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR-------NTGVYD-IESFNLLGHAWNLWKDNRA 740
              G +S +SDV+SFG+LL ET +          N    + +E               + 
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE---------------KG 331

Query: 741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
             L  P L  +A ++++ +       C   +   RP+ S +   + +
Sbjct: 332 GRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  170 bits (433), Expect = 1e-47
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 34/225 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRLSSQSGQGLKEFKNEMMLIAKL 566
            +  ++ +LGEG FG V+  +  N         VAVK L   +    K+F+ E  L+  L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQT 613
           QH ++V+  G C +    I+++EYM +  LN FL                     LG   
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 670
            + I   IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R ++  D   +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191

Query: 671 QGNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            G+T    R      +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  169 bits (431), Expect = 4e-47
 Identities = 80/320 (25%), Positives = 136/320 (42%), Gaps = 39/320 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 567
            +     +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 568 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
              +V+  G     G +   L+ EY+P+  L  FL        L     +     I +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVV 678
            YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+    ++   +      
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN 738
               + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G   ++   +
Sbjct: 196 ----WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

Query: 739 RAYELLS-----PALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT 791
           R  ELL      PA        ++++        LC      DRP+ S +   +    + 
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELM-------KLCWAPSPQDRPSFSALGPQLDMLWSG 304

Query: 792 LPYPKQSAFSYARRGEKISF 811
               +  AF+    G+  S 
Sbjct: 305 SRGCETHAFTAHPEGKHHSL 324

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  168 bits (428), Expect = 1e-46
 Identities = 71/224 (31%), Positives = 108/224 (48%), Gaps = 33/224 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKEFKNEMMLIAKL 566
            +  ++ +LGEG FG V+  +  N         VAVK L   S    ++F+ E  L+  L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------------FDPSRTHLLGWQTR 614
           QH+++VR  G C E    ++++EYM +  LN FL             +      LG    
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQ 671
           + +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R ++  D   + 
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217

Query: 672 GNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           G T    R      +M PE  L   F+ +SDV+SFGV+L E  T
Sbjct: 218 GRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  167 bits (426), Expect = 1e-46
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 40/295 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKL 566
                   LGEG FG V   +        G++VAVK L  +SG   + + K E+ ++  L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 567 QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
            H N+V+  G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RV 677
           + YL      + +HRDL A N+L++S+   KI DFG+ +    D+    ++ +       
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 737
                + +PE  +   F + SDV+SFGV L E LT   +          ++G        
Sbjct: 195 -----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249

Query: 738 NRAYELL-------SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            R    L        P    +  YQ++         C + + ++R +   ++   
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQLM-------RKCWEFQPSNRTSFQNLIEGF 297

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  171 bits (435), Expect = 2e-46
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 37/285 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +   +   +G+G FG V  G    G +VAVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 573 RLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           +L+G  VE+   + ++ EYM   SL  +L    R  +LG    +K    + + + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
                +HRDL A N+L+  D   K+SDFG+ +       Q   K  V    + +PE   +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 749
             FS KSDV+SFG+LL E  +  R     +   +    +          + Y++ +P   
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------EKGYKMDAPDGC 411

Query: 750 HEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVS----MITNEH 789
             A Y  M N        C    AA RPT  ++      + T+E 
Sbjct: 412 PPAVYDVMKN--------CWHLDAATRPTFLQLREQLEHIRTHEL 448

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  171 bits (435), Expect = 5e-46
 Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 31/279 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
            + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V+L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 334

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYA 689
            +   IHR+L A N L+  +   K++DFG++R+  GD     T      +     +PE  
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 391

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
               FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P 
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPE 442

Query: 748 LQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              E  Y+ M          C Q   +DRP+ +++    
Sbjct: 443 GCPEKVYELMRA--------CWQWNPSDRPSFAEIHQAF 473

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  165 bits (420), Expect = 7e-46
 Identities = 73/226 (32%), Positives = 110/226 (48%), Gaps = 35/226 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 565
                  +LGE  FG VYKG L         Q VA+K L     G   +EF++E ML A+
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQ 612
           LQH N+V L+G   +     +I+ Y  +  L+ FL              D +    L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--E 669
             V ++  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 670 LQGNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           L GN+    R      +M+PE  + G FS+ SD++S+GV+L E  +
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  164 bits (417), Expect = 1e-45
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 25/207 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +   +   +G+G FG V  G    G +VAVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77

Query: 573 RLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           +L+G  VE+   + I  EYM   SL  +L    R+ L G    +K    + + + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 133

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMS 685
                +HRDL A N+L+  D   K+SDFG+ +    +                    + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA-------SSTQDTGKLPVKWTA 182

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   +  FS KSDV+SFG+LL E  +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  163 bits (415), Expect = 2e-45
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 29/299 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
            + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V+L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 127

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYA 689
            +   IHRDL A N L+  +   K++DFG++R+  GD     T      +     +PE  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 184

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
               FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P 
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPE 235

Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRG 806
              E  Y+++         C Q   +DRP+ +++               +      +RG
Sbjct: 236 GCPEKVYELM-------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 287

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  162 bits (413), Expect = 3e-45
 Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 47/286 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
              +   ++G G FG V+ G  LN  +VA+K +   +    ++F  E  ++ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L G C+EQ    L+ E+M +  L+ +L   ++  L   +T + +   + +G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTK---RVVGTYGYMSPE 687
              +IHRDL A N L+  +   K+SDFGM R    D+      TK   +      + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPE 175

Query: 688 YALDGLFSVKSDVFSFGVLLLETLT-------SKRNTGVYD-IESFNLLGHAWNLWKDNR 739
                 +S KSDV+SFGVL+ E  +       ++ N+ V + I                 
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---------------T 220

Query: 740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            + L  P L     YQ++         C +E+  DRP  S+++  +
Sbjct: 221 GFRLYKPRLASTHVYQIM-------NHCWRERPEDRPAFSRLLRQL 259

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  164 bits (417), Expect = 3e-45
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 29/220 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           E  +M  +LG+G FG VY+G      +      VA+K +  + S +   EF NE  ++ +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKII 618
               ++VRL+G   +    ++I E M    L  +L        +            +++ 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTK 675
             IA G+ YL   +  + +HRDL A N ++  D   KI DFGM R ++  D     G   
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 676 ---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              R      +MSPE   DG+F+  SDV+SFGV+L E  T
Sbjct: 202 LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  163 bits (416), Expect = 3e-45
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 41/300 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL--SSQSGQGLKEFKNEMMLIAKL 566
               +   LGEG FG V +G L         VAVK +   + S + ++EF +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 567 QHRNLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKII 618
            H N++RL+G C+E       + ++I  +M    L+ +L      +    +  QT +K +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTK 675
             IA G+ YL   S    +HRDL A N +L  DM   ++DFG+++ ++ GD        K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWN 733
             V    +++ E   D +++ KSDV++FGV + E  T       GV + E ++ L     
Sbjct: 211 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL----- 262

Query: 734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
                  + L  P    +  Y+++         C +    DRPT S +   +     +LP
Sbjct: 263 ----LHGHRLKQPEDCLDELYEIM-------YSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  162 bits (412), Expect = 5e-45
 Identities = 79/284 (27%), Positives = 123/284 (43%), Gaps = 43/284 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           ++ +   +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L G C +Q    +I EYM N  L  +L      H    Q  +++ + + + + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYA 689
             + +HRDL A N L++     K+SDFG++R    DE        VG+     +  PE  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVL 193

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR-------NTGVYD-IESFNLLGHAWNLWKDNRAY 741
           +   FS KSD+++FGVL+ E  +  +       N+   + I                +  
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---------------QGL 238

Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            L  P L  E  Y ++         C  EKA +RPT   ++S I
Sbjct: 239 RLYRPHLASEKVYTIM-------YSCWHEKADERPTFKILLSNI 275

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  167 bits (425), Expect = 6e-45
 Identities = 81/278 (29%), Positives = 129/278 (46%), Gaps = 31/278 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     ++   I I E+M   SL  FL     +        +     IA+G+ ++    
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---E 301

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYAL 690
           +   IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +     +PE   
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  P  
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRPEN 409

Query: 749 QHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 785
             E  Y  M+         C + +  +RPT   + S++
Sbjct: 410 CPEELYNIMMR--------CWKNRPEERPTFEYIQSVL 439

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  162 bits (412), Expect = 6e-45
 Identities = 92/278 (33%), Positives = 132/278 (47%), Gaps = 31/278 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L   S      F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL     ++   I I EYM N SL  FL  PS   L      + +   IA+G+ ++    
Sbjct: 72  RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---E 126

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYAL 690
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +     +PE   
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234

Query: 749 QHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 785
             E  YQ M          C +E+  DRPT   + S++
Sbjct: 235 CPEELYQLMRL--------CWKERPEDRPTFDYLRSVL 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  163 bits (415), Expect = 1e-44
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 43/234 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 565
            N      +GEG FG V++ +            VAVK L    S     +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 604
             + N+V+L+G C       L++EYM    LN FL                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 663
               L    ++ I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 664 MFCGD--ELQGNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           ++  D  +  GN     R      +M PE      ++ +SDV+++GV+L E  +
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  162 bits (412), Expect = 1e-44
 Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 42/307 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRL--SSQSGQGLKEFKNEMMLIAKL 566
           + F++   LG+G FG V + +L        +VAVK L     +   ++EF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 567 QHRNLVRLMGCCVEQGEKI------LIYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKI 617
            H ++ +L+G  +    K       +I  +M +  L+ FL           L  QT V+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNT 674
           +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R ++ GD       +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAW 732
           K  V    +++ E   D L++V SDV++FGV + E +T  +    G+ + E +N L    
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---- 252

Query: 733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
                     L  P    E  Y ++         C       RP+ + +   + N    L
Sbjct: 253 -----IGGNRLKQPPECMEEVYDLM-------YQCWSADPKQRPSFTCLRMELENILGHL 300

Query: 793 PYPKQSA 799
                S 
Sbjct: 301 SVLSTSQ 307

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  160 bits (408), Expect = 1e-44
 Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 33/279 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E  ++  +LG G FG V  GK     +VAVK +   S     EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +  G C ++    ++ EY+ N  L  +L   S    L     +++   + +G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYA 689
             + IHRDL A N L+D D+  K+SDFGM R    D+        VGT     + +PE  
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVF 177

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
               +S KSDV++FG+L+ E  +  +       + E    +         ++ + L  P 
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---------SQGHRLYRPH 228

Query: 748 LQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           L  +  YQ M +        C  E    RPT  +++S I
Sbjct: 229 LASDTIYQIMYS--------CWHELPEKRPTFQQLLSSI 259

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  161 bits (410), Expect = 2e-44
 Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 39/287 (13%)

Query: 520 KLGEGGFGPVYKGKLLNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
            +G G FG VY G LL+        AVK L        + +F  E +++    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 575 MGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           +G C+      L +  YM +  L  F+ + +       +  +     +A+G+ YL   + 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 146

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPE 687
            + +HRDL A N +LD     K++DFG+AR    D        V    G      +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLS 745
                 F+ KSDV+SFGVLL E +T        V   +    L          +   LL 
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRRLLQ 253

Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
           P    +  Y+++       L C   KA  RP+ S++VS I+   +T 
Sbjct: 254 PEYCPDPLYEVM-------LKCWHPKAEMRPSFSELVSRISAIFSTF 293

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  162 bits (412), Expect = 2e-44
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 566
             F     LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            + ++ RL+G C+    ++ I + MP   L  ++ +      +G Q  +     IA+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--- 683
           YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E           Y     
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179

Query: 684 ------MSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                 M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  161 bits (409), Expect = 2e-44
 Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 31/283 (10%)

Query: 520 KLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
            +G+G FG VY G+ ++  +     A+K L      Q ++ F  E +L+  L H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 575 MGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           +G  +       +   YM +  L  F+  P R      +  +     +A+G+ YL   + 
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---AE 142

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALD 691
            + +HRDL A N +LD     K++DFG+AR     E     +         + + E    
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 749
             F+ KSDV+SFGVLL E LT        +   +  + L          +   L  P   
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL---------AQGRRLPQPEYC 253

Query: 750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            ++ YQ++         C +   A RPT   +V  +    + L
Sbjct: 254 PDSLYQVM-------QQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  163 bits (415), Expect = 9e-44
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 27/276 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   +    L     V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 297

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E             + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356

Query: 693 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            F++KSDV+SFG+LL E  T  R    G+ + E  + +          R Y +  P    
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 407

Query: 751 EASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           E+ +  M          C +++  +RPT   + + +
Sbjct: 408 ESLHDLMCQ--------CWRKEPEERPTFEYLQAFL 435

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  160 bits (406), Expect = 1e-43
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL      PS+   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR-MFCGD--ELQGNTK 675
           A G  YL        IHRD+ A N LL         KI DFGMAR ++        G   
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 676 ---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              +      +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 207 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  159 bits (405), Expect = 1e-43
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 37/228 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +   +   LG G FG V +            + VAVK L    +    +   +E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 566 L-QHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-------------FDPSRTHLLG 610
           +  H N+V L+G C + G  + +I E+    +L+ +L              +      L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDE 669
            +  +     +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR ++   +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 670 LQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                      +      +M+PE   D +++++SDV+SFGVLL E  +
Sbjct: 204 YVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  159 bits (405), Expect = 1e-43
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 43/234 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +N  +   LGEG FG V K    +         VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 604
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 663
               L     +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 664 MFCGDELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           ++  D     ++     +      +M+ E   D +++ +SDV+SFGVLL E +T
Sbjct: 200 VYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  160 bits (407), Expect = 2e-43
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGI 621
             H+N+VR +G  ++   + ++ E M    L  FL      PS+   L     + +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR-MFCGD--ELQGNTK 675
           A G  YL        IHRD+ A N LL         KI DFGMAR ++        G   
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 676 ---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              +      +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  159 bits (404), Expect = 2e-43
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 38/229 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRL-SSQSGQGLKEFKNEMMLI 563
           +  ++   LGEG FG V   + +            VAVK L    + + L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 564 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLL 609
             + +H+N++ L+G C + G   +I EY    +L  +L              +      +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD 668
            ++  V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 669 ELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
             +  T      +      +M+PE   D +++ +SDV+SFGVL+ E  T
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  160 bits (407), Expect = 2e-43
 Identities = 89/383 (23%), Positives = 146/383 (38%), Gaps = 72/383 (18%)

Query: 452 RRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAK-----GTRRDSVLPCFSLA 506
              H        +   L K        T + E S             TR  S      LA
Sbjct: 4   SHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLA 63

Query: 507 SVSAAT-----------ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRL-S 546
            VS              +  ++   LGEG FG V   + +            VAVK L  
Sbjct: 64  GVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123

Query: 547 SQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----- 600
             + + L +  +EM ++  + +H+N++ L+G C + G   +I EY    +L  +L     
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183

Query: 601 --------FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 652
                    +      + ++  V     +A+G+ YL   +  + IHRDL A N+L+  + 
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENN 240

Query: 653 NPKISDFGMAR-MFCGDELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 706
             KI+DFG+AR +   D  +  T      +      +M+PE   D +++ +SDV+SFGVL
Sbjct: 241 VMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVL 294

Query: 707 LLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVA 764
           + E  T   +   G+   E F LL            + +  PA      Y M+       
Sbjct: 295 MWEIFTLGGSPYPGIPVEELFKLL---------KEGHRMDKPANCTNELYMMM------- 338

Query: 765 LLCVQEKAADRPTMSKVVSMITN 787
             C     + RPT  ++V  +  
Sbjct: 339 RDCWHAVPSQRPTFKQLVEDLDR 361

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  164 bits (417), Expect = 2e-43
 Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 27/276 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL        L     V +   IA G+ Y+    
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---E 380

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E             + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439

Query: 693 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            F++KSDV+SFG+LL E  T  R    G+ + E  + +          R Y +  P    
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 490

Query: 751 EASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           E+ +  M          C +++  +RPT   + + +
Sbjct: 491 ESLHDLMCQ--------CWRKEPEERPTFEYLQAFL 518

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  158 bits (402), Expect = 4e-43
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 34/223 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKL-Q 567
            +   Q  +GEG FG V K ++         A+KR+    S    ++F  E+ ++ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQTR 614
           H N++ L+G C  +G   L  EY P+ +L  FL                S    L  Q  
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +     +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R    +     T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKT 199

Query: 675 K-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                 R      +M+ E     +++  SDV+S+GVLL E ++
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  158 bits (401), Expect = 5e-43
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKL 566
                   LG G FG V+KG  +   E     V +K +  +SG Q  +   + M+ I  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H ++VRL+G C     ++ + +Y+P  SL   +        LG Q  +     IA+G+ 
Sbjct: 73  DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMY 129

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL---QGNTKRVVGTYGY 683
           YL       ++HR+L A N+LL S    +++DFG+A +   D+        K  +    +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KW 183

Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           M+ E    G ++ +SDV+S+GV + E +T
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  159 bits (404), Expect = 6e-43
 Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 31/283 (10%)

Query: 520 KLGEGGFGPVYKGKLLNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
            +G G FG VY G LL+        AVK L        + +F  E +++    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 575 MGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           +G C+      L +  YM +  L  F+ + +       +  +     +A+G+ +L   + 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 210

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALD 691
            + +HRDL A N +LD     K++DFG+AR     E      +        +M+ E    
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 749
             F+ KSDV+SFGVLL E +T        V   +    L          +   LL P   
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRRLLQPEYC 321

Query: 750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
            +  Y+++       L C   KA  RP+ S++VS I+   +T 
Sbjct: 322 PDPLYEVM-------LKCWHPKAEMRPSFSELVSRISAIFSTF 357

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  157 bits (399), Expect = 9e-43
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 567
               ++  +G G  G V  G+L         VA+K L +  + +  ++F +E  ++ +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N++RL G        +++ EYM N SL+ FL              V ++ G+  G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG----- 682
           L   S L  +HRDL A N+L+DS++  K+SDFG++R      L+ +      T G     
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-----VLEDDPDAAYTTTGGKIPI 218

Query: 683 -YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            + +PE      FS  SDV+SFGV++ E L 
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  156 bits (396), Expect = 3e-42
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 14/208 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 566
              + Q  +G G FG VYKG L          VA+K L +  + +   +F  E  ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N++RL G   +    ++I EYM N +L+ FL +            V ++ GIA G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 161

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--M 684
           YL   + +  +HRDL A NIL++S++  K+SDFG++R    D+ +       G       
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +PE      F+  SDV+SFG+++ E +T
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  156 bits (396), Expect = 3e-42
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 565
            N      LG G FG V +       +      VAVK L S+      +   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHLLGWQT 613
           L QH N+V L+G C   G  ++I EY     L  FL                      + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDE--L 670
            +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR +       +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +
Sbjct: 223 KGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  155 bits (394), Expect = 5e-42
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 566
             F     LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            + ++ RL+G C+    ++ I + MP   L  ++ +      +G Q  +     IA+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--- 683
           YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E           Y     
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179

Query: 684 ------MSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                 M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  154 bits (391), Expect = 5e-42
 Identities = 65/213 (30%), Positives = 90/213 (42%), Gaps = 24/213 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRL---SSQSGQGLKEFKNEMMLIAK 565
           ++  +  KLG+G FG V +G+          VAVK L        + + +F  E+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L HRNL+RL G  +    K+ + E  P  SL   L            T  +    +A+G+
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 134

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG--- 682
            YL      R IHRDL A N+LL +    KI DFG+ R      L  N    V       
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA-----LPQNDDHYVMQEHRKV 186

Query: 683 ---YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              + +PE      FS  SD + FGV L E  T
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  156 bits (397), Expect = 6e-42
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 51/264 (19%)

Query: 490 DAKGTRRDSVLPCFSLASVSAAT-----------ENFSMQCKLGEGGFGPVYKGKLLN-- 536
           D      +++     LA VS              +   +   LGEG FG V   + +   
Sbjct: 35  DYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD 94

Query: 537 ------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 588
                   +VAVK L S  + + L +  +EM ++  + +H+N++ L+G C + G   +I 
Sbjct: 95  KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154

Query: 589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------------IAQGLLYLHQYSRL 634
           EY    +L  +L    R   L +                       +A+G+ YL   +  
Sbjct: 155 EYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASK 210

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTK---RVVGTYGYMSPEY 688
           + IHRDL A N+L+  D   KI+DFG+AR +   D  +   N +   +      +M+PE 
Sbjct: 211 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEA 264

Query: 689 ALDGLFSVKSDVFSFGVLLLETLT 712
             D +++ +SDV+SFGVLL E  T
Sbjct: 265 LFDRIYTHQSDVWSFGVLLWEIFT 288

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  154 bits (392), Expect = 6e-42
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 38/229 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 565
              S    LG G FG V +       +      VAVK L  S      +   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG---- 620
           L  H N+V L+G C   G  ++I EY     L  FL     + +    +   + +     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 621 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD 668
                      +A+G+ +L   +    IHRDL A NILL      KI DFG+AR +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 669 ELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                       +      +M+PE   + +++ +SDV+S+G+ L E  +
Sbjct: 200 NYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  153 bits (389), Expect = 8e-42
 Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 38/222 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKL--------LNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
           E+      LG+G F  ++KG          L+  EV +K L        + F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
           KL H++LV   G CV   E IL+ E++   SL+ +L        + W+  +++ + +A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--------KISDFGMARMFCGDELQGNTKR 676
           + +L       +IH ++ A NILL  + +         K+SD G++      +       
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 677 VVGTYGY-----MSPEYALDG-LFSVKSDVFSFGVLLLETLT 712
                       + PE   +    ++ +D +SFG  L E  +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  153 bits (389), Expect = 9e-42
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 19/205 (9%)

Query: 517 MQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLV 572
              +LG G FG V +G     ++   VA+K L         +E   E  ++ +L +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 573 RLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           RL+G C  Q E +++  E      L+ FL        +      +++  ++ G+ YL   
Sbjct: 74  RLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL--- 126

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL----QGNTKRVVGTYGYMSPE 687
                +HRDL A N+LL +    KISDFG+++    D+     +   K  +    + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183

Query: 688 YALDGLFSVKSDVFSFGVLLLETLT 712
                 FS +SDV+S+GV + E L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  153 bits (388), Expect = 1e-41
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 567
           E   +   +GEG FG V++G  ++ +     VA+K   +  S    ++F  E + + +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H ++V+L+G   E    I I E      L  FL    R + L   + +     ++  L Y
Sbjct: 75  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMS 685
           L      R +HRD+ A N+L+ S+   K+ DFG++R             K  +    +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE      F+  SDV+ FGV + E L 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  152 bits (386), Expect = 2e-41
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 567
           E+  +   LGEG FG VY+G   N +     VAVK      +    ++F +E +++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H ++V+L+G   E+   I I E  P   L  +L     +  L   T V     I + + Y
Sbjct: 72  HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAY 128

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMS 685
           L     +  +HRD+   NIL+ S    K+ DFG++R    ++     K  V      +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMS 182

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE      F+  SDV+ F V + E L+
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  154 bits (392), Expect = 3e-41
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 25/213 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 567
            N S+   +G G FG V  G+L    +    VA+K L    + +  ++F  E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGL 625
           H N++RL G   +    +++ EYM N SL+ FL    R H         V ++ GIA G+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGM 160

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG--- 682
            YL   S +  +HRDL A NIL++S++  K+SDFG+ R      L+ + +    T G   
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKI 212

Query: 683 ---YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              + SPE      F+  SDV+S+G++L E ++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  152 bits (385), Expect = 3e-41
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 520 KLGEGGFGPVYKGKLLNG---QEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG        + VAVK L   +       E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 575 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           +G C  + E   L+ E      LN +L        +  +  ++++  ++ G+ YL     
Sbjct: 84  IGIC--EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EE 135

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVVGTYGYMSP 686
              +HRDL A N+LL +    KISDFG+++    DE     Q + K   +      + +P
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK------WYAP 189

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E      FS KSDV+SFGVL+ E  +
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  152 bits (385), Expect = 1e-40
 Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 43/234 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 565
           EN      LG G FG V         +      VAVK L         +   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKII 618
           L  H N+V L+G C   G   LI+EY     L  +L      F          +   +  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 619 EG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 663
           +               +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 664 MFCGDELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +                +      +M+PE   +G++++KSDV+S+G+LL E  +
Sbjct: 222 IMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  155 bits (394), Expect = 1e-39
 Identities = 77/341 (22%), Positives = 130/341 (38%), Gaps = 26/341 (7%)

Query: 388 GGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALLPGFFI 447
           G     L  F  +  I+     +  +   +++  +   + L      L +   +      
Sbjct: 257 GANPTHLADFNQVQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDG 316

Query: 448 FCR---------WRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDS 498
           +CR           R  KE E  + S   L   +    V + T   SE D  A+    + 
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNE-KQGVRSHTVSVSETDDYAEIIDEED 375

Query: 499 VLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGL 553
                S        E   +   +GEG FG V++G  ++ +     VA+K   +  S    
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435

Query: 554 KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT 613
           ++F  E + + +  H ++V+L+G   E    I I E      L  FL    R   L   +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLAS 492

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQ 671
            +     ++  L YL      R +HRD+ A N+L+ S+   K+ DFG++R          
Sbjct: 493 LILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549

Query: 672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              K  +    +M+PE      F+  SDV+ FGV + E L 
Sbjct: 550 SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  153 bits (387), Expect = 4e-39
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 517 MQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLV 572
              +LG G FG V +G     ++   VA+K L         +E   E  ++ +L +  +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL+G C  +   + + E      L+ FL        +      +++  ++ G+ YL    
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---E 453

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEY 688
               +HR+L A N+LL +    KISDFG+++    D+     +   K  +    + +PE 
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510

Query: 689 ALDGLFSVKSDVFSFGVLLLETLT 712
                FS +SDV+S+GV + E L+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (364), Expect = 2e-38
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 28/217 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
            +F     +G GGFG V+K K  ++G+   +KR+   +    ++ + E+  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 572 VRLMGCCVEQGEKI----------------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 615
           V   GC                        +  E+    +L  ++ +  R   L     +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
           ++ E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D   G   
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179

Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           R  GT  YMSPE      +  + D+++ G++L E L 
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  143 bits (363), Expect = 3e-38
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 27/221 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
            +F     LG GGFG V++ K  ++    A+KR+         ++   E+  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 571 LVRLMGCCVE---------QGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           +VR     +E            K+ +Y   +    ++L  ++              + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV- 677
             IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      DE +       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 678 ---------VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
                    VGT  YMSPE      +S K D+FS G++L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (362), Expect = 1e-37
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 9/206 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           E +    K+GEG FG     K   +G++  +K   +S  S +  +E + E+ ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+      E G   ++ +Y     L F   +  +  L      +     I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
                +I+HRD+K+ NI L  D   ++ DFG+AR+             +GT  Y+SPE  
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR 715
            +  ++ KSD+++ G +L E  T K 
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH 223

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  141 bits (358), Expect = 2e-37
 Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 28/288 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQH 568
            NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLY 627
            N+++     +E  E  ++ E      L+  +    +   L  +  V K    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           +H     R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT  YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA---YELL 744
              +  ++ KSD++S G LL E    +     +  +  NL      + + +      +  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263

Query: 745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 792
           S  L+             +  +C+      RP ++ V  +    HA  
Sbjct: 264 SEELRQ------------LVNMCINPDPEKRPDVTYVYDVAKRMHACT 299

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  140 bits (356), Expect = 3e-37
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
             +F     LG+G FG V K +  L+ +  A+K++     + L    +E+ML+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVKIIE 619
           +VR     +E+   +     +  KS  F          L+D   S           ++  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF------------CG 667
            I + L Y+H      IIHRDLK  NI +D   N KI DFG+A+                
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 668 DELQGNTKRVVGTYGYMSPE-YALDGLFSVKSDVFSFGVLLLE 709
                N    +GT  Y++ E     G ++ K D++S G++  E
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (354), Expect = 4e-37
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           ++G G F  VYKG       EVA    +    +    + FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 577 CCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
                 +     +L+ E M + +L  +L    R  ++  +        I +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148

Query: 633 RLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
              IIHRDLK  NI +     + KI D G+A +          K V+GT  +M+PE   +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204

Query: 692 GLFSVKSDVFSFGVLLLETLTSK 714
             +    DV++FG+ +LE  TS+
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (346), Expect = 4e-36
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 10/211 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           E++ +   +G G +G   K +   +G+ +  K     S +    +   +E+ L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 570 NLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLL 626
           N+VR     +++    L  + EY     L   +   ++      +  V +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 627 YLHQ--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
             H+       ++HRDLK +N+ LD   N K+ DFG+AR+   D     T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSKR 715
           SPE      ++ KSD++S G LL E      
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  137 bits (347), Expect = 7e-36
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 23/217 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 570
             +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 571 L--VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
              +RL    +      ++ E   N  LN +L    +  +  W+ +    + + + +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 143

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE- 687
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT  YM PE 
Sbjct: 144 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 688 ----------YALDGLFSVKSDVFSFGVLLLETLTSK 714
                            S KSDV+S G +L      K
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (345), Expect = 7e-36
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
           LG+G +G VY G+ L N   +A+K +  +  +  +    E+ L   L+H+N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 580 EQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
           E    I I+ E +P  SL+  L           QT     + I +GL YLH     +I+H
Sbjct: 90  E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 639 RDLKASNILLDSDM-NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE---YALDGLF 694
           RD+K  N+L+++     KISDFG ++      +   T+   GT  YM+PE       G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDKGPRG-Y 202

Query: 695 SVKSDVFSFGVLLLETLTSKR 715
              +D++S G  ++E  T K 
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (351), Expect = 9e-36
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRNL--VRLM 575
           ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ  +   +RL 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
              +      ++ E   N  LN +L    +  +  W+ +      + + +  +HQ+    
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKN-MLEAVHTIHQH---G 175

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE-------- 687
           I+H DLK +N L+  D   K+ DFG+A     D         VG   YM PE        
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 688 ---YALDGLFSVKSDVFSFGVLLLETLTSK 714
                     S KSDV+S G +L      K
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  136 bits (345), Expect = 2e-35
 Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 23/217 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 570
             +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 571 L--VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
              +RL    +      ++ E   N  LN +L    +   +    R    + + + +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE- 687
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT  YM PE 
Sbjct: 125 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 688 ----------YALDGLFSVKSDVFSFGVLLLETLTSK 714
                            S KSDV+S G +L      K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (340), Expect = 6e-35
 Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 29/221 (13%)

Query: 508 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL 566
           V    +++    KLGEGGF  V   + L +G   A+KR+     Q  +E + E  +    
Sbjct: 24  VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83

Query: 567 QHRNLVRLMGCCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGI 621
            H N++RL+  C+ +        L+  +    +L   +         L     + ++ GI
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-------ELQGNT 674
            +GL  +H        HRDLK +NILL  +  P + D G     C             + 
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 675 KRVVGTYGYMSPEYALDGLFSV--------KSDVFSFGVLL 707
                T  Y +PE     LFSV        ++DV+S G +L
Sbjct: 201 AAQRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVL 236

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (339), Expect = 8e-35
 Identities = 54/216 (25%), Positives = 80/216 (37%), Gaps = 26/216 (12%)

Query: 509 SAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 565
           S   ++F    +LG G +G V+K     +G+  AVK      +  +       E+    K
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKII 618
           + QH   VRL     E G   L  E     SL             ++             
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD------ 165

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
                 L +LH      ++H D+K +NI L      K+ DFG+     G    G      
Sbjct: 166 --TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QE 217

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           G   YM+PE  L G +   +DVFS G+ +LE   + 
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  132 bits (333), Expect = 6e-34
 Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 29/251 (11%)

Query: 476 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 534
           S + +         D +G      L               + Q ++G G FG V++ K  
Sbjct: 22  SGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80

Query: 535 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY-EYMPN 593
             G + AVK++  +  +       E++  A L    +V L G   E G  + I+ E +  
Sbjct: 81  QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEG 134

Query: 594 KSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 648
            SL   +         R         +  +    +GL YLH     RI+H D+KA N+LL
Sbjct: 135 GSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT---RRILHGDVKADNVLL 183

Query: 649 DSDMNP-KISDFGMARMFCGDELQGNTKR---VVGTYGYMSPEYALDGLFSVKSDVFSFG 704
            SD +   + DFG A     D L  +      + GT  +M+PE  +      K D++S  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 705 VLLLETLTSKR 715
            ++L  L    
Sbjct: 244 CMMLHMLNGCH 254

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (324), Expect = 4e-33
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 575
           KLG GG   VY  +  +   +VA+K +     +    LK F+ E+   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
               E     L+ EY+   +L+ ++        L   T +     I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
           I+HRD+K  NIL+DS+   KI DFG+A+    +     T  V+GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 696 VKSDVFSFGVLLLETLT 712
             +D++S G++L E L 
Sbjct: 191 ECTDIYSIGIVLYEMLV 207

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (322), Expect = 9e-33
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE++++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V  +   +   E  ++ EY+   SL     D      +       +     Q L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
               ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT  +M+PE 
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 689 ALDGLFSVKSDVFSFGVLLLE 709
                +  K D++S G++ +E
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIE 208

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 9e-33
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 15/228 (6%)

Query: 486 EGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKR 544
           E + D +  +R                ++F    +LG G  G V+K     +G  +A K 
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65

Query: 545 LSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 603
           +  +       +   E+ ++ +     +V   G     GE  +  E+M   SL+  L   
Sbjct: 66  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125

Query: 604 SRT--HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 661
            R    +LG     K+   + +GL YL    + +I+HRD+K SNIL++S    K+ DFG+
Sbjct: 126 GRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           +      +   N+   VGT  YMSPE      +SV+SD++S G+ L+E
Sbjct: 179 SGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 1e-32
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 24/221 (10%)

Query: 509 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKL 566
           S +   + +   LG+G    V++G+    G   A+K  +     + +     E  ++ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 567 QHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
            H+N+V+L     E+          E+ P  SL   L +PS  + L     + ++  +  
Sbjct: 65  NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 624 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    DE       + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177

Query: 680 TYGYMSPE--------YALDGLFSVKSDVFSFGVLLLETLT 712
           T  Y+ P+              +    D++S GV      T
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 1e-32
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 12/210 (5%)

Query: 507 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLI 563
           S+    ++     +LG G +G V K + + +GQ +AVKR+ +    Q  K    ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
             +     V   G    +G+  +  E M      F+     +   +      KI   I +
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
            L +LH  S+L +IHRD+K SN+L+++    K+ DFG++     D++  +     G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDI--DAGCKPY 175

Query: 684 MSPE----YALDGLFSVKSDVFSFGVLLLE 709
           M+PE          +SVKSD++S G+ ++E
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIE 205

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (322), Expect = 2e-32
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 30/209 (14%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
                   K+GEG  G V   +   +G++VAVK +  +  Q  +   NE++++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA------- 622
           +V +    +   E  ++ E++   +L         T ++   ++V++ E  IA       
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL---------TDIV---SQVRLNEEQIATVCEAVL 151

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 680
           Q L YLH      +IHRD+K+ +ILL  D   K+SDFG    FC    +   KR  +VGT
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGT 204

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
             +M+PE     L++ + D++S G++++E
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIE 233

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (320), Expect = 3e-32
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQH 568
             +     LG+GGF   ++       +  A K +  S       +E    E+ +   L H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 569 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           +++V   G   E  + + ++ E    +SL        R  L   + R   +  I  G  Y
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQY 156

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSP 686
           LH+    R+IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++P
Sbjct: 157 LHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAP 210

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSK 714
           E       S + DV+S G ++   L  K
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (323), Expect = 4e-32
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 24/221 (10%)

Query: 509 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKL 566
           S +   + +   LG+G    V++G+    G   A+K  +     + +     E  ++ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 567 QHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
            H+N+V+L     E+          E+ P  SL   L +PS  + L     + ++  +  
Sbjct: 65  NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 624 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    DE       + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177

Query: 680 TYGYMSPE--------YALDGLFSVKSDVFSFGVLLLETLT 712
           T  Y+ P+              +    D++S GV      T
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  125 bits (317), Expect = 4e-32
 Identities = 50/236 (21%), Positives = 89/236 (37%), Gaps = 34/236 (14%)

Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQGLKEFKNEM 560
           ++   S  T  F    K+G G FG V+K  K L+G   A+KR           +    E+
Sbjct: 2   AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61

Query: 561 MLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 619
              A L QH ++VR      E    ++  EY    SL   + +  R      +  +K + 
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 620 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-------------------KISDF 659
             + +GL Y+H    + ++H D+K SNI +     P                   KI D 
Sbjct: 122 LQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 660 GMARMFCGDELQGNTKRVVGTYGYMSPE-YALDGLFSVKSDVFSFGVLLLETLTSK 714
           G            + +   G   +++ E    +     K+D+F+  + ++    ++
Sbjct: 179 GHVTRI------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (332), Expect = 5e-32
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 17/210 (8%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNL 571
            + M+ +LG GGFG V +      G++VA+K+   +     +E +  E+ ++ KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 572 VRL------MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           V        +         +L  EY     L  +L        L       ++  I+  L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 626 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
            YLH+    RIIHRDLK  NI+L      +  KI D G A+     EL       VGT  
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQ 188

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           Y++PE      ++V  D +SFG L  E +T
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (316), Expect = 5e-32
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 16/200 (8%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMG 576
           LG+GGF   ++       +  A K +  S       +E    E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 577 CCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
              E  + + ++ E    +SL        R  L   + R   +  I  G  YLH   R R
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLH---RNR 135

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLF 694
           +IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGH 192

Query: 695 SVKSDVFSFGVLLLETLTSK 714
           S + DV+S G ++   L  K
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (331), Expect = 9e-32
 Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 24/204 (11%)

Query: 520 KLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL-- 574
            +  GG G +Y      +NG+ V +K L        +     E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 575 MGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                ++    + Y   EY+  +SL            L     +  +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
             + +++ DLK  NI+L  +   K+ D G            +   + GT G+ +PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVRT 251

Query: 692 GLFSVKSDVFSFGVLLLETLTSKR 715
           G  +V +D+++ G  L        
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLP 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  124 bits (313), Expect = 2e-31
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 575
            LG GG   V+  + L + ++VAVK L +   +       F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 576 GCCVEQGEKILIY----EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
                +     +     EY+   +L   +        +  +  +++I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-NTKRVVGTYGYMSPEYAL 690
            +  IIHRD+K +NI++ +    K+ DFG+AR           T  V+GT  Y+SPE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
                 +SDV+S G +L E LT + 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  123 bits (310), Expect = 3e-31
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 17/206 (8%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            E + +  +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L+G     G+  ++ E+ P  +++  +       L   Q +V +   + + L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPE- 687
               RIIHRDLKA N+L+  + + +++DFG         L+   KR   +GT  +M+PE 
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEV 188

Query: 688 ----YALDGLFSVKSDVFSFGVLLLE 709
                  D  +  K+D++S G+ L+E
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIE 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (310), Expect = 4e-31
 Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 11/197 (5%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 575
            +G GG G VY+ +  +  + VA+K +S             + E     +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
                 G+  +    +    L   L    R   L     V I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 695
             HRD+K  NIL+ +D    + DFG+A     DE        VGT  YM+PE   +   +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 696 VKSDVFSFGVLLLETLT 712
            ++D+++   +L E LT
Sbjct: 214 YRADIYALTCVLYECLT 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (317), Expect = 5e-31
 Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 27/213 (12%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAKLQHRNLV 572
           +F  +  LG G  G +    + + ++VAVKR+  +          E+ +L    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 573 RLMGCCVEQGEKI--LIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 628
           R    C E+  +   +  E          L +    +         + +++    GL +L
Sbjct: 82  RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 629 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMARMFCGDEL-QGNTKRVVGTYG 682
           H    L I+HRDLK  NIL+        +   ISDFG+ +              V GT G
Sbjct: 135 HS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 683 YMSPEY---ALDGLFSVKSDVFSFGVLLLETLT 712
           +++PE          +   D+FS G +    ++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  123 bits (310), Expect = 7e-31
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 15/206 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLIAKLQHR 569
           E+     ++G G +G V K     +GQ +AVKR+ S    +  K+   ++ +++      
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KIIEGIAQGLLY 627
            +V+  G    +G+  +  E M + S + F               +  KI     + L +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           L     L+IIHRD+K SNILLD   N K+ DFG++        +       G   YM+PE
Sbjct: 141 LK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPE 195

Query: 688 ----YALDGLFSVKSDVFSFGVLLLE 709
                A    + V+SDV+S G+ L E
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYE 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (308), Expect = 9e-31
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 14/201 (6%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            E F +  KLGEG +G VYK      GQ VA+K++  +    L+E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+  G   +  +  ++ EY    S++  +       L   +    I++   +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 688
              +R IHRD+KA NILL+++ + K++DFG      G       KR  V+GT  +M+PE 
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPEV 196

Query: 689 ALDGLFSVKSDVFSFGVLLLE 709
             +  ++  +D++S G+  +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (303), Expect = 2e-30
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 15/206 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQH 568
           E+F +   LG+G F  VY+ + +  G EVA+K +   +    G+ +  +NE+ +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 569 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
            +++ L     E    + L+ E   N  +N +L +  +      + R   +  I  G+LY
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEAR-HFMHQIITGMLY 127

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSP 686
           LH +    I+HRDL  SN+LL  +MN KI+DFG+A      ++       + GT  Y+SP
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL---KMPHEKHYTLCGTPNYISP 181

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E A      ++SDV+S G +    L 
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLI 207

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 3e-30
 Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 33/217 (15%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 577
            L EGGF  VY+ + + +G+E A+KRL S   +  +    E+  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 578 CVEQGEK-------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
                E+        L+   +    L  FL        L   T +KI     + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR----------VVGT 680
             +  IIHRDLK  N+LL +    K+ DFG A           + +             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 681 YGYMSPEYALDGLFSV--------KSDVFSFGVLLLE 709
             Y +PE     +  +        K D+++ G +L  
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYL 245

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (304), Expect = 3e-30
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 15/202 (7%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 569
            E F+   K+G+G FG V+KG      + VA+K +  +  +  +++ + E+ ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            + +  G  ++  +  +I EY+   S      D      L       I+  I +GL YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPE 687
                + IHRD+KA+N+LL      K++DFG      G       KR   VGT  +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGTPFWMAPE 189

Query: 688 YALDGLFSVKSDVFSFGVLLLE 709
                 +  K+D++S G+  +E
Sbjct: 190 VIKQSAYDSKADIWSLGITAIE 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (302), Expect = 6e-30
 Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 20/213 (9%)

Query: 507 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLI 563
              A   +     ++G G  G V+K +    G  +AVK++      +  K    ++ +++
Sbjct: 19  RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGI 621
                  +V+  G  +   +  +  E M   +              +LG     K+   I
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAI 133

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
            + L YL    +  +IHRD+K SNILLD     K+ DFG++     D+   +     G  
Sbjct: 134 VKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDR--SAGCA 188

Query: 682 GYMSPE-----YALDGLFSVKSDVFSFGVLLLE 709
            YM+PE           + +++DV+S G+ L+E
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (300), Expect = 2e-29
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 37/227 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-----------------SQSGQGLKE 555
            ++ +   L +G F  +   +  + +  A+K+                           +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 556 FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLG 610
           FKNE+ +I  +++   +   G      E  +IYEYM N S+      FF+ D + T  + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
            Q    II+ +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 671 QGNTKRVVGTYGYMSPE-----YALDGLFSVKSDVFSFGVLLLETLT 712
           +G      GTY +M PE      + +G    K D++S G+ L     
Sbjct: 208 KG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFY 247

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  117 bits (295), Expect = 4e-29
 Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 34/190 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
           ENF    K+GEG +G VYK +  L G+ VA+K++       L             E+ L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPN------KSLNFFLFDPSRTHLLGWQTRVKI 617
            +L H N+V+L+     + +  L++E++         +               +Q     
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 677
              + QGL + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  V
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164

Query: 678 VGTYGYMSPE 687
           V T  Y +PE
Sbjct: 165 V-TLWYRAPE 173

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 7e-29
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           +++ +Q  +G G    V         ++VA+KR++  +    + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA------- 622
           +V      V + E  L+ + +   S+   +         G      + E  IA       
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVL 131

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARMFCGDELQGNTKR--VVG 679
           +GL YLH   +   IHRD+KA NILL  D + +I+DFG+ A +  G ++  N  R   VG
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 680 TYGYMSPEYALDGL-FSVKSDVFSFGVLLLE 709
           T  +M+PE       +  K+D++SFG+  +E
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  118 bits (298), Expect = 1e-28
 Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 38/223 (17%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAKLQHRNLVRLMGCC 578
            LG G  G V       G+ VAVKR+             E+ +L     H N++R    C
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76

Query: 579 VEQGEK--ILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
            E  ++   +  E   N +L   +           L      + ++  IA G+ +LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133

Query: 633 RLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKRV 677
            L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N    
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 678 VGTYGYMSPEYALDGLFSV-------KSDVFSFGVLLLETLTS 713
            GT G+ +PE   +              D+FS G +    L+ 
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  116 bits (293), Expect = 2e-28
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 567
            + FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N ++  GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      +IHRD+KA NILL      K+ DFG            N+   VGT  +M+PE
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--FVGTPYWMAPE 220

Query: 688 ---YALDGLFSVKSDVFSFGVLLLE 709
                 +G +  K DV+S G+  +E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (289), Expect = 2e-28
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 34/218 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
           + +    K+GEG +G V+K K     + VA+KR+       L +           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKII 618
            +L+H+N+VRL        +  L++E+     K          DP       +Q      
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             + +GL + H      ++HRDLK  N+L++ +   K+++FG+AR F G  ++  +  VV
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163

Query: 679 GTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKR 715
            T  Y  P+      L+S   D++S G +  E   + R
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (293), Expect = 2e-28
 Identities = 23/241 (9%), Positives = 53/241 (21%), Gaps = 45/241 (18%)

Query: 508 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLI 563
           +S       +   L  G    V+  + +   ++ A+K     +  S   L+         
Sbjct: 57  LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116

Query: 564 AKLQHRNLVRLMGCC--------------------------VEQGEKILIYEYMP---NK 594
           A+L   +                                        +L+          
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176

Query: 595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 654
             +   F        G      +   + +    L       ++H      N+ +  D   
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRL 233

Query: 655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETL 711
            + D             G            +P   L+     F+   + +  G+ +    
Sbjct: 234 MLGDVSALW------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 712 T 712
            
Sbjct: 288 C 288

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (288), Expect = 2e-28
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQ 567
           E+F +   LG+G FG VY  +   +   +A+K L      ++G    + + E+ + + L+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 622
           H N++RL G   +     LI EY P  ++   L     FD  RT           I  +A
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELA 119

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTY 681
             L Y H     R+IHRD+K  N+LL S    KI+DFG +          + +  + GT 
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-----APSSRRTDLCGTL 171

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            Y+ PE     +   K D++S GVL  E L 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (294), Expect = 2e-28
 Identities = 45/226 (19%), Positives = 82/226 (36%), Gaps = 32/226 (14%)

Query: 504 SLASVSAATENFSMQCKLGEG--GFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKN 558
            ++S       + +   +G+G      V   +    G+ V V+R  L + S + +   + 
Sbjct: 16  GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 559 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
           E+ +     H N+V      +   E  ++  +M   S            L+       + 
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA---------KDLICTHFMDGMN 126

Query: 619 EG-IA-------QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           E  IA       + L Y+H    +  +HR +KAS+IL+  D    +S             
Sbjct: 127 ELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 671 QGNT-----KRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLE 709
           +        K  V    ++SPE     L  +  KSD++S G+   E
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  115 bits (290), Expect = 2e-28
 Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 32/188 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 564
           E +    K+GEG +G VYK K   G+ VA+KR+       L             E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIE 619
           +L H N+V L+     +    L++E+M    K +   N      S+  +  +Q       
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
            + +G+ + HQ+   RI+HRDLK  N+L++SD   K++DFG+AR F G  ++  T  VV 
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV- 181

Query: 680 TYGYMSPE 687
           T  Y +P+
Sbjct: 182 TLWYRAPD 189

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (294), Expect = 3e-28
 Identities = 31/231 (13%), Positives = 64/231 (27%), Gaps = 43/231 (18%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-------- 568
           LG+       +      G+   V             +K+ K E++ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 569 --------RNLVRLMGCC-----VEQGEKILIYEY---MP-----NKSLNFFLFDPSRTH 607
                    +LV+                + +       P      ++    L   S TH
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 608 -LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
             L    R+++   + + L  LH      ++H  L+  +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261

Query: 667 GDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLT 712
           G        R        +            L +   D ++ G+ +     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (289), Expect = 7e-28
 Identities = 32/222 (14%), Positives = 65/222 (29%), Gaps = 22/222 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 565
           ++   +   LGEG F  VY+          N Q+  +K     +          M  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQ 623
                 ++     + Q   +L+ E     +L   +  +  +   ++     +     +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 624 GLLYLHQYSRLRIIHRDLKASNILL-----------DSDMNPKISDFGMARMFCGDELQG 672
            +  +H      IIH D+K  N +L           D      + D G +          
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
                  T G+   E   +  ++ + D F     +   L   
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (295), Expect = 8e-28
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 568
           +E +    KLG G +G V   +  +   E A+K +  +S S     +   E+ ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 626
            N+++L     ++    L+ E      L    FD    R           II+ +  G+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150

Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           YLH+     I+HRDLK  N+LL+S   D   KI DFG++ +F   +     K  +GT  Y
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204

Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           ++PE  L   +  K DV+S GV+L
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (293), Expect = 1e-27
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 567
           ++ +  Q  LG+G FG V   K  + GQE AVK +S    +     +    E+ L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGL 625
           H N+++L     ++G   L+ E      L    FD   SR          +II  +  G+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139

Query: 626 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
            Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   +     K  +GT  
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLL 707
           Y++PE  L G +  K DV+S GV+L
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVIL 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  113 bits (285), Expect = 1e-27
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 33/194 (17%)

Query: 510 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-----LKEFKNEMMLI 563
           +++  F    KLG G +  VYKG     G  VA+K +   S +G     ++E      L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYM----------PNKSLNFFLFDPSRTHLLGWQT 613
            +L+H N+VRL      + +  L++E+M                    + +      WQ 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 673
                  + QGL + H+    +I+HRDLK  N+L++     K+ DFG+AR F G  +   
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165

Query: 674 TKRVVGTYGYMSPE 687
           +  VV T  Y +P+
Sbjct: 166 SSEVV-TLWYRAPD 178

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  116 bits (292), Expect = 2e-27
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 20/204 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 568
            E +++ C LG+G FG V K K  +  QE AVK +  +S   +       E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 626
            N+++L     +     ++ E      L    FD    R          +II+ +  G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135

Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           Y+H+     I+HRDLK  NILL+S   D + KI DFG++  F  +      K  +GT  Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189

Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (282), Expect = 2e-27
 Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 32/188 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 564
           E +    K+GEG +G VYK +   G+  A+K++       L++           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIE 619
           +L+H N+V+L      +   +L++E++    K L        +         Q       
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
            +  G+ Y H     R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  +V 
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV- 162

Query: 680 TYGYMSPE 687
           T  Y +P+
Sbjct: 163 TLWYRAPD 170

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  112 bits (282), Expect = 4e-27
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 24/191 (12%)

Query: 508 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKN----EMM 561
           V +  + +     LGEG F  VYK +     Q VA+K++        K+        E+ 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVK 616
           L+ +L H N++ L+     +    L++++M    + +   N  +  PS            
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM---- 120

Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
                 QGL YLHQ+    I+HRDLK +N+LLD +   K++DFG+A+ F G   +  T +
Sbjct: 121 ----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQ 172

Query: 677 VVGTYGYMSPE 687
           VV T  Y +PE
Sbjct: 173 VV-TRWYRAPE 182

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (280), Expect = 5e-27
 Identities = 59/263 (22%), Positives = 88/263 (33%), Gaps = 66/263 (25%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
            +F     +G GGFG V++ K  ++    A+KR+         ++   E+  +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI------------- 617
           +VR     +E   +    E       +     P  +        VKI             
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 618 --IEGIAQGLLY----------LHQYSRLR-----------------------------I 636
                  +  LY          L  +   R                             +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK----------RVVGTYGYMSP 686
           +HRDLK SNI    D   K+ DFG+      DE +                VGT  YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 687 EYALDGLFSVKSDVFSFGVLLLE 709
           E      +S K D+FS G++L E
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFE 268

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (278), Expect = 6e-27
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 20/204 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 568
            E +++ C LG+G FG V K K  +  QE AVK +  +S   +       E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 626
            N+++L     +     ++ E      L    FD    R          +II+ +  G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135

Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           Y+H+     I+HRDLK  NILL+S   D + KI DFG++  F  +      K  +GT  Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189

Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  112 bits (282), Expect = 7e-27
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            + + +  +LG G FG V++      G+    K +++         KNE+ ++ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 628
           L+ L     ++ E +LI E++        LFD   +  + +     +  +    +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           H+     I+H D+K  NI+ ++      KI DFG+A     DE     K    T  + +P
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219

Query: 687 EYALDGLFSVKSDVFSFGVLL 707
           E          +D+++ GVL 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  111 bits (279), Expect = 7e-27
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-----LKEFKNEMMLIAKL 566
           E +    KLGEG +  VYKGK  L    VA+K +  +  +G     ++E      L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIEGI 621
           +H N+V L      +    L++EY+    K        + +     L  +Q        +
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
            +GL Y H+    +++HRDLK  N+L++     K++DFG+AR       +     VV T 
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TL 164

Query: 682 GYMSPE 687
            Y  P+
Sbjct: 165 WYRPPD 170

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 1e-26
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 21/206 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHR 569
            + F  + KLG G FG V+  +   +G E  +K ++  +S   +++ + E+ ++  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIEGIAQG 624
           N++++     +     ++ E      L     +   S        +     ++++ +   
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           L Y H      ++H+DLK  NIL          KI DFG+A +F  DE         GT 
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTA 190

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLL 707
            YM+PE       + K D++S GV++
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVM 215

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (279), Expect = 2e-26
 Identities = 35/237 (14%), Positives = 71/237 (29%), Gaps = 54/237 (22%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQ--------- 567
           LG+       +      G+   V             +K+ K E++ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 568 ----------------HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFF--LFDPSRTH 607
                            + ++R+     +        +Y  M +    F   L   S TH
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 608 -LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 666
             L    R+++   + + L  LH Y    ++H  L+  +I+LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 667 GDELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLT 712
                G       + G+  PE                L +   D ++ G+++     
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 2e-26
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHR 569
              F +   +G G +G VYKG+ +  GQ  A+K +   +G   +E K E+ ++ K   HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81

Query: 570 NLVRLMGCCVEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           N+    G  +++          L+ E+    S+   L   ++ + L  +    I   I +
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILR 140

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           GL +LHQ    ++IHRD+K  N+LL  +   K+ DFG++        + NT   +GT  +
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYW 195

Query: 684 MSPE-----YALDGLFSVKSDVFSFGVLLLE 709
           M+PE        D  +  KSD++S G+  +E
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (272), Expect = 3e-26
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            + ++++  +G G +G V            A K++     + +  FK E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 628
           ++RL     +  +  L+ E          LF+    +          +I++ +   + Y 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122

Query: 629 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
           H+   L + HRDLK  N L  +   D   K+ DFG+A  F   ++    +  VGT  Y+S
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176

Query: 686 PEYALDGLFSVKSDVFSFGVLL 707
           P+  L+GL+  + D +S GV++
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  110 bits (276), Expect = 3e-26
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 23/210 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAK 565
            + + +   +G+G F  V +      GQ+ AVK     + +S  G   ++ K E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQT-RV--KIIEG 620
           L+H ++V L+      G   +++E+M        L      R       +  V    +  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 677
           I + L Y H      IIHRD+K   +LL S       K+  FG+A      E        
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGR 193

Query: 678 VGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           VGT  +M+PE      +    DV+  GV+L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (277), Expect = 3e-26
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
             S    LG G FG V+K +    G ++A K + ++  +  +E KNE+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +L      + + +L+ EY+        LFD     ++ L     +  ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 631 YSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
              + I+H DLK  NIL  +      KI DFG+AR +   E     K   GT  +++PE 
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259

Query: 689 ALDGLFSVKSDVFSFGVLL 707
                 S  +D++S GV+ 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 3e-26
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQ 567
           ++F +   LG+G FG VY  +   N   +A+K L      + G    + + E+ + + L+
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 622
           H N++R+     ++    L+ E+ P   L   L     FD  R+     +        +A
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LA 124

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
             L Y H     ++IHRD+K  N+L+      KI+DFG +           T  + GT  
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLD 177

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           Y+ PE         K D++  GVL  E L 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  109 bits (274), Expect = 4e-26
 Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
           + +    KLGEG +G VYK    +  + VA+KR+       L+  +         E+ L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKII 618
            +LQHRN++ L           LI+EY     L  ++               +Q      
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ------ 140

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQGN 673
             +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F G  ++  
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194

Query: 674 TKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 714
           T  ++ T  Y  PE  L    +S   D++S   +  E L   
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  111 bits (280), Expect = 6e-26
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-------------SQSGQGLKEFK 557
            E++    KLG G +G V   K      E A+K +                  +  +E  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 558 NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRV 615
           NE+ L+  L H N+++L     ++    L+ E+     L    F+   +R          
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149

Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQG 672
            I++ I  G+ YLH+     I+HRD+K  NILL++    +N KI DFG++  F  D    
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205

Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
             +  +GT  Y++PE  L   ++ K DV+S GV++
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  106 bits (267), Expect = 2e-25
 Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 33/189 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
           E +    K+GEG +G V+K +    GQ VA+K+          E           E+ ++
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF-----LFDPSRTHLLGWQTRVKII 618
            +L+H NLV L+     +    L++EY  +  L+                + WQ      
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
               Q + + H++     IHRD+K  NIL+      K+ DFG AR+            V 
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164

Query: 679 GTYGYMSPE 687
            T  Y SPE
Sbjct: 165 -TRWYRSPE 172

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  108 bits (271), Expect = 3e-25
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 48/198 (24%)

Query: 519 CKLGEGGFGPVYKGK---LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQHRNL 571
           CK+G G +G VYK K     + ++ A+K++     S S         E+ L+ +L+H N+
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80

Query: 572 VRLMGCCVEQGEKI--LIYEYM-------------PNKSLNFFLFDPSRTHLLGWQTRVK 616
           + L    +   ++   L+++Y                 +             L +Q    
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ---- 136

Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQG 672
               I  G+ YLH      ++HRDLK +NIL+  +       KI+D G AR+F    L+ 
Sbjct: 137 ----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKP 188

Query: 673 NT---KRVVGTYGYMSPE 687
                  VV T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  106 bits (267), Expect = 3e-25
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 38/219 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMM---------L 562
           E +     +GEG +G V K +    G+ VA+K+        L+   ++M+         L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVK 616
           + +L+H NLV L+  C ++    L++E++ + ++   L       D        +Q    
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ---- 132

Query: 617 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 676
               I  G+ + H +    IIHRD+K  NIL+      K+ DFG AR       +     
Sbjct: 133 ----IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDE 184

Query: 677 VVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 714
           V  T  Y +PE  + D  +    DV++ G L+ E    +
Sbjct: 185 VA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (264), Expect = 4e-25
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 32/231 (13%)

Query: 496 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--------RLS 546
           RD+ LP     S     EN+  +  LG G    V +       +E AVK          S
Sbjct: 2   RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59

Query: 547 SQSGQGLKE-FKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD-- 602
           ++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L    FD  
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYL 115

Query: 603 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
             +  L   +TR KI+  + + +  LH+   L I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 TEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

Query: 663 RMFCGDELQGNTKRVVGTYGYMSPE------YALDGLFSVKSDVFSFGVLL 707
                 E     + V GT  Y++PE            +  + D++S GV++
Sbjct: 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (268), Expect = 4e-25
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
            + + +  +LG G F  V K +    G E A K     +  +      +E  + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 622
           ++ H N++ L      + + +LI E +        LFD    +  L   +     I+ I 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 678
            G+ YLH     +I H DLK  NI+L     P    K+ DFG+A            K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           GT  +++PE        +++D++S GV+ 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (269), Expect = 5e-25
 Identities = 58/250 (23%), Positives = 104/250 (41%), Gaps = 25/250 (10%)

Query: 475 MSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKL 534
           MS A           D     +       +          ++    +G G FG V++ KL
Sbjct: 5   MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQR---EIAYTNCKVIGNGSFGVVFQAKL 61

Query: 535 LNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCCVEQGEKI------LI 587
           +   EVA+K++        K FKN E+ ++  ++H N+V L       G+K       L+
Sbjct: 62  VESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNI 646
            EY+P +++       ++         +K  +  + + L Y+H    + I HRD+K  N+
Sbjct: 117 LEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNL 172

Query: 647 LLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFG 704
           LLD      K+ DFG A++    E   N   +   Y Y +PE       ++   D++S G
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRY-YRAPELIFGATNYTTNIDIWSTG 229

Query: 705 VLLLETLTSK 714
            ++ E +  +
Sbjct: 230 CVMAELMQGQ 239

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  104 bits (262), Expect = 6e-25
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
            +++ M  +LG G F  V K +    G+E A K     RLSS      +E  + E+ ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 622
           +++H N++ L      + + +LI E +        LFD    +  L   +   + ++ I 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEAT-QFLKQIL 118

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 678
            G+ YLH     RI H DLK  NI+L     P    K+ DFG+A            K + 
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           GT  +++PE        +++D++S GV+ 
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (263), Expect = 8e-25
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
            + + +  +LG G F  V K +    G E A K     +  +      +E  + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 622
           ++ H N++ L      + + +LI E +        LFD    +  L   +     I+ I 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 678
            G+ YLH     +I H DLK  NI+L     P    K+ DFG+A            K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           GT  +++PE        +++D++S GV+ 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  108 bits (272), Expect = 9e-25
 Identities = 50/241 (20%), Positives = 93/241 (38%), Gaps = 23/241 (9%)

Query: 476 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 534
            +       S    +          P           +++ +  +LG G FG V++    
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 535 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 594
             G   A K + +      +  + E+  ++ L+H  LV L     +  E ++IYE+M   
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 595 SLNFFLFD---PSRTHLLGWQTRVKIIEGIAQ---GLLYLHQYSRLRIIHRDLKASNILL 648
                LF+        +    +  + +E + Q   GL ++H+      +H DLK  NI+ 
Sbjct: 240 E----LFEKVADEHNKM----SEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMF 288

Query: 649 DSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 706
            +  +   K+ DFG+       +   + K   GT  + +PE A        +D++S GVL
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

Query: 707 L 707
            
Sbjct: 346 S 346

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (262), Expect = 1e-24
 Identities = 47/245 (19%), Positives = 84/245 (34%), Gaps = 52/245 (21%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAK 565
            + + ++  +G+G +G V            A+K     ++   + + ++  K E+ L+ K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYM-------------------------PNKSLNFFL 600
           L H N+ RL     ++    L+ E                             +      
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 601 FDPSRTHLLGWQTRV------------KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 648
            +    +      R              I+  I   L YLH      I HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 649 DSD--MNPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSPE--YALDGLFSVKSDVFS 702
            ++     K+ DFG+++ F               GT  +++PE     +  +  K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 703 FGVLL 707
            GVLL
Sbjct: 262 AGVLL 266

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  103 bits (260), Expect = 2e-24
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 32/205 (15%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQHRNLVRL- 574
           LGEG +G V +          AVK L      +   G    K E+ L+ +L+H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 575 --MGCCVEQGEKI-LIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVK---IIEGIAQGLLY 627
             +    E+ +K+ ++ EY         + D          Q       +I+G+     Y
Sbjct: 73  DVLYN--EEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      I+H+D+K  N+LL +    KIS  G+A            +   G+  +  PE
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 688 YAL-----DGLFSVKSDVFSFGVLL 707
            A       G    K D++S GV L
Sbjct: 182 IANGLDTFSGF---KVDIWSAGVTL 203

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (260), Expect = 2e-24
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 36/227 (15%)

Query: 509 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKN----EMM 561
           S AT  +    ++G G +G VYK +   +G  VA+K  R+ +  G G          E+ 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVA 63

Query: 562 LIAKLQ---HRNLVRLMGCCVEQGEKI-----LIYEYMPN------KSLNFFLFDPSRTH 607
           L+ +L+   H N+VRLM  C            L++E++                      
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123

Query: 608 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 667
            L  Q          +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++  
Sbjct: 124 DLMRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY-S 171

Query: 668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            ++   T  VV T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 172 YQMA-LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (259), Expect = 3e-24
 Identities = 68/234 (29%), Positives = 106/234 (45%), Gaps = 49/234 (20%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 577
           +G+G F  V   + +L G+EVA+K +  +  +   L++   E+ ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 578 CVEQGEKI-LIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVK---IIEGIAQGLLYLHQY 631
            +E  + + LI EY     +    FD   +   +   + R K   I+  +     Y H  
Sbjct: 83  -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE---- 687
            + RI+HRDLKA N+LLD+DMN KI+DFG +  F             G   Y +PE    
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQG 187

Query: 688 --YALDGLFSVKSDVFSFGVLL--------------LETLTSKRNTGVYDIESF 725
             Y  DG    + DV+S GV+L              L+ L  +   G Y I  +
Sbjct: 188 KKY--DGP---EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (257), Expect = 3e-24
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K +     S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 626
            N+VRL     E+    L+++ +    L    F+   +R            I+ I + + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119

Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           Y H      I+HR+LK  N+LL S       K++DFG+A                GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGY 173

Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           +SPE      +S   D+++ GV+L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (259), Expect = 3e-24
 Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 16/201 (7%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            E + +   LG G FG V++     + +    K +    G      K E+ ++   +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 628
           ++ L        E ++I+E++    +    F+   +    L  +  V  +  + + L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           H      I H D++  NI+  +  +   KI +FG AR     +     + +     Y +P
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172

Query: 687 EYALDGLFSVKSDVFSFGVLL 707
           E     + S  +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 4e-24
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 30/212 (14%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
            + +    +LG G F  V K +    G + A K     R  S      +E  + E+ ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIE 619
           ++QH N++ L      + + ILI E +        LFD    +  L    T     + ++
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESL----TEEEATEFLK 121

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTK 675
            I  G+ YLH    L+I H DLK  NI+L     P    KI DFG+A            K
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FK 175

Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
            + GT  +++PE        +++D++S GV+ 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  103 bits (260), Expect = 4e-24
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 44/228 (19%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
             +    K+G+G FG V+K +    GQ+VA+K++       ++  K         E+ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 564 AKLQHRNLVRLMGCCVEQGEKI--------LIYEYMPN--KSL---NFFLFDPSRTHLLG 610
             L+H N+V L+  C  +            L++++  +    L       F  S    + 
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF---CG 667
                     +  GL Y+H+    +I+HRD+KA+N+L+  D   K++DFG+AR F     
Sbjct: 131 QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 668 DELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 714
            +    T RVV T  Y  PE  L +  +    D++  G ++ E  T  
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  103 bits (258), Expect = 5e-24
 Identities = 48/221 (21%), Positives = 79/221 (35%), Gaps = 52/221 (23%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQS---GQGLKEFKNEMMLIA 564
            +S    LG G FG V+        +EV VK     ++          L +   E+ +++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 565 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQ 612
           +++H N++++              +   N+               LF        L    
Sbjct: 85  RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131

Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
               I   +   + YL       IIHRD+K  NI++  D   K+ DFG A      +L  
Sbjct: 132 AS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-- 185

Query: 673 NTKRVVGTYGYMSPE------YALDGLFSVKSDVFSFGVLL 707
                 GT  Y +PE      Y   G    + +++S GV L
Sbjct: 186 -FYTFCGTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTL 220

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  102 bits (257), Expect = 5e-24
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 18/202 (8%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            + F     LG G F  V+  K  L G+  A+K +           +NE+ ++ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 628
           +V L           L+ + +    L    FD    R           +I+ +   + YL
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDAS-LVIQQVLSAVKYL 122

Query: 629 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
           H+     I+HRDLK  N+L  +   +    I+DFG+++M     +        GT GY++
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175

Query: 686 PEYALDGLFSVKSDVFSFGVLL 707
           PE      +S   D +S GV+ 
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (254), Expect = 5e-24
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 47/209 (22%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 578
           LGEG +G V      +  + VAVK +  +      E  K E+ +   L H N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70

Query: 579 VEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIAQG 624
                    Y +    ++ +          LFD       +     +     ++ G+   
Sbjct: 71  ---------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
             YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y+
Sbjct: 120 --YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 685 SPE------YALDGLFSVKSDVFSFGVLL 707
           +PE      +          DV+S G++L
Sbjct: 175 APELLKRREF--HAE---PVDVWSCGIVL 198

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (259), Expect = 5e-24
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-------RLSSQSGQGLKE-FKNEMML 562
            + +  +  +G G    V +      G E AVK       RLS +  + ++E  + E  +
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 563 IAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIE 619
           + ++  H +++ L+          L+++ M    L    FD    +  L   +TR  I+ 
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
            + + + +LH      I+HRDLK  NILLD +M  ++SDFG +      E     + + G
Sbjct: 208 SLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261

Query: 680 TYGYMSPE------YALDGLFSVKSDVFSFGVLL 707
           T GY++PE            +  + D+++ GV+L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  101 bits (255), Expect = 8e-24
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQH 568
           E+F     LGEG F  V   + L   +E A+K L  +      +      E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 569 RNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
              V+L      Q ++ L     Y  N  L  ++     FD + T       R    E I
Sbjct: 90  PFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-I 139

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            Y+SPE   +      SD+++ G ++ + + 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (255), Expect = 1e-23
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 29/200 (14%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 578
           LGEG +G V      +  + VAVK +  +      E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 579 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVK---IIEGIAQGLLYLHQYSR 633
            E   + L  EY     L    FD       +     +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE------ 687
           + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 688 YALDGLFSVKSDVFSFGVLL 707
           +          DV+S G++L
Sbjct: 184 F--HAE---PVDVWSCGIVL 198

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (254), Expect = 1e-23
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 29/213 (13%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE---FKNEMML 562
            + + M   LG G  G V         ++VA+K     + +  S +        + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEG 620
           + KL H  ++++     +  +  ++ E M    L    FD       L     +      
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 677
           +   + YLH      IIHRDLK  N+LL S   D   KI+DFG +++     L    + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176

Query: 678 VGTYGYMSPE---YALDGLFSVKSDVFSFGVLL 707
            GT  Y++PE         ++   D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (259), Expect = 1e-23
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--------SQSGQGLKEFKNEMML 562
            + + M   LG G  G V         ++VA++ +S        ++        + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEG 620
           + KL H  ++++     +  +  ++ E M    L    FD       L     +      
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 677
           +   + YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301

Query: 678 VGTYGYMSPE---YALDGLFSVKSDVFSFGVLL 707
            GT  Y++PE         ++   D +S GV+L
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (255), Expect = 2e-23
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K +     S +  ++ + E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 626
            N+VRL     E+    L+++ +    L    F+   +R            I+ I + + 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 142

Query: 627 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           Y H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY
Sbjct: 143 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196

Query: 684 MSPEYALDGLFSVKSDVFSFGVLL 707
           +SPE      +S   D+++ GV+L
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  101 bits (254), Expect = 2e-23
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 34/221 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQ------GLKEFKNEMMLIA 564
           + +    ++GEG +G V+K +     G+ VA+KR+  Q+G+       ++E    +  + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69

Query: 565 KLQHRNLVRL----MGCCVEQGEKI-LIYEYMPN------KSLNFFLFDPSRTHLLGWQT 613
             +H N+VRL         ++  K+ L++E++          +            + +Q 
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ- 128

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 673
                  + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++   ++   
Sbjct: 129 -------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA-L 176

Query: 674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           T  VV T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 177 TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (252), Expect = 2e-23
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 45/221 (20%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLS-----------------SQSGQGLKEFKNEMML 562
           +G+G +G V       +    A+K LS                           +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 563 ------IA---KLQHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFD-PSRTHLL 609
                 IA   KL H N+V+L+   ++   +  +Y   E +    +     + P+   L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
             Q R    + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G +
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 670 LQGNTKRVVGTYGYMSPE--YALDGLFS-VKSDVFSFGVLL 707
                   VGT  +M+PE       +FS    DV++ GV L
Sbjct: 192 --ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  102 bits (256), Expect = 4e-23
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 505 LASVSAA--TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNE 559
           +A+++    TE + +  +LG+G F  V +   +L GQE A   +     S +  ++ + E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKI 617
             +   L+H N+VRL     E+G   LI++ +    L    F+   +R +          
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HC 115

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNT 674
           I+ I + +L+ HQ   + ++HR+LK  N+LL S       K++DFG+A    G+  Q   
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAW 170

Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
               GT GY+SPE      +    D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  101 bits (254), Expect = 5e-23
 Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 37/243 (15%)

Query: 490 DAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ 548
           D  G++  +V+             +++    +G G FG VY+ KL  +G+ VA+K++   
Sbjct: 31  DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 90

Query: 549 SGQGLKEFKN-EMMLIAKLQHRNLVRLMGCCVEQGEKI------LIYEYMP--------N 593
                K FKN E+ ++ KL H N+VRL       GEK       L+ +Y+P        +
Sbjct: 91  -----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145

Query: 594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 653
            S            L  +Q        + + L Y+H      I HRD+K  N+LLD D  
Sbjct: 146 YSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICHRDIKPQNLLLDPDTA 194

Query: 654 P-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETL 711
             K+ DFG A+     E   N   +   Y Y +PE       ++   DV+S G +L E L
Sbjct: 195 VLKLCDFGSAKQLVRGEP--NVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

Query: 712 TSK 714
             +
Sbjct: 252 LGQ 254

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 27/205 (13%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 578
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 579 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 636
            E+    L++E M   S+          R H    +    +++ +A  L +LH      I
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132

Query: 637 IHRDLKASNILL---DSDMNPKISDFGMARMF-----CGDELQGNTKRVVGTYGYMSPEY 688
            HRDLK  NIL    +     KI DF +         C            G+  YM+PE 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE- 191

Query: 689 ALDGLFSV------KSDVFSFGVLL 707
            ++           + D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.5 bits (246), Expect = 3e-22
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 39/225 (17%)

Query: 512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKL 566
            + F ++   G+G FG V  GK    G  VA+K++          F+N     M  +A L
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76

Query: 567 QHRNLVRLMGCCVEQGEK-------ILIYEYMP------NKSLNFFLFDPSRTH--LLGW 611
            H N+V+L       GE+        ++ EY+P       ++       P      +  +
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDEL 670
           Q        + + +  LH  S + + HRD+K  N+L++ +D   K+ DFG A+       
Sbjct: 137 Q--------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185

Query: 671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSK 714
           + N   +   Y Y +PE       ++   D++S G +  E +  +
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.7 bits (239), Expect = 6e-22
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 52/211 (24%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVK---RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG G FG V  G+  L G +VAVK   R   +S   + + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 577 CCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIA 622
                      Y+ +   +  F          LFD       +   + R     I+  + 
Sbjct: 77  -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
               Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  
Sbjct: 126 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPN 175

Query: 683 YMSPE------YALDGLFSVKSDVFSFGVLL 707
           Y +PE      Y   G    + D++S GV+L
Sbjct: 176 YAAPEVISGRLY--AGP---EVDIWSCGVIL 201

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.0 bits (242), Expect = 7e-22
 Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 65/242 (26%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLMG 576
           LGEG FG V         Q+VA+K +S Q      +    + E+  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 577 CCVEQGEKILIYEYMPNKSLNFF--------LFD--PSRTHLLGWQTRVK---IIEGIAQ 623
                      Y+ +   +            LFD    +  +   + R     II  I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
              Y H   R +I+HRDLK  N+LLD ++N KI+DFG++ +          K   G+  Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNY 173

Query: 684 MSPE------YALDGLFSVKSDVFSFGVLL--------------LETLTSKRNTGVYDIE 723
            +PE      Y   G    + DV+S G++L              +  L  K N+ VY + 
Sbjct: 174 AAPEVINGKLY--AGP---EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP 228

Query: 724 SF 725
            F
Sbjct: 229 DF 230

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 20/198 (10%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR-NLVRLM 575
           +LG G F  V +      GQE A K  +   +      E  +E+ ++   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
                  E ILI EY         +F    P    ++     +++I+ I +G+ YLHQ  
Sbjct: 96  EVYENTSEIILILEYAAGGE----IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149

Query: 633 RLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
              I+H DLK  NILL       + KI DFGM+R           + ++GT  Y++PE  
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205

Query: 690 LDGLFSVKSDVFSFGVLL 707
                +  +D+++ G++ 
Sbjct: 206 NYDPITTATDMWNIGIIA 223

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.5 bits (243), Expect = 3e-21
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 568
           + F     LG GGFG V+  ++    ++ A K+L+ +     +G +    E  ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 569 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLL 626
           R +V L     E    + L+   M    + + +++    +    + R       I  GL 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           +LHQ     II+RDLK  N+LLD D N +ISD G+A      +    TK   GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLT 712
           E  L   +    D F+ GV L E + 
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIA 384

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 24/207 (11%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAKL 566
            + +   LG GGFG VY G  + +   VA+K +                   E++L+ K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 567 QHR--NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 622
                 ++RL+         +LI E          LFD    R  L     R      + 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELAR-SFFWQVL 159

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTY 681
           + + + H      ++HRD+K  NIL+D +    K+ DFG   +              GT 
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212

Query: 682 GYMSPEYALDGLFS-VKSDVFSFGVLL 707
            Y  PE+     +    + V+S G+LL
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILL 239

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.8 bits (241), Expect = 4e-21
 Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 66/243 (27%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           LG G FG V  GK  L G +VAVK L+ Q   S   + + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 577 CCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIA 622
                      Y+ +   S  F          LFD       L   ++R     I+ G+ 
Sbjct: 82  -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
               Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  
Sbjct: 131 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPN 180

Query: 683 YMSPE------YALDGLFSVKSDVFSFGVLL--------------LETLTSKRNTGVYDI 722
           Y +PE      Y   G    + D++S GV+L              + TL  K   G++  
Sbjct: 181 YAAPEVISGRLY--AGP---EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT 235

Query: 723 ESF 725
             +
Sbjct: 236 PQY 238

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 4e-21
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 13/205 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 568
             F     LG+GGFG V   ++    ++ A K+L  +     +G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 569 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           R +V L     E  + + L+   M    L F ++   +      +      E I  GL  
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH   R RI++RDLK  NILLD   + +ISD G+A      +     K  VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355

Query: 688 YALDGLFSVKSDVFSFGVLLLETLT 712
              +  ++   D ++ G LL E + 
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIA 380

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.3 bits (242), Expect = 5e-21
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF------KNEMMLIAK 565
            +FS+   +G GGFG VY  +  +  ++ A+K L  +  +  +        +  + L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 566 LQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIE 619
                +V +        +K+  I + M    L++ L     F  +         R    E
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
            I  GL ++H      +++RDLK +NILLD   + +ISD G+A  F   +        VG
Sbjct: 301 -IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 352

Query: 680 TYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLT 712
           T+GYM+PE    G+    S   D FS G +L + L 
Sbjct: 353 THGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLR 386

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 93.9 bits (234), Expect = 8e-21
 Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 20/203 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
           T+ + ++  +G G +    +        E AVK +        +E     +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 628
           ++ L     +     ++ E M    L     D    +      +    ++  I + + YL
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGTYGYM 684
           H      ++HRDLK SNIL   +       +I DFG A+    +   G       T  ++
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFV 187

Query: 685 SPEYALDGLFSVKSDVFSFGVLL 707
           +PE      +    D++S GVLL
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 47/212 (22%), Positives = 77/212 (36%), Gaps = 46/212 (21%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLS----------SQSGQGLKEFKNEMMLIAKLQHR 569
           LG+GGFG V+ G  L +  +VA+K +           S S     E      + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQTRVKI 617
            ++RL              ++   +               LFD    +  L    +R   
Sbjct: 99  GVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CF 144

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKR 676
              +   + + H      ++HRD+K  NIL+D      K+ DFG   +   +        
Sbjct: 145 FGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TD 197

Query: 677 VVGTYGYMSPEYALDGLFS-VKSDVFSFGVLL 707
             GT  Y  PE+     +  + + V+S G+LL
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILL 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
           ++ F ++ +LG G    VY+ K     +  A+K L     +  K  + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIEGIAQGL 625
           +++L        E  L+ E +    L    FD    + +     +       ++ I + +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYY----SERDAADAVKQILEAV 161

Query: 626 LYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
            YLH+     I+HRDLK  N+L      D   KI+DFG++++     L    K V GT G
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPG 215

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLL 707
           Y +PE      +  + D++S G++ 
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 20/195 (10%)

Query: 520 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 577
            LGEG F    K     + Q  AVK +S +        + E+  +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 578 CVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 635
             +Q    L+ E +    L    F+    + H    +    I+  +   + ++H    + 
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126

Query: 636 IIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           ++HRDLK  N+L    + ++  KI DFG AR+   D      K    T  Y +PE     
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQN 184

Query: 693 LFSVKSDVFSFGVLL 707
            +    D++S GV+L
Sbjct: 185 GYDESCDLWSLGVIL 199

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.9 bits (226), Expect = 7e-20
 Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 44/208 (21%)

Query: 520 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 577
            LG G  G V +      GQ+ A+K L         + + E+    +     ++V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILD- 89

Query: 578 CVEQGEKILIYEYMPNKSLNFF----------LFDPSRTHLLGWQT-----RVKIIEGIA 622
                    +YE M +                LF   R    G Q        +I+  I 
Sbjct: 90  ---------VYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIG 138

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVG 679
             + +LH      I HRD+K  N+L    + D   K++DFG A+    + LQ        
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCY 191

Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           T  Y++PE      +    D++S GV++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 24/198 (12%), Positives = 58/198 (29%), Gaps = 43/198 (21%)

Query: 520 KLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRL 574
             G       ++     L  ++VA+  +  Q       L+E  +  + ++++    + R+
Sbjct: 38  FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +     +   +++ E++   SL         T        ++ ++ +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 694
            +       S + +  D        G                V+     M          
Sbjct: 149 GVALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA------- 179

Query: 695 SVKSDVFSFGVLLLETLT 712
           + + D+   G  L   L 
Sbjct: 180 NPQDDIRGIGASLYALLV 197

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.0 bits (223), Expect = 2e-19
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 22/168 (13%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDN 738
             +M+PE   D +++++SDV+SFGVLL E  +   +   GV   E F          K+ 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEG 312

Query: 739 RAYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 785
               + +P       YQ ML+        C   + + RPT S++V  +
Sbjct: 313 --TRMRAPDYTTPEMYQTMLD--------CWHGEPSQRPTFSELVEHL 350

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 35/166 (21%), Positives = 61/166 (36%), Gaps = 19/166 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 564
           +   +   LG G FG V +            + VAVK L   +     +   +E+ +LI 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 565 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
              H N+V L+G C + G  + +I E+    +L+ +L             R + +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
           G  +      +  I  DLK     + S  +   S F   +     E
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 54/211 (25%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 578
           +G G FG     +  L  + VAVK +    G  + E  + E++    L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81

Query: 579 VEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIAQG 624
                     E +   +             L++   +       + R     ++ G++  
Sbjct: 82  ---------KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS-- 130

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
             Y H    ++I HRDLK  N LLD       KI DFG ++           K  VGT  
Sbjct: 131 --YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 182

Query: 683 YMSPE------YALDGLFSVKSDVFSFGVLL 707
           Y++PE      Y  DG     +DV+S GV L
Sbjct: 183 YIAPEVLLRQEY--DGK---IADVWSCGVTL 208

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 45/245 (18%), Positives = 94/245 (38%), Gaps = 53/245 (21%)

Query: 512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHR 569
           ++ +S+   LG G FG V +   + +G+  A+K++          +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-------------- 615
           N+++L+      G++       P+        +    +                      
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 616 -----KIIEG-------------------IAQGLLYLHQYSRLRIIHRDLKASNILLDSD 651
                K+++                    + + + ++H    L I HRD+K  N+L++S 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177

Query: 652 MNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLE 709
            N  K+ DFG A+       + +   +   + Y +PE  L    ++   D++S G +  E
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 710 TLTSK 714
            +  K
Sbjct: 235 LILGK 239

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 43/208 (20%)

Query: 520 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 577
            LG G  G V +       ++ A+K L         + + E+ L  +     ++VR++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122

Query: 578 CVEQGEKILIYEYMPNKSLNFF----------LFDPSRTHLLGWQT---R--VKIIEGIA 622
                    +YE +                  LF   R    G Q    R   +I++ I 
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIG 171

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVG 679
           + + YLH    + I HRD+K  N+L  S   +   K++DFG A+         +      
Sbjct: 172 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCY 225

Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           T  Y++PE      +    D++S GV++
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 45/222 (20%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HR 569
            +++ +  KLG G +  V++   + N ++V VK L        K+ K E+ ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91

Query: 570 NLVRLMGCCVEQGEK--ILIYEYMPNKSLN------------FFLFDPSRTHLLGWQTRV 615
           N++ L     +   +   L++E++ N                F+++      +L      
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY-----EIL------ 140

Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNT 674
                  + L Y H  S   I+HRD+K  N+++D +    ++ D+G+A        Q   
Sbjct: 141 -------KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYN 188

Query: 675 KRVVGTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSKR 715
            RV   Y +  PE  +D      S D++S G +L   +  K 
Sbjct: 189 VRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 40/222 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQH 568
           ++F +   +G+G FG V    K    +  A+K ++ Q      E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 569 RNLVRLMGCCVEQ-GEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------ 620
             LV L      Q  E + ++ + +    L        R HL   Q  V   E       
Sbjct: 75  PFLVNLWYSF--QDEEDMFMVVDLLLGGDL--------RYHL---QQNVHFKEETVKLFI 121

Query: 621 --IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             +   L YL      RIIHRD+K  NILLD   +  I+DF +A M   +        + 
Sbjct: 122 CELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMA 175

Query: 679 GTYGYMSPEYALDGL-----FSVKSDVFSFGVLLLETLTSKR 715
           GT  YM+PE           F+V  D +S GV   E L  +R
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 85.3 bits (211), Expect = 2e-17
 Identities = 38/207 (18%), Positives = 82/207 (39%), Gaps = 57/207 (27%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
            + + ++  +G G +G V +    L  + VA+K++        + F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104

Query: 562 LIAKLQHRNLVRLMGCCV----EQGEKI-LIYEYMP---------NKSLN-----FFLFD 602
           ++ +L H ++V+++   +    E+ +++ ++ E               L        L+ 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163

Query: 603 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
                             +  G+ Y+H  S   I+HRDLK +N L++ D + K+ DFG+A
Sbjct: 164 ---------N--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203

Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYA 689
           R     E   +   +      M+    
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTF 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 41/222 (18%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
            + +     +G G  G V      +  + VA+K+LS       + F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 562 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMPNKSLNFFL---FDPSRTHLLGWQ 612
           L+  + H+N++ L+        +E+ + + ++ E M   +L   +    D  R   L +Q
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135

Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
                   +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR         
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM 182

Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            T  VV T  Y +PE  L   +    D++S G ++ E +   
Sbjct: 183 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 17/210 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   KL N  +V A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 569 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           + +  L     +    + L+ +Y     L   L       L     R  + E +   +  
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           +HQ   L  +HRD+K  NIL+D + + +++DFG       D     +   VGT  Y+SPE
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246

Query: 688 -----YALDGLFSVKSDVFSFGVLLLETLT 712
                    G +  + D +S GV + E L 
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 7e-17
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
            + +     +G G  G V      +  + VA+K+LS       + F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113

Query: 562 LIAKLQHRNLVRLM------GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 615
           L+  + H+N++ L+          E  +  L+ E M        L    +  L   +   
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168

Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
            + + +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR          T 
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 222

Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            VV T  Y +PE  L   +    D++S G ++ E +  K
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 58/245 (23%), Positives = 96/245 (39%), Gaps = 26/245 (10%)

Query: 478 ATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT-ENFSMQCKLGEGGFGPVYKGKL-L 535
           A +     E   +     ++  L  +   S + A  + F     LG G FG V   K   
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 536 NGQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 592
           +G   A+K L  Q    LK+     NE  ++  +    LV+L     +     ++ EY+ 
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124

Query: 593 NKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 647
              +   L     F            R    + I     YLH      +I+RDLK  N+L
Sbjct: 125 GGEMFSHLRRIGRFSEPHA-------RFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLL 173

Query: 648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 707
           +D     +++DFG A+      ++G T  + GT   ++PE  L   ++   D ++ GVL+
Sbjct: 174 IDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228

Query: 708 LETLT 712
            E   
Sbjct: 229 YEMAA 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 50/226 (22%), Positives = 83/226 (36%), Gaps = 38/226 (16%)

Query: 512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE--FKN---------EM 560
              +++Q  +  G +G V  G    G  VA+KR+ +    G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 561 MLIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMPN------KSLNFFLFDPSRTHLL 609
            L+    H N++ L             K+ L+ E M              +      + +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
            +         I  GL  LH+     ++HRDL   NILL  + +  I DF +AR    D 
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
            +  T  V     Y +PE  +    F+   D++S G ++ E    K
Sbjct: 189 NK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.2 bits (198), Expect = 7e-16
 Identities = 64/267 (23%), Positives = 101/267 (37%), Gaps = 29/267 (10%)

Query: 456 KEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENF 515
           +E  T +++  D LK      +  R+  PS+  G  +           +          F
Sbjct: 97  EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVS------LAKPKHRVTMNEF 150

Query: 516 SMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNL 571
                LG+G FG V   K        A+K L  +      E      E  ++   +H  L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 572 VRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGL 625
             L     +  +++  + EY     L F L     F   R    G +        I   L
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSAL 261

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            YLH  S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLA 317

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLT 712
           PE   D  +    D +  GV++ E + 
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMC 344

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.8 bits (197), Expect = 7e-16
 Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 19/212 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 568
           ++F +   +G G F  V   K+    +V A+K ++        E   F+ E  ++     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 569 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           R + +L     +    + L+ EY     L   L       +     R  + E I   +  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           +H+   L  +HRD+K  NILLD   + +++DFG       D     +   VGT  Y+SPE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233

Query: 688 -------YALDGLFSVKSDVFSFGVLLLETLT 712
                      G +  + D ++ GV   E   
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.9 bits (195), Expect = 8e-16
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
            + +     +G G +G V       +G++VA+K+LS       + F++         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75

Query: 562 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQ 612
           L+  +QH N++ L+        +       L+  +M     K +     +    +L+ +Q
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ 134

Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
                   + +GL Y+H      ++HRDLK  N+ ++ D   KI DFG+AR    +    
Sbjct: 135 --------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180

Query: 673 NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
            T  VV T  Y +PE  L    ++   D++S G ++ E LT K
Sbjct: 181 -TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 34/225 (15%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
              +     LG GG G V+        + VA+K++     Q +K    E+ +I +L H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 571 LVRLM--------------GCCVEQGEKILIYEYMP---NKSLNFFLFDPSRTHLLGWQT 613
           +V++               G   E     ++ EYM       L           L  +Q 
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQG 672
                  + +GL Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+AR+        
Sbjct: 129 -------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 673 N--TKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
              ++ +V T  Y SP   L    ++   D+++ G +  E LT K
Sbjct: 179 GHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQH 568
           ++F +   LG G FG V+  +  +     A+K L  +    LK+     +E ++++ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 623
             ++R+ G   +  +  +I +Y+    L   L     F            +    E +  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAE-VCL 117

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
            L YLH      II+RDLK  NILLD + + KI+DFG A+      +   T  + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDY 169

Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           ++PE      ++   D +SFG+L+ E L 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 41/224 (18%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
              ++    +GEG +G V      LN   VA+K++S         F++         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 562 LIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQT 613
           ++ + +H N++ +        +EQ + + ++ + M     K L              +Q 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136

Query: 614 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 673
                  I +GL Y+H  S   ++HRDLK SN+LL++  + KI DFG+AR+   D     
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 674 --TKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
             T+ V  T  Y +PE  L+   ++   D++S G +L E L+++
Sbjct: 187 FLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.8 bits (188), Expect = 4e-15
 Identities = 36/199 (18%), Positives = 58/199 (29%), Gaps = 46/199 (23%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRL--------SSQSGQGLKEFKNEMML 562
            TE      K+GEG FG V++    +   VA+K +        +    +  +E   E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 563 IAKLQ---------HRNLVRLMGCCVEQGE--KILIYEYMPNKSLNFFLFDPSR------ 605
             +L              + L      QG    +L+  +    S      D         
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 606 ------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 647
                             T L    T   I+  +   L        LR  HRDL   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 648 LDSDMNPKISDFGMARMFC 666
           L      K+      +   
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 64/243 (26%), Positives = 97/243 (39%), Gaps = 28/243 (11%)

Query: 483 EPSEGDGDAKGTRRDSVLPCFSLASVSAAT-ENFSMQCKLGEGGFGPVYKGKLLNGQEV- 540
           EP   + +       S       +S   A   +F     +G+G FG V   +    +   
Sbjct: 7   EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66

Query: 541 AVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKS 595
           AVK L  ++    KE K+ M     L+  ++H  LV L     +  +K+  + +Y+    
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125

Query: 596 LNFF------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 649
           L F+       F   R        R    E IA  L YLH    L I++RDLK  NILLD
Sbjct: 126 L-FYHLQRERCFLEPRA-------RFYAAE-IASALGYLHS---LNIVYRDLKPENILLD 173

Query: 650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 709
           S  +  ++DFG+ +          T    GT  Y++PE      +    D +  G +L E
Sbjct: 174 SQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231

Query: 710 TLT 712
            L 
Sbjct: 232 MLY 234

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 32/216 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 568
           E++ +   +G G FG V   +  + ++V A+K LS        +   F  E  ++A    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ----- 623
             +V+L     +     ++ EYMP               L+   +   + E  A+     
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGG------------DLVNLMSNYDVPEKWARFYTAE 176

Query: 624 ---GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
               L  +H    +  IHRD+K  N+LLD   + K++DFG   M    E        VGT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGT 232

Query: 681 YGYMSPE----YALDGLFSVKSDVFSFGVLLLETLT 712
             Y+SPE       DG +  + D +S GV L E L 
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 37/210 (17%), Positives = 73/210 (34%), Gaps = 57/210 (27%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
            +N+ ++  +G G +G VY        + VA+K+++       + F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77

Query: 562 LIAKLQHRNLVRLMGCCVEQGEKI-----LIYEYMP---------NKSLN-----FFLFD 602
           ++ +L+   ++RL    +           ++ E               L        L  
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-- 135

Query: 603 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
                   +         +  G  ++H      IIHRDLK +N LL+ D + K+ DFG+A
Sbjct: 136 --------YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
           R    ++       +            L  
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 24/210 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQH 568
            +F     LG+G FG V   +        A+K L  +      E      E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 569 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 622
             L  L     +  +++  + EY     L F L     F   R    G +        I 
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IV 115

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
             L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPE 170

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           Y++PE   D  +    D +  GV++ E + 
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 37/220 (16%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
              +     +G G +G V        G +VA+K+L        + F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76

Query: 562 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 615
           L+  ++H N++ L+        ++      L+  +M    L   +    +   LG     
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQ 131

Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
            ++  + +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+   T 
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEM---TG 184

Query: 676 RVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
            VV T  Y +PE  L+   ++   D++S G ++ E +T K
Sbjct: 185 YVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 46/222 (20%)

Query: 513 ENFSMQCKLGEGGFGPVY----KGKLLNGQEVAVKRLSSQSGQGLKEF---------KNE 559
             F +   LG+G FG V+           Q  A+K L        K           K E
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76

Query: 560 MMLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 618
             ++ ++ H  +V+L     +   K+ LI +++    L F         L      V   
Sbjct: 77  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL-FT-------RL---SKEVMFT 124

Query: 619 EG--------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
           E         +A  L +LH    L II+RDLK  NILLD + + K++DFG+++     E 
Sbjct: 125 EEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181

Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +  +    GT  YM+PE       +  +D +SFGVL+ E LT
Sbjct: 182 KAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 31/214 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQ 567
           E+F +   LG+G FG V+  +     +  A+K L         + +  M    +L    +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 568 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ--- 623
           H  L  +  C  +  E +  + EY+    L  +       H+   Q+  K     A    
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDL-MY-------HI---QSCHKFDLSRATFYA 124

Query: 624 -----GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
                GL +LH      I++RDLK  NILLD D + KI+DFGM +     +    T    
Sbjct: 125 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFC 179

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           GT  Y++PE  L   ++   D +SFGVLL E L 
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 58/273 (21%), Positives = 99/273 (36%), Gaps = 42/273 (15%)

Query: 453 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 512
             H   +  + ++++L       S      E        K +     L  F L  V    
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG-LQDFDLLRV---- 59

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 567
                   +G G +  V   +L     + A++ +  +     ++                
Sbjct: 60  --------IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 568 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
           H  LV L   C +   ++  + EY+    L F +                  R    E I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-I 162

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVG 679
           +  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    G
Sbjct: 163 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFCG 215

Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           T  Y++PE      +    D ++ GVL+ E + 
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 66/240 (27%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
           + +F ++  LGEG +G V        G+ VA+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 562 LIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMP--------NKSLN-----FFLFDP 603
           ++   +H N++ +         E   ++ +I E M          + L+     +F+   
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI--- 118

Query: 604 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 663
                  +Q          + +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR
Sbjct: 119 -------YQ--------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160

Query: 664 MFCGDELQGNTKRV--------VGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
           +        +            V T  Y +PE  L    +S   DV+S G +L E    +
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 74.7 bits (183), Expect = 6e-14
 Identities = 79/454 (17%), Positives = 158/454 (34%), Gaps = 40/454 (8%)

Query: 278 WQVFFTAPNNFCQLYGYCGANSVCSVDDTANC-ECLKGFKLKLQNNQTWPRECVRSHSSD 336
           +++   +   FC    +CG+     +     C  C     +  +     P  C   H+  
Sbjct: 105 FKIHTYSSPTFC---DHCGSLLYGLIHQGMKCDTC--MMNVHKRCVMNVPSLCGTDHTER 159

Query: 337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK--NCTCRAYANSKVTGGGSGCL 394
                     D   L  +V  + N         ++            + SK         
Sbjct: 160 RGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSS 219

Query: 395 MW-FGDLIDIRKITGYNNGQPIYVRVPDSEPDKKLLWIFVILVLPAALL-PGFFIFCRWR 452
           +    +     ++   +  + + V + D +   +  ++  +    + L   G   + +  
Sbjct: 220 LNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLL 279

Query: 453 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 512
            + + +   +    +  + +  +       +  +G    +    +++    +  +     
Sbjct: 280 SQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMK 339

Query: 513 -ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKL 566
             +F+    LG+G FG V   +     E+ AVK L         + +  M+    L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 567 QHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 620
           +   L +L   C +  +++  + EY+    L + +     F                 E 
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE- 450

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVV 678
           IA GL +L       II+RDLK  N++LDS+ + KI+DFGM    C + +     TK   
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFC 503

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           GT  Y++PE      +    D ++FGVLL E L 
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 7e-14
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 43/223 (19%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
            E +     +G G +G V        G  VAVK+LS       + F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80

Query: 562 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQ 612
           L+  ++H N++ L+        +E+   + L+   M    N  +            L +Q
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140

Query: 613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 672
                   I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+  
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-TADEM-- 186

Query: 673 NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 714
            T  V  T  Y +PE  L+   ++   D++S G ++ E LT +
Sbjct: 187 -TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.6 bits (179), Expect = 7e-14
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 34/217 (15%)

Query: 513 ENFSMQCKLGEGGFGPVY---KGKLLNGQEV-AVKRLSSQS-GQGLKEF---KNEMMLIA 564
           E F +   LG+GG+G V+   K    N  ++ A+K L      +  K+    K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 565 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           +++H  +V L+    + G K+ LI EY+    L F         L   +     +E  A 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL-FM-------QL---EREGIFMEDTAC 124

Query: 624 --------GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 675
                    L +LHQ     II+RDLK  NI+L+   + K++DFG+ +    D    +T 
Sbjct: 125 FYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT- 180

Query: 676 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
              GT  YM+PE  +    +   D +S G L+ + LT
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 567
            +F+    LG+G FG V   +     E+ AVK L         + +  M+    L    +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 568 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
              L +L   C +  +++  + EY+    L + +     F                 E I
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 130

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVG 679
           A GL +L       II+RDLK  N++LDS+ + KI+DFGM    C + +     TK   G
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFCG 183

Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           T  Y++PE      +    D ++FGVLL E L 
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 29/213 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 567
           ++F +   +G G +  V   +L     + A+K +  +     ++                
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 568 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 621
           H  LV L   C +   ++  + EY+    L F +                  R    E I
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-I 119

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVG 679
           +  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    G
Sbjct: 120 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFCG 172

Query: 680 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           T  Y++PE      +    D ++ GVL+ E + 
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 31/214 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 567
           +NF     LG+G FG V   ++    ++ AVK L         + +  M     L     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 568 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ--- 623
           H  L +L  CC +  +++  + E++    L  F       H+   Q   +  E  A+   
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL-MF-------HI---QKSRRFDEARARFYA 130

Query: 624 -----GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
                 L++LH      II+RDLK  N+LLD + + K++DFGM +    +     T    
Sbjct: 131 AEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFC 185

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           GT  Y++PE   + L+    D ++ GVLL E L 
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 54/208 (25%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
              + +  KLG+G +G V+K      G+ VAVK++          F+N         E+M
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60

Query: 562 LIAKLQ-HRNLVRLMGCCV-EQGEKI-LIYEYMP--------NKSLN-----FFLFDPSR 605
           ++ +L  H N+V L+     +    + L+++YM            L      + +     
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV----- 115

Query: 606 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 665
                +Q        + + + YLH  S   ++HRD+K SNILL+++ + K++DFG++R F
Sbjct: 116 -----YQ--------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159

Query: 666 CGDELQGNTKRVVGTYGYMSPEYALDGL 693
                  N   +       + +     L
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPIL 187

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.6 bits (171), Expect = 8e-13
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 10/96 (10%)

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           I   L +LH+   L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +       GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223

Query: 681 YGYMSPEYALDGL----FSVKSDVFSFGVLLLETLT 712
             YM+P+    G      +V  D +S GVL+ E LT
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLT 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 46/166 (27%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC 577
            LG G  G V +       ++ A+K L         + + E+ L  +  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 78

Query: 578 CVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQTR------VKIIE 619
                    +YE +                  LF     R                +I++
Sbjct: 79  ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMK 124

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 662
            I + + YLH    + I HRD+K  N+L  S   +   K++DFG A
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 42/220 (19%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFK-------NEMMLIAKLQH 568
           KLG G F  V+  K ++N   VA+K +            E K        +      +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 569 RNLVRLMGCCVEQGEKI----LIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKII 618
            ++++L+     +G       +++E +  N     K              +  Q      
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ------ 139

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP------KISDFGMARMFCGDELQG 672
             +  GL Y+H   R  IIH D+K  N+L++   +P      KI+D G A  +  +    
Sbjct: 140 --LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY-- 192

Query: 673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                + T  Y SPE  L   +   +D++S   L+ E +T
Sbjct: 193 --TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 38/191 (19%), Positives = 70/191 (36%), Gaps = 28/191 (14%)

Query: 520 KLGEGGFGPVYKGKLLNGQ------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 573
            +G+GGFG +Y   + + +         VK   S +G    E K         Q +  +R
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 574 LMGCCVEQGEKILIY--EYMPNKSLNFFLFD---PSRTHLLGWQTR---VKIIEGIAQGL 625
                     K           KS  F + D        +     +    K +  ++  +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 626 L----YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFCGDEL-----QGNT 674
           L    Y+H++     +H D+KASN+LL+     ++   D+G+A  +C + +         
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

Query: 675 KRVVGTYGYMS 685
           +   GT  + S
Sbjct: 219 RCHDGTIEFTS 229

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 44/220 (20%)

Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR- 569
           + +   +G+G FG V K    +  + VA+K + ++     Q   E +    L+  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111

Query: 570 -----NLVRLMGCCVEQGEKILIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKII 618
                 +V L    + +    L++E +  N     ++ NF     + T     Q      
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ------ 165

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKR 676
             +   LL+L     L IIH DLK  NILL +      KI DFG +    G         
Sbjct: 166 --MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR------- 214

Query: 677 VVGTY----GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
            +  Y     Y SPE  L   + +  D++S G +L+E  T
Sbjct: 215 -IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 61.4 bits (149), Expect = 1e-11
 Identities = 23/126 (18%), Positives = 43/126 (34%), Gaps = 20/126 (15%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +T    +  G+ L      +                + Y     T VW +N       
Sbjct: 2   NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNL------VLYD--HSTSVWASNTGIL-GK 50

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSY 145
                 + ++GN V+ +     +W+S+  R   N V  L + GN+V+          GS 
Sbjct: 51  KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSD 101

Query: 146 LWQSFD 151
           +W +  
Sbjct: 102 IWSTGT 107

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 61.0 bits (148), Expect = 2e-11
 Identities = 21/117 (17%), Positives = 44/117 (37%), Gaps = 13/117 (11%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           ++++    +  G  L      + L              + Y       VW +N       
Sbjct: 2   NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNT 140
               L   NNGNLV+ +Q++ +IW +  + +  + V  L    N+V+     +++ +
Sbjct: 53  CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPVVWATGS 107

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 44/190 (23%), Positives = 69/190 (36%), Gaps = 32/190 (16%)

Query: 514 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           NF +  K+G G FG +  GK L   + VA+K    +S       +             + 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL--- 626
           ++           ++ E          L  PS   L     R   +K +  IA  L+   
Sbjct: 69  QVYYFGPCGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118

Query: 627 -YLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARMFCGDE-----LQGNTK 675
            Y+H  +   +I+RD+K  N L+    N       I DF +A+ +   E          K
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175

Query: 676 RVVGTYGYMS 685
            + GT  YMS
Sbjct: 176 SLTGTARYMS 185

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 60.7 bits (147), Expect = 2e-11
 Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 19/125 (15%)

Query: 25  TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
           +D +     +  G  L      +     +        L ++     +  VW +  N    
Sbjct: 1   SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48

Query: 85  DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
            S  VL + N+GNLV+ +     IW+SN +R+  N    L    N+V+        +  +
Sbjct: 49  ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIY------DNSNN 101

Query: 145 YLWQS 149
            +W +
Sbjct: 102 AIWAT 106

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 30/202 (14%), Positives = 65/202 (32%), Gaps = 36/202 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK---------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 563
             + ++        G +Y+               Q+ ++K L ++ G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 564 AKLQHRNLVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLFD---PSRTHLLGWQTR---- 614
             LQ     +L          I   +   +      F +      S    L    +    
Sbjct: 101 KPLQVNKWKKLYST---PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157

Query: 615 VKIIEGIAQGLL----YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFCGD 668
            + +  +A  LL    +LH+      +H ++ A NI +D +   ++  + +G A  +C  
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

Query: 669 EL-----QGNTKRVVGTYGYMS 685
                  +G+     G   ++S
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFIS 236

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 36/189 (19%), Positives = 67/189 (35%), Gaps = 27/189 (14%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 575
           K+G GGFG +Y        ++ A   VK    ++G    E K    + AK          
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV-AKKDCIKKWIER 102

Query: 576 GCCVEQGEKILIY---EYMPNKSLNFFLFD---PSRTHLLGWQTR--VKIIEGIAQGLL- 626
                 G  +           +S  F + +        + G         +  +   +L 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162

Query: 627 ---YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFCGDEL-----QGNTKR 676
              Y+H+      +H D+KA+N+LL      ++  +D+G++  +C +       +   K 
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 677 VVGTYGYMS 685
             GT  + S
Sbjct: 220 HNGTIEFTS 228

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 38/194 (19%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
            ++ +  ++GEG FG +++G  LLN Q+VA+K     S + Q   E++   +L       
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL 626
            +  +     E    +L+ +          L  PS   LL    R   VK +   A+ +L
Sbjct: 67  GIPNVYYFGQEGLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQML 116

Query: 627 ----YLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARMFCGDELQGN---- 673
                +H+ S   +++RD+K  N L+    +       + DFGM + +  D +       
Sbjct: 117 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR-DPVTKQHIPY 172

Query: 674 --TKRVVGTYGYMS 685
              K + GT  YMS
Sbjct: 173 REKKNLSGTARYMS 186

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.3 bits (156), Expect = 8e-11
 Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 38/186 (20%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLM 575
           K+G G FG +Y G  +   +EVA+K   + ++  Q L E K    +   LQ    +  + 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69

Query: 576 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL----YL 628
              VE    +L+ +          L  PS   L  + +R   +K +  +A  ++    ++
Sbjct: 70  WFGVEGDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMARMFCGDELQG------NTKRVVG 679
           H  S    +HRD+K  N L+          I DFG+A+ +  D            K + G
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR-DTSTHQHIPYRENKNLTG 175

Query: 680 TYGYMS 685
           T  Y S
Sbjct: 176 TARYAS 181

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 40/194 (20%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQH- 568
             + +  K+G G FG +Y G  +  G+EVA+K   + ++  Q   E K    +   +Q  
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGG 64

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGL 625
             +  +  C  E    +++ E          L  PS   L  + +R   +K +  +A  +
Sbjct: 65  VGIPTIRWCGAEGDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQM 114

Query: 626 L----YLHQYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMARMFCGDELQGNT---- 674
           +    Y+H  +    IHRD+K  N L+          I DFG+A+ +   + + +     
Sbjct: 115 ISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR--DARTHQHIPY 169

Query: 675 ---KRVVGTYGYMS 685
              K + GT  Y S
Sbjct: 170 RENKNLTGTARYAS 183

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 61.7 bits (150), Expect = 5e-10
 Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 46/214 (21%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR------N 570
           +G+G FG V K       Q VA+K + ++     Q  +E +    ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160

Query: 571 LVRLMGCCVEQGEKILIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 624
           ++ ++     +    + +E +  N     K   F  F                   I Q 
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS--------ILQC 212

Query: 625 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTY- 681
           L  LH   + RIIH DLK  NILL        K+ DFG +  +            V TY 
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQR--------VYTYI 260

Query: 682 ---GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
               Y +PE  L   + +  D++S G +L E LT
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 56.1 bits (135), Expect = 9e-10
 Identities = 18/118 (15%), Positives = 41/118 (34%), Gaps = 14/118 (11%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +     +     L + +  + L   +          + Y+      +W +N +     
Sbjct: 3   NVLLSGQTLHADHSLQAGA--YTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNTS 141
           S   LT+ ++GNLV+ +  +  +W S    +       L   G  V+     +S   +
Sbjct: 51  SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPVLWSLGPN 108

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.4 bits (148), Expect = 1e-09
 Identities = 98/638 (15%), Positives = 165/638 (25%), Gaps = 209/638 (32%)

Query: 224 DPTNTSYLFRPIVEQKEDEIIYR---------YESYSSRILMMLKINPSGDVQRLIWH-- 272
           D  + +      +  K++E++ +         Y+   S I    +  PS   +  I    
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QPSMMTRMYIEQRD 117

Query: 273 EMSTGWQVF----------FTA---------PNNFCQLYGY--CG----ANSVCSVDDT- 306
            +    QVF          +           P     + G    G    A  VC      
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177

Query: 307 ------------ANCECLKGFKLKLQN--NQTWPRECVRSHSSDCITRE---------RF 343
                        NC   +     LQ    Q  P    RS  S  I            R 
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 344 IKFDDIKLPYLV--DVSLNESMNLKECEAECLK----NC----TCRAYANSKVTGGGSGC 393
           +K    +   LV  +V            A+       +C    T R     +VT   S  
Sbjct: 238 LKSKPYENCLLVLLNV----------QNAKAWNAFNLSCKILLTTR---FKQVTDFLSAA 284

Query: 394 LMWFGDLIDIRKITGYNNGQPIYVRV----PDSEPDKKL----LWIFVILVLPAALLPGF 445
                 L         +  + + ++     P   P + L      + +I    A  +   
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII----AESIRDG 340

Query: 446 FIFCRWRR-KH---KEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLP 501
                W   KH    +  T +ESS ++L             EP+E        R+     
Sbjct: 341 --LATWDNWKHVNCDKLTTIIESSLNVL-------------EPAE-------YRK----- 373

Query: 502 CFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 561
            F   SV      F     +       ++   + +   V V +L   S            
Sbjct: 374 MFDRLSV------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS------------ 415

Query: 562 LIAKLQHRNLVRLMGC-------CVEQGE--KILIYEYMPNKSLNFFLFDPSRTHLLGWQ 612
           L+ K    + + +             +    + ++  Y  N    F   D    +L    
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY--NIPKTFDSDDLIPPYLDQ-- 471

Query: 613 TRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFC 666
                         Y + +       +    R      + LD   +  KI     A    
Sbjct: 472 --------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNAS 517

Query: 667 GDELQGNTKRVVGTY-GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF 725
           G  L  NT + +  Y  Y+      D  +                        V  I  F
Sbjct: 518 GSIL--NTLQQLKFYKPYICDN---DPKYERL---------------------VNAILDF 551

Query: 726 NLLGHAWNLWKDNRAYELLSPALQHEAS--YQMLNRYI 761
            L     NL    +  +LL  AL  E    ++  ++ +
Sbjct: 552 -LPKIEENLICS-KYTDLLRIALMAEDEAIFEEAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 1e-06
 Identities = 56/416 (13%), Positives = 116/416 (27%), Gaps = 152/416 (36%)

Query: 434 ILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD---IYMSVATRTNEPSEGDGD 490
           I++   A+     +F  W    K++E   +  +++L+ +   +   + T   +PS     
Sbjct: 54  IIMSKDAVSGTLRLF--WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS----- 106

Query: 491 AKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG 550
                                T  +  Q            + +L N  +V  K  +    
Sbjct: 107 -------------------MMTRMYIEQ------------RDRLYNDNQVFAKY-NVSRL 134

Query: 551 QGLKEFKNEMMLIAKLQHRNLVRL--MGCCVEQGEKILIYE----YMPNKSLNFFLFDPS 604
           Q   + +  ++   +L+    V +  +      G+  +  +    Y     ++F +F   
Sbjct: 135 QPYLKLRQALL---ELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQCKMDFKIF--- 185

Query: 605 RTHLLGWQT--RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 662
                 W         E + + L  L         ++         D   N K+      
Sbjct: 186 ------WLNLKNCNSPETVLEMLQKLL--------YQIDPNWTSRSDHSSNIKLRI---- 227

Query: 663 RMFCGDELQGNTKRVVGTYGYMSPEYA-----LDGLFSVKS-DVFSFGVLLLETLTSKRN 716
                  +Q   +R++      S  Y      L  + + K+ + F+    +L  LT+ R 
Sbjct: 228 -----HSIQAELRRLL-----KSKPYENCLLVLLNVQNAKAWNAFNLSCKIL--LTT-RF 274

Query: 717 TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRP 776
             V D  S     H         + +  S  L  +    +L +Y+               
Sbjct: 275 KQVTDFLSAATTTH--------ISLDHHSMTLTPDEVKSLLLKYL--------------- 311

Query: 777 TMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLIS 832
                                          +   LP     E  + N   LS+I+
Sbjct: 312 -----------------------------DCRPQDLPR----EVLTTNPRRLSIIA 334

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 1e-04
 Identities = 60/373 (16%), Positives = 98/373 (26%), Gaps = 142/373 (38%)

Query: 49  LGFFSPGKS--------KYKYLGIWYKQVPDTVVW--VANRNSPIVDSNAVLTIGNNGNL 98
           LG    GK+         YK       ++   + W  + N NSP      VL +      
Sbjct: 159 LGS---GKTWVALDVCLSYKVQ----CKMDFKIFWLNLKNCNSP----ETVLEMLQK--- 204

Query: 99  VLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYL----------WQ 148
            LL Q D   W+S             + +    LR    S   E   L          W 
Sbjct: 205 -LLYQIDPN-WTSRSDHSSNIK--LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260

Query: 149 SFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSV 208
           +F+     LL          T R + +T     D  S    T         H+ +     
Sbjct: 261 AFNLSCKILL----------TTRFKQVT-----DFLSAATTT---------HISL----- 291

Query: 209 KLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQR 268
                   +  +    P     L    ++ +  ++    E        +L  NP      
Sbjct: 292 --------DHHSMTLTPDEVKSLLLKYLDCRPQDL--PRE--------VLTTNPR--RLS 331

Query: 269 LIW---HEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECL-KGFKLKLQNNQT 324
           +I     +    W        N+  +                NC+ L    +  L N   
Sbjct: 332 IIAESIRDGLATWD-------NWKHV----------------NCDKLTTIIESSL-NVLE 367

Query: 325 WPRECVRSHSSDCITRERFIKF----DDIKLPYLV------DVSLNESMN-LKECEAECL 373
            P E           R+ F +         +P ++      DV  ++ M  + +     L
Sbjct: 368 -PAE----------YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416

Query: 374 -----KNCTCRAY 381
                K  T    
Sbjct: 417 VEKQPKESTISIP 429

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 54.9 bits (132), Expect = 3e-09
 Identities = 17/124 (13%), Positives = 45/124 (36%), Gaps = 13/124 (10%)

Query: 20  LLSLATDTITPATL-IGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVAN 78
           + S   D   P  L   +  +++  + ++     +          + Y    +  +W  N
Sbjct: 4   IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATN 55

Query: 79  RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--F 136
                  +     +  +G LV++   +  +W S ++ +  + V  L    N+V+     +
Sbjct: 56  TGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDALW 113

Query: 137 SSNT 140
           ++ T
Sbjct: 114 ATQT 117

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 54.1 bits (130), Expect = 4e-09
 Identities = 19/120 (15%), Positives = 41/120 (34%), Gaps = 15/120 (12%)

Query: 23  LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSP 82
              + +    ++    +L + +   +L              + Y        W +N +  
Sbjct: 4   FTNNLLFSGQVLYGDGRLTAKN--HQLVMQGDCNL------VLYGG---KYGWQSNTHG- 51

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL--REKFSSNT 140
               +  L + + G L++ +     IWSS  S +    V  L D G  V+     F +++
Sbjct: 52  -NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGPAIFETSS 110

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 53.7 bits (129), Expect = 5e-09
 Identities = 24/118 (20%), Positives = 46/118 (38%), Gaps = 14/118 (11%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +     +  GE L  ++  +                + Y    D  +W  N      D
Sbjct: 2   NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNTS 141
               L++ ++GNLV+ +  +  IW+SN   E  N V  L    N+V+     +++ T+
Sbjct: 50  RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWATGTN 107

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 51.8 bits (124), Expect = 2e-08
 Identities = 23/120 (19%), Positives = 37/120 (30%), Gaps = 17/120 (14%)

Query: 23  LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSP 82
           L T+ +     +     L +    F+L           Y G W              N+ 
Sbjct: 1   LGTNYLLSGQTLDTEGHLKNGD--FDLVMQDDCNLVL-YNGNWQS------------NTA 45

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL--REKFSSNT 140
               +  LT+ + G LV+ N     +W S       N  A +   G LV+     F  + 
Sbjct: 46  NNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFKIDP 105

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 49.1 bits (117), Expect = 2e-07
 Identities = 15/109 (13%), Positives = 41/109 (37%), Gaps = 10/109 (9%)

Query: 24  ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPI 83
             + +  + ++ D  +L  +++ + L              +  K     +VW +  +   
Sbjct: 5   VRNVLFSSQVMYDNAQL--ATRDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55

Query: 84  VDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL 132
              +  + +G++G L + +     ++ SN   +  + V  L   G  V+
Sbjct: 56  -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 41.4 bits (97), Expect = 1e-04
 Identities = 14/73 (19%), Positives = 30/73 (41%), Gaps = 7/73 (9%)

Query: 78  NRNSPIVDSNAVLTIGNNGNLVL-LNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKF 136
             N+ +   +  L + ++ NLVL       I+W S  S   ++   +L  +G L + +  
Sbjct: 16  YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITD-- 73

Query: 137 SSNTSEGSYLWQS 149
                  + ++ S
Sbjct: 74  ----DRLNTVFVS 82

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 53/235 (22%), Positives = 84/235 (35%), Gaps = 54/235 (22%)

Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR- 569
           F +  K+G+G FG V   + + N +  AVK + +          E      ++ K+Q+  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92

Query: 570 ----NLVRLMGCCVEQG------EK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 617
               N+V+  G  +         E     +YE +     N+  F      L   +     
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEII--TRNNYNGFHIEDIKLYCIE----- 145

Query: 618 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR- 676
              I + L YL    ++ + H DLK  NILLD     K                  TK  
Sbjct: 146 ---ILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 677 -------------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
                              ++ T  Y +PE  L+  + V SD++SFG +L E  T
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.1 bits (123), Expect = 7e-07
 Identities = 52/241 (21%), Positives = 83/241 (34%), Gaps = 70/241 (29%)

Query: 515 FSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSG---QGLKEFK----------NE 559
           + +   LGEG FG V +       G+ VAVK + +          E +          N 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 560 MMLIAKL----QHRN---LV-RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 611
                ++    +H     +V  L+G           Y+++  K   F  F       + +
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGLST--------YDFI--KENGFLPFRLDHIRKMAY 125

Query: 612 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----------------- 654
           Q        I + + +LH     ++ H DLK  NIL                        
Sbjct: 126 Q--------ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

Query: 655 --KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 711
             K+ DFG A  +  +        +V T  Y +PE  L  L +S   DV+S G +L+E  
Sbjct: 175 DIKVVDFGSA-TYDDEHH----STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYY 228

Query: 712 T 712
            
Sbjct: 229 L 229

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 47/236 (19%), Positives = 81/236 (34%), Gaps = 60/236 (25%)

Query: 515 FSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR 569
           + +   LGEG FG V +         +VA+K + +          E      ++ K++ +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76

Query: 570 ------NLVRLMGCCVEQG------EK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 615
                   V +       G      E      +E++  K  NF  +       + +Q   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL--KENNFQPYPLPHVRHMAYQ--- 131

Query: 616 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-------------------KI 656
                +   L +LH     ++ H DLK  NIL  +                       ++
Sbjct: 132 -----LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 712
           +DFG A  F  +        +V T  Y  PE  L+  ++   DV+S G +L E   
Sbjct: 184 ADFGSA-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 54/265 (20%), Positives = 88/265 (33%), Gaps = 86/265 (32%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--------HRN 570
           KLG G F  V+    +   + VA+K + S      +   +E+ L+  ++           
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR----------VK-IIE 619
           +V+L+      G          N +    +F+    HLL W  +          VK II+
Sbjct: 103 VVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNILL------------------------------- 648
            + QGL YLH  ++ RIIH D+K  NILL                               
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 649 ------------------DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
                                +  KI+D G A  +            + T  Y S E  +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLI 266

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKR 715
              ++  +D++S   +  E  T   
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDY 291

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 46.8 bits (110), Expect = 9e-06
 Identities = 21/80 (26%), Positives = 28/80 (35%), Gaps = 11/80 (13%)

Query: 70  PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
            D  VW  N         AVL    NG + +L   +  +W+S  SR     V  L    N
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224

Query: 130 LVLREKFSSNTSEGSYLWQS 149
           L +          G  LW +
Sbjct: 225 LAIY---------GGALWTT 235

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 45.7 bits (107), Expect = 2e-05
 Identities = 25/147 (17%), Positives = 49/147 (33%), Gaps = 12/147 (8%)

Query: 71  DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
           D  VW +N       +     + ++G LV+L   + I WSS     + N V  L     +
Sbjct: 44  DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100

Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFT 190
            +             LW S      ++++  N    L + +             S     
Sbjct: 101 TIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP 151

Query: 191 FRLEIRVLPHLCIYNGSVKLSCTGPWN 217
           +RL +    +L +++   ++  T    
Sbjct: 152 YRLSMETDCNLVLFDRDDRVWSTNTAG 178

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 43.9 bits (102), Expect = 1e-04
 Identities = 35/211 (16%), Positives = 61/211 (28%), Gaps = 33/211 (15%)

Query: 22  SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNS 81
            + T  +     +  G+ L+S +Q F+L     G      L I         VWVAN   
Sbjct: 11  GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62

Query: 82  PIV------DSNAVLTIGNNGNLVLLNQTDGIIWSS-----NLSREVKNPVAQLLDTGNL 130
           P        +  A L         L + +   +W +       + +       L D GN+
Sbjct: 63  PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122

Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLI--GMNMGWDLKTGRERY-------LTSWRTA 181
           VL +  +      +         S  L     +  G     G  +        L ++   
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPN 182

Query: 182 DDPS-----PGNFTFRLEIRVLPHLCIYNGS 207
              +      G    R   +   +L +Y   
Sbjct: 183 GAATWNAGTQGKGAVRAVFQGDGNLVVYGAG 213

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 43.5 bits (101), Expect = 1e-04
 Identities = 13/88 (14%), Positives = 30/88 (34%), Gaps = 7/88 (7%)

Query: 71  DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
               W A                 +GNLV+    + ++W S+ +    + V +L   G++
Sbjct: 183 GAATWNAGTQGK---GAVRAVFQGDGNLVVYGAGNAVLWHSH-TGGHASAVLRLQANGSI 238

Query: 131 VL---REKFSSNTSEGSYLWQSFDCPSD 155
            +   +  ++    + +Y       P  
Sbjct: 239 AILDEKPVWARFGFQPTYRHIRKINPDQ 266

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	834
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.85
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.85
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.83
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.81
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.81
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.74
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.72
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.7
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.67
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.65
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.58
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.57
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.5
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.29
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.23
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.1
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.04
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.73
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.36
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.32
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.2
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.81
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.77
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.76
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.41
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.34
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.08
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.08
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.03
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.01
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.0
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.95
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.51
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.42
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.09
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.45
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.44
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.41
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.34
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.75
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	89.48
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	83.58
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.71

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.5e-53  Score=456.20  Aligned_cols=262  Identities=28%  Similarity=0.436  Sum_probs=217.8

Q ss_pred             cCccccceecccCccceEeeEec------CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            67889999999999999999864      377899999988777778899999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          587 IYEYMPNKSLNFFLFDP----------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                      |||||++|+|.++|...          .....++|.+++.|+.|||+||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999643          23457999999999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccc
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......+.  ..    ..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~----~i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IE----CI  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH----HH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HH
Confidence            99999997755444444445679999999999999999999999999999999999 8999876543211  11    11


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      ..+...         ..+..++..+.+|+..||+.||++||||+||++.|+++.+..
T Consensus       244 ~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          244 TQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            111111         111233456889999999999999999999999999885443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=457.35  Aligned_cols=262  Identities=28%  Similarity=0.438  Sum_probs=210.1

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            367888999999999999999864      37889999998877777889999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC
Q 003287          586 LIYEYMPNKSLNFFLFDPS------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  653 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~  653 (834)
                      ||||||++|+|.++++...            ....++|.+++.|+.|||+||+|||+.+   ||||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            9999999999999996532            1246999999999999999999999987   999999999999999999


Q ss_pred             eeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccc
Q 003287          654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       654 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  732 (834)
                      +||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......+.  ..   
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~---  271 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--ID---  271 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--HH---
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--HH---
Confidence            99999999998765544444556789999999999999999999999999999999999 8999876443211  11   


Q ss_pred             ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       733 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                       ....+.  ++.       .+..++..+.+|+..||+.||++||||+||++.|+.+.+.
T Consensus       272 -~i~~g~--~~~-------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 -CITQGR--ELE-------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -HHHHTC--CCC-------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -HHHcCC--CCC-------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence             111111  111       1122345688999999999999999999999999998543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-52  Score=450.48  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=214.2

Q ss_pred             cCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .++++.++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45778899999999999999863      46789999997543 345678999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          586 LIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      ||||||++|+|.++|....             ....++|.++++|+.|||+||+|||+.+   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996432             1246899999999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccc
Q 003287          653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  731 (834)
                      .+||+|||+|+.+...+.........||+.|||||++.++.|+.++|||||||+||||+| |+.||......+.  ..  
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~--~~--  258 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--VE--  258 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH--HH--
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH--HH--
Confidence            999999999998765554444556789999999999999999999999999999999998 8999876543211  11  


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                        ....+...         ..+..++..+.+|+..||+.+|++||||.||++.|+..
T Consensus       259 --~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 --MIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              11111111         11223445688999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-51  Score=442.29  Aligned_cols=264  Identities=27%  Similarity=0.424  Sum_probs=207.1

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .+++++.++||+|+||+||+|++.+  .||||+++..  ..+..++|.+|+.++++++|||||++++++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4678899999999999999998753  6999998643  34566889999999999999999999998865 56899999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      ||++|+|.++|...  ...+++.+++.|+.|||+||+|||+.+   ||||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999643  346999999999999999999999987   9999999999999999999999999998765444


Q ss_pred             cccccccccccccccCcccccC---CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .........||+.|||||++.+   +.|+.++|||||||+||||+||+.||......... .    .....+    ...|
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-~----~~~~~~----~~~p  257 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-I----FMVGRG----YASP  257 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-H----HHHHTT----CCCC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-H----HHHhcC----CCCC
Confidence            3444456789999999999964   46899999999999999999999999754422110 0    001111    0111


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      .+ ......++..+.+|+..||+.+|++||||.||++.|+.+...+|
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            11 11122344568889999999999999999999999998865554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.4e-50  Score=435.03  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=202.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|+++++||+|+||+||+|+.. +|+.||||++.+.  .....+.|.+|+.+|++++|||||++++++.+++..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999875 5999999999754  34456789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      ||++|+|.++|... ....+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+... 
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            99999999999543 2345789999999999999999999988   999999999999999999999999999876321 


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                       .......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+....  .   ..... +...     .  
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~---~~i~~-~~~~-----~--  244 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL--V---LKIIS-GSFP-----P--  244 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H---HHHHH-TCCC-----C--
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--H---HHHHc-CCCC-----C--
Confidence             1123446799999999999999999999999999999999999999976443211  0   00111 1110     0  


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        .+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11123456788999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5e-50  Score=439.95  Aligned_cols=268  Identities=26%  Similarity=0.386  Sum_probs=217.7

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCC-CceeeEe
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQH-RNLVRLM  575 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~  575 (834)
                      .....+...++|++.++||+|+||+||+|++..      ++.||||++.... ....++|.+|+++|.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            344555667899999999999999999998642      3689999997654 3456789999999999965 9999999


Q ss_pred             eeEeec-CeEEEEEEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC
Q 003287          576 GCCVEQ-GEKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL  641 (834)
Q Consensus       576 ~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DI  641 (834)
                      |+|.+. +..+||||||++|+|.++|+...             ....+++.+++.++.|||+||+|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            999765 56899999999999999996432             1345899999999999999999999987   999999


Q ss_pred             CCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCC
Q 003287          642 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVY  720 (834)
Q Consensus       642 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~  720 (834)
                      ||+||||++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765544444556789999999999999999999999999999999998 89998764


Q ss_pred             CcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .....     ....+..+.  +..       .+...+..+.+++..||+.||++|||+.||++.|+.+
T Consensus       292 ~~~~~-----~~~~i~~g~--~~~-------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          292 KIDEE-----FCRRLKEGT--RMR-------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCSHH-----HHHHHHHTC--CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHH-----HHHHHHcCC--CCC-------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            42211     011111111  111       1112345678899999999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.6e-49  Score=426.25  Aligned_cols=271  Identities=24%  Similarity=0.298  Sum_probs=205.6

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC----eEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~  588 (834)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++++|.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4688899999999999999998 689999999975432 2233445677777899999999999998764    579999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      |||++|+|.++|++    ..+++..+.+++.|+++||+|||+.     +.++|+||||||+||||+.++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999953    4589999999999999999999986     23469999999999999999999999999998


Q ss_pred             cccCCCcc--cccccccccccccCcccccCC------CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccc---
Q 003287          664 MFCGDELQ--GNTKRVVGTYGYMSPEYALDG------LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW---  732 (834)
Q Consensus       664 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---  732 (834)
                      ........  .......||+.|||||++.+.      .++.++|||||||+||||+||+.|+...............   
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543321  223346799999999999764      4788999999999999999999887654332221111100   


Q ss_pred             --ccccccccccccCccccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          733 --NLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       733 --~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                        ............+|.+... ...+....+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence              0000001112223333222 22345677889999999999999999999999998873

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.9e-49  Score=427.67  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=208.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +.|+++++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 59999999997665555677899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++.+    ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+....  
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            99999999843    35899999999999999999999998   9999999999999999999999999999774432  


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........  ..    .....     ..+.+.  
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~----~i~~~-----~~~~~~--  291 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MK----MIRDN-----LPPRLK--  291 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHS-----SCCCCS--
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HH----HHHcC-----CCCCCC--
Confidence            233457899999999999999999999999999999999999999975432211  10    00001     111111  


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .....+..+.+|+..||+.||++|||+.|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11223456788999999999999999999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.7e-49  Score=427.24  Aligned_cols=256  Identities=22%  Similarity=0.239  Sum_probs=206.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .+.|++.++||+|+||+||+|+.. +|+.||||+++....     +.+|+.++++++|||||++++++.+++..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            357889999999999999999975 589999999975422     24799999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-CeeeccccccccccCCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE  669 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~~~~~  669 (834)
                      |++|+|.++|.+   ...+++.++..++.||+.||+|||+++   ||||||||+||||+.++ ++||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999953   346999999999999999999999988   99999999999999988 69999999999875433


Q ss_pred             ccc---ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          670 LQG---NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       670 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.........     .........      
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~i~~~~~~------  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-----LKIASEPPP------  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-----HHHHHSCCG------
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-----HHHHcCCCC------
Confidence            221   223467999999999999999999999999999999999999999764432210     001111000      


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                        ....+...+..+.+++.+||+.||++|||+.|+++.|......
T Consensus       275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence              0111223446688899999999999999999999988765433

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-49  Score=425.49  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=209.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++++.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            67999999999999999999875 5899999999754   2345678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+   ...+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999953   356999999999999999999999998   999999999999999999999999999987655


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .........+||+.|||||++.+..|+.++||||+||+||||++|+.||...+....  ..   .. ....      ..+
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~---~i-~~~~------~~~  253 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI--FA---KI-IKLE------YDF  253 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HH-HHTC------CCC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HH-HcCC------CCC
Confidence            444455567899999999999999999999999999999999999999976443211  10   00 0010      001


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl  782 (834)
                          +...+..+.+|+.+||+.||++|||++|++
T Consensus       254 ----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 ----PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                112345678899999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-48  Score=415.12  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=197.9

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee----cCeEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILI  587 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV  587 (834)
                      |++.++||+|+||+||+|+.. +++.||||++...  .....+.|.+|+.++++++|||||++++++.+    +...+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            467788999999999999875 5889999999654  34456789999999999999999999999875    3468999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~~~  666 (834)
                      ||||++|+|.+++.+   ...+++..+..++.||++||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999953   456899999999999999999999875 35999999999999984 7999999999998643


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .    .......||+.|||||++.+ .|+.++|||||||+||||+||+.||........ +.    .....+     ..+
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~----~~i~~~-----~~~  248 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IY----RRVTSG-----VKP  248 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HH----HHHTTT-----CCC
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HH----HHHHcC-----CCC
Confidence            2    22345689999999998865 699999999999999999999999964332110 00    000111     000


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         ...+...+..+.+|+..||+.||++|||+.|+++
T Consensus       249 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1111222345788999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.6e-48  Score=429.09  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=208.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +.|+++++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            57999999999999999999975 58999999997765556677899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++..    ..+++.++..++.||++||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....  
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--  301 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  301 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence            99999999843    35899999999999999999999998   9999999999999999999999999999774432  


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||........  ..    .....     ..+.+.  
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~----~i~~~-----~~~~~~--  368 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MK----MIRDN-----LPPRLK--  368 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHS-----CCCCCS--
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HH----HHHcC-----CCCCCc--
Confidence            233457899999999999999999999999999999999999999975432211  10    00111     111111  


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .....+..+.+|+..||+.||++|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11123456788999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.7e-48  Score=406.38  Aligned_cols=245  Identities=24%  Similarity=0.369  Sum_probs=190.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999875 58999999997542   334567999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+ +|+|.+++.+   ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6789888843   356999999999999999999999998   999999999999999999999999999875432


Q ss_pred             CcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .   ......||+.|||||++.+..+ +.++||||+||++|||++|+.||........  ..    ....+.      ..
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~--~~----~i~~~~------~~  230 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL--FK----NISNGV------YT  230 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTC------CC
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHcCC------CC
Confidence            2   2334689999999999998876 5799999999999999999999975432211  00    000110      00


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +    +...+..+.+|+.+||+.||++|||++|+++
T Consensus       231 ~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1    1123456788999999999999999999987

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-47  Score=409.89  Aligned_cols=251  Identities=25%  Similarity=0.335  Sum_probs=192.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC--------
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--------  582 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------  582 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999875 58999999997543 345578999999999999999999999997654        


Q ss_pred             ----eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecc
Q 003287          583 ----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       583 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                          ..++||||+++|+|.+++..........+..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976554455677888999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCccc----------ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccc
Q 003287          659 FGMARMFCGDELQG----------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL  728 (834)
Q Consensus       659 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~  728 (834)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||+||||++   ||...... ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-~~~~  237 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-VRTL  237 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-HHHH
Confidence            99999875432211          1234579999999999999999999999999999999996   65421110 0000


Q ss_pred             ccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          729 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       729 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                                  ........ +.........+.+|+.+||+.||++|||+.|+++
T Consensus       238 ------------~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          238 ------------TDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ------------HHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------HHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                        00001011 1222334455678999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.2e-48  Score=414.78  Aligned_cols=247  Identities=24%  Similarity=0.301  Sum_probs=196.2

Q ss_pred             cCccccceecccCccceEeeEec----CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ++|++++.||+|+||+||+|+..    .++.||||++++..  .....++.+|+.+|++++|||||++++++.+++..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    37899999997542  2234578899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++.+   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999953   356899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...  .......||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+.  ..   ... ...      .
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~---~i~-~~~------~  243 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MT---MIL-KAK------L  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHH-HCC------C
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH--HH---HHH-cCC------C
Confidence            322  223446899999999999999999999999999999999999999976443221  10   000 010      0


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCH-----HHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTM-----SKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~  783 (834)
                      .    .+...+..+.+|+..||+.||++|||+     +|+++
T Consensus       244 ~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 G----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            0    111234567889999999999999984     56653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=399.51  Aligned_cols=264  Identities=21%  Similarity=0.309  Sum_probs=201.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEee------cCe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QGE  583 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  583 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||++++..  ....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            67999999999999999999875 59999999997542  3445678999999999999999999998764      367


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .+||||||+ |+|.+++.+   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 679888843   457999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCC--cccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cccc--------cc
Q 003287          664 MFCGDE--LQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLG--------HA  731 (834)
Q Consensus       664 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~--------~~  731 (834)
                      .+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.... ....        ..
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            775432  12233457899999999998875 569999999999999999999999976543211 0000        00


Q ss_pred             cccccccccc---cccCcccc---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          732 WNLWKDNRAY---ELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       732 ~~~~~~~~~~---~l~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +.........   ..+.+...   ..........+.+|+.+||+.||++|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000000   00000000   0011122456789999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-43  Score=386.69  Aligned_cols=283  Identities=36%  Similarity=0.608  Sum_probs=237.3

Q ss_pred             ccHHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC
Q 003287          503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  582 (834)
Q Consensus       503 ~~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  582 (834)
                      +.+.++...+++|++.+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            33445566789999999999999999999998889999999998776677788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ..++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999996543 2346899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc-cccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRA  740 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~  740 (834)
                      ++...............||+.|+|||++.+..++.++||||||+++|||++|+.|+....... .....+.......+..
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            987544333333344568999999999999999999999999999999999999987544322 1222222222333444


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ...+++.+...........+.+++..||+.+|++||++.|+++.|+.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            555666666566677888999999999999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-43  Score=390.36  Aligned_cols=201  Identities=23%  Similarity=0.351  Sum_probs=172.0

Q ss_pred             HhccCccccceecccCccceEeeEec----CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      ...++|++.++||+|+||+||+|+.+    .++.||||++.+..  ...++.+|+++|..+ +||||+++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999753    36789999986543  345688999999998 799999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeeccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  663 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DFGla~  663 (834)
                      +|||||+++|+|.+++.      .+++.++..++.||++||+|||+++   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999982      4889999999999999999999998   9999999999999877 799999999998


Q ss_pred             cccCCCcc--------------------------cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCC
Q 003287          664 MFCGDELQ--------------------------GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRN  716 (834)
Q Consensus       664 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p  716 (834)
                      ........                          ......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432110                          112335799999999999876 589999999999999999999999


Q ss_pred             CCCCC
Q 003287          717 TGVYD  721 (834)
Q Consensus       717 ~~~~~  721 (834)
                      |....
T Consensus       247 f~~~~  251 (361)
T 4f9c_A          247 FYKAS  251 (361)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            86443

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=8.6e-44  Score=374.88  Aligned_cols=235  Identities=19%  Similarity=0.179  Sum_probs=182.6

Q ss_pred             hccCCCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCC----CceEEEecCC
Q 003287           21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDS----NAVLTIGNNG   96 (834)
Q Consensus        21 ~~~~~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~----~~~l~~~~~g   96 (834)
                      ++++.|+|++||+|.+|++|+|++|+|+||||.++   ++|+   |+ ..+ |||+|||++|+.++    +++|+|+.||
T Consensus        10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G   81 (276)
T 3m7h_A           10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV   81 (276)
T ss_dssp             CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred             ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence            46688999999999999999999999999999543   6787   76 445 99999999999875    7899999999


Q ss_pred             ceEE--ecCCCCeEEeecCCcc-----cccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCcccccccc
Q 003287           97 NLVL--LNQTDGIIWSSNLSRE-----VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKT  169 (834)
Q Consensus        97 ~l~l--~~~~~~~~wst~~~~~-----~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~~t  169 (834)
                      +|||  .|++|.+||+|+++..     ..+..|+|+|+|||||+|        +.+||||  |||||||||||||.++++
T Consensus        82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--------~~~lWqS--~ptdtlLpg~~~~~~l~~  151 (276)
T 3m7h_A           82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--------SLALWNG--TPAIPLVPGAIDSLLLAP  151 (276)
T ss_dssp             SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred             cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--------CceeeCc--cccccccccccccccccc
Confidence            9999  7888999999997642     235689999999999995        3699999  999999999999999999


Q ss_pred             CcceeeEeeccCCCCCCCceEEEeecCCcceEEEEc-CCeEEEEecCCCCceecccCCCccccccceeeccCceEEEEEE
Q 003287          170 GRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYN-GSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYE  248 (834)
Q Consensus       170 g~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~-~~~~~~~~g~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  248 (834)
                      |..  |   ++.+||++|.|+++++++|.  +++|+ ++.+||++|+|++......  +...-...+..++...+.++++
T Consensus       152 g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~--l~~dGnLvl~d~~~~~vWsS~t  222 (276)
T 3m7h_A          152 GSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAV--FQGDGNLVVYGAGNAVLWHSHT  222 (276)
T ss_dssp             SEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEE--ECTTSCEEEECTTSCEEEECSC
T ss_pred             Ccc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEE--EcCCCeEEEEeCCCcEEEEecC
Confidence            876  6   67899999999999999984  55565 4689999999986321100  0000011112221223433333


Q ss_pred             ecCCceeeEEEEccCCCEEEEEEEecCCceEEEEeccCC
Q 003287          249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNN  287 (834)
Q Consensus       249 ~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~~  287 (834)
                      .  ....+|++|+.||+++.|.|   ...|..++.+|+.
T Consensus       223 ~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~  256 (276)
T 3m7h_A          223 G--GHASAVLRLQANGSIAILDE---KPVWARFGFQPTY  256 (276)
T ss_dssp             T--TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred             C--CCCCEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence            2  23358999999999999999   3567777766653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.7e-43  Score=382.28  Aligned_cols=288  Identities=40%  Similarity=0.639  Sum_probs=240.9

Q ss_pred             CCcccHHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccCh-hhHHHHHHHHHHHhccCCCceeeEeeeE
Q 003287          500 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCC  578 (834)
Q Consensus       500 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~  578 (834)
                      +..++..++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++.+++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            456888999999999999999999999999999988899999999976532 2334689999999999999999999999


Q ss_pred             eecCeEEEEEEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          579 VEQGEKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      .+....++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+....+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997643 34459999999999999999999999833349999999999999999999999


Q ss_pred             cccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC---ccccccccccccc
Q 003287          658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD---IESFNLLGHAWNL  734 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~---~~~~~~~~~~~~~  734 (834)
                      |||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....   ........+....
T Consensus       177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999998764332 222334569999999999999999999999999999999999999986321   1222233334444


Q ss_pred             ccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       735 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ........+.+..+...........+.+++..||+.+|++|||+.||++.|++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            455556666676666667778889999999999999999999999999999885

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.5e-43  Score=408.73  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=209.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+....+||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            68999999999999999999875 58999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC--CCeeeccccccccccCCC
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGDE  669 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~--~~vkl~DFGla~~~~~~~  669 (834)
                      ++|+|.++|.+.  ...+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.+....
T Consensus       237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            999999998532  346899999999999999999999998   9999999999999854  899999999999875432


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......||+.|||||++.+..|+.++|||||||+||||++|+.||........  ..   .... .      +....
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~---~i~~-~------~~~~~  376 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LR---NVKS-C------DWNMD  376 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH---HHHT-T------CCCCC
T ss_pred             ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HH---HHHh-C------CCCCC
Confidence               23446799999999999999999999999999999999999999976543211  00   0000 0      00011


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......+..+.+|+..||+.||++||++.|+++
T Consensus       377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112223456788999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.5e-42  Score=401.31  Aligned_cols=249  Identities=23%  Similarity=0.289  Sum_probs=199.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHH---HHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLK---EFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~---~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|+++++||+|+||+||+|+.. +|+.||||++.+..   .....   +.+.++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            378999999999999999999976 58999999996532   12222   234456777888999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ||||||+++|+|..+|.+   ...+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999953   356899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      +...    .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||...........  ..... ..     
T Consensus       342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i--~~~i~-~~-----  409 (689)
T 3v5w_A          342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTL-TM-----  409 (689)
T ss_dssp             CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH--HHHHH-HC-----
T ss_pred             cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhhc-CC-----
Confidence            6433    2344689999999999975 5799999999999999999999999975332211000  00000 00     


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                       ..    ..+...+..+.+|+..||+.||++|++     ++|+++
T Consensus       410 -~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 -AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -CC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -CC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence             00    111223456788999999999999998     677764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.3e-42  Score=373.64  Aligned_cols=269  Identities=26%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             HHhccCccccceecccCccceEeeEecCCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .....+|++.+.||+|+||+||+|+. .++.||||++....  ....+++.+|+.++++++||||+++++++.+....++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34457899999999999999999987 68899999997653  3455789999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++........+++..++.++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999999965443345899999999999999999999875 349999999999999999999999999998643


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........     .....     ...
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~-----~~~~~-----~~~  258 (309)
T 3p86_A          191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA-----VGFKC-----KRL  258 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-----HHHSC-----CCC
T ss_pred             ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhcC-----CCC
Confidence            221  223345789999999999999999999999999999999999999976543221000     00000     000


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCC
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  795 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p  795 (834)
                      .    .+......+.+++..||+.+|++||++.|+++.|+.+......|
T Consensus       259 ~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          259 E----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            0    11123346788999999999999999999999999986554333

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.4e-41  Score=362.67  Aligned_cols=283  Identities=36%  Similarity=0.551  Sum_probs=228.7

Q ss_pred             CCcccHHHHHHhccCcccc------ceecccCccceEeeEecCCcEEEEEEeccc----ChhhHHHHHHHHHHHhccCCC
Q 003287          500 LPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKLQHR  569 (834)
Q Consensus       500 ~~~~~~~~~~~~~~~f~~~------~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~----~~~~~~~~~~E~~~l~~l~H~  569 (834)
                      ...|++.++..++++|...      +.||+|+||.||+|+. +++.||||++...    .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568889999999988877      8999999999999987 6889999998653    234567899999999999999


Q ss_pred             ceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       570 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                      ||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||+|||+.+   |+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999976545567999999999999999999999987   99999999999999


Q ss_pred             CCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccc
Q 003287          650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  729 (834)
Q Consensus       650 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~  729 (834)
                      .++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|..|+........ +..
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence            999999999999987644332333344578999999998865 588999999999999999999999876443221 000


Q ss_pred             ccccccc-ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          730 HAWNLWK-DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       730 ~~~~~~~-~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      ....... .......+++.+ ..........+.+++..||+.+|++||++.++++.|+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            0000000 111222333322 2234556778999999999999999999999999999873

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-41  Score=377.60  Aligned_cols=260  Identities=27%  Similarity=0.433  Sum_probs=213.9

Q ss_pred             ccCccccceecccCccceEeeEec--------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  581 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  581 (834)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            478999999999999999999852        35679999997653 34567899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  648 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl  648 (834)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||++||+|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999964321             245889999999999999999999987   9999999999999


Q ss_pred             cCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccc
Q 003287          649 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  727 (834)
Q Consensus       649 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~  727 (834)
                      +.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            9999999999999987755444344444567889999999999999999999999999999999 99998764432210 


Q ss_pred             cccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       728 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                           .....+..         ...+..+...+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       316 -----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          316 -----KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             -----HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 01111110         0111223456888999999999999999999999998873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=367.14  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=215.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.++||+|+||+||+|+.. +++.||+|++........+.|.+|+.++.+++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367999999999999999999975 5899999999877777788999999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++...  ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999542  346899999999999999999999988   99999999999999999999999999987643322


Q ss_pred             cc------------ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccc
Q 003287          671 QG------------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  738 (834)
Q Consensus       671 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  738 (834)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+..............       
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-------  236 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-------  236 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-------
Confidence            11            11145799999999999999999999999999999999999999875443222111100       


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                        ....+..    .+...+..+.+++..||+.+|++||++.|+++.|+.+...+
T Consensus       237 --~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          237 --RGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             --HHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --hcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence              0000000    01122345778999999999999999999999999885544

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.4e-41  Score=367.04  Aligned_cols=273  Identities=25%  Similarity=0.330  Sum_probs=210.6

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC----eEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l  586 (834)
                      ..++|++.++||+|+||+||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.+..    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3478999999999999999999874 7999999997543 33455677999999999999999999998855    3699


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------CCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                      ||||+++|+|.+++..    ..+++..+..++.|+++||+|||+.       +..+|+||||||+|||++.++.+||+||
T Consensus       100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999943    3589999999999999999999987       1113999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccC-----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccc-cc---
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL-GH---  730 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~-~~---  730 (834)
                      |+++.+.............||+.|+|||++.+     ..++.++|||||||++|||++|+.||........... ..   
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99988765544444445679999999999987     3567789999999999999999999875433211000 00   


Q ss_pred             --ccccccccccccccCccccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          731 --AWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       731 --~~~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                        ....+..........+.+... ........+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              000000000011111111111 12234567899999999999999999999999998873

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.7e-41  Score=360.40  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=207.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999864 6899999999766656677899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++|+|.+++.+    ..+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  170 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence            999999999843    35899999999999999999999987   9999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........     .... .......      
T Consensus       171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~-~~~~~~~------  237 (297)
T 3fxz_A          171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIAT-NGTPELQ------  237 (297)
T ss_dssp             -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHH-HCSCCCS------
T ss_pred             -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHh-CCCCCCC------
Confidence             22334579999999999999999999999999999999999999987543221100     0000 0000111      


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .+......+.+++..||+.||++||++.|+++
T Consensus       238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             11223456788999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-41  Score=378.82  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=211.2

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++... ....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3468999999999999999999986 68999999997643 334567899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999953  2345889999999999999999999988   999999999999999999999999999875433


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |..|+........  .    .....+  .....  
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~----~~~~~~--~~~~~--  336 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--R----EFVEKG--GRLPC--  336 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--H----HHHHTT--CCCCC--
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHcC--CCCCC--
Confidence            22222223346788999999999999999999999999999998 9999876443211  0    001111  01111  


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                           +...+..+.+|+..||+.+|++|||+.++++.|+.+.
T Consensus       337 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                 1123356788999999999999999999999998873

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=366.27  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=209.9

Q ss_pred             ccCccccceecccCccceEeeEec----CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|++.+.||+|+||.||+|++.    .+..||||++... .....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468999999999999999999974    3556999999765 44456789999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++++|.+++...  ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999543  346899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          667 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||........  ..    .....  ... 
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~----~~~~~--~~~-  273 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--IS----SVEEG--YRL-  273 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH----HHHTT--CCC-
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHHcC--CCC-
Confidence            43221 12223456788999999999999999999999999999999 9999875443211  00    00000  000 


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                            ..+..++..+.+|+..||+.+|++||++.|+++.|+.+...
T Consensus       274 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          274 ------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                  11112345688899999999999999999999999998443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.7e-41  Score=372.96  Aligned_cols=270  Identities=26%  Similarity=0.384  Sum_probs=216.0

Q ss_pred             ccHHHHHHhccCccccceecccCccceEeeEe------cCCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeE
Q 003287          503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRL  574 (834)
Q Consensus       503 ~~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l  574 (834)
                      +...+.....++|++.+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            44556666789999999999999999999973      246899999997653 34557799999999999 89999999


Q ss_pred             eeeEeecCe-EEEEEEecCCCCchhhhcCCCC------------------------------------------------
Q 003287          575 MGCCVEQGE-KILIYEYMPNKSLNFFLFDPSR------------------------------------------------  605 (834)
Q Consensus       575 ~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------  605 (834)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999988654 8999999999999999965432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          606 ---------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       606 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                                     ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122889999999999999999999987   99999999999999999999999999987654433


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                      ........||+.|+|||++.+..++.++||||||+++|||++ |..||.........     ..........     .  
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~~~~~-----~--  316 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRM-----R--  316 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-----HHHHHHTCCC-----C--
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-----HHHHHcCCCC-----C--
Confidence            333445678999999999999999999999999999999998 99998754422110     0001111000     0  


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                        .+......+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       317 --~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 --APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence              11112346788999999999999999999999998763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-41  Score=364.67  Aligned_cols=276  Identities=26%  Similarity=0.394  Sum_probs=209.4

Q ss_pred             ccCccccceecccCccceEeeEe-----cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  584 (834)
                      .++|++.++||+|+||+||++++     .+++.||||++........+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            47899999999999999999984     25889999999877777778899999999999999999999998654  568


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++|+|.+++...  ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999543  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccc-cccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  742 (834)
                      ....... .......++..|+|||++.+..++.++||||||+++|||++|..|+.....+....... ...........+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6443211 22233457788999999999999999999999999999999999876432211000000 000000000000


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      .+........+..++..+.+++..||+.+|++|||+.|+++.|+.+...+
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            01001111112233467889999999999999999999999999886554

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.5e-41  Score=366.48  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=201.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .++|++.++||+|+||+||+|++. +++    +||+|.+... .....++|.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367999999999999999999864 344    4688888644 3345678999999999999999999999998754 78


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +|+||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999999543  346899999999999999999999987   999999999999999999999999999887


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .............+|..|+|||++.+..++.++|||||||++|||++ |+.||..........      ......  .. 
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~~~--~~-  238 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEKGE--RL-  238 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTTC--CC-
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH------HHHcCC--CC-
Confidence            55444333444567889999999999999999999999999999999 999987644322110      001010  00 


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                            ..+......+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       239 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          239 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                  011123346788999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.7e-41  Score=373.65  Aligned_cols=259  Identities=27%  Similarity=0.438  Sum_probs=199.4

Q ss_pred             ccCccccceecccCccceEeeEec----CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ..+|++.+.||+|+||.||+|++.    ++..||||+++.. .....++|.+|+.++.+++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368999999999999999999875    4678999999765 34456789999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999643  346899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          667 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++ |+.||........  ..    ....+      
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~----~i~~~------  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IK----AVDEG------  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HH----HHHTT------
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC------
Confidence            43211 11222345778999999999999999999999999999998 9999865432211  00    00000      


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                         ........++..+.+++..||+.+|++||++.|++++|+.+..
T Consensus       267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence               0001111234568889999999999999999999999988744

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.8e-40  Score=363.35  Aligned_cols=277  Identities=18%  Similarity=0.207  Sum_probs=221.2

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36899999999999999999996 4689999999865432  34688999999999 99999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC-----eeecccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARM  664 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-----vkl~DFGla~~  664 (834)
                      |+ +++|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998543  356899999999999999999999987   999999999999998887     99999999987


Q ss_pred             ccCCCccc-----ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          665 FCGDELQG-----NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       665 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........  . .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~--~-~~i~~~~  236 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER--Y-QKIGDTK  236 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH--H-HHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH--H-HHHHhhh
Confidence            64432211     12456799999999999999999999999999999999999999986432211000  0 0000000


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCccccccc
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR  805 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~~  805 (834)
                      .   ..+  ........+ .+.+++..||+.+|.+||++++|++.|+.+...+..+....+.|...
T Consensus       237 ~---~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~  296 (330)
T 2izr_A          237 R---ATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGK  296 (330)
T ss_dssp             H---HSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTS
T ss_pred             c---cCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCC
Confidence            0   000  000001122 78899999999999999999999999999888888888878888643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=371.75  Aligned_cols=268  Identities=28%  Similarity=0.427  Sum_probs=218.2

Q ss_pred             hccCccccceecccCccceEeeEec--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEee
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  580 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  580 (834)
                      ..++|++.++||+|+||.||+|+..        .+..||||++... .....+++.+|++++.++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4578999999999999999999852        2467999999765 344567899999999999 99999999999999


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  647 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NIL  647 (834)
                      .+..++||||+++|+|.+++.....             ...+++.+++.++.||++||+|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999964321             245899999999999999999999987   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccc
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  726 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~  726 (834)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+++||++ |..|+........ 
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999987755443344445667899999999999999999999999999999999 9999875443221 


Q ss_pred             ccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCC
Q 003287          727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPK  796 (834)
Q Consensus       727 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~  796 (834)
                       .    .........         ..+..+...+.+++..||+.+|++||++.|+++.|+.+....+...
T Consensus       303 -~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          303 -F----KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             -H----HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             -H----HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence             0    011111100         0111233567889999999999999999999999999865554443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-41  Score=367.10  Aligned_cols=268  Identities=25%  Similarity=0.398  Sum_probs=216.4

Q ss_pred             HHHHHhccCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeE
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCC  578 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~  578 (834)
                      ..+....++|++.+.||+|+||.||+|+...      ++.||||+++... ....+.+.+|+.++++++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3445567899999999999999999998742      4889999997653 34567899999999999999999999999


Q ss_pred             eecCeEEEEEEecCCCCchhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 003287          579 VEQGEKILIYEYMPNKSLNFFLFDPSR---------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRII  637 (834)
Q Consensus       579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  637 (834)
                      .+.+..++||||+++|+|.+++.....                     ...+++.+++.++.||++||+|||+.+   |+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            999999999999999999999964321                     256899999999999999999999987   99


Q ss_pred             ecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCC
Q 003287          638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRN  716 (834)
Q Consensus       638 H~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p  716 (834)
                      ||||||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999987654433333444568899999999999999999999999999999999 9999


Q ss_pred             CCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          717 TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                      |.........      .....+....         .+......+.+++..||+.+|++||++.++++.|+.+...
T Consensus       277 ~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          277 YYGMAHEEVI------YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTTSCHHHHH------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCCChHHHH------HHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            8754322110      0011111110         1112335688899999999999999999999999998543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-39  Score=355.04  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=213.6

Q ss_pred             cccHHHHHHhccC----------ccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCc
Q 003287          502 CFSLASVSAATEN----------FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN  570 (834)
Q Consensus       502 ~~~~~~~~~~~~~----------f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n  570 (834)
                      .++..++..+++.          |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4566666666543          777889999999999999986 69999999998766666788999999999999999


Q ss_pred             eeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC
Q 003287          571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS  650 (834)
Q Consensus       571 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~  650 (834)
                      |+++++++...+..++||||+++++|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            99999999999999999999999999999843    35899999999999999999999987   999999999999999


Q ss_pred             CCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccc
Q 003287          651 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH  730 (834)
Q Consensus       651 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~  730 (834)
                      ++.+||+|||+++.+....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||........  .. 
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--~~-  251 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MK-  251 (321)
T ss_dssp             TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH-
T ss_pred             CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-
Confidence            9999999999998764332  123345799999999999999999999999999999999999999875432111  00 


Q ss_pred             ccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       731 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         .     +.....+.+.  ........+.+++..||+.+|++||++.|+++.
T Consensus       252 ---~-----~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          252 ---R-----LRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ---H-----HHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---H-----HhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0     0011111111  111233567889999999999999999999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3e-40  Score=360.60  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=204.3

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            68999999999999999999876 68999999986543 23346789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            999999999853   345899999999999999999999987   99999999999999999999999999987644333


Q ss_pred             ccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                      ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............     +.....  ..     
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~--~~-----  228 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT--YL-----  228 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH-----HHTTCT--TS-----
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----Hhcccc--cC-----
Confidence            333445679999999999988775 78999999999999999999999764432211111     000000  00     


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       .........+.+|+..||+.+|++|||+.|+++.
T Consensus       229 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             0111233567789999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-40  Score=352.47  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=210.7

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            36899999999999999999999889999999997643 33467999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            999999999543  346899999999999999999999988   99999999999999999999999999986543221 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      .......+|+.|+|||++.+..++.++||||||++++||++ |+.||........  ..    .....  .....+.   
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--~~----~~~~~--~~~~~~~---  230 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VE----DISTG--FRLYKPR---  230 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTT--CCCCCCT---
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--HH----HHhcC--ccCCCCC---
Confidence            12233456788999999999999999999999999999999 8999875433211  00    00000  0111111   


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                          .....+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       231 ----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          231 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence                12345788999999999999999999999998873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.2e-40  Score=352.24  Aligned_cols=261  Identities=26%  Similarity=0.324  Sum_probs=201.2

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhc--cCCCceeeEeeeEeec----CeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQ----GEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~  585 (834)
                      .++|++.+.||+|+||+||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999988 7899999999754   33455666666665  7999999999997653    4589


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      +||||+++|+|.+++.    ...+++..+..++.||++||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    346899999999999999999999        655   9999999999999999999999


Q ss_pred             cccccccccCCCcc--cccccccccccccCcccccCC------CCCccCCeeeHHHHHHHHhhC----------CCCCCC
Q 003287          658 DFGMARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG------LFSVKSDVFSFGVLLLETLTS----------KRNTGV  719 (834)
Q Consensus       658 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwSlGvil~elltg----------~~p~~~  719 (834)
                      |||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999876443221  112334799999999999877      566899999999999999999          666643


Q ss_pred             CCcccccccccccccccccccccccCcccc-chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          720 YDIESFNLLGHAWNLWKDNRAYELLSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ........... ....    ......+... ..........+.+|+..||+.+|++|||+.|+++.|+.+
T Consensus       236 ~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSFEDM-RKVV----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCHHHH-HHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcchhhh-hHHH----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            32211110000 0000    0011111111 112345667899999999999999999999999999876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-40  Score=359.66  Aligned_cols=261  Identities=28%  Similarity=0.431  Sum_probs=213.6

Q ss_pred             hccCccccceecccCccceEeeEec------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      ..++|++.+.||+|+||.||+|+..      +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            3578999999999999999999862      3578999999764 34456789999999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 003287          584 KILIYEYMPNKSLNFFLFDPSR---------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  642 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIk  642 (834)
                      .++||||+++++|.+++.....                     ...+++.++..++.||++||+|||+.+   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999965322                     234889999999999999999999987   9999999


Q ss_pred             CCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCC
Q 003287          643 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYD  721 (834)
Q Consensus       643 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~  721 (834)
                      |+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654433333344567889999999999999999999999999999999 999987544


Q ss_pred             cccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          722 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .....      ........         ...+......+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       258 ~~~~~------~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          258 PERLF------NLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             GGGHH------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHH------HHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            32210      01111110         0111123456888999999999999999999999998874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6e-40  Score=353.27  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=207.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+++.. .++.||||++...   .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            368999999999999999999875 5899999998543   334567899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++..   ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999843   346899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...........     ....      ..+.
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-----~~~~------~~~~  231 (294)
T 4eqm_A          164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-----HIQD------SVPN  231 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-----HHSS------CCCC
T ss_pred             cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----Hhhc------cCCC
Confidence            22 1223345789999999999999999999999999999999999999976442211000     0000      0011


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCC-CHHHHHHHhhcccC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNEHA  790 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~  790 (834)
                      .........+..+.+++.+||+.+|++|| +++++.+.|+.+..
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            11111223345688899999999999998 99999999988743

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-40  Score=360.90  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=205.9

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999997 46999999999654  3445677899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999843   345899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccCcccccCCCCC-ccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                         .......||+.|+|||++.+..+. .++|||||||++|||++|+.||.........  .    ....+..      .
T Consensus       168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~----~i~~~~~------~  232 (328)
T 3fe3_A          168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR--E----RVLRGKY------R  232 (328)
T ss_dssp             ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--H----HHHHCCC------C
T ss_pred             ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH--H----HHHhCCC------C
Confidence               223456799999999999988765 7999999999999999999999764422110  0    0000000      0


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          .+......+.+++..||+.||.+|||++|+++-
T Consensus       233 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 ----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                011123467789999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=364.36  Aligned_cols=265  Identities=25%  Similarity=0.420  Sum_probs=210.5

Q ss_pred             hccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      ..++|++.+.||+|+||.||+|+..      .++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999999862      35689999997542 33457899999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSR--------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  642 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIk  642 (834)
                      ..++||||+++|+|.+++.....                    ...+++..+..++.||++||+|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            99999999999999999965432                    134889999999999999999999987   9999999


Q ss_pred             CCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCC
Q 003287          643 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYD  721 (834)
Q Consensus       643 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~  721 (834)
                      |+|||++.++.+||+|||++..+.............+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333344567889999999999999999999999999999998 999987644


Q ss_pred             cccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          722 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      .....     .......     ..+    ..+......+.+|+..||+.+|++||++.|+++.|+.+....
T Consensus       280 ~~~~~-----~~~~~~~-----~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDANF-----YKLIQNG-----FKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSHHH-----HHHHHTT-----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHHHH-----HHHHhcC-----CCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            32110     0001111     000    011122456788999999999999999999999999885543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=370.87  Aligned_cols=261  Identities=28%  Similarity=0.429  Sum_probs=211.5

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.+.||+|+||+||+|+..      .++.||||++... ......++.+|+.++.+++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            368999999999999999999853      3678999999754 345566799999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC---Ceeec
Q 003287          585 ILIYEYMPNKSLNFFLFDP----SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS  657 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~vkl~  657 (834)
                      ++||||+++|+|.+++...    .....+++.+++.++.||++||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999642    22346899999999999999999999998   99999999999999555   59999


Q ss_pred             cccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccc
Q 003287          658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      |||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||........  ..    ...
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~----~i~  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LE----FVT  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHH
Confidence            9999986644333334445668999999999999999999999999999999998 9999875443211  00    000


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      .+..         ...+......+.+|+..||+.+|++||++.|+++.|+.+..
T Consensus       301 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          301 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            0000         00111223467889999999999999999999999988744

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.6e-40  Score=357.27  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=202.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------  582 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999986 68999999997543 345678999999999999999999999987654       


Q ss_pred             --------------------------------------------------eEEEEEEecCCCCchhhhcCCCCCCCCCHH
Q 003287          583 --------------------------------------------------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQ  612 (834)
Q Consensus       583 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~  612 (834)
                                                                        ..++||||+++++|.+++..........+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999876655667788


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc----------ccccccccccc
Q 003287          613 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ----------GNTKRVVGTYG  682 (834)
Q Consensus       613 ~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~----------~~~~~~~gt~~  682 (834)
                      .++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999987   999999999999999999999999999876543211          12233569999


Q ss_pred             ccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHH
Q 003287          683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  762 (834)
Q Consensus       683 y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~  762 (834)
                      |+|||++.+..++.++||||||+++|||++|..|+....    ...            ..... ...+.........+.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~------------~~~~~-~~~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RII------------TDVRN-LKFPLLFTQKYPQEHM  304 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHH------------HHHHT-TCCCHHHHHHCHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHH------------HHhhc-cCCCcccccCChhHHH
Confidence            999999999999999999999999999999876532100    000            00000 0112223344566788


Q ss_pred             HHhcccccCcCCCCCHHHHHH
Q 003287          763 VALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       763 li~~cl~~~P~~RPs~~evl~  783 (834)
                      ++..||+.+|++||++.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-40  Score=349.60  Aligned_cols=256  Identities=29%  Similarity=0.417  Sum_probs=211.1

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.+.||+|+||.||+|+..++..||||++.... ...+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            47899999999999999999999888899999997643 34577999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++...  ...+++.++..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998532  345899999999999999999999987   999999999999999999999999999876443221


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       ......+|+.|+|||.+.+..++.++||||||++++||++ |+.||...........      ....  .....+..  
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~~--~~~~~~~~--  229 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK------VSQG--HRLYRPHL--  229 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------HHTT--CCCCCCTT--
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH------HHcC--CCCCCCCc--
Confidence             2223456778999999999999999999999999999999 9999875443221100      0000  01111111  


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                           ....+.+++..||+.+|++|||+.|+++.|+.+.
T Consensus       230 -----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          230 -----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             -----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             -----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                 2345788999999999999999999999999884

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.9e-41  Score=365.22  Aligned_cols=279  Identities=26%  Similarity=0.347  Sum_probs=213.1

Q ss_pred             ccCccccceecccCccceEeeEe-----cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEe--ecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV--EQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~  584 (834)
                      .++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36899999999999999999984     358899999998877777788999999999999999999999987  45678


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999999532  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCc-ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ...... ........+|..|+|||++.+..++.++||||||++++||++|+.|+.....+..................+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            643322 1122335678889999999999999999999999999999999999764332111110000000000011111


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCC
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  795 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p  795 (834)
                      +........+..+...+.+|+..||+.+|++||++.|+++.|+.+....+..
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            1111111122234467889999999999999999999999999986555433

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=356.68  Aligned_cols=263  Identities=27%  Similarity=0.433  Sum_probs=205.9

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.+.||+|+||+||+++. .++.||||++...  ...+.|.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            6799999999999999999988 4789999998643  345789999999999999999999998873  5799999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC-eeeccccccccccCCCcc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQ  671 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-vkl~DFGla~~~~~~~~~  671 (834)
                      +|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976554456889999999999999999999954345999999999999998887 799999999765321   


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||............   ... ...     .+...  
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~-~~~-----~~~~~--  226 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW---AVH-NGT-----RPPLI--  226 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH---HHH-TTC-----CCCCB--
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH---HHh-cCC-----CCCcc--
Confidence              22346899999999999999999999999999999999999998754322111100   000 000     01111  


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCC
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQS  798 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~  798 (834)
                        ......+.+++.+||+.+|++||++.|+++.|+.+...++.+..+
T Consensus       227 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          227 --KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             --cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence              122346788999999999999999999999999987666655443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-40  Score=363.42  Aligned_cols=267  Identities=24%  Similarity=0.402  Sum_probs=196.8

Q ss_pred             HhccCccccceecccCccceEeeEecCC----cEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~~g----~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      ...++|++.+.||+|+||.||+|+....    ..||||++...  .....+++.+|+.++++++||||+++++++.+...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            3457899999999999999999987543    27999999764  34456789999999999999999999999988765


Q ss_pred             E------EEEEEecCCCCchhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCe
Q 003287          584 K------ILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  654 (834)
Q Consensus       584 ~------~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~v  654 (834)
                      .      ++||||+++|+|.+++...   .....+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence            5      9999999999999998532   22236899999999999999999999988   9999999999999999999


Q ss_pred             eeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccc
Q 003287          655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  733 (834)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.........  .    
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--~----  250 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY--N----  250 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--H----
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH--H----
Confidence            9999999987654443333444567889999999999999999999999999999999 89998754432110  0    


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCC
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPY  794 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~  794 (834)
                      ........         .........+.+++..||+.+|++||++.++++.|+++...+..
T Consensus       251 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          251 YLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             HHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             HHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence            00000000         01112335678999999999999999999999999998655433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.8e-40  Score=353.30  Aligned_cols=275  Identities=17%  Similarity=0.226  Sum_probs=220.8

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999996 468999999986543  235678899999999 89999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC-----eeecccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARM  664 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-----vkl~DFGla~~  664 (834)
                      |+ +++|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999543  345899999999999999999999987   999999999999987776     99999999987


Q ss_pred             ccCCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccccccccc
Q 003287          665 FCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDN  738 (834)
Q Consensus       665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~  738 (834)
                      .......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....    ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~----~~~~  236 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----IGEK  236 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH----HHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH----HHhh
Confidence            6543221     123446799999999999999999999999999999999999999976432211 00000    0000


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCccccc
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYA  803 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~  803 (834)
                      .     .+..........+..+.+++..||+.+|++||++.+|++.|+.+...+.......+.|.
T Consensus       237 ~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          237 K-----QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             H-----HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             c-----cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence            0     00000111123346788999999999999999999999999999888877777777774

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.4e-40  Score=378.45  Aligned_cols=261  Identities=27%  Similarity=0.419  Sum_probs=212.4

Q ss_pred             HHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ....++|++.+.||+|+||.||+|++.+++.||||+++... ...+.|.+|+.++++++||||+++++++. .+..++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            33457899999999999999999999888999999997643 45688999999999999999999999986 66789999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++... ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            999999999999542 1235788999999999999999999987   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ... ......+|..|+|||++....++.++|||||||+||||++ |+.||........  ..    ....+  .....  
T Consensus       338 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--~~----~i~~~--~~~~~--  406 (454)
T 1qcf_A          338 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IR----ALERG--YRMPR--  406 (454)
T ss_dssp             HHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHHHT--CCCCC--
T ss_pred             cee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC--CCCCC--
Confidence            211 1223346789999999999999999999999999999999 9999875442211  00    00000  11111  


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                           +..++..+.+|+.+||+.+|++|||+.+|+++|+.+...
T Consensus       407 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          407 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                 122345688899999999999999999999999998543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.4e-40  Score=348.63  Aligned_cols=254  Identities=30%  Similarity=0.450  Sum_probs=197.6

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccC----hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+|+. .++.||||++....    ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            36899999999999999999997 48999999986542    23357789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC--------CCCeeeccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--------DMNPKISDF  659 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~--------~~~vkl~DF  659 (834)
                      |||+++++|.+++.    ...+++..+..++.|+++||+|||+.+..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    346899999999999999999999987556999999999999986        778999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      |+++......    .....||+.|+|||.+.+..++.++||||||++++||++|+.||...........     ..... 
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~-  230 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-----VAMNK-  230 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-----HHTSC-
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-----hhcCC-
Confidence            9998654322    2235689999999999999999999999999999999999999976443211000     00000 


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                              .....+......+.+++..||+.+|++||++.|+++.|+.+
T Consensus       231 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 --------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                    00011112235688899999999999999999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-40  Score=362.21  Aligned_cols=273  Identities=29%  Similarity=0.392  Sum_probs=211.2

Q ss_pred             CccccceecccCccceEeeEec-----CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEE
Q 003287          514 NFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI  585 (834)
Q Consensus       514 ~f~~~~~lG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  585 (834)
                      .|+++++||+|+||+||++.+.     +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3499999999999999887642     57899999997653 34567899999999999999999999999884  5789


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999943    34899999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          666 CGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ...... .......+|..|+|||++.+..++.++||||||++++||++|+.|+........................+.+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            543221 2233456788999999999999999999999999999999999998653222111111111111111111111


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      ........+..++..+.+|+..||+.+|++||++.|+++.|+.+.+.+.
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            1111111222344678899999999999999999999999998865443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.9e-40  Score=379.77  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=213.4

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ...+|++.++||+|+||.||+|++.. ++.||||+++... ...++|.+|+.++++++||||+++++++.+....++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45679999999999999999999865 8899999997643 346789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|.+++... ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999643 2345889999999999999999999987   9999999999999999999999999998764432


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .. ......++..|+|||++....++.++|||||||+||||++ |..|+...+....  .    .....+         .
T Consensus       373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~----~~~~~~---------~  436 (495)
T 1opk_A          373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y----ELLEKD---------Y  436 (495)
T ss_dssp             EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H----HHHHTT---------C
T ss_pred             ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHcC---------C
Confidence            21 2223456789999999999999999999999999999999 8889876443211  0    011110         1


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ....+..++..+.+|+.+||+.+|++||++.++++.|+.+..
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            111112234568889999999999999999999999998743

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-39  Score=359.14  Aligned_cols=251  Identities=23%  Similarity=0.280  Sum_probs=206.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChh------hHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ------GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+....      ..+.+.+|+.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999976 5899999999764321      357899999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC----Ceeecccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  660 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~vkl~DFG  660 (834)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999943   346899999999999999999999987   99999999999998877    79999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      +++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ..    .....  
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~----~i~~~--  233 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA----NITAV--  233 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH----HHHTT--
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhc--
Confidence            998764322   23345799999999999999999999999999999999999999975432211  00    00000  


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          ...............+.+++..||+.||++|||+.|+++
T Consensus       234 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 ----SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                000111122233456889999999999999999999885

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.5e-40  Score=357.61  Aligned_cols=263  Identities=25%  Similarity=0.379  Sum_probs=213.2

Q ss_pred             hccCccccceecccCccceEeeEe------cCCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      ..++|++.+.||+|+||.||+|+.      .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            347899999999999999999985      246899999997653 34567899999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSR---------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  647 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NIL  647 (834)
                      ..++||||+++|+|.+++.....               ...+++..+..++.||++||+|||+.+   |+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999964322               225899999999999999999999987   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccc
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  726 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~  726 (834)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999999987654433333334567889999999999999999999999999999999 99998754432110


Q ss_pred             ccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       727 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                           .......     ..+..    .......+.+++..||+.+|++||++.|+++.|+.+..
T Consensus       258 -----~~~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          258 -----YKMIKEG-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             -----HHHHHHT-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHhccC-----CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                 0000000     00000    11223567889999999999999999999999988743

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.4e-40  Score=376.97  Aligned_cols=262  Identities=28%  Similarity=0.437  Sum_probs=207.9

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            457899999999999999999999888899999997643 345789999999999999999999999876 678999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++|+|.+++... ....+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999532 2245889999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                       .......++..|+|||++.+..++.++||||||+++|||++ |+.|+........  ..    ....+  ...      
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~----~i~~~--~~~------  400 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD----QVERG--YRM------  400 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----HHHTT--CCC------
T ss_pred             -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC--CCC------
Confidence             12223456889999999999999999999999999999999 8999875432211  00    00000  011      


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCC
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPY  794 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~  794 (834)
                       ..+..++..+.+|+..||+.+|++|||++++++.|+.+......
T Consensus       401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence             11122345688899999999999999999999999998655443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=352.61  Aligned_cols=252  Identities=20%  Similarity=0.277  Sum_probs=207.2

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            368999999999999999999876 4889999998754 34456789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC--CCCeeeccccccccccCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGD  668 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~--~~~vkl~DFGla~~~~~~  668 (834)
                      +++|+|.+++..  ....+++.++..++.||++||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999953  2346899999999999999999999987   999999999999987  789999999999876433


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ..   .... ..      ...
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~---~i~~-~~------~~~  222 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IE---NIMN-AE------YTF  222 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHH-TC------CCC
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--HH---HHHc-CC------CCC
Confidence            2   23345789999999999999899999999999999999999999975432211  00   0000 00      001


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ........+..+.+++..||+.||++|||+.|+++.
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111122345678899999999999999999999983

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-40  Score=350.86  Aligned_cols=257  Identities=29%  Similarity=0.431  Sum_probs=208.2

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..++|++.+.||+|+||.||+++..+++.||||++.... ...+++.+|++++.+++||||+++++++.+....++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            357899999999999999999999888899999997643 2347789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++...  ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999999642  345899999999999999999999987   99999999999999999999999999987543221


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                       .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........  .    .....  .....+.  
T Consensus       176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~--~----~~~~~--~~~~~~~--  244 (283)
T 3gen_A          176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--E----HIAQG--LRLYRPH--  244 (283)
T ss_dssp             -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--H----HHHTT--CCCCCCT--
T ss_pred             -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH--H----HHhcc--cCCCCCC--
Confidence             12223456788999999999999999999999999999998 99998764432110  0    00000  0111111  


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                           .....+.+++..||+.+|++||++.|+++.|..+.
T Consensus       245 -----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          245 -----LASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             -----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                 11346788999999999999999999999998763

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.9e-39  Score=350.81  Aligned_cols=264  Identities=24%  Similarity=0.313  Sum_probs=202.5

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|+++++||+|+||+||+|+..+++.||||++....  ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            47899999999999999999999889999999997542  2335678999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++ +|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 777777442  345899999999999999999999987   9999999999999999999999999998764221


Q ss_pred             cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cc-c-------cccccccc--
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LL-G-------HAWNLWKD--  737 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~-~-------~~~~~~~~--  737 (834)
                        .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .. .       ..+.....  
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence              22233568999999999876 56899999999999999999999999765432210 00 0       00000000  


Q ss_pred             ---cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          738 ---NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       738 ---~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         ......................+.+|+..||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               0000111111111112223456789999999999999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=353.61  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=206.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccCh------hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ++|++.+.||+|+||.||+++.. +++.||||++.....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            57999999999999999999976 589999999875432      24678999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC----Ceeeccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGM  661 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~vkl~DFGl  661 (834)
                      +||||+++++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999943   346899999999999999999999987   99999999999999887    899999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ...    ...    
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~----~~~----  231 (326)
T 2y0a_A          165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN----VSA----  231 (326)
T ss_dssp             CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH----HHH----
T ss_pred             CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHH----HHh----
Confidence            98764322   22345799999999999999999999999999999999999999875432211  000    000    


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        ................+.+++..||+.+|++|||+.|+++.
T Consensus       232 --~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          232 --VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              00011111222334567889999999999999999999873

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-39  Score=356.82  Aligned_cols=249  Identities=22%  Similarity=0.275  Sum_probs=205.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++++.||+|+||+||+++.. +++.||||++++.   .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999876 5899999999754   233467789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999998843   346899999999999999999999987   99999999999999999999999999986432


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ......      ..
T Consensus       158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~----~i~~~~------~~  223 (337)
T 1o6l_A          158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILMEE------IR  223 (337)
T ss_dssp             T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC------CC
T ss_pred             C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HH----HHHcCC------CC
Confidence            2  1223456799999999999999999999999999999999999999875432211  00    000000      00


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~  784 (834)
                      .    +......+.+++..||+.+|++||     +++|+++-
T Consensus       224 ~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            1    112345678899999999999999     89998763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-39  Score=372.22  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=206.1

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC-eEEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYE  589 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  589 (834)
                      ..++|++.+.||+|+||.||+|+.. ++.||||+++...  ..+.|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4578999999999999999999884 7899999997643  4578999999999999999999999988765 7899999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|.+++... ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            99999999999643 2234789999999999999999999987   999999999999999999999999999854321 


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                          .....++..|+|||++.+..++.++||||||+++|||++ |+.|+........  .    .....+  ...     
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~----~~i~~~--~~~-----  405 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V----PRVEKG--YKM-----  405 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--H----HHHHTT--CCC-----
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHcC--CCC-----
Confidence                122357889999999999999999999999999999998 9999876443221  0    001111  011     


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                        ..+..++..+.+|+..||+.+|++|||+.++++.|+.+
T Consensus       406 --~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          406 --DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              11122345688899999999999999999999999887

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=350.26  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccCh--------------------------hhHHHHHHHHHHHh
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------------------------QGLKEFKNEMMLIA  564 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------------------------~~~~~~~~E~~~l~  564 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999875 588999999865421                          12356899999999


Q ss_pred             ccCCCceeeEeeeEee--cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 003287          565 KLQHRNLVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  642 (834)
Q Consensus       565 ~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIk  642 (834)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++.++..++.||++||+|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56899999999999998876    2346899999999999999999999987   9999999


Q ss_pred             CCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCC---CCccCCeeeHHHHHHHHhhCCCCCCC
Q 003287          643 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGV  719 (834)
Q Consensus       643 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltg~~p~~~  719 (834)
                      |+|||++.++.+||+|||+++.+....  .......||+.|+|||++.+..   ++.++|||||||++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999998764332  1223457899999999998765   47889999999999999999999875


Q ss_pred             CCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          720 YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......  ..    ...... .....       .......+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~~~--~~----~~~~~~-~~~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMCL--HS----KIKSQA-LEFPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHHH--HH----HHHHCC-CCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHHH--HH----HHhccc-CCCCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            432111  00    000000 00000       0112346788999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-39  Score=357.18  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=212.6

Q ss_pred             hccCccccceecccCccceEeeEec--------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEee
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  580 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  580 (834)
                      ..++|++.+.||+|+||.||+|+..        +++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3478999999999999999999863        46789999997653 34567899999999999 99999999999999


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  647 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NIL  647 (834)
                      .+..++||||+++|+|.+++.....             ...+++.+++.++.||++||+|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999965432             234889999999999999999999987   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccc
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  726 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~  726 (834)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+........ 
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence            99999999999999987654433333344567889999999999999999999999999999999 9999875432211 


Q ss_pred             ccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       727 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                       .    ........     +.    .+......+.+++..||+.+|++||++.|+++.|+.+..
T Consensus       269 -~----~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          269 -F----KLLKEGHR-----MD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -H----HHHHHTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -H----HHHhcCCC-----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             0    00001100     00    111233567889999999999999999999999998844

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.3e-40  Score=355.19  Aligned_cols=271  Identities=25%  Similarity=0.385  Sum_probs=206.3

Q ss_pred             cCccccceecccCccceEeeEe-----cCCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  584 (834)
                      +.|++.+.||+|+||.||++++     .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5689999999999999999983     358899999997543 34567899999999999999999999999877  678


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            999999999999999843  2345899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++|..|+..........................
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            6543321 223345688899999999999999999999999999999999988543211000000000000000000010


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      +........+...+..+.+++..||+.+|++|||+.|+++.|+.+
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            000011111223345788999999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-39  Score=361.90  Aligned_cols=285  Identities=15%  Similarity=0.191  Sum_probs=215.5

Q ss_pred             hccCccccceecccCccceEeeEecC------CcEEEEEEecccChhh-----------HHHHHHHHHHHhccCCCceee
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-----------LKEFKNEMMLIAKLQHRNLVR  573 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~  573 (834)
                      ..++|++.++||+|+||.||+|++..      ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998754      4789999987654221           122345667788889999999


Q ss_pred             EeeeEeec----CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          574 LMGCCVEQ----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       574 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                      +++++.+.    ...+|||||+ +++|.+++..  ....+++.++..++.||++||+|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99999875    4589999999 9999999854  2356899999999999999999999987   99999999999999


Q ss_pred             --CCCCeeeccccccccccCCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCc
Q 003287          650 --SDMNPKISDFGMARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI  722 (834)
Q Consensus       650 --~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~  722 (834)
                        .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876433211     111334599999999999999999999999999999999999999975322


Q ss_pred             ccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccc
Q 003287          723 ESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY  802 (834)
Q Consensus       723 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~  802 (834)
                      .... ....... ......+++++.+..   ...+..+.+++..||+.+|++||++.++++.|+.+...+..+....+.|
T Consensus       267 ~~~~-~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          267 DPKY-VRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             CHHH-HHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             CHHH-HHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            1110 0000000 001111111111110   1224568899999999999999999999999999988888888888877


Q ss_pred             cccC
Q 003287          803 ARRG  806 (834)
Q Consensus       803 ~~~~  806 (834)
                      ....
T Consensus       342 ~~~~  345 (364)
T 3op5_A          342 SVVE  345 (364)
T ss_dssp             ----
T ss_pred             Eecc
Confidence            6543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=349.32  Aligned_cols=270  Identities=21%  Similarity=0.284  Sum_probs=213.6

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC--eEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV  587 (834)
                      .++|++.++||+|+||+||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3689999999999999999999864 8999999997543 344677889999999999999999999998765  78999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE----cCCCCeeeccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  663 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~vkl~DFGla~  663 (834)
                      |||+++++|.+++........+++.++..++.||++||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999987   9999999999999    788889999999998


Q ss_pred             cccCCCcccccccccccccccCccccc--------CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYAL--------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      .+....   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||........... ......
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~  240 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE-VMYKII  240 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH-HHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH-HHHHHh
Confidence            764432   223456899999999986        57899999999999999999999999875432211000 000000


Q ss_pred             ccc---c---cccc------c--CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          736 KDN---R---AYEL------L--SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       736 ~~~---~---~~~l------~--~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ...   .   ....      .  +..............+.+++..||+.||++||+++|+++-..+.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            000   0   0000      0  00011133456677888999999999999999999999998775

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6e-40  Score=358.47  Aligned_cols=257  Identities=27%  Similarity=0.387  Sum_probs=204.4

Q ss_pred             cCccccceecccCccceEeeEecC-Cc----EEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ++|++.+.||+|+||+||+|+... ++    .||+|.+.... ....+.+.+|+.++.+++||||+++++++. +...++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            679999999999999999998653 44    48888875442 333456788999999999999999999886 567899


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999643  346888999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ............+|..|+|||++.+..++.++||||||+++|||++ |+.||..........      ......  ....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~~--~~~~  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD------LLEKGE--RLAQ  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH------HHHTTC--BCCC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH------HHHcCC--CCCC
Confidence            5444444455678889999999999999999999999999999999 999987644322110      011110  1111


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      +..       ....+.+++..||+.+|++||++.|+++.|+.+..
T Consensus       239 ~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          239 PQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111       12346679999999999999999999999988744

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.9e-40  Score=357.63  Aligned_cols=266  Identities=27%  Similarity=0.411  Sum_probs=214.7

Q ss_pred             HHHHhccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEe
Q 003287          507 SVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV  579 (834)
Q Consensus       507 ~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  579 (834)
                      +.....++|++.+.||+|+||.||+|+..      .++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34455688999999999999999999764      36789999997543 345567999999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCCchhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          580 EQGEKILIYEYMPNKSLNFFLFDPS-------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      +.+..++||||+++|+|.+++....       ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence            9999999999999999999985421       1245789999999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccc
Q 003287          653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  731 (834)
                      .+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+........  ..  
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~--  251 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LR--  251 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HH--
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--HH--
Confidence            999999999987654433333334567889999999999999999999999999999999 8888875432211  00  


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                        .........         ........+.+++..||+.+|++||++.|+++.|+....
T Consensus       252 --~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 --FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             --HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             --HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence              000111100         111233567889999999999999999999999998744

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.7e-39  Score=345.33  Aligned_cols=255  Identities=27%  Similarity=0.525  Sum_probs=203.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChh-------hHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      .++|++.+.||+|+||+||+|+.. +++.||||++......       ..+.+.+|+.++.+++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            478999999999999999999975 6899999998654321       1267899999999999999999999987655 


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC-----eeecc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISD  658 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-----vkl~D  658 (834)
                       ++||||+++|+|.+++.+.  ...+++..+..++.|+++||+|||+.+ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999998888543  346899999999999999999999875 34999999999999988776     99999


Q ss_pred             ccccccccCCCcccccccccccccccCcccc--cCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYA--LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      ||+++....     ......||+.|+|||++  ....++.++||||||+++|||++|+.||..............    .
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI----R  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH----H
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH----h
Confidence            999975422     23346789999999998  455688999999999999999999999976543322111100    0


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      ..    ...+..    +......+.+++..||+.+|++||++.|+++.|+++
T Consensus       244 ~~----~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EE----GLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HS----CCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cc----CCCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            00    011111    122345688999999999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-39  Score=353.70  Aligned_cols=269  Identities=26%  Similarity=0.418  Sum_probs=203.1

Q ss_pred             HHHHhccCccccceecccCccceEeeEecC----CcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee
Q 003287          507 SVSAATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  580 (834)
Q Consensus       507 ~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  580 (834)
                      ++....++|++.+.||+|+||.||+|+...    ++.||||++...  .....+.+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            334456889999999999999999998642    458999998754  34456789999999999999999999999987


Q ss_pred             cC-----eEEEEEEecCCCCchhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          581 QG-----EKILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       581 ~~-----~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      ..     ..++||||+++++|.+++...   .....+++..++.++.||++||+|||+.+   |+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence            65     359999999999999998432   23456899999999999999999999987   99999999999999999


Q ss_pred             CeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccc
Q 003287          653 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       653 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  731 (834)
                      .+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+........  ..  
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~--  260 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YD--  260 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HH--
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH--
Confidence            999999999987654433333344567889999999999999999999999999999999 8888875433211  00  


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                        ......     .+    ..+......+.+++..||+.+|++||++.++++.|+.+...+|
T Consensus       261 --~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          261 --YLLHGH-----RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             --HHHTTC-----CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --HHHcCC-----CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence              000000     00    0111233568889999999999999999999999998866554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-39  Score=358.16  Aligned_cols=253  Identities=21%  Similarity=0.258  Sum_probs=207.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            368999999999999999999875 5899999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC--CCCeeeccccccccccCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGD  668 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~--~~~vkl~DFGla~~~~~~  668 (834)
                      +++|+|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999998532  346899999999999999999999987   999999999999974  577999999999876433


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ...   ... ... . .+   
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~---i~~-~~~-~-~~---  270 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQN---VKR-CDW-E-FD---  270 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH---HHH-CCC-C-CC---
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--HHH---HHh-CCC-C-CC---
Confidence            2   22345789999999999999999999999999999999999999876432111  000   000 000 0 01   


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ..........+.+++..||+.||++||++.|+++-
T Consensus       271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             11111234567899999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-39  Score=346.98  Aligned_cols=260  Identities=28%  Similarity=0.454  Sum_probs=196.0

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.++||+|+||+||+|+..  ..||||+++..  .....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            478999999999999999999864  36999998754  344567899999999999999999999965 5567899999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++...  ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999999999543  356899999999999999999999987   9999999999999999999999999998664433


Q ss_pred             cccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          670 LQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .........||+.|+|||++.   +..++.++||||||+++|||++|+.||........ ..    .........    +
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~----~~~~~~~~~----~  245 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II----EMVGRGSLS----P  245 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HH----HHHHHTSCC----C
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HH----HHhcccccC----c
Confidence            333344567899999999986   66789999999999999999999999975432211 00    001111100    0


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .. ......++..+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       246 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          246 DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            00 0011123456889999999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-39  Score=353.53  Aligned_cols=269  Identities=26%  Similarity=0.375  Sum_probs=214.9

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEe------cCCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEe
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLM  575 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~  575 (834)
                      .........++|++.+.||+|+||.||+|+.      .+++.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445555678999999999999999999974      246899999997653 34556799999999999 799999999


Q ss_pred             eeEeecC-eEEEEEEecCCCCchhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC
Q 003287          576 GCCVEQG-EKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL  641 (834)
Q Consensus       576 ~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DI  641 (834)
                      +++.+.+ ..++||||+++++|.+++.....             ...+++..+..++.||++||+|||+.+   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9988765 58999999999999999965432             223789999999999999999999987   999999


Q ss_pred             CCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCC
Q 003287          642 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVY  720 (834)
Q Consensus       642 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~  720 (834)
                      ||+||+++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |..|+...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654433333344567899999999999999999999999999999998 99998754


Q ss_pred             CcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          721 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      ......     ..........     ..    +......+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       255 ~~~~~~-----~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDEEF-----CRRLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSHHH-----HHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHHH-----HHHhccCccC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            322110     0001111000     01    1112346788999999999999999999999998873

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-39  Score=357.64  Aligned_cols=253  Identities=22%  Similarity=0.283  Sum_probs=204.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-----hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ++|++.+.||+|+||+||+++.. +++.||||++....     ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            57999999999999999999875 58999999986431     1246789999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC---eeecccccc
Q 003287          587 IYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMA  662 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---vkl~DFGla  662 (834)
                      ||||+++++|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998877532 22345899999999999999999999987   999999999999987655   999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      +.+....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+..   .    .......  
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~----~i~~~~~--  249 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF---E----GIIKGKY--  249 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHH---H----HHHHTCC--
T ss_pred             eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHH---H----HHHcCCC--
Confidence            8764432  122345799999999999999999999999999999999999999875321100   0    0000000  


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          .............+.+|+..||+.||++||++.|+++
T Consensus       250 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 ----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0011111233467889999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.1e-39  Score=356.43  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=205.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            468999999999999999999875 5899999999654  3345677899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC---Ceeeccccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~vkl~DFGla~~~  665 (834)
                      ||+++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++   .+||+|||+++..
T Consensus       108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999998853   346899999999999999999999987   99999999999998654   5999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...+....  ..    ....+. .... 
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~----~i~~~~-~~~~-  250 (362)
T 2bdw_A          182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA----QIKAGA-YDYP-  250 (362)
T ss_dssp             TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTC-CCCC-
T ss_pred             cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHhCC-CCCC-
Confidence            4322   22345799999999999999999999999999999999999999875432211  00    000000 0000 


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          ..........+.+|+..||+.||++||++.|+++.
T Consensus       251 ----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 ----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                01111234567889999999999999999998863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-38  Score=342.23  Aligned_cols=263  Identities=20%  Similarity=0.251  Sum_probs=199.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|++.++||+|+||+||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999986 58999999997542  3345778999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |++++.+..+..   ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  154 (292)
T 3o0g_A           82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-  154 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred             cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence            998654444432   2346899999999999999999999997   999999999999999999999999999876422 


Q ss_pred             cccccccccccccccCcccccCCC-CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccc----------ccccccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG----------HAWNLWKDN  738 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~  738 (834)
                       ........||+.|+|||++.+.. ++.++|||||||+++||++|..|+.........+..          ..+..+...
T Consensus       155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence             12233457899999999998766 899999999999999999998885432221110000          000000000


Q ss_pred             ----ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          739 ----RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       739 ----~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          .....................+.+++..||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                000000000001111223456788999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.7e-39  Score=359.01  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=198.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|+++++||+|+||+||+++.. +++.||||++++..   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            478999999999999999999976 47899999997642   22345678899999887 89999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|..++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999853   346899999999999999999999988   9999999999999999999999999998632


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc---cccccccccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL---LGHAWNLWKDNRAYEL  743 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~l  743 (834)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........   ............    
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----  278 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  278 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence            21  223445689999999999999999999999999999999999999996533211100   000000000000    


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                        .    ..+......+.+|+..||+.||++||++
T Consensus       279 --~----~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 --I----RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --c----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence              0    0111234567889999999999999996

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-39  Score=366.85  Aligned_cols=264  Identities=19%  Similarity=0.251  Sum_probs=209.0

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEe
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV  579 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  579 (834)
                      .+.++....++|+++++||+|+||+||+|+... ++.||||++.+..   ....+.+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            344555667899999999999999999999865 7899999997532   122334889999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                      +.+..+|||||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999999642  346899999999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  734 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  734 (834)
                      |+++.+..... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+....  ..   ..
T Consensus       220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~---~i  293 (437)
T 4aw2_A          220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KI  293 (437)
T ss_dssp             TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HH
T ss_pred             hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--HH---hh
Confidence            99987643322 1223457999999999997     56799999999999999999999999976442211  00   00


Q ss_pred             ccccccccccCccccchhHHHHHHHHHHHHhcccccCcCC--CCCHHHHHHH
Q 003287          735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  784 (834)
Q Consensus       735 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~  784 (834)
                      .....  ...-|...    ......+.+|+..||+.+|++  ||+++|+++-
T Consensus       294 ~~~~~--~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          294 MNHKE--RFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HTHHH--HCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhccc--cccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            00000  00011110    112356788999999888888  9999999873

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=365.28  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=204.7

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..++|++.+.||+|+||+||++... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3578999999999999999999875 68999999987543  33456789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc---CCCCeeecccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARM  664 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~vkl~DFGla~~  664 (834)
                      |||+++|+|.+.+..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999998853   346899999999999999999999998   99999999999998   467899999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|..||...+....  ..    ....+. ....
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--~~----~i~~~~-~~~~  233 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQ----QIKAGA-YDFP  233 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH----HHHHTC-CCCC
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--HH----HHHhCC-CCCC
Confidence            64332  222346799999999999999999999999999999999999999875442211  00    000010 0011


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+     ........+.+|+..||+.||++|||+.|+++-
T Consensus       234 ~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          234 SP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11     111234567889999999999999999999873

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.1e-39  Score=343.62  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=199.6

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||+|+||+||+|+..+++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5799999999999999999999779999999996543  22346788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            985 888887542  346889999999999999999999987   9999999999999999999999999998753221 


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc--cc----cccccccccccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--LG----HAWNLWKDNRAYEL  743 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~~----~~~~~~~~~~~~~l  743 (834)
                       .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..........  ..    .....+........
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence             122335689999999999764 58999999999999999999999997644221100  00    00000000000000


Q ss_pred             cCccc-------cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPAL-------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .++..       ...........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000       01111223456788999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.2e-39  Score=346.27  Aligned_cols=256  Identities=21%  Similarity=0.317  Sum_probs=196.5

Q ss_pred             ccCccccceecccCccceEeeEecC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|++.+.||+|+||.||+|+...    +..||||++... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4689999999999999999998743    457999998764 3445678999999999999999999999984 567899


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999532  345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||........  ..    ........    
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~----~i~~~~~~----  236 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGERL----  236 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTCCC----
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HH----HHHcCCCC----
Confidence            33221 2233456789999999999999999999999999999997 8899875443211  00    00001000    


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                           ..+...+..+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       237 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          237 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 011123456788999999999999999999999998863

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-39  Score=357.30  Aligned_cols=263  Identities=28%  Similarity=0.432  Sum_probs=211.0

Q ss_pred             HHhccCccccceecccCccceEeeEecC------CcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEee
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  580 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  580 (834)
                      ....++|++.+.||+|+||.||+|+...      ...||||++.... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999998643      2489999997653 34567799999999999 89999999999999


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPS-----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  649 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~  649 (834)
                      .+..++||||+++|+|.+++....           ....+++..+..++.||++||+|||+.+   |+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence            999999999999999999985321           1345789999999999999999999987   99999999999999


Q ss_pred             CCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccc
Q 003287          650 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  728 (834)
Q Consensus       650 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~  728 (834)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+.........  
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--
Confidence            999999999999987644333223334567889999999999999999999999999999999 88888754322110  


Q ss_pred             ccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          729 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       729 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                         .......  .....+       ......+.+++..||+.+|.+||++.|+++.|+.+
T Consensus       277 ---~~~~~~~--~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 ---YKLVKDG--YQMAQP-------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ---HHHHHHT--CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhcC--CCCCCC-------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence               0000000  001111       11234678899999999999999999999999876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=357.39  Aligned_cols=253  Identities=24%  Similarity=0.305  Sum_probs=197.3

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCC--CceeeEeeeEeecCeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~l  586 (834)
                      ..++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  +||+++++++.+....++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            34679999999999999999999988999999998654  34456789999999999976  999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||| +.+++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++ ++.+||+|||+++.+.
T Consensus        87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 568899999953   346899999999999999999999987   99999999999997 6789999999998765


Q ss_pred             CCCcccccccccccccccCcccccC-----------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      ............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........         
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------  229 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------  229 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---------
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH---------
Confidence            4433333445679999999999865           67899999999999999999999998753221100         


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          ....+++......+......+.+|+..||+.+|++|||+.|+++.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          230 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                001111111111111112457789999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=348.06  Aligned_cols=244  Identities=24%  Similarity=0.236  Sum_probs=194.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.++||+|+||+||+|+.. +++.||||++....  .....++..|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999986 68999999986542  33444556666666665 9999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+ +++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 67888887532  346899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .   ......||+.|+|||++.+ .++.++|||||||++|||++|..++.....                 ...+.....
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------------~~~~~~~~~  269 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------------WQQLRQGYL  269 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------------HHHHTTTCC
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------------HHHHhccCC
Confidence            2   2234568999999998876 799999999999999999999776543111                 001111111


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ...........+.+++..||+.+|++|||+.|+++
T Consensus       270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            22233344567889999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-39  Score=347.68  Aligned_cols=260  Identities=27%  Similarity=0.421  Sum_probs=213.8

Q ss_pred             HhccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ...++|++.+.||+|+||.||+|+... ++.||||++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            356789999999999999999999865 889999999754 345678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++... ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999999643 2345899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .. .......+|+.|+|||++.+..++.++||||||+++|||++ |..|+...+.....      ......         
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~------~~~~~~---------  228 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKD---------  228 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------HHHHTT---------
T ss_pred             cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHhcc---------
Confidence            22 22333557889999999999999999999999999999999 88898754432210      000000         


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      .....+...+..+.+++..||+.+|++||++.|+++.|+.+..
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            0001111233568889999999999999999999999988743

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.3e-39  Score=342.01  Aligned_cols=254  Identities=22%  Similarity=0.374  Sum_probs=205.9

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec--CeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+|+. +++.||||++...  .....+.|.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            36799999999999999999998 4889999999764  344567899999999999999999999999887  788999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++... ....+++..+..++.||++||+|||+.+ .+|+||||||+||+++.++.++|+|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999999653 2335899999999999999999999864 349999999999999999999999998876432 


Q ss_pred             CCcccccccccccccccCcccccCCCCCc---cCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSV---KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                            .....||+.|+|||++.+..++.   ++||||||+++|||++|+.||..........     ......     .
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~~~-----~  228 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-----KVALEG-----L  228 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-----HHHHSC-----C
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-----HHHhcC-----C
Confidence                  12346799999999998766554   7999999999999999999987544321100     000000     1


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .+..    +......+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       229 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          229 RPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1111    1123356788999999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-39  Score=343.16  Aligned_cols=256  Identities=28%  Similarity=0.441  Sum_probs=210.0

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.+.||+|+||.||+++..+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            36799999999999999999999888999999997643 23478999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            999999999542  345889999999999999999999988   99999999999999999999999999987543211 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.|+........  ..    ....+  .....+.   
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~----~i~~~--~~~~~~~---  228 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VE----DISTG--FRLYKPR---  228 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTT--CCCCCCT---
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--HH----HHhcC--CcCCCCc---
Confidence            11223456789999999999999999999999999999999 8989875432211  00    00000  0111111   


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                          .....+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       229 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          229 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                12346788999999999999999999999998873

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-39  Score=351.83  Aligned_cols=264  Identities=23%  Similarity=0.316  Sum_probs=199.9

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe----
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE----  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  583 (834)
                      .++|++.+.||+|+||.||+++. .+++.||||++....   ....+.+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36899999999999999999997 468999999997642   3345678999999999999999999999887653    


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||+++++|.+++..   ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            4999999999999999953   346899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          664 MFCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      .+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........     .......   
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~~~---  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----QHVREDP---  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHCCC---
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhcCCC---
Confidence            76443221 22334568999999999999999999999999999999999999987544321100     0000000   


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHH-HHHHhhcccCCCC
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK-VVSMITNEHATLP  793 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e-vl~~L~~~~~~l~  793 (834)
                          ..........+..+.+++..||+.+|++||++.+ +.+.|.......|
T Consensus       237 ----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          237 ----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             ----CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             ----CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence                0001111223456888999999999999995554 5556666544433

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.3e-39  Score=352.12  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=201.6

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36899999999999999999997 468999999986532   22346789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+ +|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6888888743   346899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..   ......||+.|+|||++.+..+ ++++|||||||++|||++|+.||........  ..    ..... ...    
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~----~i~~~-~~~----  226 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FK----KVNSC-VYV----  226 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BC----CCCSS-CCC----
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HH----HHHcC-CCC----
Confidence            32   2234579999999999998876 7899999999999999999999875432211  00    00000 000    


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                           .+......+.+|+..||+.||.+|||+.|+++-
T Consensus       227 -----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          227 -----MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -----CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 011123467789999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-38  Score=356.23  Aligned_cols=270  Identities=18%  Similarity=0.262  Sum_probs=206.4

Q ss_pred             hccCccccceeccc--CccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          511 ATENFSMQCKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ..++|++.++||+|  +||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34789999999999  99999999986 58999999997543  345577889999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++|+|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999998643 2245899999999999999999999988   999999999999999999999999998754


Q ss_pred             cCCC-----cccccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc--cc-cc
Q 003287          666 CGDE-----LQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA--WN-LW  735 (834)
Q Consensus       666 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~--~~-~~  735 (834)
                      ....     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||..............  .. ..
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            3221     1112233478999999999987  5799999999999999999999999976443221100000  00 00


Q ss_pred             c-----ccc-------------cccccC---c------cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          736 K-----DNR-------------AYELLS---P------ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       736 ~-----~~~-------------~~~l~~---~------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .     ...             ..+...   +      .............+.+|+.+||+.||++|||+.|+++-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0     000             000000   0      00001223345678899999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=356.57  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=199.9

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  585 (834)
                      ..++|++++.||+|+||+||+|+.. +++.||||++++.   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999976 5899999999754   233456788999999988 7999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999853   346899999999999999999999988   999999999999999999999999999854


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   ... ...   .. 
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~---~i~-~~~---~~-  242 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--FE---AIL-NDE---VV-  242 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHH-HCC---CC-
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--HH---HHH-cCC---CC-
Confidence            222  2233456799999999999999999999999999999999999999976443211  00   000 000   00 


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCH------HHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTM------SKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~  783 (834)
                            .+......+.+++..||+.+|++||++      .|+++
T Consensus       243 ------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 ------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  011133457789999999999999998      66765

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=353.34  Aligned_cols=258  Identities=26%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      .++|++.+.||+|+||.||+|+.. +++    +||+|.+... .....+++.+|+.++.+++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            368999999999999999999864 344    4688887544 3446788999999999999999999999998764 88


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +|+||+++|+|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998543  345899999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........      ......  .. 
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~~~~~--~~-  238 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEKGE--RL-  238 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTTC--CC-
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------HHHcCC--CC-
Confidence            54433333344567889999999999999999999999999999999 999987654332110      000110  00 


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                            ..+......+.+++..||+.+|++||++.|+++.|+.+..
T Consensus       239 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          239 ------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                  0111223457889999999999999999999999998853

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=378.83  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=211.3

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++|+||+++++++.+ +..+|||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            457899999999999999999999888899999997643 345789999999999999999999999876 678999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++|+|.+++... ....+++.+++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            9999999999532 2245889999999999999999999987   99999999999999999999999999987643221


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                       .......++..|+|||++....++.++|||||||+||||++ |+.||......+.  ..    ....+  ....     
T Consensus       419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--~~----~i~~~--~~~~-----  484 (535)
T 2h8h_A          419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD----QVERG--YRMP-----  484 (535)
T ss_dssp             -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--HH----HHHTT--CCCC-----
T ss_pred             -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC--CCCC-----
Confidence             11223456789999999999999999999999999999999 8999875432211  00    00001  0111     


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                        .+..+...+.+|+..||+.+|++||++.+|+++|+.+....
T Consensus       485 --~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          485 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence              11123456788999999999999999999999999985443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.8e-39  Score=343.77  Aligned_cols=258  Identities=31%  Similarity=0.462  Sum_probs=209.0

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            46899999999999999999998888899999997543 34578999999999999999999999986 45689999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++++|.+++... ....+++.++..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            999999999532 1225899999999999999999999988   999999999999999999999999999876543221


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                       ......++..|+|||++.+..++.++||||||++++||++ |+.|+........  ..    .....  .....     
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~----~~~~~--~~~~~-----  231 (279)
T 1qpc_A          166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQ----NLERG--YRMVR-----  231 (279)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----HHHTT--CCCCC-----
T ss_pred             -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--HH----HHhcc--cCCCC-----
Confidence             2223456789999999998999999999999999999999 8888875432211  00    00000  00011     


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                        +......+.+++..||+.+|++||++.++++.|+.+...
T Consensus       232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence              112235678899999999999999999999999987543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-38  Score=337.68  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=206.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            367999999999999999999976 58999999986543 3456789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999853   346899999999999999999999987   9999999999999999999999999998764333


Q ss_pred             cccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .........|++.|+|||++.+..+ +.++||||||++++||++|+.||............     +......  .    
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~--~----  228 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKTY--L----  228 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-----HHTTCTT--S----
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----hhhcccc--c----
Confidence            2233344678999999999988765 78999999999999999999999764432211111     1111000  0    


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        .........+.+++..||+.+|++||++.|+++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              011123356778999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-38  Score=347.87  Aligned_cols=275  Identities=24%  Similarity=0.347  Sum_probs=202.3

Q ss_pred             HHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhcc--CCCceeeEeeeEeec----C
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL--QHRNLVRLMGCCVEQ----G  582 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~  582 (834)
                      ....++|++.+.||+|+||.||+|+.. ++.||||++....   ...+..|.+++..+  +||||+++++++.+.    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            344578999999999999999999884 8999999986432   34445555555554  999999999999887    7


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEecCCCCCcEEEcCCCCeeec
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      ..++||||+++|+|.+++..    ..+++..+..++.|+++||+|||+..     ..+|+||||||+|||++.++.+||+
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            89999999999999999943    35899999999999999999999871     1239999999999999999999999


Q ss_pred             cccccccccCCCccc--ccccccccccccCcccccCCCCCcc------CCeeeHHHHHHHHhhCCCCCCCCCcccccccc
Q 003287          658 DFGMARMFCGDELQG--NTKRVVGTYGYMSPEYALDGLFSVK------SDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  729 (834)
Q Consensus       658 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDVwSlGvil~elltg~~p~~~~~~~~~~~~~  729 (834)
                      |||+++.+.......  ......||+.|+|||++.+.....+      +|||||||++|||++|..|+............
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999998764332211  1224579999999999988776665      99999999999999995444322111110000


Q ss_pred             c-----ccccccccccccccCccccc-hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          730 H-----AWNLWKDNRAYELLSPALQH-EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       730 ~-----~~~~~~~~~~~~l~~~~l~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                      .     ...............+.... .....+...+.+|+..||+.+|++||++.|+++.|+.+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            0     00000000001111122211 12235677899999999999999999999999999987443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-39  Score=344.26  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             ccCccccc-eecccCccceEeeEec---CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~-~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|.+.+ .||+|+||.||+|+..   +++.||||++... .....+.+.+|+.++.+++||||+++++++ +.+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35677776 9999999999999863   5788999999765 344567899999999999999999999999 5667999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999953  3346899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCc-ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          667 GDEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........  ..    ......     
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~i~~~~-----  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGK-----  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH----HHHTTC-----
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHhcCC-----
Confidence            3322 122233456889999999998899999999999999999998 9999875443211  00    000110     


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCC
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  795 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p  795 (834)
                      .+    ..+...+..+.+++..||+.+|++||++.|+++.|+.+......+
T Consensus       231 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          231 RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             cC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            00    111223456888999999999999999999999999875444333

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-38  Score=349.60  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=199.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++.+.||+|+||.||+++.. +++.||||++.+.   .....+.+.+|..++.++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            67999999999999999999986 4889999999764   234456788999999988 899999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999853   346899999999999999999999987   99999999999999999999999999986422


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc---cccccccccccccccccc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN---LLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~l~  744 (834)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .............     
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  235 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  235 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence            2  12234567999999999999999999999999999999999999999653221100   0000000000000     


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                       ..    .+......+.+++..||+.+|++||++
T Consensus       236 -~~----~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -IR----IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -CC----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -CC----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence             00    111234567889999999999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.6e-39  Score=360.43  Aligned_cols=252  Identities=24%  Similarity=0.308  Sum_probs=197.5

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccC--CCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..+|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4579999999999999999999888999999998654  3445678999999999996  59999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      || +.+++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 6788999998543   46889999999999999999999987   99999999999995 58999999999987654


Q ss_pred             CCcccccccccccccccCcccccC-----------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---------  277 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---------  277 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH---------
Confidence            333333345679999999999875           468999999999999999999999987532211000         


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                          ..++++......+......+.+|+..||+.+|++||++.|+++.
T Consensus       278 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 ----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                01111111100011113457889999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.9e-39  Score=343.67  Aligned_cols=276  Identities=19%  Similarity=0.268  Sum_probs=216.7

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeE-eecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC-VEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+++.+|+.++.+++|++++..+..+ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            47899999999999999999997 4689999999865432  24688999999999988766666555 56678899999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---cCCCCeeecccccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC  666 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~vkl~DFGla~~~~  666 (834)
                      |+ +++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999998532  346899999999999999999999987   9999999999999   588999999999998765


Q ss_pred             CCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccccccccccc
Q 003287          667 GDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRA  740 (834)
Q Consensus       667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  740 (834)
                      .....     .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....    .......
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~  235 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----RISEKKM  235 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----HHHHHHH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh----hhccccc
Confidence            43321     122446799999999999999999999999999999999999999976432211 0000    0000000


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccccc
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR  804 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~  804 (834)
                      .   .+  ........+..+.+++..||+.+|++||++.++++.|+.+......+....+.|..
T Consensus       236 ~---~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 3uzp_A          236 S---TP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             H---SC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred             C---Cc--hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence            0   00  00111223457889999999999999999999999999998777777777777753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-39  Score=347.59  Aligned_cols=245  Identities=23%  Similarity=0.312  Sum_probs=204.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+..   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999975 58999999997542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999953   346899999999999999999999987   99999999999999999999999999987532


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                           ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .   ..... ..   .   .
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~i~~-~~---~---~  221 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--Y---EKILN-AE---L---R  221 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHHHH-CC---C---C
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--H---HHHHh-CC---C---C
Confidence                 22346799999999999999999999999999999999999999875432111  0   00000 00   0   0


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      .    +......+.+++..||+.+|++||     +++|+++
T Consensus       222 ~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             C----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            1    112235678899999999999999     8888884

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=354.40  Aligned_cols=248  Identities=25%  Similarity=0.325  Sum_probs=197.9

Q ss_pred             cccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCCC
Q 003287          516 SMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  594 (834)
Q Consensus       516 ~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  594 (834)
                      ...+.||+|+||.||+|+.. +|+.||||++........+++.+|+.++.+++||||+++++++.+.+..+|||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33578999999999999875 58999999998766667788999999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE--cCCCCeeeccccccccccCCCccc
Q 003287          595 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl--~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.+....   
T Consensus       172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---  243 (373)
T 2x4f_A          172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---  243 (373)
T ss_dssp             EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence            999888532  245889999999999999999999988   9999999999999  567899999999998764332   


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchh
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..   ......  ..     .....
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~---~i~~~~--~~-----~~~~~  311 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LN---NILACR--WD-----LEDEE  311 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHHTC--CC-----SCSGG
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HHHhcc--CC-----CChhh
Confidence            22334689999999999999999999999999999999999999976443211  00   000000  00     00111


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......+.+|+..||+.+|++||++.|+++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1223456889999999999999999999997

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7e-39  Score=344.30  Aligned_cols=276  Identities=19%  Similarity=0.268  Sum_probs=212.3

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeE-eecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC-VEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+.++.+++|++++..+..+ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            47899999999999999999997 4689999998754322  24578899999999988777766655 66778899999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---cCCCCeeecccccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC  666 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~vkl~DFGla~~~~  666 (834)
                      |+ +++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            99 99999998532  345899999999999999999999998   9999999999999   789999999999998765


Q ss_pred             CCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccccccccccc
Q 003287          667 GDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRA  740 (834)
Q Consensus       667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  740 (834)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ....    .......
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~  235 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----RISEKKM  235 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----HHHHHHH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh----hhhcccc
Confidence            43321     122346789999999999999999999999999999999999999976432211 0000    0000000


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccccc
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR  804 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~  804 (834)
                         ..+  ........+..+.+++..||+.+|++||+++++++.|+.+......+....+.|..
T Consensus       236 ---~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 4hgt_A          236 ---STP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             ---HSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred             ---cch--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence               000  00011122457889999999999999999999999999987777666666666654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.9e-39  Score=347.32  Aligned_cols=268  Identities=23%  Similarity=0.367  Sum_probs=202.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..+|++.+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            467999999999999999999874 6899999999753   344567899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |||+++++|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998532 12456899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...  .......|++.|+|||++.+..++.++||||||+++|||++|+.||.........+..    .........    
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~----  257 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEQCDYPP----  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH----HHHTTCSCC----
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH----HhhcccCCC----
Confidence            322  1223356899999999999999999999999999999999999998653322111110    000011000    


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCC
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPK  796 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~  796 (834)
                       ..   .......+.+++..||+.||++||++.++++.|+.+.+....|.
T Consensus       258 -~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          258 -LP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             -CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             -Cc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence             00   11233567889999999999999999999999999976665554

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-39  Score=363.88  Aligned_cols=259  Identities=19%  Similarity=0.238  Sum_probs=207.1

Q ss_pred             HHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeec
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  581 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  581 (834)
                      .++....++|+++++||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            345556789999999999999999999986 48899999997532   12234588999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      ...++||||+++|+|.+++.+    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999843    35889999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCC----CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD  737 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  737 (834)
                      ++.+..... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+....  .   ......
T Consensus       215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~---~~i~~~  288 (410)
T 3v8s_A          215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--Y---SKIMNH  288 (410)
T ss_dssp             CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHHHTH
T ss_pred             eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--H---HHHHhc
Confidence            987643321 1223467999999999998765    88999999999999999999999975442211  0   000000


Q ss_pred             cccccccCccccchhHHHHHHHHHHHHhcccccCcCC--CCCHHHHHHH
Q 003287          738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  784 (834)
Q Consensus       738 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~  784 (834)
                      ........       .......+.+|+..||+.+|.+  ||+++|+++-
T Consensus       289 ~~~~~~p~-------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHCCCCT-------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cccccCCC-------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00000000       0112356788999999999988  9999999974

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-39  Score=342.51  Aligned_cols=251  Identities=22%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             ccCccccceecccCccceEeeEecC-C-------cEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-G-------QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g-------~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      .++|++.+.||+|+||.||+|+... +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3689999999999999999998653 3       5799999987766777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC--------ee
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PK  655 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--------vk  655 (834)
                      .++||||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999542  234899999999999999999999988   999999999999998887        99


Q ss_pred             eccccccccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCC-CCCCcccccccccccc
Q 003287          656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNT-GVYDIESFNLLGHAWN  733 (834)
Q Consensus       656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~-~~~~~~~~~~~~~~~~  733 (834)
                      |+|||++.....      .....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+ ..........      
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~------  229 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ------  229 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH------
Confidence            999999875422      233567899999999987 77999999999999999999965543 3322111000      


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ....  .... .+        .....+.+++..||+.+|++||++.|+++.|+.+..
T Consensus       230 ~~~~--~~~~-~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 FYED--RHQL-PA--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHT--TCCC-CC--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             Hhhc--cCCC-CC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0000  0000 00        012346789999999999999999999999999844

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=352.04  Aligned_cols=270  Identities=23%  Similarity=0.274  Sum_probs=196.6

Q ss_pred             HHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEe-------
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCV-------  579 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~-------  579 (834)
                      .....+|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++.       
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            334568999999999999999999975 68999999997766667788999999999996 999999999994       


Q ss_pred             -ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecc
Q 003287          580 -EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                       .....++||||++ |+|.+++........+++.++..++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence             3345899999996 788888854334456999999999999999999999874 3499999999999999999999999


Q ss_pred             ccccccccCCCcc----------cccccccccccccCcccc---cCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc
Q 003287          659 FGMARMFCGDELQ----------GNTKRVVGTYGYMSPEYA---LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF  725 (834)
Q Consensus       659 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~  725 (834)
                      ||+++.+......          .......||+.|+|||++   .+..++.++||||||+++|||++|+.||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            9999876433211          111234589999999998   566789999999999999999999999865332111


Q ss_pred             cccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCC
Q 003287          726 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQS  798 (834)
Q Consensus       726 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~  798 (834)
                        ..        .. .....+       ......+.+|+..||+.+|++||++.|+++.|..+....+.++..
T Consensus       262 --~~--------~~-~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~  316 (337)
T 3ll6_A          262 --VN--------GK-YSIPPH-------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS  316 (337)
T ss_dssp             ---------------CCCCTT-------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             --hc--------Cc-ccCCcc-------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence              00        00 000000       011123667999999999999999999999999986655544444

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=351.02  Aligned_cols=251  Identities=22%  Similarity=0.272  Sum_probs=189.7

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3578999999999999999999986 47899999997543  34678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCeeecccccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFC  666 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vkl~DFGla~~~~  666 (834)
                      |+++++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999854   345899999999999999999999987   999999999999975   8999999999998754


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........     ....... .... 
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----~i~~~~~-~~~~-  272 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR-----RILNCEY-YFIS-  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH-----HHHTTCC-CCCT-
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH-----HHHhCCC-ccCC-
Confidence            321   22345789999999999999999999999999999999999999875433211100     0000000 0000 


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          .........+.+|+..||+.||++||++.|+++
T Consensus       273 ----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 ----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                111223456788999999999999999999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.1e-39  Score=351.71  Aligned_cols=261  Identities=19%  Similarity=0.206  Sum_probs=202.1

Q ss_pred             HHHhccCccccceecccCccceEeeEec-CCcEEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec
Q 003287          508 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  581 (834)
Q Consensus       508 ~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  581 (834)
                      +....++|++.+.||+|+||.||+|+.. +++.||||++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4455688999999999999999999875 5889999998653     234567899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPS-------------------------------------RTHLLGWQTRVKIIEGIAQG  624 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~  624 (834)
                      +..++||||+++|+|.+++....                                     ....+++..+..++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                     01123567788999999999


Q ss_pred             HHHHhhcCCCceEecCCCCCcEEEcCCC--CeeeccccccccccCCCc--ccccccccccccccCcccccC--CCCCccC
Q 003287          625 LLYLHQYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARMFCGDEL--QGNTKRVVGTYGYMSPEYALD--GLFSVKS  698 (834)
Q Consensus       625 L~yLH~~~~~~iiH~DIkp~NILl~~~~--~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~ks  698 (834)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||+++.+.....  ........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999987   99999999999998776  899999999987643221  112344679999999999975  6789999


Q ss_pred             CeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCH
Q 003287          699 DVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTM  778 (834)
Q Consensus       699 DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  778 (834)
                      ||||||+++|||++|+.||.........     ........  ..     ...........+.+++..||+.+|++||++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~--~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTI-----SQVLNKKL--CF-----ENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHCCC--CT-----TSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHH-----HHHHhccc--cc-----CCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            9999999999999999998754432110     00000000  00     011111234567889999999999999999


Q ss_pred             HHHHH
Q 003287          779 SKVVS  783 (834)
Q Consensus       779 ~evl~  783 (834)
                      .|+++
T Consensus       326 ~~~l~  330 (345)
T 3hko_A          326 MRALQ  330 (345)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            99987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.7e-39  Score=352.72  Aligned_cols=266  Identities=17%  Similarity=0.199  Sum_probs=200.6

Q ss_pred             ccCccccceecccCccceEeeEec----CCcEEEEEEecccChh-----------hHHHHHHHHHHHhccCCCceeeEee
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLMG  576 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~  576 (834)
                      .++|++.+.||+|+||.||+|+..    .+..||||++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999975    4678999998754321           1234677889999999999999999


Q ss_pred             eEee----cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC
Q 003287          577 CCVE----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  652 (834)
Q Consensus       577 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~  652 (834)
                      ++.+    ....++||||+ +++|.+++...   ..+++.+++.++.||++||+|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67899999999 99999998532   37899999999999999999999987   99999999999999887


Q ss_pred             --CeeeccccccccccCCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc
Q 003287          653 --NPKISDFGMARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF  725 (834)
Q Consensus       653 --~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~  725 (834)
                        .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211     112345799999999999999999999999999999999999999864222111


Q ss_pred             cccccccccccccccccccCccccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          726 NLLGHAWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       726 ~~~~~~~~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ......      ......+.+.+... .....+..+.+++..||+.+|++||++.+|++.|+....
T Consensus       269 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AVQTAK------TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHH------HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHH------HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            110000      00000000000000 000234578899999999999999999999999998744

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=342.60  Aligned_cols=261  Identities=26%  Similarity=0.344  Sum_probs=206.9

Q ss_pred             cCccccceecccCccceEeeEecC----CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE-EE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK-IL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~l  586 (834)
                      -.|++.++||+|+||+||+|+..+    +..||||++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            356677999999999999998643    2379999997643 34567899999999999999999999999877655 99


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+.+++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999965  2356889999999999999999999987   9999999999999999999999999998664


Q ss_pred             CCCc--ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCC-CCCcccccccccccccccccccccc
Q 003287          667 GDEL--QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTG-VYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       667 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ....  ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+. ..+....  ..    ......  ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--~~----~~~~~~--~~  247 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--TH----FLAQGR--RL  247 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--HH----HHHTTC--CC
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--HH----HhhcCC--CC
Confidence            4321  222334567899999999999999999999999999999999666543 2222111  00    000000  00


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      .       .+......+.+++..||+.+|++|||+.++++.|+.+...+.
T Consensus       248 ~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          248 P-------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             C-------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            0       111123467889999999999999999999999999866554

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.5e-39  Score=354.05  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=203.5

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  584 (834)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            44588999999999999999999986 58999999997642   23456788899999887 999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999853   346899999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .....      
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~----~i~~~------  233 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FH----SIRMD------  233 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC------
T ss_pred             cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHHhC------
Confidence            43221  223456799999999999999999999999999999999999999875443211  00    00000      


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHH-HHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMS-KVV  782 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl  782 (834)
                      .+...    ......+.+++..||+.+|++||++. |++
T Consensus       234 ~~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 NPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            01111    11335678899999999999999997 665

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=347.93  Aligned_cols=266  Identities=21%  Similarity=0.261  Sum_probs=207.9

Q ss_pred             hccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee----cCeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~  585 (834)
                      ..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            457899999999999999999997 4689999999977666777889999999999999999999999873    34789


Q ss_pred             EEEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +||||+++|+|.+++... .....+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999998542 23456899999999999999999999987   99999999999999999999999999876


Q ss_pred             ccCCCcc-------cccccccccccccCcccccCCC---CCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccc
Q 003287          665 FCGDELQ-------GNTKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  734 (834)
Q Consensus       665 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  734 (834)
                      .......       .......||+.|+|||++.+..   ++.++||||||+++|||++|+.||............    .
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~  259 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----A  259 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----H
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----H
Confidence            5321110       0112345799999999987654   788999999999999999999998532111100000    0


Q ss_pred             ccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       735 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      ...  .....       ........+.+++..||+.+|++||++.++++.|+.+....
T Consensus       260 ~~~--~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          260 VQN--QLSIP-------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             HHC--C--CC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             hhc--cCCCC-------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            000  00000       01122356888999999999999999999999999984433

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-39  Score=351.44  Aligned_cols=261  Identities=28%  Similarity=0.424  Sum_probs=203.7

Q ss_pred             ccCccccceecccCccceEeeEecC-----CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ..+|++.+.||+|+||.||+|+...     +..||||++... .......+.+|+.++.+++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4678889999999999999998653     246999999765 3345567999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++++|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999999542  346899999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccc
Q 003287          666 CGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ...... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||........  ..    ....+.  ..
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~----~~~~~~--~~  269 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MK----AINDGF--RL  269 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTTC--CC
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHHCCC--cC
Confidence            433211 11223346789999999999999999999999999999999 9999865432211  00    000000  00


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      .       .+......+.+++..||+.+|++||++.++++.|+.+....
T Consensus       270 ~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          270 P-------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             C-------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             C-------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            0       11123456788999999999999999999999999875433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2e-38  Score=337.75  Aligned_cols=250  Identities=19%  Similarity=0.285  Sum_probs=205.3

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||.||+|+... +..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4679999999999999999999764 779999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---cCCCCeeeccccccccccC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~vkl~DFGla~~~~~  667 (834)
                      +++++|.+++..   ...+++.++..++.|+++||+|||+.+   |+||||||+|||+   +.++.+||+|||++..+..
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998843   345899999999999999999999988   9999999999999   7889999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..   ......||+.|+|||++.+. ++.++||||||++++||++|+.||..........      ......      ..
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~------~~  225 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML------KIREGT------FT  225 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCC------CC
T ss_pred             cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhCC------CC
Confidence            32   22345689999999988654 8999999999999999999999987644221100      000000      00


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ............+.+++..||+.+|++||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011111123457889999999999999999999985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=351.21  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=202.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++++.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67999999999999999999876 48899999996542   334577899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999954   346899999999999999999999988   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccCcccccC---CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                         .......||+.|+|||++..   ..++.++|||||||++|||++|+.||............   ......      .
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~~------~  236 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFETT------V  236 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---HHHHHC------C
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhhc------c
Confidence               22345679999999999974   45899999999999999999999999754322110000   000000      0


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCC-HHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPT-MSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~  783 (834)
                      .    ..+......+.+|+..||+.+|++||+ ++++++
T Consensus       237 ~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0    011123456788999999999999998 677664

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-38  Score=353.48  Aligned_cols=253  Identities=22%  Similarity=0.264  Sum_probs=193.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999986 68999999997543 2346788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC--eeeccccccccccCC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARMFCGD  668 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--vkl~DFGla~~~~~~  668 (834)
                      +++|+|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999843   345899999999999999999999988   999999999999987765  999999999753221


Q ss_pred             CcccccccccccccccCcccccCCCCCcc-CCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                         .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ....         .......
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~---------~~~~~~~  238 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTI---------QRILSVK  238 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHH---------HHHHTTC
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHH---------HHHhcCC
Confidence               22334579999999999988887665 89999999999999999999754322110 0000         0000000


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ............+.+|+.+||+.+|++|||+.|+++-
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0000011123567889999999999999999999873

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3e-38  Score=344.28  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=206.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccCh------hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++.....      ...+++.+|+.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            367999999999999999999976 589999999875432      1367899999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC----Ceeecccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  660 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~vkl~DFG  660 (834)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954   345889999999999999999999987   99999999999999888    79999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ..    .....  
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~i~~~--  233 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA----NITSV--  233 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH----HHHTT--
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHhc--
Confidence            998764322   22345689999999999999999999999999999999999999875432211  00    00000  


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          ...............+.+++..||+.+|++||++.|+++
T Consensus       234 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          234 ----SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ----CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ----ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                000111122233456889999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-38  Score=346.16  Aligned_cols=266  Identities=24%  Similarity=0.314  Sum_probs=189.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++++.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999875 58999999997543 2344678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          590 YMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       590 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |++ |+|.+++...   .....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5888887432   22345889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cc--------cccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LL--------GHAWNLWK  736 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~--------~~~~~~~~  736 (834)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..        ...+....
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            221  12234568999999999976 46899999999999999999999999765432110 00        00000000


Q ss_pred             cc-----ccccccCc----cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 DN-----RAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ~~-----~~~~l~~~----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..     ........    .+...........+.+++..||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00     00000000    0000011123456889999999999999999999885

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-39  Score=357.18  Aligned_cols=261  Identities=30%  Similarity=0.436  Sum_probs=197.6

Q ss_pred             cCccccceecccCccceEeeEecC----CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEee-cCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l  586 (834)
                      ..|++.+.||+|+||.||+|+..+    +..||||.+.... ....++|.+|+.++++++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            457888999999999999998642    2468999987543 3456789999999999999999999998765 457899


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999999543  345789999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcc--cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccc
Q 003287          667 GDELQ--GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       667 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|||++ |..|+........  ..    ....+.  ..
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~----~~~~~~--~~  315 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TV----YLLQGR--RL  315 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HH----HHHTTC--CC
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HH----HHHcCC--CC
Confidence            33221  12233457889999999999999999999999999999999 5666654332211  00    000010  11


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      ..+       ...+..+.+++..||+.+|++||++.|+++.|+.+...+.
T Consensus       316 ~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            111       1223467889999999999999999999999999866554

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-38  Score=350.95  Aligned_cols=244  Identities=21%  Similarity=0.246  Sum_probs=203.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++++.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999976 58999999996542   234577899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999953   245899999999999999999999988   999999999999999999999999999876332


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  .    .....+..      ..
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~----~~i~~~~~------~~  257 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--Y----EKIVSGKV------RF  257 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHHHHCCC------CC
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH--H----HHHHcCCC------CC
Confidence                 2345799999999999999999999999999999999999999875432211  0    00000100      01


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                          +......+.+++..||+.+|++||+     ++|+++
T Consensus       258 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                1123456788999999999999998     888875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=341.20  Aligned_cols=265  Identities=25%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC-----hhhHHHHHHHHHHHhccC---CCceeeEeeeEeec
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQ  581 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~  581 (834)
                      ..++|++.++||+|+||+||+|+.. +++.||||++....     ......+.+|+.++++++   ||||+++++++.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999974 58999999986432     112345667777777664   99999999999876


Q ss_pred             C-----eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          582 G-----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       582 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                      .     ..++||||++ ++|.+++.... ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999997 59999886542 234899999999999999999999998   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cc-cc----
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LL-GH----  730 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~-~~----  730 (834)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. ..    
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999865332   2234567899999999999999999999999999999999999999765432110 00 00    


Q ss_pred             cccccccc-----ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          731 AWNLWKDN-----RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       731 ~~~~~~~~-----~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ....|...     .......+.............+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000000     000000000011112234467889999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-38  Score=341.92  Aligned_cols=262  Identities=30%  Similarity=0.435  Sum_probs=204.8

Q ss_pred             ccCccccceecccCccceEeeEecC----CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEe-ecCeEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV-EQGEKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~  585 (834)
                      ..+|++.+.||+|+||.||+|+..+    ...||||.+.... ....+.+.+|+.++++++||||+++++++. +++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3578999999999999999998643    2368999987643 345678999999999999999999999865 456789


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++|+|.+++..  ....+++.++..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999964  2346789999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCcc--cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCC-CCCCCCCccccccccccccccccccccc
Q 003287          666 CGDELQ--GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ......  .......+|+.|+|||.+.+..++.++||||||++++||++|. .|+.........  .    ......  .
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~--~----~~~~~~--~  250 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--V----YLLQGR--R  250 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH--H----HHHTTC--C
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH--H----HHhcCC--C
Confidence            443221  2223456788999999999999999999999999999999954 455433322110  0    000000  0


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      ...+       ......+.+++..||+.+|++||++.|+++.|+.+...+.
T Consensus       251 ~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          251 LLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1111       1123467889999999999999999999999999865443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.5e-38  Score=349.35  Aligned_cols=210  Identities=28%  Similarity=0.328  Sum_probs=182.0

Q ss_pred             CcccHHHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-----CCceeeE
Q 003287          501 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----HRNLVRL  574 (834)
Q Consensus       501 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l  574 (834)
                      ..+++.......++|++.++||+|+||+||+|+.. +++.||||++.. .....+.+..|+.++..++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34555566666789999999999999999999975 588999999974 3344567788999999996     9999999


Q ss_pred             eeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC----
Q 003287          575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----  650 (834)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~----  650 (834)
                      ++++.+.+..++||||+ +++|.+++.... ...+++.++..++.||++||+|||+.+   |+||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence            99999999999999999 999999986432 235899999999999999999999987   999999999999975    


Q ss_pred             ---------------------CCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHH
Q 003287          651 ---------------------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE  709 (834)
Q Consensus       651 ---------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~e  709 (834)
                                           ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 88999999999986432     1234578999999999999999999999999999999


Q ss_pred             HhhCCCCCCCCC
Q 003287          710 TLTSKRNTGVYD  721 (834)
Q Consensus       710 lltg~~p~~~~~  721 (834)
                      |++|+.||....
T Consensus       252 ll~g~~pf~~~~  263 (360)
T 3llt_A          252 LYTGSLLFRTHE  263 (360)
T ss_dssp             HHHSSCSCCCSS
T ss_pred             HHHCCCCCCCCc
Confidence            999999997644

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=352.32  Aligned_cols=273  Identities=26%  Similarity=0.406  Sum_probs=209.9

Q ss_pred             ccCccccceecccCccceEeeEe-----cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC--eE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~  584 (834)
                      .++|++.+.||+|+||.||+++.     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46799999999999999999984     358899999998776677788999999999999999999999987654  78


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999543  245899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc-ccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNLWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  742 (834)
                      ....... .......++..|+|||.+.+..++.++||||||++++||++|..|+.....+........ ..........+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            6543221 112234567889999999999999999999999999999999988753211100000000 00000000001


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .+........+...+..+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11000001111223457889999999999999999999999998873

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.1e-39  Score=344.61  Aligned_cols=259  Identities=25%  Similarity=0.355  Sum_probs=206.1

Q ss_pred             hccCccccc-eecccCccceEeeEec---CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          511 ATENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       511 ~~~~f~~~~-~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      ..++|++.+ .||+|+||.||+|...   .++.||||++....  ....+++.+|+.++++++||||+++++++ +.+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788888 9999999999999643   36889999997643  33467899999999999999999999999 66788


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            999999999999999954   345899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........  .    ........  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~----~~~~~~~~--  238 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--T----AMLEKGER--  238 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H----HHHHTTCC--
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--H----HHHHcCCC--
Confidence            6443221 11223446789999999999899999999999999999999 9999876443211  0    00111100  


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                         +    ..+......+.+++..||+.+|++||++.++++.|+.+...
T Consensus       239 ---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          239 ---M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence               0    11122345688899999999999999999999999987443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.4e-39  Score=349.59  Aligned_cols=261  Identities=28%  Similarity=0.429  Sum_probs=206.0

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.+.||+|+||.||+|+..      +++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            478999999999999999999842      4678999999754 345567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCeeec
Q 003287          585 ILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKIS  657 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vkl~  657 (834)
                      ++||||+++++|.+++....    ....+++.+++.++.||++||+|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999996432    2245899999999999999999999987   999999999999984   4569999


Q ss_pred             cccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccc
Q 003287          658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      |||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+........  ..    ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LE----FVT  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH--HH----HHh
Confidence            9999987654443333444567899999999999999999999999999999998 8888875432211  00    000


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ....     +    .........+.+++..||+.+|++||++.|+++.|..+..
T Consensus       260 ~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          260 SGGR-----M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             TTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCC-----C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            0100     0    0111233567889999999999999999999999988743

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=377.01  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             cCccccc-eecccCccceEeeEec---CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~-~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      +++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.++++++||||+++++++.+ +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            4555555 7999999999999864   46689999997653 3457889999999999999999999999976 569999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9999999999999543  456899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          668 DELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       668 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+.  ..    ....+.  .   
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~----~i~~~~--~---  557 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGK--R---  557 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--HH----HHHTTC--C---
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HH----HHHcCC--C---
Confidence            3211 11222345789999999999999999999999999999998 9999876543221  00    111111  0   


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                          ...+..++..+.+|+..||+.+|++||++.+|++.|+.+..
T Consensus       558 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                01112234578889999999999999999999999988743

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-38  Score=340.69  Aligned_cols=256  Identities=27%  Similarity=0.379  Sum_probs=203.4

Q ss_pred             hccCccccceecccCccceEeeEecC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ..++|++.+.||+|+||.||+|+...    +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34789999999999999999998643    346999999765 34456789999999999999999999999765 4568


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999953  2345889999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.........  .    ......  ...
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~--~----~~~~~~--~~~  234 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--G----VLEKGD--RLP  234 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH--H----HHHHTC--CCC
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH--H----HHhcCC--CCC
Confidence            43321 12233456889999999999999999999999999999998 99998754332210  0    000000  000


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .+       ......+.+++..||+.+|++||++.|+++.|+.+
T Consensus       235 ~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          235 KP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            11       11235678899999999999999999999999876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=342.01  Aligned_cols=264  Identities=22%  Similarity=0.277  Sum_probs=200.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|+++++||+|+||+||+|+.. +++.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999986 48999999986543  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999988843   345899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc-ccc--------ccccccccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGH--------AWNLWKDNR  739 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~~~--------~~~~~~~~~  739 (834)
                        .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ...        ....+....
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence              12234568999999999976 568999999999999999999999997654321100 000        000000000


Q ss_pred             ---cccccCccccc---hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 ---AYELLSPALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ---~~~l~~~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         .....++....   .........+.+++..||+.+|++|||++|+++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence               00011111000   0112234567899999999999999999999863

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-38  Score=347.67  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=193.5

Q ss_pred             ccCccccceecccCccceEeeEe----cCCcEEEEEEecccC----hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      .++|++.+.||+|+||.||+++.    .+++.||||++++..    ......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999987    368999999997642    2345668899999999999999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999843   346889999999999999999999987   9999999999999999999999999997


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ..   .... ..    
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~---~i~~-~~----  237 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--ID---KILK-CK----  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH---HHHH-TC----
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--HH---HHHh-CC----
Confidence            643221  122345789999999999999999999999999999999999999975432211  00   0000 00    


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                        ..+    +......+.+++.+||+.+|++||     ++.|+++
T Consensus       238 --~~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 --LNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --CCC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --CCC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              001    112235678899999999999999     6777765

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-38  Score=344.80  Aligned_cols=264  Identities=22%  Similarity=0.252  Sum_probs=199.2

Q ss_pred             cCcccc-ceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~-~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      +.|++. +.||+|+||+||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            578885 78999999999999865 6899999999876666678899999999985 79999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC---eeecccccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFC  666 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---vkl~DFGla~~~~  666 (834)
                      |+++++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.   +||+|||+++.+.
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999953   346899999999999999999999987   999999999999998776   9999999998653


Q ss_pred             CCCc-----ccccccccccccccCcccccC-----CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccc-ccccc
Q 003287          667 GDEL-----QGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLW  735 (834)
Q Consensus       667 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~-~~~~~  735 (834)
                      ....     ........||+.|+|||++..     ..++.++|||||||++|||++|+.||............. .....
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211     111223468999999999975     568899999999999999999999997644322100000 00000


Q ss_pred             ccccccccc---CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          736 KDNRAYELL---SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       736 ~~~~~~~l~---~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .....+.+   ...............+.+|+.+||+.||++||++.|+++
T Consensus       246 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 -QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             -HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             00000000   000111111223457889999999999999999999987

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.8e-38  Score=336.82  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=204.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999875 5899999998654  3445677899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC---eeeccccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---vkl~DFGla~~~  665 (834)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999888843   346899999999999999999999988   999999999999987665   999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ....   ......||+.|+|||++.+..++.++||||||++++||++|+.||.........  .    ....+. .....
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~----~~~~~~-~~~~~  228 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY--A----QIKAGA-YDYPS  228 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--H----HHHHTC-CCCCT
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH--H----HHHhcc-ccCCc
Confidence            4322   223456899999999999999999999999999999999999998754322110  0    000000 00001


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +     ........+.+++..||+.+|++||++.|+++
T Consensus       229 ~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0     11122356788999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-39  Score=354.62  Aligned_cols=278  Identities=14%  Similarity=0.180  Sum_probs=215.6

Q ss_pred             ccCccccceecccCccceEeeEecC---------CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceee---------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR---------  573 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------  573 (834)
                      .++|++.+.||+|+||.||+|+...         ++.||||++...     +.+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998764         789999998754     46789999999999999988         


Q ss_pred             ------EeeeEee-cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcE
Q 003287          574 ------LMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  646 (834)
Q Consensus       574 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NI  646 (834)
                            +++++.+ +...++||||+ +++|.+++... ....+++.++..++.||++||+|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777776 67889999999 99999999643 1356899999999999999999999997   99999999999


Q ss_pred             EEcCCC--CeeeccccccccccCCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCC
Q 003287          647 LLDSDM--NPKISDFGMARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV  719 (834)
Q Consensus       647 Ll~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~  719 (834)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999876433211     112345799999999999999999999999999999999999999876


Q ss_pred             CCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCc
Q 003287          720 YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSA  799 (834)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~  799 (834)
                      .......+.......  ......+.+....   .......+.+++..||+.+|++||++++++++|+.+..........+
T Consensus       271 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~  345 (352)
T 2jii_A          271 CLPNTEDIMKQKQKF--VDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP  345 (352)
T ss_dssp             GTTCHHHHHHHHHHH--HHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             CCcCHHHHHHHHHhc--cCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence            432211111100000  0001111111100   00123567889999999999999999999999999987777776666


Q ss_pred             ccccc
Q 003287          800 FSYAR  804 (834)
Q Consensus       800 ~~~~~  804 (834)
                      +.|..
T Consensus       346 ~dw~~  350 (352)
T 2jii_A          346 IGLPM  350 (352)
T ss_dssp             CCCCC
T ss_pred             ccCcC
Confidence            66654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-39  Score=359.75  Aligned_cols=263  Identities=20%  Similarity=0.232  Sum_probs=207.4

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEe
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV  579 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  579 (834)
                      .+.+.....++|++.+.||+|+||+||+++.. +++.||||++.+..   ....+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455566789999999999999999999985 58999999997532   223345889999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          580 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                      +.+..++||||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            999999999999999999999532  236899999999999999999999987   999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCccccc-------CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYAL-------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  732 (834)
                      |+++.+..... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||...+....  ..   
T Consensus       207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~---  280 (412)
T 2vd5_A          207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--YG---  280 (412)
T ss_dssp             TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---
T ss_pred             hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--HH---
Confidence            99987643321 1223457999999999997       45789999999999999999999999976442211  00   


Q ss_pred             ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCC---CCHHHHHHH
Q 003287          733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR---PTMSKVVSM  784 (834)
Q Consensus       733 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~evl~~  784 (834)
                      .......  .+.-+.    .....+..+.+|+.+||+ +|++|   |+++|+++-
T Consensus       281 ~i~~~~~--~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 KIVHYKE--HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHhccc--CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            0000000  000011    112234567889999999 99998   589998763

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-38  Score=341.51  Aligned_cols=264  Identities=21%  Similarity=0.233  Sum_probs=200.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999975 58899999997542   23457899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++..   ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999953   346899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ... .......|++.|+|||++.+..++.++||||||+++|||++|+.||........  .    ...... .   ..+ 
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~~~~-~---~~~-  254 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM--G----AHINQA-I---PRP-  254 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH--H----HHHHSC-C---CCG-
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH--H----HHhccC-C---CCc-
Confidence            321 122345689999999999999999999999999999999999999875432210  0    000000 0   000 


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCC-CHHHHHHHhhcccCCCCCC
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNEHATLPYP  795 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~l~~p  795 (834)
                        .......+..+.+++..||+.+|++|| +++++++.|+.........
T Consensus       255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD  301 (309)
T ss_dssp             --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred             --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence              011122334677899999999999999 9999999999885554433

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=351.50  Aligned_cols=256  Identities=14%  Similarity=0.136  Sum_probs=206.5

Q ss_pred             HHhccCccccceecccCccceEeeE------ecCCcEEEEEEecccChhhHHHHHHHHHHHhccC---CCceeeEeeeEe
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGK------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCV  579 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~------~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~  579 (834)
                      ....++|++.++||+|+||+||+|.      ...++.||||++....   ..++..|+.++.+++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3456789999999999999999994      3458899999997643   456777888888886   999999999999


Q ss_pred             ecCeEEEEEEecCCCCchhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-------
Q 003287          580 EQGEKILIYEYMPNKSLNFFLFDP--SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------  650 (834)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-------  650 (834)
                      +.+..++||||+++|+|.+++...  .....+++..+..++.||++||+|||+.+   |+||||||+||||+.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence            999999999999999999999532  13456999999999999999999999987   999999999999998       


Q ss_pred             ----CCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc
Q 003287          651 ----DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN  726 (834)
Q Consensus       651 ----~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~  726 (834)
                          ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                8999999999998654333333344567999999999999999999999999999999999999997543221110


Q ss_pred             ccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCC-CCHHHHHHHhhcccC
Q 003287          727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR-PTMSKVVSMITNEHA  790 (834)
Q Consensus       727 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~evl~~L~~~~~  790 (834)
                      .             ...+...    .   ..+.+.+++..|++.+|.+| |++.++.+.|+....
T Consensus       295 ~-------------~~~~~~~----~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          295 P-------------EGLFRRL----P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             E-------------CSCCTTC----S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             e-------------chhcccc----C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            0             0001100    0   12356678899999999999 688999998887643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-38  Score=354.31  Aligned_cols=266  Identities=22%  Similarity=0.314  Sum_probs=192.4

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecC--eE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQG--EK  584 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~  584 (834)
                      ..++|++++.||+|+||.||+|... +++.||||++...  .....+++.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3578999999999999999999875 5899999998653  3445677889999999997 999999999997554  78


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||++ ++|..++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999998 688888843    46889999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCC-------------------cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc
Q 003287          665 FCGDE-------------------LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  724 (834)
Q Consensus       665 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~  724 (834)
                      +....                   .........||+.|+|||++.+ ..++.++|||||||+++||++|+.||...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            63311                   0112234579999999999987 679999999999999999999999997654211


Q ss_pred             c-ccccccccccccccccccc------------------Cccccchh------------HHHHHHHHHHHHhcccccCcC
Q 003287          725 F-NLLGHAWNLWKDNRAYELL------------------SPALQHEA------------SYQMLNRYITVALLCVQEKAA  773 (834)
Q Consensus       725 ~-~~~~~~~~~~~~~~~~~l~------------------~~~l~~~~------------~~~~~~~l~~li~~cl~~~P~  773 (834)
                      . .................+.                  ........            .......+.+|+.+||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            1 0000000000000000000                  00000000            002245688999999999999


Q ss_pred             CCCCHHHHHHH
Q 003287          774 DRPTMSKVVSM  784 (834)
Q Consensus       774 ~RPs~~evl~~  784 (834)
                      +|||+.|+++-
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999865

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-38  Score=350.76  Aligned_cols=249  Identities=24%  Similarity=0.316  Sum_probs=203.3

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  585 (834)
                      ..++|++++.||+|+||.||+++... ++.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34789999999999999999999864 7899999997642   23456788999999988 8999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999853   245899999999999999999999987   999999999999999999999999999864


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .... ..      
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~---~i~~-~~------  237 (353)
T 2i0e_A          172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ---SIME-HN------  237 (353)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHH-CC------
T ss_pred             ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH--HH---HHHh-CC------
Confidence            222  1223456799999999999999999999999999999999999999975432211  00   0000 00      


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                      ..    .+......+.+|+..||+.+|++||+     +.|+++
T Consensus       238 ~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 VA----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CC----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            00    11123456788999999999999995     466654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-38  Score=335.10  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=183.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467999999999999999999874 68999999996542   22357789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999999642  346899999999999999999999987   99999999999999999999999999987542


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..  .......||+.|+|||.+.+..++.++||||||++++||++|+.|+.........  .   ...    ....   .
T Consensus       165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~---~~~----~~~~---~  230 (278)
T 3cok_A          165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--N---KVV----LADY---E  230 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC----SSCC---C
T ss_pred             CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--H---HHh----hccc---C
Confidence            22  1223356899999999999999999999999999999999999998754322110  0   000    0000   0


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .    +......+.+++.+||+.+|++||++.++++
T Consensus       231 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 M----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             C----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1    1112346778999999999999999999885

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.7e-38  Score=358.00  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=204.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999976 69999999997542   23456789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999953   346899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........  ..    ....+. .  ..+
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~----~i~~~~-~--~~p  236 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--FK----KICDGI-F--YTP  236 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--HH----HHHTTC-C--CCC
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--HH----HHhcCC-c--CCC
Confidence            32   2234579999999999998775 7899999999999999999999875432211  00    000000 0  001


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                             ......+.+|+..||+.||++|||+.|+++
T Consensus       237 -------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          237 -------QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                   112345788999999999999999999997

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.2e-39  Score=350.71  Aligned_cols=272  Identities=25%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHH--HhccCCCceeeEeeeEee-----cCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML--IAKLQHRNLVRLMGCCVE-----QGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~~~  584 (834)
                      .++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            47899999999999999999987 68999999997543   2344444444  555899999999986543     2357


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceEecCCCCCcEEEcCCCCeeecc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------RLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                      ++||||+++|+|.+++..    ...++..+..++.||++||+|||+..      ..+|+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            899999999999999943    33588999999999999999999981      11399999999999999999999999


Q ss_pred             ccccccccCCCc------ccccccccccccccCcccccC-------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCc-cc
Q 003287          659 FGMARMFCGDEL------QGNTKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ES  724 (834)
Q Consensus       659 FGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~elltg~~p~~~~~~-~~  724 (834)
                      ||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+..... ..
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987654321      112224569999999999987       4567899999999999999999877643322 11


Q ss_pred             cccccccccccc---cccc-----ccccCccccc--hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          725 FNLLGHAWNLWK---DNRA-----YELLSPALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       725 ~~~~~~~~~~~~---~~~~-----~~l~~~~l~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      .... .......   ....     .....+.+..  .........+.+|+..||+.+|++|||+.|+++.|+.+...+
T Consensus       244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          244 YQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCT-THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             HHHh-hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            1000 0000000   0000     0000111111  112235567899999999999999999999999999985444

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.1e-38  Score=344.54  Aligned_cols=266  Identities=24%  Similarity=0.311  Sum_probs=207.1

Q ss_pred             HHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhc--cCCCceeeEeeeEeecC----
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQG----  582 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----  582 (834)
                      ....++|++.+.||+|+||.||+|+. +++.||||++...   ....+.+|++++..  ++||||+++++++.+..    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            44457899999999999999999998 5899999999653   34667888888887  79999999999998876    


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecCCCCCcEEEcCCCCe
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMNP  654 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~DIkp~NILl~~~~~v  654 (834)
                      ..++||||+++|+|.+++.+    ..+++.+++.++.|+++||+|||        +.+   |+||||||+|||++.++.+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred             eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence            78999999999999999943    35899999999999999999999        555   9999999999999999999


Q ss_pred             eeccccccccccCCCccc--ccccccccccccCcccccCC------CCCccCCeeeHHHHHHHHhhC----------CCC
Q 003287          655 KISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEYALDG------LFSVKSDVFSFGVLLLETLTS----------KRN  716 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwSlGvil~elltg----------~~p  716 (834)
                      ||+|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998765433211  22345789999999999876      344789999999999999999          556


Q ss_pred             CCCCCcccccccccccccccccccccccCccccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          717 TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      |............. ....    ......+.+... ........+.+|+.+||+.+|++||++.|+++.|+.+..
T Consensus       267 ~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          267 YYDLVPSDPSVEEM-RKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTSCSSCCHHHH-HHHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCcCcccHHHH-HHHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            54332211110000 0000    011112222211 223566788999999999999999999999999998743

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.9e-38  Score=345.35  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=205.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcE--EEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQE--VAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~--vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++.+.||+|+||.||+|+.. ++..  ||||++... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67999999999999999999875 4554  499998753 334556789999999999 999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCe
Q 003287          588 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  654 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~v  654 (834)
                      |||+++++|.+++....             ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996542             2356899999999999999999999987   9999999999999999999


Q ss_pred             eeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccc
Q 003287          655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  733 (834)
                      ||+|||+++....   ........+++.|+|||++.+..++.++||||||+++|||++ |+.||........  ..    
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~----  252 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE----  252 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HH----
Confidence            9999999974321   112233456889999999999999999999999999999998 9999875442211  00    


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      ....+     ...    ..+......+.+++..||+.+|++||++.|+++.|+.+....
T Consensus       253 ~~~~~-----~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          253 KLPQG-----YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HGGGT-----CCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HhhcC-----CCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            00000     000    011122356788999999999999999999999999875443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=353.94  Aligned_cols=272  Identities=21%  Similarity=0.280  Sum_probs=213.5

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC--eEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV  587 (834)
                      .++|++.++||+|+||+||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3689999999999999999999864 8999999997543 334677889999999999999999999998765  78999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE----cCCCCeeeccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  663 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~vkl~DFGla~  663 (834)
                      |||+++|+|.+++........+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976554555999999999999999999999988   9999999999999    778889999999998


Q ss_pred             cccCCCcccccccccccccccCcccccC--------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALD--------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      ......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.......... .......
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII  240 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHh
Confidence            764332   2234568999999999865        567889999999999999999999986543211100 0000000


Q ss_pred             ccc---c---cc-------ccc-CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          736 KDN---R---AY-------ELL-SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       736 ~~~---~---~~-------~l~-~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ...   .   ..       +.. +..............+.+++..||+.||++||++.|+++.++.+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            000   0   00       000 0001112345667788899999999999999999999999988744

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=346.64  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=201.8

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccCh--------hhHHHHHHHHHHHhccCCCceeeEeeeEeec
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  581 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  581 (834)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3578999999999999999999864 589999999975421        1334678899999999999999999999999


Q ss_pred             CeEEEEEEecCCC-CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          582 GEKILIYEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      +..++||||+..| +|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 99998854   345899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +++.+....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........              
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------  238 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------------  238 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------
Confidence            998764332   2234578999999999998876 8899999999999999999999864221100              


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       .....+.       .....+.+|+..||+.+|++||++.|+++-
T Consensus       239 -~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 -AAIHPPY-------LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -hccCCCc-------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000011       123457889999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-38  Score=351.01  Aligned_cols=246  Identities=30%  Similarity=0.443  Sum_probs=199.2

Q ss_pred             cCccccceecccCccceEeeEe-cCCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +.|++.+.||+|+||+||+|+. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            5699999999999999999986 468999999996542   334567899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||++ |+|.+++..  ....+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus       134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            9997 677777642  2346899999999999999999999987   99999999999999999999999999986532 


Q ss_pred             CcccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                           .....||+.|+|||++.   ...++.++|||||||++|||++|+.|+........     ........      .
T Consensus       207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~------~  270 (348)
T 1u5q_A          207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE------S  270 (348)
T ss_dssp             -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC------C
T ss_pred             -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC------C
Confidence                 22357899999999985   56799999999999999999999999875432111     00000100      1


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +....   ......+.+++..||+.+|++||++.++++.
T Consensus       271 ~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11111   1123457789999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.4e-38  Score=334.85  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=202.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccCh------hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ++|++.+.||+|+||.||+++.. +++.||||++.....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999986 589999999865421      24678999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC----Ceeeccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGM  661 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~vkl~DFGl  661 (834)
                      +||||+++++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999843   346899999999999999999999987   99999999999998877    899999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      +.......   ......+++.|+|||++.+..++.++||||||++++||++|+.||........  ..    ....    
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~----  225 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LT----NISA----  225 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHT----
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HH----HhHh----
Confidence            98764322   22345689999999999999999999999999999999999999875432211  00    0000    


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ................+.+++.+||+.+|++||++.|+++
T Consensus       226 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          226 --VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             --TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence              0001111122233456889999999999999999999997

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.2e-38  Score=346.13  Aligned_cols=248  Identities=22%  Similarity=0.229  Sum_probs=179.7

Q ss_pred             ceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          519 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      +.||+|+||+||+++.. +++.||||++.+.   ....+.+|+.++.++. ||||+++++++.+....++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            78999999999999986 5899999999653   3467788999999997 99999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC---CeeeccccccccccCCCcccc
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~vkl~DFGla~~~~~~~~~~~  673 (834)
                      .+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++   .+||+|||+++......  ..
T Consensus        94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~  165 (325)
T 3kn6_A           94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP  165 (325)
T ss_dssp             HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence            999954   356899999999999999999999987   99999999999997765   89999999998654322  22


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cccccccccccccccccccCccccchh
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRAYELLSPALQHEA  752 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~~  752 (834)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ............+      ........
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~------~~~~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG------DFSFEGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT------CCCCCSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC------CCCCCccc
Confidence            2345689999999999999999999999999999999999999976432110 0000000000000      01111222


Q ss_pred             HHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          753 SYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       753 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......+.+|+..||+.||++||+++|+++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            3345567889999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-38  Score=337.23  Aligned_cols=248  Identities=25%  Similarity=0.341  Sum_probs=200.9

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      +.++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3478999999999999999999876 47799999986532   2235678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999843   245899999999999999999999987   9999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........  .    ....      ...
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~------~~~  224 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY--K----RISR------VEF  224 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--H----HHHH------TCC
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH--H----HHHh------CCC
Confidence            22    223457899999999999999999999999999999999999998754322110  0    0000      000


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..    +......+.+++..||+.+|++||++.|+++-
T Consensus       225 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 TF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            01    11123457789999999999999999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.9e-39  Score=364.43  Aligned_cols=248  Identities=22%  Similarity=0.262  Sum_probs=194.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++...   .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            468999999999999999999875 5899999999754   233456788999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |||+++|+|.+++..   ...+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999843   3468999999999999999999998 66   9999999999999999999999999998643


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....  .    ......      .
T Consensus       301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~----~i~~~~------~  366 (446)
T 4ejn_A          301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--E----LILMEE------I  366 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--H----HHHHCC------C
T ss_pred             CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH--H----HHHhCC------C
Confidence            22  12234467999999999999999999999999999999999999999754432110  0    000000      0


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                      ..    +......+.+|+..||+.||++||     ++.|+++
T Consensus       367 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 RF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            01    112235678899999999999999     9999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.6e-38  Score=336.93  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=205.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999986 4789999998654   234567789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++..   ...+++.++..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998843   346899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..  .......||+.|+|||++.+..++.++||||||++++||++|+.||..........      ...... .     .
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~-~-----~  233 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNE-Y-----S  233 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTTC-C-----C
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhhcc-C-----C
Confidence            22  12234568999999999999999999999999999999999999987544221100      000000 0     0


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      +.    ......+.+++.+||+.+|++||++.|+++.
T Consensus       234 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          234 IP----KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             Cc----cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11    1123457789999999999999999999973

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.7e-38  Score=345.13  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=201.3

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.+.||+|+||.||+++... ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3689999999999999999999864 8999999986543  334566889999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999888743   345899999999999999999999988   999999999999999999999999999865432


Q ss_pred             CcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc--c-------ccccc-----
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--L-------GHAWN-----  733 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~-------~~~~~-----  733 (834)
                      .  .......||+.|+|||++.+. .++.++||||||+++|||++|+.||..........  .       .....     
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  122345689999999999875 78999999999999999999999997654321100  0       00000     


Q ss_pred             -cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          734 -LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       734 -~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .+......+.................+.+|+..||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00001111111111111112234567889999999999999999999886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-38  Score=339.28  Aligned_cols=250  Identities=27%  Similarity=0.409  Sum_probs=197.7

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec-CeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||.||+++. .++.||||++....  ..+.+.+|+.++.+++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            47899999999999999999987 58899999997543  457899999999999999999999997655 478999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++... ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999998532 1223788999999999999999999987   999999999999999999999999999865322  


Q ss_pred             ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         .....+++.|+|||.+.+..++.++||||||++++||++ |+.|+........  .    .....+.     .+   
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~----~~~~~~~-----~~---  233 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V----PRVEKGY-----KM---  233 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--H----HHHTTTC-----CC---
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHhcCC-----CC---
Confidence               223357889999999999999999999999999999998 9999875433211  0    0000010     00   


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                       ..+...+..+.+++..||+.+|++||++.|+++.|+.+
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          234 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence             11112345678899999999999999999999999886

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.8e-38  Score=339.01  Aligned_cols=251  Identities=26%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee---------
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE---------  580 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  580 (834)
                      ...+|++.+.||+|+||.||+|+.. +++.||||++....    +.+.+|++++.+++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467999999999999999999986 68999999997643    356789999999999999999998864         


Q ss_pred             -------cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC
Q 003287          581 -------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  653 (834)
Q Consensus       581 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~  653 (834)
                             ....++||||+++++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   44589999999999999999542 2346899999999999999999999987   999999999999999999


Q ss_pred             eeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc
Q 003287          654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       654 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  733 (834)
                      +||+|||+++......   ......|++.|+|||++.+..++.++||||||+++|||++|..|+.....    .    ..
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~----~~  229 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----F----FT  229 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----H----HH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----H----HH
Confidence            9999999998764432   22335689999999999999999999999999999999999887532110    0    00


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCC
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  792 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l  792 (834)
                      .....        .+..    .....+.+++.+||+.+|++||++.|+++.|..+....
T Consensus       230 ~~~~~--------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          230 DLRDG--------IISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHHTT--------CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             Hhhcc--------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            00001        1111    12245778999999999999999999999999885443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.3e-38  Score=337.19  Aligned_cols=245  Identities=21%  Similarity=0.299  Sum_probs=198.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||+||+|+.. +++.||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            468999999999999999999986 6899999998754  234567788999999999 999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC---------------
Q 003287          588 YEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---------------  651 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---------------  651 (834)
                      |||+++++|.+++.... ....+++.++..++.||++||+|||+.+   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999995421 1256899999999999999999999987   9999999999999844               


Q ss_pred             ----CCeeeccccccccccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc
Q 003287          652 ----MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN  726 (834)
Q Consensus       652 ----~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~  726 (834)
                          ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||++++||++|..++......   
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---  237 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---  237 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence                479999999998764322      23589999999999876 6778999999999999999998775432110   


Q ss_pred             ccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       727 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                            .....+..     +.+.    ......+.+++..||+.+|++||++.|+++
T Consensus       238 ------~~~~~~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 ------HEIRQGRL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------HHHHTTCC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHcCCC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                  00111111     1111    122356788999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-37  Score=352.85  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=192.4

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC--------hhhHHHHHHHHHHHhccCCCceeeEeeeEeec
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  581 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  581 (834)
                      ..++|++.+.||+|+||+||+|... +++.||||++....        ......+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            4578999999999999999999875 48999999986532        112235889999999999999999999975 5


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC---Ceeecc
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISD  658 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~vkl~D  658 (834)
                      +..++||||+++|+|.+++..   ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++   .+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            568999999999999998853   356899999999999999999999987   99999999999997544   599999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccC---CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      ||+++.....   .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........ +..    ..
T Consensus       286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~----~i  357 (419)
T 3i6u_A          286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----QI  357 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHH----HH
T ss_pred             cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHH----HH
Confidence            9999876432   22334679999999999863   6788999999999999999999999875332111 000    00


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .....      .............+.+++..||+.+|++||++.|+++
T Consensus       358 ~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 TSGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HTTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00000      0111122234567889999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.6e-38  Score=337.98  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=206.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            367999999999999999999875 58999999997543 3456889999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..+....
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999843    46899999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                        .......|++.|+|||++.+..++.++||||||+++|||++|+.|+..........      .....     ..+.+.
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-----~~~~~~  240 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------LIPKN-----NPPTLE  240 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS-----CCCCCC
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH------HhhcC-----CCCCCc
Confidence              12234578999999999999999999999999999999999999987543221100      00000     011111


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .    .....+.+++..||+.+|++||++.|+++.
T Consensus       241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             c----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1    123457889999999999999999999874

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=1.4e-37  Score=322.45  Aligned_cols=217  Identities=14%  Similarity=0.192  Sum_probs=170.1

Q ss_pred             cCCCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEec
Q 003287           23 LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLN  102 (834)
Q Consensus        23 ~~~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~  102 (834)
                      ++.|+|++||+|.+|++|  ++|.|+|||+.+++     +.+ |.  .+|+||+|||+.|   ..+.|+|+.||||||+|
T Consensus         6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~--~~~~vW~an~~~~---~~~~l~l~~dGnLvl~d   72 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FD--SDVRVWASNTAGA---TGCRAVLQSDGLLVILT   72 (236)
T ss_dssp             CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EE--SSSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred             eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EE--CCEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence            567999999999999999  59999999998775     334 43  2799999999988   66889999999999999


Q ss_pred             CCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCccc-ccCCcccccc-ccCc-----ceee
Q 003287          103 QTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTL-LIGMNMGWDL-KTGR-----ERYL  175 (834)
Q Consensus       103 ~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtl-Lpg~~l~~~~-~tg~-----~~~L  175 (834)
                      ++|.+||+|++........|+|+|+|||||++       .  ++||||||||||+ ||||  |.|. .+|+     +++|
T Consensus        73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~-------~--~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L  141 (236)
T 1dlp_A           73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-------P--GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTL  141 (236)
T ss_dssp             TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-------S--EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEE
T ss_pred             CCCcEEEeCCccccCCcEEEEEeCCCCEEEec-------C--CEEECCCCCCcccccCCc--cceEEecCCcCCCccceE
Confidence            99999999998654445678999999999984       1  8999999999888 6776  6665 5666     6678


Q ss_pred             EeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecCCCCceecccCCCccccccceeeccCceEEEEEEecCCcee
Q 003287          176 TSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRIL  255 (834)
Q Consensus       176 ~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (834)
                      +|   .+||++|.|+++++++|  ++++++++.+||++++|++. +...+++...-.......+.++++++|..... ..
T Consensus       142 ~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~  214 (236)
T 1dlp_A          142 HA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GR  214 (236)
T ss_dssp             CS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SC
T ss_pred             Ec---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CC
Confidence            74   78999999999999998  78888988899999999753 54555543211111112224556665554433 46


Q ss_pred             eEEEEccCCCEEEEE
Q 003287          256 MMLKINPSGDVQRLI  270 (834)
Q Consensus       256 ~rl~l~~~G~l~~~~  270 (834)
                      .|++|+.||++++|.
T Consensus       215 ~rl~Ld~dG~l~ly~  229 (236)
T 1dlp_A          215 YVFVLQPDRNLAIYG  229 (236)
T ss_dssp             CEEEECSSSCEEEEC
T ss_pred             EEEEEcCCCcEEEeC
Confidence            899999999999884

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=337.27  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=200.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555569999999999999974 58899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-CCCeeeccccccccccCCCc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++++|.+++........+++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999965544456778999999999999999999987   999999999999987 8999999999998764321 


Q ss_pred             ccccccccccccccCcccccCCC--CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                       .......|++.|+|||++.+..  ++.++||||||+++|||++|+.||............       .  ......+.+
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------~--~~~~~~~~~  247 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-------V--GMFKVHPEI  247 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-------H--HHHCCCCCC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-------h--ccccccccc
Confidence             1223456899999999997654  889999999999999999999998643321110000       0  000011111


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          +......+.+++..||+.+|++||++.|+++
T Consensus       248 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 ----PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1123456788999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.8e-38  Score=343.23  Aligned_cols=249  Identities=23%  Similarity=0.309  Sum_probs=205.6

Q ss_pred             hccCccccceecccCccceEeeEecC-CcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ...+|.+.+.||+|+||.||+++..+ ++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            34789999999999999999999864 789999998654   23456778999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999998843   346899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...  .......||..|+|||++.+..++.++||||||+++|||++|+.||..........      ......      .
T Consensus       193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~------~  258 (335)
T 2owb_A          193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNE------Y  258 (335)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTC------C
T ss_pred             cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHhcCC------C
Confidence            322  12234568999999999999999999999999999999999999987543221100      000000      0


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+.    ......+.+++.+||+.||++||++.|+++
T Consensus       259 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 SIP----KHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            011    112345778999999999999999999997

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-38  Score=335.68  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=198.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            67999999999999999999875 58899999987653 33567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---cCCCCeeecccccccccc
Q 003287          591 MPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC  666 (834)
Q Consensus       591 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~vkl~DFGla~~~~  666 (834)
                      +++|+|.+++... .....+++..+..++.|+++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988542 22356899999999999999999999987   9999999999999   456889999999998654


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...   ......||+.|+|||++. ..++.++||||||++++||++|+.||............     .. .      .+
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~-----~~-~------~~  242 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-----TY-K------EP  242 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HH-C------CC
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-----cc-C------Cc
Confidence            322   233456899999999875 56899999999999999999999998764432211000     00 0      00


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .... ........+.+++..||+.+|++||++.|+++
T Consensus       243 ~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000 00012345778999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.4e-38  Score=343.06  Aligned_cols=265  Identities=22%  Similarity=0.284  Sum_probs=194.6

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccCh--hhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ...++|++.++||+|+||+||+|+.. +++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999999865 689999999975432  234668899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-----CCCCeeeccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----SDMNPKISDFGM  661 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-----~~~~vkl~DFGl  661 (834)
                      ||||++ |+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999998 589888843   345899999999999999999999987   99999999999994     455699999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc-c-c-------cc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-L-G-------HA  731 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~-~-------~~  731 (834)
                      ++.+....  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... . .       ..
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            98764221  222345679999999999875 58999999999999999999999997644321100 0 0       00


Q ss_pred             cccccc-----cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          732 WNLWKD-----NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       732 ~~~~~~-----~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +.....     ..........+...........+.+|+..||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000000     0000011111111112223467789999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.4e-37  Score=346.37  Aligned_cols=253  Identities=19%  Similarity=0.222  Sum_probs=191.8

Q ss_pred             ccCcccc-ceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhc-cCCCceeeEeeeEee----cCeE
Q 003287          512 TENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAK-LQHRNLVRLMGCCVE----QGEK  584 (834)
Q Consensus       512 ~~~f~~~-~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~  584 (834)
                      .++|.+. +.||+|+||+||+++.. +++.||||++...     ..+.+|+.++.+ .+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567776 68999999999999875 5889999999642     456788888754 489999999999876    5678


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCeeeccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  661 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vkl~DFGl  661 (834)
                      +|||||+++|+|.+++... ....+++.++..++.||++||+|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999999653 2346899999999999999999999987   999999999999998   78999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .........+. .
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~-~  284 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQ-Y  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTC-C
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCc-c
Confidence            9865422   1233467899999999999999999999999999999999999999754322110  00000000000 0


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ....     .........+.+|+..||+.||++|||+.|+++-
T Consensus       285 ~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 EFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000     0111234567899999999999999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.5e-38  Score=375.24  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=198.4

Q ss_pred             ceecccCccceEeeEec---CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....+++.+|+.++.+++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   36789999997643  344688999999999999999999999986 4568999999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc-cc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-QG  672 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~  672 (834)
                      |+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999953   346899999999999999999999987   99999999999999999999999999987654322 12


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.........      .....+.         ...
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------~~i~~~~---------~~~  592 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLEKGE---------RMG  592 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHHTTC---------CCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCC---------CCC
Confidence            2233456889999999999999999999999999999998 99998765432210      0111111         011


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .+..++..+.+|+..||+.+|++||++.+|++.|+.+.
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11223456888999999999999999999999998763

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-37  Score=355.60  Aligned_cols=261  Identities=24%  Similarity=0.259  Sum_probs=196.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------C
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  582 (834)
                      .++|+++++||+|+||+||+|+.. +++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999875 5899999999754  344567889999999999999999999999654      4


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||++++ |.+.+.     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999876 555552     23889999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc----cc-------
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GH-------  730 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~----~~-------  730 (834)
                      +.....   .......||+.|+|||++.+..++.++|||||||+++||++|+.||...+.... ...    ..       
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            875432   223446799999999999999999999999999999999999999976542110 000    00       


Q ss_pred             -----cccccc------ccccccccCccc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          731 -----AWNLWK------DNRAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       731 -----~~~~~~------~~~~~~l~~~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                           ......      ...........+   ...........+.+|+.+||+.||++|||+.|+++-
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000000      000000110000   011223346678999999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-37  Score=353.76  Aligned_cols=196  Identities=23%  Similarity=0.370  Sum_probs=155.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec-----Ce
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  583 (834)
                      .++|++++.||+|+||+||+|+.. +++.||||++...  .....+++.+|+.++++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999875 5899999999653  334567899999999999999999999999543     57


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||++ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 788888843   356899999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcc-------------------------cccccccccccccCcccc-cCCCCCccCCeeeHHHHHHHHhhCC
Q 003287          664 MFCGDELQ-------------------------GNTKRVVGTYGYMSPEYA-LDGLFSVKSDVFSFGVLLLETLTSK  714 (834)
Q Consensus       664 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwSlGvil~elltg~  714 (834)
                      ........                         .......||+.|+|||++ ....++.++|||||||+||||++|.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            76432110                         122345789999999986 4567999999999999999999943

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-37  Score=353.10  Aligned_cols=201  Identities=24%  Similarity=0.378  Sum_probs=169.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec-----Ce
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  583 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+++.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999875 4889999999754  334567899999999999999999999999876     57


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||++ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999987 589998843   356899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcc--------------------cccccccccccccCcccc-cCCCCCccCCeeeHHHHHHHHhhCCCCCCC
Q 003287          664 MFCGDELQ--------------------GNTKRVVGTYGYMSPEYA-LDGLFSVKSDVFSFGVLLLETLTSKRNTGV  719 (834)
Q Consensus       664 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwSlGvil~elltg~~p~~~  719 (834)
                      ........                    .......||+.|+|||++ ....++.++|||||||++|||++|..|+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            76433211                    123456789999999986 556799999999999999999997666543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.5e-38  Score=337.88  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=201.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            367999999999999999999975 6899999999865544556789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---cCCCCeeeccccccccccC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~vkl~DFGla~~~~~  667 (834)
                      +++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999998843   345889999999999999999999987   9999999999999   7889999999999976432


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .    ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ..    ...... ... .  
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~i~~~~-~~~-~--  227 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--FE----KIKEGY-YEF-E--  227 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHCC-CCC-C--
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHcCC-CCC-C--
Confidence            1    22345689999999999999999999999999999999999999875432211  00    000000 000 0  


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ..........+.+++..||+.+|++||++.|+++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 --SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0111123456788999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-37  Score=340.58  Aligned_cols=262  Identities=23%  Similarity=0.295  Sum_probs=206.3

Q ss_pred             cHHHHHHhccCcccc-ceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcc-CCCceeeEeeeE
Q 003287          504 SLASVSAATENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCC  578 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~-~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  578 (834)
                      .+.......+.|.+. +.||+|+||.||+|+.. +++.||||++....  .....++.+|+.++.++ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344445556778887 88999999999999876 58999999987542  33467899999999999 569999999999


Q ss_pred             eecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCee
Q 003287          579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPK  655 (834)
Q Consensus       579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vk  655 (834)
                      .+....++||||+++|+|.+++... ....+++.++..++.|+++||+|||+.+   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            9999999999999999999998543 3356899999999999999999999987   999999999999998   78999


Q ss_pred             eccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........     . 
T Consensus       175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----i-  245 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-----I-  245 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----H-
T ss_pred             EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----H-
Confidence            99999998764322   22345789999999999999999999999999999999999999876443211000     0 


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...      ...............+.+++..||+.+|++||++.|+++-
T Consensus       246 ~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQV------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHT------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hhc------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            000      0000111112234567889999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-38  Score=338.07  Aligned_cols=259  Identities=23%  Similarity=0.369  Sum_probs=204.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee--cCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l  586 (834)
                      .++|++.+.||+|+||.||+++.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999876 5899999999754  34456789999999999999999999998854  568999


Q ss_pred             EEEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      ||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986432 2345899999999999999999999976  2349999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ......  .......|++.|+|||++.+..++.++||||||+++|||++|+.|+........  ..    ....+...  
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~i~~~~~~--  234 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AG----KIREGKFR--  234 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTCCC--
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--HH----HHhhcccc--
Confidence            754321  112335689999999999999999999999999999999999999876442211  00    01111110  


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  787 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~  787 (834)
                         .+    +......+.+++..||+.+|++||++.|+++.+..
T Consensus       235 ---~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          235 ---RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ---CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---cC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence               11    11234568889999999999999999999986543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-38  Score=351.31  Aligned_cols=245  Identities=22%  Similarity=0.274  Sum_probs=191.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHH-HhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMML-IAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|++++.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999986 48899999997643   2234556677776 567899999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999853   346889999999999999999999988   9999999999999999999999999998643


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|..||...+....  ..   .... ...      
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~---~i~~-~~~------  256 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YD---NILN-KPL------  256 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--HH---HHHH-SCC------
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HH---HHHh-ccc------
Confidence            22  1233456799999999999999999999999999999999999999875432211  00   0000 000      


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSK  780 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e  780 (834)
                      .+.    ......+.+|+..||+.+|++||++.+
T Consensus       257 ~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 QLK----PNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CCC----SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCC----CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            011    112346788999999999999999853

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9e-38  Score=358.10  Aligned_cols=274  Identities=19%  Similarity=0.253  Sum_probs=213.9

Q ss_pred             ccCccccceecccCccceEeeEe-cCCcEEEEEEecccChhhHHHHHHHHHHHhccCC-CceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.++||+|+||.||+|+. .+++.||||++.....  ..++.+|++++..++| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999996 4689999998865432  2457889999999976 566667777788889999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---cCCCCeeecccccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC  666 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~vkl~DFGla~~~~  666 (834)
                      |+ +++|.+++...  ...+++.+++.|+.||+.||+|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998532  346899999999999999999999987   9999999999999   689999999999998765


Q ss_pred             CCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccccccccccc
Q 003287          667 GDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRA  740 (834)
Q Consensus       667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  740 (834)
                      .....     .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ....    .......
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----~i~~~~~  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----KISEKKV  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH----HHHHHHH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH----HHhhccc
Confidence            43321     122356799999999999999999999999999999999999999976443211 0000    0000000


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccc
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY  802 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~  802 (834)
                      ...     .......+...+.+|+..||+.+|++||++.+|+++|+.+......+....|.|
T Consensus       234 ~~~-----~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW  290 (483)
T 3sv0_A          234 ATS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW  290 (483)
T ss_dssp             HSC-----HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred             ccc-----HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence            000     011112334678899999999999999999999999998866555555444444

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.4e-38  Score=363.22  Aligned_cols=254  Identities=26%  Similarity=0.327  Sum_probs=206.2

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      ..++|++.+.||+|+||.||+++.. +|+.||||++.+..   ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3478999999999999999999975 58999999996542   2345678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999986532 345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .........      ...
T Consensus       338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~------~~~  406 (576)
T 2acx_A          338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE------VPE  406 (576)
T ss_dssp             TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHH------CCC
T ss_pred             cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhc------ccc
Confidence            322   223457999999999999999999999999999999999999999754321100  000000000      000


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                          ..+......+.+|+..||+.||++||     ++.|+++
T Consensus       407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                11122345678899999999999999     6788875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.9e-39  Score=347.31  Aligned_cols=276  Identities=24%  Similarity=0.362  Sum_probs=202.3

Q ss_pred             HHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          507 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       507 ~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      +.....++|++.+.||+|+||.||+|+...  .||||++....  ....+.+.+|+.++++++||||+++++++.+....
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            334456889999999999999999998753  59999987542  23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++ ++.+||+|||+++.
T Consensus       105 ~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             EEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            9999999999999999542  346889999999999999999999987   99999999999998 68999999999876


Q ss_pred             ccCCC---cccccccccccccccCcccccC---------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccc
Q 003287          665 FCGDE---LQGNTKRVVGTYGYMSPEYALD---------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW  732 (834)
Q Consensus       665 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  732 (834)
                      .....   .........|++.|+|||++..         ..++.++||||||+++|||++|+.||.........     +
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~  253 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-----W  253 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-----H
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----H
Confidence            53211   1122233568999999999874         45789999999999999999999998754432110     0


Q ss_pred             ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccccc
Q 003287          733 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR  804 (834)
Q Consensus       733 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~  804 (834)
                       .............        .....+.+++..||+.+|++||++.+++++|+.+.........+..+|..
T Consensus       254 -~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~  316 (319)
T 2y4i_B          254 -QMGTGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS  316 (319)
T ss_dssp             -HHHTTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred             -HhccCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence             0000100111110        12235778999999999999999999999999998777777777777754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-37  Score=344.38  Aligned_cols=264  Identities=23%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            478999999999999999999975 5899999999653  3344577899999999999999999999998763      


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 8899998843    45899999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc----cc----cc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GH----AW  732 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~----~~----~~  732 (834)
                      +....     ......+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...+.... ...    ..    ..
T Consensus       176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            87532     2234578999999999987 6799999999999999999999999976542110 000    00    00


Q ss_pred             ccccccc-------cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH--Hhhccc
Q 003287          733 NLWKDNR-------AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS--MITNEH  789 (834)
Q Consensus       733 ~~~~~~~-------~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~  789 (834)
                      ..+....       ........+ ..........+.+|+.+||+.||++|||+.|+++  .++...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            0000000       000000000 0111223456889999999999999999999998  355543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.1e-37  Score=331.01  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=199.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee----cCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  584 (834)
                      ...|++.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            356888999999999999999875 5789999998654  34456789999999999999999999999876    3568


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCeeeccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMAR  663 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vkl~DFGla~  663 (834)
                      ++||||+++++|.+++..   ...+++..+..++.||++||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999999943   356889999999999999999999875 3499999999999997 78999999999997


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      .....    ......||+.|+|||++. +.++.++||||||++++||++|+.||..........     .......    
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~----  246 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----RRVTSGV----  246 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-----HHHTTTC----
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-----HHHhccC----
Confidence            54322    223456899999999886 458999999999999999999999987533221100     0000000    


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       .   ...........+.+++..||+.+|++||++.|+++
T Consensus       247 -~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 -K---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -C---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -C---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             0   01111122346788999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.2e-38  Score=337.50  Aligned_cols=258  Identities=28%  Similarity=0.376  Sum_probs=197.9

Q ss_pred             ccCccccceecccCccceEeeEec--CCc--EEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL--NGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~--~g~--~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.+.||+|+||+||+|++.  +++  .||||+++..   .....+.+.+|+.++.+++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            468999999999999999999863  233  6999998754   2345678999999999999999999999998765 8


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++|+||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998532  245889999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||........  ..   .......  .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~---~~~~~~~--~  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LH---KIDKEGE--R  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH---HHHTSCC--C
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--HH---HHHccCC--C
Confidence            6443221 12233457889999999999999999999999999999999 9999875443211  00   0000000  0


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                      .       ......+..+.+++..||+.+|++||++.++++.|+.+.
T Consensus       244 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          244 L-------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             C-------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            0       011123456888999999999999999999999999873

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-38  Score=341.42  Aligned_cols=269  Identities=22%  Similarity=0.316  Sum_probs=197.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||+|+||+||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999986 6899999999754322 122456799999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++ |+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            98 5888887532  346899999999999999999999988   9999999999999999999999999998653221 


Q ss_pred             ccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cc--------cccccc-ccccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LL--------GHAWNL-WKDNR  739 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~--------~~~~~~-~~~~~  739 (834)
                       .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..        ...+.. .....
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             22233568999999999876 56899999999999999999999999765432210 00        000000 00000


Q ss_pred             cccccCcccc----chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH--Hhhccc
Q 003287          740 AYELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS--MITNEH  789 (834)
Q Consensus       740 ~~~l~~~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~  789 (834)
                      ......+...    ..........+.+|+..||+.||++|||+.|+++  .|....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            0000000000    0111223456789999999999999999999987  355543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.3e-37  Score=355.89  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=205.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+..   ....+.+.+|+.++.+++||||+++++++.+....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            478999999999999999999985 58999999997542   23457789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |||+++|+|..++.... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999986542 2456899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... ...      .
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~-~~~------~  410 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVL-EQA------V  410 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHH-HCC------C
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHh-hcc------c
Confidence            332  123345799999999999999999999999999999999999999975432110 000000000 000      0


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCH-----HHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTM-----SKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~  783 (834)
                          ..+......+.+|+..||+.+|++||++     .++++
T Consensus       411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                0112234567889999999999999976     55653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5e-38  Score=348.19  Aligned_cols=262  Identities=25%  Similarity=0.324  Sum_probs=204.2

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            368999999999999999999986 5899999999765 34456789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      |+++++|.+++..   ...+++..+..++.|+++||+|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999953   34588999999999999999999986 6   999999999999999999999999999765321


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccc----------cccccc--
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH----------AWNLWK--  736 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~----------~~~~~~--  736 (834)
                          ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.........          ......  
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence                2234578999999999999999999999999999999999999997654322110000          000000  


Q ss_pred             ------------ccccccccCc----cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 ------------DNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ------------~~~~~~l~~~----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                                  .....+.++.    .............+.+|+..||+.+|++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                        0000000000    0000001113456889999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.9e-38  Score=344.48  Aligned_cols=250  Identities=20%  Similarity=0.269  Sum_probs=198.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++.+...    .+.+|++++.++ +||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467999999999999999999876 588999999976532    235688888888 79999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC----CCeeeccccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARMF  665 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~----~~vkl~DFGla~~~  665 (834)
                      |+++|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||+..+    +.+||+|||+++.+
T Consensus        97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999999854   346899999999999999999999998   9999999999998543    35999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~l~  744 (834)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|..||........ .+..    ....+..    
T Consensus       171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~----  240 (342)
T 2qr7_A          171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKF----  240 (342)
T ss_dssp             BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCC----
T ss_pred             cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCc----
Confidence            4332  223345789999999999988899999999999999999999999975322111 0100    0000100    


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        .............+.+|+..||+.||++||++.|+++
T Consensus       241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              0111111223456788999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.7e-37  Score=337.02  Aligned_cols=267  Identities=23%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEee--------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--------  580 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------  580 (834)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++.+        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999984 68999999986543  2234678899999999999999999999987        


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      .+..++||||+++ +|.+.+...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            4468999999985 666666432  245899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCC--cccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-c--------c
Q 003287          661 MARMFCGDE--LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-L--------L  728 (834)
Q Consensus       661 la~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~--------~  728 (834)
                      +++.+....  .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .        .
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            998764322  1222344578999999999876 46899999999999999999999998765432110 0        0


Q ss_pred             ccccccccccccccccCccc--cchhH-----HHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          729 GHAWNLWKDNRAYELLSPAL--QHEAS-----YQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       729 ~~~~~~~~~~~~~~l~~~~l--~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+.........+.+....  .....     ......+.+|+..||+.||++|||+.|+++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00011111111111110000  00000     1113457899999999999999999999873

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.3e-37  Score=331.00  Aligned_cols=246  Identities=22%  Similarity=0.292  Sum_probs=203.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999876 47899999986532   22356789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999999853   245899999999999999999999987   99999999999999999999999999976532


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      .    ......|++.|+|||++.+..++.++||||||+++|||++|..||.........  .    .....      +..
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~~------~~~  230 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--R----RIVNV------DLK  230 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--H----HHHTT------CCC
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH--H----HHhcc------ccC
Confidence            2    123456899999999999999999999999999999999999998754322110  0    00000      001


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..    ......+.+++..||+.+|++||++.|+++
T Consensus       231 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 FP----PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            11    122346788999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.6e-38  Score=339.94  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=187.2

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            44578999999999999999999865 58999999986543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          588 YEYMPNKSLNFFLFD-----PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      |||+++++|.+++..     ......+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999853     123456899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCc---ccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccc
Q 003287          663 RMFCGDEL---QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  738 (834)
Q Consensus       663 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  738 (834)
                      ..+.....   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||............     .. .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~-~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-----LQ-N  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-----HT-S
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-----hc-c
Confidence            87643221   112234568999999999876 56899999999999999999999998765432211000     00 0


Q ss_pred             ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       739 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .....................+.+++..||+.+|++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000000000000011122346788999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.6e-37  Score=339.36  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=204.3

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChh-----------------hHHHHHHHHHHHhccCCCceeeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-----------------GLKEFKNEMMLIAKLQHRNLVRL  574 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l  574 (834)
                      .++|++.+.||+|+||.||+|+. +++.||||++......                 ..+.+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 9999999998654221                 12789999999999999999999


Q ss_pred             eeeEeecCeEEEEEEecCCCCchhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEE
Q 003287          575 MGCCVEQGEKILIYEYMPNKSLNFF------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNIL  647 (834)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NIL  647 (834)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||++||+|||+ .+   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 124679999999999999999999998 76   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccCC-CCCc-cCCeeeHHHHHHHHhhCCCCCCCCCcc-c
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSV-KSDVFSFGVLLLETLTSKRNTGVYDIE-S  724 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDVwSlGvil~elltg~~p~~~~~~~-~  724 (834)
                      ++.++.+||+|||++......    ......|+..|+|||++.+. .++. ++||||||++++||++|+.||...... .
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999876432    23345789999999999887 6766 999999999999999999999765431 1


Q ss_pred             c-cccccc-ccccc-ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          725 F-NLLGHA-WNLWK-DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       725 ~-~~~~~~-~~~~~-~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      . ...... ..... .........+.............+.+++..||+.+|++||++.|+++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1 000000 00000 00000000000001111234457889999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-38  Score=353.90  Aligned_cols=242  Identities=14%  Similarity=0.152  Sum_probs=188.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHH---HHHhccCCCceeeEe-------ee
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEM---MLIAKLQHRNLVRLM-------GC  577 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~  577 (834)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            478999999999999999999974 5899999999743   344567899999   556666899999998       55


Q ss_pred             EeecC-----------------eEEEEEEecCCCCchhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003287          578 CVEQG-----------------EKILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI  636 (834)
Q Consensus       578 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  636 (834)
                      +.+.+                 ..++||||+ +|+|.+++....    ....+++..+..++.||++||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 378999999 689999995421    1123446888899999999999999988   9


Q ss_pred             EecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCC-----------CCCccCCeeeHHH
Q 003287          637 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-----------LFSVKSDVFSFGV  705 (834)
Q Consensus       637 iH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDVwSlGv  705 (834)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986321     2334567 999999999887           8999999999999


Q ss_pred             HHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          706 LLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       706 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ++|||++|+.||........  ...         .....         ......+.+|+..||+.||++||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~--~~~---------~~~~~---------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG--SEW---------IFRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC--SGG---------GGSSC---------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc--hhh---------hhhhc---------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999875432211  000         00000         112346788999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.6e-37  Score=341.19  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=204.5

Q ss_pred             HHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccC--------hhhHHHHHHHHHHHhcc-CCCceeeEeee
Q 003287          508 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLMGC  577 (834)
Q Consensus       508 ~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~~~  577 (834)
                      .....++|++.+.||+|+||.||+|++. +|+.||||++....        ....+.+.+|+.++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3444578999999999999999999986 69999999986543        12245688999999999 89999999999


Q ss_pred             EeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      +......++||||+++++|.+++.+   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999853   346899999999999999999999987   9999999999999999999999


Q ss_pred             cccccccccCCCcccccccccccccccCcccccC------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc
Q 003287          658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~  731 (834)
                      |||++..+....   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||........  ..  
T Consensus       243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~--  315 (365)
T 2y7j_A          243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--LR--  315 (365)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH--
T ss_pred             ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--HH--
Confidence            999998764332   2234678999999999863      3588999999999999999999999865332110  00  


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ....... .     ............+.+++..||+.+|++||++.|+++
T Consensus       316 --~i~~~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 --MIMEGQY-Q-----FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --HHHHTCC-C-----CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHhCCC-C-----CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0000000 0     000111123456788999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-37  Score=347.02  Aligned_cols=254  Identities=10%  Similarity=0.065  Sum_probs=181.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccCh---hhHHHHHHHHHHHhcc--CCCceeeEe-------eeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKL--QHRNLVRLM-------GCC  578 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~  578 (834)
                      ..+|++.+.||+|+||+||+|+.. +++.||||++.....   ...+.+.+|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456999999999999999999975 689999999987532   3456678885544444  699988755       444


Q ss_pred             eec-----------------CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCc
Q 003287          579 VEQ-----------------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR------VKIIEGIAQGLLYLHQYSRLR  635 (834)
Q Consensus       579 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~  635 (834)
                      ...                 ...++||||++ |+|.+++...  ...+.+..+      ..++.||++||+|||+.+   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            333                 23799999999 8999999542  123344555      788899999999999988   


Q ss_pred             eEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhC
Q 003287          636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTS  713 (834)
Q Consensus       636 iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg  713 (834)
                      |+||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            99999999999999999999999999986532     1224567799999999987  6799999999999999999999


Q ss_pred             CCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          714 KRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       714 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +.||.............       ......................+.+|+..||+.||++||++.|+++
T Consensus       290 ~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKR-------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCCCB-------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccchhh-------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99998654322111110       0000000000000111123456888999999999999999999974

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-37  Score=343.62  Aligned_cols=254  Identities=24%  Similarity=0.292  Sum_probs=201.0

Q ss_pred             ccCccccceecccCccceEeeEe----cCCcEEEEEEecccC----hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      .++|++.+.||+|+||.||+++.    .+++.||||+++...    ....+.+.+|+.++.++ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999987    368999999987532    23345678899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999953   345899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      +.+..... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||......... ........     
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~-----  279 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRIL-----  279 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHH-----
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHHh-----
Confidence            87543221 22334579999999999986  34789999999999999999999998754322110 00000000     


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHHH
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  784 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~  784 (834)
                       . ..+.    .+......+.+|+..||+.+|++||     ++.|+++.
T Consensus       280 -~-~~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          280 -K-SEPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -H-CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -c-cCCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence             0 0011    1122335678899999999999999     89999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.1e-37  Score=334.95  Aligned_cols=257  Identities=19%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEee--cCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVE--QGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV  587 (834)
                      .++|++.++||+|+||+||+|+.. +++.||||++...   ..+.+.+|+.++.+++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            378999999999999999999864 6899999999753   3467899999999997 9999999999988  6678999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-Ceeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~~  666 (834)
                      |||+++++|.+++.      .+++.++..++.||++||+|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999883      3789999999999999999999988   99999999999999777 89999999998764


Q ss_pred             CCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc--------cccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA--------WNLWKD  737 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~  737 (834)
                      ...   ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.........+....        ......
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            332   2234568999999999987 6799999999999999999999999854332111100000        000000


Q ss_pred             c--------------ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          738 N--------------RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       738 ~--------------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .              .....................+.+|+..||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0              000000000111112224567889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.6e-38  Score=339.73  Aligned_cols=261  Identities=24%  Similarity=0.305  Sum_probs=199.6

Q ss_pred             ccHHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccC--CCceeeEeeeE
Q 003287          503 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLMGCC  578 (834)
Q Consensus       503 ~~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~  578 (834)
                      +.+.++....++|++.+.||+|+||.||+++..+++.||||++...  .....+.+.+|+.++.+++  |+||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3444455567889999999999999999999888999999998653  3445678999999999997  59999999999


Q ss_pred             eecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecc
Q 003287          579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                      .+.+..++||| +.+++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||+++ +.+||+|
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence            99999999999 678899999853   346889999999999999999999987   999999999999964 8999999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccC-----------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL  727 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~  727 (834)
                      ||+++.+.............||+.|+|||++.+           ..++.++||||||+++|||++|+.||.........+
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  249 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence            999987654333223344578999999999875           468889999999999999999999987533211100


Q ss_pred             cccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       728 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                                   ....++......+......+.+++..||+.+|++||++.|+++-
T Consensus       250 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          250 -------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -------------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                         00111111000111113467889999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.6e-37  Score=355.42  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=201.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.++||+|+||+||+++.. +++.||||++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            367999999999999999999975 6899999998653  2335678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc---CCCCeeeccccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~vkl~DFGla~~~  665 (834)
                      ||+++|+|.+.+..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++   .++.+||+|||+++.+
T Consensus       101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999888843   346899999999999999999999988   99999999999995   4567999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........  ..    ....... .   
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~i~~~~~-~---  240 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LK----RVETGKY-A---  240 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTCC-C---
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCCC-C---
Confidence            4322   2334579999999999876 599999999999999999999999875442211  00    0000000 0   


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                        .........+..+.+++..||+.+|++|||+.|+++.
T Consensus       241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0001112234567899999999999999999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=334.32  Aligned_cols=264  Identities=23%  Similarity=0.305  Sum_probs=196.0

Q ss_pred             ccCccccceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEe-----------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV-----------  579 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-----------  579 (834)
                      .++|++.+.||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            3689999999999999999999864 8999999998777677788999999999999999999999873           


Q ss_pred             ---ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCee
Q 003287          580 ---EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK  655 (834)
Q Consensus       580 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vk  655 (834)
                         +....++||||++ |+|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               4467899999998 699999843    45889999999999999999999987   99999999999997 567999


Q ss_pred             eccccccccccCCCc-ccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccccc
Q 003287          656 ISDFGMARMFCGDEL-QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAW  732 (834)
Q Consensus       656 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~  732 (834)
                      |+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999987643211 122234567999999998875 6799999999999999999999999976543211 0000000


Q ss_pred             ccccccccccc---c---------Ccccc-chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          733 NLWKDNRAYEL---L---------SPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       733 ~~~~~~~~~~l---~---------~~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .........++   +         .+... ..........+.+++..||+.+|++||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00000000000   0         00000 0111224567889999999999999999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.2e-37  Score=357.11  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=204.5

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999986 68999999986542   34567899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---cCCCCeeecccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARM  664 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~vkl~DFGla~~  664 (834)
                      |||+++|+|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999988543   45899999999999999999999988   9999999999999   5678999999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      +....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........  ..    ....+.. .  
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~i~~~~~-~--  245 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--LK----KVEKGKY-T--  245 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCCC-C--
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHcCCC-C--
Confidence            64322   2344579999999999876 699999999999999999999999976443211  00    0000000 0  


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         .........+..+.+++..||+.+|++|||+.|+++
T Consensus       246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               000111223456789999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.6e-38  Score=335.82  Aligned_cols=253  Identities=25%  Similarity=0.377  Sum_probs=187.2

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hh-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..++|++.+.||+|+||+||+++.. +++.||||++.... .. ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999974 68999999997642 22 233455566668888999999999999999999999


Q ss_pred             EEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          588 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      |||++ |+|.+++... .....+++..+..++.|+++||+|||+. +   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99998 4777776431 2345689999999999999999999998 7   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccc----cCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYA----LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||.........+..    .....   
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~---  230 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEEP---  230 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----HHHSC---
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----HhccC---
Confidence            4322   22234689999999996    5667899999999999999999999998753322111110    00000   


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         .+...   .......+.+++..||+.+|++|||+.|+++
T Consensus       231 ---~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ---SPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---CCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence               00010   1122356788999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-37  Score=335.80  Aligned_cols=252  Identities=23%  Similarity=0.407  Sum_probs=198.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            468999999999999999999986 4899999999876666778899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++++|.+++...  ...+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  170 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--  170 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999988532  345899999999999999999999987   999999999999999999999999998643211  


Q ss_pred             ccccccccccccccCcccc-----cCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          671 QGNTKRVVGTYGYMSPEYA-----LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ........||+.|+|||++     .+..++.++||||||+++|||++|+.|+..........     .... ....... 
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~-~~~~~~~-  243 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-----KIAK-SDPPTLL-  243 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHH-SCCCCCS-
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-----HHhc-cCCcccC-
Confidence            1112235689999999998     46778999999999999999999999987644321100     0000 0000011 


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                            .+......+.+++..||+.+|++||++.|+++
T Consensus       244 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          244 ------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  11122356788999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.9e-37  Score=329.31  Aligned_cols=252  Identities=22%  Similarity=0.239  Sum_probs=199.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC----hhhHHHHHHHHHHHhccCCCceeeEeeeEe--ecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV--EQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~  584 (834)
                      .++|++.+.||+|+||.||++... +++.||||++....    ....+.+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999975 58899999997542    245678999999999999999999999984  45688


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||++++ |.+++... ....+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 66666432 2356899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCCC--CCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ..............||+.|+|||++.+..  ++.++||||||+++|||++|+.||........  .    .......   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~i~~~~---  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL--F----ENIGKGS---  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H----HHHHHCC---
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--H----HHHhcCC---
Confidence            65433333334567899999999998654  47899999999999999999999875432111  0    0000000   


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         ....    ......+.+++.+||+.+|++||++.|+++.
T Consensus       230 ---~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ---YAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---CCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---CCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               0011    1123467789999999999999999999963

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.4e-37  Score=327.95  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=195.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999986 68999999986542   23456889999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999853   245889999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..   ......+++.|+|||.+.+..+ +.++||||||++++||++|+.||........  .    ....... .     
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~----~~~~~~~-~-----  228 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--F----KKIRGGV-F-----  228 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHHHHCC-C-----
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H----HHhhcCc-c-----
Confidence            22   1233568999999999988765 6899999999999999999999875432211  0    0000000 0     


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..    +......+.+++..||+.+|++||++.|+++.
T Consensus       229 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00    11123457789999999999999999999973

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.5e-37  Score=341.58  Aligned_cols=270  Identities=21%  Similarity=0.261  Sum_probs=200.0

Q ss_pred             cHHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccC-----------hhhHHHHHHHHHHHhccCCCcee
Q 003287          504 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-----------GQGLKEFKNEMMLIAKLQHRNLV  572 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-----------~~~~~~~~~E~~~l~~l~H~niv  572 (834)
                      ...++....++|++.+.||+|+||.||+|+..+++.||||++....           ....+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3566777889999999999999999999998889999999986432           12247899999999999999999


Q ss_pred             eEeeeEeec-----CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 003287          573 RLMGCCVEQ-----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  647 (834)
Q Consensus       573 ~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NIL  647 (834)
                      ++++++...     ...++||||++ |+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            999998543     36799999998 677777753  2346899999999999999999999997   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN  726 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~  726 (834)
                      ++.++.+||+|||+++.....   .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ 
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-  242 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-  242 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred             EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            999999999999999754322   22334568999999999987 6799999999999999999999999976442111 


Q ss_pred             cccccccc-----------ccccccccc-------cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          727 LLGHAWNL-----------WKDNRAYEL-------LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       727 ~~~~~~~~-----------~~~~~~~~l-------~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       .......           +......+.       ................+.+|+..||+.+|++|||+.|+++-
T Consensus       243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence             0000000           000000000       00000011112234568899999999999999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.7e-37  Score=355.99  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=197.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|+++++||+|+||+||+|+.. +++.||||++.+..  ......+.+|+.++++++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999976 58899999997542  334577899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC---CCeeeccccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~vkl~DFGla~~~  665 (834)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++..   +.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999888843   345899999999999999999999987   9999999999999764   55999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ....   ......||+.|+|||++. ..++.++|||||||++|||++|..||........  ..    ...... .... 
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~i~~~~-~~~~-  257 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LR----KVEKGK-YTFD-  257 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTC-CCCC-
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCC-CCCC-
Confidence            4332   233457999999999886 5699999999999999999999999976443211  00    000000 0000 


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          .......+..+.+++..||+.+|++|||+.|+++
T Consensus       258 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 ----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                1111223456788999999999999999999885

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-36  Score=339.01  Aligned_cols=261  Identities=23%  Similarity=0.245  Sum_probs=194.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999875 5889999999753  3345577899999999999999999999997665      


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+++ +|.+++.     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999985 6777773     24889999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-c-ccccc----cccc-
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLGHA----WNLW-  735 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~-~~~~~----~~~~-  735 (834)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . +....    ...+ 
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865322   122345789999999999999999999999999999999999999976542110 0 00000    0000 


Q ss_pred             ----------------cccccccccCccc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          736 ----------------KDNRAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       736 ----------------~~~~~~~l~~~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                                      .......+.....   ...........+.+|+.+||+.||++|||++|+++-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                            0000000000000   112233446778999999999999999999999873

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.6e-37  Score=354.82  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=201.2

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccCh-------------hhHHHHHHHHHHHhccCCCceeeEee
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLMG  576 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~  576 (834)
                      ..++|+++++||+|+||+||+|+.. +++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999976 478999999865421             33577899999999999999999999


Q ss_pred             eEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC---C
Q 003287          577 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---N  653 (834)
Q Consensus       577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~  653 (834)
                      ++.+....++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999988843   346899999999999999999999987   99999999999998776   6


Q ss_pred             eeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc
Q 003287          654 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       654 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  733 (834)
                      +||+|||+++.+....   ......||+.|+|||++. ..++.++|||||||++|||++|..||........  ..    
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--IK----  257 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----
Confidence            9999999998764332   233457999999999987 4699999999999999999999999976443211  00    


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ....+..      ..........+..+.+|+..||+.+|.+|||+.|+++
T Consensus       258 ~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000000      0011111233466889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.4e-37  Score=329.15  Aligned_cols=251  Identities=23%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---------hhhHHHHHHHHHHHhccC-CCceeeEeeeEee
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVE  580 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~  580 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....         ....+.+.+|+.++.++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999986 58999999986542         123467889999999995 9999999999999


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ....++||||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999953   346899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCccccc------CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccc
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYAL------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  734 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  734 (834)
                      ++..+....   ......+++.|+|||++.      ...++.++||||||++++||++|+.|+........  ..    .
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~----~  240 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LR----M  240 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----H
T ss_pred             chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HH----H
Confidence            998764322   223456899999999985      45688999999999999999999999865432111  00    0


Q ss_pred             ccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       735 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..... ....     ..........+.+++..||+.+|++||++.|+++
T Consensus       241 ~~~~~-~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 IMSGN-YQFG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHTC-CCCC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhcCC-cccC-----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00000 0000     0111223456889999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.8e-37  Score=334.20  Aligned_cols=251  Identities=21%  Similarity=0.281  Sum_probs=196.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--------hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  582 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....        ......+.+|+.++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            468999999999999999999875 48899999986532        122345889999999999999999999987654


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC---eeeccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDF  659 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---vkl~DF  659 (834)
                       .++||||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             8999999999999998853   346899999999999999999999987   999999999999987665   999999


Q ss_pred             cccccccCCCcccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      |+++......   ......||+.|+|||++.   ...++.++||||||+++|||++|..||........ +..    ...
T Consensus       162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~----~~~  233 (322)
T 2ycf_A          162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----QIT  233 (322)
T ss_dssp             TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHH----HHH
T ss_pred             ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHH----HHH
Confidence            9998763321   123456899999999974   56789999999999999999999999875432211 000    000


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+..      .............+.+++..||+.+|++||++.|+++
T Consensus       234 ~~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCcc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0000      0111122234567889999999999999999999884

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.3e-37  Score=340.74  Aligned_cols=260  Identities=25%  Similarity=0.291  Sum_probs=184.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------C
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  582 (834)
                      .++|++++.||+|+||.||+|+.. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999864 5899999999653  334567889999999999999999999998754      5


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++|+||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 6889888843    46899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccccc--------cc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH--------AW  732 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~--------~~  732 (834)
                      +....     ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...+.... .....        ..
T Consensus       180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            86532     2334578999999999987 6799999999999999999999999976542110 00000        00


Q ss_pred             ccccccccc---cccCc--c-ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          733 NLWKDNRAY---ELLSP--A-LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       733 ~~~~~~~~~---~l~~~--~-l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .........   +.+..  . ............+.+|+.+||+.||++|||+.|+++-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000000000   00000  0 0000111224567899999999999999999999873

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-37  Score=338.00  Aligned_cols=266  Identities=24%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChh-----hHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++......     ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578999999999999999999975 5899999998753221     124688999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||+++ +|..++...  ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 788887542  345888899999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc--cccc----ccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--LLGH----AWNLWKD  737 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~~----~~~~~~~  737 (834)
                      +....  .......+|+.|+|||++.+. .++.++|||||||++|||++|..|+.........  +...    ....|..
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            64322  223345789999999999764 5899999999999999999999998764421110  0000    0000000


Q ss_pred             -cccccccC----ccc-cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          738 -NRAYELLS----PAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       738 -~~~~~l~~----~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                       ....+...    +.. ...........+.+|+..||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             00000000    000 001112334678899999999999999999999975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.7e-37  Score=331.73  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=199.9

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++....  ..+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4578999999999999999999876 48999999997543  34678999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++++|.+++..  ....+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||++..+....
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999842  2356899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                        .......|++.|+|||++.+..++.++||||||+++|||++|+.||..........      ......     .+...
T Consensus       180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~-----~~~~~  246 (314)
T 3com_A          180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MIPTNP-----PPTFR  246 (314)
T ss_dssp             --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSC-----CCCCS
T ss_pred             --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCC-----CcccC
Confidence              22234568999999999999999999999999999999999999987543211100      000000     00000


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ........+.+++..||+.+|++||++.++++
T Consensus       247 --~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 --KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              11122356788999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.9e-37  Score=367.45  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  585 (834)
                      ..++|++++.||+|+||.||+|+.. +++.||||++++.   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999976 4889999999754   233456788899999988 7999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      |||||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999953   246899999999999999999999987   999999999999999999999999999864


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ....  .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+....  ..   .... ..      
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~~---~i~~-~~------  558 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ---SIME-HN------  558 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHS-SC------
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--HH---HHHh-CC------
Confidence            3222  234456899999999999999999999999999999999999999976443211  00   0000 00      


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCH-----HHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTM-----SKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~  783 (834)
                        .  ..+......+.+|+..||+.+|++||++     +||++
T Consensus       559 --~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 --V--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --C--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --C--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              0  0111234567889999999999999998     66664

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=338.68  Aligned_cols=258  Identities=25%  Similarity=0.400  Sum_probs=198.8

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEee--
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE--  580 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--  580 (834)
                      +.++....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++..  
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3344456689999999999999999999975 68999999986543 3457789999999999 89999999999987  


Q ss_pred             ----cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeee
Q 003287          581 ----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  656 (834)
Q Consensus       581 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl  656 (834)
                          ....++||||+++++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence                46889999999999999999643 2346889999999999999999999987   999999999999999999999


Q ss_pred             ccccccccccCCCcccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc
Q 003287          657 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA  731 (834)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~  731 (834)
                      +|||++..+....  .......||+.|+|||++.     +..++.++||||||+++|||++|+.|+.........     
T Consensus       171 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----  243 (326)
T 2x7f_A          171 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----  243 (326)
T ss_dssp             CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----
T ss_pred             eeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-----
Confidence            9999998653221  1223456899999999987     567899999999999999999999998654321110     


Q ss_pred             cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          732 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       732 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .. ...........        ......+.+++..||+.+|++||++.|+++
T Consensus       244 ~~-~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 FL-IPRNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HH-HHHSCCCCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH-hhcCccccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00 00000001111        112346788999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-36  Score=344.17  Aligned_cols=199  Identities=24%  Similarity=0.288  Sum_probs=172.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc------CCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL------QHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~  584 (834)
                      ..+|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++..+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999875 4899999999753 34456778888888877      577999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC--eeecccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMA  662 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--vkl~DFGla  662 (834)
                      ++||||++ ++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6888888543 2235899999999999999999999998   999999999999999987  999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                      +....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            76432     2234578999999999999999999999999999999999999987654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.5e-37  Score=345.72  Aligned_cols=263  Identities=19%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe------EE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE------KI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~  585 (834)
                      ..+|++.+.||+|+||+||+|+...+..||||++.....    ...+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            467999999999999999999998877899998865322    12369999999999999999999966543      78


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCeeecccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARM  664 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vkl~DFGla~~  664 (834)
                      +||||++++.+............+++..+..++.||++||+|||+.+   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999988655444322223456899999999999999999999987   99999999999999 799999999999987


Q ss_pred             ccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc--cccc-----------
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--LLGH-----------  730 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~~-----------  730 (834)
                      +....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+.....  +...           
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            64332   22345689999999999765 5899999999999999999999999865422110  0000           


Q ss_pred             ccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       731 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .............................+.+|+.+||+.||++|||+.|+++-
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            000000000000000000011111234578899999999999999999999873

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.9e-37  Score=342.55  Aligned_cols=261  Identities=21%  Similarity=0.238  Sum_probs=199.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC--------CCceeeEeeeEe---
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLMGCCV---  579 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~---  579 (834)
                      .++|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            378999999999999999999865 5889999999753 345677899999999995        788999999988   


Q ss_pred             -ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCC-----
Q 003287          580 -EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM-----  652 (834)
Q Consensus       580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~-----  652 (834)
                       +....++||||+. ++|.+.+... ....+++..+..++.||++||+|||++ +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             5568999999995 4555554322 224589999999999999999999998 6   99999999999999775     


Q ss_pred             --------------------------------------------CeeeccccccccccCCCcccccccccccccccCccc
Q 003287          653 --------------------------------------------NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY  688 (834)
Q Consensus       653 --------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  688 (834)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        8999999999875422     233568999999999


Q ss_pred             ccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc----cccc------------------cccccc-cccccccC
Q 003287          689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL----LGHA------------------WNLWKD-NRAYELLS  745 (834)
Q Consensus       689 ~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~----~~~~------------------~~~~~~-~~~~~l~~  745 (834)
                      +.+..++.++|||||||++|||++|+.||..........    ....                  ...+.. .....+.+
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999997654322100    0000                  000000 00000000


Q ss_pred             ccc---------cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PAL---------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ...         ...........+.+|+.+||+.||++|||+.|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000         00123456678899999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.2e-37  Score=338.70  Aligned_cols=265  Identities=21%  Similarity=0.261  Sum_probs=201.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeec-----CeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  584 (834)
                      .++|++++.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999875 58899999997543 33457899999999999999999999998765     368


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||++ ++|.+++..    ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 588888843    45899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcc-cccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cccc-----c---cc
Q 003287          665 FCGDELQ-GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGH-----A---WN  733 (834)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~~-----~---~~  733 (834)
                      ....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ....     .   +.
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            6433221 12234579999999998764 45899999999999999999999999765432110 0000     0   00


Q ss_pred             cccc----cccccccCcccc--chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          734 LWKD----NRAYELLSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       734 ~~~~----~~~~~l~~~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .+..    ........+...  ..........+.+|+..||+.||++|||+.|+++-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000    000000000000  01112234567899999999999999999999873

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-37  Score=343.40  Aligned_cols=264  Identities=19%  Similarity=0.240  Sum_probs=194.9

Q ss_pred             HHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------  581 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  581 (834)
                      ....++|++.+.||+|+||+||+|+.. +++.||||++.....    ...+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999874 689999999865422    234799999999999999999998543      


Q ss_pred             --------------------------------CeEEEEEEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 003287          582 --------------------------------GEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYL  628 (834)
Q Consensus       582 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL  628 (834)
                                                      ...++||||++ |+|.+.+... .....+++..+..++.||++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999998 5777666431 2345689999999999999999999


Q ss_pred             hhcCCCceEecCCCCCcEEEc-CCCCeeeccccccccccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHH
Q 003287          629 HQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVL  706 (834)
Q Consensus       629 H~~~~~~iiH~DIkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvi  706 (834)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.+....   ......+|+.|+|||++.+. .++.++|||||||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9987   99999999999998 68999999999998764332   22345689999999998875 48999999999999


Q ss_pred             HHHHhhCCCCCCCCCccccc--ccc---cc--------cccccccccccccCccccchhHHHHHHHHHHHHhcccccCcC
Q 003287          707 LLETLTSKRNTGVYDIESFN--LLG---HA--------WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAA  773 (834)
Q Consensus       707 l~elltg~~p~~~~~~~~~~--~~~---~~--------~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~  773 (834)
                      +|||++|+.||.........  +..   ..        .....................+......+.+|+..||+.+|+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999999865422110  000   00        000000000000011111111222345688999999999999


Q ss_pred             CCCCHHHHHH
Q 003287          774 DRPTMSKVVS  783 (834)
Q Consensus       774 ~RPs~~evl~  783 (834)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5e-37  Score=339.85  Aligned_cols=272  Identities=19%  Similarity=0.228  Sum_probs=190.2

Q ss_pred             HHHHHhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe-
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-  583 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-  583 (834)
                      .......++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            344566789999999999999999999985 58999999986532 333456788889999999999999999976543 


Q ss_pred             ------EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCceEecCCCCCcEEEcC-CCCe
Q 003287          584 ------KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--QYSRLRIIHRDLKASNILLDS-DMNP  654 (834)
Q Consensus       584 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiH~DIkp~NILl~~-~~~v  654 (834)
                            .++||||++++.+..+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987543322221234456889999999999999999999  766   999999999999997 8999


Q ss_pred             eeccccccccccCCCcccccccccccccccCcccccCCC-CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc-ccc--
Q 003287          655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGH--  730 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~~~--  730 (834)
                      ||+|||+++.+....   ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... ...  
T Consensus       172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            999999998764332   223456899999999987654 8999999999999999999999997654321100 000  


Q ss_pred             ---cccc---ccc-cccccccCcc------ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          731 ---AWNL---WKD-NRAYELLSPA------LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       731 ---~~~~---~~~-~~~~~l~~~~------l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                         ....   ... .......+..      ............+.+|+..||+.||++|||+.|+++-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence               0000   000 0000000000      0001111235678899999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-36  Score=335.25  Aligned_cols=264  Identities=25%  Similarity=0.316  Sum_probs=199.8

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeec-----CeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  584 (834)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999976 58999999997543 34456788999999999999999999998764     678


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ++||||++ ++|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 688888843    46899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCccc--------ccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccc-----c-
Q 003287          665 FCGDELQG--------NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL-----G-  729 (834)
Q Consensus       665 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~-----~-  729 (834)
                      +.......        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......     . 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            64322111        1223468999999998765 6799999999999999999999999976542211000     0 


Q ss_pred             ----ccccccccccccc----ccC--ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          730 ----HAWNLWKDNRAYE----LLS--PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       730 ----~~~~~~~~~~~~~----l~~--~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          ............+    +..  ..............+.+++..||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                0000000000000    000  00000111234467789999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-36  Score=337.85  Aligned_cols=259  Identities=22%  Similarity=0.302  Sum_probs=197.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE----
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK----  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----  584 (834)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            478999999999999999999875 5899999999764  333467889999999999999999999999887655    


Q ss_pred             --EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          585 --ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       585 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                        ++||||++ ++|.+++.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 67877772     23899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc-c----ccc----c
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-L----GHA----W  732 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~----~~~----~  732 (834)
                      +....     ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...+...... .    ...    .
T Consensus       192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            86532     2234568999999999987 689999999999999999999999997644211100 0    000    0


Q ss_pred             ccccccc---cccccCcccc---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          733 NLWKDNR---AYELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       733 ~~~~~~~---~~~l~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ..+....   ..+.+.....   ..........+.+|+..||+.+|++|||+.|+++-
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0000000   0000000000   01112235678899999999999999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.5e-37  Score=365.07  Aligned_cols=258  Identities=21%  Similarity=0.313  Sum_probs=204.7

Q ss_pred             HHhccCccccceecccCccceEeeEecC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  583 (834)
                      ....++|++.+.||+|+||.||+|++..    +..||||++... .....+.|.+|+.++++++||||+++++++. ++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3445789999999999999999998742    567999998764 3445578999999999999999999999985 456


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||+++|+|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence            89999999999999999532  335889999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||........  ..    ....+..  
T Consensus       540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~~----~i~~~~~--  610 (656)
T 2j0j_A          540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGER--  610 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHHTCC--
T ss_pred             ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH----HHHcCCC--
Confidence            7643322 12223456789999999999999999999999999999997 8899875432211  00    0000000  


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                         .    ..+...+..+.+++..||+.+|++||++.|+++.|+.+
T Consensus       611 ---~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 ---L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               0    01112345678899999999999999999999999886

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-36  Score=331.46  Aligned_cols=265  Identities=26%  Similarity=0.373  Sum_probs=199.2

Q ss_pred             hccCccccceecccCccceEeeEec--CCcEEEEEEecccCh--hhHHHHHHHHHHHhcc---CCCceeeEeeeEe----
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKL---QHRNLVRLMGCCV----  579 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~----  579 (834)
                      ..++|++.+.||+|+||.||+|+..  +++.||||++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999973  588999999865321  1223566777777666   8999999999987    


Q ss_pred             -ecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecc
Q 003287          580 -EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  658 (834)
Q Consensus       580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~D  658 (834)
                       .....++||||++ |+|.+++.... ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 69999885432 234899999999999999999999987   99999999999999999999999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc--cccc----cc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--LLGH----AW  732 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~~----~~  732 (834)
                      ||+++.....   .......||..|+|||++.+..++.++||||||+++|||++|+.||.........  +...    ..
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            9999865322   1233456899999999999999999999999999999999999999765432110  0000    00


Q ss_pred             cccccc-----ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          733 NLWKDN-----RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       733 ~~~~~~-----~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+...     .....................+.+|+..||+.+|++||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000     000000000001111223456788999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.5e-37  Score=345.91  Aligned_cols=260  Identities=23%  Similarity=0.288  Sum_probs=192.6

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------CeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~  584 (834)
                      ..+|++.+.||+|+||.||+|++. +++.||||++....    ..+.+|++++++++||||+++++++...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            357999999999999999999986 58999999986542    2234799999999999999999998642      236


Q ss_pred             EEEEEecCCCCchhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeecccccc
Q 003287          585 ILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA  662 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DFGla  662 (834)
                      ++||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+||||+.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 45554432 123456899999999999999999999987   9999999999999965 56899999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccc-------cc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW-------NL  734 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------~~  734 (834)
                      +.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.....       ..
T Consensus       205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHH
T ss_pred             hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHH
Confidence            8764332   22335789999999999765 799999999999999999999999976542110 000000       00


Q ss_pred             cc--ccccccccCccccc-----hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          735 WK--DNRAYELLSPALQH-----EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       735 ~~--~~~~~~l~~~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +.  .....+..-+.+..     .........+.+|+.+||+.||++||++.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00  00000111111110     011123457889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-36  Score=326.54  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=192.0

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee----------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----------  580 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----------  580 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467999999999999999999975 689999999964 34456789999999999999999999999865          


Q ss_pred             ---cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          581 ---QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                         ....++||||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               35689999999999999999642  235778999999999999999999987   9999999999999999999999


Q ss_pred             cccccccccCCCc------------ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccc
Q 003287          658 DFGMARMFCGDEL------------QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  724 (834)
Q Consensus       658 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~  724 (834)
                      |||+++.......            ........||+.|+|||++.+. .++.++||||||+++|||++   |+...... 
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-  234 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-  234 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence            9999987643210            1122345689999999999865 68999999999999999998   43321110 


Q ss_pred             ccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .....    ....      ................+.+++..||+.||++||++.|+++
T Consensus       235 ~~~~~----~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 VNILK----KLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHH----HHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHH----hccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            00000    0000      0011111122233456788999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-36  Score=330.43  Aligned_cols=255  Identities=26%  Similarity=0.375  Sum_probs=178.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHH-HHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999985 58999999997653 334455666666 777789999999999999999999999


Q ss_pred             EecCCCCchhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          589 EYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      ||+++ +|.+++..  ......+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 77776632  11245689999999999999999999998 7   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccc----cCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYA----LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||.........+..    ... +.. 
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~-~~~-  247 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----VVK-GDP-  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC----CCC-SCC-
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH----Hhc-CCC-
Confidence            4322   12234689999999998    4567899999999999999999999998754321111100    000 100 


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          +.+...........+.+++..||+.+|++||++.|+++
T Consensus       248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                11111111122356888999999999999999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=341.02  Aligned_cols=203  Identities=27%  Similarity=0.434  Sum_probs=154.9

Q ss_pred             cCccc-cceecccCccceEeeEec---CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee--cCeEEE
Q 003287          513 ENFSM-QCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKIL  586 (834)
Q Consensus       513 ~~f~~-~~~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l  586 (834)
                      +.|++ .++||+|+||+||+|+..   +++.||||++....  ....+.+|+.++++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            45665 458999999999999965   47899999997543  23568899999999999999999999965  678999


Q ss_pred             EEEecCCCCchhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE----cCCCCeee
Q 003287          587 IYEYMPNKSLNFFLFD------PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKI  656 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~vkl  656 (834)
                      ||||+++ +|.+++..      ......+++..+..++.||+.||+|||+.+   |+||||||+||||    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 67666632      112235899999999999999999999988   9999999999999    77899999


Q ss_pred             ccccccccccCCCc-ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          657 SDFGMARMFCGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       657 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                      +|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999987643221 1223446789999999999874 59999999999999999999999997543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-36  Score=329.52  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=201.8

Q ss_pred             ccCccccceecccCccceEeeEe--cCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCc------eeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKL--LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN------LVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  583 (834)
                      .++|++.+.||+|+||.||++..  .+++.||||++... ....+.+.+|+.++..++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            36899999999999999999986  35889999999753 345677899999999997664      9999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-------------
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------------  650 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-------------  650 (834)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999988543 2235889999999999999999999987   999999999999987             


Q ss_pred             ------CCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc
Q 003287          651 ------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  724 (834)
Q Consensus       651 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~  724 (834)
                            ++.+||+|||+++....     ......||+.|+|||++.+..++.++||||||+++|||++|..||...+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  67899999999986432     2234578999999999999999999999999999999999999997654321


Q ss_pred             cc-ccccc-----cccc---ccccc------------------ccccCccc-cchhHHHHHHHHHHHHhcccccCcCCCC
Q 003287          725 FN-LLGHA-----WNLW---KDNRA------------------YELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRP  776 (834)
Q Consensus       725 ~~-~~~~~-----~~~~---~~~~~------------------~~l~~~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RP  776 (834)
                      .. .....     ...+   .....                  .+...+.. ...........+.+|+..||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            10 00000     0000   00000                  00000000 0001223456788999999999999999


Q ss_pred             CHHHHHH
Q 003287          777 TMSKVVS  783 (834)
Q Consensus       777 s~~evl~  783 (834)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.6e-36  Score=323.36  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            478999999999999999999986 68999999986542  345678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC---CCeeeccccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMF  665 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~vkl~DFGla~~~  665 (834)
                      ||+++++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+||+++.+   +.+||+|||++...
T Consensus       101 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999888843   245899999999999999999999987   9999999999999754   46999999999876


Q ss_pred             cCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ....   ......+++.|+|||.+.+ .++.++||||||++++||++|+.||........  ..    ....+... .  
T Consensus       175 ~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~~~~-~--  241 (287)
T 2wei_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LK----RVETGKYA-F--  241 (287)
T ss_dssp             CCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCCCC-C--
T ss_pred             cCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHcCCCC-C--
Confidence            4322   2233458999999998875 489999999999999999999999875432211  00    00000000 0  


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         ...........+.+++..||+.+|++||++.|+++
T Consensus       242 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 ---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ---CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence               00011123456788999999999999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.8e-36  Score=340.81  Aligned_cols=253  Identities=23%  Similarity=0.298  Sum_probs=187.5

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +.|.+.+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345567889999999998776668999999998653   245678899999886 8999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-------------CCe
Q 003287          592 PNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-------------MNP  654 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-------------~~v  654 (834)
                      + |+|.+++.......    ...+..++.++.||+.||+|||+.+   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999996542211    1133456789999999999999987   9999999999999754             489


Q ss_pred             eeccccccccccCCCcc--cccccccccccccCcccccC-------CCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccc
Q 003287          655 KISDFGMARMFCGDELQ--GNTKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIES  724 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~  724 (834)
                      ||+|||+++.+......  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543221  12234579999999999976       678999999999999999999 899987543221


Q ss_pred             ccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......       .  ...  +.............+.+++.+||+.+|++||++.|+++
T Consensus       248 ~~i~~~-------~--~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 SNIIRG-------I--FSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHT-------C--CCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhcC-------C--CCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            111110       0  000  00011112345677889999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.9e-36  Score=330.67  Aligned_cols=257  Identities=22%  Similarity=0.287  Sum_probs=195.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe-----
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-----  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  583 (834)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            368999999999999999999875 5899999999754  23345778999999999999999999999987654     


Q ss_pred             -EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          584 -KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       584 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                       .++||||++ ++|.+++.     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999998 68887773     24899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc-c---c----cc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G---H----AW  732 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~-~---~----~~  732 (834)
                      +....     ......+|+.|+|||++.+ ..++.++||||||++++||++|+.||...+.... ... .   .    ..
T Consensus       174 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            86532     1234578999999999887 6789999999999999999999999876442110 000 0   0    00


Q ss_pred             ccccccc-------cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          733 NLWKDNR-------AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       733 ~~~~~~~-------~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+....       ......+.+ ..........+.+++..||+.||++||++.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000000       000000000 0111233467889999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.4e-36  Score=328.20  Aligned_cols=257  Identities=19%  Similarity=0.215  Sum_probs=175.5

Q ss_pred             ccCccccc-eecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEee----cCeEE
Q 003287          512 TENFSMQC-KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKI  585 (834)
Q Consensus       512 ~~~f~~~~-~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~  585 (834)
                      .++|++.+ .||+|+||+||+|+.. +++.||||++....    ....+....+..++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46898865 6999999999999986 58999999996531    122223344667799999999999976    44689


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCeeecccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA  662 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vkl~DFGla  662 (834)
                      +||||+++|+|.+++... ....+++.++..++.||++||+|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999653 2346899999999999999999999997   999999999999976   455999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      +.....    ......+|+.|+|||++.+..++.++||||||+++|||++|+.||............  ....... ...
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~-~~~  251 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLG-QYG  251 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhcc-ccc
Confidence            865422    223456899999999999999999999999999999999999998754332110000  0000000 000


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH--Hhhcc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS--MITNE  788 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~  788 (834)
                           ............+.+|+..||+.+|++|||+.|+++  .+...
T Consensus       252 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          252 -----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                 001111123456788999999999999999999998  44443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-35  Score=329.80  Aligned_cols=261  Identities=20%  Similarity=0.291  Sum_probs=198.4

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-----------CCceeeEeeeEe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLMGCCV  579 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~  579 (834)
                      .++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            368999999999999999999974 6899999999753 344567889999999886           899999999998


Q ss_pred             ecC----eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEc-----
Q 003287          580 EQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLD-----  649 (834)
Q Consensus       580 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~-----  649 (834)
                      ..+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            754    789999999 899999985432 34589999999999999999999997 7   99999999999994     


Q ss_pred             -CCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc--
Q 003287          650 -SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--  726 (834)
Q Consensus       650 -~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~--  726 (834)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4447999999999875322     23356899999999999999999999999999999999999999754422110  


Q ss_pred             --ccccccc------------------cccccccccccCc-cc---------cchhHHHHHHHHHHHHhcccccCcCCCC
Q 003287          727 --LLGHAWN------------------LWKDNRAYELLSP-AL---------QHEASYQMLNRYITVALLCVQEKAADRP  776 (834)
Q Consensus       727 --~~~~~~~------------------~~~~~~~~~l~~~-~l---------~~~~~~~~~~~l~~li~~cl~~~P~~RP  776 (834)
                        .......                  .+........+.. ..         ....+......+.+|+..||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence              0000000                  0000000000000 00         0112345677889999999999999999


Q ss_pred             CHHHHHH
Q 003287          777 TMSKVVS  783 (834)
Q Consensus       777 s~~evl~  783 (834)
                      |+.|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-35  Score=329.54  Aligned_cols=203  Identities=25%  Similarity=0.319  Sum_probs=171.9

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-CC-----ceeeEeeeEeecC
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLMGCCVEQG  582 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~  582 (834)
                      ...++|++.+.||+|+||+||+|+.. +++.||||++... .....++..|+.++..++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999875 5889999999753 344567788999988885 44     4999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc--CCCCeeecccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFG  660 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~~vkl~DFG  660 (834)
                      ..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||++. .+|+||||||+|||++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999996 58988885432 245899999999999999999999531 2499999999999994  57889999999


Q ss_pred             ccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCC
Q 003287          661 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  721 (834)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~  721 (834)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99876322     234578999999999999999999999999999999999999998654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=327.96  Aligned_cols=243  Identities=22%  Similarity=0.371  Sum_probs=190.2

Q ss_pred             HHhccCccccceecccCccceEeeEec-CCcEEEEEEecccCh------hhHHHHHHHHHHHhcc----CCCceeeEeee
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKL----QHRNLVRLMGC  577 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~~  577 (834)
                      ....++|++.+.||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++.++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            344578999999999999999999874 588999999975432      1233466799999998    89999999999


Q ss_pred             EeecCeEEEEEEe-cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCee
Q 003287          578 CVEQGEKILIYEY-MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK  655 (834)
Q Consensus       578 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vk  655 (834)
                      +.+.+..++|+|| +++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 789999999953   345899999999999999999999998   99999999999999 889999


Q ss_pred             eccccccccccCCCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccc
Q 003287          656 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  734 (834)
Q Consensus       656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  734 (834)
                      |+|||+++......    .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.....    ...     
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~-----  247 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----ILE-----  247 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHH-----
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----Hhh-----
Confidence            99999998764332    234568999999999987766 4589999999999999999999864211    000     


Q ss_pred             ccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       735 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         ..      ...    .......+.+++..||+.+|++||++.|+++
T Consensus       248 ---~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          248 ---AE------LHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---TC------CCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---hc------cCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00      000    1112345788999999999999999999997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.2e-35  Score=323.21  Aligned_cols=261  Identities=20%  Similarity=0.256  Sum_probs=198.0

Q ss_pred             ccCccccceecccCccceEeeEec-CC-cEEEEEEecccChhhHHHHHHHHHHHhccCCCc------eeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN------LVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g-~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  583 (834)
                      .++|++.+.||+|+||+||+|+.. ++ +.||||++... ....+.+.+|+.++.+++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            478999999999999999999875 34 78999999753 345577889999999998766      9999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE---------------
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---------------  648 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl---------------  648 (834)
                      .++||||+ +++|.+++... ....+++.++..++.||++||+|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 55565665432 2246899999999999999999999987   9999999999999               


Q ss_pred             ----cCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccc
Q 003287          649 ----DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  724 (834)
Q Consensus       649 ----~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~  724 (834)
                          +.++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                6788999999999986432     2234578999999999999999999999999999999999999998654321


Q ss_pred             cc-cccc--------cccccccccc------------------ccccCccc-cchhHHHHHHHHHHHHhcccccCcCCCC
Q 003287          725 FN-LLGH--------AWNLWKDNRA------------------YELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRP  776 (834)
Q Consensus       725 ~~-~~~~--------~~~~~~~~~~------------------~~l~~~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RP  776 (834)
                      .. ....        ..........                  .+...+.. ...........+.+|+..||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            10 0000        0000000000                  00000000 0001123345788999999999999999


Q ss_pred             CHHHHHH
Q 003287          777 TMSKVVS  783 (834)
Q Consensus       777 s~~evl~  783 (834)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999984

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-36  Score=328.35  Aligned_cols=242  Identities=21%  Similarity=0.344  Sum_probs=198.0

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccCh------hhHHHHHHHHHHHhccC--CCceeeEeeeEee
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVE  580 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~  580 (834)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++.....      ...+.+.+|+.++.+++  |+||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34578999999999999999999864 689999999965422      12345778999999996  5999999999999


Q ss_pred             cCeEEEEEEecCC-CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCeeecc
Q 003287          581 QGEKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISD  658 (834)
Q Consensus       581 ~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vkl~D  658 (834)
                      .+..++|+|++.. ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++ .++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999986 899999853   346899999999999999999999987   99999999999999 789999999


Q ss_pred             ccccccccCCCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccc
Q 003287          659 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD  737 (834)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  737 (834)
                      ||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......    .       . 
T Consensus       194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~-------~-  257 (320)
T 3a99_A          194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----I-------R-  257 (320)
T ss_dssp             CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----H-------H-
T ss_pred             Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----h-------c-
Confidence            99998764322    233568999999999987765 78899999999999999999998642210    0       0 


Q ss_pred             cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          738 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       738 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..  ....    .    .....+.+++.+||+.+|++||++.|+++
T Consensus       258 ~~--~~~~----~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQ--VFFR----Q----RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CC--CCCS----S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc--cccc----c----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  0000    1    12346778999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=334.70  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=186.8

Q ss_pred             hccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ...+|++.+.||+|+||+|+.....+++.||||++.....   ..+.+|+.+++++ +||||+++++++.+....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            3457999999999999997655556899999999965432   2356799999999 89999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-----CCCeeecccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARM  664 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-----~~~vkl~DFGla~~  664 (834)
                      |++ |+|.+++....  ..+.+.++..++.||++||+|||+.+   |+||||||+|||++.     ...+||+|||+++.
T Consensus        99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            997 58999986432  23444566799999999999999988   999999999999953     33578999999987


Q ss_pred             ccCCCc-ccccccccccccccCccccc---CCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccc
Q 003287          665 FCGDEL-QGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||...........       ....
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-------~~~~  245 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-------LGAC  245 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------TTCC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------hccC
Confidence            643321 12234467999999999997   4567889999999999999999 8888864332221110       0000


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ......      ........+.+|+..||+.+|++||++.|+++
T Consensus       246 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            001111      11123445778999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.8e-35  Score=318.69  Aligned_cols=252  Identities=21%  Similarity=0.357  Sum_probs=179.4

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccCh-h-hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-Q-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3478999999999999999999985 689999999976432 2 233455566678888999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      |||+ ++.+..+...  ....+++..+..++.||++||+|||+. +   |+||||||+||+++.++.+||+|||++..+.
T Consensus       103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 4444444421  234689999999999999999999985 6   9999999999999999999999999997654


Q ss_pred             CCCcccccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ...   ......+|+.|+|||++.     ...++.++||||||+++|||++|+.||........ ...   .... ..  
T Consensus       177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---~~~~-~~--  246 (318)
T 2dyl_A          177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLT---KVLQ-EE--  246 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHH---HHHH-SC--
T ss_pred             CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHH---HHhc-cC--
Confidence            322   223356899999999994     45688999999999999999999999875332111 000   0000 00  


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                         .+.+..  .......+.+++..||+.+|.+||++.|+++
T Consensus       247 ---~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 ---PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ---CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               000000  0112346788999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-35  Score=346.50  Aligned_cols=260  Identities=25%  Similarity=0.282  Sum_probs=198.8

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEee------cCeE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QGEK  584 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~  584 (834)
                      ++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++.+++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            68999999999999999999875 5899999998764 44556789999999999999999999999765      6678


Q ss_pred             EEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCC---eeeccccc
Q 003287          585 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGM  661 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---vkl~DFGl  661 (834)
                      ++||||+++|+|.+++........+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976555556899999999999999999999987   999999999999997765   89999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc---------cccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN---------LLGHAW  732 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~---------~~~~~~  732 (834)
                      +.......   ......||+.|+|||++.+..++.++||||||+++|||++|..||.........         ......
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            98764332   223457899999999999999999999999999999999999998653211000         000000


Q ss_pred             cccccc-ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHH
Q 003287          733 NLWKDN-RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK  780 (834)
Q Consensus       733 ~~~~~~-~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e  780 (834)
                      ...... ......  .............+.+++..||+.||++|||+.|
T Consensus       248 ~~l~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          248 DDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCCSSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhcccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            000000 000000  0011123335567889999999999999999977

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.6e-35  Score=348.67  Aligned_cols=239  Identities=20%  Similarity=0.299  Sum_probs=194.4

Q ss_pred             ccCccccceecccCccceEeeEec--CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCe-----
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-----  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~--~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  583 (834)
                      .++|++.+.||+|+||.||++++.  +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            378999999999999999999875  5899999998654 34456778999999999999999999999988765     


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .+|||||+++++|.+++..     .+++.+++.++.||++||+|||+.+   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999887732     6899999999999999999999988   9999999999999986 99999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      .....      ....||+.|+|||++.+.. +.++|||||||+++||++|..|+.......                  +
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~  284 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------L  284 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------C
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------c
Confidence            76432      3456999999999987664 889999999999999999988765311100                  0


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCC-CHHHHHHHhhcc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNE  788 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~  788 (834)
                      .    ...........+.+|+.+||+.+|++|| +++++.+.|..+
T Consensus       285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            0    0111222345688999999999999999 566676666554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.1e-34  Score=308.73  Aligned_cols=231  Identities=13%  Similarity=0.087  Sum_probs=185.5

Q ss_pred             cCccccceecccCccceEeeEecC-CcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||.||+|+... ++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            679999999999999999999864 8999999997653   334578999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++++|.+++.+    . ....++.+++.|+++||+|||+.+   |+||||||+|||++.++.+||++++        
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999943    1 355678999999999999999998   9999999999999999999998543        


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                                    |++       .++.++|||||||++|||++|+.||..........  .+.......       +..
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--~~~~~~~~~-------~~~  224 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--PAERDTAGQ-------PIE  224 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--ECCBCTTSC-------BCC
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--HHHHHhccC-------CCC
Confidence                          333       36889999999999999999999998654322100  000000000       000


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ...........+.+++.+||+.||++| |+.|+++.|+....
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            011122334568899999999999999 99999999998743

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-33  Score=304.98  Aligned_cols=230  Identities=18%  Similarity=0.214  Sum_probs=179.5

Q ss_pred             cCcccc-ceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHH-hccCCCceeeEeeeEee----cCeEE
Q 003287          513 ENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLI-AKLQHRNLVRLMGCCVE----QGEKI  585 (834)
Q Consensus       513 ~~f~~~-~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~  585 (834)
                      ++|.+. +.||+|+||.||+++.. +++.||||++...     ..+.+|+.++ +.++||||+++++++.+    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            567777 78999999999999874 5899999999642     4567888887 55699999999999987    67889


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCeeecccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA  662 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vkl~DFGla  662 (834)
                      +||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999653 2346899999999999999999999988   999999999999998   789999999998


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ....                        +..++.++|||||||++|||++|+.||...........  .....      .
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~------~  215 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRI------R  215 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--SCCSS------C
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--HHHHH------h
Confidence            7532                        24567899999999999999999999875432211000  00000      0


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .................+.+++..||+.+|++||++.|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00001111111234567889999999999999999999997

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-34  Score=316.43  Aligned_cols=242  Identities=16%  Similarity=0.154  Sum_probs=185.9

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccC--------hhhHHHHHHHHHHHhccC---------CCceeeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVRL  574 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l  574 (834)
                      .++|++.++||+|+||+||+|+. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999998 78999999997542        223477899999998886         7777777


Q ss_pred             eeeEe-----------------e-------------cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 003287          575 MGCCV-----------------E-------------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG  624 (834)
Q Consensus       575 ~~~~~-----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  624 (834)
                      .+++.                 +             ....+|||||+++|++.+.+.+    ..+++.++..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            66543                 2             6789999999999977776632    458999999999999999


Q ss_pred             HHHHh-hcCCCceEecCCCCCcEEEcCCC--------------------CeeeccccccccccCCCcccccccccccccc
Q 003287          625 LLYLH-QYSRLRIIHRDLKASNILLDSDM--------------------NPKISDFGMARMFCGDELQGNTKRVVGTYGY  683 (834)
Q Consensus       625 L~yLH-~~~~~~iiH~DIkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y  683 (834)
                      |+||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 887   99999999999999887                    8999999999876432       34799999


Q ss_pred             cCcccccCCCCCccCCeeeHHHH-HHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHH
Q 003287          684 MSPEYALDGLFSVKSDVFSFGVL-LLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  762 (834)
Q Consensus       684 ~aPE~~~~~~~~~ksDVwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~  762 (834)
                      +|||++.+.. +.++||||++++ .+++++|..|+....... ....   .....    ..................+.+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~-~~~~---~~~~~----~~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH-YLTD---KMLKQ----MTFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH-HHHH---HHHHT----CCCSSCCCSHHHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh-HHHH---hhhhh----hccCcccchhhhhhcCHHHHH
Confidence            9999998776 899999998777 777888988864210000 0000   00000    001111122345567788999


Q ss_pred             HHhcccccCcCCCCCHHHHH
Q 003287          763 VALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       763 li~~cl~~~P~~RPs~~evl  782 (834)
                      |+..||+.+     |+.|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999966     888887

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-34  Score=322.41  Aligned_cols=242  Identities=14%  Similarity=0.160  Sum_probs=178.8

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCC-Cce---------e----
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQH-RNL---------V----  572 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H-~ni---------v----  572 (834)
                      .+..|+..+.||+|+||+||+|++. +|+.||||++....   ....+.|.+|+.++..++| +|.         +    
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            4456888899999999999999964 68999999987432   2336789999999999987 221         1    


Q ss_pred             --eE------eeeEee-----cCeEEEEEEecCCCCchhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 003287          573 --RL------MGCCVE-----QGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR  635 (834)
Q Consensus       573 --~l------~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  635 (834)
                        .+      ..+...     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||+.+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence              11      111111     12356666654 6889888831    122445788899999999999999999987   


Q ss_pred             eEecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccc----------cCCCCCccCCeeeHHH
Q 003287          636 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA----------LDGLFSVKSDVFSFGV  705 (834)
Q Consensus       636 iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDVwSlGv  705 (834)
                      |+||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999999864322     334567 999999999          5556889999999999


Q ss_pred             HHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHH
Q 003287          706 LLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV  782 (834)
Q Consensus       706 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl  782 (834)
                      ++|||++|+.||........  ..            ..+..  ..    ..+..+.+|+..||+.+|++||++.|++
T Consensus       306 il~elltg~~Pf~~~~~~~~--~~------------~~~~~--~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGG--SE------------WIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSC--SG------------GGGSS--CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHCCCCCCCcchhhh--HH------------HHHhh--cc----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999875432211  00            00000  00    1125688899999999999999976654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=8.6e-28  Score=280.84  Aligned_cols=185  Identities=16%  Similarity=0.141  Sum_probs=131.4

Q ss_pred             eecccCccceEeeEe-cCCcEEEEEEeccc----------ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEE
Q 003287          520 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ----------SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       520 ~lG~G~fG~Vy~~~~-~~g~~vAVK~l~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ..+.|++|.+..++. --|+.+|||++.+.          .....++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            467778887777653 34889999999653          123456799999999999 799999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||++|++|.++|.+.   ..++..   +|+.||+.||+|||+++   ||||||||+||||++++++||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999543   345543   58999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCC
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN  716 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p  716 (834)
                      ..  ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  23345689999999999876 466789999999999887765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=4.6e-25  Score=256.32  Aligned_cols=185  Identities=18%  Similarity=0.181  Sum_probs=146.1

Q ss_pred             cccceecccCccceEeeEecCCcEEEEEEecccC--------hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          516 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       516 ~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ...++||+|+||+||+++. .++.+|+|+.....        ....+++.+|++++++++||||+++..++.+.+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999954 57889999864321        11245689999999999999999777777788888999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++++|.+++.+           +..++.|+++||+|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999953           5689999999999999988   999999999999999  999999999998744


Q ss_pred             CCccc-----ccccccccccccCcccccC--CCCCccCCeeeHHHHHHHHhhCCCCC
Q 003287          668 DELQG-----NTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNT  717 (834)
Q Consensus       668 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltg~~p~  717 (834)
                      .....     ......||+.|||||++..  ..|+.+.|+|+..+-..+.+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32111     1235679999999999987  66888999999999888887766543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.2e-22  Score=214.51  Aligned_cols=154  Identities=18%  Similarity=0.128  Sum_probs=124.5

Q ss_pred             HHHHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccCh------------------hhHHHHHHHHHHHhcc
Q 003287          505 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAKL  566 (834)
Q Consensus       505 ~~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------------------~~~~~~~~E~~~l~~l  566 (834)
                      +..+......|++.+.||+|+||.||+|+..+|+.||||+++....                  .....+.+|+.+++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3445556677888899999999999999997799999999964321                  1356789999999999


Q ss_pred             CCCceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcE
Q 003287          567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  646 (834)
Q Consensus       567 ~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NI  646 (834)
                      +  | +++.+++.. +..++||||+++++|.+ +..         .....++.|+++||+|||+.+   |+||||||+||
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI  224 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV  224 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence            9  4 666665543 56699999999999988 421         224579999999999999988   99999999999


Q ss_pred             EEcCCCCeeeccccccccccCCCcccccccccccccccCcccccC
Q 003287          647 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD  691 (834)
Q Consensus       647 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  691 (834)
                      |++ ++.+||+|||+++.               +..++|||++..
T Consensus       225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            999 99999999999974               345788998753

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.85  E-value=7e-21  Score=169.98  Aligned_cols=104  Identities=18%  Similarity=0.355  Sum_probs=91.8

Q ss_pred             CCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCCC
Q 003287           26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTD  105 (834)
Q Consensus        26 d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~  105 (834)
                      |+|.+||.|..|++|.|  |.|.|.|...++     |.++.   ..++||+|||+.|. ...+.|+|+.||||||+|+++
T Consensus         2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~~   70 (105)
T 4h3o_A            2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSSG   70 (105)
T ss_dssp             CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECTTC
T ss_pred             CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCC-CccEEEEEeCCccEEEECCCc
Confidence            78999999999999998  889999998887     67754   46999999999994 456789999999999999999


Q ss_pred             CeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287          106 GIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus       106 ~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      .+||+|++.+......|+|+|+|||||++.         .||||
T Consensus        71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S  105 (105)
T 4h3o_A           71 RSLWASHSTRGSGNYILILQDDGNVIIYGS---------DIWST  105 (105)
T ss_dssp             CEEEECCCCCCSSCEEEEECTTSCEEEEES---------EEEEC
T ss_pred             EEEEEecCCCCCCCEEEEEeCCCeEEEECC---------cEecC
Confidence            999999987665667889999999999963         69998

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.85  E-value=1e-20  Score=172.98  Aligned_cols=108  Identities=16%  Similarity=0.334  Sum_probs=94.7

Q ss_pred             cCCCCcCCCcccCCCCeEE--eCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEE
Q 003287           23 LATDTITPATLIGDGEKLV--SSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVL  100 (834)
Q Consensus        23 ~~~d~~~~~~~~~~~~~l~--s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l  100 (834)
                      ++.|+|++||+|.+|++|+  |++|.|+|+|+.+++     + +||++  +++||+||++.|  +.++.|.|..||||||
T Consensus         6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl   75 (119)
T 1b2p_A            6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV   75 (119)
T ss_dssp             CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred             ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence            5679999999999999999  999999999999876     2 58875  899999999876  4568899999999999


Q ss_pred             ecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287          101 LNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus       101 ~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      +|.++.++|+|++........++|+|+|||||++         .++|||
T Consensus        76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~S  115 (119)
T 1b2p_A           76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---------DALWAT  115 (119)
T ss_dssp             ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---------SEEEEC
T ss_pred             EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---------ccEeCC
Confidence            9999999999997654445578999999999985         279998

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.83  E-value=2.9e-20  Score=167.80  Aligned_cols=110  Identities=23%  Similarity=0.429  Sum_probs=95.3

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      +|+|.+||.|.+|++|+ ++|.|+|+|+..|+     | +||+  ..++||.||++.|  +.++.|.|..||||||+|.+
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~   69 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS   69 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence            48999999999999999 99999999998876     3 6776  4799999999876  34678999999999999999


Q ss_pred             CCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCC
Q 003287          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPS  154 (834)
Q Consensus       105 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~Pt  154 (834)
                      +.++|+|++........++|+|+|||||++       .  ++||||+||.
T Consensus        70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~-------~--~~W~S~~~~~  110 (110)
T 3a0c_A           70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYG-------P--VVWATGSGPA  110 (110)
T ss_dssp             CCEEEECCCCCSSSCCEEEECTTSCEEEEC-------S--EEEECSCCC-
T ss_pred             CcEEEecCCCCCCCCEEEEEeCCccEEEEC-------C--CEecCCCcCC
Confidence            999999998655445578999999999984       1  7999999983

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.81  E-value=1.1e-19  Score=165.69  Aligned_cols=110  Identities=18%  Similarity=0.326  Sum_probs=93.9

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      .|||.+||+|.+|++|+  +|.|+|+|+.+++     + ++|+  ..++||+||++.|  +.++.|.|+.||||||+|.+
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~   69 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN   69 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence            58999999999999998  7999999998775     2 2465  5799999999988  35688999999999999998


Q ss_pred             CCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCc
Q 003287          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSD  155 (834)
Q Consensus       105 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtD  155 (834)
                      +.++|+|++........++|+|+|||||++       .  ++||||.+++.
T Consensus        70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~-------~--~~W~S~~~~~~  111 (115)
T 2dpf_A           70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG-------P--VLWSLGPNGCR  111 (115)
T ss_dssp             CCEEEECCCCCSSSCCEEEECTTSCEEEEC-------S--EEECSSTTCBC
T ss_pred             ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC-------C--CEEECCCCCCc
Confidence            999999998654445678999999999984       2  79999998764

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.81  E-value=1.2e-19  Score=164.52  Aligned_cols=110  Identities=24%  Similarity=0.438  Sum_probs=93.6

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      +|||.+||.|.+|++|  ++|.|+|+|+.+++     + +||++  .++||+||++.+  +.++.|.|..||||||+| +
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~   67 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G   67 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence            4899999999999999  58999999999887     2 46765  799999999763  456789999999999999 8


Q ss_pred             CCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCC
Q 003287          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCP  153 (834)
Q Consensus       105 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~P  153 (834)
                      +.++|+|++........++|+++|||||++.      .+.++||||++.
T Consensus        68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~------~~~~~W~S~~~~  110 (112)
T 1xd5_A           68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNV  110 (112)
T ss_dssp             TEEEEECCCCCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCC
T ss_pred             CEEEEECCccCCCCCEEEEEeCCCcEEEECC------CCceEEECCCcc
Confidence            8899999976554456789999999999974      467999999985

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.77  E-value=1.1e-18  Score=157.26  Aligned_cols=104  Identities=24%  Similarity=0.401  Sum_probs=88.6

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      .+||.|||.|.+|++|+  +|.|+|+|+.+++     +.+ |..  .++||++|++.+  +.++.|.|..||||||+|.+
T Consensus         1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~   68 (109)
T 3dzw_A            1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR   68 (109)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred             CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence            36899999999999997  7999999998876     333 553  699999999876  45688999999999999999


Q ss_pred             CCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus       105 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      +.++|+|++.+......|+|+|+|||||++.         ++|||
T Consensus        69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---------~~W~s  104 (109)
T 3dzw_A           69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT---------ARWAT  104 (109)
T ss_dssp             SCEEEECCCCCSSSCEEEEECTTSCEEEEES---------CCCCC
T ss_pred             CCEEEECCCCCCCCCEEEEEeCCCEEEEECC---------CEEeC
Confidence            9999999986554456789999999999963         79997

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.74  E-value=3e-18  Score=180.08  Aligned_cols=142  Identities=17%  Similarity=0.182  Sum_probs=109.0

Q ss_pred             HHhccCccccceecccCccceEeeEe-cCCcE--EEEEEecccCh------------------------hhHHHHHHHHH
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKL-LNGQE--VAVKRLSSQSG------------------------QGLKEFKNEMM  561 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~-~~g~~--vAVK~l~~~~~------------------------~~~~~~~~E~~  561 (834)
                      .....-|++.+.||+|+||.||+|+. .+|+.  ||||+++....                        .....+.+|+.
T Consensus        43 ~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           43 SAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             HHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             HhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            33334577889999999999999998 67888  99998754311                        11236889999


Q ss_pred             HHhccCCCce--eeEeeeEeecCeEEEEEEecCC-C----CchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCC
Q 003287          562 LIAKLQHRNL--VRLMGCCVEQGEKILIYEYMPN-K----SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-QYSR  633 (834)
Q Consensus       562 ~l~~l~H~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~  633 (834)
                      ++.+++|+++  ..++..    ...+|||||+.+ |    +|.++...      .++..+..++.|++++|.||| +.+ 
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g-  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE-  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence            9999988764  334432    356899999952 4    55554421      224467789999999999999 877 


Q ss_pred             CceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          634 LRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       634 ~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                        |+||||||+|||++.  .++|+|||+|...
T Consensus       192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 --LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             --EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             --EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence              999999999999998  9999999999764

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.72  E-value=1.5e-17  Score=149.72  Aligned_cols=106  Identities=18%  Similarity=0.302  Sum_probs=87.7

Q ss_pred             ccCCCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEe
Q 003287           22 SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLL  101 (834)
Q Consensus        22 ~~~~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~  101 (834)
                      +-|.|||.|||.|..|+.|+|  |.|.|-|...|+     |.+ |..   ++||++|++..  +..+.|.|..||||||+
T Consensus         3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~   69 (110)
T 3r0e_B            3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIK   69 (110)
T ss_dssp             CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred             ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence            457899999999999999998  559997766665     555 543   58999999863  44578999999999999


Q ss_pred             cCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287          102 NQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus       102 ~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      |.++.++|+|++........|+|+|+|||||++         ..+|+|
T Consensus        70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---------~~~W~t  108 (110)
T 3r0e_B           70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---------PAIFET  108 (110)
T ss_dssp             CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred             eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---------CCEecC
Confidence            999999999998654445678999999999995         279997

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.70  E-value=1.1e-16  Score=145.07  Aligned_cols=109  Identities=15%  Similarity=0.268  Sum_probs=91.0

Q ss_pred             ccCCCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEe
Q 003287           22 SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLL  101 (834)
Q Consensus        22 ~~~~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~  101 (834)
                      +.+.|+|.+||.|..|+.|.+  |.|.|-|...|+     |.++.. -..++||.+|+..+  +..+.|.|..||||||+
T Consensus         3 ~~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~   72 (113)
T 3mez_B            3 PRVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT   72 (113)
T ss_dssp             CCCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred             cccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence            347799999999999999975  889999988776     666432 14799999999875  34678999999999999


Q ss_pred             cCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287          102 NQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus       102 ~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      |.++.++|+|++........|+|+|+|||||++         ..+|+|
T Consensus        73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---------~~~W~s  111 (113)
T 3mez_B           73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---------PAVWST  111 (113)
T ss_dssp             CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred             CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---------CCEecC
Confidence            999999999998654445688999999999985         379997

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.67  E-value=2.8e-16  Score=142.37  Aligned_cols=98  Identities=22%  Similarity=0.409  Sum_probs=81.2

Q ss_pred             CCCCcCCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCccccc
Q 003287           80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLI  159 (834)
Q Consensus        80 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLp  159 (834)
                      +.|+.+...+|.|..||+|||++. +.+||++|+.+...+..|+|+++|||||++       .+.++||||+        
T Consensus        13 g~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-------~~~~~W~S~~--------   76 (112)
T 1xd5_A           13 GGSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-------GSRAIWASNT--------   76 (112)
T ss_dssp             TCEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-------TTEEEEECCC--------
T ss_pred             CCEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-------CCEEEEECCc--------
Confidence            345556678899999999999987 789999998655455788999999999997       2479999993        


Q ss_pred             CCccccccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEc-CCeEEEEecCCCC
Q 003287          160 GMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYN-GSVKLSCTGPWNG  218 (834)
Q Consensus       160 g~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~-~~~~~~~~g~w~g  218 (834)
                                             ||++|.|++.++++|.  +++|. +..+||++++|+|
T Consensus        77 -----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 -----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             -----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             -----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence                                   5667899999999997  55665 5789999999987

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.65  E-value=4.7e-16  Score=139.71  Aligned_cols=108  Identities=21%  Similarity=0.339  Sum_probs=88.9

Q ss_pred             CCCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecC
Q 003287           24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQ  103 (834)
Q Consensus        24 ~~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~  103 (834)
                      |.|||.|||.|..|+.|  .+|.|.|.|...++     |-+ |..     +|.+|+..+  +.++.|.|..||||||+|.
T Consensus         2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d~   66 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKNG   66 (109)
T ss_dssp             CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred             ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEeC
Confidence            67999999999999999  57999999988776     333 431     699998764  4468899999999999999


Q ss_pred             CCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccC
Q 003287          104 TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIG  160 (834)
Q Consensus       104 ~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg  160 (834)
                      ++.++|+|++.+......|+|+|+|||||++         ..+|+|     .|.+||
T Consensus        67 ~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---------~~~W~s-----~t~~~~  109 (109)
T 3r0e_A           67 DGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---------PSVFKI-----DPWVRG  109 (109)
T ss_dssp             TSCEEEECCCCCSSSCCEEEEETTTEEEEEC---------SEEEEE-----CTTSCC
T ss_pred             CCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---------cCEECC-----CCccCC
Confidence            9999999998654445678999999999985         379997     565554

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.65  E-value=5.2e-16  Score=139.85  Aligned_cols=90  Identities=21%  Similarity=0.342  Sum_probs=75.8

Q ss_pred             CCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCccc
Q 003287           85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMG  164 (834)
Q Consensus        85 ~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~  164 (834)
                      +...+|.|+.||||||+| .+.+||++|+.+...+..++|+|+|||||++.      .+.++||||              
T Consensus        19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~------~~~~~W~S~--------------   77 (110)
T 3a0c_A           19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ------SNRVIWQTK--------------   77 (110)
T ss_dssp             TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEECC--------------
T ss_pred             CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC------CCcEEEecC--------------
Confidence            456789999999999998 57899999987655567889999999999985      568999999              


Q ss_pred             cccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecCC
Q 003287          165 WDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW  216 (834)
Q Consensus       165 ~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w  216 (834)
                                       .+|++|.|++.++++|.  ++++++  .||+++++
T Consensus        78 -----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~  108 (110)
T 3a0c_A           78 -----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG  108 (110)
T ss_dssp             -----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred             -----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence                             35678999999999987  566775  79999875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=1.9e-16  Score=173.27  Aligned_cols=146  Identities=13%  Similarity=0.153  Sum_probs=104.7

Q ss_pred             HHHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccC--------------hhhHHH--------HHHHHHHH
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--------------GQGLKE--------FKNEMMLI  563 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--------------~~~~~~--------~~~E~~~l  563 (834)
                      ..+.....-|++.+.||+|+||.||+|...+|+.||||+++...              ......        ...|...|
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            44444455599999999999999999999899999999875321              001111        23466666


Q ss_pred             hccCCCceeeEeeeEeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCC
Q 003287          564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKA  643 (834)
Q Consensus       564 ~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp  643 (834)
                      .++.+.++.-..-+..  ...+|||||+++++|..+...         .....++.|++.+|.|||+.+   ||||||||
T Consensus       168 ~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp  233 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNE  233 (397)
T ss_dssp             HHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred             HHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence            6665444322111111  233799999999988765421         134578899999999999987   99999999


Q ss_pred             CcEEEcCCCC----------eeeccccccccc
Q 003287          644 SNILLDSDMN----------PKISDFGMARMF  665 (834)
Q Consensus       644 ~NILl~~~~~----------vkl~DFGla~~~  665 (834)
                      .|||+++++.          +.|+||+-+...
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            9999988773          899999987643

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.58  E-value=7.6e-15  Score=133.96  Aligned_cols=87  Identities=25%  Similarity=0.310  Sum_probs=73.6

Q ss_pred             CceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCccccc
Q 003287           87 NAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (834)
Q Consensus        87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~  166 (834)
                      ..+|.|..||+|||++. +.+||++|+.....+..|+|+|+|||||+|.      .+.++||||                
T Consensus        31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~------~~~~lW~S~----------------   87 (119)
T 1b2p_A           31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN------ENVTVWQSP----------------   87 (119)
T ss_dssp             EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEECS----------------
T ss_pred             CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC------CCcEEEcCC----------------
Confidence            35699999999999987 8999999986555567899999999999985      568999999                


Q ss_pred             cccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecC
Q 003287          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (834)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~  215 (834)
                                     .||++|.|++.++++|.  ++++.  .+||++|+
T Consensus        88 ---------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~  117 (119)
T 1b2p_A           88 ---------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT  117 (119)
T ss_dssp             ---------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred             ---------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence                           46778999999999997  55666  38999986

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.57  E-value=1.1e-14  Score=132.51  Aligned_cols=92  Identities=29%  Similarity=0.381  Sum_probs=76.7

Q ss_pred             CCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCcccc
Q 003287           86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGW  165 (834)
Q Consensus        86 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~  165 (834)
                      ....|.|..||+|||++ .+.++|++|+.+...+..++|+++|||||+|.      .+.++|||||+             
T Consensus        20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~------~~~~vW~S~~~-------------   79 (115)
T 2dpf_A           20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH------NNNDVWGSACW-------------   79 (115)
T ss_dssp             TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT------TCCEEEECCCC-------------
T ss_pred             CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC------CceEEEEcCCC-------------
Confidence            34679999999999998 57899999986554557889999999999985      46799999997             


Q ss_pred             ccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecCCCCc
Q 003287          166 DLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGL  219 (834)
Q Consensus       166 ~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w~g~  219 (834)
                                        |++|.|++.++++|.  +++++.  .||++++|...
T Consensus        80 ------------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~  111 (115)
T 2dpf_A           80 ------------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR  111 (115)
T ss_dssp             ------------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred             ------------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence                              456889999999997  566765  89999999764

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.50  E-value=6.5e-14  Score=126.15  Aligned_cols=103  Identities=16%  Similarity=0.250  Sum_probs=83.1

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      .|+|.|||.|.+|+.|  .+|.|.|.|...++     |.+ |..  .. ||.+|+..+  +..+.|.|..||||||+|.+
T Consensus         2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~   68 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN   68 (111)
T ss_dssp             TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred             cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence            5899999999999999  47999999988776     444 432  24 999999876  34578999999999999988


Q ss_pred             CC-eEEeecCCc--ccccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287          105 DG-IIWSSNLSR--EVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus       105 ~~-~~wst~~~~--~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      +. ++|+|++..  ......++|+|+|||||++         ..+|+|
T Consensus        69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s  107 (111)
T 3mez_A           69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---------PAIWST  107 (111)
T ss_dssp             CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---------SEEEEC
T ss_pred             CCEEEEEeccccCCCCcCEEEEECCCCeEEEec---------cCEEcc
Confidence            76 599999642  2234578999999999984         479997

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.29  E-value=1e-11  Score=112.16  Aligned_cols=95  Identities=20%  Similarity=0.313  Sum_probs=73.7

Q ss_pred             CCCCcCCCceEEEecCCceEEecC-CCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccc
Q 003287           80 NSPIVDSNAVLTIGNNGNLVLLNQ-TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLL  158 (834)
Q Consensus        80 ~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlL  158 (834)
                      +.|+.+...+|.++.||||||++. .+.++|++++.+...+..++|+++|||||++.      .+.++|||=.+      
T Consensus        18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~------~~~~iW~S~t~------   85 (113)
T 3mez_B           18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD------RLNTVFVSNTV------   85 (113)
T ss_dssp             TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT------TSCEEEECSCC------
T ss_pred             CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC------CCCEEEECCCc------
Confidence            566667778899999999999998 58999999987554567889999999999985      45789997210      


Q ss_pred             cCCccccccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecC
Q 003287          159 IGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (834)
Q Consensus       159 pg~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~  215 (834)
                                               -..|.|.+.++.+|...+  |.  .+.|.+|+
T Consensus        86 -------------------------~~~~~~~~~L~~dGnlvl--y~--~~~W~s~~  113 (113)
T 3mez_B           86 -------------------------GQEGDYVLILQINGQAVV--YG--PAVWSTAA  113 (113)
T ss_dssp             -------------------------CSSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred             -------------------------CCCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence                                     012558899999987665  44  57898875

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.4e-11  Score=129.13  Aligned_cols=147  Identities=18%  Similarity=0.105  Sum_probs=116.3

Q ss_pred             HHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEE
Q 003287          509 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       509 ~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  587 (834)
                      ......|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888999999999999864 6899999987532223346888999999984 67888999999998999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS-----------------------------------  632 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------  632 (834)
                      |||+++.+|.+.+..        ......++.+++++|+.||+..                                   
T Consensus        89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999776411        1223478899999999999821                                   


Q ss_pred             ---------------------CCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          633 ---------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       633 ---------------------~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                                           +..++|+|++|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                 14589999999999998766667999998753

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.23  E-value=1.8e-11  Score=128.46  Aligned_cols=112  Identities=17%  Similarity=0.388  Sum_probs=87.0

Q ss_pred             CCCCcCCCcc----cCCCCeEEeCCCeEEEEeecCC--CCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCc
Q 003287           24 ATDTITPATL----IGDGEKLVSSSQIFELGFFSPG--KSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGN   97 (834)
Q Consensus        24 ~~d~~~~~~~----~~~~~~l~s~~g~f~~gf~~~~--~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~   97 (834)
                      .+||+.|||.    |..|+.|.|+ ..++.|+|+..  .....+  + |++ ..+++|.+++..+  +. ..|.++.||+
T Consensus       135 ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~-~~~~yW~Sgt~~~--~~-~~l~l~~dGn  206 (276)
T 3m7h_A          135 PAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP-NGAATWNAGTQGK--GA-VRAVFQGDGN  206 (276)
T ss_dssp             TTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT-TSSEEEECCCTTT--TC-CEEEECTTSC
T ss_pred             cccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC-CCeEEEECCCCCC--cc-EEEEEcCCCe
Confidence            5799999999    8899999664 56777766531  222333  3 322 3589999999876  22 7899999999


Q ss_pred             eEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCC
Q 003287           98 LVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (834)
Q Consensus        98 l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~  152 (834)
                      |+++|.++.++|++++.+. ....|+|+++|||||++.        +++||||||
T Consensus       207 Lvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~--------~~~Wqsf~~  252 (276)
T 3m7h_A          207 LVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE--------KPVWARFGF  252 (276)
T ss_dssp             EEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE--------EEEEESSSC
T ss_pred             EEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC--------CCeEEccCc
Confidence            9999998899999997644 357889999999999962        589999997

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.17  E-value=8.3e-11  Score=105.77  Aligned_cols=96  Identities=17%  Similarity=0.196  Sum_probs=71.4

Q ss_pred             CCCCcCCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCccccc
Q 003287           80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLI  159 (834)
Q Consensus        80 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLp  159 (834)
                      +.++.+....|.++.||||||++.++  +|++++.+......++|+++|||||++..     .+.++|||.-+       
T Consensus        14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~-----~~~~vW~S~t~-------   79 (111)
T 3mez_A           14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN-----SNTPVWVYPRS-------   79 (111)
T ss_dssp             TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS-----CSSCSEEESSS-------
T ss_pred             CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC-----CCEEEEEeccc-------
Confidence            34445556789999999999999876  99999876555578899999999999851     22359998621       


Q ss_pred             CCccccccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecC
Q 003287          160 GMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (834)
Q Consensus       160 g~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~  215 (834)
                                            .....|.|.+.++.+|...++  .  .++|.++.
T Consensus        80 ----------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t  109 (111)
T 3mez_A           80 ----------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA  109 (111)
T ss_dssp             ----------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred             ----------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence                                  011347899999999976654  4  67888764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=1e-10  Score=122.07  Aligned_cols=138  Identities=17%  Similarity=0.187  Sum_probs=103.6

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCc--eeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ..+.+....+.|..+.||++...+|+.++||+....   ....+.+|+.+++.+.+.+  +.+++++..+++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            455554444466679999998777888999997653   2245778999999885444  55688888888889999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS--------------------------------------  632 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------  632 (834)
                      +++.+|.  ...      ..   ...++.++++.|+.||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999884  211      11   2367788888889888753                                      


Q ss_pred             -----------------CCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          633 -----------------RLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       633 -----------------~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                                       +..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             12399999999999998776677999998764

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.10  E-value=3.4e-10  Score=101.57  Aligned_cols=89  Identities=20%  Similarity=0.334  Sum_probs=67.3

Q ss_pred             CcCCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCc
Q 003287           83 IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMN  162 (834)
Q Consensus        83 ~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~  162 (834)
                      +.+.+..|.++.||||||++.  .++|++++.+.+....++|+++|||||++.      .+.++|||-.+-         
T Consensus        21 L~sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~------~~~~iW~S~t~~---------   83 (110)
T 3r0e_B           21 LTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD------DFKTIWSSRSSS---------   83 (110)
T ss_dssp             EECSSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT------TCCEEEECCCCC---------
T ss_pred             EEeCCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC------CCCEEEEcCCcC---------
Confidence            344557899999999999987  589999987655556889999999999985      567999983210         


Q ss_pred             cccccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEec
Q 003287          163 MGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTG  214 (834)
Q Consensus       163 l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g  214 (834)
                                            ..|.|.+.++.+|...+  |.  ...|.+|
T Consensus        84 ----------------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~  109 (110)
T 3r0e_B           84 ----------------------KQGEYVLILQDDGFGVI--YG--PAIFETS  109 (110)
T ss_dssp             ----------------------SSSCCEEEECTTSCEEE--EC--SEEEESC
T ss_pred             ----------------------CCCCEEEEEcCCccEEE--ec--CCEecCC
Confidence                                  12458889999987654  44  3788776

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.04  E-value=6.7e-10  Score=99.47  Aligned_cols=93  Identities=24%  Similarity=0.407  Sum_probs=70.7

Q ss_pred             CCCCcCCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCccccc
Q 003287           80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLI  159 (834)
Q Consensus        80 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLp  159 (834)
                      +.|+.+....|.++.||||||+++    +|+|++.+.+.+..++|+++|||||+|.      .+.++|+|-     |   
T Consensus        15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~------~~~~vWss~-----t---   76 (109)
T 3r0e_A           15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG------DGSTVWKSG-----A---   76 (109)
T ss_dssp             TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT------TSCEEEECC-----C---
T ss_pred             CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC------CCCEEEcCC-----C---
Confidence            445555667899999999999985    7999987655567889999999999975      457899761     1   


Q ss_pred             CCccccccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecCCC
Q 003287          160 GMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWN  217 (834)
Q Consensus       160 g~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w~  217 (834)
                                             ....+.|.+.++++|...+  +.  .+.|.+++|-
T Consensus        77 -----------------------~~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~~  107 (109)
T 3r0e_A           77 -----------------------QSVKGNYAAVVHPDGRLVV--FG--PSVFKIDPWV  107 (109)
T ss_dssp             -----------------------CCSSSCCEEEEETTTEEEE--EC--SEEEEECTTS
T ss_pred             -----------------------cCCCcCEEEEEcCCCeEEE--Ee--cCEECCCCcc
Confidence                                   0023568899999986654  44  6899999873

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.02  E-value=6.3e-10  Score=99.74  Aligned_cols=89  Identities=24%  Similarity=0.335  Sum_probs=66.0

Q ss_pred             CCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCccc
Q 003287           85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMG  164 (834)
Q Consensus        85 ~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~  164 (834)
                      +....|.|..||||||++. +.++|++++.+...+..++|+++|||||++.      .+.++|||....           
T Consensus        18 ~g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~------~~~~~W~S~t~~-----------   79 (109)
T 3dzw_A           18 NGRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP------RNNPIWASNTGG-----------   79 (109)
T ss_dssp             ETTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT------TSCEEEECCCCC-----------
T ss_pred             CCCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC------CCCEEEECCCCC-----------
Confidence            3456799999999999987 6899999986554456789999999999985      457899974210           


Q ss_pred             cccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecC
Q 003287          165 WDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (834)
Q Consensus       165 ~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~  215 (834)
                                          ..+.|.+.++.+|...+  ++.  +.|.+|.
T Consensus        80 --------------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~t  106 (109)
T 3dzw_A           80 --------------------ENGNYVCVLQKDRNVVI--YGT--ARWATGT  106 (109)
T ss_dssp             --------------------SSSCEEEEECTTSCEEE--EES--CCCCCCC
T ss_pred             --------------------CCCCEEEEEeCCCEEEE--ECC--CEEeCCC
Confidence                                12467888998887654  332  5565543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.93  E-value=3.7e-09  Score=116.08  Aligned_cols=142  Identities=14%  Similarity=0.239  Sum_probs=108.4

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEEec--ccC-hhhHHHHHHHHHHHhccC--CCceeeEeeeEeec---CeEEEEE
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLS--SQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQ---GEKILIY  588 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~  588 (834)
                      ..+.|+.|.++.||+.+.. +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4578999999999999875 4688899876  322 122356788999999996  45688899888776   4589999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------------------------------------  632 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  632 (834)
                      ||+++..+.+..     ...++..++..++.++++.|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998875422     123678888999999999999999731                                    


Q ss_pred             -------------------CCceEecCCCCCcEEEcCCCC--eeecccccccc
Q 003287          633 -------------------RLRIIHRDLKASNILLDSDMN--PKISDFGMARM  664 (834)
Q Consensus       633 -------------------~~~iiH~DIkp~NILl~~~~~--vkl~DFGla~~  664 (834)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               256999999999999997753  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.73  E-value=3.5e-09  Score=113.47  Aligned_cols=187  Identities=18%  Similarity=0.193  Sum_probs=122.7

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCc--eeeEeeeEeecC---eEEEEEEec
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRN--LVRLMGCCVEQG---EKILIYEYM  591 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~~~~~---~~~lV~Ey~  591 (834)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+.++..+ .+..  +.+++.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999874    56889986532  3456789999999888 3332  444554443333   358899999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS---------------------------------------  632 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  632 (834)
                      ++..|.....     ..++..++..++.++++.|+.||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998865432     23667788888999999999998621                                       


Q ss_pred             ----------------CCceEecCCCCCcEEEcC--CCCeeeccccccccccCCCcccccc------------ccccccc
Q 003287          633 ----------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGDELQGNTK------------RVVGTYG  682 (834)
Q Consensus       633 ----------------~~~iiH~DIkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~~------------~~~gt~~  682 (834)
                                      ...++|+|++|.||++++  ...+.|+||+.+..-..........            ......+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            235899999999999998  4567899999987532211000000            0000001


Q ss_pred             ccC-cccccCCCCCccCCeeeHHHHHHHHhhCCCCC
Q 003287          683 YMS-PEYALDGLFSVKSDVFSFGVLLLETLTSKRNT  717 (834)
Q Consensus       683 y~a-PE~~~~~~~~~ksDVwSlGvil~elltg~~p~  717 (834)
                      ... |+....  .....+.|+++.+++++.+|..++
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 222111  112358899999999999997653

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.71  E-value=7.5e-08  Score=85.36  Aligned_cols=55  Identities=29%  Similarity=0.450  Sum_probs=45.1

Q ss_pred             ceEEEecCCceEEecCCCCeEEeecCCccc-ccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287           88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREV-KNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus        88 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      -+|.+..||||||++. +.+||++|+.... ....+.|.++|||||+|.      .++++|+|
T Consensus        21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~------~~~~vWss   76 (105)
T 4h3o_A           21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS------SGRSLWAS   76 (105)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT------TCCEEEEC
T ss_pred             EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC------CcEEEEEe
Confidence            4589999999999975 5799999985443 345679999999999986      56789986

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.47  E-value=2.8e-07  Score=94.69  Aligned_cols=87  Identities=24%  Similarity=0.327  Sum_probs=66.6

Q ss_pred             CCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCcccc
Q 003287           86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGW  165 (834)
Q Consensus        86 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~  165 (834)
                      ..-+|.++.||+|+|.+++ .++|++++.+......++|+++||||+++.      ++.++||||.+             
T Consensus       150 G~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~------~~~~vw~s~~~-------------  209 (236)
T 1dlp_A          150 SPYRLSMETDCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTN------QNIAVWTSGNS-------------  209 (236)
T ss_dssp             SSCEEEEETTTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEET------TTEEEEECCCC-------------
T ss_pred             CcEEEEECCCCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeC------CCcEEEEeCCC-------------
Confidence            3457999999999999775 689999976544456789999999999974      45799999943             


Q ss_pred             ccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEec
Q 003287          166 DLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTG  214 (834)
Q Consensus       166 ~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g  214 (834)
                                  |      ++|.|.+.++++|..+++  .  ..||.+|
T Consensus       210 ------------~------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg  236 (236)
T 1dlp_A          210 ------------R------SAGRYVFVLQPDRNLAIY--G--GALWTTG  236 (236)
T ss_dssp             ------------C------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred             ------------C------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence                        1      236789999999987764  3  2677654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.32  E-value=2.7e-06  Score=91.02  Aligned_cols=136  Identities=21%  Similarity=0.206  Sum_probs=98.6

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCC---ceeeEeeeEe-ecCeEEEEEEecCC
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR---NLVRLMGCCV-EQGEKILIYEYMPN  593 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~Ey~~~  593 (834)
                      .+.++.|....||+.    ++.++||+-.  .......+.+|+.+|..+.+.   .+.+++.+.. ..+..++|||++++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356888988899988    5678889853  233456789999999999652   3566666664 34567899999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS-----------------------------------------  632 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------------  632 (834)
                      ..|.....     ..++..+...++.++++.|+.||+..                                         
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            98876431     12355566667777777777776532                                         


Q ss_pred             ----------------CCceEecCCCCCcEEEcC---CCCe-eecccccccc
Q 003287          633 ----------------RLRIIHRDLKASNILLDS---DMNP-KISDFGMARM  664 (834)
Q Consensus       633 ----------------~~~iiH~DIkp~NILl~~---~~~v-kl~DFGla~~  664 (834)
                                      +..++|+|+++.|||++.   ++.+ .|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            235799999999999987   4554 8999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.28  E-value=2.6e-06  Score=89.15  Aligned_cols=136  Identities=18%  Similarity=0.183  Sum_probs=99.1

Q ss_pred             ceecccCcc-ceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEEecCCCC
Q 003287          519 CKLGEGGFG-PVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKS  595 (834)
Q Consensus       519 ~~lG~G~fG-~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gs  595 (834)
                      +.+..|..+ .||+.... ++..+++|+-...   ....+.+|+..|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            355666666 58988765 4678999986532   3456788999998884 4457788999999999999999999988


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 003287          596 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY--------------------------------------------  631 (834)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------------  631 (834)
                      +.+....       .......+..++++.|+.||..                                            
T Consensus       107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            7665421       1122345666677777777742                                            


Q ss_pred             -----------CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          632 -----------SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       632 -----------~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                                 ....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       112379999999999999877778999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.20  E-value=3e-06  Score=92.57  Aligned_cols=81  Identities=7%  Similarity=-0.006  Sum_probs=57.8

Q ss_pred             ccee-cccCccceEeeEec-------CCcEEEEEEecccC---hhhHHHHHHHHHHHhccC-C--CceeeEeeeEeec--
Q 003287          518 QCKL-GEGGFGPVYKGKLL-------NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQ-H--RNLVRLMGCCVEQ--  581 (834)
Q Consensus       518 ~~~l-G~G~fG~Vy~~~~~-------~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--  581 (834)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4577 88999999998764       26789999865432   001245678888888884 3  3577788877665  


Q ss_pred             -CeEEEEEEecCCCCchh
Q 003287          582 -GEKILIYEYMPNKSLNF  598 (834)
Q Consensus       582 -~~~~lV~Ey~~~gsL~~  598 (834)
                       +..++||||+++..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35789999999987764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.81  E-value=4.5e-05  Score=84.53  Aligned_cols=75  Identities=9%  Similarity=0.127  Sum_probs=50.2

Q ss_pred             cceecccCccceEeeEec-CCcEEEEEEecccCh-------hhHHHHHHHHHHHhccCC--C-ceeeEeeeEeecCeEEE
Q 003287          518 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQH--R-NLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~~~~~~~~~~~l  586 (834)
                      .+.||.|..+.||+++.. +++.++||.......       ...+++..|++++..+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999764 468899998653211       123456778888887742  3 34455543  4456789


Q ss_pred             EEEecCCC
Q 003287          587 IYEYMPNK  594 (834)
Q Consensus       587 V~Ey~~~g  594 (834)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.77  E-value=0.0002  Score=77.17  Aligned_cols=141  Identities=16%  Similarity=0.180  Sum_probs=81.4

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCC--CceeeEee------eEeecCeEEEEEEe
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMG------CCVEQGEKILIYEY  590 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~------~~~~~~~~~lV~Ey  590 (834)
                      +.|+.|..+.||+....+| .+++|+....    ..++..|+.++..|..  -.+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987554 5899998752    1333445555555521  12333332      12346678999999


Q ss_pred             cCCCCchh-----------h---hcC----C--CC-----CCCCCHHHH-------------------------------
Q 003287          591 MPNKSLNF-----------F---LFD----P--SR-----THLLGWQTR-------------------------------  614 (834)
Q Consensus       591 ~~~gsL~~-----------~---l~~----~--~~-----~~~l~~~~~-------------------------------  614 (834)
                      +++..+..           .   ++.    .  ..     .....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99876531           0   110    0  00     011223211                               


Q ss_pred             HHHHHHHHHHHHHHhh----------cCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          615 VKIIEGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       615 ~~i~~~ia~~L~yLH~----------~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ..+...+.+++++|+.          ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111224446667763          1245699999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.76  E-value=0.00016  Score=77.25  Aligned_cols=139  Identities=20%  Similarity=0.137  Sum_probs=93.5

Q ss_pred             ccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC---CCceeeEeeeEeecCeEEEEEEecCC
Q 003287          517 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      -.+.|+.|....+|+... +++.++||+....   ....+..|+..|+.|.   ...+.+++.++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346799999999999986 5678899987542   3567888999988883   36788888888888899999999999


Q ss_pred             CCchhh-----------hcCCCC-C------------------CCCCHHHHH---HHH----------------HHHHH-
Q 003287          594 KSLNFF-----------LFDPSR-T------------------HLLGWQTRV---KII----------------EGIAQ-  623 (834)
Q Consensus       594 gsL~~~-----------l~~~~~-~------------------~~l~~~~~~---~i~----------------~~ia~-  623 (834)
                      ..+..-           |+.... .                  -.-+|.+..   ++.                ..+++ 
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            875311           111110 0                  012344322   111                11111 


Q ss_pred             HHHHHhh-cCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          624 GLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       624 ~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ....|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1223432 2346799999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.71  E-value=8.1e-05  Score=78.55  Aligned_cols=81  Identities=16%  Similarity=0.210  Sum_probs=60.1

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC-C--CceeeEeeeEeecCeEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H--RNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV~  588 (834)
                      ...+.-.+.+|.|..+.||+.++.+|+.|+||+-..........|..|+..|+.|. .  --+.+++++.    ..++||
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            34566678899999999999999999999999876544444456888999988884 2  2344455432    347899


Q ss_pred             EecCCCCc
Q 003287          589 EYMPNKSL  596 (834)
Q Consensus       589 Ey~~~gsL  596 (834)
                      ||++.+..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.41  E-value=0.00036  Score=77.88  Aligned_cols=77  Identities=9%  Similarity=0.021  Sum_probs=46.7

Q ss_pred             CCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccccccccc--ccccccCcccccCC---CCCccCCeeeHHHHH
Q 003287          633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV--GTYGYMSPEYALDG---LFSVKSDVFSFGVLL  707 (834)
Q Consensus       633 ~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~ksDVwSlGvil  707 (834)
                      ...++|+|+++.|||++.++ ++|+||+.+..-....   ......  -...|++|+.....   .-....++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            45699999999999998876 9999999887531110   000000  12346666655311   112234455777777


Q ss_pred             HHHhhC
Q 003287          708 LETLTS  713 (834)
Q Consensus       708 ~elltg  713 (834)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777664

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.34  E-value=0.00084  Score=71.75  Aligned_cols=158  Identities=15%  Similarity=0.138  Sum_probs=86.9

Q ss_pred             cHHHHHHhccCccc-----cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCc--eeeEee
Q 003287          504 SLASVSAATENFSM-----QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMG  576 (834)
Q Consensus       504 ~~~~~~~~~~~f~~-----~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~  576 (834)
                      +..++.....+|.+     .+.|+.|....+|+....+| .+++|+.....  ..+.+..|+.++..+...+  +.+++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            33444444444543     34577788899999987655 68899886521  1234556777777663212  333332


Q ss_pred             e------EeecCeEEEEEEecCCCCchhh--------------hcC------CCCCCCC---CHHHHHH-----------
Q 003287          577 C------CVEQGEKILIYEYMPNKSLNFF--------------LFD------PSRTHLL---GWQTRVK-----------  616 (834)
Q Consensus       577 ~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~------~~~~~~l---~~~~~~~-----------  616 (834)
                      .      ....+..+++++|+++..+...              ++.      .......   .|.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      1234567899999998765321              110      0000001   1222110           


Q ss_pred             -HHHHHHHHHHHHhhc----CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          617 -IIEGIAQGLLYLHQY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       617 -i~~~ia~~L~yLH~~----~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                       +...+.+.++.++..    .+..++|+|+++.|||++.+..+.|+||+.+..
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             011234455555532    234699999999999999876668999998753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.08  E-value=0.0016  Score=71.21  Aligned_cols=141  Identities=21%  Similarity=0.245  Sum_probs=84.1

Q ss_pred             ceecccCccceEeeEec--------CCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEE
Q 003287          519 CKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.|. +.-..++++++.++    +|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            56777888899998864        2578999986432 223456678999998884 33235666665442    9999


Q ss_pred             ecCCCCchhh-h----------------cCC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 003287          590 YMPNKSLNFF-L----------------FDP--SRTHLLG--WQTRVKIIEGIAQ-------------------GLLYL-  628 (834)
Q Consensus       590 y~~~gsL~~~-l----------------~~~--~~~~~l~--~~~~~~i~~~ia~-------------------~L~yL-  628 (834)
                      |+++..|..- +                +..  ...+...  +.++.++..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998766421 1                111  0111122  3444444443321                   22333 


Q ss_pred             ---hhc-CCCceEecCCCCCcEEEcCC----CCeeecccccccc
Q 003287          629 ---HQY-SRLRIIHRDLKASNILLDSD----MNPKISDFGMARM  664 (834)
Q Consensus       629 ---H~~-~~~~iiH~DIkp~NILl~~~----~~vkl~DFGla~~  664 (834)
                         ... .+..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               222 23468999999999999876    7899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.08  E-value=0.0011  Score=70.09  Aligned_cols=128  Identities=15%  Similarity=0.159  Sum_probs=76.0

Q ss_pred             cceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCce-eeEeeeEeecCeEEEEEEec-CCCC
Q 003287          518 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYM-PNKS  595 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~-~~gs  595 (834)
                      .+.|+.|....+|+.     +.+++|+........ ....+|+.++..+...++ .+++++  +.+.-++++||+ ++..
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            578999999999998     568889876532211 123567777777743222 455544  344457899999 6555


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------------
Q 003287          596 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ---------------------------------------------  630 (834)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~---------------------------------------------  630 (834)
                      |......          .+..++.++++.|+-||+                                             
T Consensus        95 l~~~~~~----------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  164 (301)
T 3dxq_A           95 MSPEKFK----------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS  164 (301)
T ss_dssp             CCHHHHH----------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred             CCHhhHh----------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence            5321000          000112222222222222                                             


Q ss_pred             -----cCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          631 -----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       631 -----~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                           ..+..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                 12345899999999999 6677889999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.03  E-value=0.0012  Score=73.74  Aligned_cols=73  Identities=18%  Similarity=0.272  Sum_probs=50.3

Q ss_pred             cceecccCccceEeeEecC--------CcEEEEEEecccChhhHHHHHHHHHHHhccCCCce-eeEeeeEeecCeEEEEE
Q 003287          518 QCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIY  588 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  588 (834)
                      .+.|+.|....+|+....+        ++.+++|+.....  ..+.+..|+.++..+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3578889899999998753        5789999884321  12455578888888843333 566665543    2899


Q ss_pred             EecCCCCc
Q 003287          589 EYMPNKSL  596 (834)
Q Consensus       589 Ey~~~gsL  596 (834)
                      ||+++..|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.01  E-value=0.005  Score=65.83  Aligned_cols=142  Identities=15%  Similarity=0.150  Sum_probs=82.9

Q ss_pred             ceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCC--CceeeEeee-----EeecCeEEEEEEec
Q 003287          519 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGC-----CVEQGEKILIYEYM  591 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~-----~~~~~~~~lV~Ey~  591 (834)
                      +.|+ |....||+....+|+.+++|+..... ...+.+..|..++..+..  -.+++++..     ....+..+++||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889999887778789999986431 123556678888777742  224444443     22345668899999


Q ss_pred             CCCCchh----h----------hc----CC--CCCCCCCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 003287          592 PNKSLNF----F----------LF----DP--SRTHLLGWQTR----VKI---------------IEGIAQGLLYLHQY-  631 (834)
Q Consensus       592 ~~gsL~~----~----------l~----~~--~~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~-  631 (834)
                      ++..+..    .          ++    ..  .......+...    ..+               ...+.+.++.+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            9865431    0          01    00  00111222111    001               11111223333221 


Q ss_pred             ---CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          632 ---SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       632 ---~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                         .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234689999999999999 4 899999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.00  E-value=0.0027  Score=71.37  Aligned_cols=75  Identities=13%  Similarity=0.090  Sum_probs=49.1

Q ss_pred             cceecccCccceEeeEecC-CcEEEEEEecccChhhHHHHHHHHHHHhccCCCce-eeEeeeEeecCeEEEEEEecCCCC
Q 003287          518 QCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKS  595 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gs  595 (834)
                      .+.|+.|-...+|+....+ ++.+++|+........ ....+|+.++..|...++ .++++++.  +  .+||||+++..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3578889999999998865 5789999875432221 112578888888864444 56777663  2  25999999865


Q ss_pred             ch
Q 003287          596 LN  597 (834)
Q Consensus       596 L~  597 (834)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.95  E-value=0.0027  Score=68.25  Aligned_cols=141  Identities=14%  Similarity=0.147  Sum_probs=72.1

Q ss_pred             ceecccCccc-eEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCC--CceeeEeeeEeecCeEEEEEEecCCCC
Q 003287          519 CKLGEGGFGP-VYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKILIYEYMPNKS  595 (834)
Q Consensus       519 ~~lG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gs  595 (834)
                      +.|+.|.... +|+....+++.+++|.......   +.+..|+.++..+..  -.+.+++.+..+.+  +++||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3565554444 6677654467788886543221   223456666666632  23556666543333  78999997766


Q ss_pred             chhhhcC---------------------CCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 003287          596 LNFFLFD---------------------PSR--THLLGWQTRV-------K-------------IIEGIAQGLLYLH---  629 (834)
Q Consensus       596 L~~~l~~---------------------~~~--~~~l~~~~~~-------~-------------i~~~ia~~L~yLH---  629 (834)
                      +.+.+..                     ...  ...+......       .             ....+.+.++.|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            5433211                     000  0111111100       0             0011112222221   


Q ss_pred             hcCCCceEecCCCCCcEEEcCC----CCeeecccccccc
Q 003287          630 QYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM  664 (834)
Q Consensus       630 ~~~~~~iiH~DIkp~NILl~~~----~~vkl~DFGla~~  664 (834)
                      ...+..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1124569999999999999875    6789999998865

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.51  E-value=0.0029  Score=69.09  Aligned_cols=73  Identities=12%  Similarity=0.120  Sum_probs=44.5

Q ss_pred             ceecccCccceEeeEecC---------CcEEEEEEecccChhhHHHHHHHHHHHhccCCCc-eeeEeeeEeecCeEEEEE
Q 003287          519 CKLGEGGFGPVYKGKLLN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~  588 (834)
                      +.|+.|..-.+|+....+         ++.+++|+....... ......|..++..+...+ +.++++..  .  -.+||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            567888888999998654         268899987543222 122356888888774333 34566543  2  36899


Q ss_pred             EecCCCCc
Q 003287          589 EYMPNKSL  596 (834)
Q Consensus       589 Ey~~~gsL  596 (834)
                      ||+++..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.42  E-value=0.015  Score=62.59  Aligned_cols=32  Identities=22%  Similarity=0.415  Sum_probs=28.2

Q ss_pred             CCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          633 RLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       633 ~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35699999999999999888899999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.45  E-value=0.011  Score=58.49  Aligned_cols=102  Identities=13%  Similarity=0.027  Sum_probs=64.4

Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcccc
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  673 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  673 (834)
                      -+|.++|.  ....++++++++.++.|.+++|.-+-... .+ ..+=+.|..|++..+|.|.+.+ ..+.          
T Consensus        33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            36777774  24568999999999999999987762211 01 1233446899999999998764 1111          


Q ss_pred             cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCC
Q 003287          674 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR  715 (834)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~  715 (834)
                          .....+.|||... ...+.+.=|||||+++|..+--..
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence                1233466888653 345677889999999999886443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.44  E-value=0.02  Score=63.50  Aligned_cols=141  Identities=14%  Similarity=0.152  Sum_probs=84.2

Q ss_pred             cceecccCccceEeeEecC--------CcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEE
Q 003287          518 QCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++.|..|-...+|+....+        ++.+++|+....... .....+|..+++.+. +.-..++++.+  .  -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3567788889999998753        578999987543322 122356888887774 32244555433  2  27899


Q ss_pred             EecCCCCchhh-h----------------cC--C-----C---CCCCCCHHHHHHHHHHH-------------------H
Q 003287          589 EYMPNKSLNFF-L----------------FD--P-----S---RTHLLGWQTRVKIIEGI-------------------A  622 (834)
Q Consensus       589 Ey~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a  622 (834)
                      ||+++..|..- +                +.  .     .   .....-+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998765321 0                00  0     0   01111233333333222                   1


Q ss_pred             HHHHHHh---------------------hcCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          623 QGLLYLH---------------------QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       623 ~~L~yLH---------------------~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      +.+..|.                     ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2223332                     112346899999999999 8888999999998864

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.41  E-value=0.31  Score=34.83  Aligned_cols=17  Identities=29%  Similarity=0.182  Sum_probs=7.7

Q ss_pred             HHHHHHHHHHHhhcccc
Q 003287          440 ALLPGFFIFCRWRRKHK  456 (834)
Q Consensus       440 ~~l~~~~~~~~~rr~~~  456 (834)
                      ++++++.+++++||++.
T Consensus        24 ~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           24 LLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHhhhhHh
Confidence            33444444445555444

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.34  E-value=0.37  Score=52.88  Aligned_cols=30  Identities=27%  Similarity=0.388  Sum_probs=25.5

Q ss_pred             ceEecCCCCCcEEE------cCCCCeeecccccccc
Q 003287          635 RIIHRDLKASNILL------DSDMNPKISDFGMARM  664 (834)
Q Consensus       635 ~iiH~DIkp~NILl------~~~~~vkl~DFGla~~  664 (834)
                      .++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998864

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.75  E-value=0.51  Score=33.60  Aligned_cols=18  Identities=22%  Similarity=0.257  Sum_probs=8.4

Q ss_pred             HHHHHHHHHHHhhccccC
Q 003287          440 ALLPGFFIFCRWRRKHKE  457 (834)
Q Consensus       440 ~~l~~~~~~~~~rr~~~~  457 (834)
                      ++++++.+++++||++.+
T Consensus        23 v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           23 LVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHhhhhhhh
Confidence            334444444555555443

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=89.48  E-value=14  Score=37.61  Aligned_cols=73  Identities=11%  Similarity=0.212  Sum_probs=44.7

Q ss_pred             EEEEEeecCCeeEEeeCCCCC--C----cCCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEec
Q 003287           62 LGIWYKQVPDTVVWVANRNSP--I----VDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK  135 (834)
Q Consensus        62 ~~iw~~~~~~~~vW~anr~~p--~----~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~  135 (834)
                      +.|| +.-..+++|...+..+  +    ...++.+-++.++.+..+|.+|.++|.-..........+..+.+||+++-+.
T Consensus        17 v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~   95 (276)
T 3no2_A           17 IAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC   95 (276)
T ss_dssp             EEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred             EEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence            4454 2225688898877541  1    1234445556666677778889999988763211222356778888888764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=83.58  E-value=1.4  Score=31.34  Aligned_cols=13  Identities=15%  Similarity=0.169  Sum_probs=4.9

Q ss_pred             HHHHHHHHhhccc
Q 003287          443 PGFFIFCRWRRKH  455 (834)
Q Consensus       443 ~~~~~~~~~rr~~  455 (834)
                      +++.+++++||++
T Consensus        27 ~~l~~~~~~RRR~   39 (44)
T 2jwa_A           27 LGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHHHC
T ss_pred             HHHHHHhheehhh
Confidence            3333333334333

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.71  E-value=0.24  Score=55.50  Aligned_cols=61  Identities=11%  Similarity=0.108  Sum_probs=18.6

Q ss_pred             ccceecccCccceEeeEecC-CcEEEE------EEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee
Q 003287          517 MQCKLGEGGFGPVYKGKLLN-GQEVAV------KRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  580 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~~-g~~vAV------K~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  580 (834)
                      +.++||   ||.||+|.+.. ..+|||      |..+..  ..+....|.+|..++..++|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            445676   99999999864 467888      766542  22334568889999999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	834
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-70
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-26
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-21
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	2e-14
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	3e-14
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	3e-14
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	1e-07
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	1e-12
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	3e-08

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 9e-70
 Identities = 71/284 (25%), Positives = 126/284 (44%), Gaps = 19/284 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
              ++  ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
             MG      +  ++ ++    SL   L              + I    AQG+ YLH   
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-- 690
              IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 691 -DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 749
               +S +SDV++FG++L E +T +         + N       +         LS    
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 793
           +            +   C+++K  +RP   ++++ I     +LP
Sbjct: 237 N-----CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 2e-66
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 25/275 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
              +   ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L G C+EQ    L++E+M +  L    +  ++  L   +T + +   + +G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
              +IHRDL A N L+  +   K+SDFGM R    D+   ++        + SPE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 693 LFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
            +S KSDV+SFGVL+ E  +  +       + E    +   + L+K      L S  +  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP----RLASTHVYQ 233

Query: 751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
                       +   C +E+  DRP  S+++  +
Sbjct: 234 ------------IMNHCWKERPEDRPAFSRLLRQL 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 9e-66
 Identities = 87/273 (31%), Positives = 130/273 (47%), Gaps = 21/273 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           RL      Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ +  
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E             + +PE    G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            F++KSDV+SFG+LL E +T  R         +  + +   +    R Y ++ P    E 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
            YQ       +  LC +E+  DRPT   + S++
Sbjct: 239 LYQ-------LMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 5e-64
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 21/275 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           ++ +   +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L G C +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
             + +HRDL A N L++     K+SDFG++R    DE   +         +  PE  +  
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176

Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            FS KSD+++FGVL+ E  +  +                +  + ++   E ++  L+   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 222

Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            +    +  T+   C  EKA +RPT   ++S I +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 2e-62
 Identities = 64/291 (21%), Positives = 117/291 (40%), Gaps = 29/291 (9%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 579
            +G+G FG V++GK   G+EVAVK  SS+  +     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67

Query: 580 EQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ----- 630
           +         L+ +Y  + SL  +L      + +  +  +K+    A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSPEY 688
             +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM+PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 689 ALDGL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-----NLLGHAWNLWKD 737
             D +         ++D+++ G++  E        G+++              +    + 
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 738 NRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
               + L P +     S + L     +   C     A R T  ++   ++ 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 2e-62
 Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 21/285 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 573 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
           +L      +    ++ EYM   SL  FL   +  +L      V +   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132

Query: 633 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 692
               +HRDL+A+NIL+  ++  K++DFG+AR+   +E             + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 693 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 752
            F++KSDV+SFG+LL E  T  R                +    +    + +    +   
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPC 235

Query: 753 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQ 797
             +       +   C +++  +RPT   + + + +   +     Q
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 4e-62
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQH 568
             ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
             +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
               + +I+HRD+K SNIL++S    K+ DFG++       +       VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR 715
                +SV+SD++S G+ L+E    + 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 5e-62
 Identities = 70/274 (25%), Positives = 116/274 (42%), Gaps = 27/274 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +   +   +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 573 RLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           +L+G  VE+   + ++ EYM   SL  +L    R+ +LG    +K    + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
                +HRDL A N+L+  D   K+SDFG+ +     E             + +PE   +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             FS KSDV+SFG+LL E  +  R                +           +    + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKDVVPRVEKGYKMD 220

Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
           A          V   C    AA RP+  ++   +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (527), Expect = 2e-61
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 21/274 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
            + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V+L+G C  +    +I E+M   +L  +L + +R   +     + +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132

Query: 632 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
            +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             FS+KSDV++FGVLL E  T   +               +     ++ YELL    + E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRME 236

Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
                  +   +   C Q   +DRP+ +++    
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (525), Expect = 5e-61
 Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 36/300 (12%)

Query: 503 FSLASVSAATENFS---------MQCKLGEGGFGPVYKGKLL----NGQEVAVKRL-SSQ 548
           F+    + A   F+         ++  +G G FG V  G L         VA+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 549 SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL 608
           + +  ++F +E  ++ +  H N++ L G   +    ++I E+M N SL+ FL        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 609 LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 668
                 V ++ GIA G+ YL        +HRDL A NIL++S++  K+SDFG++R    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 669 ELQGNTKRVVG---TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF 725
                    +G      + +PE      F+  SDV+S+G+++ E ++             
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 726 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
                 +    +      +    +        +    + L C Q+    RP   ++V+ +
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 4e-59
 Identities = 64/296 (21%), Positives = 116/296 (39%), Gaps = 26/296 (8%)

Query: 511 ATENFSMQ-CKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 565
             +N  +   +LG G FG V +G         +VA+K L   + +   +E   E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L +  +VRL+G C +    +L+ E      L+ FL        +      +++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYM 684
            YL +      +HRDL A N+LL +    KISDFG+++    D+     +        + 
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 744
           +PE      FS +SDV+S+GV + E L+  +                +   K       +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFI 225

Query: 745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAF 800
               + E   +       +   C   K  DRP    V   +   + +L    +   
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-58
 Identities = 78/275 (28%), Positives = 122/275 (44%), Gaps = 27/275 (9%)

Query: 520 KLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
            +G G FG VY G LL+        AVK L+  +  G + +F  E +++    H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 575 MGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           +G C+  +G  +++  YM +  L    F  + TH    +  +     +A+G+      + 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALD 691
            + +HRDL A N +LD     K++DFG+AR     E      +        +M+ E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             F+ KSDV+SFGVLL E +T             N       L +  R   LL P    +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRR---LLQPEYCPD 261

Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
             Y+       V L C   KA  RP+ S++VS I+
Sbjct: 262 PLYE-------VMLKCWHPKAEMRPSFSELVSRIS 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (507), Expect = 2e-58
 Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 45/301 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGL-KEFKNEMMLIAK 565
            N      +GEG FG V++ +            VAVK L  ++   +  +F+ E  L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL----------------- 608
             + N+V+L+G C       L++EYM    LN FL   S   +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 609 ----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
               L    ++ I   +A G+ YL +    + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES 724
               +             +M PE      ++ +SDV+++GV+L E  +            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------P 242

Query: 725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 784
           +  + H   ++       L  P                +  LC  +  ADRP+   +  +
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPE-------NCPLELYNLMRLCWSKLPADRPSFCSIHRI 295

Query: 785 I 785
           +
Sbjct: 296 L 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 3e-58
 Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 27/274 (9%)

Query: 520 KLGEGGFGPVYKGKLLN---GQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQHRNLVRL 574
           +LG G FG V KG        + VAVK L +++       E   E  ++ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 575 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
           +G C E    +L+ E      LN +L        +  +  ++++  ++ G+ YL +    
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126

Query: 635 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK-RVVGTYGYMSPEYALDGL 693
             +HRDL A N+LL +    KISDFG+++    DE     +        + +PE      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 694 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 753
           FS KSDV+SFGVL+ E  +  +                +   K +    +L    +    
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERMGCP 232

Query: 754 YQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                    +  LC      +RP  + V   + N
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-58
 Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 22/274 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 570
           E++ +   LGEG +G V         + VAVK +   ++    +  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+  G   E   + L  EY     L   +        +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
              + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 691 DGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 749
              F +   DV+S G++L   L      G    +  +     ++ WK+ + Y      + 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAML-----AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS 783
                 +L++        + E  + R T+  +  
Sbjct: 234 SAP-LALLHK-------ILVENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-58
 Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 39/299 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 565
              S    LG G FG V +              VAVK L   +     +   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL---------------L 609
           L  H N+V L+G C   G  ++I EY     L  FL     + +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
             +  +     +A+G+ +L        IHRDL A NILL      KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 729
                        +M+PE   + +++ +SDV+S+G+ L E  +   +             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 788
               +  D++ Y+++    +  +          +   C       RPT  ++V +I  +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 8e-58
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 25/278 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 569
           E++ +   +G G +G   K +   +G+ +  K L   S +    +   +E+ L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 570 NLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLL 626
           N+VR     +++    L  + EY     L   +   ++    L  +  ++++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 627 YLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
             H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   D      K  VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 744
           SPE      ++ KSD++S G LL E          +   S   L       K  R     
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 782
           S  L              +    +  K   RP++ +++
Sbjct: 239 SDELNE------------IITRMLNLKDYHRPSVEEIL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 1e-57
 Identities = 68/304 (22%), Positives = 117/304 (38%), Gaps = 44/304 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 565
           EN      LG G FG V               +VAVK L  ++     +   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 566 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--------------------PS 604
           L  H N+V L+G C   G   LI+EY     L  +L                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 605 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 664
             ++L ++  +     +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES 724
              D              +M+PE   +G++++KSDV+S+G+LL E  +   N        
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------- 265

Query: 725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 784
                    +  D   Y+L+    + +  +        +   C    +  RP+   + S 
Sbjct: 266 -----PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 785 ITNE 788
           +  +
Sbjct: 321 LGCQ 324

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (501), Expect = 2e-57
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 33/279 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 567
            + FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H N ++  GC + +    L+ EY    + +           L       +  G  QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      +IHRD+KA NILL      K+ DFG A +             VGT  +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPE 181

Query: 688 YAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 744
             L   +G +  K DV+S G+  +E            + + N +   +++ ++      L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA-----ERKPPLFNMNAMSALYHIAQNE--SPAL 234

Query: 745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS 783
                 E     ++        C+Q+   DRPT   ++ 
Sbjct: 235 QSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-57
 Identities = 62/276 (22%), Positives = 123/276 (44%), Gaps = 26/276 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 570
            + + +  +LG+G FG VYK +        A K + ++S + L+++  E+ ++A   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L+     +    ++ E+    +++  + +  R   L       + +     L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               +IIHRDLKA NIL   D + K++DFG++        + ++   +GT  +M+PE  +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 691 -----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
                D  +  K+DV+S G+ L+E    +     +++    +L         +    L  
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP--PHHELNPMRVL----LKIAKSEPPTLAQ 237

Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           P+         L +       C+++    R T S++
Sbjct: 238 PSRWSSNFKDFLKK-------CLEKNVDARWTTSQL 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-57
 Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 26/279 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLS-SQSGQGLKEFKNEMMLIAKL 566
             F     LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            + ++ RL+G C+      LI + MP   L  ++ +       G Q  +     IA+G+ 
Sbjct: 69  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMN 125

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
           YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ 
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 746
           E  L  +++ +SDV+S+GV + E +T                   ++    +    +L  
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEK 228

Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
             +             + + C    A  RP   +++   
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 5e-57
 Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 26/280 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSGQG-LKEFKNEMMLIAKL 566
              + Q  +G G FG VYKG L          VA+K L +   +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 567 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
            H N++RL G   +    ++I EYM N +     F   +         V ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 627 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMS 685
           YL     +  +HRDL A NIL++S++  K+SDFG++R+   D     T         + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 686 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 745
           PE      F+  SDV+SFG+++ E +T                   +    ++   + ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKAIN 227

Query: 746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
              +        +    + + C Q++ A RP  + +VS++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 4e-56
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 38/291 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLS-SQSGQGLKEFKNEMMLIAKL-Q 567
            +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQTR 614
           H N++ L+G C  +G   L  EY P+ +L  FL                S    L  Q  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 615 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 674
           +     +A+G+ YL Q    + IHRDL A NIL+  +   KI+DFG++R           
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 675 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 734
                   +M+ E     +++  SDV+S+GVLL E ++                   +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------------TPYCG 229

Query: 735 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
                 YE L    + E      +    +   C +EK  +RP+ ++++  +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 30/272 (11%)

Query: 520 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG 576
           ++G G F  VYKG       EVA   L  +  +    + FK E  ++  LQH N+VR   
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 577 CCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 632
                 +     +L+ E M + +L  +L    R  ++  +        I +GL +LH  +
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 633 RLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
              IIHRDLK  NI +     + KI D G+A +          K V+GT  +M+PE   +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 751
             +    DV++FG+ +LE  TS+         +  +     +  K     ++  P ++  
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPASFDKVAIPEVKE- 244

Query: 752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS 783
                      +   C+++   +R ++  +++
Sbjct: 245 -----------IIEGCIRQNKDERYSIKDLLN 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 3e-55
 Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 33/304 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLS-SQSGQGLKEFKNEMMLIAK 565
           E  +M  +LG+G FG VY+G             VA+K ++ + S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLF-------DPSRTHLLGWQTRVKII 618
               ++VRL+G   +    ++I E M    L  +L        +            +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 619 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 678
             IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 679 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN 738
               +MSPE   DG+F+  SDV+SFGV+L E  T                   +    + 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNE 242

Query: 739 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQS 798
           +    +      +      +    +  +C Q     RP+  +++S I  E    P  ++ 
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREV 300

Query: 799 AFSY 802
           +F Y
Sbjct: 301 SFYY 304

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-55
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 30/275 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 568
           E+F +   LG+G FG VY  +   +   +A+K L     +      + + E+ + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
            N++RL G   +     LI EY P  ++   L   S+      Q     I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H     R+IHRD+K  N+LL S    KI+DFG +              + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
               +   K D++S GVL  E L  K     ++  ++         +K     E   P  
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQ------ETYKRISRVEFTFPDF 226

Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS 783
             E +  +++R        ++   + RP + +V+ 
Sbjct: 227 VTEGARDLISR-------LLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-55
 Identities = 65/279 (23%), Positives = 122/279 (43%), Gaps = 23/279 (8%)

Query: 504 SLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 563 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 622
           + + ++ N+V  +   +   E  ++ EY+   SL   + +              +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECL 126

Query: 623 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 682
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG       +  Q     +VGT  
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE 742
           +M+PE      +  K D++S G++ +E +      G     + N L   + +  +    E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMI-----EGEPPYLNENPLRALYLIATNGT-PE 235

Query: 743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           L +P          LNR       C+      R +  ++
Sbjct: 236 LQNPEKLSAIFRDFLNR-------CLDMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-54
 Identities = 74/283 (26%), Positives = 108/283 (38%), Gaps = 29/283 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAK 565
           ++  +  KLG+G FG V +G+          VAVK L        + + +F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           L HRNL+RL G         ++ E  P  SL                T  +    +A+G+
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-NTKRVVGTYGYM 684
            YL      R IHRDL A N+LL +    KI DFG+ R    ++      +     + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK-DNRAYEL 743
           +PE      FS  SD + FGV L E  T  +       E +  L  +  L K D     L
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-------EPWIGLNGSQILHKIDKEGERL 234

Query: 744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 786
             P                V + C   K  DRPT   +   + 
Sbjct: 235 PRPE-------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-52
 Identities = 58/280 (20%), Positives = 109/280 (38%), Gaps = 26/280 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQ 567
           E   +   +GEG FG V++G  ++       VA+K   + +   ++E F  E + + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H ++V+L+G   E     +I E      L    F   R + L   + +     ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           L      R +HRD+ A N+L+ S+   K+ DFG++R            +      +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 747
                 F+  SDV+ FGV + E L                    +   K+N     +   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV--------------KPFQGVKNNDVIGRIENG 225

Query: 748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
            +            ++   C     + RP  +++ + ++ 
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-51
 Identities = 69/297 (23%), Positives = 113/297 (38%), Gaps = 38/297 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 564
           +   +   LG G FG V +            + VAVK L   +     +   +E+ +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 565 KLQHRNLVRLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHL-------------LG 610
              H N+V L+G C + G  +++  E+    +L+ +L       +             L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 611 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 670
            +  +     +A+G+ +L      + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 671 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 730
                       +M+PE   D +++++SDV+SFGVLL E  +              +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEE 245

Query: 731 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
                K+                           L C   + + RPT S++V  + N
Sbjct: 246 FCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-51
 Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 40/296 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLI 563
           +   +   LGEG FG V   + +           +VAVK L S  + + L +  +EM ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 564 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------------L 609
             + +H+N++ L+G C + G   +I EY    +L  +L       L             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 610 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 669
             +  V     +A+G+ YL      + IHRDL A N+L+  D   KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 729
               T        +M+PE   D +++ +SDV+SFGVLL E  T                 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-------------- 235

Query: 730 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 785
             +        ++LL    + +      N    +   C     + RPT  ++V  +
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-50
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 10/207 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   + L   +E A+K L          +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
              V+L     +  +      Y  N  L  ++                    I   L YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
           H      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT  Y+SPE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR 715
             +      SD+++ G ++ + +    
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP 208

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (447), Expect = 1e-49
 Identities = 56/273 (20%), Positives = 110/273 (40%), Gaps = 25/273 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           +++ +  +LG G FG V++      G   A K + +      +  + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           V L     +  E ++IYE+M    L   + D      +     V+ +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141

Query: 632 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
                +H DLK  NI+  +  +   K+ DFG+       +   + K   GT  + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
                   +D++S GVL    L+      G  D E+   +  + +   D+ A+  +S   
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSGISEDG 256

Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           +       + +        +      R T+ + 
Sbjct: 257 KD-----FIRK-------LLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (436), Expect = 5e-48
 Identities = 62/315 (19%), Positives = 125/315 (39%), Gaps = 28/315 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           + + +  +LG G FG V++      G+    K +++         KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           + L     ++ E +LI E++    L   +   +  + +     +  +    +GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 632 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               I+H D+K  NI+ ++      KI DFG+A     DE+    K    T  + +PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 748
                   +D+++ GVL    L+      G  D+E+   +    +   D  A+  +SP  
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-DWEFDEDAFSSVSPEA 259

Query: 749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEHATLP-YPKQSAFSYARR 805
           +       +          +Q++   R T+   +    +  +H+ L      S ++  R+
Sbjct: 260 K-----DFIKN-------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307

Query: 806 GEKISFLPSSRVSEA 820
             K  +        A
Sbjct: 308 KIKEKYADWPAPQPA 322

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (410), Expect = 6e-45
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 568
           ++F +   LG G FG V+  +   NG+  A+K L        + ++   +E ++++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
             ++R+ G   +  +  +I +Y+        LF   R          K     A+  L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY--AAEVCLAL 117

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
                  II+RDLK  NILLD + + KI+DFG A+      +   T  + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR 715
                ++   D +SFG+L+ E L    
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (405), Expect = 1e-44
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 15/213 (7%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  + L   ++VAVK L    ++       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 568 HRNLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           H  +V +      +        ++ EY+   +L   +        +  +  +++I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYG 682
            L + H   +  IIHRD+K +NI++ +    K+ DFG+AR           T  V+GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 683 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 715
           Y+SPE A       +SDV+S G +L E LT + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (409), Expect = 3e-44
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 18/210 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNE---MMLIAK 565
            +FS+   +G GGFG VY  +    G+  A+K L  +     QG     NE   + L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
                +V +        +   I + M    L++ L                    I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
            ++H      +++RDLK +NILLD   + +ISD G+A  F   +        VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 686 PEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
           PE    G+ +   +D FS G +L + L   
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 4e-44
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 7/207 (3%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 569
              ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N++ +         + +   Y+    +   L+   +T  L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEY 688
                 ++HRDLK SN+LL++  + KI DFG+AR+   D          V T  Y +PE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 689 ALDGLFSVKS-DVFSFGVLLLETLTSK 714
            L+     KS D++S G +L E L+++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 24/277 (8%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           K+G G FG +Y G  +  G+EVA+K    ++     +   E  +   +Q    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 579 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 638
             +G+  ++   +   SL       SR      +T + + + +   + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 639 RDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGN-----TKRVVGTYGYMSPEYAL 690
           RD+K  N L           I DFG+A+ +       +      K + GT  Y S    L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 691 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 750
               S + D+ S G +L+               +        +  K +   E+L      
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246

Query: 751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           E     LN        C   +  D+P  S +  +  N
Sbjct: 247 EF-ATYLNF-------CRSLRFDDKPDYSYLRQLFRN 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-43
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 12/206 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
           E + +   LG G FG V++     + +    K +  + G      K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           + L        E ++I+E++    +   +   +    L  +  V  +  + + L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 632 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
               I H D++  NI+  +  +   KI +FG AR     +   N + +     Y +PE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVH 175

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR 715
              + S  +D++S G L+   L+   
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN 201

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-43
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 13/208 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKLQ 567
           E+F +   LG+G FG V+  +     Q  A+K L         + +     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 568 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
           H  L  +      +     + EY+    L + +    +               I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           LH      I++RDLK  NILLD D + KI+DFGM +     + + NT    GT  Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 688 YALDGLFSVKSDVFSFGVLLLETLTSKR 715
             L   ++   D +SFGVLL E L  + 
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 42/288 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--------SSQSGQGLKE-FKNEMML 562
           EN+  +  LG G    V +       +E AVK +        S++  Q L+E    E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 563 IAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           + K+  H N+++L           L+++ M    L  +L   +    L  +   KI+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 681
            + +  LH   +L I+HRDLK  NILLD DMN K++DFG +      E     + V GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173

Query: 682 GYMSPEYALDGL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW 735
            Y++PE     +      +  + D++S GV++   L      G         +     + 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-----AGSPPFWHRKQMLMLRMIM 228

Query: 736 KDNRAYELLSPALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKV 781
             N  Y+  SP      +    +++R        +  +   R T  + 
Sbjct: 229 SGN--YQFGSPEWDDYSDTVKDLVSR-------FLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 4e-42
 Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 26/275 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 569
            + +  +  LG G F  V   +     + VA+K ++ ++ +G     +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V L       G   LI + +    L   + +         +   ++I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124

Query: 630 QYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 686
                 I+HRDLK  N+L    D D    ISDFG+++M     +        GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178

Query: 687 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 746
           E      +S   D +S GV+    L      G       N       + K    ++    
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILL-----CGYPPFYDENDAKLFEQILKAEYEFDSPYW 233

Query: 747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
               +++   +          +++    R T  + 
Sbjct: 234 DDISDSAKDFIRH-------LMEKDPEKRFTCEQA 261

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (387), Expect = 5e-42
 Identities = 51/286 (17%), Positives = 100/286 (34%), Gaps = 26/286 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 571
            ++ +  ++GEG FG +++G  LLN Q+VA+K    +S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 572 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 631
           +  +    ++G   ++   +   SL   L    R      +T     + +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE- 119

Query: 632 SRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQGN-----TKRVVGTY 681
               +++RD+K  N L+    +       + DFGM + +     + +      K + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 741
            YMS    L    S + D+ + G + +  L             +  L  A N  K  R  
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--------WQGLKAATNKQKYERIG 229

Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 787
           E        E        +               P    +  + + 
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 6e-42
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 9/206 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+V+L+     + +  L++E++      F   D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++++   K++DFG+AR   G  ++  T  VV  +        
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR 715
               +S   D++S G +  E +T + 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-41
 Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 27/292 (9%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQSGQG--LKEFKNE---MMLI 563
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+         E   +  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 564 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN---FFLFDPSRTHLLGWQTRVKIIEG 620
              +H N+VRL   C            +  + ++       D      +  +T   ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 680
           + +GL +LH     R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178

Query: 681 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFNLLGHAWNL----- 734
             Y +PE  L   ++   D++S G +  E    K    G  D++    +     L     
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 735 WKDNRAYELLSPALQHEASYQMLNRYITVALL-----CVQEKAADRPTMSKV 781
           W  + A    +   +     +     I          C+    A R +    
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 15/202 (7%)

Query: 520 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQHRNLVR 573
            LGEG F  VYK +  N  Q VA+K++        K+        E+ L+ +L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 574 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 633
           L+     +    L++++M              + +L        +    QGL YLHQ+  
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 634 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-G 692
             I+HRDLK +N+LLD +   K++DFG+A+ F            V T  Y +PE      
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176

Query: 693 LFSVKSDVFSFGVLLLETLTSK 714
           ++ V  D+++ G +L E L   
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 11/205 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K  RL  +          E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 571 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 630
           +V+L      +   +L++E++                 L   T    +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118

Query: 631 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFG+AR F            + T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173

Query: 691 -DGLFSVKSDVFSFGVLLLETLTSK 714
               +S   D++S G +  E +   
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 4e-39
 Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 32/280 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL------SSQSGQGLKEFKNEMMLIAK 565
           + +    +LG G F  V K +    G + A K +      SS+ G   ++ + E+ ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 566 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
           +QH N++ L      + + ILI E +    L  FL +      L  +   + ++ I  G 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGTY 681
             ++    L+I H DLK  NI+L     P    KI DFG+A            K + GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 682 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 741
            +++PE        +++D++S GV+    L     +G              N+   N  +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILL-----SGASPFLGDTKQETLANVSAVNYEF 235

Query: 742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 781
           E    +     +   + R        + +    R T+   
Sbjct: 236 EDEYFSNTSALAKDFIRR-------LLVKDPKKRMTIQDS 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 5e-39
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 19/211 (9%)

Query: 514 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 572
           +++    +G G FG VY+ KL  +G+ VA+K++        +    E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 573 RLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 626
           RL       GEK       L+ +Y+P                L        +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 627 YLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 685
           Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   +    + +  Y +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190

Query: 686 PEYALDGL-FSVKSDVFSFGVLLLETLTSKR 715
           PE       ++   DV+S G +L E L  + 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-38
 Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 12/207 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 568
            +F     LG+G FG V   +    G+  A+K L  +   +   +     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 569 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
             L  L            + EY     L F L   SR  +   +         A+ +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118

Query: 629 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 688
                  +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176

Query: 689 ALDGLFSVKSDVFSFGVLLLETLTSKR 715
             D  +    D +  GV++ E +  + 
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-37
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 10/206 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 569
           + +    K+GEG +G V+K K     + VA+K  RL             E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
           N+VRL        +  L++E+       +F          G      +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 689
                 ++HRDLK  N+L++ +   K+++FG+AR F G  ++  +  VV  +        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174

Query: 690 LDGLFSVKSDVFSFGVLLLETLTSKR 715
              L+S   D++S G +  E   + R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 569
             +    K+G+G FG V+K +    GQ+VA+K++   ++          E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 570 NLVRLMGCCVEQGEKI--------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 621
           N+V L+  C  +            L++++  +           +          ++++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126

Query: 622 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVG 679
             GL Y+H+    +I+HRD+KA+N+L+  D   K++DFG+AR F    +         V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 680 TYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKR 715
           T  Y  PE  L +  +    D++  G ++ E  T   
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-37
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 20/212 (9%)

Query: 515 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE------FKNEMMLIAKLQ 567
           + +   LG GGFG VY G  + +   VA+K +         E         E++L+ K+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 568 --HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
                ++RL+         +LI E        F     +    L  +        + + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123

Query: 626 LYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
            + H      ++HRD+K  NIL+D +    K+ DFG   +              GT  Y 
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176

Query: 685 SPEYAL-DGLFSVKSDVFSFGVLLLETLTSKR 715
            PE+          + V+S G+LL + +    
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-36
 Identities = 49/272 (18%), Positives = 97/272 (35%), Gaps = 33/272 (12%)

Query: 521 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCC 578
           LG G  G V +       ++ A+K L         + + E+ L  +  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 579 ----VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 634
                 +   +++ E +    L   + D         +   +I++ I + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 635 RIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 691
            I HRD+K  N+L  S       K++DFG A+                T  Y++PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 692 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH- 750
             +    D++S GV++   L        +       +            YE  +P     
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 751 -EASYQMLNRYITVALLCVQEKAADRPTMSKV 781
            E    ++          ++ +   R T+++ 
Sbjct: 245 SEEVKMLIRN-------LLKTEPTQRMTITEF 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (343), Expect = 1e-35
 Identities = 55/244 (22%), Positives = 94/244 (38%), Gaps = 15/244 (6%)

Query: 476 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 534
           + A + +E           + D +    + +  +A  + F     LG G FG V   K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63

Query: 535 LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 591
            +G   A+K L  Q     + ++   NE  ++  +    LV+L     +     ++ EY+
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123

Query: 592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 651
               +   L    R               I     YLH    L +I+RDLK  N+L+D  
Sbjct: 124 AGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177

Query: 652 MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 711
              +++DFG A+        G T  + GT   ++PE  L   ++   D ++ GVL+ E  
Sbjct: 178 GYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 712 TSKR 715
               
Sbjct: 233 AGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-34
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 569
             +     +G G +G V        G +VA+K+L    QS    K    E+ L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 570 NLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           N++ L+             +  L+  +M             +   LG      ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     +        V T  Y
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 684 MSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 714
            +PE  L+ + ++   D++S G ++ E +T K
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 7e-34
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLS----SQSGQGLKEFKNEMMLIA 564
           ENF +   LG G +G V+  + +     G+  A+K L      Q  +  +  + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 565 KLQHR-NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
            ++    LV L      + +  LI +Y+    L   L    R       T  ++   + +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGE 137

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
            +L L    +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +       GT  Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 684 MSPEYALDGL--FSVKSDVFSFGVLLLETLTSKR 715
           M+P+    G        D +S GVL+ E LT   
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (315), Expect = 4e-32
 Identities = 43/209 (20%), Positives = 90/209 (43%), Gaps = 21/209 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRN 570
           +++ +  KLG G +  V++   + N ++V VK L        K+ K E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 571 LVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 628
           ++ L     +   +   L++E++ N               L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 629 HQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           H    + I+HRD+K  N+++D +    ++ D+G+A  +   +        V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 688 YALD-GLFSVKSDVFSFGVLLLETLTSKR 715
             +D  ++    D++S G +L   +  K 
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 3e-31
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQHR 569
           + +     +G G  G V      +  + VA+K+LS   Q+    K    E++L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 570 NLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 623
           N++ L+     Q       +  L+ E M          +         +    ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130

Query: 624 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 683
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +       V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 684 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
            +PE  L   +    D++S G ++ E +  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-29
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 13/208 (6%)

Query: 512 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 568
            E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 569 RNLVRLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 627
            N++ L+               Y+    +   L +  +   L       +I  I +GL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 628 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 687
           +H      IIHRDLK SN+ ++ D   KI DFG+AR              V T  Y +PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 188

Query: 688 YALDGL-FSVKSDVFSFGVLLLETLTSK 714
             L+ + ++   D++S G ++ E LT +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (290), Expect = 1e-28
 Identities = 42/210 (20%), Positives = 80/210 (38%), Gaps = 18/210 (8%)

Query: 520 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 578
           KLG G F  V+  K ++N   VA+K +        +  ++E+ L+ ++   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 579 VEQGEKILIY-------------EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 625
                K+L +              +         L        +      +I + +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 626 LYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 684
            Y+H+  R  IIH D+K  N+L++  D    +    +A +        +    + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 685 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 714
           SPE  L   +   +D++S   L+ E +T  
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  103 bits (257), Expect = 9e-26
 Identities = 30/154 (19%), Positives = 60/154 (38%), Gaps = 20/154 (12%)

Query: 520 KLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLK--------EFKNEMMLIAKLQHR 569
            +GEG    V+        E  VK  ++   S + +K         F    +  A+ + R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 570 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 629
            L +L G  V +     +Y +  N ++   L D    + +  +   ++++ I + +   +
Sbjct: 67  ALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 630 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 663
                 I+H DL   N+L+  +    I DF  + 
Sbjct: 121 HR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 86.9 bits (215), Expect = 4e-21
 Identities = 24/117 (20%), Positives = 47/117 (40%), Gaps = 14/117 (11%)

Query: 34  IGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIG 93
           + +GE L  + Q  ++  +     +   L ++      T VW +N             + 
Sbjct: 4   LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGIL-GKKGCKAVLQ 58

Query: 94  NNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSF 150
           ++GN V+ +     +W+S+  R   N V  L + GN+V+          GS +W + 
Sbjct: 59  SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSDIWSTG 106

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 67.7 bits (165), Expect = 2e-14
 Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 21/126 (16%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +     +  GE L   S  F              L ++     D  +W  N       
Sbjct: 2   NILYSGETLSTGEFLNYGS--FVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSY 145
            +  L++  +GNLV+ N ++  IW+SN   +  N V  L    N+V+          G+ 
Sbjct: 50  RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY---------GTD 100

Query: 146 LWQSFD 151
            W +  
Sbjct: 101 RWATGT 106

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 67.7 bits (165), Expect = 3e-14
 Identities = 22/131 (16%), Positives = 46/131 (35%), Gaps = 20/131 (15%)

Query: 20  LLSLATDTITPATLI-GDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVAN 78
           + S   D   P  L   +  +++  + ++     +          + Y    +  +W  N
Sbjct: 4   IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYD--NNNPIWATN 55

Query: 79  RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSS 138
                    AVL    +G LV++   +  +W S ++ +  + V  L    N+V+      
Sbjct: 56  TGGLGNGCRAVLQ--PDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY----- 108

Query: 139 NTSEGSYLWQS 149
               G  LW +
Sbjct: 109 ----GDALWAT 115

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 67.6 bits (165), Expect = 3e-14
 Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 10/99 (10%)

Query: 64  IWY-KQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVA 122
           I Y  Q  D      +    +  S   L++  + NLVL ++ D  +WS+N + +     A
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70

Query: 123 QLLDTGNLVLREKFSSNTSEGSYLWQSFD--CPSDTLLI 159
            L   G + +       T++   +W S +       + +
Sbjct: 71  VLQPNGRMDVL------TNQNIAVWTSGNSRSAGRYVFV 103

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 48.4 bits (115), Expect = 1e-07
 Identities = 15/63 (23%), Positives = 24/63 (38%), Gaps = 2/63 (3%)

Query: 70  PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
            D  VW    N+    +     +  NG + +L   +  +W+S  SR     V  L    N
Sbjct: 52  RDDRVWS--TNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 109

Query: 130 LVL 132
           L +
Sbjct: 110 LAI 112

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 63.3 bits (153), Expect = 1e-12
 Identities = 25/131 (19%), Positives = 48/131 (36%), Gaps = 19/131 (14%)

Query: 25  TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
           +D +     +  G  L      +     +          + Y    +  VW +  N    
Sbjct: 1   SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYD--NNRAVWASGTNGKA- 49

Query: 85  DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
            S  VL + N+GNLV+ +     IW+SN +R+  N    L    N+V+ +      +  +
Sbjct: 50  -SGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD------NSNN 101

Query: 145 YLWQSFDCPSD 155
            +W +     +
Sbjct: 102 AIWATHTNVGN 112

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 50.3 bits (120), Expect = 3e-08
 Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 16/124 (12%)

Query: 20  LLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANR 79
           L  L+ +   P TL    + L  SS  F     S        L ++     D  VW +N 
Sbjct: 4   LFGLSHEGSHPQTLHAA-QSLELSS--FRFTMQSDCN-----LVLFD---SDVRVWASNT 52

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FS 137
                 +     + ++G LV+L   + I WSS     + N V  L     + +     + 
Sbjct: 53  AG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWD 109

Query: 138 SNTS 141
           S TS
Sbjct: 110 SGTS 113

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	834
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.84
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.82
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.82
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.64
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.58
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.47
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.36
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.08
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.96
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.9
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.77
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.44
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.24
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.68
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.55
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	90.52

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=422.09  Aligned_cols=264  Identities=29%  Similarity=0.437  Sum_probs=207.4

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|++.++||+|+||+||+|++.  ..||||+++..  .....+.|++|+.++++++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999874  36999998654  45567889999999999999999999998754 56899999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+++|+|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999643  345899999999999999999999987   9999999999999999999999999998775544


Q ss_pred             cccccccccccccccCcccccC---CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .........||+.|||||++.+   ..|+.++|||||||+||||+||+.||.........     ......+    ...+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-----~~~~~~~----~~~p  229 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IFMVGRG----YLSP  229 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----HHHHHHT----SCCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-----HHHHhcC----CCCC
Confidence            4444456789999999999864   35899999999999999999999998764432110     0001111    0111


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      .+ ......++..+.+|+.+||+.+|++||||+||++.|+.+.+.+|
T Consensus       230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            11 11122334578899999999999999999999999999876665

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=417.40  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=200.3

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            579999999999999999999988899999999764 3445789999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|+|.+++...  ...+++..+..++.|||+||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            99999998643  356889999999999999999999987   99999999999999999999999999987644332 2


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCC-CCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......||+.|||||++.+..++.++|||||||++|||+|+..| +.......  +..    ....  ..+...|.    
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~----~i~~--~~~~~~p~----  225 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE----DIST--GFRLYKPR----  225 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHH----HHHH--TCCCCCCT----
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHh--cCCCCCcc----
Confidence            22345789999999999999999999999999999999996554 44322111  111    0000  11111222    


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                         ..+..+.+|+..||+.+|++||||+||++.|+++
T Consensus       226 ---~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         226 ---LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence               2235678899999999999999999999999876

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=414.58  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=205.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|+++++||+|+||+||+|+.. +|+.||||++.... .+..+++.+|+.++++++|||||++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999975 58999999997543 33456789999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999953   346999999999999999999999988   99999999999999999999999999998755444


Q ss_pred             ccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                      ........||+.|||||++.+..+ +.++|||||||+||||++|+.||...........     .......        .
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-----~~~~~~~--------~  225 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKT--------Y  225 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-----HHHTTCT--------T
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-----HHhcCCC--------C
Confidence            444455789999999999988876 6789999999999999999999975443211110     0001100        0


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......+..+.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0111123356778999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-49  Score=420.24  Aligned_cols=261  Identities=27%  Similarity=0.404  Sum_probs=213.1

Q ss_pred             HhccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          510 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       510 ~~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ...++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||++++++.+++..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            34578999999999999999999986 48899999997543 45678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.+. ....+++..+..++.||++||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            999999999998543 3357899999999999999999999987   999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      .. .......|++.|||||++.+..++.++|||||||++|||++|..|+....... .+    ......+         .
T Consensus       169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~----~~~i~~~---------~  233 (287)
T d1opja_         169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QV----YELLEKD---------Y  233 (287)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HH----HHHHHTT---------C
T ss_pred             Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HH----HHHHhcC---------C
Confidence            22 22333568899999999999999999999999999999999877654322111 00    0111111         1


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                      ....+...+..+.+|+..||+.||++|||++||++.|+.+..
T Consensus       234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111122334578899999999999999999999999988743

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-49  Score=415.19  Aligned_cols=256  Identities=32%  Similarity=0.474  Sum_probs=207.3

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46899999999999999999999888999999997543 445789999999999999999999998765 5679999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++... ....+++.++++|+.||++||+|||+.+   |+||||||+||||++++.+||+|||+|+.+......
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            999999987543 2235899999999999999999999987   999999999999999999999999999987543322


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                       ......||+.|||||++.++.++.++|||||||++|||+||..|+....... ....    ....+  .+...|     
T Consensus       166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~----~i~~~--~~~~~p-----  232 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ----NLERG--YRMVRP-----  232 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH----HHHTT--CCCCCC-----
T ss_pred             -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHhc--CCCCCc-----
Confidence             2334578999999999999999999999999999999999766644322111 0110    00111  111111     


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                        ...+..+.+|+.+||+.+|++||||+||+++|+.+
T Consensus       233 --~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence              12345688899999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-48  Score=417.26  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=199.8

Q ss_pred             cCccccceecccCccceEeeEecC-C---cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++.++||+|+||+||+|++.. +   ..||||++... .....++|.+|+++|++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            568888999999999999998753 3   36899998654 445567899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++...  ...+++.++..++.|||+||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999988543  346899999999999999999999987   99999999999999999999999999987754


Q ss_pred             CCcccc---cccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccc
Q 003287          668 DELQGN---TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       668 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ......   .....||+.|||||.+.++.++.++|||||||+||||+| |+.||........  ..    ....+     
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~--~~----~i~~~-----  249 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV--IN----AIEQD-----  249 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTT-----
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC-----
Confidence            332211   223457899999999999999999999999999999998 8999875443211  10    00111     


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                          .....+.+.+..+.+|+.+||+.+|++||||.||++.|+.+.
T Consensus       250 ----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         250 ----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                011112234456889999999999999999999999998873

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=404.20  Aligned_cols=254  Identities=29%  Similarity=0.439  Sum_probs=212.7

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecC
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  592 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  592 (834)
                      ++|++.++||+|+||+||+|++++++.||||++++.. ...++|++|+.++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888999999997643 345789999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCccc
Q 003287          593 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  672 (834)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  672 (834)
                      +|+|..++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999999754  3346889999999999999999999987   999999999999999999999999999876544332 


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.  ..    ....  ......|.    
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~----~i~~--~~~~~~p~----  224 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE----HIAQ--GLRLYRPH----  224 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH----HHHT--TCCCCCCT----
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HH----HHHh--CCCCCCcc----
Confidence            2334568999999999999999999999999999999998 7889876553321  11    0111  11122222    


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                         ..+..+.+|+..||+.+|++|||++|+++.|.++
T Consensus       225 ---~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         225 ---LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ---cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence               2235678999999999999999999999998653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-48  Score=409.52  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=208.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|+++++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999874 59999999998766566788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++.+    ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+|+.+....  
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            99999998743    35899999999999999999999988   9999999999999999999999999999765432  


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      .......||+.|||||++.+..++.++|||||||++|||++|+.||........     ........ ...+       .
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~-~~~~-------~  237 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNG-TPEL-------Q  237 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHHC-SCCC-------S
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-----HHHHHhCC-CCCC-------C
Confidence            223446799999999999999999999999999999999999999975432211     00000000 0011       1


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11223456788999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=419.22  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=208.1

Q ss_pred             ccCccccceecccCccceEeeEecC------CcEEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCe
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~------g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  583 (834)
                      .++|++.++||+|+||+||+|+...      ...||||++... .......|.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4689999999999999999998643      237999998654 333456789999999998 89999999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCC
Q 003287          584 KILIYEYMPNKSLNFFLFDPSR--------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKA  643 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp  643 (834)
                      .++||||+++|+|.++|.....                    ...+++.+++.++.||++||+|||+.+   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965421                    245899999999999999999999987   99999999


Q ss_pred             CcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCc
Q 003287          644 SNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDI  722 (834)
Q Consensus       644 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~  722 (834)
                      +|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655444334445678999999999999999999999999999999998 8999875443


Q ss_pred             ccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhh
Q 003287          723 ESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  786 (834)
Q Consensus       723 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~  786 (834)
                      ... +    ......+.         ..+.+...+..+.+|+..||+.+|++|||++||++.|.
T Consensus       273 ~~~-~----~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN-F----YKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH-H----HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH-H----HHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211 0    11111110         11111223456889999999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-48  Score=404.00  Aligned_cols=245  Identities=25%  Similarity=0.342  Sum_probs=205.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999985 5899999998653   2334677899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999853   346899999999999999999999988   999999999999999999999999999865432


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                          ......||+.|||||++.+..++.++|||||||+||||++|+.||........  ..    ......      ..+
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~----~i~~~~------~~~  223 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YK----RISRVE------FTF  223 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHTTC------CCC
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH--HH----HHHcCC------CCC
Confidence                23446799999999999999999999999999999999999999975442211  00    000110      001


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          +...+..+.+|+.+||+.||++|||++|+++
T Consensus       224 ----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                1123456788999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=409.24  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=195.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee--cCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV  587 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||++...  .....+.+.+|++++++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999875 5899999999754  34456779999999999999999999999865  4568999


Q ss_pred             EEecCCCCchhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          588 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      |||+++|+|.+++.+. .....+++..++.++.||++||+|||+.+  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998542 23457999999999999999999999865  23599999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      +....  .......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+.  ..    .........  
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--~~----~i~~~~~~~--  233 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AG----KIREGKFRR--  233 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH----HHHHTCCCC--
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH--HH----HHHcCCCCC--
Confidence            64332  223446799999999999999999999999999999999999999976443221  10    011111111  


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                             .+...+..+.+|+.+||+.||++|||++|+++
T Consensus       234 -------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 -------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   11123456888999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=407.53  Aligned_cols=257  Identities=24%  Similarity=0.366  Sum_probs=208.5

Q ss_pred             ccCccccc-eecccCccceEeeEec---CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~-~lG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|.+.+ +||+|+||+||+|.+.   ++..||||+++... ....++|.+|+++|++++|||||++++++.+ +..+|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            35677777 4999999999999764   35579999997653 4456789999999999999999999999864 56899


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++...  ...+++.++..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        86 vmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            99999999999998432  346899999999999999999999987   9999999999999999999999999999875


Q ss_pred             CCCc-ccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCccccccccccccccccccccccc
Q 003287          667 GDEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      .... ........||+.|||||++.++.++.++|||||||++|||+| |+.||......+.  ..    ....+...   
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~----~i~~~~~~---  231 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGKRM---  231 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH----HHHTTCCC---
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcCCCC---
Confidence            4332 222334568999999999999999999999999999999998 8999876543211  11    11111111   


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                            ..+...+..+.+|+.+||+.+|++||||.+|++.|+...
T Consensus       232 ------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         232 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  111223456789999999999999999999999998753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-48  Score=409.41  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=201.0

Q ss_pred             cCccccceecccCccceEeeEecCC-----cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g-----~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      +.|++.++||+|+||+||+|++...     ..||||++... .....++|++|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688999999999999999987542     47999999754 34455679999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+.+++|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999887532  346899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ..... .......||+.|||||++.++.++.++|||||||++|||+++..|+....... .+..    ....+       
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~----~i~~~-------  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMK----AINDG-------  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH----HHHTT-------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHH----HHhcc-------
Confidence            43322 22334568999999999999999999999999999999999766654322111 1110    11111       


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                        .....+...+..+.+|+.+||+.+|++||+|.||+++|+.+.
T Consensus       230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence              111112223456889999999999999999999999998873

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=409.05  Aligned_cols=261  Identities=28%  Similarity=0.438  Sum_probs=205.9

Q ss_pred             ccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      .++|++.+.||+|+||+||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            3689999999999999999999988889999999754 3455789999999999999999999999854 5689999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|..++... ....+++.+++.++.||++||+|||+.+   |+||||||+||||+.++++||+|||+++.+..... 
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999999888543 2345899999999999999999999987   99999999999999999999999999987643332 


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      .......||+.|+|||++.++.++.++|||||||++|||++|..|+....... .....    ...+         ....
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~----i~~~---------~~~~  234 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ----VERG---------YRMP  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHH----HHTT---------CCCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHH----HHhc---------CCCC
Confidence            22334578999999999999999999999999999999999777654432211 01110    1111         0111


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCC
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  793 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~  793 (834)
                      .+...++.+.+++.+||+.+|++||+|++|+++|+......+
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            122334568899999999999999999999999998755544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-48  Score=407.31  Aligned_cols=248  Identities=26%  Similarity=0.364  Sum_probs=199.1

Q ss_pred             ceecccCccceEeeEecC---CcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEecCC
Q 003287          519 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  593 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~---g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  593 (834)
                      ++||+|+||+||+|.+.+   ++.||||+++..  .....++|.+|+.++++++|||||+++++|.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   568999999654  23345789999999999999999999999854 567899999999


Q ss_pred             CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc-c
Q 003287          594 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-G  672 (834)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~  672 (834)
                      |+|.+++..   ...+++.+++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999853   356899999999999999999999987   999999999999999999999999999876543322 2


Q ss_pred             ccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccch
Q 003287          673 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  751 (834)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  751 (834)
                      ......||+.|||||++.+..++.++|||||||++|||+| |+.||......+.  ..    ....+..         ..
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~----~i~~~~~---------~~  230 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TA----MLEKGER---------MG  230 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----HHHTTCC---------CC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HH----HHHcCCC---------CC
Confidence            2334578999999999999999999999999999999998 8999876443211  10    1111111         11


Q ss_pred             hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          752 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       752 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .+..++..+.+|+.+||+.+|++|||+++|+++|+..
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            1122345688999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=406.80  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      +.|++++.||+|+||+||+|+.. +++.||||++........+.|.+|++++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999975 58999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++.+  ....+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|+......  
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            99999998743  2346899999999999999999999988   9999999999999999999999999997653221  


Q ss_pred             cccccccccccccCccccc-----CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          672 GNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      .......||+.|||||++.     +..|+.++|||||||++|||++|+.||........  .   .... ......+.  
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~---~~i~-~~~~~~~~--  236 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--L---LKIA-KSEPPTLA--  236 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H---HHHH-HSCCCCCS--
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--H---HHHH-cCCCCCCC--
Confidence            1223467999999999984     45689999999999999999999999976443221  0   0000 11111111  


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                           .+...+..+.+|+.+||+.||++|||++|+++
T Consensus       237 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 -----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11223456788999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=412.27  Aligned_cols=260  Identities=25%  Similarity=0.342  Sum_probs=205.5

Q ss_pred             hccCccccceecccCccceEeeEec-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ..++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+.+|++++|||||++++++.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999975 5899999999764 3344578999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      ||+++|+|.+++.+   ...+++..+..++.|+++||.|||+. +   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999953   34689999999999999999999975 6   99999999999999999999999999987642


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccc-----------ccc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN-----------LWK  736 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~  736 (834)
                      .    ......||+.|||||++.+..|+.++||||+||++|||++|+.||...+............           ...
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2    2234689999999999999999999999999999999999999997654322111000000           000


Q ss_pred             cc-------------ccccc-------cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 DN-------------RAYEL-------LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ~~-------------~~~~l-------~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..             ...+.       ..+.+.   ....+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00             00000       000000   0012356788999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-47  Score=408.05  Aligned_cols=265  Identities=26%  Similarity=0.405  Sum_probs=214.1

Q ss_pred             HHHHHhccCccccceecccCccceEeeEec------CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeE
Q 003287          506 ASVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCC  578 (834)
Q Consensus       506 ~~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~  578 (834)
                      .+++...++|++.+.||+|+||+||+|+..      +++.||||+++... .+..++|.+|+.++++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344555688999999999999999999864      35789999997653 34467899999999999999999999999


Q ss_pred             eecCeEEEEEEecCCCCchhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 003287          579 VEQGEKILIYEYMPNKSLNFFLFDPS---------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII  637 (834)
Q Consensus       579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  637 (834)
                      .+....++||||+++|+|.+++....                     ....+++..++.++.|+++||+|||+.+   |+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence            99999999999999999999985321                     1235889999999999999999999987   99


Q ss_pred             ecCCCCCcEEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCC-CC
Q 003287          638 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RN  716 (834)
Q Consensus       638 H~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~-~p  716 (834)
                      ||||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998765544444445567899999999999999999999999999999999996 46


Q ss_pred             CCCCCcccccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          717 TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      +......+.  ..    ....+....         .+...+.++.+|+..||+.+|++||||.||+++|+.+
T Consensus       243 ~~~~~~~e~--~~----~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         243 YYGMAHEEV--IY----YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTSCHHHH--HH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCHHHH--HH----HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            655433221  11    111111111         1122335688999999999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=405.35  Aligned_cols=249  Identities=23%  Similarity=0.306  Sum_probs=203.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++++.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 5899999999753   2334578999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|.+++.   ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999884   3356899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                      ..........||+.|||||++.+..++.++|||||||++|||++|+.||...+....  ..   .. ....      ..+
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~---~i-~~~~------~~~  229 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--FQ---KI-IKLE------YDF  229 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HH-HTTC------CCC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH--HH---HH-HcCC------CCC
Confidence            444444556899999999999999999999999999999999999999976442211  00   00 0010      001


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                          +......+.+|+.+||+.||++|||++|+++
T Consensus       230 ----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 ----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                1123456788999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=394.71  Aligned_cols=247  Identities=25%  Similarity=0.376  Sum_probs=197.2

Q ss_pred             ccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee----cCeEEEE
Q 003287          515 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILI  587 (834)
Q Consensus       515 f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV  587 (834)
                      |++.++||+|+||+||+|+.. +++.||||++...  .....+.|.+|+++|++++|||||++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            467778999999999999975 5889999998654  34456789999999999999999999999875    3467999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc-CCCCeeecccccccccc
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFC  666 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~vkl~DFGla~~~~  666 (834)
                      |||+++|+|.+++.+   ...+++.++..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+...
T Consensus        91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999999953   356899999999999999999999875 4599999999999996 57999999999998643


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCc
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  746 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  746 (834)
                      ..    ......||+.|||||++.+ .++.++|||||||++|||++|+.||........ +..    ....+     .. 
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~----~i~~~-----~~-  230 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYR----RVTSG-----VK-  230 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHH----HHTTT-----CC-
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHH----HHHcC-----CC-
Confidence            22    2345679999999998865 599999999999999999999999874332110 000    00000     00 


Q ss_pred             cccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          747 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       747 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ....+......+.+|+.+||+.||++|||++|+++
T Consensus       231 --~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence              01111223345788999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.8e-46  Score=405.28  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=209.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            58999999999999999999875 58999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc--CCCCeeeccccccccccCCC
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~~vkl~DFGla~~~~~~~  669 (834)
                      ++|+|.+++.+.  ...+++.++..++.||+.||+|||+.+   |+||||||+|||++  .++.+||+|||+++.+....
T Consensus       106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999998543  345899999999999999999999998   99999999999996  46889999999998764332


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......||+.|||||++.+..++.++|||||||++|||++|+.||...+....  ..   .... ..      ....
T Consensus       181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~---~i~~-~~------~~~~  245 (350)
T d1koaa2         181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LR---NVKS-CD------WNMD  245 (350)
T ss_dssp             ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHH-TC------CCSC
T ss_pred             ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--HH---HHHh-CC------CCCC
Confidence               23446799999999999999999999999999999999999999975443211  10   0000 00      0011


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      .......+..+.+|+.+||+.||++|||+.|+++-
T Consensus       246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11112234567889999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-46  Score=401.33  Aligned_cols=250  Identities=21%  Similarity=0.280  Sum_probs=190.2

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      +.|++.+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            66999999999999999999975 58999999997543 23346788999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc---CCCCeeeccccccccccC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCG  667 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~vkl~DFGla~~~~~  667 (834)
                      +++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||+.   +++.+||+|||+++....
T Consensus        89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999954   346999999999999999999999988   99999999999994   578999999999987543


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..   ......||+.|||||++.+..++.++|||||||+||||++|+.||........  ..   ......       ..
T Consensus       163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~---~i~~~~-------~~  227 (307)
T d1a06a_         163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FE---QILKAE-------YE  227 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH---HHHTTC-------CC
T ss_pred             CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HH---HHhccC-------CC
Confidence            22   23346799999999999999999999999999999999999999975432211  00   000000       00


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .........+..+.+|+..||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            011111233456889999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-46  Score=403.08  Aligned_cols=245  Identities=30%  Similarity=0.462  Sum_probs=201.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      +.|+.+++||+|+||+||+|+.. +++.||||++....   ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999875 58899999997543   334567999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|..++.   ....+++.++..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+|+.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987663   2356899999999999999999999988   99999999999999999999999999986532 


Q ss_pred             CcccccccccccccccCcccccC---CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccC
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                           .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||........     ...... ...     
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~~-~~~-----  231 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQ-NES-----  231 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHH-SCC-----
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHh-CCC-----
Confidence                 234579999999999864   4689999999999999999999999875432111     000011 111     


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      +...   ....+..+.+|+..||+.||++|||++|+++
T Consensus       232 ~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1111   1122356788999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-45  Score=402.62  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=212.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999975 69999999998766666778899999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc--CCCCeeeccccccccccCCC
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~~vkl~DFGla~~~~~~~  669 (834)
                      ++|+|.+++..  ....+++.++..++.||++||+|||+.+   |+||||||+||||+  .++.+||+|||+|+.+....
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999887743  3346899999999999999999999988   99999999999998  67899999999998875432


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......||+.|||||++.+..++.++|||||||++|||++|+.||........  ..   ... ...      ....
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~---~i~-~~~------~~~~  248 (352)
T d1koba_         184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQ---NVK-RCD------WEFD  248 (352)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH---HHH-HCC------CCCC
T ss_pred             ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HHH-hCC------CCCC
Confidence               23446789999999999999999999999999999999999999976443211  00   000 000      0011


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcccCCC
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEHATL  792 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~l  792 (834)
                      .......+..+.+|+..||+.||++|||+.|+++-  |.+....+
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~  293 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL  293 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchh
Confidence            11112234567889999999999999999999873  55443333

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=401.31  Aligned_cols=264  Identities=27%  Similarity=0.387  Sum_probs=201.8

Q ss_pred             HHHhccCccccceecccCccceEeeEec------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEe
Q 003287          508 VSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV  579 (834)
Q Consensus       508 ~~~~~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  579 (834)
                      .+...++|++.++||+|+||.||+|+..      +++.||||+++.. .....+++.+|...+.++ +|+||+++++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            3344578999999999999999999863      2468999999754 334556788888888887 7899999999987


Q ss_pred             ecC-eEEEEEEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 003287          580 EQG-EKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  645 (834)
Q Consensus       580 ~~~-~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~N  645 (834)
                      +.+ ..++||||+++|+|.+++....             ....+++.++..++.||++||+|||+++   |+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccc
Confidence            654 6899999999999999995432             1345889999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCC-CCCCCCCccc
Q 003287          646 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIES  724 (834)
Q Consensus       646 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~-~p~~~~~~~~  724 (834)
                      |||++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. .|+.......
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998776554444455678999999999999999999999999999999999975 4665433221


Q ss_pred             ccccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          725 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .     .......+...     .    .+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       245 ~-----~~~~~~~~~~~-----~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         245 E-----FCRRLKEGTRM-----R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             H-----HHHHHHHTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-----HHHHHhcCCCC-----C----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1     00111111111     1    1112335678899999999999999999999999876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=393.33  Aligned_cols=250  Identities=23%  Similarity=0.304  Sum_probs=206.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC------hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||++.+..      ....+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            67999999999999999999975 68999999986532      224678999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC----Ceeeccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGM  661 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~vkl~DFGl  661 (834)
                      |||||+++|+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999853   346999999999999999999999988   99999999999998776    499999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..   .. ..    
T Consensus       164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~---~i-~~----  230 (293)
T d1jksa_         164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA---NV-SA----  230 (293)
T ss_dssp             CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HH-HT----
T ss_pred             hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HH---HH-Hh----
Confidence            98764332   23345789999999999999999999999999999999999999976443211  00   00 00    


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        .............+..+.+|+.+||+.||++|||++|+++
T Consensus       231 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         231 --VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0111112222334567889999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=403.10  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             cCccccceecccCccceEeeEec-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .+|+++++||+|+||+||+|++. +|+    +||||+++.. ..+..++|.+|+.++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999875 343    6899998654 345678899999999999999999999999865 5678


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ++||+.+|+|.+++..  ....+++..+++++.|||+||+|||+++   |+||||||+||||+.++.+||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999888754  3456899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      ............||+.|||||++.++.++.++|||||||+||||+| |..|+........  .    .....+.  .+. 
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~----~~i~~~~--~~~-  233 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S----SILEKGE--RLP-  233 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--H----HHHHHTC--CCC-
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--H----HHHHcCC--CCC-
Confidence            5554444455678999999999999999999999999999999998 7888775443221  0    1111111  111 


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                            .+..++..+.+|+.+||+.+|++|||+.|+++.|..+.
T Consensus       234 ------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         234 ------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                  11223456788999999999999999999999987763

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=391.81  Aligned_cols=249  Identities=27%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec-CeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey~  591 (834)
                      ++|++.+.||+|+||.||+|++ .|+.||||+++..  ...+.|.+|++++++++||||++++|+|.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            5789999999999999999998 5789999999754  3457899999999999999999999999654 5689999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++... ....+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999542 2235899999999999999999999987   999999999999999999999999999865322   


Q ss_pred             cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccCccccc
Q 003287          672 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  750 (834)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  750 (834)
                        .....+|..|+|||++.++.+++++|||||||++|||+| |+.|+........  ...    ...+.     .    .
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--~~~----i~~~~-----~----~  219 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR----VEKGY-----K----M  219 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHH----HTTTC-----C----C
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH--HHH----HHcCC-----C----C
Confidence              233467899999999999999999999999999999998 6777665433221  110    11111     1    1


Q ss_pred             hhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          751 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       751 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      +.+.....++.+|+.+||+.||++||||.|++++|+.+
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11222335678999999999999999999999999876

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=396.54  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=210.6

Q ss_pred             ccCccccceecccCccceEeeEecC--------CcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeec
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  581 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  581 (834)
                      .++|++.+.||+|+||.||+|+...        +..||||++++.. .....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4689999999999999999998632        3479999997654 34567899999999998 899999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEE
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  648 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl  648 (834)
                      +..++||||+++|+|.+++....             ....+++.+++.++.||++||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999996542             1346899999999999999999999998   9999999999999


Q ss_pred             cCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccc
Q 003287          649 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  727 (834)
Q Consensus       649 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~  727 (834)
                      +.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |..|+........  
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~--  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH--
Confidence            9999999999999998866655555666789999999999999999999999999999999998 6778765443211  


Q ss_pred             cccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          728 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       728 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                          ...+..+...         ..+...+.++.+|+.+||+.+|++|||+.||+++|+++
T Consensus       247 ----~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         247 ----FKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             ----HHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                1111111111         11122345688999999999999999999999999887

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-46  Score=391.80  Aligned_cols=255  Identities=22%  Similarity=0.325  Sum_probs=197.1

Q ss_pred             ccCccccceecccCccceEeeEecC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  586 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  586 (834)
                      .++|++.+.||+|+||+||+|++..    +..||||+++.. .....+.|.+|+.++++++|||||++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3689999999999999999998743    457999998754 3445678999999999999999999999986 467899


Q ss_pred             EEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccccccc
Q 003287          587 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  666 (834)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~  666 (834)
                      ||||+++|+|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+|+.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998753  2346899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccccC
Q 003287          667 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  745 (834)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  745 (834)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |..|+........  ..    ....+...    
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~----~i~~~~~~----  228 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGERL----  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTCCC----
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HH----HHHcCCCC----
Confidence            4322 22334568999999999999999999999999999999998 7888876443221  11    01111111    


Q ss_pred             ccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          746 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       746 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                           ..+...+..+.+|+.+||+.||++|||++||++.|+.+
T Consensus       229 -----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         229 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 11122345688999999999999999999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-46  Score=392.33  Aligned_cols=256  Identities=27%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             cCccccceecccCccceEeeEecC--C--cEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ++|++.+.||+|+||+||+|++..  +  ..||||++.+.   ..+..++|.+|+.++++++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            679999999999999999998642  2  47999998754   33456789999999999999999999999975 4678


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++|+|.+++..  ....+++..++.++.|||+||+|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999988753  2346899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCCcc-cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhh-CCCCCCCCCcccccccccccccccccccccc
Q 003287          666 CGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  743 (834)
Q Consensus       666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  743 (834)
                      ...... .......||..|+|||++.+..++.++|||||||++|||+| |+.||...+..+.  .   ......+.  . 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~---~~i~~~~~--~-  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--L---HKIDKEGE--R-  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H---HHHHTSCC--C-
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--H---HHHHhCCC--C-
Confidence            544322 22334567889999999999999999999999999999998 8999875543321  0   01111111  0 


Q ss_pred             cCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          744 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       744 ~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                            .+.+...+..+.+|+.+||+.||++||||.||+++|.+.
T Consensus       234 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  111122335688999999999999999999999999764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=397.79  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=212.0

Q ss_pred             hccCccccceecccCccceEeeEe------cCCcEEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecC
Q 003287          511 ATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  582 (834)
Q Consensus       511 ~~~~f~~~~~lG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  582 (834)
                      ..++|++.++||+|+||.||+|++      ..++.||||+++... .....+|.+|+.+++++ +|||||++++++.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            347899999999999999999975      236789999997653 34556799999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCchhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 003287          583 EKILIYEYMPNKSLNFFLFDPS---------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  647 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NIL  647 (834)
                      ..++||||+++|+|.++++...               ....+++..+..++.||++||+|||+++   ++||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            9999999999999999986432               2336889999999999999999999998   999999999999


Q ss_pred             EcCCCCeeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCC-CCCCCccccc
Q 003287          648 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFN  726 (834)
Q Consensus       648 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p-~~~~~~~~~~  726 (834)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|+..| +........ 
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            999999999999999987655444445567899999999999999999999999999999999995554 443322111 


Q ss_pred             ccccccccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          727 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       727 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                          .......+         .....+...+..+.+|+.+||+.||++||||+||+++|++.
T Consensus       257 ----~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 ----FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             ----HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                01111111         11111122345688999999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=390.89  Aligned_cols=271  Identities=24%  Similarity=0.306  Sum_probs=204.0

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC----eEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~  588 (834)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4688899999999999999997 689999999965422 2222344555666789999999999998765    579999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      ||+++|+|.+++.+    ..+++..+++++.|+|.||+|||+.     +..+|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999953    3589999999999999999999974     23469999999999999999999999999998


Q ss_pred             cccCCCc--ccccccccccccccCcccccCCC------CCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccc---
Q 003287          664 MFCGDEL--QGNTKRVVGTYGYMSPEYALDGL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW---  732 (834)
Q Consensus       664 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---  732 (834)
                      .......  ........||+.|||||++.+..      ++.++|||||||+||||+||..|+...............   
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            8754332  22334567999999999987653      678999999999999999999887654332211111000   


Q ss_pred             --ccccccccccccCccccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhccc
Q 003287          733 --NLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  789 (834)
Q Consensus       733 --~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~  789 (834)
                        ............+|.+... ...+....+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence              0000011111223333222 23345667889999999999999999999999998873

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-45  Score=393.64  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=205.8

Q ss_pred             cCccccceecccCccceEeeEecC-Cc--EEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++.++||+|+||+||+|++.+ +.  .||||++... .....+.|.+|+++|.++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            679999999999999999998754 43  5788988644 344567899999999999 799999999999999999999


Q ss_pred             EEecCCCCchhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCe
Q 003287          588 YEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  654 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~v  654 (834)
                      |||+++|+|.++|+..             .....+++..+.+++.|||+||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23467999999999999999999999987   9999999999999999999


Q ss_pred             eeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCC-CCCCCCcccccccccccc
Q 003287          655 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWN  733 (834)
Q Consensus       655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~  733 (834)
                      ||+|||+++.....   .......||..|+|||.+.+..++.++|||||||++|||++|.. |+........  ...   
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~--~~~---  238 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEK---  238 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH---
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH--HHH---
Confidence            99999999865322   22234568999999999999999999999999999999999765 5654332211  110   


Q ss_pred             cccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCC
Q 003287          734 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  791 (834)
Q Consensus       734 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~  791 (834)
                       ...+.     .    .+.+...+..+.+|+.+||+.+|++||||+||++.|+.+.+.
T Consensus       239 -i~~~~-----~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         239 -LPQGY-----R----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -GGGTC-----C----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -HHhcC-----C----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence             01110     0    111122345788999999999999999999999999988543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-45  Score=394.93  Aligned_cols=248  Identities=22%  Similarity=0.271  Sum_probs=206.7

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      .++|++++.||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            367999999999999999999974 6999999999754   233567889999999999999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++.+   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999853   456899999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..  .......||+.|||||++.+..|+.++|||||||++|||++|+.||...+....  ..    ......      ..
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~i~~~~------~~  223 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILMEE------IR  223 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC------CC
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HH----HHhcCC------CC
Confidence            22  233456899999999999999999999999999999999999999986543221  00    000110      01


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                          .+...+..+.+|+.+||+.||++||+     ++|+++
T Consensus       224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                11123456788999999999999995     777775

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=393.46  Aligned_cols=259  Identities=28%  Similarity=0.419  Sum_probs=212.6

Q ss_pred             ccCccccceecccCccceEeeEec------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  584 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  584 (834)
                      .++|++.++||+|+||+||+|.+.      +++.||||+++.. .......|.+|+.++++++||||+++++++......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            478999999999999999999863      2578999999764 344556799999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          585 ILIYEYMPNKSLNFFLFDP-------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      ++||||+++|+|.+++...       .....+++..+.+++.|+|+||.|||+.+   |+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999998532       22345789999999999999999999987   9999999999999999999999


Q ss_pred             cccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCC-CCCCCCCccccccccccccccc
Q 003287          658 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWK  736 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~  736 (834)
                      |||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .|+......+.  ..    ...
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~--~~----~i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LR----FVM  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HH----HHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHH
Confidence            999999876554444455567899999999999999999999999999999999985 56654332211  00    011


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcc
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  788 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~  788 (834)
                      .+...         ..+..++..+.+|+.+||+.+|++||||+||+++|+..
T Consensus       250 ~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             hCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11111         11122345688999999999999999999999999886

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.6e-45  Score=391.33  Aligned_cols=244  Identities=23%  Similarity=0.317  Sum_probs=204.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 5899999999753   2334678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+++|+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999998884   3446788999999999999999999987   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                           .....||+.|||||++.+..++.++|||||||+||||++|+.||...+....  ..   ... ...      ...
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~---~i~-~~~------~~~  220 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YE---KIL-NAE------LRF  220 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHH-HCC------CCC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH--HH---HHH-cCC------CCC
Confidence                 3346899999999999999999999999999999999999999976442211  00   000 000      001


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                          +...+..+.+++.+||+.+|.+||     +++|+++
T Consensus       221 ----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 ----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                112235678899999999999996     8999886

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-44  Score=384.24  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=202.2

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC----e
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----E  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~  583 (834)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++...   ....+.|.+|++++++++||||+++++++.+.+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999874 69999999997542   344567999999999999999999999998754    3


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .+|||||+++++|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.++|+|||+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999988843   346899999999999999999999987   9999999999999999999999999997


Q ss_pred             cccCCC-cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          664 MFCGDE-LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       664 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ...... .........||+.|||||++.+..++.++|||||||++|||+||+.||........     ........... 
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~~~~~~-  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPIP-  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCCCCC-
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----HHHHHhcCCCC-
Confidence            654332 22233456799999999999999999999999999999999999999975442211     00011111000 


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCC-CHHHHHHHhhcc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNE  788 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~  788 (834)
                            ........+..+.+++.+||+.||++|| +++++++.|..+
T Consensus       234 ------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 ------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                  0111122345688899999999999999 899999988765

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=388.65  Aligned_cols=254  Identities=30%  Similarity=0.460  Sum_probs=203.5

Q ss_pred             cceecccCccceEeeEecCC----cEEEEEEeccc-ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec-CeEEEEEEec
Q 003287          518 QCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEYM  591 (834)
Q Consensus       518 ~~~lG~G~fG~Vy~~~~~~g----~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey~  591 (834)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997542    36899999754 455668899999999999999999999998764 5889999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCcc
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  671 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~  671 (834)
                      ++|+|.+++...  ...+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999998643  345778899999999999999999987   999999999999999999999999999977544322


Q ss_pred             --cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          672 --GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       672 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                        .......||+.|+|||.+....++.++||||||+++|||++|+.|+...... .+...   ......   +...|.  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~---~i~~g~---~~~~p~--  257 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV---YLLQGR---RLLQPE--  257 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHH---HHHTTC---CCCCCT--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHH---HHHcCC---CCCCcc--
Confidence              2223457899999999999999999999999999999999988887643211 11111   111111   111221  


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccC
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  790 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~  790 (834)
                           .....+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus       258 -----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         258 -----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 223467889999999999999999999999999844

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.1e-44  Score=377.94  Aligned_cols=250  Identities=23%  Similarity=0.281  Sum_probs=203.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---------hhhHHHHHHHHHHHhccC-CCceeeEeeeEeec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ  581 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~  581 (834)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.+..         ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999874 68999999986542         112346889999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccc
Q 003287          582 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  661 (834)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGl  661 (834)
                      +..+|||||+++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999953   346899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccC------CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALD------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  735 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  735 (834)
                      ++.+....   ......||+.|+|||++.+      ..++.++||||+||+||||++|+.||........  .    ...
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--~----~~i  227 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--L----RMI  227 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHH
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--H----HHH
Confidence            98864432   2334679999999999853      3478899999999999999999999986543211  0    000


Q ss_pred             cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          736 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       736 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      ..+.. +     .........++.+.+|+.+||+.+|++|||+.|+++
T Consensus       228 ~~~~~-~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGNY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTCC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCCC-C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11100 0     111112234467889999999999999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=382.96  Aligned_cols=250  Identities=20%  Similarity=0.275  Sum_probs=205.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEec
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  591 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  591 (834)
                      ++|++++.||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            67999999999999999999875 58899999997653 33466889999999999999999999999999999999999


Q ss_pred             CCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC--CCeeeccccccccccCCC
Q 003287          592 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGDE  669 (834)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~--~~vkl~DFGla~~~~~~~  669 (834)
                      ++|+|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.+  ..+||+|||+++......
T Consensus        84 ~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          84 SGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            999999999532  346899999999999999999999988   9999999999999854  589999999998764322


Q ss_pred             cccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcccc
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  749 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  749 (834)
                         ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||........  ..   .... .      .....
T Consensus       159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~---~i~~-~------~~~~~  223 (321)
T d1tkia_         159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IE---NIMN-A------EYTFD  223 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHH-T------CCCCC
T ss_pred             ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HH---HHHh-C------CCCCC
Confidence               23345789999999999999999999999999999999999999976443211  00   0000 0      00111


Q ss_pred             chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          750 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       750 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .......+..+.+|+..||+.||++|||+.|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1122234556889999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-44  Score=390.27  Aligned_cols=244  Identities=21%  Similarity=0.235  Sum_probs=204.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  588 (834)
                      ++|++++.||+|+||+||+|+.. +|+.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 6999999998653   2334577899999999999999999999999999999999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  668 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~  668 (834)
                      ||+.+|+|..++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999843   346899999999999999999999988   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCccc
Q 003287          669 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  748 (834)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  748 (834)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||........  ..    ......      .. 
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~----~i~~~~------~~-  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YE----KIVSGK------VR-  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC------CC-
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH--HH----HHhcCC------CC-
Confidence                 2346799999999999999999999999999999999999999975432211  00    000000      00 


Q ss_pred             cchhHHHHHHHHHHHHhcccccCcCCCC-----CHHHHHH
Q 003287          749 QHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  783 (834)
Q Consensus       749 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~  783 (834)
                         .+...+..+.+++..||+.||.+|+     +++|+++
T Consensus       257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               1112345678899999999999994     8999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=383.69  Aligned_cols=251  Identities=18%  Similarity=0.214  Sum_probs=199.7

Q ss_pred             cCccccc-eecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhcc-CCCceeeEeeeEee----cCeEE
Q 003287          513 ENFSMQC-KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE----QGEKI  585 (834)
Q Consensus       513 ~~f~~~~-~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~  585 (834)
                      ++|+++. .||+|+||+||+|+.. +++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    +...+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            6798875 5999999999999874 6899999999643     4567899887655 89999999999875    45789


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC---CCCeeecccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA  662 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~vkl~DFGla  662 (834)
                      +|||||++|+|.+++.+. ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999643 2346899999999999999999999988   999999999999985   567999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      +......   ......||+.|||||++.+..|+.++|||||||+||||+||+.||.........  ..........    
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~~~~~i~~~----  232 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMG----  232 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC----
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HHHHHHHhcC----
Confidence            8765432   234467999999999999999999999999999999999999999754322110  0000000000    


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ............+..+.+|+..||+.||++|||+.|+++
T Consensus       233 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 --QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              011112233445677899999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=378.89  Aligned_cols=269  Identities=21%  Similarity=0.280  Sum_probs=202.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|+++++||+|+||+||+|+.. +|+.||||+++...  ....+++.+|++++++++|||||++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999974 68999999996543  2345789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      |+.++.+......  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9986655444322  3456899999999999999999999988   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccCcccccCCC-CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccc---------ccccccccccc-
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL---------LGHAWNLWKDN-  738 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~-  738 (834)
                        .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+......         ....+...... 
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              2233457999999999987765 5789999999999999999999997543211000         00000000000 


Q ss_pred             ccccccCcccc---chhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhcc
Q 003287          739 RAYELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  788 (834)
Q Consensus       739 ~~~~l~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~  788 (834)
                      ...........   ..........+.+|+.+||+.||++|||++|+++-  |.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00000000000   11112334577889999999999999999999984  5555

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.3e-44  Score=390.64  Aligned_cols=248  Identities=23%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccC---hhhHHHHH---HHHHHHhccCCCceeeEeeeEeecCeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFK---NEMMLIAKLQHRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~  585 (834)
                      ++|++++.||+|+||.||+|+.. +|+.||||++.+..   ......+.   +|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999975 58999999986432   12223333   4577788889999999999999999999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      +||||+++|+|.+++.+   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999953   356889999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccccc
Q 003287          666 CGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  744 (834)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  744 (834)
                      ...    ......||+.|||||++.. ..++.++|||||||+||||++|+.||...........      ......   .
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------~~~~~~---~  224 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI------DRMTLT---M  224 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH------HHHSSS---C
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhccc---C
Confidence            433    2334579999999999975 5689999999999999999999999976443221100      000000   0


Q ss_pred             CccccchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          745 SPALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       745 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                      ...    .+...+..+.+|+..||+.||++|||     ++|+++
T Consensus       225 ~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCC----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCC----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            000    11123356788999999999999999     688875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=380.49  Aligned_cols=259  Identities=23%  Similarity=0.267  Sum_probs=195.3

Q ss_pred             ccceecccCccceEeeEec-CCcEEEEEEecccChh-----hHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          517 MQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       517 ~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      .+++||+|+||+||+|+.. +|+.||||+++.....     ..+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999975 5899999998654221     134688999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      ++++++..++.   ....+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            99988776663   3456888999999999999999999988   9999999999999999999999999998764432 


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc--------ccccccccccc-
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------GHAWNLWKDNR-  739 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~--------~~~~~~~~~~~-  739 (834)
                       .......||+.|+|||++... .++.++|||||||++|||++|..||......+. ...        ...+....... 
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence             222345789999999998754 689999999999999999999999875442211 000        00000000000 


Q ss_pred             --cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          740 --AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       740 --~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                        ....................+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence              00000000001111223456889999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-44  Score=385.92  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=202.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc---ChhhHHHHHHHHHHHh-ccCCCceeeEeeeEeecCeEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV  587 (834)
                      ++|++++.||+|+||+||+|+.. +++.||||++++.   .....+.+..|..++. .++|||||++++++.+++..+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999975 5899999999753   2334566777777765 68999999999999999999999


Q ss_pred             EEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccC
Q 003287          588 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  667 (834)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~  667 (834)
                      |||+++|+|.+++..   ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999953   346889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccccccCcc
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  747 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  747 (834)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..    ....+      .+.
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~----~i~~~------~~~  221 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FH----SIRMD------NPF  221 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC------CCC
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--HH----HHHcC------CCC
Confidence            22  233446799999999999999999999999999999999999999976443221  00    00011      111


Q ss_pred             ccchhHHHHHHHHHHHHhcccccCcCCCCCHH-HHHH
Q 003287          748 LQHEASYQMLNRYITVALLCVQEKAADRPTMS-KVVS  783 (834)
Q Consensus       748 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~  783 (834)
                      .    +...+..+.+|+.+||+.||++||++. |+++
T Consensus       222 ~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1    112345678999999999999999996 6754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.4e-43  Score=373.68  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             cCccccceecccCccceEeeEecCCcEEEEEEecccC--hhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|+++++||+|+||+||+|+..+|+.||||++....  ....+.+.+|+.+|++++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999889999999996543  33457899999999999999999999999999999999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCCc
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  670 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~~  670 (834)
                      +.++.+..+..   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            99888877763   3467999999999999999999999987   9999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-cc-----c---ccccc----ccc
Q 003287          671 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL-----L---GHAWN----LWK  736 (834)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~-----~---~~~~~----~~~  736 (834)
                       .......+++.|+|||.+.+. .++.++|||||||+++||++|+.||......+. ..     .   ...+.    ...
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence             223344689999999999764 578999999999999999999999975432111 00     0   00000    000


Q ss_pred             ccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          737 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       737 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .........+.............+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000001111111122223456789999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=372.81  Aligned_cols=264  Identities=25%  Similarity=0.349  Sum_probs=196.7

Q ss_pred             ccCccccceecccCccceEeeEec-C-CcEEEEEEecccC--hhhHHHHHHHHHHHhcc---CCCceeeEeeeEee----
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-N-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVE----  580 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----  580 (834)
                      .++|+++++||+|+||+||+|+.. + ++.||||+++...  ......+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999874 4 6679999986542  22233456677776665   79999999999863    


Q ss_pred             -cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccc
Q 003287          581 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  659 (834)
Q Consensus       581 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DF  659 (834)
                       ....+++|||++++.+......  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             3468999999999877655432  3456889999999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc----c-cccc
Q 003287          660 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----G-HAWN  733 (834)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~----~-~~~~  733 (834)
                      |+++.....   .......||+.|||||++.+..|+.++||||+||++|||++|+.||........ ...    . ....
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            999865322   233456799999999999999999999999999999999999999976542211 000    0 0000


Q ss_pred             cccc-----cccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          734 LWKD-----NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       734 ~~~~-----~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                      .+..     ........+...........+.+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000     0000000000011112223456778999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=367.62  Aligned_cols=239  Identities=21%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccCh------hhHHHHHHHHHHHhccC--CCceeeEeeeEeecCe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGE  583 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~  583 (834)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.+...      ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999975 689999999865321      12244678999999996  8999999999999999


Q ss_pred             EEEEEEecCC-CCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCC-CCeeeccccc
Q 003287          584 KILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGM  661 (834)
Q Consensus       584 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~vkl~DFGl  661 (834)
                      .++||||+.+ +++.+++.   ....+++.++..++.||++||+|||+.+   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 57777773   3356899999999999999999999988   9999999999999854 7999999999


Q ss_pred             cccccCCCcccccccccccccccCcccccCCCC-CccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccc
Q 003287          662 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  740 (834)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  740 (834)
                      |+.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....    ..       . .. 
T Consensus       158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~-------~-~~-  220 (273)
T d1xwsa_         158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----II-------R-GQ-  220 (273)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HH-------H-CC-
T ss_pred             ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----Hh-------h-cc-
Confidence            9865332    2334679999999999987765 6779999999999999999999874221    00       0 00 


Q ss_pred             ccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          741 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       741 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       ....+        ..+..+.+|+.+||+.||++|||++|+++
T Consensus       221 -~~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 -VFFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -CCCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -cCCCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             00111        12346788999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-42  Score=367.44  Aligned_cols=276  Identities=19%  Similarity=0.264  Sum_probs=206.0

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCcee-eEeeeEeecCeEEEEEEe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCCVEQGEKILIYEY  590 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey  590 (834)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....  .+++..|++++++++|+|++ .+..+..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999874 589999999875432  24578899999999876654 555666778889999999


Q ss_pred             cCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEc---CCCCeeeccccccccccC
Q 003287          591 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCG  667 (834)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~vkl~DFGla~~~~~  667 (834)
                      +++ +|...+..  ....+++..+..++.|+++||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            954 45444432  2346899999999999999999999988   99999999999985   456799999999998754


Q ss_pred             CCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccccccccccccccccccc
Q 003287          668 DELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  742 (834)
Q Consensus       668 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  742 (834)
                      ....     .......||+.|||||++.+..++.++|||||||++|||++|+.||.............   .....   .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~---~~~~~---~  232 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE---RISEK---K  232 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH---HHHHH---H
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH---Hhhcc---c
Confidence            3321     22345679999999999999999999999999999999999999997654322111000   00000   0


Q ss_pred             ccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCcccccc
Q 003287          743 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR  804 (834)
Q Consensus       743 l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~  804 (834)
                      ...+  .......++..+.+++..||+.+|++||+++++.+.|+.+........+..|.|..
T Consensus       233 ~~~~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~  292 (299)
T d1ckia_         233 MSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  292 (299)
T ss_dssp             HHSC--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred             CCCC--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence            0000  01111233466888999999999999999999999998875544444555566644

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.9e-42  Score=364.07  Aligned_cols=276  Identities=17%  Similarity=0.219  Sum_probs=214.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCC-CceeeEeeeEeecCeEEEEEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  589 (834)
                      .++|+++++||+|+||+||+|+.. +|+.||||++.....  ...+.+|++++..++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999975 589999999865432  2457788999999965 899999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcC-----CCCeeecccccccc
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARM  664 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~-----~~~vkl~DFGla~~  664 (834)
                      |+ +++|.+++...  ...+++.++..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 68888887532  346899999999999999999999988   999999999999974     57899999999998


Q ss_pred             ccCCCcc-----cccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccc
Q 003287          665 FCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  739 (834)
Q Consensus       665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  739 (834)
                      +......     .......||+.|||||++.+..++.++|||||||++|||++|+.||...........   ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~---~~~i~~~~  232 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK---YERIGEKK  232 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH---HHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH---HHHHHhcc
Confidence            6543211     223346799999999999999999999999999999999999999976443211100   00000000


Q ss_pred             cccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHHhhcccCCCCCCCCCccccc
Q 003287          740 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYA  803 (834)
Q Consensus       740 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~  803 (834)
                      .  ..   ...+.....+..+.+++..|++.+|++||+++.+.+.|+++..+.....+..|.|.
T Consensus       233 ~--~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~  291 (293)
T d1csna_         233 Q--ST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  291 (293)
T ss_dssp             H--HS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             C--CC---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence            0  00   00111122345688899999999999999999999999887666666666566553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=360.92  Aligned_cols=267  Identities=22%  Similarity=0.348  Sum_probs=197.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee--------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--------  580 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------  580 (834)
                      .++|+++++||+|+||+||+|+.. +|+.||||++...  .....+++.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999975 6999999998654  23345778999999999999999999999865        


Q ss_pred             cCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccc
Q 003287          581 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  660 (834)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFG  660 (834)
                      ....++||||++++.+..+.   .....++...+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34689999999988776555   23456889999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcc--cccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc--------
Q 003287          661 MARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------  728 (834)
Q Consensus       661 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~--------  728 (834)
                      +++.+......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99876543321  222335799999999999765 689999999999999999999999975442211 000        


Q ss_pred             ccccccccccccccccC------ccccch-hHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          729 GHAWNLWKDNRAYELLS------PALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       729 ~~~~~~~~~~~~~~l~~------~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                      ...+.............      +..... ........+.+|+.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000011111111100      000000 011223466789999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-41  Score=368.01  Aligned_cols=264  Identities=23%  Similarity=0.271  Sum_probs=196.1

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecC------
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  582 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  582 (834)
                      .++|+++++||+|+||+||+|+.. +|+.||||+++..  .....+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            368999999999999999999975 5999999999754  3345678899999999999999999999998665      


Q ss_pred             eEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeecccccc
Q 003287          583 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  662 (834)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla  662 (834)
                      ..++||||+ +.+|..++.    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            579999999 556766663    346999999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-ccc--------ccc
Q 003287          663 RMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLG--------HAW  732 (834)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~--------~~~  732 (834)
                      +....     ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..... ...        ..+
T Consensus       169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            87533     23346789999999998764 5789999999999999999999999765422110 000        000


Q ss_pred             cccccc-------ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH--hhccc
Q 003287          733 NLWKDN-------RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEH  789 (834)
Q Consensus       733 ~~~~~~-------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~  789 (834)
                      ......       ...+.....+ ..........+.+|+.+||+.||++|||+.|+++-  |+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            000000       0000000000 01111223457789999999999999999999984  55553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-41  Score=365.43  Aligned_cols=266  Identities=20%  Similarity=0.234  Sum_probs=197.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEecccC-hhhHHHHHHHHHHHhccCCCceeeEeeeEeecC----eEE
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKI  585 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~  585 (834)
                      +++|+++++||+|+||+||+|+.. +|+.||||++.+.. ....+.+++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            367999999999999999999864 69999999997543 345678999999999999999999999987653    345


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  665 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~  665 (834)
                      ++++|+.+|+|.+++..    ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            56677789999999943    35899999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCc-ccccccccccccccCccccc-CCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cccccccccc------
Q 003287          666 CGDEL-QGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGHAWNLWK------  736 (834)
Q Consensus       666 ~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~------  736 (834)
                      ..... ........||+.|+|||++. +..++.++||||+||+++||++|+.||......... ..........      
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            44322 22234567999999999985 456789999999999999999999999764421110 0000000000      


Q ss_pred             -----ccc-cccccCccc--cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          737 -----DNR-AYELLSPAL--QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       737 -----~~~-~~~l~~~~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                           ... .........  ..........++.+|+.+||+.||++|||++|+++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 000 000000000  001111223467899999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-41  Score=367.29  Aligned_cols=261  Identities=21%  Similarity=0.255  Sum_probs=194.1

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccCCCceeeEeeeEeec------CeEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GEKI  585 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~  585 (834)
                      .+|+.+++||+|+||+||+|+.. +|+.||||++.....    .+.+|+.+|++++||||+++++++...      ...+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            36889999999999999999985 589999999976432    234799999999999999999998643      3478


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-Ceeecccccccc
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARM  664 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~  664 (834)
                      |||||++++.+..+.........+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999987755444332234457899999999999999999999987   99999999999999775 899999999987


Q ss_pred             ccCCCcccccccccccccccCcccccC-CCCCccCCeeeHHHHHHHHhhCCCCCCCCCcccc-ccc-----ccccccc--
Q 003287          665 FCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-----GHAWNLW--  735 (834)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~-----~~~~~~~--  735 (834)
                      +.....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...     ......+  
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            644332   233578999999998875 4689999999999999999999999976542211 000     0000000  


Q ss_pred             -----cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          736 -----KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       736 -----~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                           ........................+.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 000000000000000111123446788999999999999999999996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-40  Score=353.02  Aligned_cols=263  Identities=20%  Similarity=0.249  Sum_probs=202.6

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeecCeEEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      ++|+++++||+|+||+||+|+.. +++.||||+++..  .....+++.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 6889999998654  23456789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccccccCCC
Q 003287          590 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  669 (834)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~~~~~~  669 (834)
                      ++.+++|..++..   ...+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999999888743   356789999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccCcccccCCC-CCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccc----------cccccc---
Q 003287          670 LQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG----------HAWNLW---  735 (834)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~---  735 (834)
                      .  ......++..|+|||.+.... ++.++|||||||+++||++|+.|+.........+..          ..+...   
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            2  223345788999999988765 689999999999999999999997433221100000          000000   


Q ss_pred             -cccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          736 -KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       736 -~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                       ........................+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000000000011112223456788999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.8e-40  Score=356.50  Aligned_cols=256  Identities=19%  Similarity=0.283  Sum_probs=196.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeec--CeEEEEE
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKILIY  588 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~  588 (834)
                      ++|+++++||+|+||+||+|+.. +++.||||+++...   .+++.+|+.+|.+++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999999974 68999999997543   467889999999995 99999999998744  5689999


Q ss_pred             EecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCC-CeeeccccccccccC
Q 003287          589 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCG  667 (834)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~vkl~DFGla~~~~~  667 (834)
                      ||+++++|..+.      +.+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      35899999999999999999999998   99999999999998655 599999999987643


Q ss_pred             CCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccc--------c------
Q 003287          668 DELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA--------W------  732 (834)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------~------  732 (834)
                      ..   ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..............        .      
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            32   23445789999999998865 479999999999999999999999875443211000000        0      


Q ss_pred             --------ccccccccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH
Q 003287          733 --------NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  783 (834)
Q Consensus       733 --------~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~  783 (834)
                              ...........................+.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    000000000000000111112223456788999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-40  Score=358.87  Aligned_cols=264  Identities=23%  Similarity=0.264  Sum_probs=197.9

Q ss_pred             ccCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEeec-----Ce
Q 003287          512 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  583 (834)
Q Consensus       512 ~~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  583 (834)
                      .++|+++++||+|+||+||+|+.. +|+.||||++++.  .....+++.+|+.+|++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999864 6999999999754  234456789999999999999999999998643     34


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .+++++|+.+|+|.+++..    +.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5777888899999999843    45999999999999999999999988   9999999999999999999999999997


Q ss_pred             cccCCCcccccccccccccccCcccccCC-CCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc-cccc-----c---cc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGH-----A---WN  733 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~~-----~---~~  733 (834)
                      ...     .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..... ....     .   ..
T Consensus       170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            642     223345789999999987765 4688999999999999999999999765422110 0000     0   00


Q ss_pred             ccccc-------ccccccCccccchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHH--Hhhcc
Q 003287          734 LWKDN-------RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS--MITNE  788 (834)
Q Consensus       734 ~~~~~-------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~  788 (834)
                      .....       ...+.....+ ..........+.+|+.+||+.||++|||+.|+++  .|.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hccchhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            00000       0000000000 0011123456788999999999999999999997  45544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-40  Score=354.06  Aligned_cols=252  Identities=24%  Similarity=0.314  Sum_probs=199.8

Q ss_pred             cCccccceecccCccceEeeEec----CCcEEEEEEecccC----hhhHHHHHHHHHHHhccCC-CceeeEeeeEeecCe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGE  583 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~  583 (834)
                      ++|++++.||+|+||+||+|+..    +|+.||||++++..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999752    47899999986532    2345678899999999976 899999999999999


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||+.+|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999843   345778899999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccCcccccCC--CCCccCCeeeHHHHHHHHhhCCCCCCCCCcccccccccccccccccccc
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  741 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  741 (834)
                      .+...... ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.........  ..   ... ....
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~---i~~-~~~~  250 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AE---ISR-RILK  250 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HH---HHH-HHHH
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH---HHH-hccc
Confidence            76433322 23346799999999999765  4788999999999999999999999765432210  00   000 0000


Q ss_pred             cccCccccchhHHHHHHHHHHHHhcccccCcCCCCC-----HHHHHH
Q 003287          742 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  783 (834)
Q Consensus       742 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~  783 (834)
                        ..+.    .+...+..+.+++..||+.||++||+     ++|+++
T Consensus       251 --~~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 --SEPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --CCCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence              0011    11234467888999999999999994     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-39  Score=354.55  Aligned_cols=260  Identities=23%  Similarity=0.229  Sum_probs=192.7

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhccCCCceeeEeeeEee------cCe
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QGE  583 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  583 (834)
                      ++|+++++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999976 5999999999754  33455678999999999999999999999964      368


Q ss_pred             EEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeeccccccc
Q 003287          584 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  663 (834)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~  663 (834)
                      .++||||+.++.+..+.      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999876655432      34789999999999999999999998   9999999999999999999999999988


Q ss_pred             cccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc------cccccccccc-
Q 003287          664 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN------LLGHAWNLWK-  736 (834)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~------~~~~~~~~~~-  736 (834)
                      .....   .......+|+.|+|||++.+..+++++||||+||+++||++|+.||...+.....      +.......+. 
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            65432   2334457899999999999999999999999999999999999998754321100      0000000000 


Q ss_pred             ----------------ccccccccCccc---cchhHHHHHHHHHHHHhcccccCcCCCCCHHHHHHH
Q 003287          737 ----------------DNRAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  784 (834)
Q Consensus       737 ----------------~~~~~~l~~~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~  784 (834)
                                      ............   ...........+.+|+.+||+.||++|||++|+++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            000011111111   122344567788999999999999999999999854

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-35  Score=324.03  Aligned_cols=262  Identities=19%  Similarity=0.236  Sum_probs=191.9

Q ss_pred             cCccccceecccCccceEeeEec-CCcEEEEEEecccChhhHHHHHHHHHHHhccC-----------CCceeeEeeeEee
Q 003287          513 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLMGCCVE  580 (834)
Q Consensus       513 ~~f~~~~~lG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~  580 (834)
                      .+|+++++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999975 69999999997642 33467788999888875           5789999988865


Q ss_pred             c--CeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcCCCC----
Q 003287          581 Q--GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMN----  653 (834)
Q Consensus       581 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~----  653 (834)
                      .  ...+++++++..+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            4  4667778777666544443333455678899999999999999999998 55   999999999999987654    


Q ss_pred             --eeeccccccccccCCCcccccccccccccccCcccccCCCCCccCCeeeHHHHHHHHhhCCCCCCCCCccccc----c
Q 003287          654 --PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN----L  727 (834)
Q Consensus       654 --vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltg~~p~~~~~~~~~~----~  727 (834)
                        +|++|||.+.....     ......||+.|+|||++.+..++.++||||+||+++||++|+.||...+.....    .
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              89999999986532     223457999999999999999999999999999999999999998754321100    0


Q ss_pred             c-------ccc-cccc----------cccccccccCcc----------ccchhHHHHHHHHHHHHhcccccCcCCCCCHH
Q 003287          728 L-------GHA-WNLW----------KDNRAYELLSPA----------LQHEASYQMLNRYITVALLCVQEKAADRPTMS  779 (834)
Q Consensus       728 ~-------~~~-~~~~----------~~~~~~~l~~~~----------l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  779 (834)
                      .       ... ...+          ........+...          ............+.+|+..||+.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            0       000 0000          000000000000          01112345677899999999999999999999


Q ss_pred             HHHH
Q 003287          780 KVVS  783 (834)
Q Consensus       780 evl~  783 (834)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=2.5e-22  Score=198.94  Aligned_cols=164  Identities=17%  Similarity=0.172  Sum_probs=121.7

Q ss_pred             cccceecccCccceEeeEecCCcEEEEEEecccC------------------hhhHHHHHHHHHHHhccCCCceeeEeee
Q 003287          516 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS------------------GQGLKEFKNEMMLIAKLQHRNLVRLMGC  577 (834)
Q Consensus       516 ~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~~~  577 (834)
                      .+.++||+|+||+||+|+..+|+.||||+++...                  ......+..|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999999889999999875321                  0112345678899999999999988765


Q ss_pred             EeecCeEEEEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEEcCCCCeeec
Q 003287          578 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  657 (834)
Q Consensus       578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~vkl~  657 (834)
                      .    ..+++|||+++..+..+          +......++.|++++|+|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    23799999988766432          23445689999999999999988   9999999999999865 48999


Q ss_pred             cccccccccCCCcccccccccccccccCc------ccccCCCCCccCCeeeHHHHHH
Q 003287          658 DFGMARMFCGDELQGNTKRVVGTYGYMSP------EYALDGLFSVKSDVFSFGVLLL  708 (834)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~ksDVwSlGvil~  708 (834)
                      |||+|........          ..|...      | ...+.|+.++|+||..--++
T Consensus       145 DFG~a~~~~~~~~----------~~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGW----------REILERDVRNIIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTH----------HHHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCc----------HHHHHHHHHHHHH-HHcCCCCCcccHHHHHHHHh
Confidence            9999976532211          011111      1 12356788999999765443

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.84  E-value=4.6e-21  Score=171.57  Aligned_cols=112  Identities=22%  Similarity=0.401  Sum_probs=96.0

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      +|||.|||.|..|++|+|  |.|+|.|+.+|+     |.|+.   ..++||.||++.|  ...+.|.|+.||+|||+|. 
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~-   67 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG-   67 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence            599999999999999985  999999999887     66755   5799999999987  3456899999999999986 


Q ss_pred             CCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCc
Q 003287          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSD  155 (834)
Q Consensus       105 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtD  155 (834)
                      +.++|++++........|+|+|+|||||++.      .+.++|||+.+|+|
T Consensus        68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~------~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNVGN  112 (112)
T ss_dssp             TEEEEECCCCCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCCCC
T ss_pred             CCeEEEEeeccCCCceEEEEcCCCCEEEECC------CCcEEecCCCccCC
Confidence            5678888776555566889999999999985      56799999999986

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.82  E-value=1.5e-20  Score=166.53  Aligned_cols=107  Identities=22%  Similarity=0.343  Sum_probs=93.9

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      +|+|.+||.|..|+.|.  +|.|.|.|+.+||     |.||.   ..++||.||++.|  +..+.|.++.||+|+|+|++
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~   68 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS   68 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred             CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence            48999999999999995  6999999999987     77765   5689999999987  45578999999999999999


Q ss_pred             CCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCC
Q 003287          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (834)
Q Consensus       105 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~  152 (834)
                      |.+||+|++.......+|+|+|+|||||++.         .+||||+|
T Consensus        69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S~t~  107 (108)
T d1jpca_          69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT---------DRWATGTH  107 (108)
T ss_dssp             CCEEEECCCCCSCSCEEEEECTTSCEEEEEC---------CCCCCCCC
T ss_pred             ccceEEccccCCCCcEEEEEcCCCCEEEeCC---------CcccCCCC
Confidence            9999999987665666789999999999963         48999987

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.82  E-value=5.8e-20  Score=162.78  Aligned_cols=108  Identities=19%  Similarity=0.308  Sum_probs=92.2

Q ss_pred             CCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCC
Q 003287           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (834)
Q Consensus        25 ~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  104 (834)
                      .|+|.|||.|.+|++|.+  |.|.|+|...++     |.++.   ..++||+||++.|. ...+.|.|+.||+|||+|++
T Consensus         1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~   69 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE   69 (109)
T ss_dssp             CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred             CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence            378999999999999975  889999998877     55543   56899999999994 45678999999999999999


Q ss_pred             CCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCC
Q 003287          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (834)
Q Consensus       105 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~  152 (834)
                      |.+||+|+++.......|+|+|+|||||++.         .+|||+-|
T Consensus        70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---------~~W~S~t~  108 (109)
T d1kj1a_          70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---------DIWSTGTY  108 (109)
T ss_dssp             SCEEEECCCCCCSSCCEEEECTTSCEEEECC---------EEEECCCC
T ss_pred             CcEEEEEeeECCCCCEEEEEeCCCcEEEECC---------CEecCCCc
Confidence            9999999987555556789999999999853         59999864

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.64  E-value=1.3e-16  Score=143.31  Aligned_cols=101  Identities=22%  Similarity=0.302  Sum_probs=86.4

Q ss_pred             EEEEeec-CCeeEEeeCCCCCCcCCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCC
Q 003287           63 GIWYKQV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTS  141 (834)
Q Consensus        63 ~iw~~~~-~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~  141 (834)
                      -|||.++ .++.+|++|++.|+......|.|+.||||||++. +.++|++++.+.+....|.|+++|||||++.      
T Consensus        11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~------   83 (120)
T d1dlpa2          11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN------   83 (120)
T ss_dssp             EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET------
T ss_pred             eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC------
Confidence            6899887 5699999999999988888999999999999986 6789999987776677899999999999985      


Q ss_pred             CCceEEeecCCCCcccccCCccccccccCcceeeEeeccCCCCCCCceEEEeecCCcceE
Q 003287          142 EGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHL  201 (834)
Q Consensus       142 ~~~~~WqSFd~PtDtlLpg~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~  201 (834)
                      .++++||||.                               +.++|.|.+.++++|...+
T Consensus        84 ~~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl  112 (120)
T d1dlpa2          84 QNIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI  112 (120)
T ss_dssp             TTEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred             CCCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence            6789999973                               3467889999999987654

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.58  E-value=6.5e-15  Score=131.59  Aligned_cols=103  Identities=15%  Similarity=0.355  Sum_probs=83.8

Q ss_pred             CCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCCC
Q 003287           26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTD  105 (834)
Q Consensus        26 d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~  105 (834)
                      ++|.++|+|    .+.+..|.|.|.|...||     |.+ |+  ..++||.||+..|  +..+.|.|..||+|+|.|++|
T Consensus        15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g   80 (119)
T d1b2pa_          15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNEN   80 (119)
T ss_dssp             CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTC
T ss_pred             CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCC
Confidence            466666655    346789999999999988     555 33  5789999999876  345789999999999999999


Q ss_pred             CeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecC
Q 003287          106 GIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFD  151 (834)
Q Consensus       106 ~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd  151 (834)
                      .+||++++.+......++|+|+|||||++.         ++|||-.
T Consensus        81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~---------~~W~S~T  117 (119)
T d1b2pa_          81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---------ALWATQT  117 (119)
T ss_dssp             CEEEECSCCCCSSCEEEEECTTSCEEEEES---------EEEECCC
T ss_pred             cEEEECCCcCCCCceEEEEcCCCCEEEECC---------CEeccCC
Confidence            999999987665556789999999999853         6999854

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.47  E-value=9.5e-15  Score=129.54  Aligned_cols=109  Identities=24%  Similarity=0.288  Sum_probs=87.6

Q ss_pred             EEEeec-CCeeEEeeCCCCCCcCCCceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCC
Q 003287           64 IWYKQV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSE  142 (834)
Q Consensus        64 iw~~~~-~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~  142 (834)
                      |||.-. ..+..|+.+.++++.+...+|.|+.||||||++ .+.++|++++.+. ....|.|+++|||||++.      .
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~------~   74 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTA------Q   74 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCT------T
T ss_pred             EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEcc------C
Confidence            555432 457779999999998888899999999999998 4688999998653 456789999999999975      6


Q ss_pred             CceEEeecCCCCcccccCCccccccccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecC
Q 003287          143 GSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (834)
Q Consensus       143 ~~~~WqSFd~PtDtlLpg~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~  215 (834)
                      +.+||||+-                               +.++|.|.+.++++|...  +|.  .++|.+|.
T Consensus        75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY~--~~~Wssgt  112 (115)
T d1dlpa1          75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IYG--PGLWDSGT  112 (115)
T ss_dssp             TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EEC--SEEEECSC
T ss_pred             CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--EeC--CCeecCCC
Confidence            678999862                               346899999999999854  453  47898875

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.36  E-value=6.4e-13  Score=117.56  Aligned_cols=99  Identities=24%  Similarity=0.361  Sum_probs=78.6

Q ss_pred             CCCCcCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecC
Q 003287           24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQ  103 (834)
Q Consensus        24 ~~d~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~  103 (834)
                      +.+||.++|      .|  .+|.|.|.|...|+     |.|+.   ..++||.+|...   ...+.+.|..||+|||+|.
T Consensus        13 ~~~tl~~~~------~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~   73 (115)
T d1dlpa1          13 HPQTLHAAQ------SL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAG---ATGCRAVLQSDGLLVILTA   73 (115)
T ss_dssp             SCSCCCTTC------EE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCT
T ss_pred             CcceecCCC------cE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCC---CCceEEEEeccCCEEEEcc
Confidence            445555555      44  46779999999888     77754   468899999754   3457899999999999999


Q ss_pred             CCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeec
Q 003287          104 TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSF  150 (834)
Q Consensus       104 ~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSF  150 (834)
                      ++.+||++++.......+++|+++|||||++         ..+|+|-
T Consensus        74 ~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssg  111 (115)
T d1dlpa1          74 QNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---------PGLWDSG  111 (115)
T ss_dssp             TTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---------SEEEECS
T ss_pred             CCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---------CCeecCC
Confidence            9999999998766566678999999999984         2699984

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.08  E-value=9.7e-11  Score=104.38  Aligned_cols=98  Identities=20%  Similarity=0.322  Sum_probs=73.2

Q ss_pred             CcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEeeCCCCCCcCCCceEEEecCCceEEecCCCCeEEe
Q 003287           31 ATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWS  110 (834)
Q Consensus        31 ~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws  110 (834)
                      .+.|..++.|  ..|.|.|.|-..|+     |.|+.   ...+||.+|...  .+..+.+.|..+|||||+|.++.++|+
T Consensus        23 ~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~   90 (120)
T d1dlpa2          23 PQTLHATQSL--QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWT   90 (120)
T ss_dssp             CCEECSSCCC--BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred             ccEEcCCCee--EcCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence            3444444444  24668888877766     55542   467889998543  355678999999999999999999999


Q ss_pred             ecCCcccccceEEEecCCceEEEeccCCCCCCCceEEee
Q 003287          111 SNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (834)
Q Consensus       111 t~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqS  149 (834)
                      |++........++|+++|||||++.         .+|.|
T Consensus        91 S~t~~~~~~~~l~Lq~DGnlvlY~~---------~~W~t  120 (120)
T d1dlpa2          91 SGNSRSAGRYVFVLQPDRNLAIYGG---------ALWTT  120 (120)
T ss_dssp             CCCCCSSSCCEEEECSSSCEEEECC---------CCCBC
T ss_pred             eCCCCCCCcEEEEECCCCcEEEeCC---------CcccC
Confidence            9987655566789999999999842         57875

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.96  E-value=1.1e-09  Score=95.65  Aligned_cols=76  Identities=24%  Similarity=0.368  Sum_probs=60.1

Q ss_pred             ceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCcccccc
Q 003287           88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL  167 (834)
Q Consensus        88 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~  167 (834)
                      -+|.+..||||||++. +.+||++++.+.+....+.|+++|||||++.      .+.++|+|                  
T Consensus        21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~------~g~~vWsS------------------   75 (108)
T d1jpca_          21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP------SNKPIWAS------------------   75 (108)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEEC------------------
T ss_pred             EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECC------CccceEEc------------------
Confidence            3588999999999974 5789999987776667889999999999985      67899986                  


Q ss_pred             ccCcceeeEeeccCCCCCCCceEEEeecCCcceE
Q 003287          168 KTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHL  201 (834)
Q Consensus       168 ~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~  201 (834)
                                   ....+++.|.+.++.+|...+
T Consensus        76 -------------~t~~~~~~~~l~L~ddGNlVl   96 (108)
T d1jpca_          76 -------------NTGGQNGNYVCILQKDRNVVI   96 (108)
T ss_dssp             -------------CCCCSCSCEEEEECTTSCEEE
T ss_pred             -------------cccCCCCcEEEEEcCCCCEEE
Confidence                         111245678889998886554

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.90  E-value=3.5e-09  Score=93.75  Aligned_cols=85  Identities=25%  Similarity=0.308  Sum_probs=66.0

Q ss_pred             eEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCccccccc
Q 003287           89 VLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLK  168 (834)
Q Consensus        89 ~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~~  168 (834)
                      .|.+..||||||+++ +.++|++++.+......+.|.++|||||++.      .+.++|+|.                  
T Consensus        33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~------~g~~vWsS~------------------   87 (119)
T d1b2pa_          33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN------ENVTVWQSP------------------   87 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEECS------------------
T ss_pred             EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC------CCcEEEECC------------------
Confidence            588999999999875 5689999987766667889999999999985      678899852                  


Q ss_pred             cCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecC
Q 003287          169 TGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (834)
Q Consensus       169 tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~  215 (834)
                                   ..-+.|.|.+.++++|...+  |.  .+.|.++.
T Consensus        88 -------------t~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T  117 (119)
T d1b2pa_          88 -------------VAGKAGHYVLVLQPDRNVVI--YG--DALWATQT  117 (119)
T ss_dssp             -------------CCCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred             -------------CcCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence                         11135678899999987665  43  36887764

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.77  E-value=3.3e-08  Score=86.09  Aligned_cols=87  Identities=28%  Similarity=0.405  Sum_probs=64.2

Q ss_pred             ceEEEecCCceEEecCCCCeEEeecCCccc-ccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCccccc
Q 003287           88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREV-KNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (834)
Q Consensus        88 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~  166 (834)
                      -.|.|..||||||++ .+.+||++|+...+ ....+.|.++|||||++.      .+.++|+|                 
T Consensus        21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~s-----------------   76 (109)
T d1kj1a_          21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA------EGRSLWAS-----------------   76 (109)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS------SSCEEEEC-----------------
T ss_pred             EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC------CCcEEEEE-----------------
Confidence            458889999999986 56789999986443 345689999999999985      67889986                 


Q ss_pred             cccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecCC
Q 003287          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW  216 (834)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w  216 (834)
                                    ....+.|.|.+.++++|...+  +.  ..+|.|+.+
T Consensus        77 --------------~t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~  108 (109)
T d1kj1a_          77 --------------HSVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY  108 (109)
T ss_dssp             --------------CCCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred             --------------eeECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence                          111134678899999987654  43  357877653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=2e-07  Score=94.74  Aligned_cols=149  Identities=18%  Similarity=0.124  Sum_probs=105.5

Q ss_pred             HHHHhccCccccceecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEE
Q 003287          507 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKI  585 (834)
Q Consensus       507 ~~~~~~~~f~~~~~lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~  585 (834)
                      ++....+.|+..+..+-++...||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555567787766655455578998865 56678899887654444456778888887773 445677888888889999


Q ss_pred             EEEEecCCCCchhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 003287          586 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY----------------------------------  631 (834)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------  631 (834)
                      +||+++++..+.+.....        .....++.++++.++.||+.                                  
T Consensus        87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998886554221        11234555666666666642                                  


Q ss_pred             ----------------------CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          632 ----------------------SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       632 ----------------------~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                                            ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  112379999999999999877677999998864

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.44  E-value=6.5e-07  Score=78.24  Aligned_cols=90  Identities=22%  Similarity=0.351  Sum_probs=65.6

Q ss_pred             CceEEEecCCceEEecCCCCeEEeecCCcccccceEEEecCCceEEEeccCCCCCCCceEEeecCCCCcccccCCccccc
Q 003287           87 NAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (834)
Q Consensus        87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~  166 (834)
                      .-.|.|..||||||++ .+.+||++++.+...+..++|..+|||||++.       ++.+|.|                 
T Consensus        20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-------~~~~w~s-----------------   74 (112)
T d1xd5a_          20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-------SRAIWAS-----------------   74 (112)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-------TEEEEEC-----------------
T ss_pred             CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-------CCeEEEE-----------------
Confidence            3468999999999986 56899999987665667789999999999973       3556654                 


Q ss_pred             cccCcceeeEeeccCCCCCCCceEEEeecCCcceEEEEcCCeEEEEecCC
Q 003287          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW  216 (834)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w  216 (834)
                                    ...-..|.|.+.++.+|...++ -....+.|.++.-
T Consensus        75 --------------~t~~~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t~  109 (112)
T d1xd5a_          75 --------------NTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHTN  109 (112)
T ss_dssp             --------------CCCCSCCCCEEEECTTSCEEEE-CTTSCEEEECCCC
T ss_pred             --------------eeccCCCceEEEEcCCCCEEEE-CCCCcEEecCCCc
Confidence                          1122346788999999876543 2234578887653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=2e-05  Score=78.91  Aligned_cols=131  Identities=18%  Similarity=0.170  Sum_probs=88.4

Q ss_pred             eecccCc-cceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccC--CCceeeEeeeEeecCeEEEEEEecCCCCc
Q 003287          520 KLGEGGF-GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGEKILIYEYMPNKSL  596 (834)
Q Consensus       520 ~lG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (834)
                      .+..|.. +.||+....++..+++|.-.....   ..+..|+..++.+.  .-.+.+++.+..+.+..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555554 678999887888899998765432   34566777777663  33467788888888899999999998776


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------------
Q 003287          597 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ----------------------------------------------  630 (834)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~----------------------------------------------  630 (834)
                      .+..        ...   ...+.++++.|+-||+                                              
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        111   1122333444444442                                              


Q ss_pred             -----c----CCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          631 -----Y----SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       631 -----~----~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                           .    .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                 1    122479999999999999877778999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.24  E-value=0.0003  Score=75.13  Aligned_cols=76  Identities=11%  Similarity=0.169  Sum_probs=49.3

Q ss_pred             ceecccCccceEeeEecC-CcEEEEEEeccc-------ChhhHHHHHHHHHHHhcc-CC--CceeeEeeeEeecCeEEEE
Q 003287          519 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-------SGQGLKEFKNEMMLIAKL-QH--RNLVRLMGCCVEQGEKILI  587 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~-g~~vAVK~l~~~-------~~~~~~~~~~E~~~l~~l-~H--~niv~l~~~~~~~~~~~lV  587 (834)
                      +.||.|....||+....+ ++.|+||.-...       ......+...|++.|..+ .+  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            568999999999998765 678999964321       111234455677777766 23  345556554  45567899


Q ss_pred             EEecCCCCc
Q 003287          588 YEYMPNKSL  596 (834)
Q Consensus       588 ~Ey~~~gsL  596 (834)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.68  E-value=0.0014  Score=67.75  Aligned_cols=135  Identities=14%  Similarity=0.127  Sum_probs=78.9

Q ss_pred             cceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCce--eeEe-----eeEeecCeEEEEEEecCCCCchhh
Q 003287          527 GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL--VRLM-----GCCVEQGEKILIYEYMPNKSLNFF  599 (834)
Q Consensus       527 G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~~~  599 (834)
                      -.||+++..+|+.|++|+..... ...+++..|...+..|...++  +..+     .....++..+.+++++++..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999999999999999986542 234667788888887743222  1111     123445678899999987554211


Q ss_pred             ----h--------------c--CCCCCCCCCHH-------------------HHHHHHHHHHHHHHHHhh----cCCCce
Q 003287          600 ----L--------------F--DPSRTHLLGWQ-------------------TRVKIIEGIAQGLLYLHQ----YSRLRI  636 (834)
Q Consensus       600 ----l--------------~--~~~~~~~l~~~-------------------~~~~i~~~ia~~L~yLH~----~~~~~i  636 (834)
                          +              .  .......+++.                   ....+...+.+.++.+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0              0  00111111211                   111122222333333332    223468


Q ss_pred             EecCCCCCcEEEcCCCCeeecccccccc
Q 003287          637 IHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       637 iH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.38  E-value=0.0035  Score=66.49  Aligned_cols=73  Identities=15%  Similarity=0.208  Sum_probs=50.2

Q ss_pred             ceecccCccceEeeEecC--------CcEEEEEEecccChhhHHHHHHHHHHHhccC-CCceeeEeeeEeecCeEEEEEE
Q 003287          519 CKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  589 (834)
Q Consensus       519 ~~lG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  589 (834)
                      +.|+.|-.=.+|+....+        .+.|.+++... .. ......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            578888889999998754        35677777653 22 2345567888888884 4334567777643    68999


Q ss_pred             ecCCCCch
Q 003287          590 YMPNKSLN  597 (834)
Q Consensus       590 y~~~gsL~  597 (834)
                      |+++..|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.55  E-value=0.14  Score=51.50  Aligned_cols=158  Identities=13%  Similarity=0.073  Sum_probs=81.8

Q ss_pred             cHHHHHHhccCccccce-----ecccCccceEeeEecCCcEEEEEEecccChhhHHHHHHHHHHHhccCCCce--eeEee
Q 003287          504 SLASVSAATENFSMQCK-----LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL--VRLMG  576 (834)
Q Consensus       504 ~~~~~~~~~~~f~~~~~-----lG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~  576 (834)
                      +..++.....+|.+.+.     |..|---+.|+.+..+| .+++|+......  .++...|+.++..|.+.++  ...+.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence            34556666667766433     45666677899987665 489999865322  2344456666666643221  11111


Q ss_pred             ------eEeecCeEEEEEEecCCCCchhhh--------------------cCCCCCCCCCHH------------------
Q 003287          577 ------CCVEQGEKILIYEYMPNKSLNFFL--------------------FDPSRTHLLGWQ------------------  612 (834)
Q Consensus       577 ------~~~~~~~~~lV~Ey~~~gsL~~~l--------------------~~~~~~~~l~~~------------------  612 (834)
                            +.........++.+..+.......                    +...........                  
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence                  122345567777777665442211                    000000000000                  


Q ss_pred             HHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEEcCCCCeeecccccccc
Q 003287          613 TRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  664 (834)
Q Consensus       613 ~~~~i~~~ia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~vkl~DFGla~~  664 (834)
                      .....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            111112222222222222 1234699999999999999887778999998853

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.52  E-value=0.043  Score=34.83  Aligned_cols=31  Identities=29%  Similarity=0.690  Sum_probs=25.3

Q ss_pred             CCCccccCCCCCccccCC-CCCccccccccccc
Q 003287          287 NFCQLYGYCGANSVCSVD-DTANCECLKGFKLK  318 (834)
Q Consensus       287 ~~Cd~y~~CG~~g~C~~~-~~~~C~C~~Gf~~~  318 (834)
                      |.|.+-+.|| ||-|+.- ..-.|.|-.||+|.
T Consensus         2 dECsignpCG-nGTCtNviGgFec~C~~GFepg   33 (39)
T d1emoa2           2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG   33 (39)
T ss_dssp             CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred             CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence            6899999998 7899743 34579999999985